000005|N05AX0801|Risperdal|töflur|0,5|mg|20|stk|1|ţpakki|ţp|N05AX08|01.04.2000||R|||0|0|0|0|JAS|0|1|0|100|SEK|1587|3150|lyfalmen|V0045|1588||20|0|2,0000|Vistor hf|Janssen-Cilag AB|Risperídón||1587||1587|3150|
000018|G01AF0501|Pevaryl|krem/sti|||15|g|1|sett|krem+3 stílar|G01AF05|01.05.1978||L|||0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa||||15|0|4,5000|Vistor hf|McNeil Sweden AB|Ekónazól||||||
000054|B03XA0103|NeoRecormon|stl|4000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|||0|1|0|1|ROC|0|0|0|100|DKK|33482|43902|lyfsjukr||||2|0|24,0000|Icepharma hf|Roche|Epóetín||33482||33482|43902|
000145|B03XA0103|NeoRecormon|stl|6000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|||0|1|0|1|ROC|0|0|0|100|DKK|50300|65009|lyfsjukr||||2|0|36,0000|Icepharma hf|Roche|Epóetín||50300||50300|65009|
000153|A02BC0102|Losec|sh-tfl|20|mg|7|stk|1|ţpakki||A02BC01|01.09.2009||L|||0|0|0|0|AZD|0|0|0|100|IKR|||lyflausa||||7|0|7,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól||||||
000159|N05AH0302|Zyprexa Velotab|munndr.t|5|mg|28|stk|1|ţpakki||N05AH03|01.06.2002||R|||0|0|0|0|ELD|0|1|0|100|XEU|10603|15483|lyfalmen|V0457|5147||28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||10603||10603|15483|
000184|N05AH0302|Zyprexa Velotab|munndr.t|15|mg|28|stk|1|ţpakki||N05AH03|01.06.2002||R|||0|0|0|0|ELD|0|1|0|100|XEU|30902|41327|lyfalmen|V0475|20433||28|0|42,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||30902||30902|41327|
000193|N05AH0302|Zyprexa Velotab|munnltfl|20|mg|28|stk|1|ţpakki||N05AH03|01.12.2003||R|||0|0|0|0|ELD|0|1|0|100|XEU|40189|52982|lyfalmen|V0540|31565||28|0|56,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||40189||40189|52982|
000198|N05AH0302|Zyprexa Velotab|munndr.t|10|mg|28|stk|1|ţpakki||N05AH03|01.06.2002||R|||0|0|0|0|ELD|0|1|0|100|XEU|21617|29674|lyfalmen|V0456|11063||28|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||21617||21617|29674|
000223|G02CX0101|Tractocile|stl|7,5|mg/ml|0,9|ml|1|hgl|lausn|G02CX01|01.12.2006||R|||0|1|0|1|FER|0|0|0|100|DKK|5037|7270|lyfsjukr||||1|0|0,0400|Vistor hf|Ferring|Atosíban||5037||5037|7270|
000225|QM01AC0601|Metacam|mixtúra|1,5|mg/ml|100|ml|1|fl||QM01AC06|01.05.2004||R|||0|0|0|0|BOI|0|0|0|100|DKK|7620|14804|vetalmen||||100|0||Vistor hf|Boehringer Ingelheim|||7620||7620|14804|
000237|G02CX0101|Tractocile|irţ|7,5|mg/ml|5|ml|1|hgl|lausn|G02CX01|01.12.2006||R|||0|1|0|1|FER|0|0|0|100|DKK|13493|18816|lyfsjukr||||5|0|0,2300|Vistor hf|Ferring|Atosíban||13493||13493|18816|
000290|G03GA0601|Puregon|stl|300|ae/rörly|0,36|ml|1|pakki||G03GA06|01.02.2002||R|||0|1|E|0|ORG|0|0|0|100|DKK|20294|28014|lyfalmen||||0|0|4,0000|Vistor hf|N.V. Organon|Follitrópín beta||20294||20294|28014|
000316|G03GA0601|Puregon|stl|600|ae/rörly|0,72|ml|1|pakki||G03GA06|01.02.2002||R|||0|1|E|0|ORG|0|0|0|100|DKK|39391|51981|lyfalmen||||1|0|8,0000|Vistor hf|N.V. Organon|Follitrópín beta||39391||39391|51981|
000373|N02CC0402|Maxalt Smelt|munnltfl|10|mg|6|stk|1|ţpakki||N02CC04|01.03.1999||R|||0|0|E|0|MSD|0|0|0|100|DKK|5355|8304|lyfalmen||||6|0|6,0000|Vistor hf|M.S.D.|Rizatriptan||5355||5355|8304|
000390|J01CR0202|Augmentin|sts|600|mg/hgl|10|hgl|1|pakki|500+100 mg|J01CR02|01.01.2000||R|||0|0|0|1|GSK|0|0|0|100|IKR|2534|3657|lyfsjukr||||10|0|1,6700|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||2534||2534|3657|
000402|J01CR0202|Augmentin|sts|1200|mg/hgl|5|hgl|1|pakki|1000+200 mg|J01CR02|01.01.2000||R|||0|0|0|1|GSK|0|0|0|100|IKR|2175|3139|lyfsjukr||||5|0|1,6700|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||2175||2175|3139|
000448|D07AC1301|Elocon|húđlausn|0,1|%|100|ml|1|glas||D07AC13|01.03.2009||R|||0|0|B|0|SPL|0|0|1|100|DKK|3288|5477|lyfalmen||||100|0||Vistor hf|Schering-Plough Europe|Mómetasón||||3288|5477|
000530|J07BF0301|Imovax Polio|bóluefni|||0,5|ml|20|spr|án nála|J07BF03|01.06.2005||R|||0|0|0|0|SPM|0|0|0|100|XEU|27999|37684|lyfalmen||||10|0||Icepharma hf|Sanofi Pasteur MSD|Mćnusótt, dauđ veira||27999||27999|37684|
000548|S01GX0801|Zaditen|augndr|0,25|mg/ml|5|ml|1|glas||S01GX08|01.07.2001||R|||0|0|E|0|LTH|0|0|0|100|SEK|1786|3422|lyfalmen||||5|0||Vistor hf|Laboratoires THEA|Ketotifen||1786||1786|3422|
000552|G04BE0105|Caverject  Dual|sts|20|mcg/lykj|2|lykjur|1|pakki|2ja hólfa lykja|G04BE01|01.03.2002||R|||0|0|0|0|PER|0|0|0|100|DKK|4896|7676|lyfalmen||||2|0|2,0000|Icepharma hf|Pfizer ApS|Alprostadíl||4896||4896|7676|
000555|N03AX1101|Topimax|hylki|15|mg|60|stk|1|plglas||N03AX11|01.05.2001||R|||0|0|E|0|JAS|0|0|0|100|SEK|3637|5954|lyfalmen||||60|0|3,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||3637||3637|5954|
000565|S01GX0801|Zaditen|augndr|0,25|mg/ml|0,4|ml|20|sk-hyl||S01GX08|01.07.2001||L|||0|0|0|0|LTH|0|0|0|100|IKR|||lyflausa||||8|0||Vistor hf|Laboratoires THEA|Ketotifen||||||
000573|S01GX0801|Zaditen|augndr|0,25|mg/ml|0,4|ml|60|sk-hyl||S01GX08|01.07.2001||R|||0|0|E|0|LTH|0|0|0|100|SEK|5303|8233|lyfalmen||||24|0||Vistor hf|Laboratoires THEA|Ketotifen||5303||5303|8233|
000641|B05BA0202|Intralipid 200 mg/ml|irl|200|mg/ml|100|ml|10|fl||B05BA02|01.04.2004||R|||0|0|0|1|FRP|0|0|0|100|DKK|7131|10292|lyfsjukr||||1000|0||Icepharma hf|Fresenius Kabi|Fitusambönd||7131||7131|10292|
000646|C08CA0101|Norvasc|töflur|10|mg|30|stk|1|ţpakki||C08CA01|01.01.1992||R|||0|0|B|0|PER|0|0|0|100|DKK|3086|5200|lyfalmen||||30|0|60,0000|Icepharma hf|Pfizer ApS|Amlódipín||3086||3086|5200|
000784|G04BE0105|Caverject  Dual|sts|10|mcg/lykj|2|lykjur|1|pakki|2ja hólfa lykja|G04BE01|01.03.2002||R|||0|0|0|0|PER|0|0|0|100|DKK|3800|6177|lyfalmen||||2|0|1,0000|Icepharma hf|Pfizer ApS|Alprostadíl||3800||3800|6177|
000801|R06AA0201|Benylan|mixtúra|2,8|mg/ml|125|ml|1|glas||R06AA02|01.05.1999||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||125|0|1,7500|Vistor hf|McNeil Denmark ApS|Dífenhýdramín||||||
000815|R06AA0201|Benylan|mixtúra|1,4|mg/ml|125|ml|1|glas||R06AA02|01.06.2001||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||125|0|0,8750|Vistor hf|McNeil Denmark ApS|Dífenhýdramín||||||
000879|L03AB0702|Rebif|stl|44|mcg/spr|0,5|ml|12|spr|Áfylltar sprautur|L03AB07|01.01.2001||R|||0|1|0|1|MSE|0|0|0|100|SEK|167521|212121|lyfsjukr||||6|0|122,7907|Icepharma hf|Merck Serono Europe Ltd|Interferón beta-1a||167521||167521|212121|
000957|H01AC0101|Genotropin|sts|5|mg|1|rörlyk|1|pakki|tvíhólfa|H01AC01|01.05.2001||R|||0|1|0|1|PER|0|0|0|100|DKK|22512|30135|lyfsjukr||||1|0|7,5000|Icepharma hf|Pfizer ApS|Sómatrópín||22512||22512|30135|
001167|H01CC0101|Orgalutran|stl|0,5|mg/ml|0,5|ml|1|spr||H01CC01|01.05.2001||R|||0|1|0|1|ORG|0|0|0|100|DKK|5745|8291|lyfsjukr||||0|0|1,0000|Vistor hf|N.V. Organon|Ganirelix||5745||5745|8291|
001194|M01AH0101|Celebra|hylki|200|mg|10|stk|1|ţpakki||M01AH01|01.03.2003||R|||0|0|E|0|PER|0|0|1|100|DKK|1466|2984|lyfalmen|V0037|2424||10|0|10,0000|Icepharma hf|Pfizer ApS|Celekoxíb||1466||1466|2984|
001225|C10AA0501|Zarator|töflur|80|mg|30|stk|1|ţpakki||C10AA05|01.06.2002||R|||0|0|0|0|PER|0|0|0|100|DKK|6404|9739|lyfalmen||||30|0|120,0000|Icepharma hf|Pfizer ApS|Atorvastatín||6404||6404|9739|
001239|C10AA0501|Zarator|töflur|80|mg|100|stk|1|ţpakki||C10AA05|01.06.2002||R|||0|0|0|0|PER|0|0|0|100|DKK|21189|29137|lyfalmen|V0115|18735||100|0|400,0000|Icepharma hf|Pfizer ApS|Atorvastatín||21189||21189|29137|
001291|C07AB0206|Seloken ZOC|forđatfl|23,75|mg|100|stk|1|plglas||C07AB02|01.05.2006||R|||0|0|B|0|AZD|0|0|0|100|SEK|2324|4158|lyfalmen||||100|0|15,8300|Vistor hf|AstraZeneca A/S DK|Metóprólól||2324||2324|4158|
001399|H01CC0101|Orgalutran|stl|0,5|mg/ml|0,5|ml|5|spr||H01CC01|01.05.2001||R|||0|1|0|1|ORG|0|0|0|100|DKK|28723|37930|lyfsjukr||||2|0|5,0000|Vistor hf|N.V. Organon|Ganirelix||28723||28723|37930|
001437|N05AH0308|Lazapix|filmhtfl|2,5|mg|28|stk|1|ţpakki||N05AH03|01.10.2011||R|||0|0|*|0|POF|0|1|0|100|XEU|2576|1994|lyfalmen|V0278|1857||28|0|7,0000|Portfarma ehf|Portfarma|Olanzapín||742||742|1994|
001490|A10AD0502|NovoMix 30 Penfill|stl|100|ein/ml|3|ml|5|rörlyk|í lyfjapenna|A10AD05|01.08.2002||R|||0|0|*|0|NAS|0|0|0|100|DKK|6150|9392|lyfalmen||||15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insulín aspart||6150||6150|9392|
001512|C04AD0301|Trental|forđatfl|400|mg|100|stk|1|ţpakki||C04AD03|01.05.2002||R|||0|0|E|0|SNO|0|0|0|100|NOK|4307|6871|lyfalmen||||100|0|40,0000|Vistor hf|Sanofi-aventis Norge AS|Pentoxífýllín||4307||4307|6871|
001517|N06AB0308|Fluoxetin Actavis|hylki|20|mg|30|stk|1|ţpakki||N06AB03|01.03.2000||R|||0|0|B|0|ACA|0|1|0|100|IKR|883|2187|lyfalmen||||30|0|30,0000|Actavis Group hf|Actavis hf|Flúoxetín||883||883|2187|
001528|N06AB0308|Fluoxetin Actavis|hylki|20|mg|100|stk|1|ţpakki||N06AB03|01.03.2000||R|||0|0|B|0|ACA|0|1|0|100|IKR|2456|4339|lyfalmen||||100|0|100,0000|Actavis Group hf|Actavis hf|Flúoxetín||2456||2456|4339|
001588|B05BA1014|Kabiven|irl|900|kcal|1026|ml|4|pokar||B05BA10|01.08.2003||R|||0|0|0|1|FRP|0|0|0|100|DKK|22136|29663|lyfsjukr||||4104|0||Icepharma hf|Fresenius Kabi|Blöndur||22136||22136|29663|
001599|B03AC0201|Venofer|stl|20|mg/ml|5|ml|5|hgl||B03AC02|01.07.2005||R|||0|0|E|0|VIF|0|0|1|100|CHF|15398|21870|lyfalmen|V0034|19396||25|0|5,0000|Vistor hf|Vifor France SA|Járnoxíđ (sykurflétta)||15398||15398|21870|
001605|B05BA1014|Kabiven|irl|1400|kcal|1540|ml|4|pokar||B05BA10|01.08.2003||R|||0|0|0|1|FRP|0|0|0|100|DKK|32255|42363|lyfsjukr||||6160|0||Icepharma hf|Fresenius Kabi|Blöndur||32255||32255|42363|
001874|G02AB0101|Methergin|stl|0,2|mg/ml|1|ml|10|lykjur||G02AB01|01.11.2001||R|||0|0|0|1|NOH|0|0|0|100|DKK|2441|3523|lyfsjukr||||10|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Metýlergómetrín||2441||2441|3523|
001878|S01EC0401|Azopt|augndr|10|mg/ml|5|ml|3|glös||S01EC04|01.11.2001||R|||0|0|*|0|ALC|0|0|0|100|USD|4338|6913|lyfalmen|V0444|6913||15|0|75,0000|K.Pétursson hf|Alcon|Brinzólamíđ||4338||4338|6913|
001889|A02BC0501|Nexium|sh-tfl|20|mg|7|stk|1|veski||A02BC05|01.11.2000||R|||0|0|0|0|AZD|0|0|0|100|SEK|835|2121|lyfalmen|V0004|432||7|0|4,6700|Vistor hf|AstraZeneca A/S DK|Esómeprazól||835||835|2121|
001954|N05AX0802|Rison|töflur|1|mg|60|stk|1|glas||N05AX08|01.05.2000||R|||0|0|*|0|ACA|0|1|0|100|IKR|1946|3373|lyfalmen|V0291|3373||60|0|12,0000|Actavis Group hf|Actavis hf|Risperídón||1750||1750|3373|
001957|N05AX0802|Rison|töflur|4|mg|60|stk|1|glas||N05AX08|01.05.2000||R|||0|0|*|0|ACA|0|1|0|100|IKR|6936|10467|lyfalmen|V0294|10467||60|0|48,0000|Actavis Group hf|Actavis hf|Risperídón||6936||6936|10467|
001962|N01BX0401|Capsina|krem|0,75|mg/g|45|g|1|túpa||N01BX04|01.06.1998||R|||0|0|0|0|BIG|0|0|1|100|SEK|4277|6830|lyfalmen||||45|0||Icepharma hf|Bioglan AB|Capsaicin||4277||4277|6830|
001965|N05AX0802|Rison|töflur|2|mg|60|stk|1|glas||N05AX08|01.05.2000||R|||0|0|*|0|ACA|0|1|0|100|IKR|3353|5566|lyfalmen|V0292|5566||60|0|24,0000|Actavis Group hf|Actavis hf|Risperídón||3353||3353|5566|
001974|J01CA0801|Selexid|töflur|200|mg|100|stk|1|glas||J01CA08|01.10.1990|31.05.2012|R|||0|0|0|0|LEP|0|0|1|100|DKK|9358|13780|lyfalmen||||100|0|33,3333|Vistor hf|LEO Pharma A/S|Pívmecillínam||9358||9358|13780|
001980|A02BC0501|Nexium|sh-tfl|20|mg|28|stk|1|veski||A02BC05|01.11.2000||R|||0|0|0|0|AZD|0|0|0|100|SEK|4348|2032|lyfalmen|V0004|1730||28|0|18,6700|Vistor hf|AstraZeneca A/S DK|Esómeprazól||770||770|2032|
001986|N05AX0802|Rison|töflur|3|mg|60|stk|1|glas||N05AX08|01.05.2000||R|||0|0|*|0|ACA|0|1|0|100|IKR|5263|8178|lyfalmen|V0293|8178||60|0|36,0000|Actavis Group hf|Actavis hf|Risperídón||5263||5263|8178|
001991|A02BC0501|Nexium|sh-tfl|20|mg|56|stk|1|veski||A02BC05|01.11.2000||R|||0|0|0|0|AZD|0|0|0|100|SEK|8632|4025|lyfalmen|V0011|3141||56|0|37,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||2227||2227|4025|
002011|A02BC0501|Nexium|sh-tfl|40|mg|7|stk|1|veski||A02BC05|01.11.2000||R|||0|0|0|0|AZD|0|0|0|100|SEK|1371|2854|lyfalmen|V0005|459||7|0|9,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||1371||1371|2854|
002033|A02BC0501|Nexium|sh-tfl|40|mg|28|stk|1|veski||A02BC05|01.11.2000||R|||0|0|0|0|AZD|0|0|0|100|SEK|6084|2032|lyfalmen|V0005|1835||28|0|37,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||770||770|2032|
002071|A07EC0204|Asacol|sh-tfl|400|mg|100|stk|1|ţpakki||A07EC02|01.01.2000||R|||0|0|B|0|TIL|0|0|0|100|SEK|5308|8240|lyfalmen||||100|0|26,6667|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||5308||5308|8240|
002180|A02BC0501|Nexium|sh-tfl|20|mg|50|stk|1|ţpakki|stakskammtar|A02BC05|01.11.2000||R|||0|0|0|0|AZD|0|0|0|100|SEK|5327|3599|lyfalmen|V0011|2805||50|0|33,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||1915||1915|3599|
002194|B05BA1010|Kabiven Peripheral|irl|1000|kcal|1440|ml|4|pokar|fleyti|B05BA10|01.02.2002||R|||0|0|0|1|FRP|0|0|0|100|DKK|26059|34587|lyfsjukr||||5760|0||Icepharma hf|Fresenius Kabi|Blöndur||26059||26059|34587|
002197|A02BC0501|Nexium|sh-tfl|20|mg|100|stk|1|glas||A02BC05|01.11.2000||R|||0|0|0|0|AZD|0|0|0|100|SEK|13230|7159|lyfalmen|V0011|5609||100|0|66,6700|Vistor hf|AstraZeneca A/S DK|Esómeprazól||4518||4518|7159|
002205|A02BC0501|Nexium|sh-tfl|40|mg|50|stk|1|veski|stakskammtar|A02BC05|01.11.2000||R|||0|0|0|0|AZD|0|0|0|100|SEK|9703|3599|lyfalmen|V0012|2805||50|0|66,6700|Vistor hf|AstraZeneca A/S DK|Esómeprazól||1915||1915|3599|
002208|A10AB0504|NovoRapid|stl|100|ae/ml|10|ml|1|hgl||A10AB05|01.04.2006||R|||0|0|*|0|NAS|0|0|0|100|DKK|3150|5288|lyfalmen||||10|0|25,0000|Vistor hf|Novo-Nordisk A/S|Insúlín aspart||3150||3150|5288|
002219|A02BC0501|Nexium|sh-tfl|40|mg|100|stk|1|glas||A02BC05|01.11.2000||R|||0|0|0|0|AZD|0|0|0|100|SEK|17593|7159|lyfalmen|V0012|5609||100|0|133,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||4518||4518|7159|
002312|D01AE1501|Lamisil|hlaup|10|mg/g|15|g|1|túpa||D01AE15|01.04.2003||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||15|0||Artasan ehf|Novartis Healthcare A/S-A|Terbínafín||||||
002328|R03DC0301|Singulair|tuggutfl|4|mg|98|stk|1|ţpakki||R03DC03|01.08.2002||R|||0|0|B|0|MSD|0|0|0|100|DKK|17280|24232|lyfalmen|V0492|19721||98|0|39,2000|Vistor hf|M.S.D.|Montelúkast||17280||17280|24232|
002342|B02BD0204|Helixate NexGen|sts|1000|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.12.2003||R|||0|0|0|1|BAY|0|0|0|100|SEK|100081|127484|lyfsjukr||||1|0|2,0000|Icepharma hf|Bayer AB "Bayer Schering Pharma"|Storkuţáttur VIII||||100081|127484|
002356|B02BD0204|Helixate NexGen|sts|500|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.12.2003||R|||0|0|0|1|BAY|0|0|0|100|SEK|51012|65903|lyfsjukr||||1|0|1,0000|Icepharma hf|Bayer AB "Bayer Schering Pharma"|Storkuţáttur VIII||||51012|65903|
002367|B02BD0204|Helixate NexGen|sts|250|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.12.2003||R|||0|0|0|1|BAY|0|0|0|100|SEK|26410|35027|lyfsjukr||||1|0|0,5000|Icepharma hf|Bayer AB "Bayer Schering Pharma"|Storkuţáttur VIII||||26410|35027|
002391|G03AA1201|Yasmin|töflur|||63|stk|1|ţpakki|3+0,03 mg|G03AA12|01.02.2001||R|||0|0|0|0|BYP|0|0|0|100|SEK|3191|5344|lyfalmen||||63|0|84,0000|Icepharma hf|Bayer Pharma AG|Dróspírenón og östrógen||||3191|5344|
002413|G03AA1204|Yasmin 28|töflur|||84|stk|1|ţpakki|3+0,03 mg|G03AA12|01.10.2007||R|||0|0|0|0|BYP|0|0|0|100|SEK|3191|5344|lyfalmen||||84|0|84,0000|Icepharma hf|Bayer Pharma AG|Dróspírenón og östrógen||3191||3191|5344|
002487|R06AX1304|Loritin|töflur|10|mg|10|stk|1|ţpakki||R06AX13|01.10.2000||L|||0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa||||10|0|10,0000|Actavis Group hf|Actavis hf|Lóratadín||||||
002499|R06AX1304|Loritin|töflur|10|mg|30|stk|1|ţpakki||R06AX13|01.10.2000||L|||0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa||||30|0|30,0000|Actavis Group hf|Actavis hf|Lóratadín||||||
002510|R06AX1304|Loritin|töflur|10|mg|100|stk|1|ţpakki||R06AX13|01.10.2000||R|||0|0|E|0|ACA|0|0|1|100|XEU|1668|2455|lyfalmen|V0362|2321||100|0|100,0000|Actavis Group hf|Actavis hf|Lóratadín||1079||1079|2455|
002616|S01LA0101|Visudyne|irs|15|mg/hgl|1|hgl|1|pakki||S01LA01|01.12.2000||R|||0|1|0|1|NOO|0|0|0|100|DKK|218235|275767|lyfsjukr||||1|0||Vistor hf|Novartis Ophthalmics Europe Ltd.|Verteporfin||218235||218235|275767|
002659|QP52AA0101|Droncit vet.|sts|57|mg/ml|10|ml|1|hgl|lausn|QP52AA01|01.03.2009||R|||0|0|0|0|BAN|0|0|0|100|SEK|3451|6020|vetorma||||10|0||Icepharma hf|Bayer Animal Health GmbH|||3451||3451|6020|
002754|N07BA0107|Nicotinell Mint|munnstfl|1|mg|204|stk|1|pakki||N07BA01|01.06.2002||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||204|0|6,8000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
002830|S01ED0106|Timosan Depot|augngel|1|mg/g|5|g|1|glas||S01ED01|01.08.2000||R|||0|0|*|0|SAO|0|0|0|100|XEU|1267|2712|lyfalmen||||5|0|28,0000|Icepharma hf|Santen Oy|Tímólól||1267||1267|2712|
002853|M03AX0101|Botox|sts|100|ae/hgl|1|hgl|1|pakki||M03AX01|01.07.1994||R|||0|1|0|1|ALL|0|0|0|100|SEK|30320|39934|lyfsjukr||||1|0||Vistor hf|Allergan|Clostridium botulinum toxín-A||30320||30320|39934|
003023|C09DA0104|Cozaar Comp Forte|filmhtfl|125|mg|98|stk|1|ţpakki|100+25 mg|C09DA01|01.06.2007||R|||0|0|0|0|MSD|0|0|0|100|DKK|14281|15490|lyfalmen|V0089|3031||98|0|98,0000|Vistor hf|M.S.D.|Lósartan og ţvagrćsilyf||10608||10608|15490|
003078|N03AX1401|Keppra|filmhtfl|250|mg|100|stk|1|ţpakki||N03AX14|01.10.2005||R|||0|0|0|0|UCB|0|0|0|100|DKK|10556|15419|lyfalmen|V0515|6626||100|0|16,6700|Vistor hf|U.C.B|Levetíracetam||10556||10556|15419|
003099|L01DB0104|Myocet|irl|50|mg|2|sett|1|pakki||L01DB01|01.07.2006||R|||0|1|0|1|ZEP|0|0|0|100|DKK|248309|313510|lyfsjukr||||2|0||Icepharma hf|Zeneus Pharma Limited-|Doxórúbicín||248309||248309|313510|
003112|N03AX1401|Keppra|filmhtfl|500|mg|100|stk|1|ţpakki||N03AX14|01.10.2005||R|||0|0|0|0|UCB|0|0|0|100|DKK|18226|25419|lyfalmen|V0253|10136||100|0|33,3300|Vistor hf|U.C.B|Levetíracetam||18226||18226|25419|
003158|N03AX1401|Keppra|filmhtfl|1000|mg|100|stk|1|ţpakki||N03AX14|01.10.2005||R|||0|0|0|0|UCB|0|0|0|100|DKK|35413|46988|lyfalmen|V0516|20556||100|0|66,6700|Vistor hf|U.C.B|Levetíracetam||35413||35413|46988|
003164|L01CA0401|Navelbine|hylki|20|mg|1|stk|1|pakki|mjúkt|L01CA04|01.05.2007||R|||0|1|*|0|PFP|0|0|0|100|SEK|10271|15029|lyfalmen||||1|0||Vistor hf|Pierre Fabre Pharma|Vínorelbín||10271||10271|15029|
003175|L01CA0401|Navelbine|hylki|30|mg|1|stk|1|pakki|mjúkt|L01CA04|01.05.2007||R|||0|1|*|0|PFP|0|0|0|100|SEK|15268|21706|lyfalmen||||1|0||Vistor hf|Pierre Fabre Pharma|Vínorelbín||15268||15268|21706|
003298|V08CA0901|Gadovist|stl|1|mmol/ml|15|ml|10|hgl|lausn|V08CA09|01.04.2007||R|||0|0|0|1|BYP|0|0|0|100|SEK|189677|239927|lyfsjukr||||150|0||Icepharma hf|Bayer Pharma AG|Gadóbútról||189677||189677|239927|
003310|R03AK0701|Symbicort Turbuhaler|innúđadu|164,5|mcg/sk|120|sk|1|pakki|160+4,5 mcg/sk|R03AK07|01.05.2001||R|||0|0|0|0|AZD|0|0|0|100|SEK|9284|13679|lyfalmen|V0356|12500||120|0|30,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||9284||9284|13679|
003325|R03AK0702|Symbicort mite Turbuhaler|innúđadu|84,5|mcg/sk|120|sk|1|pakki|80+4,5 mcg/sk|R03AK07|01.08.2002||R|||0|0|0|0|AZD|0|0|0|100|SEK|8606|12751|lyfalmen||||120|0|30,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||8606||8606|12751|
003353|L04AA1001|Rapamune|töflur|1|mg|100|stk|1|ţpakki||L04AA10|01.04.2004||R|||0|1|*|0|WTE|0|0|0|100|DKK|59996|77840|lyfalmen|V0567|77840||100|0|33,3300|Icepharma hf|Wyeth Europe|Sirolimus||59996||59996|77840|
003423|A10BG0301|Actos|töflur|15|mg|28|stk|1|ţpakki||A10BG03|01.12.2000||R|||0|0|*|0|TKE|0|0|0|100|SEK|4379|6969|lyfalmen||||28|0|14,0000|Icepharma hf|Takeda Europe -|Píóglítazón||4379||4379|6969|
003455|A02BB0101|Cytotec|töflur|0,2|mg|60|stk|1|ţpakki||A02BB01|01.08.2002||R|||0|0|E|0|PER|0|0|0|100|DKK|3264|5444|lyfalmen||||60|0|15,0000|Icepharma hf|Pfizer ApS|Mísóprostól||3264||3264|5444|
003800|A10BG0301|Actos|töflur|15|mg|98|stk|1|ţpakki||A10BG03|01.12.2000||R|||0|0|*|0|TKE|0|0|0|100|SEK|15129|21532|lyfalmen||||98|0|49,0000|Icepharma hf|Takeda Europe -|Píóglítazón||15129||15129|21532|
003809|A10BG0301|Actos|töflur|30|mg|28|stk|1|ţpakki||A10BG03|01.12.2000||R|||0|0|*|0|TKE|0|0|0|100|SEK|6623|10039|lyfalmen||||28|0|28,0000|Icepharma hf|Takeda Europe -|Píóglítazón||6623||6623|10039|
003831|A10BG0301|Actos|töflur|30|mg|98|stk|1|ţpakki||A10BG03|01.12.2000||R|||0|0|*|0|TKE|0|0|0|100|SEK|22605|30914|lyfalmen||||98|0|98,0000|Icepharma hf|Takeda Europe -|Píóglítazón||22605||22605|30914|
003869|R01BA5202|Clarinase|forđatfl|10|mg|10|stk|1|pakki|ţp 10+240 mg|R01BA52|01.09.1998||R|||0|0|E|0|SCP|0|0|1|100|DKK|885|2190|lyfalmen||||10|0|10,0000|Vistor hf|Schering-Plough|Pseudóefedrín í blöndum||885||885|2190|
003927|N06AB0602|Sertral|töflur|50|mg|28|stk|1|glas||N06AB06|01.11.2000||R|||0|0|B|0|ACA|0|1|0|100|IKR|1017|2049|lyfalmen|V0151|2049||28|0|28,0000|Actavis Group hf|Actavis hf|Sertralín||782||782|2049|
003939|M01AB0505|Voltaren|sh-tfl|50|mg|20|stk|1|ţpakki||M01AB05|01.03.1984||R|||0|0|E|0|NOH|0|0|1|100|DKK|596|1794|lyfalmen||||20|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||596||596|1794|
003950|N06AB0602|Sertral|töflur|50|mg|98|stk|1|ţpakki||N06AB06|01.11.2000||R|||0|0|B|0|ACA|0|1|0|100|IKR|2389|4247|lyfalmen|V0322|4247||98|0|98,0000|Actavis Group hf|Actavis hf|Sertralín||2389||2389|4247|
003974|J05AE0601|Kaletra|mixtúra|100|mg/ml|60|ml|5|glös|80 + 20 mg/ml|J05AE06|01.08.2003||R|||0|1|0|1|ABL|0|0|0|100|DKK|73757|94448|lyfsjukr||||300|0|30,0000|Vistor hf|Abbott Laboratories A/S|Lopinavír||73757||73757|94448|
003988|M01AB0505|Voltaren|sh-tfl|50|mg|100|stk|1|ţpakki||M01AB05|01.03.1984||R|||0|0|E|0|NOH|0|0|1|100|DKK|2158|3931|lyfalmen|V0469|2399||100|0|50,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||2158||2158|3931|
004002|L04AD0101|Sandimmun|irţ|50|mg/ml|5|ml|10|lykjur||L04AD01|01.10.1985||R|||0|0|0|1|NOH|0|0|0|100|DKK|22127|29652|lyfsjukr||||50|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||22127||22127|29652|
004014|N03AF0201|Trileptal|mixtúra|60|mg/ml|250|ml|1|fl||N03AF02|01.01.2002||R|||0|0|E|0|NOH|0|0|0|100|DKK|8032|11966|lyfalmen||||250|0|15,0000|Vistor hf|Novartis Healthcare A/S-|Oxkarbazepín||8032||8032|11966|
004028|A07DA0301|Imodium|mixtúra|0,2|mg/ml|100|ml|1|fl||A07DA03|01.01.1990||L|||0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa||||100|0|2,0000|Vistor hf|McNeil Sweden AB|Lóperamíđ||||||
004050|R03AK0601|Seretide|innúđal|75|mcg/sk|120|skammtar|1|pakki|25+50 mcg/sk|R03AK06|01.10.2002||R|||0|0|B|0|GSK|0|0|0|100|GBP|4337|6912|lyfalmen||||120|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||4337||4337|6912|
004086|N06AB0601|Zoloft|töflur|25|mg|7|stk|1|ţpakki||N06AB06|01.05.2003||R|||0|0|0|0|PER|0|1|0|100|DKK|601|1801|lyfalmen||||7|0|3,5000|Icepharma hf|Pfizer ApS|Sertralín||601||601|1801|
004111|N05CD0102|Dalmadorm medium|hylki|15|mg|30|stk|1|ţpakki||N05CD01|01.12.2000||R|||0|0|0|0|MAB|0|0|1|100|DKK|1075|2449|lyfalmen||||30|0|15,0000|Vistor hf|Meda AB|Flúrazepam||1075||1075|2449|
004259|N05AE0401|Zeldox|hylki|40|mg|14|stk|1|ţpakki|hart hylki|N05AE04|01.03.2003||R|||0|0|0|0|PER|0|1|0|100|DKK|5554|8576|lyfalmen||||14|0|7,0000|Icepharma hf|Pfizer ApS|Ziprasidon||5554||5554|8576|
004282|R03AK0601|Seretide|innúđal|150|mcg/sk|120|skammtar|1|pakki|25+125 mcg/sk|R03AK06|01.10.2002||R|||0|0|0|0|GSK|0|0|0|100|GBP|8012|11939|lyfalmen||||120|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||8012||8012|11939|
004293|R03AK0601|Seretide|innúđal|275|mcg/sk|120|skammtar|1|pakki|25+250 mcg/sk|R03AK06|01.10.2002||R|||0|0|0|0|GSK|0|0|0|100|GBP|11254|16374|lyfalmen||||120|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||11254||11254|16374|
004298|R06AX2701|Aerius|töflur|5|mg|10|stk|1|ţpakki||R06AX27|01.05.2001||R|||0|0|E|0|SCP|0|0|1|100|DKK|644|1860|lyfalmen|V0366|938||10|0|10,0000|Vistor hf|Schering-Plough|Deslóratadín||644||644|1860|
004301|N06AX1101|Remeron|mixtúra|15|mg/ml|66|ml|1|fl|lausn|N06AX11|01.01.2003||R|||0|0|0|0|ORG|0|1|0|100|DKK|6015|9207|lyfalmen||||66|0|33,0000|Vistor hf|N.V. Organon|Mirtazapín||6015||6015|9207|
004352|J02AC0301|Vfend|irs|200|mg|1|hgl|1|pakki||J02AC03|01.11.2002||R|||0|0|0|1|PER|0|0|0|100|DKK|21378|28712|lyfsjukr||||1|0|0,5000|Icepharma hf|Pfizer ApS|Voricónazól||21378||21378|28712|
004370|R06AX2701|Aerius|töflur|5|mg|30|stk|1|ţpakki||R06AX27|01.05.2001||R|||0|0|E|0|SCP|0|0|1|100|DKK|1679|3276|lyfalmen|V0366|2813||30|0|30,0000|Vistor hf|Schering-Plough|Deslóratadín||1679||1679|3276|
004374|A04AA0101|Zofran|töflur|4|mg|10|stk|1|glas||A04AA01|01.01.2009||R|||0|0|E|0|GSK|0|0|0|100|GBP|7485|11218|lyfalmen||||10|0|2,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ondansetrón||7485||7485|11218|
004378|R06AX2701|Aerius|töflur|5|mg|100|stk|1|ţpakki||R06AX27|01.05.2001||R|||0|0|E|0|SCP|0|0|1|100|DKK|4700|7408|lyfalmen|V0458|6437||100|0|100,0000|Vistor hf|Schering-Plough|Deslóratadín||4700||4700|7408|
004388|QJ51RC2501|Benestermycin, vet.|spenalyf|||5|ml|20|spr||QJ51RC25|01.12.1978||R|||0|0|0|0|BOI|0|0|0|100|DKK|4867|9518|vetalmen||||100|0||Vistor hf|Boehringer Ingelheim|||4867||4867|9518|
004455|N02AX0208|Zytram|forđatfl|75|mg|56|stk|1|glas||N02AX02|01.01.2001||R|||0|0|E|0|NOP|0|0|1|100|DKK|3295|5486|lyfalmen||||56|0|14,0000|Icepharma hf|Norpharma |Tramadól||3295||3295|5486|
004465|C01DA0801|Sorbangil|töflur|5|mg|100|stk|1|ţpakki||C01DA08|01.06.1980||R|||0|0|B|0|REP|0|0|0|100|SEK|639|1853|lyfalmen||||100|0|8,3333|Vistor hf|Recip AB|Ísósorbíđ dínítrat||639||639|1853|
004478|N02AX0208|Zytram|forđatfl|100|mg|56|stk|1|glas||N02AX02|01.01.2001||R|||0|0|E|0|NOP|0|0|1|100|DKK|4395|6991|lyfalmen|V0226|2783||56|0|18,6667|Icepharma hf|Norpharma |Tramadól||4395||4395|6991|
004489|N02AX0208|Zytram|forđatfl|150|mg|56|stk|1|glas||N02AX02|01.01.2001||R|||0|0|E|0|NOP|0|0|1|100|DKK|6207|9470|lyfalmen|V0227|4252||56|0|28,0000|Icepharma hf|Norpharma |Tramadól||6207||6207|9470|
004500|N02AX0208|Zytram|forđatfl|200|mg|56|stk|1|glas||N02AX02|01.01.2001||R|||0|0|E|0|NOP|0|0|1|100|DKK|8262|12281|lyfalmen|V0228|5479||56|0|37,3333|Icepharma hf|Norpharma |Tramadól||8262||8262|12281|
004502|J07BC0101|Engerix-B|bóluefni|20|mcg/ml|0,5|ml|1|dćla|einnota dćla|J07BC01|01.01.1990||R|||0|0|0|0|GSK|0|0|0|100|GBP|2298|4122|lyfalmen||||0|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lifrarbólga-B, hreinsađir  mótefnavakar||2298||2298|4122|
004586|A10BB1201|Amaryl|töflur|4|mg|90|stk|1|ţpakki||A10BB12|01.06.2005||R|||0|0|*|0|AVP|0|0|0|100|NOK|3621|5932|lyfalmen|V0494|3288||90|0|180,0000|Vistor hf|Aventis Pharma |Glímepíríđ||3621||3621|5932|
004589|N06AB0402|Oropram|töflur|20|mg|100|stk|1|glas||N06AB04|01.01.2001||R|||0|0|B|0|ACA|0|1|0|100|IKR|2556|4475|lyfalmen|V0318|4475||100|0|100,0000|Actavis Group hf|Actavis hf|Cítalópram||2556||2556|4475|
004611|H01AC0104|Saizen|sts|8|mg/hgl|1|hgl|1|pakki|+ leysir f.click easy|H01AC01|01.05.2002||R|||0|1|0|1|EMA|0|0|0|100|SEK|35913|46953|lyfsjukr||||1|0|12,0000|Icepharma hf|E. Merck AB|Sómatrópín||35913||35913|46953|
004612|D06BX0105|Metronidazol Actavis|krem|10|mg/g|25|g|1|túpa||D06BX01|01.07.1987||R|||0|0|0|0|AGT|0|0|1|100|DKK|1439|2947|lyfalmen||||25|0||Actavis Group hf|Actavis Group hf|Metrónídazól||1439||1439|2947|
004613|J07BC0101|Engerix-B|bóluefni|20|mcg/ml|1|ml|1|dćla|einnotadćl|J07BC01|01.01.1990||R|||0|0|0|0|GSK|0|0|0|100|GBP|3393|5620|lyfalmen||||1|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lifrarbólga-B, hreinsađir  mótefnavakar||3393||3393|5620|
004625|N06AB0402|Oropram|töflur|40|mg|28|stk|1|glas||N06AB04|01.01.2001||R|||0|0|B|0|ACA|0|1|0|100|IKR|1836|2164|lyfalmen|V0071|2164||28|0|56,0000|Actavis Group hf|Actavis hf|Cítalópram||866||866|2164|
004645|N06AB0402|Oropram|töflur|40|mg|100|stk|1|glas||N06AB04|01.01.2001||R|||0|0|B|0|ACA|0|1|0|100|IKR|5614|7418|lyfalmen|V0320|7418||100|0|200,0000|Actavis Group hf|Actavis hf|Cítalópram||4707||4707|7418|
004656|N06AB0402|Oropram|töflur|10|mg|28|stk|1|glas||N06AB04|01.01.2001||R|||0|0|B|0|ACA|0|1|0|100|IKR|776|2040|lyfalmen|V0062|2040||28|0|14,0000|Actavis Group hf|Actavis hf|Cítalópram||776||776|2040|
004667|N06AB0402|Oropram|töflur|10|mg|100|stk|1|glas||N06AB04|01.01.2001||R|||0|0|B|0|ACA|0|1|0|100|IKR|2703|4676|lyfalmen|V0317|4676||100|0|50,0000|Actavis Group hf|Actavis hf|Cítalópram||2703||2703|4676|
004678|N06AB0402|Oropram|töflur|20|mg|28|stk|1|glas||N06AB04|01.01.2001||R|||0|0|B|0|ACA|0|1|0|100|IKR|926|1921|lyfalmen|V0067|1921||28|0|28,0000|Actavis Group hf|Actavis hf|Cítalópram||689||689|1921|
004687|A02AA0403|Magnesia "medic"|filmhtfl|500|mg|100|stk|1|glas||A02AA04|01.02.2006||L|||0|0|0|0|MET|0|0|0|100|DKK|||lyfalmen||||100|0|16,6700|Vistor hf|Medic Team|Magnesíum hýdroxíđ|||||1774|
004688|L04AC0301|Kineret|stl|100|mg/spr|0,67|ml|7|spr||L04AC03|01.07.2002||R|||0|1|0|1|BIA|0|0|0|100|DKK|38676|50421|lyfsjukr||||5|0|7,0000|Vistor hf|Biovitrum AB (publ)|Anakinra||38676||38676|50421|
004691|N06AB0402|Oropram|töflur|20|mg|56|stk|1|glas||N06AB04|01.01.2001||R|||0|0|B|0|ACA|0|1|0|100|IKR|1778|3411|lyfalmen|V0318|2506||56|0|56,0000|Actavis Group hf|Actavis hf|Cítalópram||1778||1778|3411|
004696|R05DA0901|Dexomet|mixtúra|3|mg/ml|150|ml|1|glas||R05DA09|01.06.2001||L|||0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa||||150|0|5,0000|Actavis Group hf|Actavis hf|Dextrómetorfan||||||
004699|L04AC0301|Kineret|stl|100|mg/spr|0,67|ml|28|spr||L04AC03|01.04.2007|31.05.2012|R|||0|1|0|1|BIA|0|0|0|100|DKK|142871|181186|lyfsjukr||||19|0|28,0000|Vistor hf|Biovitrum AB (publ)|Anakinra||142871||142871|181186|
004733|H01AC0104|Saizen|sts|8|mg/hgl|5|hgl|1|pakki|+ leysir f.click easy|H01AC01|01.05.2002||R|||0|1|0|1|EMA|0|0|0|100|SEK|179566|227238|lyfsjukr||||5|0|60,0000|Icepharma hf|E. Merck AB|Sómatrópín||179566||179566|227238|
004746|A10AE0405|Lantus [Clikstar]|stl|100|ein/ml|3|ml|5|rörlyk|rörlykjur fyrir Clikstar penna|A10AE04|01.06.2004||R|||0|0|*|0|SDE|0|0|0|100|NOK|10743|15675|lyfalmen||||15|0|37,5000|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||10743||10743|15675|
004834|N03AX1201|Neurontin|hylki|300|mg|100|stk|1|ţpakki||N03AX12|01.03.2009||R|||0|0|E|0|PER|0|0|0|100|DKK|6984|7542|lyfalmen|V0250|4988||100|0|16,6667|Icepharma hf|Pfizer ApS|Gabapentín||4798||4798|7542|
004845|N03AX1201|Neurontin|hylki|400|mg|100|stk|1|ţpakki||N03AX12|01.03.2009||R|||0|0|E|0|PER|0|0|0|100|DKK|9024|8786|lyfalmen|V0251|4864||100|0|22,2222|Icepharma hf|Pfizer ApS|Gabapentín||5707||5707|8786|
004855|P01AB0105|Metronidazol Actavis|töflur|250|mg|24|stk|1|ţpakki||P01AB01|01.12.1972||R|||0|0|0|0|AGT|0|0|1|100|DKK|659|1880|lyfalmen||||24|0|3,0000|Actavis Group hf|Actavis Group hf|Metrónídazól||659||659|1880|
004874|N05AH0308|Lazapix|filmhtfl|10|mg|56|stk|1|ţpakki||N05AH03|01.09.2011||R|||0|0|*|0|POF|0|1|0|100|XEU|15074|8363|lyfalmen|V0282|7774||56|0|56,0000|Portfarma ehf|Portfarma|Olanzapín||5398||5398|8363|
004880|J01FA1001|Zitromax|irs|500|mg/hgl|1|hgl|1|pakki||J01FA10|01.05.2003||R|||0|0|0|1|PER|0|0|0|100|DKK|5496|7932|lyfsjukr||||1|0|1,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||5496||5496|7932|
004888|P01AB0105|Metronidazol Actavis|töflur|500|mg|8|stk|1|glas||P01AB01|01.03.1981||R|||0|0|0|0|AGT|0|0|1|100|DKK|379|1497|lyfalmen|V0352|721||8|0|2,0000|Actavis Group hf|Actavis Group hf|Metrónídazól||379||379|1497|
004921|P01AB0105|Metronidazol Actavis|töflur|500|mg|14|stk|1|glas||P01AB01|01.01.1988||R|||0|0|0|0|AGT|0|0|1|100|DKK|666|1890|lyfalmen|V0352|1261||14|0|3,5000|Actavis Group hf|Actavis Group hf|Metrónídazól||666||666|1890|
004976|P01AB0105|Metronidazol Actavis|töflur|500|mg|30|stk|1|glas||P01AB01|01.01.1988||R|||0|0|0|0|AGT|0|0|1|100|DKK|1260|2703|lyfalmen|V0352|2703||30|0|7,5000|Actavis Group hf|Actavis Group hf|Metrónídazól||1260||1260|2703|
005048|N07BA0107|Nicotinell Mint|munnstfl|2|mg|36|stk|1|pakki||N07BA01|01.04.2003||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||36|0|2,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
005059|N07BA0107|Nicotinell Mint|munnstfl|2|mg|96|stk|1|pakki||N07BA01|01.04.2003||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||96|0|6,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
005070|N07BA0107|Nicotinell Mint|munnstfl|2|mg|204|stk|1|pakki||N07BA01|01.04.2003||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
005085|J07AJ5205|Boostrix|stl|||0,5|ml|1|spr|áfyllt, dreifa|J07AJ52|01.01.2007||R|||0|0|0|0|GSK|0|0|0|100|GBP|1862|3526|lyfalmen||||0|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Kíghósti, í blöndum međ öđrum toxóíđum||1862||1862|3526|
005089|J07AL0103|Pneumovax|stl|||0,5|ml|1|hgl|lausn|J07AL01|01.11.2008||R|||0|0|0|0|SPM|0|0|0|100|XEU|2346|4188|lyfalmen||||0|0||Icepharma hf|Sanofi Pasteur MSD|Hreinsuđ pneumococca poly­sakkaríđ mótefnavakar||||2346|4188|
005108|G04CA0201|Omnic|forđahlk|0,4|mg|90|stk|1|ţpakki||G04CA02|01.08.1998||R|||0|0|E|0|ASP|0|0|0|100|XEU|8882|7163|lyfalmen|V0148|3997||90|0|90,0000|Vistor hf|Astellas Pharma A/S|Tamsúlósín||4521||4521|7163|
005178|J01CF0102|Staklox|hylki|250|mg|30|stk|1|ţpakki||J01CF01|01.05.2001||R|||0|0|0|0|ACA|0|0|1|100|DKK|1124|2516|lyfalmen||||30|0|3,7500|Actavis Group hf|Actavis hf|Díkloxacillín||1124||1124|2516|
005189|J01CF0102|Staklox|hylki|500|mg|20|stk|1|ţpakki||J01CF01|01.05.2001||R|||0|0|0|0|ACA|0|0|1|100|DKK|1295|2750|lyfalmen||||20|0|5,0000|Actavis Group hf|Actavis hf|Díkloxacillín||1295||1295|2750|
005200|J01CF0102|Staklox|hylki|500|mg|30|stk|1|ţpakki||J01CF01|01.05.2001||R|||0|0|0|0|ACA|0|0|1|100|DKK|1771|3402|lyfalmen||||30|0|7,5000|Actavis Group hf|Actavis hf|Díkloxacillín||1771||1771|3402|
005241|R03AK0701|Symbicort Turbuhaler|innúđadu|164,5|mcg/sk|360|sk|1|pakki|160+4,5 mcg/sk|R03AK07|01.05.2001||R|||0|0|0|0|AZD|0|0|0|100|SEK|27852|37499|lyfalmen|V0356|37499||360|0|90,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||27852||27852|37499|
005296|N05AH0401|Seroquel|filmhtfl|300|mg|100|stk|1|ţpakki||N05AH04|01.12.2002||R|||0|0|0|0|AZA|0|1|0|100|SEK|51173|66767|lyfalmen||||100|0|75,0000|Vistor hf|AstraZeneca AB|Quetíapín||51173||51173|66767|
005303|N02CC0303|Zomig Nasal|nefúđi|5|mg/sk|5|mg|2|stauk||N02CC03|01.02.2003||R|||0|0|E|0|ASZ|0|0|0|100|SEK|3356|5570|lyfalmen||||10|0|4,0000|Vistor hf|AstraZeneca UK Ltd|Zolmítriptan||3356||3356|5570|
005330|D08AG0201|Betadine|áburđur|100|mg/ml|500|ml|1|fl|sprittl.|D08AG02|01.09.1982||L|||0|0|0|0|NOR|0|0|0|100|IKR|||lyflausa||||500|0||Icepharma hf|Norpharma a/s|Jođ/pólývídón||||||
005336|R01AA0704|Otrivin ukonserveret|nefúđi|0,5|mg/ml|10|ml|1|glas|sk-úđari|R01AA07|01.07.2003||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||10|0|6,2500|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín||||||
005355|S01AA1301|Fucithalmic|augndr|10|mg/g|0,2|g|12|sk-hyl|2 mg/sk|S01AA13|01.04.1992||R|||0|0|E|0|LEP|0|0|1|100|DKK|1143|2542|lyfalmen||||2|0||Vistor hf|LEO Pharma A/S|Fúsidínsýra||1143||1143|2542|
005363|L02AE0301|Zoladex|vefjalyf|10,8|mg|1|stk|1|áf.spr|+ dćla|L02AE03|01.04.1996||R|||0|1|*|0|AZA|0|0|0|100|SEK|61895|80223|lyfalmen|V0451|77809||1|0|83,7209|Vistor hf|AstraZeneca AB|Góserelín||61895||61895|80223|
005390|R03BB0101|Atrovent|innúđal|20|mcg/sk|200|skammtar|1|stauk||R03BB01|01.08.2004||R|||0|0|B|0|BOI|0|0|0|100|DKK|1508|3042|lyfalmen||||200|0|33,3300|Vistor hf|Boehringer Ingelheim|Ípratrópíumbrómíđ||1508||1508|3042|
005503|N05AH0301|Zyprexa|húđuđtfl|15|mg|28|stk|1|ţpakki||N05AH03|01.06.2002||R|||0|0|*|0|ELD|0|1|0|100|XEU|29938|18622|lyfalmen|V0283|9719||28|0|42,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||12810||12810|18622|
005526|N05AH0301|Zyprexa|húđuđtfl|20|mg|28|stk|1|ţpakki||N05AH03|01.12.2003||R|||0|0|0|0|ELD|0|1|0|100|XEU|38076|50331|lyfalmen||||28|0|56,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||38076||38076|50331|
005538|G03AA0702|Microgyn|töflur|||63|stk|1|ţpakki||G03AA07|01.06.1977||R|||0|0|0|0|BAP|0|0|0|100|SEK|1239|2674|lyfalmen|V0545|2672||63|0|84,0000|Icepharma hf|Bayer Schering Pharma AG|Levónorgestrel og östrógen||1239||1239|2674|
005576|R05CA1002|Tussol|mixtúra|||150|ml|1|glas||R05CA10|01.10.2001||L|||0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa||||150|0||Actavis Group hf|Actavis hf|Blöndur||||||
005588|R03BB0401|Spiriva|innönddu|18|mcg/hylk|30|hylki|1|pakki|hart hylki|R03BB04|01.01.2003||R|||0|0|0|0|BII|0|0|0|100|DKK|6350|9665|lyfalmen||||30|0|30,0000|Vistor hf|Boehringer Ingelheim International|Tíótrópíumbrómíđ||6350||6350|9665|
005600|R03BB0401|Spiriva|innönddu|18|mcg/hylk|30|hylki|1|pakki|hart hylki + Handihaler|R03BB04|01.01.2003||R|||0|0|0|0|BII|0|0|0|100|DKK|6692|10133|lyfalmen||||30|0|30,0000|Vistor hf|Boehringer Ingelheim International|Tíótrópíumbrómíđ||||6692|10133|
005606|J07AH0703|NeisVac-C|bóluefni|||0,5|ml|1|spr|áfyllt sprauta|J07AH07|01.09.2001||R|||0|0|0|0|BAX|0|0|0|100|USD|4360|6943|lyfalmen||||0|0||Icepharma hf|Baxter|Hreinsuđ meningókokka C, poly­sakkaríđ mótefnavakar||4360||4360|6943|
005624|A10BB0902|Diamicron Uno|töflur|30|mg|30|stk|1|ţpakki||A10BB09|01.04.2002||R|||0|0|*|0|LLS|0|0|0|100|DKK|1621|3196|lyfalmen||||30|0|15,0000|Icepharma hf|Les Laboratoires Servier|Glíklazíđ||1621||1621|3196|
005641|A10BB0902|Diamicron Uno|töflur|30|mg|60|stk|1|ţpakki||A10BB09|01.04.2002||R|||0|0|*|0|LLS|0|0|0|100|DKK|2825|4843|lyfalmen|V0020|3747||60|0|30,0000|Icepharma hf|Les Laboratoires Servier|Glíklazíđ||2825||2825|4843|
005672|A10BB0902|Diamicron Uno|töflur|30|mg|180|stk|1|ţpakki||A10BB09|01.04.2002||R|||0|0|*|0|LLS|0|0|0|100|DKK|7501|11240|lyfalmen|V0020|11240||180|0|90,0000|Icepharma hf|Les Laboratoires Servier|Glíklazíđ||7501||7501|11240|
005674|A10BB0902|Diamicron Uno|töflur|30|mg|90|stk|1|ţpakki||A10BB09|01.04.2002||R|||0|0|*|0|LLS|0|0|0|100|DKK|4122|6618|lyfalmen|V0020|5620||90|0|45,0000|Icepharma hf|Les Laboratoires Servier|Glíklazíđ||4122||4122|6618|
005689|B01AC0601|Hjartamagnyl|töflur|75|mg|100|stk|1|plglas||B01AC06|01.06.2007||L|||0|0|0|0|ACA|0|0|0|100|IKR|||lyflausa||||100|0|100,0000|Actavis Group hf|Actavis hf|Asetýlsalicýlsýra||||||
005757|N06AB1001|Cipralex|töflur|5|mg|28|stk|1|ţpakki||N06AB10|01.08.2002||R|||0|0|0|0|LBK|0|1|0|100|DKK|1813|3459|lyfalmen||||28|0|14,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||1813||1813|3459|
005790|N06AB1001|Cipralex|töflur|5|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|||0|0|0|0|LBK|0|1|0|100|DKK|6742|9196|lyfalmen|V0324|3335||100|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||6007||6007|9196|
005812|N06AB1001|Cipralex|töflur|10|mg|28|stk|1|ţpakki||N06AB10|01.08.2002||R|||0|0|0|0|LBK|0|1|0|100|DKK|3197|5017|lyfalmen|V0035|3672||28|0|28,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||2952||2952|5017|
005822|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|5|l|1|fl||QP54AA01|01.08.2001||R|||0|0|0|0|MEF|0|0|0|100|XEU|18179|31712|vetorma||||5|0||Vistor hf|Merial (MSD)|||18179||18179|31712|
005823|N06AB1001|Cipralex|töflur|10|mg|56|stk|1|ţpakki||N06AB10|01.08.2002||R|||0|0|0|0|LBK|0|1|0|100|DKK|6354|9671|lyfalmen|V0325|3156||56|0|56,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||6354||6354|9671|
005845|N06AB1001|Cipralex|töflur|10|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|||0|0|0|0|LBK|0|1|0|100|DKK|10720|14398|lyfalmen|V0325|5635||100|0|100,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||9810||9810|14398|
005867|N06AB1001|Cipralex|töflur|15|mg|28|stk|1|ţpakki||N06AB10|01.08.2002||R|||0|0|0|0|LBK|0|1|0|100|DKK|5135|7577|lyfalmen||||28|0|42,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||4823||4823|7577|
005872|C09DA0701|MicardisPlus|töflur|52,5|mg|28|stk|1|ţpakki|40 + 12,5 mg|C09DA07|01.02.2008||R|||0|0|0|0|BII|0|0|0|100|DKK|3036|5132|lyfalmen||||28|0|28,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan og ţvagrćsilyf||3036||3036|5132|
005884|P01BC0201|Lariam|töflur|250|mg|8|stk|1|ţpakki||P01BC02|01.01.1993||R|||0|0|0|0|ROC|0|0|0|100|DKK|3545|5828|lyfalmen||||8|0|2,0000|Icepharma hf|Roche|Meflókvín||3545||3545|5828|
005885|N05AH0301|Zyprexa|sts|10|mg|1|hgl|1|pakki||N05AH03|01.02.2004||R|||0|0|*|0|ELD|0|1|0|100|XEU|894|2202|lyfalmen||||1|0|1,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||894||894|2202|
005894|C09DA0701|MicardisPlus|töflur|52,5|mg|98|stk|1|ţpakki|40 + 12,5 mg|C09DA07|01.02.2008||R|||0|0|0|0|BII|0|0|0|100|DKK|10408|15217|lyfalmen||||98|0|98,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan og ţvagrćsilyf||10408||10408|15217|
005902|N06AB1001|Cipralex|töflur|15|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|||0|0|0|0|LBK|0|1|0|100|DKK|16597|21134|lyfalmen|V0326|5399||100|0|150,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||14812||14812|21134|
005910|C09CA0301|Diovan|töflur|80|mg|28|stk|1|ţpakki|filmuhúđađar töflur|C09CA03|01.01.2001||R|||0|0|0|0|NOH|0|0|0|100|DKK|3621|5932|lyfalmen||||28|0|28,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||3621||3621|5932|
005922|N06AB1001|Cipralex|töflur|20|mg|28|stk|1|ţpakki||N06AB10|01.08.2002||R|||0|0|0|0|LBK|0|1|0|100|DKK|6558|8877|lyfalmen|V0246|4556||28|0|56,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||5774||5774|8877|
005932|C09CA0301|Diovan|töflur|80|mg|98|stk|1|ţpakki|filmuhúđađar töflur|C09CA03|01.01.2001||R|||0|0|0|0|NOH|0|0|0|100|DKK|9579|12663|lyfalmen|V0072|3213||98|0|98,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||8541||8541|12663|
005933|N06AB1001|Cipralex|töflur|20|mg|56|stk|1|ţpakki||N06AB10|01.08.2002||R|||0|0|0|0|LBK|0|1|0|100|DKK|12851|18673|lyfalmen|V0327|3023||56|0|112,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||12851||12851|18673|
005954|C09CA0301|Diovan|töflur|160|mg|28|stk|1|ţpakki|filmuhúđađar töflur|C09CA03|01.01.2001||R|||0|0|0|0|NOH|0|0|0|100|DKK|4759|7489|lyfalmen||||28|0|56,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||4759||4759|7489|
005976|C09CA0301|Diovan|töflur|160|mg|98|stk|1|ţpakki|filmuhúđađar töflur|C09CA03|01.01.2001||R|||0|0|0|0|NOH|0|0|0|100|DKK|13019|18054|lyfalmen|V0073|3293||98|0|196,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||12358||12358|18054|
006000|R07AA0201|Curosurf|innö.guf|80|mg/ml|1,5|ml|1|hgl||R07AA02|01.01.1995||R|||0|1|0|1|NYG|0|0|0|100|DKK|85378|109032|lyfsjukr||||2|0|0,7500|Gróco ehf|Nycomed Danmark A/S|Náttúrulegir fosfólípíđar||85378||85378|109032|
006024|A10AD0501|NovoMix 30 FlexPen|stl|100|ein/ml|3|ml|5|rörlyk|í lyfjapenna|A10AD05|01.07.2002||R|||0|0|*|0|NAS|0|0|0|100|DKK|5865|9002|lyfalmen||||15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insulín aspart||5865||5865|9002|
006079|J02AX0403|Cancidas|irţ|70|mg/hgl|1|hgl|1|pakki||J02AX04|01.02.2002||R|||0|1|0|1|MSD|0|0|0|100|DKK|105887|134771|lyfsjukr||||1|0|1,4000|Vistor hf|M.S.D.|Caspofungin||105887||105887|134771|
006102|A10AB0501|NovoRapid FlexPen|stl|100|ein/ml|3|ml|5|rörlyk|einnota pennar|A10AB05|01.12.2001||R|||0|0|*|0|NAS|0|0|0|100|DKK|5690|8763|lyfalmen||||15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín aspart||5690||5690|8763|
006111|R07AA0201|Curosurf|innö.guf|80|mg/ml|3|ml|1|hgl||R07AA02|01.01.1995||R|||0|1|0|1|NYG|0|0|0|100|DKK|158987|201411|lyfsjukr||||3|0|1,5000|Gróco ehf|Nycomed Danmark A/S|Náttúrulegir fosfólípíđar||158987||158987|201411|
006115|J02AX0403|Cancidas|irţ|50|mg/hgl|1|hgl|1|pakki||J02AX04|01.02.2002||R|||0|1|0|1|MSD|0|0|0|100|DKK|80866|103369|lyfsjukr||||1|0|1,0000|Vistor hf|M.S.D.|Caspofungin||80866||80866|103369|
006239|J01CF0501|Heracillin|töflur|500|mg|30|stk|1|glas||J01CF05|01.10.1995||R|||0|0|0|0|REP|0|0|1|100|SEK|2567|4490|lyfalmen||||30|0|7,5000|Vistor hf|Recip AB|Flúkloxacillín||2567||2567|4490|
006443|QM01AC0601|Metacam|stl|20|mg/ml|50|ml|1|hgl||QM01AC06|01.05.2004||R|||0|0|0|0|BOI|1|0|0|100|DKK|8943|17344|vetalmen||||50|0||Vistor hf|Boehringer Ingelheim|||8943||8943|17344|
006547|B01AX0501|Arixtra|stl|2,5|mg/spr|0,5|ml|10|spr|áfyllt sprauta|B01AX05|01.07.2012||R|||0|0|E|0|GGL|0|0|0|100|GBP|6871|10378|lyfalmen||||5|0|10,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Fondaparinux||6871||6871|10378|
006558|B01AX0501|Arixtra|stl|2,5|mg/spr|0,5|ml|20|spr|áfyllt sprauta|B01AX05|01.03.2011||R|||0|0|E|0|GGL|0|0|0|100|GBP|13670|19701|lyfalmen||||10|0|20,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Fondaparinux||13670||13670|19701|
006579|D05AX5201|Daivobet|smyrsli|||60|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.04.2002||R|||0|0|B|0|LEP|0|0|0|100|DKK|7085|10671|lyfalmen||||60|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||7085||7085|10671|
006637|D05AX5201|Daivobet|smyrsli|||120|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.04.2002|31.05.2012|R|||0|0|B|0|LEP|0|0|0|100|DKK|13016|18880|lyfalmen||||120|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||13016||13016|18880|
006681|N02BE0109|Panodil Hot|skammtar|500|mg|10|skammtar|1|pakki||N02BE01|01.05.2003||L|||0|0|0|0|GSH|0|0|1|100|IKR|||lyflausa||||10|0|1,6700|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól||||||
006732|A16AB0401|Fabrazyme|irţ|5|mg/ml|35|mg|1|hgl|lausn|A16AB04|01.05.2012||R|||0|1|0|1|GZE|0|0|0|100|XEU|548054|689690|lyfsjukr||||35|0|35,0000|Vistor hf|Genzyme Europe B.V.|Agalsidase beta||548054||548054|689690|
006785|G03AD0101|NorLevo|töflur|750|mcg|2|stk|1|ţpakki||G03AD01|01.01.2005||L|||0|0|0|0|LHP|0|0|0|100|IKR|||lyflausa||||2|0|1,0000|Gróco ehf|Laboratoire HRA Pharma|Levonorgestrel||||||
006928|C09CA0101|Cozaar|töflur|100|mg|98|stk|1|ţpakki||C09CA01|01.05.2002||R|||0|0|0|0|MSD|0|0|0|100|DKK|14856|21189|lyfalmen||||98|0|196,0000|Vistor hf|M.S.D.|Lósartan||14856||14856|21189|
007099|C10AA0701|Crestor|filmhtfl|10|mg|28|stk|1|ţpakki||C10AA07|01.06.2003||R|||0|0|0|0|AZD|0|0|0|100|SEK|4537|7185|lyfalmen||||28|0|28,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||4537||4537|7185|
007104|N05AA0201|Nozinan|töflur|5|mg|100|stk|1|glas||N05AA02|01.10.1995||R|||0|0|0|0|SNO|0|1|0|100|NOK|728|1975|lyfalmen||||100|0|1,6667|Vistor hf|Sanofi-aventis Norge AS|Levómeprómazín||728||728|1975|
007126|QJ01CE9002|Mamyzin vet.|sts|10|millj ae|20|hgl|1|pakki|+ leysir|QJ01CE90|01.12.2002||R|||0|0|0|0|BID|0|0|0|100|DKK|25777|49668|vetalmen||||20|0||Vistor hf|Boehringer Ingelheim Danmark|||25777||25777|49668|
007133|C10AA0701|Crestor|filmhtfl|10|mg|98|stk|1|ţpakki||C10AA07|01.07.2003||R|||0|0|0|0|AZD|0|0|0|100|SEK|13717|19760|lyfalmen|V0117|19760||98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||13717||13717|19760|
007138|N05AA0201|Nozinan|töflur|25|mg|100|stk|1|glas||N05AA02|01.10.1995||R|||0|0|*|0|SNO|0|1|0|100|NOK|2133|3897|lyfalmen||||100|0|8,3333|Vistor hf|Sanofi-aventis Norge AS|Levómeprómazín||2133||2133|3897|
007144|C10AA0701|Crestor|filmhtfl|20|mg|28|stk|1|ţpakki||C10AA07|01.06.2003||R|||0|0|0|0|AZD|0|0|0|100|SEK|6842|10338|lyfalmen||||28|0|56,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||6842||6842|10338|
007155|C10AA0701|Crestor|filmhtfl|20|mg|98|stk|1|ţpakki||C10AA07|01.06.2003||R|||0|0|0|0|AZD|0|0|0|100|SEK|20706|28531|lyfalmen|V0118|28531||98|0|196,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||20706||20706|28531|
007161|N05AA0201|Nozinan|töflur|100|mg|100|stk|1|glas||N05AA02|01.10.1995||R|||0|0|*|0|SNO|0|1|0|100|NOK|5417|8389|lyfalmen||||100|0|33,3333|Vistor hf|Sanofi-aventis Norge AS|Levómeprómazín||5417||5417|8389|
007166|C10AA0701|Crestor|filmhtfl|40|mg|28|stk|1|ţpakki||C10AA07|01.07.2003||R|||0|0|0|0|AZD|0|0|0|100|SEK|8599|12742|lyfalmen||||28|0|112,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||8599||8599|12742|
007186|C10AA0701|Crestor|filmhtfl|40|mg|98|stk|1|ţpakki||C10AA07|01.07.2003||R|||0|0|0|0|AZD|0|0|0|100|SEK|25903|35053|lyfalmen||||98|0|392,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||25903||25903|35053|
007223|B01AD1201|Ceprotin|sts|500|ae/hgl|1|hgl|1|pakki|+ 5 ml leysir|B01AD12|01.02.2002||R|||0|1|0|1|BAX|0|0|0|100|SEK|167863|212551|lyfsjukr||||1|0||Icepharma hf|Baxter|Prótein C||167863||167863|212551|
007268|B01AD1201|Ceprotin|sts|1000|ae/hgl|1|hgl|1|pakki|+ 10 ml leysir|B01AD12|01.02.2002||R|||0|1|0|1|BAX|0|0|0|100|SEK|320336|403904|lyfsjukr||||1|0||Icepharma hf|Baxter|Prótein C||320336||320336|403904|
007292|S01EE0301|Lumigan|augndr|0,3|mg/ml|3|ml|1|glös||S01EE03|01.04.2005||R|||0|0|*|0|ALL|0|0|0|100|SEK|3000|5083|lyfalmen|V0377|4354||3|0|30,0000|Vistor hf|Allergan|Bimatóprost||3000||3000|5083|
007297|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|204|stk|1|ţpakki||N07BA01|01.04.2002||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
007375|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|204|stk|1|ţpakki||N07BA01|01.04.2002||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||204|0|27,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
007378|J01XX0801|Zyvoxid|irl|2|mg/ml|300|ml|10|pokar||J01XX08|01.12.2001||R|||0|1|0|1|PER|0|0|0|100|DKK|99690|126993|lyfsjukr||||3000|0|5,0000|Icepharma hf|Pfizer ApS|Linezolíd||99690||99690|126993|
007385|A02BA0205|Zantac|töflur|150|mg|20|stk|1|ţpakki||A02BA02|01.09.1983||L|||0|0|0|0|GSK|0|0|0|100|IKR|||lyflausa||||20|0|10,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ranitidín||||||
007424|J01XX0801|Zyvoxid|töflur|600|mg|30|stk|1|ţpakki||J01XX08|01.12.2001||R|||0|1|0|1|PER|0|0|0|100|DKK|285002|359560|lyfsjukr||||30|0|15,0000|Icepharma hf|Pfizer ApS|Linezolíd||285002||285002|359560|
007434|S01ED5106|Xalcom|augndr|5,05|mg/ml|2,5|ml|1|glas|5mg/ml+50mcg/ml |S01ED51|01.12.2001||R|||0|0|*|0|PER|0|0|0|100|DKK|3276|5460|lyfalmen|V0374|4371||2|0|25,0000|Icepharma hf|Pfizer ApS|Tímólól í blöndum||3276||3276|5460|
007448|B05XC04|Cernevit|sts|||5|ml|10|hgl||B05XC|01.05.2002||R|||0|0|0|1|CPS|0|0|0|100|SEK|8623|12445|lyfsjukr||||50|0||Icepharma hf|Clintec parenteral SA|Vítamín||8623||8623|12445|
007449|V03AB3401|Fomepizole OPi|irţ|5|mg/ml|20|ml|5|hgl||V03AB34|01.09.2003||R|||0|0|0|1|OPO|0|0|0|100|XEU|119828|152267|lyfsjukr||||100|0||Swedish Orphan International AB|OPi Orphan Pharma international (S)|Fómepízól||119828||119828|152267|
007462|N01AB0801|Sevorane|innönd.l|||250|ml|1|plastf||N01AB08|01.03.2002||R|||0|0|0|1|ABS|0|0|0|100|DKK|23715|31645|lyfsjukr||||250|0||Vistor hf|Abbott Scandinavia AB|Sevóflúran||23715||23715|31645|
007494|QP52AA0101|Droncit vet.|hlaup|9|%|6,67|g|1|dćla|til inntöku|QP52AA01|01.04.2002||L|||0|0|0|0|BAN|0|0|0|100|DKK|1997|3484|vetorma||||7|0||Icepharma hf|Bayer Animal Health GmbH|||||1997|3484|
007505|G04BD0702|Detrusitol Retard|forđahlk|1,4|mg|30|stk|1|plglas||G04BD07|01.01.2001||R|||0|0|E|0|PER|0|0|0|100|DKK|6336|9646|lyfalmen||||30|0|10,5000|Icepharma hf|Pfizer ApS|Tólteródín||6336||6336|9646|
007534|C09CA0601|Atacand|töflur|16|mg|28|stk|1|ţpakki||C09CA06|01.02.1998||R|||0|0|0|0|AZD|0|0|0|100|SEK|3649|5971|lyfalmen|V0079|5971||28|0|56,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||3649||3649|5971|
007538|R03BA0701|Asmanex Twisthaler|innúđadu|400|mcg|30|skammtar|1|pakki||R03BA07|01.04.2003||R|||0|0|0|0|SPL|0|0|0|100|DKK|5029|7858|lyfalmen||||30|0|30,0000|Vistor hf|Schering-Plough Europe|Mometasón||5029||5029|7858|
007540|N02BE0111|Perfalgan|irl|10|mg/ml|100|ml|12|hgl||N02BE01|01.08.2003||R|||0|0|0|1|BRS|0|0|0|100|DKK|4558|6578|lyfsjukr||||1200|0|4,0000|Vistor hf|Bristol-Myers Squibb|Paracetamól||4558||4558|6578|
007541|J07BL0101|Stamaril|bóluefni|||0,5|ml|10|lykjur|+leysir|J07BL01|01.01.1996||R|||0|0|0|0|SPM|0|0|0|100|XEU|21764|29859|lyfalmen||||5|0||Icepharma hf|Sanofi Pasteur MSD|Gulusótt, veikluđ veira||21764||21764|29859|
007549|R03BA0701|Asmanex Twisthaler|innúđadu|400|mcg|60|skammtar|1|pakki||R03BA07|01.03.2003||R|||0|0|B|0|SPL|0|0|0|100|DKK|9802|14388|lyfalmen||||60|0|60,0000|Vistor hf|Schering-Plough Europe|Mometasón||9802||9802|14388|
007760|G04BD0702|Detrusitol Retard|forđahlk|2,8|mg|30|stk|1|plglas||G04BD07|01.01.2001||R|||0|0|E|0|PER|0|0|0|100|DKK|6505|9877|lyfalmen||||30|0|21,0000|Icepharma hf|Pfizer ApS|Tólteródín||6505||6505|9877|
007769|G04BD0702|Detrusitol Retard|forđahlk|2,8|mg|100|stk|1|plglas||G04BD07|01.01.2001||R|||0|0|E|0|PER|0|0|0|100|DKK|22083|30259|lyfalmen||||100|0|70,0000|Icepharma hf|Pfizer ApS|Tólteródín||22083||22083|30259|
007778|N05AX0802|Rison|töflur|0,5|mg|60|stk|1|glas||N05AX08|01.10.2001||R|||0|0|*|0|ACA|0|1|0|100|IKR|1728|3099|lyfalmen|V0290|3099||60|0|6,0000|Actavis Group hf|Actavis hf|Risperídón||1550||1550|3099|
007852|G02BB0101|NuvaRing|sk-hring|||3|stk|1|pakki|međ forđaverkun|G02BB01|01.11.2002||R|||0|0|0|0|ORG|0|0|0|100|DKK|4059|6531|lyfalmen||||3|0|84,0000|Vistor hf|N.V. Organon|Skeiđarinnleg međ progestógeni og östrógeni||4059||4059|6531|
007878|V07AB0001|Sterilt vatten Baxter Viaflo|leysir|||50|ml|50|pokar|leysir f.stungulyf|V07AB00|01.08.2005||L|||0|0|0|0|BAM|0|0|0|100|IKR|||lyflausa||||2500|0||Icepharma hf|Baxter Medical AB|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar||||||
007889|V07AB0002|Sterilt Vand "Baxter" Viaflo|leysir|||100|ml|50|pokar|leysir f.stungulyf|V07AB00|01.02.2006||L|||0|0|0|0|BAX|0|0|0|100|IKR|||lyflausa||||5000|0||Icepharma hf|Baxter|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar||||||
007921|S01GX0901|Opatanol|augndr|1|mg/ml|5|ml|1|glas||S01GX09|01.05.2004||R|||0|0|0|0|ALC|0|0|0|100|USD|1386|2875|lyfalmen||||5|0||K.Pétursson hf|Alcon|Ólópatadín||1386||1386|2875|
007978|B01AD1001|Xigris|irs|20|mg|1|hgl|1|pakki|lausn|B01AD10|01.11.2002|30.06.2012|R|||0|1|0|1|ELD|0|0|0|100|XEU|185394|234552|lyfsjukr||||1|0|0,5000|Icepharma hf|Eli Lilly Nederland B.V.|Drotrecogin alfa (virkjađ)||185394||185394|234552|
007986|D07AA0208|Mildison Lipid|krem|10|mg/g|15|g|1|túpa|feitt|D07AA02|01.01.1990||L|||0|0|0|0|ASP|0|0|1|100|IKR|||lyflausa||||15|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón||||||
007995|R07AX0101|INOmax|innö.gas|400|ppm|10|l|1|gashyl||R07AX01|01.01.2004||R|||0|1|0|1|AGA|0|0|0|100|XEU|20782|27964|lyfsjukr||||10|0||Ísaga ehf|AGA AB|Nituroxíđ||20782||20782|27964|
007997|H02AB0104|Betapred|lausnart|0,5|mg|30|stk|1|glas||H02AB01|01.09.1998||R|||0|0|E|0|LOL|0|0|1|100|IKR|729|1976|lyfalmen||||30|1|10,0000|Lyfjaver ehf|Lyfjaver- óskráđ|Betametasón||729||729|1976|
008010|B01AD1001|Xigris|irs|5|mg|1|hgl|1|pakki|lausn|B01AD10|01.11.2002|30.06.2012|R|||0|1|0|1|ELD|0|0|0|100|XEU|46355|60058|lyfsjukr||||1|0|0,1300|Icepharma hf|Eli Lilly Nederland B.V.|Drotrecogin alfa (virkjađ)||46355||46355|60058|
008023|A10BA0201|Glucophage|töflur|1000|mg|30|stk|1|ţpakki||A10BA02|01.01.2002||R|||0|0|*|0|MCK|0|0|0|100|SEK|607|1809|lyfalmen||||30|0|15,0000|Icepharma hf|Merck Santé s.a.s.|Metformín||607||607|1809|
008058|B05BA1011|Oliclinomel N4 550E|irl|||1500|ml|4|plpok|fleyti|B05BA10|01.06.2002||R|||0|0|0|1|BAM|0|0|0|100|SEK|23782|31729|lyfsjukr||||6000|0||Icepharma hf|Baxter Medical AB|Blöndur||23782||23782|31729|
008069|B05BA1011|Oliclinomel N4 550E|irl|||2000|ml|4|plpok|fleyti|B05BA10|01.06.2002||R|||0|0|0|1|BAM|0|0|0|100|SEK|29506|38913|lyfsjukr||||8000|0||Icepharma hf|Baxter Medical AB|Blöndur||29506||29506|38913|
008097|N02CC0402|Maxalt Smelt|munnltfl|5|mg|6|stk|1|ţpakki||N02CC04|01.03.2003||R|||0|0|E|0|MSD|0|0|0|100|DKK|5586|8620|lyfalmen||||6|0|3,0000|Vistor hf|M.S.D.|Rizatriptan||5586||5586|8620|
008101|L03AB1001|PegIntron|sts|50|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.12.2002||R|||0|1|0|1|SCP|0|0|0|100|DKK|56016|72183|lyfsjukr||||4|0|26,6700|Vistor hf|Schering-Plough|Peginterferón alfa 2b||56016||56016|72183|
008108|L03AB1001|PegIntron|sts|100|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.12.2002||R|||0|1|0|1|SCP|0|0|0|100|DKK|112032|142483|lyfsjukr||||4|0|53,3300|Vistor hf|Schering-Plough|Peginterferón alfa 2b||112032||112032|142483|
008131|L03AB1001|PegIntron|sts|80|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.08.2003||R|||0|1|0|1|SCP|0|0|0|100|DKK|89276|113924|lyfsjukr||||4|0|42,6700|Vistor hf|Schering-Plough|Peginterferón alfa 2b||89276||89276|113924|
008134|L03AB1001|PegIntron|sts|120|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.08.2003||R|||0|1|0|1|SCP|0|0|0|100|DKK|132069|167629|lyfsjukr||||4|0|64,0000|Vistor hf|Schering-Plough|Peginterferón alfa 2b||132069||132069|167629|
008145|L03AB1001|PegIntron|sts|150|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.12.2002||R|||0|1|0|1|SCP|0|0|0|100|DKK|155142|196586|lyfsjukr||||4|0|80,0000|Vistor hf|Schering-Plough|Peginterferón alfa 2b||155142||155142|196586|
008194|D07AA0208|Mildison Lipid|krem|10|mg/g|30|g|1|túpa|feitt|D07AA02|01.01.1990||L|||0|0|0|0|ASP|0|0|1|100|IKR|||lyflausa||||30|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón||||||
008196|D07AA0208|Mildison Lipid|krem|10|mg/g|100|g|1|túpa|feitt|D07AA02|01.01.1990||R|||0|0|B|0|ASP|0|0|1|100|XEU|1546|3094|lyfalmen||||100|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón||1546||1546|3094|
008219|D07AC0101|Betnovat|húđfl|1|mg/ml|20|ml|1|plglas||D07AC01|01.12.1980||R|||0|0|B|0|GSK|0|0|1|100|GBP|302|1392|lyfalmen||||20|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Betametasón||302||302|1392|
008223|B05BA1013|Oliclinomel N6 900E|irl|||1000|ml|6|plpok|fleyti|B05BA10|01.06.2002||R|||0|0|0|1|BAM|0|0|0|100|SEK|36795|48060|lyfsjukr||||6000|0||Icepharma hf|Baxter Medical AB|Blöndur||36795||36795|48060|
008234|B05BA1013|Oliclinomel N6 900E|irl|||1500|ml|4|plpok|fleyti|B05BA10|01.06.2002||R|||0|0|0|1|BAM|0|0|0|100|SEK|28812|38042|lyfsjukr||||6000|0||Icepharma hf|Baxter Medical AB|Blöndur||28812||28812|38042|
008243|D07AC0101|Betnovat|húđlausn|1|mg/g|30|ml|1|plglas|í hársvörđ|D07AC01|01.01.1985||R|||0|0|B|0|GSK|0|0|1|100|GBP|590|1786|lyfalmen||||30|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Betametasón||590||590|1786|
008245|B05BA1013|Oliclinomel N6 900E|irl|||2000|ml|4|plpok|fleyti|B05BA10|01.06.2002||R|||0|0|0|1|BAM|0|0|0|100|SEK|33665|44132|lyfsjukr||||8000|0||Icepharma hf|Baxter Medical AB|Blöndur||33665||33665|44132|
008301|N02AX0209|Tramol-L|forđatfl|100|mg|20|stk|1|ţpakki||N02AX02|01.04.2002||R|||0|0|E|0|ACA|0|0|1|100|XEU|903|2061|lyfalmen||||20|0|6,6700|Actavis Group hf|Actavis hf|Tramadól||791||791|2061|
008326|D07AC0101|Betnovat|húđlausn|1|mg/g|100|ml|1|plglas|í hársvörđ|D07AC01|01.07.1988||R|||0|0|B|0|GSK|0|0|1|100|GBP|1331|2800|lyfalmen||||100|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Betametasón||1331||1331|2800|
008338|N02AX0209|Tramol-L|forđatfl|100|mg|100|stk|1|ţpakki||N02AX02|01.04.2002||R|||0|0|E|0|ACA|0|0|1|100|XEU|2917|4969|lyfalmen|V0226|4969||100|0|33,3300|Actavis Group hf|Actavis hf|Tramadól||2917||2917|4969|
008360|N02AX0209|Tramol-L|forđatfl|150|mg|100|stk|1|ţpakki||N02AX02|01.04.2002||R|||0|0|E|0|ACA|0|0|1|100|XEU|4835|7593|lyfalmen|V0227|7593||100|0|50,0000|Actavis Group hf|Actavis hf|Tramadól||4835||4835|7593|
008368|N02AX0209|Tramol-L|forđatfl|200|mg|100|stk|1|ţpakki||N02AX02|01.04.2002||R|||0|0|E|0|ACA|0|0|1|100|XEU|6524|9784|lyfalmen|V0228|9784||100|0|66,6700|Actavis Group hf|Actavis hf|Tramadól||6437||6437|9784|
008370|V04CJ0101|Thyrogen|sts|0,9|mg/hgl|2|hgl|1|pakki|lausn|V04CJ01|01.01.2006||R|||0|1|0|1|GEZ|0|0|0|100|XEU|155763|197365|lyfsjukr||||2|0||Vistor hf|Genzyme BV|Thýrótrópín||155763||155763|197365|
008396|H03AA0104|Euthyrox|töflur|50|mcg|100|stk|1|ţpakki||H03AA01|01.05.2002||R|||0|0|B|0|MKA|0|0|0|100|SEK|823|2105|lyfalmen|V0153|2105||100|0|33,3300|Icepharma hf|Merck KgaA|Levótýroxínnatríum||823||823|2105|
008435|H03AA0104|Euthyrox|töflur|100|mcg|100|stk|1|ţpakki||H03AA01|01.05.2002||R|||0|0|B|0|MKA|0|0|0|100|SEK|715|1957|lyfalmen|V0154|1957||100|0|66,6700|Icepharma hf|Merck KgaA|Levótýroxínnatríum||715||715|1957|
008484|QP52AC1303|Zerofen, vet.|mixtúra|10|%|1000|ml|1|plbrús||QP52AC13|01.11.2001||R|||0|0|0|0|CHP|0|0|0|100|USD|5342|9319|vetorma||||1000|0||Icepharma hf|Chanelle Pharmaceuticals |||5342||5342|9319|
008497|QN05CM9203|Chanazine, vet.|stl|10|%|50|ml|1|hgl||QN05CM92|01.11.2001||R|||0|0|0|0|CHP|1|0|0|100|XEU|12862|24870|vetalmen||||50|0||Icepharma hf|Chanelle Pharmaceuticals |||12862||12862|24870|
008498|R06AX2201|Kestine|töflur|10|mg|10|stk|1|ţpakki||R06AX22|01.04.1998||L|||0|0|0|0|APS|0|0|1|100|IKR|||lyflausa||||10|0|10,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín||||||
008523|R06AX2201|Kestine|töflur|10|mg|100|stk|1|ţpakki||R06AX22|01.04.1998||R|||0|0|E|0|APS|0|0|1|100|DKK|4298|6858|lyfalmen||||100|0|100,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín||4298||4298|6858|31.05.2012
008534|R06AX2201|Kestine|töflur|10|mg|30|stk|1|ţpakki||R06AX22|01.04.1998||L|||0|0|0|0|APS|0|0|1|100|IKR|||lyflausa||||30|0|30,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín||||||
008545|G03FB0506|NovoFem|filmhtfl|||84|stk|1|skífup|1+1mg|G03FB05|01.06.2002||R|||0|0|E|0|NAS|0|0|0|100|DKK|2931|4988|lyfalmen||||84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Noretísterón og östrógen||2931||2931|4988|
008745|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|24|stk|1|ţpakki||N07BA01|01.12.2003||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||24|0|1,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
008767|L03AB1101|Pegasys|stl|135|mcg/spr|0,5|ml|4|spr|áfyllt sprauta|L03AB11|01.11.2002||R|||0|1|0|1|RRL|0|0|0|100|DKK|110718|140834|lyfsjukr||||2|0|20,7700|Icepharma hf|Roche Registration Limited|Peginterferón alfa 2a||110718||110718|140834|
008768|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|24|stk|1|ţpakki||N07BA01|01.12.2003||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||24|0|3,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
008782|L03AB1101|Pegasys|stl|180|mcg/spr|0,5|ml|4|spr|áfyllt sprauta|L03AB11|01.11.2002||R|||0|1|0|1|RRL|0|0|0|100|DKK|116794|148459|lyfsjukr||||2|0|27,6900|Icepharma hf|Roche Registration Limited|Peginterferón alfa 2a||116794||116794|148459|
008831|D11AH0201|Elidel|krem|1|%|15|g|1|túpa||D11AH02|01.11.2002||R|||0|0|E|0|MAB|0|0|1|100|DKK|3122|5250|lyfalmen||||15|0||Vistor hf|Meda AB|Pímekrólímus||3122||3122|5250|
008888|C09DA0601|Atacand Plus|töflur|28,5|mg|28|stk|1|ţpakki|16 + 12,5 mg|C09DA06|01.01.2001||R|||0|0|0|0|AZD|0|0|0|100|SEK|3791|6165|lyfalmen||||28|0|28,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og ţvagrćsilyf||3791||3791|6165|30.04.2012
008904|D10AF0101|Dalacin|lausn|10|mg/ml|60|ml|1|glas|Áburđur, lausn|D10AF01|01.01.1994||R|||0|0|0|0|PER|0|0|0|100|DKK|1964|3666|lyfalmen||||60|0||Icepharma hf|Pfizer ApS|Klindamýcín||1964||1964|3666|
008927|G04BE0801|Cialis|filmhtfl|20|mg|4|stk|1|ţpakki||G04BE08|01.02.2003||R|||0|0|0|0|LIL|0|0|0|100|XEU|6120|9351|lyfalmen|V0145|8837||4|0|8,0000|Icepharma hf|Lilly ICOS Limited|Tadalafíl||||6120|9351|
008950|G04BE0801|Cialis|filmhtfl|20|mg|8|stk|1|ţpakki||G04BE08|01.02.2003||R|||0|0|0|0|LIL|0|0|0|100|XEU|12055|17674|lyfalmen|V0145|17674||8|0|16,0000|Icepharma hf|Lilly ICOS Limited|Tadalafíl||||12055|17674|
009065|D11AH0201|Elidel|krem|1|%|30|g|1|túpa||D11AH02|01.11.2002||R|||0|0|E|0|MAB|0|0|1|100|DKK|5267|8184|lyfalmen||||30|0||Vistor hf|Meda AB|Pímekrólímus||5267||5267|8184|
009113|B05DB0005|Balance|kviđ.sk|1,5|%|2500|ml|4|pokar|lausn|B05DB|01.04.2011||R|||0|0|0|1|FMC|0|0|0|100|XEU|8878|12813|lyfsjukr||||10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||8878||8878|12813|
009213|B05DB0005|Balance|kviđ.sk|2,3|%|2500|ml|4|pokar|lausn|B05DB|01.04.2011||R|||0|0|0|1|FMC|0|0|0|100|XEU|8878|12813|lyfsjukr||||10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||8878||8878|12813|
009214|M01AH0401|Dynastat|sts|40|mg/hgl|10|hgl|1|pakki||M01AH04|01.06.2002||R|||0|0|0|0|IPI|0|0|1|100|DKK|14503|20746|lyfalmen||||10|0|10,0000|Icepharma hf|Pfizer Limited|Parekoxíb||14503||14503|20746|
009216|B05DB0005|Balance|kviđ.sk|4,25|%|2500|ml|4|pokar|lausn|B05DB|01.04.2011||R|||0|0|0|1|FMC|0|0|0|100|XEU|8878|12813|lyfsjukr||||10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||8878||8878|12813|
009278|J02AC0301|Vfend|töflur|50|mg|30|stk|1|ţpakki||J02AC03|01.11.2002||R|||0|0|0|1|PER|0|0|0|100|DKK|52904|68277|lyfsjukr||||30|0|3,7500|Icepharma hf|Pfizer ApS|Voricónazól||52904||52904|68277|
009282|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|20|ml|20|lykjur|fyrir stl|V07AB|01.07.1995||L|||0|0|0|0|FRP|0|0|0|100|DKK|||lyfalmen||||400|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar|||||1824|
009285|D11AH0101|Protopic|smyrsli|0,03|%|30|g|1|túpa||D11AH01|01.07.2003||R|||0|0|E|0|ASP|0|0|1|100|XEU|5517|8526|lyfalmen||||30|0||Vistor hf|Astellas Pharma A/S|Takrólímus||5517||5517|8526|
009340|V07AB13|Sterilt vatten/vann/vand  Fresenius Kabi|leysir|||20|ml|20|plastl|fyrir stungulyf|V07AB|01.10.1994||L|||0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa||||400|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar||||||
009409|G03CA0316|Vivelle Dot|forđapl|37,5|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|||0|0|E|0|NOH|0|0|0|100|DKK|1157|2562|lyfalmen||||8|0|21,0000|Vistor hf|Novartis Healthcare A/S-|Estradíól||1157||1157|2562|
009443|G03CA0316|Vivelle Dot|forđapl|50|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|||0|0|E|0|NOH|0|0|0|100|DKK|1276|2724|lyfalmen|V0130|1658||8|0|28,0000|Vistor hf|Novartis Healthcare A/S-|Estradíól||1276||1276|2724|
009465|G03CA0316|Vivelle Dot|forđapl|75|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|||0|0|E|0|NOH|0|0|0|100|DKK|1476|2998|lyfalmen|V0131|2428||8|0|42,0000|Vistor hf|Novartis Healthcare A/S-|Estradíól||1476||1476|2998|
009489|G03CA0316|Vivelle Dot|forđapl|100|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|||0|0|E|0|NOH|0|0|0|100|DKK|1849|3508|lyfalmen|V0132|2695||8|0|56,0000|Vistor hf|Novartis Healthcare A/S-|Estradíól||1849||1849|3508|
009525|B05DB0005|Balance|kviđ.sk|1,5|%|2000|ml|4|pokar|lausn|B05DB|01.11.2009||R|||0|0|0|1|FMC|0|0|0|100|XEU|7344|10599|lyfsjukr||||8000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||7344||7344|10599|
009560|B05DB0005|Balance|kviđ.sk|4,25|%|2000|ml|4|pokar|lausn|B05DB|01.11.2009||R|||0|0|0|1|FMC|0|0|0|100|XEU|7344|10599|lyfsjukr||||8000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||7344||7344|10599|
009591|B05DB0005|Balance|kviđ.sk|2,3|%|2000|ml|4|pokar|lausn|B05DB|01.11.2009||R|||0|0|0|1|FMC|0|0|0|100|XEU|7344|10599|lyfsjukr||||8000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||7344||7344|10599|
009609|J02AC0301|Vfend|töflur|200|mg|30|stk|1|ţpakki||J02AC03|01.11.2002||R|||0|0|0|1|PER|0|0|0|100|DKK|201950|255330|lyfsjukr||||30|0|15,0000|Icepharma hf|Pfizer ApS|Voricónazól||201950||201950|255330|
009649|D11AH0101|Protopic|smyrsli|0,1|%|30|g|1|túpa||D11AH01|01.07.2003||R|||0|0|E|0|ASP|0|0|1|100|XEU|5343|8288|lyfalmen||||30|0||Vistor hf|Astellas Pharma A/S|Takrólímus||5343||5343|8288|
009679|J05AF0701|Viread|filmhtfl|245|mg|30|stk|1|glas||J05AF07|01.04.2003||R|||0|1|0|1|GIS|0|0|0|100|DKK|60432|77725|lyfsjukr||||30|0|30,0000|Gilead Sience Sweden AB|Gilead Science International ltd.|Tenófóvír dísóproxíl||60432||60432|77725|
009900|N01BB0303|Carbocain dental|stl|30|mg/ml|1,8|ml|100|rörlyk|sjálfs|N01BB03|01.03.1984||R|||0|0|0|0|DPL|0|0|1|100|XEU|8822|13047|lyfalmen||||180|0||Vistor hf|Dentsply Limited|Mepívakaín||8822||8822|13047|
009905|N01BB5402|Citanest Dental Octapressin|stl|||1,8|ml|100|rörlyk||N01BB54|01.12.1983||R|||0|0|0|0|DPL|0|0|1|100|XEU|8303|12337|lyfalmen||||180|0||Vistor hf|Dentsply Limited|Prílókaín í blöndum||8303||8303|12337|
009911|N01BB5204|Xylocain Dental adrenalin|stl|20|mg/ml|1,8|ml|100|rörlyk|20mg+12.5mcg/ml|N01BB52|01.12.1983||R|||0|0|0|0|DPL|0|0|1|100|XEU|8148|12125|lyfalmen||||180|0||Vistor hf|Dentsply Limited|Lídókaín í blöndum||8148||8148|12125|
009942|N01BB5402|Citanest Dental Octapressin|stl|||1,8|ml|100|rörlyk|sjálfsog|N01BB54|01.12.1983||R|||0|0|0|0|DPL|0|0|1|100|XEU|9549|14041|lyfalmen||||180|0||Vistor hf|Dentsply Limited|Prílókaín í blöndum||9549||9549|14041|
009945|N01BB5204|Xylocain Dental adrenalin|stl|20|mg/ml|1,8|ml|100|rörlyk|20mg+12.5mcg/ml-sjálfsog|N01BB52|01.12.1983||R|||0|0|0|0|DPL|0|0|1|100|XEU|8318|12358|lyfalmen||||180|0||Vistor hf|Dentsply Limited|Lídókaín í blöndum||8318||8318|12358|
009947|N01BB0303|Carbocain dental|stl|30|mg/ml|1,8|ml|100|rörlyk||N01BB03|01.12.1983||R|||0|0|0|0|DPL|0|0|1|100|XEU|8176|12163|lyfalmen||||180|0||Vistor hf|Dentsply Limited|Mepívakaín||8176||8176|12163|
010002|N06AX1102|Remeron Smelt|munndr.t|15|mg|30|stk|1|ţpakki||N06AX11|01.05.2003||R|||0|0|0|0|ORG|0|1|0|100|DKK|2204|3994|lyfalmen|V0329|2492||30|0|15,0000|Vistor hf|N.V. Organon|Mirtazapín||2204||2204|3994|
010035|N06AX1102|Remeron Smelt|munndr.t|30|mg|30|stk|1|ţpakki||N06AX11|01.05.2003||R|||0|0|0|0|ORG|0|1|0|100|DKK|4195|6717|lyfalmen|V0330|2869||30|0|30,0000|Vistor hf|N.V. Organon|Mirtazapín||4195||4195|6717|
010057|N06AX1102|Remeron Smelt|munndr.t|45|mg|30|stk|1|ţpakki||N06AX11|01.05.2003||R|||0|0|0|0|ORG|0|1|0|100|DKK|5995|9180|lyfalmen||||30|0|45,0000|Vistor hf|N.V. Organon|Mirtazapín||5995||5995|9180|
010182|J05AB1401|Valcyte|filmhtfl|450|mg|60|stk|1|plglas||J05AB14|01.11.2002||R|||0|0|0|1|ROA|0|0|0|100|DKK|229763|290235|lyfsjukr||||60|0|30,0000|Icepharma hf|Roche A.S.|Valgancíklóvír||229763||229763|290235|
010234|J01DH0301|Invanz|irs|1|g/hgl|1|hgl|1|pakki||J01DH03|01.08.2002||R|||0|1|0|1|MSD|0|0|0|100|DKK|7368|10634|lyfsjukr||||1|0|1,0000|Vistor hf|M.S.D.|Ertapenem||7368||7368|10634|
010240|N06AX1102|Remeron Smelt|munndr.t|30|mg|96|stk|1|ţpakki||N06AX11|01.05.2003||R|||0|0|0|0|ORG|0|1|0|100|DKK|13022|18888|lyfalmen|V0331|5280||96|0|96,0000|Vistor hf|N.V. Organon|Mirtazapín||13022||13022|18888|
010254|N06AX1102|Remeron Smelt|munndr.t|45|mg|96|stk|1|ţpakki||N06AX11|01.05.2003||R|||0|0|0|0|ORG|0|1|0|100|DKK|18361|25588|lyfalmen|V0332|8680||96|0|144,0000|Vistor hf|N.V. Organon|Mirtazapín||18361||18361|25588|
010290|N06DX0101|Ebixa|dropar|10|mg/g|50|g|1|fl||N06DX01|01.08.2010||R|||0|0|E|0|LBK|0|0|0|100|DKK|14514|20760|lyfalmen||||50|0|25,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||||14514|20760|
010334|N06DX0101|Ebixa|töflur|10|mg|100|stk|1|ţpakki||N06DX01|01.10.2002||R|||0|0|E|0|LBK|0|0|0|100|DKK|23528|32073|lyfalmen||||100|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||23528||23528|32073|
010339|C09DA0701|MicardisPlus|töflur|92,5|mg|28|stk|1|ţpakki|80 + 12,5 mg|C09DA07|01.02.2008||R|||0|0|0|0|BII|0|0|0|100|DKK|3760|6122|lyfalmen||||28|0|28,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan og ţvagrćsilyf||3760||3760|6122|
010348|J07BB0203|Vaxigrip|bóluefni|||0,5|ml|10|spr|einnotaspr|J07BB02|01.10.1995||R|||0|0|0|0|SPM|0|0|0|100|XEU|7471|11199|lyfalmen||||5|0||Icepharma hf|Sanofi Pasteur MSD|Inflúensa, hreinsađir  mótefnavakar||7471||7471|11199|
010361|C09DA0701|MicardisPlus|töflur|92,5|mg|98|stk|1|ţpakki|80 + 12,5 mg|C09DA07|01.02.2008||R|||0|0|0|0|BII|0|0|0|100|DKK|12729|18520|lyfalmen||||98|0|98,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan og ţvagrćsilyf||12729||12729|18520|
010437|QI09AB1301|Stellamune One|stl|||100|ml|10|glös|Fleyti|QI09AB13|01.09.2008||R|||0|0|0|0|ELA|0|0|0|100|DKK|75111|131027|vetorma||||1000|0||Icepharma hf|Elanco Animal Health A/S|Óvirkar bakteríur í bóluefnum||75111||75111|131027|
010446|A07EC0204|Asacol|sh-tfl|800|mg|60|stk|1|ţpakki||A07EC02|01.01.2003||R|||0|0|B|0|TIL|0|0|0|100|SEK|6858|10360|lyfalmen||||60|0|32,0000|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||6858||6858|10360|
010464|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|50|ml|50|pokar|lausn|B05BB01|01.11.2002||R|||0|0|0|1|BAM|0|0|0|100|SEK|7268|10490|lyfsjukr||||2500|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||7268||7268|10490|
010534|B05BA0108|Vaminolac|irl|||100|ml|10|fl||B05BA01|01.03.2004||R|||0|0|0|1|FRP|0|0|0|100|DKK|9347|13490|lyfsjukr||||1000|0||Icepharma hf|Fresenius Kabi|Amínósýrur||9347||9347|13490|
010573|S01AX1901|Oftaquix|augndr|5|mg/ml|5|ml|1|glas||S01AX19|01.08.2002||R|||0|0|0|0|SAO|0|0|1|100|XEU|1203|2625|lyfalmen||||5|0||Icepharma hf|Santen Oy|Levófloxacín||1203||1203|2625|
010591|M05BA0702|Optinate Septimum|filmhtfl|35|mg|4|stk|1|ţpakki||M05BA07|01.12.2002||R|||0|0|0|0|SNO|0|0|0|100|NOK|5743|8835|lyfalmen|V0207|1213||4|0|28,0000|Vistor hf|Sanofi-aventis Norge AS|Rísedrónsýru||5743||5743|8835|
010669|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|250|ml|30|pokar|lausn|B05BA03|01.11.2002||R|||0|0|0|1|BAM|0|0|0|100|SEK|5964|8608|lyfsjukr||||7500|0||Icepharma hf|Baxter Medical AB|Kolvetni||5964||5964|8608|
010672|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|100|ml|50|pokar|lausn|B05BA03|01.11.2002||R|||0|0|0|1|BAM|0|0|0|100|SEK|9172|13237|lyfsjukr||||5000|0||Icepharma hf|Baxter Medical AB|Kolvetni||9172||9172|13237|
010683|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|500|ml|20|pokar|lausn|B05BA03|01.11.2002||R|||0|0|0|1|BAM|0|0|0|100|SEK|4057|5855|lyfsjukr||||10000|0||Icepharma hf|Baxter Medical AB|Kolvetni||4057||4057|5855|
010691|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|1000|ml|10|pokar|lausn|B05BA03|01.11.2002||R|||0|0|0|1|BAM|0|0|0|100|SEK|2326|3357|lyfsjukr||||10000|0||Icepharma hf|Baxter Medical AB|Kolvetni||2326||2326|3357|
010705|A02BC0110|Omeprazol ratiopharm|sţ-hylki|20|mg|28|stk|1|glas|hart|A02BC01|01.02.2012||L|||0|0|0|0|RAT|0|0|0|100|IKR|||lyflausa||||28|0|28,0000|LYFIS ehf|ratiopharm GmbH|Ómeprazól||||||
010706|S01EE0301|Lumigan|augndr|0,3|mg/ml|3|ml|3|glös||S01EE03|01.04.2005||R|||0|0|*|0|ALL|0|0|0|100|SEK|8833|13062|lyfalmen|V0377|13062||9|0|90,0000|Vistor hf|Allergan|Bimatóprost||8833||8833|13062|
010707|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|100|ml|50|pokar|lausn|B05BB01|01.11.2002||R|||0|0|0|1|BAM|0|0|0|100|SEK|9160|13220|lyfsjukr||||5000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||9160||9160|13220|
010716|A02BC0110|Omeprazol ratiopharm|sţ-hylki|20|mg|56|stk|1|glas|hart|A02BC01|01.02.2012||R|||0|0|E|0|RAT|0|0|0|100|XEU|2486|3153|lyfalmen|V0006|2617||56|0|56,0000|LYFIS ehf|ratiopharm GmbH|Ómeprazól||1589||1589|3153|
010729|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|250|ml|30|pokar|lausn|B05BB01|01.11.2002||R|||0|0|0|1|BAM|0|0|0|100|SEK|6576|9491|lyfsjukr||||7500|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||6576||6576|9491|
010740|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|500|ml|20|pokar|lausn|B05BB01|01.11.2002||R|||0|0|0|1|BAM|0|0|0|100|SEK|3992|5761|lyfsjukr||||10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||3992||3992|5761|
010746|M05BA0702|Optinate Septimum|filmhtfl|35|mg|12|stk|1|ţpakki||M05BA07|01.12.2002||R|||0|0|0|0|SNO|0|0|0|100|NOK|14847|5983|lyfalmen|V0207|3640||12|0|84,0000|Vistor hf|Sanofi-aventis Norge AS|Rísedrónsýru||3658||3658|5983|
010760|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|1000|ml|10|pokar|lausn|B05BB01|01.11.2002||R|||0|0|0|1|BAM|0|0|0|100|SEK|2149|3102|lyfsjukr||||10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||2149||2149|3102|
010804|C02KX0101|Tracleer|filmhtfl|62,5|mg|56|stk|1|ţpakki||C02KX01|01.11.2003||R|||0|1|0|1|ACT|0|0|0|100|DKK|358771|452140|lyfsjukr||||56|0|14,0000|Lyfjaver ehf|Actelion Registration Ltd.|Bósentan||358771||358771|452140|
010826|C02KX0101|Tracleer|filmhtfl|125|mg|56|stk|1|ţpakki||C02KX01|01.11.2003||R|||0|1|0|1|ACL|0|0|0|100|DKK|358771|452140|lyfsjukr||||56|0|28,0000|Actelion Registration Ltd|Actelion Registration Ltd.|Bósentan||358771||358771|452140|
010890|A02BC0107|Lomex-T|sh-tfl|20|mg|28|stk|1|glas||A02BC01|01.06.2002||R|||0|0|0|0|ACA|0|0|0|100|XEU|1377|2055|lyfalmen||||28|0|28,0000|Actavis Group hf|Actavis hf|Ómeprazól||787||787|2055|
010900|A01AB0301|Corsodyl|munnh.l|2|mg/ml|300|ml|1|fl||A01AB03|01.07.1986||L|||0|0|0|0|SMB|0|0|1|100|IKR|||lyflausa||||300|0|20,0000|GlaxoSmithKline ehf|SmithKline Beecham Ltd|Klórhexidín||||||
010912|A02BC0107|Lomex-T|sh-tfl|20|mg|100|stk|1|glas||A02BC01|01.06.2002||R|||0|0|E|0|ACA|0|0|0|100|XEU|5005|5605|lyfalmen|V0006|4674||100|0|100,0000|Actavis Group hf|Actavis hf|Ómeprazól||3382||3382|5605|
010923|A02BC0107|Lomex-T|sh-tfl|20|mg|56|stk|1|glas||A02BC01|01.06.2002||R|||0|0|E|0|ACA|0|0|0|100|XEU|3227|3150|lyfalmen|V0006|2617||56|0|56,0000|Actavis Group hf|Actavis hf|Ómeprazól||1587||1587|3150|
010924|L01DC0103|Bleomycin Baxter|sts|15000|ae|10|hgl|1|pakki||L01DC01|01.04.1998||R|||0|1|0|1|BAM|0|0|0|100|SEK|48995|63371|lyfsjukr||||10|0||Icepharma hf|Baxter Medical AB|Bleómýcín||48995||48995|63371|
010935|J01CF0201|Ekvacillin|sts/irs|1|g|10|hgl|1|pakki||J01CF02|01.10.2003||R|||0|0|0|1|REP|0|0|0|100|SEK|3172|4578|lyfsjukr||||10|0|5,0000|Vistor hf|Recip AB|Kloxacillín||3172||3172|4578|
010938|A02BC0304|Lanzo Melt|munndr.t|15|mg|28|stk|1|ţpakki||A02BC03|01.01.2004||R|||0|0|0|0|PER|0|0|0|100|DKK|3013|5101|lyfalmen||||28|0|14,0000|Icepharma hf|Pfizer ApS|Lansóprazól||3013||3013|5101|
010951|N05AX1201|Abilify|töflur|10|mg|28|stk|1|ţpakki||N05AX12|01.01.2005||R|||0|0|0|0|OTS|0|1|0|100|DKK|20546|28330|lyfalmen||||28|0|18,6670|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||20546||20546|28330|
010953|N05AX1201|Abilify|töflur|15|mg|28|stk|1|ţpakki||N05AX12|01.01.2005||R|||0|0|0|0|OTS|0|1|0|100|DKK|20307|28030|lyfalmen||||28|0|28,0000|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||20307||20307|28030|
010959|A01AB0301|Corsodyl|munnh.hl|10|mg/g|50|g|1|túpa||A01AB03|01.09.1982||L|||0|0|0|0|SMB|0|0|1|100|IKR|||lyflausa||||50|0|16,6667|GlaxoSmithKline ehf|SmithKline Beecham Ltd|Klórhexidín||||||
011008|N05AX1201|Abilify|töflur|10|mg|56|stk|1|ţpakki||N05AX12|01.01.2005||R|||0|0|0|0|OTS|0|1|0|100|DKK|34983|46449|lyfalmen||||56|0|37,3330|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||34983||34983|46449|
011019|N05AX1201|Abilify|töflur|15|mg|56|stk|1|ţpakki||N05AX12|01.01.2005||R|||0|0|0|0|OTS|0|1|0|100|DKK|34745|46150|lyfalmen||||56|0|56,0000|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||34745||34745|46150|
011163|A07EA0601|Entocort|forđahlk|3|mg|100|stk|1|glas||A07EA06|01.10.1996||R|||0|0|B|0|AZD|0|0|0|100|SEK|19107|26524|lyfalmen||||100|0|33,3300|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||19107||19107|26524|
011207|M01AH0501|Arcoxia|filmhtfl|60|mg|28|stk|1|ţpakki||M01AH05|01.10.2002||R|||0|0|E|0|MSD|0|0|1|100|DKK|4589|7256|lyfalmen||||28|0|28,0000|Vistor hf|M.S.D.|Etoríkoxíb||4589||4589|7256|
011271|M01AH0501|Arcoxia|filmhtfl|90|mg|28|stk|1|ţpakki||M01AH05|01.10.2002||R|||0|0|E|0|MSD|0|0|1|100|DKK|4768|7501|lyfalmen||||28|0|42,0000|Vistor hf|M.S.D.|Etoríkoxíb||4768||4768|7501|
011314|N06AB1001|Cipralex|töflur|20|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|||0|0|0|0|LBK|0|1|0|100|DKK|20647|26858|lyfalmen|V0327|5399||100|0|200,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||19373||19373|26858|
011326|M01AH0501|Arcoxia|filmhtfl|120|mg|7|stk|1|ţpakki||M01AH05|01.01.2010||R|||0|0|E|0|MSD|0|0|1|100|DKK|1217|2644|lyfalmen||||7|0|14,0000|Vistor hf|M.S.D.|Etoríkoxíb||1217||1217|2644|
011335|C09CA0102|Lopress|töflur|12,5|mg|28|stk|1|glas||C09CA01|01.11.2002||R|||0|0|0|0|ACA|0|0|0|100|XEU|780|2046|lyfalmen||||28|0|7,0000|Actavis Group hf|Actavis hf|Lósartan||780||780|2046|
011336|N05AH0309|Kozylex|munndr.t|5|mg|28|stk|1|ţpakki||N05AH03|01.10.2011||R|||0|0|*|0|POF|0|1|0|100|XEU|7520|5820|lyfalmen|V0457|5147||28|0|14,0000|Portfarma ehf|Portfarma|Olanzapín||3539||3539|5820|
011353|N05AF0502|Cisordinol Depot|stl|500|mg/ml|1|ml|5|lykjur||N05AF05|01.10.1988||R|||0|0|*|0|LBK|0|1|0|100|DKK|12384|18087|lyfalmen||||5|0|166,6667|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||12384||12384|18087|
011369|C09CA0102|Lopress|töflur|50|mg|28|stk|1|glas||C09CA01|01.11.2002||R|||0|0|0|0|ACA|0|0|0|100|XEU|1079|2455|lyfalmen||||28|0|28,0000|Actavis Group hf|Actavis hf|Lósartan||1079||1079|2455|
011380|C09CA0102|Lopress|töflur|50|mg|98|stk|1|glas||C09CA01|01.11.2002||R|||0|0|B|0|ACA|0|0|0|100|XEU|2975|2786|lyfalmen|V0069|2518||98|0|98,0000|Actavis Group hf|Actavis hf|Lósartan||1321||1321|2786|
011409|R03AK0703|Symbicort forte Turbuhaler|innönddu|329|mcg/sk|60|sk|1|pakki|320+9 mcg/sk|R03AK07|01.05.2003||R|||0|0|0|0|AZD|0|0|0|100|SEK|9310|13715|lyfalmen|V0357|12532||60|0|30,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||9310||9310|13715|
011489|N06BA0402|Concerta|forđatfl|18|mg|30|stk|1|glas||N06BA04|01.01.2003||R|||1|0|0|0|JAS|0|0|0|100|SEK|7188|10812|lyfalmen||||30|0|18,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||7188||7188|10812|
011532|B05BC0101|Mannitol Baxter Viaflo|irl|150|mg/ml|500|ml|20|plpok|lausn|B05BC01|01.11.2007||R|||0|0|0|1|BAM|0|0|0|100|SEK|9151|13207|lyfsjukr||||10000|0||Icepharma hf|Baxter Medical AB|Mannitól||9151||9151|13207|
011540|N01AX1401|S-Ketamin "Pfizer"|stl|5|mg/ml|5|ml|10|lykjur|lausn|N01AX14|01.08.2005||R|||1|0|0|1|PER|0|0|0|100|DKK|2473|3569|lyfsjukr||||50|0||Icepharma hf|Pfizer ApS|Esketamín||2473||2473|3569|
011555|N06BA0402|Concerta|forđatfl|36|mg|30|stk|1|glas||N06BA04|01.01.2003||R|||1|0|0|0|JAS|0|0|0|100|SEK|9434|13884|lyfalmen||||30|0|36,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||9434||9434|13884|
011561|QN05CM9203|Chanazine, vet.|stl|2|%|25|ml|1|hgl||QN05CM92|01.09.2002||R|||0|0|0|0|CHP|1|0|0|100|XEU|1958|3895|vetalmen||||25|0||Icepharma hf|Chanelle Pharmaceuticals |||1958||1958|3895|
011609|N01AX1401|S-Ketamin "Pfizer"|stl|25|mg/ml|2|ml|10|lykjur|lausn|N01AX14|01.08.2005||R|||1|0|0|1|PER|0|0|0|100|DKK|5042|7277|lyfsjukr||||20|0||Icepharma hf|Pfizer ApS|Esketamín||5042||5042|7277|
011620|G03CA0311|Estrogel|hlaup|0,6|mg/g|64|sk|1|fl|međ skammtadćlu|G03CA03|01.03.2000||R|||0|0|E|0|OLF|0|0|0|100|SEK|1604|3173|lyfalmen||||64|0||Gróco ehf|Oy Leiras Finland Ab|Estradíól||1604||1604|3173|
011690|J05AB0402|Copegus|töflur|200|mg|168|stk|1|plglas||J05AB04|01.03.2003||R|||0|1|0|1|ROA|0|0|0|100|DKK|89854|114649|lyfsjukr||||168|0|33,6000|Icepharma hf|Roche A.S.|Ribavirin||89854||89854|114649|
011810|D11AH0201|Elidel|krem|1|%|60|g|1|túpa||D11AH02|01.11.2002||R|||0|0|E|0|MAB|0|0|1|100|DKK|10478|15312|lyfalmen||||60|0||Vistor hf|Meda AB|Pímekrólímus||10478||10478|15312|
011863|N06AB0602|Sertral|töflur|100|mg|28|stk|1|ţpakki||N06AB06|01.10.2005||R|||0|0|B|0|ACA|0|1|0|100|IKR|1486|2049|lyfalmen|V0152|2049||28|0|56,0000|Actavis Group hf|Actavis hf|Sertralín||782||782|2049|
011880|N06AB0602|Sertral|töflur|100|mg|98|stk|1|ţpakki||N06AB06|01.10.2005||R|||0|0|B|0|ACA|0|1|0|100|IKR|4738|6676|lyfalmen|V0323|6676||98|0|196,0000|Actavis Group hf|Actavis hf|Sertralín||4165||4165|6676|
011953|N01BB0103|Marcain spinal|stl|5|mg/ml|4|ml|5|gl-lyk||N01BB01|01.01.2003||R|||0|0|0|1|AZD|0|0|0|100|SEK|4434|6399|lyfsjukr||||20|0||Vistor hf|AstraZeneca A/S DK|Búpívakaín||4434||4434|6399|
011969|N01BB0105|Marcain spinal tung|stl|5|mg/ml|4|ml|5|gl-lyk||N01BB01|01.01.2003||R|||0|0|0|1|AZD|0|0|0|100|SEK|2565|3702|lyfsjukr||||20|0||Vistor hf|AstraZeneca A/S DK|Búpívakaín||2565||2565|3702|
011985|N06DX0101|Ebixa|filmhtfl|10|mg|28|stk|1|ţpakki||N06DX01|01.06.2009||R|||0|0|E|0|LBK|0|0|0|100|DKK|8128|12098|lyfalmen||||28|0|14,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||||8128|12098|
012030|J05AG0301|Stocrin|töflur|600|mg|30|stk|1|glas||J05AG03|01.01.2003||R|||0|1|0|1|MSD|0|0|0|100|DKK|41319|53738|lyfsjukr||||30|0|30,0000|Vistor hf|M.S.D.|Efavirenz||41319||41319|53738|
012209|G04CB0201|Avodart|hylki|0,5|mg|90|stk|1|pakki|mjúk hylki|G04CB02|01.05.2003||R|||0|0|E|0|GSK|0|0|0|100|GBP|13754|19806|lyfalmen||||90|0|90,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Dútasteríđ||13754||13754|19806|
012243|G04CB0201|Avodart|hylki|0,5|mg|30|stk|1|ţpakki|hylki mjúk|G04CB02|01.03.2012||R|||0|0|E|0|GSK|0|0|0|100|GBP|4787|7527|lyfalmen||||30|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Dútasteríđ||4787||4787|7527|
012273|G04BE0801|Cialis|filmhtfl|10|mg|4|stk|1|ţpakki||G04BE08|01.02.2003||R|||0|0|0|0|LIL|0|0|0|100|XEU|6099|9322|lyfalmen||||4|0|4,0000|Icepharma hf|Lilly ICOS Limited|Tadalafíl||6099||6099|9322|
012278|N07BA0106|Nicotinell|forđapl|7|mg/sólh|7|stk|1|pakki||N07BA01|01.04.1992||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||7|0|3,5000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
012326|N06BA0402|Concerta|forđatfl|54|mg|30|stk|1|glas||N06BA04|01.08.2005||R|||1|0|0|0|JAS|0|0|0|100|SEK|12019|17629|lyfalmen||||30|0|54,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||12019||12019|17629|
012461|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|24|stk|1|ţpakki||N07BA01|01.12.2003||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||24|0|3,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
012504|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|24|stk|1|ţpakki||N07BA01|01.12.2003||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||24|0|1,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
012508|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|24|stk|1|ţpakki||N07BA01|01.12.2003||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||24|0|3,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
012577|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|24|stk|1|ţpakki||N07BA01|01.12.2003||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||24|0|1,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
012716|N07BA0106|Nicotinell|forđapl|14|mg/sólh|7|stk|1|pakki||N07BA01|01.04.1992||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||7|0|7,0000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
012738|M05BC0101|InductOs|ígr.sett|12|mg|1|stk|1|pakki||M05BC01|01.09.2003||R|||0|1|0|1|WTE|0|0|0|100|DKK|454975|572876|lyfsjukr||||1|0||Icepharma hf|Wyeth Europe|Díbótermín alfa||454975||454975|572876|
012799|N07BA0106|Nicotinell|forđapl|21|mg/sólh|7|stk|1|pakki||N07BA01|01.04.1992||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||7|0|10,5000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
012880|J01CR0202|Augmentin|mixtduft|62,5|mg/ml|80|ml|1|glas|50+12.5 mg|J01CR02|01.10.1989||R|||0|0|0|0|GSK|0|0|1|100|IKR|718|1961|lyfalmen||||80|0|4,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||718||718|1961|
012921|G03AA1301|Evra|forđapl|||9|stk|1|pakki|6 mg+600 mcg|G03AA13|01.11.2003||R|||0|0|0|0|JCI|0|0|0|100|SEK|4703|7412|lyfalmen||||9|0||Vistor hf|Janssen-Cilag International N.V.|Norelgestromín og östrógen||4703||4703|7412|
012953|G03BA0306|Testogel|hlaup|50|mg|30|sk-pokar|1|pakki||G03BA03|01.12.2003||R|||0|0|E|0|LBI|0|0|0|100|SEK|6807|10291|lyfalmen||||30|0|30,0000|Icepharma hf|Laboratoires Besins International|Testósterón||6807||6807|10291|
012966|N03AX1208|Gabapentin ratiopharm|hylki|300|mg|100|stk|1|ţpakki||N03AX12|01.03.2012||R|||0|0|E|0|RGM|0|0|0|100|XEU|3408|4999|lyfalmen|V0250|4988||100|0|16,6667|Medical ehf|ratiopharm GmbH|Gabapentín||2939||2939|4999|
012988|N03AX1208|Gabapentin ratiopharm|hylki|400|mg|100|stk|1|ţpakki||N03AX12|01.03.2012||R|||0|0|E|0|RGM|0|0|0|100|XEU|3711|4864|lyfalmen|V0251|4864||100|0|22,2200|Medical ehf|ratiopharm GmbH|Gabapentín||2840||2840|4864|
013068|N06BA0403|Ritalin Uno|hylki|20|mg|30|stk|1|glas||N06BA04|01.02.2004||R|||1|0|0|0|NOH|0|0|0|100|DKK|6276|9564|lyfalmen||||30|0|20,0000|Vistor hf|Novartis Healthcare A/S-|Metýlfenídat||6276||6276|9564|
013070|QM01AE9101|Rimadyl vet.|tuggutfl|50|mg|100|stk|1|pakki||QM01AE91|01.08.2005||R|||0|0|0|0|PAL|0|0|0|100|DKK|7089|13785|vetalmen||||100|0||Icepharma hf|Pfizer Oy Animal Health|||7089||7089|13785|
013079|N06BA0403|Ritalin Uno|hylki|40|mg|30|stk|1|glas||N06BA04|01.02.2004||R|||1|0|0|0|NOH|0|0|0|100|DKK|9476|13942|lyfalmen||||30|0|40,0000|Vistor hf|Novartis Healthcare A/S-|Metýlfenídat||9476||9476|13942|
013082|QM01AE9101|Rimadyl vet.|tuggutfl|50|mg|20|stk|1|pakki||QM01AE91|01.08.2005||R|||0|0|0|0|PAL|0|0|0|100|DKK|1785|3551|vetalmen||||20|0||Icepharma hf|Pfizer Oy Animal Health|||1785||1785|3551|
013100|R07AX0101|INOmax|innö.gas|400|ppm|2|l|1|gashyl||R07AX01|01.01.2004||R|||0|1|0|1|AGA|0|0|0|100|XEU|22522|30148|lyfsjukr||||2|0||Ísaga ehf|AGA AB|Nituroxíđ||22522||22522|30148|
013172|J06BB0101|Rhophylac|stl|1500|ae|2|ml|1|spr||J06BB01|01.02.2004||R|||0|0|0|1|ZLB|0|0|0|100|SEK|7050|10175|lyfsjukr||||2|0||Icepharma hf|ZLB GmbH|And-D(rh) immúnóglóbúlín||7050||7050|10175|
013259|B02BD0901|BeneFIX|sts|||250|ae|1|hgl|+leysir|B02BD09|01.02.2004||R|||0|1|0|1|WTE|0|0|0|100|DKK|30076|39628|lyfsjukr||||250|0|0,5600|Icepharma hf|Wyeth Europe|Storkuţáttur IX||30076||30076|39628|
013270|B02BD0901|BeneFIX|sts|||500|ae|1|hgl|+leysir|B02BD09|01.02.2004||R|||0|1|0|1|WTE|0|0|0|100|DKK|50907|65771|lyfsjukr||||500|0|1,1100|Icepharma hf|Wyeth Europe|Storkuţáttur IX||50907||50907|65771|
013302|C02CA0405|Cardosin Retard|forđatfl|4|mg|100|stk|1|ţpakki||C02CA04|01.09.2009||R|||0|0|E|0|ANO|0|0|0|100|XEU|3423|4752|lyfalmen|V0042|4752||100|0|100,0000|Actavis Group PTC hf|Actavis Nordic A/S|Doxazósín||2758||2758|4752|
013308|QM01AE9101|Rimadyl vet.|tuggutfl|20|mg|100|stk|1|pakki||QM01AE91|01.08.2005||R|||0|0|0|0|PAL|0|0|0|100|DKK|4656|9113|vetalmen||||100|0||Icepharma hf|Pfizer Oy Animal Health|||4656||4656|9113|
013317|QM01AE9101|Rimadyl vet.|tuggutfl|100|mg|100|stk|1|pakki||QM01AE91|01.08.2005||R|||0|0|0|0|PAL|0|0|0|100|DKK|10864|21033|vetalmen||||100|0||Icepharma hf|Pfizer Oy Animal Health|||10864||10864|21033|
013328|QM01AE9101|Rimadyl vet.|tuggutfl|20|mg|20|stk|1|pakki||QM01AE91|01.08.2005||R|||0|0|0|0|PAL|0|0|0|100|DKK|1140|2268|vetalmen||||20|0||Icepharma hf|Pfizer Oy Animal Health|||1140||1140|2268|
013341|B02BD0206|Advate|sts|1500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|||0|0|0|1|BAL|0|0|0|100|SEK|150121|190284|lyfsjukr||||1|0|3,0000|Lyfjaver ehf|Baxter Medical AB (L)|Storkuţáttur VIII||||150121|190284|
013347|L01XE0201|Iressa|töflur|250|mg|30|stk|1|ţpakki||L01XE02|01.03.2010||R|||0|1|0|1|AZD|0|0|0|100|SEK|409247|455140|lyfsjukr||||30|0||Vistor hf|AstraZeneca A/S DK|Gefitiníb||361161||361161|455140|
013362|B02BD0206|Advate|sts|250|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|||0|0|0|1|BER|0|0|0|100|SEK|26405|35021|lyfsjukr||||1|0|0,5000|Lyfjaver ehf|Baxter AG (L)|Storkuţáttur VIII||||26405|35021|
013365|B02BD0206|Advate|sts|1000|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|||0|0|0|1|BER|0|0|0|100|SEK|100081|127484|lyfsjukr||||1|0|2,0000|Lyfjaver ehf|Baxter AG (L)|Storkuţáttur VIII||||100081|127484|
013373|B02BD0206|Advate|sts|500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|||0|0|0|1|BER|0|0|0|100|SEK|51012|65903|lyfsjukr||||1|0|1,0000|Lyfjaver ehf|Baxter AG (L)|Storkuţáttur VIII||||51012|65903|
013386|C10AX0901|Ezetrol|töflur|10|mg|28|stk|1|ţpakki||C10AX09|01.01.2010||R|||0|0|0|0|MSD|0|0|0|100|DKK|5517|8526|lyfalmen||||28|0||Vistor hf|M.S.D.|Ezetimíb||5517||5517|8526|
013485|C10AX0901|Ezetrol|töflur|10|mg|98|stk|1|ţpakki||C10AX09|01.05.2003||R|||0|0|0|0|MSD|0|0|0|100|DKK|18783|26118|lyfalmen||||98|0|98,0000|Vistor hf|M.S.D.|Ezetimíb||18783||18783|26118|
013551|N02AA0503|Oxynorm|stl|10|mg/ml|1|ml|5|lykjur||N02AA05|01.08.2009||R|||1|0|0|0|NOP|0|0|0|100|DKK|1339|2811|lyfalmen||||5|0|1,6700|Icepharma hf|Norpharma|Oxýcódon||1339||1339|2811|
013593|A01AA3001|Xerodent|munnstfl|||90|stk|1|plglas|28,6 mg /0,25 mg|A01AA30|01.01.2008||L|||0|0|0|0|AGT|0|0|1|100|IKR|||lyfalmen||||90|0||Actavis Group hf|Actavis Group hf|Blöndur|||||1510|
013628|N02AA0503|Oxynorm|stl|10|mg/ml|2|ml|5|lykjur||N02AA05|01.08.2009||R|||1|0|0|0|NOP|0|0|0|100|DKK|2559|4479|lyfalmen||||10|0|3,3300|Icepharma hf|Norpharma|Oxýcódon||2559||2559|4479|
013672|N03AG0101|Depakine|mixtúra|200|mg/ml|40|ml|1|glas||N03AG01|01.12.1978||R|||0|0|E|0|SNO|0|0|0|100|NOK|1477|2917|lyfalmen||||40|0|5,3333|Vistor hf|Sanofi-aventis Norge AS|Valpróínsýra||1417||1417|2917|
013707|N01BB0203|Xylocain|hlaup|20|mg/ml|30|g|1|túpa||N01BB02|01.10.2003||R|||0|0|0|0|AZD|0|0|1|100|SEK|410|1540|lyfalmen||||30|0||Vistor hf|AstraZeneca A/S DK|Lídókaín||410||410|1540|
013718|M05BA0801|Zometa|irţ|4|mg/hgl|5|ml|1|hgl|lausn|M05BA08|01.05.2004||R|||0|1|0|1|NOE|0|0|0|100|DKK|38070|49660|lyfsjukr||||5|0|1,0000|Vistor hf|Novartis Europharm Ltd|Zoledronsýra||38070||38070|49660|
013756|C09DA0307|Diovan Comp 160/25 mg|filmhtfl|185|mg|28|stk|1|ţpakki||C09DA03|01.04.2005||R|||0|0|0|0|NOH|0|0|0|100|DKK|4778|7515|lyfalmen||||28|0|28,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan og ţvagrćsilyf||4778||4778|7515|
013802|H02AB0103|Diprospan|stl|7|mg/ml|1|ml|1|lykja||H02AB01|01.08.2009||R|||0|0|B|0|SPL|0|0|1|100|DKK|982|2322|lyfalmen||||1|0|4,6700|Vistor hf|Schering-Plough Europe|Betametasón||||982|2322|
013861|J01CR0202|Augmentin|töflur|625|mg|20|stk|1|ţpakki|500+125 mg|J01CR02|01.01.2003||R|||0|0|0|0|GSK|0|0|1|100|IKR|1215|2641|lyfalmen|V0168|2641||20|0|10,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||1215||1215|2641|
013901|A10AC0108|Insulatard InnoLet|stl|100|ae/ml|3|ml|5|spr|áfylltar spr.|A10AC01|01.02.2002||R|||0|0|*|0|NAS|0|0|0|100|DKK|6314|9616|lyfalmen||||15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín (manna)||6314||6314|9616|
013950|A10AB0101|Actrapid|stl|100|ae/ml|10|ml|1|hgl||A10AB01|01.03.2004||R|||0|0|*|0|NAS|0|0|0|100|DKK|2630|4577|lyfalmen||||10|0|25,0000|Vistor hf|Novo-Nordisk A/S|Insúlín (manna)||2630||2630|4577|
013957|A10AC0109|Insulatard FlexPen|stl|100|ae/ml|3|ml|5|pennar||A10AC01|01.02.2004||R|||0|0|*|0|NAS|0|0|0|100|DKK|4716|7430|lyfalmen||||15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín (manna)||4716||4716|7430|
013971|L01XE0101|Glivec|filmhtfl|100|mg|60|stk|1|ţpakki||L01XE01|01.06.2012||R|||0|1|0|1|NOE|0|0|0|100|DKK|180772|228751|lyfsjukr||||60|0||Vistor hf|Novartis Europharm Ltd|Imatiníb||180772||180772|228751|
013982|L01XE0101|Glivec|filmhtfl|400|mg|30|stk|1|ţpakki||L01XE01|01.05.2004||R|||0|1|0|1|NOE|0|0|0|100|DKK|384272|484144|lyfsjukr||||30|0||Vistor hf|Novartis Europharm Ltd|Imatiníb||384272||384272|484144|
014010|A10AC0103|Insulatard|stl|100|ae/ml|10|ml|1|hgl||A10AC01|01.04.1986||R|||0|0|*|0|NAS|0|0|0|100|DKK|2545|4460|lyfalmen||||10|0|25,0000|Vistor hf|Novo-Nordisk A/S|Insúlín (manna)||2545||2545|4460|
014031|A02BC0501|Nexium|sts|40|mg|5|ml|10|hgl|lausn|A02BC05|01.04.2004||R|||0|0|0|1|AZD|0|0|0|100|SEK|9069|13089|lyfsjukr||||50|0|13,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||9069||9069|13089|
014081|N03AX1401|Keppra|mixtúra|100|mg/ml|300|ml|1|glas||N03AX14|01.12.2006||R|||0|0|0|0|UCB|0|0|0|100|DKK|18464|25717|lyfalmen||||300|0|20,0000|Vistor hf|U.C.B|Levetíracetam||18464||18464|25717|
014094|H05AA0202|Forsteo|stl|250|mcg/ml|3|ml|1|penni|20 mcg/80 mcl|H05AA02|01.11.2003||R|||0|0|0|0|ELD|0|0|0|100|XEU|58107|75469|lyfalmen||||3|0|37,5000|Icepharma hf|Eli Lilly Nederland B.V.|Teriparatíđ||58107||58107|75469|
014138|B05BA1020|StructoKabiven elektrolyfri|irl|1600|kcal|1477|ml|4|pokar|fleyti|B05BA10|01.03.2004||R|||0|0|0|1|FRP|0|0|0|100|DKK|30310|39922|lyfsjukr||||5908|0||Icepharma hf|Fresenius Kabi|Blöndur||30310||30310|39922|
014185|R03AK0703|Symbicort forte Turbuhaler|innönddu|329|mcg/sk|180|sk|1|pakki|320+9 mcg/sk|R03AK07|01.08.2009||R|||0|0|0|0|AZD|0|0|0|100|SEK|27930|37597|lyfalmen|V0357|37597||180|0|90,0000|Vistor hf|AstraZeneca A/S DK|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||27930||27930|37597|
014261|D10AX0302|Finacea|hlaup|15|%|30|g|1|túpa||D10AX03|01.04.2005||R|||0|0|0|0|IGB|0|0|0|100|SEK|1552|3102|lyfalmen||||30|0||Icepharma hf|Intendis GmbH Berlin|Azelainsýra||1552||1552|3102|
014290|S01GX0201|Livostin|augndr|0,5|mg/ml|4|ml|1|glas||S01GX02|01.10.1991||L|||0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa||||4|0||Vistor hf|McNeil Sweden AB|Levókabastín||||||
014352|B05BA1015|StructoKabiven|irl|1100|kcal|986|ml|4|pokar|fleyti|B05BA10|01.03.2004||R|||0|0|0|1|FRP|0|0|0|100|DKK|20133|27149|lyfsjukr||||3944|0||Icepharma hf|Fresenius Kabi|Blöndur||20133||20133|27149|
014361|B05BA1015|StructoKabiven|irl|1600|kcal|1477|ml|4|pokar|fleyti|B05BA10|01.03.2004||R|||0|0|0|1|FRP|0|0|0|100|DKK|26356|34959|lyfsjukr||||5908|0||Icepharma hf|Fresenius Kabi|Blöndur||26356||26356|34959|
014415|P01AB0106|Flagyl|mixtúra|40|mg/ml|100|ml|1|fl||P01AB01|01.08.2009||R|||0|0|0|0|PCO|0|0|1|100|NOK|2657|4614|lyfalmen||||100|1||Distica|Distica - óskráđ lyf|Metrónídazól||2657||2657|4614|
014435|QM01AE03|Dolovet vet.|duft|2,4|g|15|g|3|pokar||QM01AE03|01.06.2009||R|||0|0|0|0|VET|0|0|0|100|XEU|2327|4629|vetalmen||||45|0||Dýraheilsa ehf|Vetcare Ltd.|||||2327|4629|
014453|G02BA0302|Mirena|leginnle|20|mcg/sólh|1|stk|1|pakki||G02BA03|01.04.1994||R|||0|0|0|0|BOY|0|0|0|100|SEK|18506|25770|lyfalmen||||1|0||Icepharma hf|Bayer OY|Plast lyfjalykkja (IUD) međ prógestógen||18506||18506|25770|
014510|J05AF0801|Hepsera|töflur|10|mg|30|stk|1|glas||J05AF08|01.03.2009||R|||0|1|0|1|GIS|0|0|0|100|DKK|84193|107545|lyfsjukr||||30|0|30,0000|Gilead Sience Sweden AB|Gilead Science International ltd.|Adefovír||||84193|107545|
014541|QA02BX1202|Orbesealer vet.|spenalyf|2,6|g/dćlu|24|dćlur|1|pakki||QA02BX12|01.04.2005||R|||0|0|0|0|PAL|0|0|0|100|XEU|5785|11281|vetalmen||||24|0||Icepharma hf|Pfizer Oy Animal Health|||5785||5785|11281|
014583|J05AX0701|Fuzeon|sts|90|mg/ml|60|hgl|1|pakki|+ leysir|J05AX07|01.12.2003||R|||0|1|0|1|RRL|0|0|0|100|DKK|245336|309779|lyfsjukr||||60|0|36,0000|Icepharma hf|Roche Registration Limited|Enfúvirtíđ||245336||245336|309779|
014679|N02AA0501|Oxycontin|forđatfl|5|mg|28|stk|1|ţpakki||N02AA05|01.12.2005||R|||1|0|E|0|NOP|0|0|0|100|DKK|2338|4177|lyfalmen||||28|0|1,8600|Icepharma hf|Norpharma |Oxýcódon||2338||2338|4177|
014696|C03EA0111|Miloride|töflur|55|mg|100|stk|1|glas|5+50 mg|C03EA01|01.02.2010||R|||0|0|E|0|MYL|0|0|0|100|SEK|1343|2816|lyfalmen||||100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Hýdróklórtíazíđ og kalíumsparandi lyf||1343||1343|2816|
014728|L03AA0201|Neupogen|stl|0,6|mg/ml|0,5|ml|5|spr|áfyllt sprauta, lausn|L03AA02|01.12.2003||R|||0|1|0|1|AEU|0|0|0|100|DKK|64123|82357|lyfsjukr||||2|0|4,2900|Vistor hf|Amgen Europe B.V.|Fílgrastím||64123||64123|82357|
014739|L03AA0201|Neupogen|stl|0,96|mg/ml|0,5|ml|5|spr|áfyllt sprauta, lausn|L03AA02|01.12.2003||R|||0|1|0|1|AEU|0|0|0|100|DKK|102594|130638|lyfsjukr||||2|0|6,8600|Vistor hf|Amgen Europe B.V.|Fílgrastím||102594||102594|130638|
014795|C03EA0112|Miloride mite|töflur|27,5|mg|100|stk|1|glas|2,5+25 mg|C03EA01|01.11.2009||R|||0|0|E|0|MYL|0|0|0|100|SEK|883|2187|lyfalmen||||100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Hýdróklórtíazíđ og kalíumsparandi lyf||||883|2187|
014847|L04AA1801|Certican|töflur|0,25|mg|60|stk|1|ţpakki||L04AA18|01.04.2007||R|||0|1|*|0|NOH|0|0|0|100|DKK|19648|27203|lyfalmen||||60|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Everolímus||19648||19648|27203|
014852|A06AD6502|Movicol|mixtduft|13,8|g|20|pokar|1|pakki|lausn|A06AD65|01.09.2011||L|||0|0|0|0|NOI|0|0|0|100|IKR|||lyflausa||||20|0|10,0000|Artasan ehf|Norgine A/S|Makrógól 3350||||||
014853|L04AA1801|Certican|töflur|0,75|mg|60|stk|1|ţpakki||L04AA18|01.04.2007||R|||0|1|*|0|NOH|0|0|0|100|DKK|59288|76952|lyfalmen||||60|0|30,0000|Vistor hf|Novartis Healthcare A/S-|Everolímus||59288||59288|76952|
014859|L04AA1801|Certican|töflur|0,5|mg|60|stk|1|ţpakki||L04AA18|01.04.2007||R|||0|1|*|0|NOH|0|0|0|100|DKK|39464|52072|lyfalmen||||60|0|20,0000|Vistor hf|Novartis Healthcare A/S-|Everolímus||39464||39464|52072|
015037|M01AX0502|Glucosamin Pharma Nord|hylki|400|mg|90|stk|1|glas||M01AX05|01.10.2006||L|||0|0|0|0|PNA|0|0|1|100|IKR|||lyflausa||||90|0|30,5400|Icepharma hf|Pharma Nord ApS|Glúkósamín||||||
015230|R01AC0301|Lastin|nefúđi|1|mg/ml|10|ml|1|glas||R01AC03|01.06.1998||R|||0|0|E|0|MAB|0|0|1|100|SEK|772|2035|lyfalmen||||10|0|17,8571|Vistor hf|Meda AB|Azelastínum||772||772|2035|
015301|M01AX0502|Glucosamin Pharma Nord|hylki|400|mg|270|stk|1|glas||M01AX05|01.10.2006||L|||0|0|0|0|PNA|0|0|1|100|IKR|||lyflausa||||270|0|91,6200|Icepharma hf|Pharma Nord ApS|Glúkósamín||||||
015316|N06AX1103|Miron|filmhtfl|30|mg|100|stk|1|plglas||N06AX11|01.07.2003||R|||0|0|B|0|ACA|0|1|0|100|XEU|3244|5417|lyfalmen||||100|0|100,0000|Actavis Group hf|Actavis hf|Mirtazapín||3244||3244|5417|
015343|A10AE0501|Levemir FlexPen|stl|100|ae/ml|3|ml|5|pennar||A10AE05|01.12.2005||R|||0|0|*|0|NAS|0|0|0|100|DKK|8754|12954|lyfalmen||||15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín detemír||8754||8754|12954|
015344|N06AX1103|Miron|filmhtfl|30|mg|30|stk|1|plglas||N06AX11|01.07.2003||R|||0|0|B|0|ACA|0|1|0|100|XEU|1123|2492|lyfalmen||||30|0|30,0000|Actavis Group hf|Actavis hf|Mirtazapín||1106||1106|2492|
015381|H02AB0104|Betapred|lausnart|0,5|mg|100|stk|1|glas||H02AB01|01.01.1998||R|||0|0|E|0|LOL|0|0|1|100|IKR|2760|4754|lyfalmen||||100|1|33,3333|Lyfjaver ehf|Lyfjaver- óskráđ|Betametasón||2760||2760|4754|
015419|G03CA0316|Vivelle Dot|forđapl|25|mcg/sólh|8|stk|1|pakki||G03CA03|01.02.2006||R|||0|0|E|0|NOH|0|0|0|100|DKK|1109|2496|lyfalmen|V0129|1678||8|0|14,0000|Vistor hf|Novartis Healthcare A/S-|Estradíól||1109||1109|2496|
015442|N02CC0103|Imigran Radis|filmhtfl|100|mg|6|stk|1|ţpakki||N02CC01|01.10.2005||R|||0|0|E|0|GSK|0|0|0|100|GBP|2027|2634|lyfalmen|V0234|2492||6|0|12,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Súmatriptan||1210||1210|2634|
015443|N02CC0103|Imigran Radis|filmhtfl|50|mg|12|stk|1|ţpakki||N02CC01|01.10.2005||R|||0|0|E|0|GSK|0|0|0|100|GBP|2895|3031|lyfalmen|V0233|2887||12|0|12,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Súmatriptan||1500||1500|3031|
015448|A10AE0502|Levemir Penfill|stl|100|ae/ml|3|ml|5|rörlyk||A10AE05|01.03.2007||R|||0|0|*|0|NAS|0|0|0|100|DKK|10430|15247|lyfalmen||||15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín detemír||10430||10430|15247|
015532|L01CX0101|Yondelis|irţ|1|mg/hgl|1|hgl|1|pakki||L01CX01|01.03.2008||R|||0|1|0|1|PAM|0|0|0|100|DKK|351825|443423|lyfsjukr||||1|0||Lyfjaver ehf|Pharma Mar S.A.|Trabecetedín||351825||351825|443423|
015598|L01CX0101|Yondelis|irţ|0,25|mg/hgl|1|hgl|1|pakki||L01CX01|01.03.2008||R|||0|1|0|1|PAM|0|0|0|100|DKK|93513|119241|lyfsjukr||||1|0||Lyfjaver ehf|Pharma Mar S.A.|Trabecetedín||93513||93513|119241|
015605|N04BA0301|Stalevo|filmhtfl|262,5|mg|30|stk|1|glas|50+12,5+200mg|N04BA03|01.03.2004||R|||0|0|E|0|ORC|0|0|0|100|DKK|5408|8377|lyfalmen||||30|0|3,3300|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||5408||5408|8377|
015652|N04BA0301|Stalevo|filmhtfl|262,5|mg|100|stk|1|glas|50+12,5+200mg|N04BA03|01.03.2004||R|||0|0|E|0|ORC|0|0|0|100|DKK|13749|19800|lyfalmen||||100|0|11,1100|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||13749||13749|19800|
015655|N04BA0301|Stalevo|filmhtfl|387,5|mg|30|stk|1|glas|150+37,5+200mg|N04BA03|01.03.2004||R|||0|0|E|0|ORC|0|0|0|100|DKK|5408|8377|lyfalmen||||30|0|10,0000|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||5408||5408|8377|
015663|N04BA0301|Stalevo|filmhtfl|387,5|mg|100|stk|1|glas|150+37,5+200mg|N04BA03|01.03.2004||R|||0|0|E|0|ORC|0|0|0|100|DKK|14863|21198|lyfalmen||||100|0|33,3300|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||14863||14863|21198|
015679|J05AE0801|Reyataz|hylki|200|mg|60|stk|1|ţpakki||J05AE08|01.04.2005||R|||0|1|0|1|BRS|0|0|0|100|DKK|71732|91906|lyfsjukr||||60|0|40,0000|Vistor hf|Bristol-Myers Squibb|Atazanavír||71732||71732|91906|
015695|J05AE0801|Reyataz|hylki|150|mg|60|stk|1|ţpakki||J05AE08|01.04.2005||R|||0|1|0|1|BRS|0|0|0|100|DKK|71732|91906|lyfsjukr||||60|0|30,0000|Vistor hf|Bristol-Myers Squibb|Atazanavír||71732||71732|91906|
015699|J05AE0801|Reyataz|hylki|150|mg|60|stk|1|plglas||J05AE08|01.06.2008||R|||0|1|0|1|BRS|0|0|0|100|DKK|62376|80164|lyfsjukr||||60|0|30,0000|Vistor hf|Bristol-Myers Squibb|Atazanavír||62376||62376|80164|
015707|N04BA0301|Stalevo|filmhtfl|325|mg|30|stk|1|glas|100+25+200mg|N04BA03|01.03.2004||R|||0|0|E|0|ORC|0|0|0|100|DKK|5408|8377|lyfalmen||||30|0|6,6700|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||5408||5408|8377|
015718|N04BA0301|Stalevo|filmhtfl|325|mg|100|stk|1|glas|100+25+200mg|N04BA03|01.03.2004||R|||0|0|E|0|ORC|0|0|0|100|DKK|13604|19618|lyfalmen||||100|0|22,2200|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||13604||13604|19618|
015723|J05AE0801|Reyataz|hylki|200|mg|60|stk|1|plglas||J05AE08|01.06.2008||R|||0|1|0|1|BRS|0|0|0|100|DKK|71732|91906|lyfsjukr||||60|0|40,0000|Vistor hf|Bristol-Myers Squibb|Atazanavír||71732||71732|91906|
015733|L04AA0602|Myfortic|sh-tfl|180|mg|120|stk|1|ţpakki||L04AA06|01.11.2004||R|||0|1|*|0|NOH|0|0|0|100|DKK|23002|31413|lyfalmen||||120|0|10,8000|Vistor hf|Novartis Healthcare A/S-|Mýcófenólsýra||23002||23002|31413|
015755|L04AA0602|Myfortic|sh-tfl|360|mg|120|stk|1|ţpakki||L04AA06|01.11.2004||R|||0|1|*|0|NOH|0|0|0|100|DKK|47911|62673|lyfalmen||||120|0|21,6000|Vistor hf|Novartis Healthcare A/S-|Mýcófenólsýra||47911||47911|62673|
015823|QP54AB5205|Advocate stórir kettir|bl.lausn|110|mg|0,8|ml|3|túpa|100+10 mg|QP54AB52|01.02.2006||R|||0|0|0|0|BAN|0|0|0|100|DKK|3244|5659|vetorma||||2|0||Icepharma hf|Bayer Animal Health GmbH|||3244||3244|5659|
015855|QP54AB5206|Advocate yfirstćrđar hundar|bl.lausn|125|mg|4|ml|3|túpa|100+25 mg|QP54AB52|01.02.2006||R|||0|0|0|0|BAN|0|0|0|100|DKK|4559|7953|vetorma||||12|0||Icepharma hf|Bayer Animal Health GmbH|||4559||4559|7953|
015873|QP54AB5202|Advocate litlir kettir|bl.lausn|110|mg|0,4|ml|3|túpa|100+10 mg|QP54AB52|01.02.2006||R|||0|0|0|0|BAN|0|0|0|100|DKK|2894|5048|vetorma||||1|0||Icepharma hf|Bayer Animal Health GmbH|||2894||2894|5048|
015882|QP54AB5203|Advocate millistórir hundar|bl.lausn|125|mg|1|ml|3|túpa|100+25 mg|QP54AB52|01.02.2006||R|||0|0|0|0|BAN|0|0|0|100|DKK|3629|6331|vetorma||||3|0||Icepharma hf|Bayer Animal Health GmbH|||3629||3629|6331|
015883|M01CC0101|Atamir|hylki|250|mg|50|stk|1|ţpakki||M01CC01|01.05.1978||R|||0|0|B|0|SGM|0|0|0|100|DKK|4624|7304|lyfalmen|V0200|5577||50|0|25,0000|Swedish Orphan International AB|Sandoz GmbH (S)|Penicillamín||4624||4624|7304|
015904|QP54AB5204|Advocate stórir hundar|bl.lausn|125|mg|2,5|ml|3|túpa|100+25 mg|QP54AB52|01.02.2006||R|||0|0|0|0|BAN|0|0|0|100|DKK|4066|7093|vetorma||||8|0||Icepharma hf|Bayer Animal Health GmbH|||4066||4066|7093|
015910|D01AC0804|Ketoconazol ratiopharm|hársápa|20|mg/ml|100|ml|1|fl||D01AC08|01.04.2012||L|||0|0|0|0|RPO|0|0|1|100|IKR|||lyflausa||||100|0||LYFIS ehf|ratiopharm Oy|Ketókónazól||||||
015912|D11AH0101|Protopic|smyrsli|0,03|%|10|g|1|túpa||D11AH01|01.03.2009||R|||0|0|E|0|ASP|0|0|1|100|XEU|2040|3770|lyfalmen||||10|0||Vistor hf|Astellas Pharma A/S|Takrólímus||||2040|3770|
015923|D11AH0101|Protopic|smyrsli|0,1|%|10|g|1|túpa||D11AH01|01.10.2007||R|||0|0|E|0|ASP|0|0|1|100|XEU|2291|4113|lyfalmen||||10|0||Vistor hf|Astellas Pharma A/S|Takrólímus||2291||2291|4113|
015929|N02AA0110|Morphine Sulphate BP|stl|10|mg/ml|1|ml|10|lykjur||N02AA01|01.07.2003||R|||1|0|0|0|MAP|0|0|0|100|GBP|1643|3226|lyfalmen||||10|0|3,3300|Icepharma hf|Martindale Pharmaceuticals|Morfín||1643||1643|3226|
015944|QP54AB5201|Advocate litlir hundar|bl.lausn|125|mg|0,4|ml|3|túpa|100+25 mg|QP54AB52|01.02.2006||R|||0|0|0|0|BAN|0|0|0|100|DKK|3244|5659|vetorma||||1|0||Icepharma hf|Bayer Animal Health GmbH|||3244||3244|5659|
015956|D01AC0804|Ketoconazol ratiopharm|hársápa|20|mg/ml|60|ml|1|fl||D01AC08|01.04.2012||L|||0|0|0|0|RPO|0|0|1|100|IKR|||lyflausa||||60|0||LYFIS ehf|ratiopharm Oy|Ketókónazól||||||
015964|N06AB0501|Seroxat|töflur|10|mg|28|stk|1|ţpakki||N06AB05|01.12.2006||R|||0|0|0|0|GSK|0|1|0|100|GBP|2096|3846|lyfalmen||||28|0|14,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Paroxetín||2096||2096|3846|
016017|C10AA0701|Crestor|filmhtfl|10|mg|100|stk|1|ţpakki||C10AA07|01.03.2004||R|||0|0|0|0|AZD|0|0|0|100|SEK|14877|21216|lyfalmen|V0117|20163||100|0|100,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||14877||14877|21216|
016021|N02AB0203|Pethidine BP|stl|50|mg/ml|1|ml|10|lykjur||N02AB02|01.07.2003||R|||1|0|0|0|MAP|0|0|0|100|GBP|1220|2648|lyfalmen||||10|0|1,2500|Icepharma hf|Martindale Pharmaceuticals|Petidín||1220||1220|2648|
016028|C10AA0701|Crestor|filmhtfl|20|mg|100|stk|1|ţpakki||C10AA07|01.03.2004||R|||0|0|0|0|AZD|0|0|0|100|SEK|22276|30502|lyfalmen|V0118|29113||100|0|200,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||22276||22276|30502|
016032|N02AB0203|Pethidine BP|stl|50|mg/ml|2|ml|10|lykjur||N02AB02|01.01.2004||R|||1|0|0|0|MAP|0|0|0|100|GBP|1294|2749|lyfalmen||||20|0|2,5000|Icepharma hf|Martindale Pharmaceuticals|Petidín||1294||1294|2749|
016038|N02CC0501|Almogran|töflur|12,5|mg|3|stk|1|ţpakki|filmuhúđađar töflur|N02CC05|01.05.2001||R|||0|0|E|0|ALM|0|0|0|100|SEK|2544|4459|lyfalmen|V0236|3826||3|0|3,0000|Vistor hf|Almirall S.A.|Almótriptan||2544||2544|4459|
016066|R02AA0303|Strepsils Sukkerfri med Citron og Örter|sogtfl|||24|stk|1|ţpakki||R02AA03|01.10.2005||L|||0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa||||24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól||||||
016209|N05AX0801|Risperdal|töflur|2|mg|28|stk|1|ţpakki|frostţ. töflur|N05AX08|01.09.2004|31.05.2012|R|||0|0|*|0|JAS|0|1|0|100|SEK|8090|12046|lyfalmen||||28|0|11,2000|Vistor hf|Janssen-Cilag AB|Risperídón||8090||8090|12046|
016285|N03AX1601|Lyrica|hylki|150|mg|14|stk|1|ţpakki||N03AX16|01.12.2004||R|||0|0|0|0|PER|0|0|0|100|DKK|2707|4682|lyfalmen||||14|0|7,0000|Icepharma hf|Pfizer ApS|Pregabalín||2707||2707|4682|
016294|N03AX1601|Lyrica|hylki|75|mg|56|stk|1|ţpakki||N03AX16|01.12.2004||R|||0|0|0|0|PER|0|0|0|100|DKK|6813|10299|lyfalmen||||56|0|14,0000|Icepharma hf|Pfizer ApS|Pregabalín||6813||6813|10299|
016296|G03GA0801|Ovitrelle|stl|250|mcg/spr|0,5|ml|1|spr|lausn|G03GA08|01.03.2004||R|||0|1|E|0|MSE|0|0|0|100|SEK|5132|7999|lyfalmen||||0|0|1,0000|Icepharma hf|Merck Serono Europe Ltd|Chóríógónadótrópín alfa||5132||5132|7999|
016315|N03AX1601|Lyrica|hylki|150|mg|56|stk|1|ţpakki||N03AX16|01.12.2004||R|||0|0|0|0|PER|0|0|0|100|DKK|10332|15113|lyfalmen||||56|0|28,0000|Icepharma hf|Pfizer ApS|Pregabalín||10332||10332|15113|
016318|N03AX1601|Lyrica|hylki|75|mg|14|stk|1|ţpakki||N03AX16|01.12.2004||R|||0|0|0|0|PER|0|0|0|100|DKK|1785|3421|lyfalmen||||14|0|3,5000|Icepharma hf|Pfizer ApS|Pregabalín||1785||1785|3421|
016323|N03AX1601|Lyrica|hylki|300|mg|56|stk|1|ţpakki||N03AX16|01.12.2004||R|||0|0|0|0|PER|0|0|0|100|DKK|15010|21383|lyfalmen||||56|0|56,0000|Icepharma hf|Pfizer ApS|Pregabalín||15010||15010|21383|
016337|C08CA0302|Lomir Retard|forđahlk|5|mg|100|stk|1|ţpakki||C08CA03|01.04.1992||R|||0|0|B|0|NOH|0|0|0|100|DKK|9010|13304|lyfalmen||||100|0|100,0000|Vistor hf|Novartis Healthcare A/S-|Ísradipín||9010||9010|13304|
016353|N05AX0801|Risperdal|töflur|1|mg|28|stk|1|ţpakki|frostţ. töflur|N05AX08|01.08.2004|31.05.2012|R|||0|0|*|0|JAS|0|1|0|100|SEK|4294|6853|lyfalmen||||28|0|5,6000|Vistor hf|Janssen-Cilag AB|Risperídón||4294||4294|6853|
016382|J02AC0301|Vfend|mixtúra|40|mg/ml|70|ml|1|fl||J02AC03|01.03.2005||R|||0|0|0|1|PER|0|0|0|100|DKK|98042|124925|lyfsjukr||||70|0|7,0000|Icepharma hf|Pfizer ApS|Voricónazól||98042||98042|124925|
016385|L01BC0108|Cytarabine Pfizer|stl/irl|100|mg/ml|10|ml|1|hgl||L01BC01|01.10.1995||R|||0|1|0|1|PER|0|0|0|100|DKK|4341|6265|lyfsjukr||||10|0||Icepharma hf|Pfizer ApS|Cýtarabín||4341||4341|6265|
016395|N03AX1601|Lyrica|hylki|25|mg|56|stk|1|ţpakki||N03AX16|01.01.2007||R|||0|0|0|0|PER|0|0|0|100|DKK|2663|4622|lyfalmen||||56|0|4,6667|Icepharma hf|Pfizer ApS|Pregabalín||2663||2663|4622|
016502|N07BA0111|Nicorette Classic|tyggigúm|2|mg|30|stk|1|ţpakki||N07BA01|01.03.2004||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín||||||
016524|N07BA0111|Nicorette Classic|tyggigúm|2|mg|210|stk|1|ţpakki||N07BA01|01.03.2004||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín||||||
016528|N07BA0111|Nicorette Classic|tyggigúm|4|mg|210|stk|1|ţpakki||N07BA01|01.03.2004||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín||||||
016572|N07BA0113|Nicorette Freshmint|tyggigúm|2|mg|210|stk|1|ţpakki||N07BA01|01.09.2005||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín||||||
016589|N07BA0113|Nicorette Freshmint|tyggigúm|4|mg|30|stk|1|ţpakki||N07BA01|01.01.2005||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||30|0|4,0000|Vistor hf|McNeil Denmark ApS|Nikótín||||||
016590|N07BA0113|Nicorette Freshmint|tyggigúm|2|mg|30|stk|1|ţpakki||N07BA01|01.01.2005||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín||||||
016596|N05AX1201|Abilify|töflur|5|mg|28|stk|1|ţpakki||N05AX12|01.02.2006||R|||0|0|0|0|OTS|0|1|0|100|DKK|17908|25020|lyfalmen||||28|0|9,3330|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||17908||17908|25020|
016611|N07BA0113|Nicorette Freshmint|tyggigúm|4|mg|210|stk|1|ţpakki||N07BA01|01.09.2005||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín||||||
016622|A06AG1101|Microlax|innhl|||5|ml|50|túpa||A06AG11|01.09.2005||L|||0|0|0|0|MCN|0|0|0|100|DKK|||lyfalmen||||250|0|50,0000|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, ţ.m.t. í blöndum|||||7270|
016635|N05AX1201|Abilify|töflur|5|mg|56|stk|1|ţpakki||N05AX12|01.02.2006||R|||0|0|0|0|OTS|0|1|0|100|DKK|34983|46449|lyfalmen||||56|0|18,6670|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||34983||34983|46449|
016637|J01CR0201|Amoksiklav|töflur|1000|mg|12|stk|1|pakki|875+125 mg|J01CR02|01.08.2003||R|||0|0|0|0|LPM|0|0|1|100|IKR|1026|2367|lyfalmen|V0169|2367||12|0|10,5000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||1015||1015|2367|
016640|B03XA0103|NeoRecormon|stl|30000|ae/spr|0,6|ml|4|spr||B03XA01|01.05.2007||R|||0|1|0|1|ROC|0|0|0|100|DKK|188600|238576|lyfsjukr||||2|0|120,0000|Icepharma hf|Roche|Epóetín||188600||188600|238576|
016727|N06BA0403|Ritalin Uno|hylki|30|mg|30|stk|1|glas||N06BA04|01.02.2004||R|||1|0|0|0|NOH|0|0|0|100|DKK|7984|11901|lyfalmen||||30|0|30,0000|Vistor hf|Novartis Healthcare A/S-|Metýlfenídat||7984||7984|11901|
016736|N03AF0107|Tegretol Retard (Lyfjaver)|forđatfl|200|mg|200|stk|1|plglas||N03AF01|01.09.2003||R|||0|0|E|0|LVR|0|0|0|100|DKK|3125|5254|lyfalmen|V0240|5254||200|0|40,0000|Lyfjaver ehf|Lyfjaver ehf|Karbamazepín||3125||3125|5254|
016772|N03AF0107|Tegretol Retard (Lyfjaver)|forđatfl|400|mg|200|stk|1|plglas||N03AF01|01.09.2003||R|||0|0|E|0|LVR|0|0|0|100|DKK|5768|8869|lyfalmen|V0433|8869||200|0|80,0000|Lyfjaver ehf|Lyfjaver ehf|Karbamazepín||5768||5768|8869|
016791|H05BX0101|Mimpara|filmhtfl|60|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|||0|0|0|0|AEU|0|0|0|100|DKK|62406|80865|lyfalmen||||28|0|28,0000|Vistor hf|Amgen Europe B.V.|Cinacalcet||62406||62406|80865|
016802|H05BX0101|Mimpara|filmhtfl|90|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|||0|0|0|0|AEU|0|0|0|100|DKK|91955|117949|lyfalmen||||28|0|42,0000|Vistor hf|Amgen Europe B.V.|Cinacalcet||91955||91955|117949|
016868|H05BX0101|Mimpara|filmhtfl|30|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|||0|0|0|0|AEU|0|0|0|100|DKK|29716|39839|lyfalmen||||28|0|14,0000|Vistor hf|Amgen Europe B.V.|Cinacalcet||29716||29716|39839|
016930|A16AB0401|Fabrazyme|irţ|5|mg/ml|5|mg|1|hgl|lausn|A16AB04|01.05.2012||R|||0|1|0|1|GZE|0|0|0|100|XEU|80135|102452|lyfsjukr||||5|0|5,0000|Vistor hf|Genzyme Europe B.V.|Agalsidase beta||80135||80135|102452|
016943|A02BC0301|Lanzo|munndr.t|30|mg|14|stk|1|ţpakki||A02BC03|01.02.2007||R|||0|0|0|0|PER|0|0|0|100|DKK|2051|3785|lyfalmen||||14|0|14,0000|Icepharma hf|Pfizer ApS|Lansóprazól||2051||2051|3785|
016946|A02BC0301|Lanzo|munndr.t|15|mg|56|stk|1|ţpakki||A02BC03|01.11.2009||R|||0|0|0|0|PER|0|0|0|100|DKK|3627|5940|lyfalmen|V0007|5940||56|0|28,0000|Icepharma hf|Pfizer ApS|Lansóprazól||||3627|5940|
016957|A02BC0301|Lanzo|munndr.t|15|mg|98|stk|1|ţpakki||A02BC03|01.01.2004||R|||0|0|0|0|PER|0|0|0|100|DKK|7998|11920|lyfalmen|V0007|10395||98|0|49,0000|Icepharma hf|Pfizer ApS|Lansóprazól||7998||7998|11920|
016973|J05AF0901|Emtriva|hylki|200|mg|30|stk|1|glas||J05AF09|01.04.2004||R|||0|1|0|1|GIS|0|0|0|100|XEU|40495|52704|lyfsjukr||||30|0|30,0000|Gilead Sience Sweden AB|Gilead Science International ltd.|Emtrícítabín||40495||40495|52704|
016976|A02BC0301|Lanzo|munndr.t|30|mg|98|stk|1|ţpakki||A02BC03|01.02.2007||R|||0|0|0|0|PER|0|0|0|100|DKK|14230|20404|lyfalmen||||98|0|98,0000|Icepharma hf|Pfizer ApS|Lansóprazól||14230||14230|20404|
016979|N02AE0103|Norspan|forđapl|5|mg|4|stk|1|ţpakki||N02AE01|01.01.2006||R|||1|0|E|0|NOP|0|0|0|100|DKK|3213|5374|lyfalmen||||4|0|16,6700|Icepharma hf|Norpharma |Búprenorfín||3213||3213|5374|
016981|QA02BX1202|Orbesealer vet.|spenalyf|2,6|g/dćlu|60|dćlur|1|pakki||QA02BX12|01.12.2006||R|||0|0|0|0|PAL|0|0|0|100|DKK|19193|37026|vetalmen||||60|0||Icepharma hf|Pfizer Oy Animal Health|||19193||19193|37026|
017006|B05BA1019|StructoKabiven Perifer|irl|830|kcal|1206|ml|4|pokar|fleyti|B05BA10|01.06.2005||R|||0|0|0|1|FRP|0|0|0|100|DKK|26059|34587|lyfsjukr||||4824|0||Icepharma hf|Fresenius Kabi|Blöndur||26059||26059|34587|
017020|G03DA0201|Depo-Provera|stl|50|mg/ml|3|ml|1|hgl||G03DA02|01.12.1972||R|||0|0|E|0|PER|0|0|0|100|DKK|1563|3117|lyfalmen||||3|0|21,4286|Icepharma hf|Pfizer ApS|Medroxýprógesterón||1563||1563|3117|
017111|A09AA0201|Combizym|töflur|||100|stk|1|ţpakki||A09AA02|01.07.1988||R|||0|0|E|0|DSG|0|0|0|100|XEU|1463|2980|lyfalmen||||100|0|25,0000|Icepharma hf|Daiichi Sankyo Europe GmbH|Hvatablöndur (lípasi, próteasi o.s.frv.)||1463||1463|2980|
017130|L01BC0109|DepoCyte|stl|50|mg/hgl|5|ml|1|hgl||L01BC01|01.07.2005||R|||0|1|0|1|SKY|0|0|0|100|DKK|269817|340503|lyfsjukr||||5|0||Icepharma hf|SkyPharma PLC|Cýtarabín||269817||269817|340503|
017145|C08DB0102|Cardizem Retard|forđatfl|180|mg|60|stk|1|glas||C08DB01|01.04.1990||R|||0|0|B|0|FRO|0|0|0|100|DKK|8078|12029|lyfalmen||||60|0|45,0000|Vistor hf|Ferrosan A/S|Diltíazem||8078||8078|12029|
017195|L01XX3201|Velcade|sts|3,5|mg/hgl|1|hgl|1|pakki|lausn|L01XX32|01.09.2004||R|||0|1|0|1|JCI|0|0|0|100|SEK|180077|227879|lyfsjukr||||1|0||Vistor hf|Janssen-Cilag International N.V.|Bortezomíb||180077||180077|227879|
017203|M05BA0601|Bondronat|irţ|1|mg/ml|6|ml|1|hgl||M05BA06|01.09.2004||R|||0|0|0|1|ROC|0|0|0|100|DKK|41182|53566|lyfsjukr||||6|0|1,0000|Icepharma hf|Roche|Íbandrónsýra||41182||41182|53566|
017210|C03DA0102|Spirix|töflur|25|mg|100|stk|1|glas||C03DA01|01.02.2003||R|||0|0|E|0|NYG|0|0|0|100|DKK|1394|2886|lyfalmen|V0046|2274||100|0|33,3333|Gróco ehf|Nycomed Danmark A/S|Spírónólaktón||1394||1394|2886|
017234|L03AB0701|Avonex|stl|30|mcg/spr|0,5|ml|4|spr|lausn, áfylltar sprautur|L03AB07|01.12.2003||R|||0|1|0|1|BIB|0|0|0|100|XEU|130550|165723|lyfsjukr||||2|0|27,9100|Icepharma hf|Biogen Idec Ltd|Interferón beta-1a||130550||130550|165723|
017238|M05BA0601|Bondronat|filmhtfl|50|mg|28|stk|1|ţpakki||M05BA06|01.08.2004||R|||0|0|0|0|ROC|0|0|0|100|DKK|48943|63969|lyfalmen||||28|0|280,0000|Icepharma hf|Roche|Íbandrónsýra||48943||48943|63969|
017247|M05BA0601|Bondronat|filmhtfl|50|mg|84|stk|1|ţpakki||M05BA06|01.08.2004||R|||0|0|0|0|ROC|0|0|0|100|DKK|151987|193289|lyfalmen||||84|0|840,0000|Icepharma hf|Roche|Íbandrónsýra||151987||151987|193289|
017266|N02AE0103|Norspan|forđapl|10|mg|4|stk|1|ţpakki||N02AE01|01.01.2006||R|||1|0|E|0|NOP|0|0|0|100|DKK|5577|8608|lyfalmen||||4|0|33,3300|Icepharma hf|Norpharma |Búprenorfín||5577||5577|8608|
017326|N02AE0103|Norspan|forđapl|20|mg|4|stk|1|ţpakki||N02AE01|01.01.2006||R|||1|0|E|0|NOP|0|0|0|100|DKK|10620|15507|lyfalmen||||4|0|66,6600|Icepharma hf|Norpharma |Búprenorfín||10620||10620|15507|
017327|C03DA0102|Spirix|töflur|50|mg|100|stk|1|glas||C03DA01|01.02.2003||R|||0|0|E|0|NYG|0|0|0|100|DKK|2756|4749|lyfalmen||||100|0|66,6667|Gróco ehf|Nycomed Danmark A/S|Spírónólaktón||2756||2756|4749|
017331|A04AD1201|Emend|hylki|||3|stk|1|ţpakki|samsett pakkning|A04AD12|01.04.2004||R|||0|0|0|1|MSD|0|0|0|100|DKK|9228|13318|lyfsjukr||||3|0|3,0000|Vistor hf|M.S.D.|Aprepitant||9228||9228|13318|
017365|J01CR0201|Amoksiklav|töflur|375|mg|20|stk|1|glas|250+125 mg|J01CR02|01.12.2003||R|||0|0|0|0|LPM|0|0|1|100|XEU|905|2217|lyfalmen||||20|0|5,0000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||905||905|2217|
017384|H02AB0701|Deltison|töflur|50|mg|30|stk|1|glas||H02AB07|01.08.2005||R|||0|0|E|0|REP|0|0|1|100|SEK|3013|5101|lyfalmen||||30|0|150,0000|Vistor hf|Recip AB|Prednisón||3013||3013|5101|
017556|J01CR0201|Amoksiklav|töflur|625|mg|20|stk|1|glas|500+125 mg|J01CR02|01.12.2003||R|||0|0|0|0|LPM|0|0|1|100|IKR|1459|2724|lyfalmen|V0168|2641||20|0|10,0000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||1276||1276|2724|
017564|QM01AC0601|Metacam|mixtúra|15|mg/ml|100|ml|1|fl||QM01AC06|01.09.2004||R|||0|0|0|0|BOI|0|0|0|100|DKK|6850|13326|vetalmen||||100|0||Vistor hf|Boehringer Ingelheim|||6850||6850|13326|
017763|N06DA0401|Reminyl|forđahlk|16|mg|84|stk|1|ţpakki||N06DA04|01.08.2005||R|||0|0|E|0|JAS|0|0|0|100|SEK|40629|32025|lyfalmen|V0350|27702||84|0|84,0000|Vistor hf|Janssen-Cilag AB|Galantamín||23490||23490|32025|
017773|N06DA0401|Reminyl|forđahlk|8|mg|28|stk|1|ţpakki||N06DA04|01.08.2005||R|||0|0|E|0|JAS|0|0|0|100|SEK|13238|11866|lyfalmen|V0348|10772||28|0|14,0000|Vistor hf|Janssen-Cilag AB|Galantamín||7959||7959|11866|
017792|C03DA0401|Inspra|filmhtfl|50|mg|30|stk|1|ţpakki||C03DA04|01.08.2005||R|||0|0|0|0|PER|0|0|0|100|DKK|10662|15564|lyfalmen||||30|0|30,0000|Icepharma hf|Pfizer ApS|Eplerenón||10662||10662|15564|
017809|N06DA0401|Reminyl|forđahlk|24|mg|84|stk|1|ţpakki||N06DA04|01.08.2005||R|||0|0|E|0|JAS|0|0|0|100|SEK|43670|57351|lyfalmen||||84|0|126,0000|Vistor hf|Janssen-Cilag AB|Galantamín||43670||43670|57351|
017963|C03DA0401|Inspra|filmhtfl|25|mg|30|stk|1|ţpakki||C03DA04|01.08.2005||R|||0|0|0|0|PER|0|0|0|100|DKK|9737|14299|lyfalmen||||30|0|15,0000|Icepharma hf|Pfizer ApS|Eplerenón||9737||9737|14299|
018268|G03FA1701|Angemin|töflur|||84|stk|1|ţpakki|2+1 mg|G03FA17|01.06.2005||R|||0|0|0|0|BYP|0|0|0|100|SEK|7187|10810|lyfalmen||||84|0|84,0000|Icepharma hf|Bayer Pharma AG|Dróspírenón og östrogen||7187||7187|10810|
018311|C09CA0801|Olmetec|filmhtfl|10|mg|28|stk|1|ţpakki||C09CA08|01.05.2005||R|||0|0|0|0|DSH|0|0|0|100|DKK|2320|4153|lyfalmen||||28|0|14,0000|Gróco ehf|Daiichi Sankyo Europe GmbH-|Olmesartanmedoxomil||2320||2320|4153|
018446|C09CA0801|Olmetec|filmhtfl|40|mg|28|stk|1|ţpakki||C09CA08|01.05.2005||R|||0|0|0|0|DSH|0|0|0|100|DKK|3406|5638|lyfalmen||||28|0|56,0000|Gróco ehf|Daiichi Sankyo Europe GmbH-|Olmesartanmedoxomil||3406||3406|5638|
018502|C09CA0801|Olmetec|filmhtfl|40|mg|98|stk|1|ţpakki||C09CA08|01.05.2005||R|||0|0|0|0|DSH|0|0|0|100|DKK|10993|16017|lyfalmen||||98|0|196,0000|Gróco ehf|Daiichi Sankyo Europe GmbH-|Olmesartanmedoxomil||10993||10993|16017|
018512|C09CA0801|Olmetec|filmhtfl|10|mg|98|stk|1|ţpakki||C09CA08|01.05.2005||R|||0|0|0|0|DSH|0|0|0|100|DKK|7652|11446|lyfalmen||||98|0|49,0000|Gróco ehf|Daiichi Sankyo Europe GmbH-|Olmesartanmedoxomil||7652||7652|11446|
018514|J07BA0101|FSME-Immun Junior|stl|1,2|mcg/sk|0,25|ml|1|spr|bóluefni|J07BA01|01.06.2004||R|||0|0|0|0|BAA|0|0|0|100|SEK|3888|6297|lyfalmen||||0|0||Icepharma hf|Baxter AG|Heilabólguveira óvirk, borin međ blóđmaur||3888||3888|6297|
018527|J07BA0102|FSME-Immun Vuxen|stl|2,4|mcg/sk|0,5|ml|1|spr|bóluefni|J07BA01|01.06.2004||R|||0|0|0|0|BAA|0|0|0|100|SEK|4246|6787|lyfalmen||||0|0||Icepharma hf|Baxter AG|Heilabólguveira óvirk, borin međ blóđmaur||4246||4246|6787|
018534|C09CA0801|Olmetec|filmhtfl|20|mg|98|stk|1|ţpakki||C09CA08|01.05.2005||R|||0|0|0|0|DSH|0|0|0|100|DKK|9092|13416|lyfalmen||||98|0|98,0000|Gróco ehf|Daiichi Sankyo Europe GmbH-|Olmesartanmedoxomil||9092||9092|13416|
018535|N03AX0901|Lamictal|dreifit.|25|mg|42|stk|1|ţpakki||N03AX09|01.11.2004||R|||0|0|E|0|GSK|0|0|0|100|IKR|1499|2025|lyfalmen|V0243|1793||42|0|3,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||765||765|2025|
018586|C09CA0801|Olmetec|filmhtfl|20|mg|28|stk|1|ţpakki||C09CA08|01.05.2005||R|||0|0|0|0|DSH|0|0|0|100|DKK|2849|4876|lyfalmen||||28|0|28,0000|Gróco ehf|Daiichi Sankyo Europe GmbH-|Olmesartanmedoxomil||2849||2849|4876|
018594|G04BD0801|Vesicare|filmhtfl|10|mg|30|stk|1|ţpakki||G04BD08|01.11.2004||R|||0|0|E|0|ASP|0|0|0|100|XEU|8431|12512|lyfalmen||||30|0|60,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||8431||8431|12512|
018663|J01DD0401|Rocephalin|sts|1|g|1|stk|5|hgl|+ leysir, lausn|J01DD04|01.10.1985||R|||0|0|0|1|ROC|0|0|0|100|DKK|13989|19439|lyfsjukr||||5|0|2,5000|Icepharma hf|Roche|Ceftríaxón||13989||13989|19439|
018677|G04BD0801|Vesicare|filmhtfl|10|mg|90|stk|1|ţpakki||G04BD08|01.11.2004||R|||0|0|E|0|ASP|0|0|0|100|XEU|20673|28490|lyfalmen|V0441|28489||90|0|180,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||20673||20673|28490|
018681|C09CA0301|Diovan|filmhtfl|40|mg|28|stk|1|ţpakki||C09CA03|01.07.2005||R|||0|0|0|0|NOH|0|0|0|100|DKK|2987|5065|lyfalmen||||28|0|14,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||2987||2987|5065|
018682|H02AB0604|Decortin H|töflur|5|mg|100|stk|1|ţpakki||H02AB06|11.06.2004||R|||0|0|B|0|MKA|0|0|1|100|SEK|973|2310|lyfalmen|V0414|2036||100|0|50,0000|Icepharma hf|Merck KgaA|Prednisólón||973||973|2310|
018685|G04BD0801|Vesicare|filmhtfl|5|mg|30|stk|1|ţpakki||G04BD08|01.11.2004||R|||0|0|E|0|ASP|0|0|0|100|XEU|5971|9147|lyfalmen||||30|0|30,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||5971||5971|9147|
018694|G04BD0801|Vesicare|filmhtfl|5|mg|90|stk|1|ţpakki||G04BD08|01.11.2004||R|||0|0|E|0|ASP|0|0|0|100|XEU|16832|23669|lyfalmen|V0440|23668||90|0|90,0000|Vistor hf|Astellas Pharma A/S|Sólífenacín||16832||16832|23669|
018714|C03DA0401|Inspra|filmhtfl|50|mg|100|stk|1|ţpakki||C03DA04|01.08.2005||R|||0|0|0|0|PER|0|0|0|100|DKK|35193|46712|lyfalmen||||100|0|100,0000|Icepharma hf|Pfizer ApS|Eplerenón||35193||35193|46712|
018779|L03AX1301|Copaxone|stl|20|mg/spr|28|spr|1|pakki|+ leysir|L03AX13|01.08.2004||R|||0|1|0|1|TEP|0|0|0|100|NOK|125906|159895|lyfsjukr||||28|0|28,0000|Vistor hf|Teva Pharmaceuticals Limited UK|Glatíramer acetat||125906||125906|159895|
018956|R06AX2201|Kestine|töflur|20|mg|30|stk|1|ţpakki||R06AX22|01.10.2005||R|||0|0|E|0|APS|0|0|1|100|DKK|3087|5202|lyfalmen||||30|0|60,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín||3087||3087|5202|31.05.2012
018967|R06AX2201|Kestine|töflur|20|mg|100|stk|1|ţpakki||R06AX22|01.10.2005||R|||0|0|E|0|APS|0|0|1|100|DKK|9974|14623|lyfalmen||||100|0|200,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín||9974||9974|14623|31.05.2012
018975|J05AE0701|Telzir|filmhtfl|700|mg|60|stk|1|glas||J05AE07|01.12.2004||R|||0|1|0|1|VII|0|0|0|100|GBP|62897|80818|lyfsjukr||||60|0|30,0000|GlaxoSmithKline ehf|Viiv Healthcare UK Ltd|Fosamprenavír||62897||62897|80818|
018978|C03CA0101|Furix|töflur|20|mg|100|stk|1|glas||C03CA01|01.03.2003||R|||0|0|E|0|NYG|0|0|0|100|DKK|609|1812|lyfalmen||||100|0|50,0000|Gróco ehf|Nycomed Danmark A/S|Fúrósemíđ||609||609|1812|
018980|QN01BB5202|Lidokel Adrenalin vet. Kela|stl|20|mg/ml|100|ml|1|hgl|20mg/ml+36mcg/ml|QN01BB52|01.02.2004||R|||0|0|0|0|KEL|1|0|0|100|NOK|1346|2677|vetalmen||||100|0||Icepharma hf|Kela Laboratoria NV|||1346||1346|2677|
018995|N02AB0301|Durogesic|forđapl|75|mcg/klst|5|stk|1|ţpakki||N02AB03|01.01.1996||R|||1|0|E|0|JAS|0|0|0|100|SEK|10277|15037|lyfalmen|V0221|11483||5|0|22,5000|Vistor hf|Janssen-Cilag AB|Fentanýl||10277||10277|15037|
019066|V08AB0201|Omnipaque|stl|140|mg J/ml|50|ml|10|plastf||V08AB02|01.04.2011||R|||0|0|0|1|GEH|0|0|0|100|NOK|21912|29382|lyfsjukr||||500|0||Icepharma hf|GE Healthcare AS|Jóhexól||21912||21912|29382|
019094|N02AB0301|Durogesic|forđapl|50|mcg/klst|5|stk|1|ţpakki||N02AB03|01.01.1996||R|||1|0|E|0|JAS|0|0|0|100|SEK|7345|11026|lyfalmen|V0220|9077||5|0|15,0000|Vistor hf|Janssen-Cilag AB|Fentanýl||7345||7345|11026|
019099|V08AB0201|Omnipaque|stl|300|mg J/ml|50|ml|10|plastf||V08AB02|01.06.2004||R|||0|0|0|1|GEH|0|0|0|100|NOK|24729|32917|lyfsjukr||||500|0||Icepharma hf|GE Healthcare AS|Jóhexól||24729||24729|32917|
019108|N02AB0301|Durogesic|forđapl|25|mcg/klst|5|stk|1|ţpakki||N02AB03|01.01.1996||R|||1|0|E|0|JAS|0|0|0|100|SEK|4073|6551|lyfalmen|V0219|5682||5|0|7,5000|Vistor hf|Janssen-Cilag AB|Fentanýl||4073||4073|6551|
019112|V08AB0201|Omnipaque|stl|350|mg J/ml|50|ml|10|plastf||V08AB02|01.06.2004||R|||0|0|0|1|GEH|0|0|0|100|NOK|34332|44969|lyfsjukr||||500|0||Icepharma hf|GE Healthcare AS|Jóhexól||34332||34332|44969|
019121|V08AB0901|Visipaque|stl|270|mg J/ml|50|ml|10|plastf|lausn|V08AB09|01.06.2004||R|||0|0|0|1|GEH|0|0|0|100|NOK|35203|46062|lyfsjukr||||500|0||Icepharma hf|GE Healthcare AS|Jódixanól||35203||35203|46062|
019132|V08AB0901|Visipaque|stl|320|mg J/ml|50|ml|10|plastf|lausn|V08AB09|01.06.2004||R|||0|0|0|1|GEH|0|0|0|100|NOK|43013|55864|lyfsjukr||||500|0||Icepharma hf|GE Healthcare AS|Jódixanól||43013||43013|55864|
019167|N02AB0301|Durogesic|forđapl|100|mcg/klst|5|stk|1|ţpakki||N02AB03|01.01.1996||R|||1|0|E|0|JAS|0|0|0|100|SEK|9560|14057|lyfalmen|V0223|13219||5|0|30,0000|Vistor hf|Janssen-Cilag AB|Fentanýl||9560||9560|14057|
019175|C09CA0601|Atacand|töflur|32|mg|98|stk|1|ţpakki||C09CA06|01.02.2010||R|||0|0|0|0|AZD|0|0|0|100|SEK|14164|20321|lyfalmen||||98|0|392,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||14164||14164|20321|
019194|C09CA0601|Atacand|töflur|32|mg|28|stk|1|ţpakki||C09CA06|01.02.2010||R|||0|0|0|0|AZD|0|0|0|100|SEK|4857|7623|lyfalmen||||28|0|112,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||4857||4857|7623|
019293|B02BC3001|TachoSil|svampur|5,5|mg|1|stk|1|pakki|+ 2,0 IU - 9,5x4,8 cm|B02BC30|01.05.2005||R|||0|1|0|1|NYG|0|0|0|100|DKK|53060|68473|lyfsjukr||||1|0||Gróco ehf|Nycomed Danmark A/S|Fíbrínógen og Mannatromnín manna||53060||53060|68473|
019295|B01AE0601|Angiox|sts/irs|250|mg|10|hgl|1|pakki|ţykkni, lausn|B01AE06|01.05.2005||R|||0|1|0|1|THE|0|0|0|100|XEU|757163|952122|lyfsjukr||||10|0|10,0000|The Medicines Company UK Ltd.|The Medicines Company UK Ltd.|Bívalirúdín||757163||757163|952122|
019308|QG03X0001|Alizin, vet.|stl|30|mg/ml|10|ml|1|hgl|fyrir hunda (tíkur)|QG03X|01.05.2012||R|||0|0|0|0|VIR|1|0|0|100|IKR|4877|9537|vetalmen||||10|0||Vistor hf|Virbac S.A|Aglepristóne||4877||4877|9537|
019339|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|96|stk|1|ţpakki||N07BA01|01.12.2006||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||96|0|6,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
019403|QJ51CE0901|Carepen vet.|spenalyf|600|mg|10|g|100|stk|10 áf.spr|QJ51CE09|01.04.2010||R|||0|0|0|0|VET|0|0|0|100|DKK|21602|41652|vetalmen||||1000|0||Dýraheilsa ehf|Vetcare Ltd.|Benzylpenicillínprokaín||||21602|41652|
019421|N06AX2102|Yentreve|hylki|20|mg|56|stk|1|ţpakki|sýruţ.hylki, hörđ|N06AX21|01.10.2004||R|||0|0|0|0|ELD|0|0|0|100|XEU|6964|10505|lyfalmen||||56|0|18,6700|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||6964||6964|10505|
019445|L01XC0701|Avastin|irţ|25|mg/ml|4|ml|1|hgl|lausn|L01XC07|01.05.2005||R|||0|1|0|1|RRL|0|0|0|100|DKK|53478|68997|lyfsjukr||||4|0||Icepharma hf|Roche Registration Limited|Bevacizúmab||53478||53478|68997|
019469|N06AX2102|Yentreve|hylki|40|mg|56|stk|1|ţpakki|sýruţ.hylki, hörđ|N06AX21|01.10.2004||R|||0|0|0|0|ELD|0|0|0|100|XEU|6964|10505|lyfalmen||||56|0|37,3300|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||6964||6964|10505|
019513|C03CA0101|Furix|töflur|40|mg|100|stk|1|glas||C03CA01|01.03.2003||R|||0|0|E|0|NYG|0|0|0|100|DKK|612|1816|lyfalmen||||100|0|100,0000|Gróco ehf|Nycomed Danmark A/S|Fúrósemíđ||612||612|1816|
019659|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|96|stk|1|ţpakki||N07BA01|01.12.2006||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||96|0|12,8000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
019670|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|96|stk|1|ţpakki||N07BA01|01.12.2006||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||96|0|12,8000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
019672|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|96|stk|1|ţpakki||N07BA01|01.12.2006||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||96|0|12,8000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
019681|N07BA0114|Nicotinell Classic|tyggigúm|2|mg|24|stk|1|ţpakki||N07BA01|01.01.2005||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||24|0|1,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
019711|L01BC0501|Gemzar|irs|200|mg|1|hgl|1|pakki||L01BC05|01.03.1999||R|||0|1|0|1|ELI|0|0|0|100|XEU|3813|5503|lyfsjukr||||1|0||Icepharma hf|Eli Lilly Danmark A/S|Gemcitabín||3813||3813|5503|
019713|N07BA0114|Nicotinell Classic|tyggigúm|2|mg|204|stk|1|ţpakki||N07BA01|01.01.2005||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
019724|N07BA0114|Nicotinell Classic|tyggigúm|4|mg|24|stk|1|ţpakki||N07BA01|01.01.2005||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||24|0|3,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
019745|C03CA0101|Furix|töflur|40|mg|250|stk|1|glas|til vélskömmtunar|C03CA01|01.04.2005||R|||0|0|E|0|NYG|0|0|0|100|DKK|639|1853|lyfalmen||||250|0|250,0000|Gróco ehf|Nycomed Danmark A/S|Fúrósemíđ||639||639|1853|
019760|L01BC0501|Gemzar|irs|1|g|1|hgl|1|pakki||L01BC05|01.03.1999||R|||0|1|0|1|ELI|0|0|0|100|XEU|16751|22905|lyfsjukr||||1|0||Icepharma hf|Eli Lilly Danmark A/S|Gemcitabín||16751||16751|22905|
019781|L01XC0701|Avastin|irţ|25|mg/ml|16|ml|1|hgl|lausn|L01XC07|01.05.2005||R|||0|1|0|1|RRL|0|0|0|100|DKK|198591|251114|lyfsjukr||||16|0||Icepharma hf|Roche Registration Limited|Bevacizúmab||198591||198591|251114|
019782|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|96|stk|1|ţpakki||N07BA01|01.12.2006||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||96|0|6,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
019786|J01CA0411|Amoxicillin Mylan|hylki|500|mg|20|stk|1|glas||J01CA04|01.04.1993||R|||0|0|0|0|MYL|0|0|1|100|SEK|1119|2510|lyfalmen|V0159|2508||20|0|10,0000|Actavis Group PTC ehf|Mylan AB|Amoxicillín||1119||1119|2510|
019793|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|96|stk|1|pakki||N07BA01|01.12.2006||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||96|0|6,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
019797|L01BA0401|Alimta|irţ|500|mg/hgl|1|hgl|1|pakki||L01BA04|01.03.2005||R|||0|1|0|1|ELD|0|0|0|100|XEU|201929|255303|lyfsjukr||||1|0||Icepharma hf|Eli Lilly Nederland B.V.|Pemetrexed||201929||201929|255303|
019811|N06BA0901|Strattera|hylki|10|mg|28|stk|1|glas|hart|N06BA09|01.08.2006||R|||0|1|0|0|ELI|0|0|0|100|XEU|13131|19025|lyfalmen||||28|0|3,5000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||13131||13131|19025|
019833|N06BA0901|Strattera|hylki|18|mg|28|stk|1|glas|hart|N06BA09|01.08.2006||R|||0|1|0|0|ELI|0|0|0|100|XEU|13131|19025|lyfalmen||||28|0|6,3000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||13131||13131|19025|
019837|G03GA0601|Puregon|stl|900|ae/rörly|1,08|ml|1|lykja||G03GA06|01.10.2005||R|||0|1|E|0|ORG|0|0|0|100|DKK|56831|73868|lyfalmen||||1|0|12,0000|Vistor hf|N.V. Organon|Follitrópín beta||56831||56831|73868|
019857|N06BA0901|Strattera|hylki|25|mg|28|stk|1|glas|hart|N06BA09|01.08.2006||R|||0|1|0|0|ELI|0|0|0|100|XEU|13131|19025|lyfalmen||||28|0|8,7500|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||13131||13131|19025|
019882|N06BA0901|Strattera|hylki|40|mg|28|stk|1|glas|hart|N06BA09|01.08.2006||R|||0|1|0|0|ELI|0|0|0|100|XEU|13131|19025|lyfalmen||||28|0|14,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||13131||13131|19025|
019904|N06BA0901|Strattera|hylki|60|mg|28|stk|1|glas|hart|N06BA09|01.08.2006||R|||0|1|0|0|ELI|0|0|0|100|XEU|13131|19025|lyfalmen||||28|0|21,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||13131||13131|19025|
019916|V03AF0801|Kepivance|sts|6,25|mg/hgl|6|hgl|1|pakki|lausn|V03AF08|01.07.2006||R|||0|1|0|1|BIA|0|0|0|100|DKK|802247|1008702|lyfsjukr||||6|0|8,9300|Vistor hf|Biovitrum AB (publ)|Palifermín||802247||802247|1008702|
019931|N04BC0403|Adartrel|filmhtfl|0,25|mg|12|stk|1|ţpakki||N04BC04|01.12.2006||R|||0|0|E|0|GSK|0|0|0|100|GBP|415|1547|lyfalmen||||12|0|0,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||415||415|1547|
019938|J05AR0201|Kivexa|filmhtfl|900|mg|30|stk|1|ţpakki|600+300 mg|J05AR02|01.05.2004||R|||0|1|0|1|GGL|0|0|0|100|GBP|71274|91331|lyfsjukr||||30|0|30,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Lamívúdín og abacavír||71274||71274|91331|
019968|J01CA0411|Amoxicillin Mylan|hylki|500|mg|30|stk|1|glas||J01CA04|01.04.1995||R|||0|0|0|0|MYL|0|0|1|100|SEK|1676|3218|lyfalmen|V0160|3217||30|0|15,0000|Actavis Group PTC ehf|Mylan AB|Amoxicillín||1637||1637|3218|
020016|B03AA0704|Duroferon|forđatfl|100|mg|100|stk|1|glas||B03AA07|01.03.1979||L|||0|0|0|0|GSC|0|0|1|100|IKR|||lyflausa||||100|0|50,0000|GlaxoSmithKline ehf|GlaxoSmithKline CH AB c/o GSK CH A/S|Ferrósúlfat||||||
020048|M02AA1502|Voltaren|hlaup|11,6|mg/g|100|g|1|túpa||M02AA15|01.03.2009||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||100|0||Artasan ehf|Novartis Healthcare A/S-A|Díklófenak||||||
020193|N07BA0114|Nicotinell Classic|tyggigúm|2|mg|96|stk|1|ţpakki||N07BA01|01.01.2005||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||96|0|6,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
020238|G04CA0203|Omnic Ocas|forđatfl|0,4|mg|30|stk|1|ţpakki||G04CA02|01.04.2006||R|||0|0|E|0|ASP|0|0|0|100|XEU|2970|5042|lyfalmen||||30|0|30,0000|Vistor hf|Astellas Pharma A/S|Tamsúlósín||2970||2970|5042|
020244|J07CA0204|Boostrix Polio|stl|||0,5|ml|10|áf.spr|dreifa|J07CA02|01.09.2007||R|||0|0|0|0|GSK|0|0|0|100|GBP|27790|37422|lyfalmen||||5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|barnaveiki, kíghósti, mćnusótt, stífkrampi||27790||27790|37422|
020276|A06AB0203|Dulcolax (Lyfjaver)|eţ-stíll|10|mg|50|stk|1|ţpakki||A06AB02|01.07.2005||R|||0|0|0|0|LVR|0|0|0|100|NOK|2863|4895|lyfalmen||||50|0|50,0000|Lyfjaver ehf|Lyfjaver ehf|Bisakódýl||2863||2863|4895|
020277|N06AX1602|Efexor Depot|forđahlk|37,5|mg|7|stk|1|ţpakki||N06AX16|01.02.2007||R|||0|0|0|0|PER|0|1|0|100|DKK|590|1786|lyfalmen|V0333|1607||7|0|2,6300|Icepharma hf|Pfizer ApS|Venlafaxín||590||590|1786|
020292|M02AA1502|Voltaren|hlaup|11,6|mg/g|50|g|1|túpa||M02AA15|01.06.2010||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||50|0||Artasan ehf|Novartis Healthcare A/S-A|Díklófenak||||||
020338|G04CA0203|Omnic Ocas|forđatfl|0,4|mg|90|stk|1|ţpakki||G04CA02|01.04.2006||R|||0|0|E|0|ASP|0|0|0|100|XEU|6933|10463|lyfalmen||||90|0|90,0000|Vistor hf|Astellas Pharma A/S|Tamsúlósín||6933||6933|10463|
020355|L02AE0203|Eligard|sts|22,5|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.07.2006||R|||0|1|*|0|ASP|0|0|0|100|XEU|54115|70459|lyfalmen||||2|0|155,7500|Vistor hf|Astellas Pharma A/S|Leuprórelín||54115||54115|70459|
020364|N04BC0403|Adartrel|filmhtfl|0,5|mg|84|stk|1|ţpakki||N04BC04|01.06.2006||R|||0|0|E|0|GSK|0|0|0|100|GBP|6599|6546|lyfalmen|V0530|6546||84|0|7,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||4070||4070|6546|
020417|N04BC0403|Adartrel|filmhtfl|2|mg|84|stk|1|ţpakki||N04BC04|01.12.2006||R|||0|0|E|0|GSK|0|0|0|100|GBP|14703|7769|lyfalmen|V0531|7769||84|0|28,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||4964||4964|7769|
020427|L02AE0203|Eligard|sts|7,5|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.07.2006||R|||0|1|*|0|ASP|0|0|0|100|XEU|24421|33193|lyfalmen||||2|0|51,9400|Vistor hf|Astellas Pharma A/S|Leuprórelín||24421||24421|33193|
020444|D07AB0201|Locoid|krem|1|mg/g|30|g|1|túpa||D07AB02|01.07.1985||R|||0|0|B|0|ASP|0|0|1|100|XEU|615|1820|lyfalmen||||30|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||615||615|1820|
020456|M05BX0301|Protelos|mixt.kyr|2|g|28|sk-pokar|1|pakki|dreifa|M05BX03|01.08.2005||R|||0|0|0|0|SEV|0|0|0|100|DKK|5810|8927|lyfalmen||||28|0|28,0000|Icepharma hf|Servier|Strontíum ranelat||5810||5810|8927|
020457|D07AB0201|Locoid|krem|1|mg/g|100|g|1|túpa||D07AB02|01.03.1977||R|||0|0|B|0|ASP|0|0|1|100|XEU|1873|3541|lyfalmen||||100|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||1873||1873|3541|
020533|M05BX0301|Protelos|mixt.kyr|2|g|84|sk-pokar|1|pakki|dreifa|M05BX03|01.08.2005||R|||0|0|0|0|SEV|0|0|0|100|DKK|16921|23781|lyfalmen||||84|0|84,0000|Icepharma hf|Servier|Strontíum ranelat||16921||16921|23781|
020648|R06AX2201|Kestine|töflur|20|mg|10|stk|1|ţpakki||R06AX22|01.10.2005||L|||0|0|0|0|APS|0|0|1|100|IKR|||lyflausa||||10|0|20,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín||||||
020711|G03AD0102|Postinor|töflur|1500|mcg|1|stk|1|ţpakki||G03AD01|01.01.2007||L|||0|0|0|0|MEI|0|0|0|100|IKR|||lyflausa||||1|0|1,0000|Icepharma hf|Medimpex UK Limited|Levonorgestrel||||||
020770|QP54AA5101|Eqvalan Duo|pasta|||7,74|g|1|sk-dćl||QP54AA51|01.10.2006||R|||0|0|0|0|MES|0|0|0|100|XEU|2263|3948|vetorma||||8|0||Vistor hf|Merial SAS|||2263||2263|3948|
020774|L04AB0101|Enbrel|sts|50|mg|4|hgl|1|pakki|+ leysir|L04AB01|01.10.2005||R|||0|1|0|1|WTE|0|0|0|100|DKK|159353|201871|lyfsjukr||||4|0|28,5700|Icepharma hf|Wyeth Europe|Etanercept||159353||159353|201871|
020861|QP52AF0202|Twinhip Vet.|pasta|439|mg/g|52|g|1|spr||QP52AF02|01.08.2011||R|||0|0|0|0|VEB|0|0|0|100|XEU|2647|4618|vetorma||||52|0||Dýraheilsa ehf|Le Vet Beheer B.V.|||2647||2647|4618|
020924|J01FA1003|Zithromax (D.A.C.)|töflur|500|mg|3|stk|1|ţpakki||J01FA10|01.09.2007||R|||0|0|0|0|DAC|0|0|1|100|DKK|2060|3797|lyfalmen|V0174|3797||3|0|5,0000|D.A.C. ehf|D.A.C. ehf|Azitrómýcín||2060||2060|3797|
020992|C09AA0402|Coversyl Novum|filmhtfl|5|mg|30|stk|1|glas||C09AA04|01.08.2011||R|||0|0|0|0|SEV|0|0|0|100|DKK|3071|5180|lyfalmen||||30|0|37,5000|Icepharma hf|Servier|Perindópríl||3071||3071|5180|
021053|D10AD0301|Differin|hlaup|0,1|%|60|g|1|túpa||D10AD03|01.12.2007||R|||0|0|0|0|GAN|0|0|0|100|SEK|2499|4397|lyfalmen||||60|0||Icepharma hf|Galderma Nordic AB|Adapalen||2499||2499|4397|
021057|J01CR0203|Augmentine (D.A.C.)|töflur|625|mg|12|stk|1|ţpakki|500+125 mg|J01CR02|01.05.2005||R|||0|0|0|0|DAC|0|0|1|100|IKR|827|1956|lyfalmen||||12|0|6,0000|D.A.C. ehf|D.A.C. ehf|Amoxicillín og ensímblokkar||714||714|1956|
021149|J01CR0203|Augmentine (D.A.C.)|töflur|1000|mg|12|stk|1|ţpakki|875+125 mg|J01CR02|01.05.2005||R|||0|0|0|0|DAC|0|0|1|100|IKR|1025|2381|lyfalmen|V0169|2367||12|0|10,5000|D.A.C. ehf|D.A.C. ehf|Amoxicillín og ensímblokkar||1025||1025|2381|
021161|M01AB0513|Vostar-S|filmhtfl|50|mg|30|stk|1|ţpakki||M01AB05|01.03.2005||R|||0|0|E|0|ACA|0|0|1|100|IKR|453|1389|lyfalmen|V0188|1389||30|0|15,0000|Actavis Group hf|Actavis hf|Díklófenak||300||300|1389|
021169|S01XA1201|Corneregel|augnhl|50|mg/g|10|g|1|túpa||S01XA12|01.08.2005||R|||0|0|E|0|GEM|0|0|0|100|XEU|1035|2395|lyfalmen||||10|0||Actavis Group hf|Gerhard Mann|Dexpantenól||1035||1035|2395|
021227|M01AB0513|Vostar-S|filmhtfl|50|mg|100|stk|1|ţpakki||M01AB05|01.03.2005||R|||0|0|E|0|ACA|0|0|1|100|IKR|1187|2116|lyfalmen|V0189|2116||100|0|50,0000|Actavis Group hf|Actavis hf|Díklófenak||831||831|2116|
021257|G03BA0307|Nebido|stl|250|mg/ml|4|ml|1|lykja||G03BA03|01.07.2005||R|||0|0|E|0|BAP|0|0|0|100|SEK|17393|24373|lyfalmen|V0546|24373||4|0|55,5600|Icepharma hf|Bayer Schering Pharma AG|Testósterón||17393||17393|24373|
021341|R03AK0603|Seretide Diskus (Lyfjaver)|innúđadu|550|mcg/sk|60|sk|1|pakki|50+500 mcg, discus|R03AK06|01.05.2012||R|||0|0|0|0|LVR|0|0|0|100|GBP|10052|14730|lyfalmen|V0437|14505||60|0|30,0000|Lyfjaver ehf|Lyfjaver ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||10052||10052|14730|
021345|R03DC0301|Singulair|filmhtfl|10|mg|98|stk|1|ţpakki||R03DC03|01.09.1998||R|||0|0|B|0|MSD|0|0|0|100|DKK|17481|24484|lyfalmen|V0490|10747||98|0|98,0000|Vistor hf|M.S.D.|Montelúkast||17481||17481|24484|
021365|R03AK0603|Seretide Diskus (Lyfjaver)|innúđadu|300|mcg/sk|60|sk|1|pakki|50+250 mcg, discus|R03AK06|01.05.2012||R|||0|0|0|0|LVR|0|0|0|100|GBP|7162|10776|lyfalmen|V0436|10776||60|0|30,0000|Lyfjaver ehf|Lyfjaver ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||7162||7162|10776|
021375|M01AB0512|Voltaren Dolo|töflur|12,5|mg|20|stk|1|ţpakki||M01AB05|01.10.2004||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||20|0|2,5000|Artasan ehf|Novartis Healthcare A/S-A|Díklófenak||||||
021417|R01AD0504|Rhinocort (D.A.C.)|nefúđi|64|mcg/sk|120|sk|1|fl||R01AD05|01.11.2004||R|||0|0|E|0|DAC|0|0|1|100|SEK|1681|3228|lyfalmen|V0443|3228||120|0|38,4000|D.A.C. ehf|D.A.C. ehf|Búdesóníđ||1644||1644|3228|
021428|A06AB0201|Dulcolax|eţ-stíll|10|mg|6|stk|1|pakki||A06AB02|01.01.1995||L|||0|0|0|0|BOI|0|0|0|100|IKR|||lyflausa||||6|0|6,0000|Vistor hf|Boehringer Ingelheim|Bisakódýl||||||
021469|R03DC0301|Singulair|tuggutfl|5|mg|98|stk|1|ţpakki||R03DC03|01.09.1998||R|||0|0|B|0|MSD|0|0|0|100|DKK|17759|24833|lyfalmen|V0491|19721||98|0|49,0000|Vistor hf|M.S.D.|Montelúkast||17759||17759|24833|
021494|N01AX1003|Propolipid|stl|10|mg/ml|20|ml|5|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|||0|0|0|1|FRP|0|0|0|100|DKK|1612|2327|lyfsjukr||||100|0||Icepharma hf|Fresenius Kabi|Própófól||1612||1612|2327|
021593|H01BA0201|Minirin|frţ.tfl|60|mcg|30|stk|1|ţpakki||H01BA02|01.10.2005||R|||0|0|E|0|FEL|0|0|0|100|DKK|4481|7109|lyfalmen||||30|0|4,5000|Vistor hf|Ferring Lćgemidler A/S|Desmópressín||4481||4481|7109|
021604|H01BA0201|Minirin|frţ.tfl|60|mcg|100|stk|1|ţpakki||H01BA02|01.10.2005||R|||0|0|E|0|FEL|0|0|0|100|DKK|13716|19759|lyfalmen||||100|0|15,0000|Vistor hf|Ferring Lćgemidler A/S|Desmópressín||13716||13716|19759|
021613|C10AA0701|Crestor|filmhtfl|5|mg|98|stk|1|ţpakki||C10AA07|01.01.2006||R|||0|0|0|0|AZD|0|0|0|100|SEK|14544|20798|lyfalmen||||98|0|49,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||14544||14544|20798|
021614|H01BA0201|Minirin|frţ.tfl|120|mcg|30|stk|1|ţpakki||H01BA02|01.10.2005||R|||0|0|E|0|FAB|0|0|0|100|DKK|7248|10894|lyfalmen||||30|0|9,0000|Vistor hf|Ferring AB, Svíţjóđ|Desmópressín||7248||7248|10894|
021625|A07EC0203|Pentasa Sachets|forđakyr|2|g|60|pokar|1|pakki||A07EC02|01.05.2011||R|||0|0|B|0|FER|0|0|0|100|DKK|15402|21875|lyfalmen||||60|0|80,0000|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||15402||15402|21875|
021636|N01AX1003|Propolipid|stl|10|mg/ml|100|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|||0|0|0|1|FRP|0|0|0|100|DKK|16124|22118|lyfsjukr||||1000|0||Icepharma hf|Fresenius Kabi|Própófól||16124||16124|22118|
021641|H01BA0201|Minirin|frţ.tfl|120|mcg|100|stk|1|ţpakki||H01BA02|01.10.2005||R|||0|0|E|0|FEL|0|0|0|100|DKK|23089|31522|lyfalmen||||100|0|30,0000|Vistor hf|Ferring Lćgemidler A/S|Desmópressín||23089||23089|31522|
021647|N01AX1003|Propolipid|stl|20|mg/ml|50|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|||0|0|0|1|FRP|0|0|0|100|DKK|16124|22118|lyfsjukr||||500|0||Icepharma hf|Fresenius Kabi|Própófól||16124||16124|22118|
021659|V01AA0304|Alutard SQ, derm. pter.|stl|||5|ml|4|hgl|byrjunarsett|V01AA03|01.07.1999||R|||0|1|E|0|ALK|0|0|0|100|DKK|24818|33692|lyfalmen||||20|0||Vistor hf|ALK-Abello A/S|rykmaurar||24818||24818|33692|
021674|C10AA0701|Crestor|filmhtfl|5|mg|28|stk|1|ţpakki||C10AA07|01.01.2006||R|||0|0|0|0|AZD|0|0|0|100|SEK|4534|7181|lyfalmen||||28|0|14,0000|Vistor hf|AstraZeneca A/S DK|Rósuvastatín||4534||4534|7181|
021676|N01AX1003|Propolipid|stl|10|mg/ml|50|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|||0|0|0|1|FRP|0|0|0|100|DKK|9272|13382|lyfsjukr||||500|0||Icepharma hf|Fresenius Kabi|Própófól||9272||9272|13382|
021677|B02AA0202|Tranexamsyre "Pfizer"|stl|100|mg/ml|5|ml|10|lykjur||B02AA02|01.11.2005||R|||0|0|0|1|PER|0|0|0|100|DKK|4679|6753|lyfsjukr||||50|0|2,5000|Icepharma hf|Pfizer ApS|Tranexamsýra||4679||4679|6753|
021709|V01AA0304|Alutard SQ, derm. pter.|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA03|01.07.1999||R|||0|1|E|0|ALK|0|0|0|100|DKK|19869|27481|lyfalmen||||5|0||Vistor hf|ALK-Abello A/S|rykmaurar||19869||19869|27481|
021721|N06AX2101|Cymbalta|sh-hylki|30|mg|28|stk|1|ţpakki||N06AX21|01.04.2005||R|||0|0|0|0|ELD|0|1|0|100|XEU|3899|6313|lyfalmen||||28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||3899||3899|6313|
021950|B05AA0705|HyperHAES|irl|||250|ml|10|pokar||B05AA07|01.07.2005||R|||0|0|0|1|FRP|0|0|0|100|DKK|22010|29505|lyfsjukr||||2500|0||Icepharma hf|Fresenius Kabi|Hýdróxyetýl sterkja||22010||22010|29505|
021967|N06AX2101|Cymbalta|sh-hylki|60|mg|28|stk|1|ţpakki||N06AX21|01.04.2005||R|||0|0|0|0|ELD|0|1|0|100|XEU|5389|8351|lyfalmen||||28|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||5389||5389|8351|
021975|N06AX2101|Cymbalta|sh-hylki|60|mg|98|stk|1|ţpakki||N06AX21|01.04.2005||R|||0|0|0|0|ELD|0|1|0|100|XEU|18572|25853|lyfalmen||||98|0|98,0000|Icepharma hf|Eli Lilly Nederland B.V.|Duloxetín||18572||18572|25853|
022020|V01AA0304|Alutard SQ, derm. pter.|stl|0,01|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA03|01.07.1999||R|||0|1|E|0|ALK|0|0|0|100|DKK|19869|27481|lyfalmen||||5|0||Vistor hf|ALK-Abello A/S|rykmaurar||19869||19869|27481|
022045|L01XE0301|Tarceva|filmhtfl|25|mg|30|stk|1|ţpakki||L01XE03|01.01.2006||R|||0|1|0|1|RRL|0|0|0|100|DKK|85559|109259|lyfsjukr||||30|0||Icepharma hf|Roche Registration Limited|Erlótiníb||85559||85559|109259|
022112|B05AA0112|Flexbumin|irl|200|g/líter|100|ml|12|pokar|lausn|B05AA01|01.06.2010||R|||0|0|0|1|BAM|0|0|0|100|SEK|124367|157963|lyfsjukr||||1200|0||Icepharma hf|Baxter Medical AB|Albúmín||124367||124367|157963|
022128|A01AA0117|Fludent Banan|munnstfl|0,25|mg|200|stk|1|plglas||A01AA01|01.01.2008||L|||0|0|0|0|AGT|0|0|1|100|IKR|||lyflausa||||200|0|45,4500|Actavis Group hf|Actavis Group hf|Natríumflúoríđ||||||
022135|C10BA0201|Inegy|töflur|30|mg|28|stk|1|ţpakki|10 mg + 20 mg|C10BA02|01.01.2010||R|||0|0|0|0|MSD|0|0|0|100|DKK|7343|11024|lyfalmen||||28|0|28,0000|Vistor hf|M.S.D.|Ezetimíb og simvastatín||7343||7343|11024|
022157|C10BA0201|Inegy|töflur|50|mg|28|stk|1|ţpakki|10 mg + 40 mg|C10BA02|01.01.2010||R|||0|0|0|0|MSD|0|0|0|100|DKK|8605|12750|lyfalmen||||28|0|28,0000|Vistor hf|M.S.D.|Ezetimíb og simvastatín||8605||8605|12750|
022159|C10BA0201|Inegy|töflur|50|mg|98|stk|1|ţpakki|10 mg + 40 mg|C10BA02|01.09.2005||R|||0|0|0|0|MSD|0|0|0|100|DKK|26388|35662|lyfalmen||||98|0|98,0000|Vistor hf|M.S.D.|Ezetimíb og simvastatín||26388||26388|35662|
022165|A10AB0606|Apidra [Clikstar]|stl|100|ein/ml|3|ml|5|lykjur|rörlykjur fyrir Clikstar penna|A10AB06|01.07.2010||R|||0|0|*|0|SAA|0|0|0|100|NOK|5587|8622|lyfalmen||||15|0|37,5000|Vistor hf|Sanofi - Aventis|Insúlín glúlisín||5587||5587|8622|
022174|C10BA0201|Inegy|töflur|90|mg|28|stk|1|ţpakki|10 mg + 80 mg|C10BA02|01.01.2010||R|||0|0|0|0|MSD|0|0|0|100|DKK|9177|13533|lyfalmen||||28|0|28,0000|Vistor hf|M.S.D.|Ezetimíb og simvastatín||9177||9177|13533|
022191|L01XE0301|Tarceva|filmhtfl|100|mg|30|stk|1|ţpakki||L01XE03|01.01.2006||R|||0|1|0|1|RRL|0|0|0|100|DKK|299423|377658|lyfsjukr||||30|0||Icepharma hf|Roche Registration Limited|Erlótiníb||299423||299423|377658|
022205|L01XE0301|Tarceva|filmhtfl|150|mg|30|stk|1|ţpakki||L01XE03|01.01.2006||R|||0|1|0|1|RRL|0|0|0|100|DKK|330437|416581|lyfsjukr||||30|0||Icepharma hf|Roche Registration Limited|Erlótiníb||330437||330437|416581|
022218|QP52AA5102|Drontal Comp.vet.|töflur|||24|stk|1|ţpakki||QP52AA51|01.01.2006||R|||0|0|0|0|BAN|0|0|0|100|DKK|11517|20091|vetorma||||24|0||Icepharma hf|Bayer Animal Health GmbH|||11517||11517|20091|
022250|M03AX0103|Vistabel|sts|50|ein/hgl|1|hgl|1|pakki|4 Allerg.ein/0,1ml|M03AX01|01.02.2008||R|||0|1|0|0|ALL|0|0|0|100|SEK|24783|33648|lyfalmen||||1|0||Vistor hf|Allergan|Clostridium botulinum toxín-A||24783||24783|33648|
022261|QP52AA5107|Profender fyrir kisur 5-8 kg|bl.lausn|1,12|ml/sk|1,12|ml|2|skammt||QP52AA51|01.09.2006||R|||0|0|0|0|BAN|0|0|0|100|DKK|2315|4038|vetorma||||2|0||Icepharma hf|Bayer Animal Health GmbH|||2315||2315|4038|
022269|C08CA0101|Norvasc|töflur|5|mg|30|stk|1|ţpakki||C08CA01|01.01.1992||R|||0|0|B|0|PER|0|0|0|100|DKK|1324|2790|lyfalmen||||30|0|30,0000|Icepharma hf|Pfizer ApS|Amlódipín||1324||1324|2790|
022281|QP52AA5102|Drontal Comp.vet.|töflur|||2|stk|1|ţpakki||QP52AA51|01.10.1991||L|||0|0|0|0|BAN|0|0|0|100|DKK|1410|2460|vetorma||||2|0||Icepharma hf|Bayer Animal Health GmbH|||||1410|2460|
022293|C08CA0101|Norvasc|töflur|5|mg|100|stk|1|ţpakki||C08CA01|01.01.1992||R|||0|0|B|0|PER|0|0|0|100|DKK|3911|2748|lyfalmen|V0056|1801||100|0|100,0000|Icepharma hf|Pfizer ApS|Amlódipín||1293||1293|2748|
022368|C08CA0101|Norvasc|töflur|10|mg|100|stk|1|ţpakki||C08CA01|01.01.1992||R|||0|0|B|0|PER|0|0|0|100|DKK|6875|3787|lyfalmen|V0057|2231||100|0|200,0000|Icepharma hf|Pfizer ApS|Amlódipín||2053||2053|3787|
022407|QP52AA5106|Profender fyrir kisur 2,5-5 kg|bl.lausn|0,7|ml/sk|0,7|ml|2|skammt||QP52AA51|01.09.2006||R|||0|0|0|0|BAN|0|0|0|100|DKK|2193|3826|vetorma||||1|0||Icepharma hf|Bayer Animal Health GmbH|||2193||2193|3826|
022440|D07AB0203|Locoid Lipid|krem|1|mg/g|30|g|1|túpa|feitt|D07AB02|01.07.1986||R|||0|0|B|0|ASP|0|0|1|100|XEU|641|1856|lyfalmen||||30|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||641||641|1856|
022451|D07AB0203|Locoid Lipid|krem|1|mg/g|100|g|1|túpa|feitt|D07AB02|01.04.1987||R|||0|0|B|0|ASP|0|0|1|100|XEU|1921|3607|lyfalmen||||100|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||1921||1921|3607|
022465|QP52AA5105|Profender fyrir kisur 0,5-2,5 kg|bl.lausn|0,35|ml/sk|0,35|ml|2|skammt||QP52AA51|01.09.2006||R|||0|0|0|0|BAN|0|0|0|100|DKK|1420|2477|vetorma||||1|0||Icepharma hf|Bayer Animal Health GmbH|||1420||1420|2477|
022532|C09DA0303|Diovan Comp 160/12,5 mg|filmhtfl|172,5|mg|28|stk|1|ţpakki||C09DA03|01.11.2003||R|||0|0|0|0|NOH|0|0|0|100|DKK|4777|7514|lyfalmen||||28|0|28,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan og ţvagrćsilyf||4777||4777|7514|
022537|N06AB0504|Paxetin|töflur|20|mg|100|stk|1|glas||N06AB05|01.01.2005||R|||0|0|B|0|ACA|0|1|0|100|IKR|2129|2993|lyfalmen|V0321|2993||100|0|100,0000|Actavis Group hf|Actavis hf|Paroxetín||1472||1472|2993|
022577|N06AB0504|Paxetin|töflur|20|mg|60|stk|1|glas||N06AB05|01.01.2005||R|||0|0|B|0|ACA|0|1|0|100|IKR|1554|2046|lyfalmen|V0321|1796||60|0|60,0000|Actavis Group hf|Actavis hf|Paroxetín||780||780|2046|
022757|S01XA2019|Oftagel|augnhl|2,5|mg/g|0,5|g|60|sk-hyl||S01XA20|01.07.2012||L|||0|0|E|0|SAO|0|0|0|100|XEU|||lyfalmen||||30|0||Icepharma hf|Santen Oy|Gervitár og ađrar óvirkar samsetningar|||||4843|
022783|B01AX0501|Arixtra|stl|10|mg/spr|0,8|ml|10|spr|áfyllt sprauta|B01AX05|01.10.2011||R|||0|0|E|0|GGL|0|0|0|100|GBP|27341|36858|lyfalmen||||8|0|40,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Fondaparinux||27341||27341|36858|
022802|L01XC0401|MabCampath|irţ|30|mg/ml|1|ml|3|hgl||L01XC04|01.07.2007||R|||0|1|0|1|GEU|0|0|0|100|SEK|227764|287726|lyfsjukr||||3|0||Icepharma hf|Genzyme Europe B.V. (I)|Alemtuzumab||227764||227764|287726|
022815|B01AX0501|Arixtra|stl|5|mg/spr|0,4|ml|10|spr|áfyllt sprauta|B01AX05|01.10.2011||R|||0|0|E|0|GGL|0|0|0|100|GBP|13671|19702|lyfalmen||||4|0|20,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Fondaparinux||13671||13671|19702|
022831|B01AX0501|Arixtra|stl|7,5|mg/spr|0,6|ml|10|spr|áfyllt sprauta|B01AX05|01.04.2012||R|||0|0|E|0|GGL|0|0|0|100|GBP|20528|28308|lyfalmen||||6|0|30,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Fondaparinux||20528||20528|28308|
022845|S01XA2019|Oftagel|augnhl|2,5|mg/g|0,5|g|30|sk-hyl||S01XA20|01.05.2007||L|||0|0|E|0|SAO|0|0|0|100|XEU|||lyfalmen||||15|0||Icepharma hf|Santen Oy|Gervitár og ađrar óvirkar samsetningar|||||2910|
022904|D10BA0102|Decutan|hylki|10|mg|30|stk|1|ţpakki||D10BA01|01.02.2006||R|||0|1|C|0|ACA|0|0|0|30|IKR|1407|2827|lyfalmen|V0124|2827||30|0|10,0000|Actavis Group hf|Actavis hf|Ísótretínóín||1351||1351|2827|
022915|D10BA0102|Decutan|hylki|20|mg|30|stk|1|ţpakki||D10BA01|01.02.2006||R|||0|1|C|0|ACA|0|0|0|30|IKR|2450|4196|lyfalmen|V0125|4196||30|0|20,0000|Actavis Group hf|Actavis hf|Ísótretínóín||2352||2352|4196|
022962|V01AA1104|Alutard SQ, hrossavćrur|stl|||5|ml|4|hgl|byrjunarsett|V01AA11|01.07.1999||R|||0|1|E|0|ALK|0|0|0|100|DKK|24818|33692|lyfalmen||||20|0||Vistor hf|ALK-Abello A/S|dýr||24818||24818|33692|
022970|V01AA1104|Alutard SQ, hrossavćrur|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|||0|1|E|0|ALK|0|0|0|100|DKK|19869|27481|lyfalmen||||5|0||Vistor hf|ALK-Abello A/S|dýr||19869||19869|27481|
023047|G04BD1001|Emselex|forđatfl|7,5|mg|28|stk|1|ţpakki||G04BD10|01.07.2005||R|||0|0|E|0|NOE|0|0|0|100|DKK|5776|8880|lyfalmen||||28|0|28,0000|Vistor hf|Novartis Europharm Ltd|Darífenacín||5776||5776|8880|
023063|J05AR0301|Truvada|filmhtfl|445|mg|30|stk|1|glas|200+245 mg|J05AR03|01.03.2006||R|||0|1|0|1|GIS|0|0|0|100|DKK|85552|109250|lyfsjukr||||30|0|30,0000|Gilead Sience Sweden AB|Gilead Science International ltd.|Tenófóvír dísóproxíl og emtrícítabín||85552||85552|109250|
023066|V03AE0301|Fosrenol|tuggutfl|500|mg|90|stk|1|pakki||V03AE03|01.03.2006||R|||0|1|0|0|SHI|0|0|0|100|DKK|26266|35509|lyfalmen||||90|0|20,0000|Lyfjaver ehf|Shire Pharmaceuticals Contracts Ltd.|Lanthanum karbónat||26266||26266|35509|
023080|V03AE0301|Fosrenol|tuggutfl|750|mg|90|stk|1|pakki||V03AE03|01.03.2006||R|||0|1|0|0|SHI|0|0|0|100|DKK|41008|54010|lyfalmen||||90|0|30,0000|Lyfjaver ehf|Shire Pharmaceuticals Contracts Ltd.|Lanthanum karbónat||41008||41008|54010|
023124|G04BD1001|Emselex|forđatfl|7,5|mg|98|stk|1|ţpakki||G04BD10|01.07.2005||R|||0|0|E|0|NOE|0|0|0|100|DKK|20767|28608|lyfalmen||||98|0|98,0000|Vistor hf|Novartis Europharm Ltd|Darífenacín||20767||20767|28608|
023146|G04BD1001|Emselex|forđatfl|15|mg|28|stk|1|ţpakki||G04BD10|01.07.2005||R|||0|0|E|0|NOE|0|0|0|100|DKK|5834|8960|lyfalmen||||28|0|56,0000|Vistor hf|Novartis Europharm Ltd|Darífenacín||5834||5834|8960|
023193|G04BD1001|Emselex|forđatfl|15|mg|98|stk|1|ţpakki||G04BD10|01.07.2005||R|||0|0|E|0|NOE|0|0|0|100|DKK|20977|28871|lyfalmen||||98|0|196,0000|Vistor hf|Novartis Europharm Ltd|Darífenacín||20977||20977|28871|
023329|N03AX1206|Gabapentin Mylan|hylki|300|mg|100|stk|1|glas||N03AX12|01.01.2010||R|||0|0|E|0|MYL|0|0|0|100|SEK|4891|4988|lyfalmen|V0250|4988||100|0|16,6667|Actavis Group PTC ehf|Mylan AB|Gabapentín||2931||2931|4988|
023376|N03AX1206|Gabapentin Mylan|hylki|400|mg|100|stk|1|glas||N03AX12|01.01.2010||R|||0|0|E|0|MYL|0|0|0|100|SEK|3662|5988|lyfalmen|V0251|4864||100|0|22,2200|Actavis Group PTC ehf|Mylan AB|Gabapentín||3662||3662|5988|
023409|N01BB2004|Oraqix|thhlaup|5|%|1,7|g|20|rörlyk||N01BB20|01.09.2006||R|||0|0|0|0|DED|0|0|1|100|XEU|18804|26144|lyfalmen||||34|0||Vistor hf|Dentsply DeTrey GmbH|Blöndur||18804||18804|26144|
023414|B03XA0201|Aranesp|stl|20|mcg/pen|0,5|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|||0|1|0|1|AMG|0|0|0|100|DKK|7557|10907|lyfsjukr||||0|0|4,4400|Vistor hf|Amgen|Darbepóetín alfa||7557||7557|10907|
023419|B03XA0201|Aranesp|stl|80|mcg/pen|0,4|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|||0|1|0|1|AMG|0|0|0|100|DKK|29058|38350|lyfsjukr||||0|0|17,7800|Vistor hf|Amgen|Darbepóetín alfa||29058||29058|38350|
023425|B03XA0201|Aranesp|stl|60|mcg/pen|0,3|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|||0|1|0|1|AMG|0|0|0|100|DKK|22004|29498|lyfsjukr||||0|0|13,3300|Vistor hf|Amgen|Darbepóetín alfa||22004||22004|29498|
023441|B03XA0201|Aranesp|stl|150|mcg/pen|0,3|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|||0|1|0|1|AMG|0|0|0|100|DKK|52405|67651|lyfsjukr||||0|0|33,3300|Vistor hf|Amgen|Darbepóetín alfa||52405||52405|67651|
023447|B03XA0201|Aranesp|stl|100|mcg/pen|0,5|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|||0|1|0|1|AMG|0|0|0|100|DKK|35412|46325|lyfsjukr||||0|0|22,2200|Vistor hf|Amgen|Darbepóetín alfa||35412||35412|46325|
023448|J06BA0207|Kiovig|irl|100|mg/ml|10|ml|1|glerfl||J06BA02|01.09.2007||R|||0|0|0|1|BAA|0|0|0|100|SEK|8543|12330|lyfsjukr||||10|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í ćđ||8543||8543|12330|
023452|B03XA0201|Aranesp|stl|300|mcg/pen|0,6|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|||0|1|0|1|AMG|0|0|0|100|DKK|105548|134345|lyfsjukr||||1|0|66,6700|Vistor hf|Amgen|Darbepóetín alfa||105548||105548|134345|
023459|J06BA0207|Kiovig|irl|100|mg/ml|25|ml|1|glerfl||J06BA02|01.09.2007||R|||0|0|0|1|BAA|0|0|0|100|SEK|21359|28688|lyfsjukr||||25|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í ćđ||21359||21359|28688|
023463|B03XA0201|Aranesp|stl|40|mcg/pen|0,4|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|||0|1|0|1|AMG|0|0|0|100|DKK|15190|20946|lyfsjukr||||0|0|8,8900|Vistor hf|Amgen|Darbepóetín alfa||15190||15190|20946|
023470|J06BA0207|Kiovig|irl|100|mg/ml|50|ml|1|glerfl||J06BA02|01.09.2007||R|||0|0|0|1|BAA|0|0|0|100|SEK|37144|48498|lyfsjukr||||50|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í ćđ||37144||37144|48498|
023476|J06BA0207|Kiovig|irl|100|mg/ml|100|ml|1|glerfl||J06BA02|01.09.2007||R|||0|0|0|1|BAA|0|0|0|100|SEK|74289|95115|lyfsjukr||||100|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í ćđ||74289||74289|95115|
023480|B03XA0201|Aranesp|stl|500|mcg/pen|1|ml|1|penni|áfyllur penni|B03XA02|01.07.2007||R|||0|1|0|1|AMG|0|0|0|100|DKK|183939|232726|lyfsjukr||||1|0|111,1100|Vistor hf|Amgen|Darbepóetín alfa||183939||183939|232726|
023487|J06BA0207|Kiovig|irl|100|mg/ml|200|ml|1|glerfl||J06BA02|01.09.2007||R|||0|0|0|1|BAA|0|0|0|100|SEK|148578|188348|lyfsjukr||||200|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í ćđ||148578||148578|188348|
023501|B01AX0501|Arixtra|stl|7,5|mg/spr|0,6|ml|7|spr|áfyllt sprauta|B01AX05|01.08.2006||R|||0|0|E|0|GGL|0|0|0|100|GBP|14354|20559|lyfalmen||||4|0|21,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Fondaparinux||14354||14354|20559|
023506|J05AE0901|Aptivus|hylki|250|mg|120|stk|1|glas||J05AE09|01.03.2007||R|||0|1|0|1|BII|0|0|0|100|DKK|137982|175050|lyfsjukr||||120|0|30,0000|Vistor hf|Boehringer Ingelheim International |Tipranavír||137982||137982|175050|
023509|B01AC0401|Plavix|töflur|75|mg|100|stk|1|ţpakki||B01AC04|01.07.2007||R|||0|0|E|0|SBM|0|0|0|100|NOK|27510|31952|lyfalmen|V0029|8509||100|0|100,0000|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Klópídógrel||23432||23432|31952|
023590|S01ED0106|Timosan Depot|augnhl|1|mg/g|0,4|g|30|sk-hyl||S01ED01|01.07.2007||R|||0|0|*|0|SAO|0|0|0|100|XEU|3674|6005|lyfalmen||||12|0|30,0000|Icepharma hf|Santen Oy|Tímólól||3674||3674|6005|
023608|N01AB0802|Sevofluran Baxter|innönd.l|100|%|250|ml|6|fl||N01AB08|01.04.2012||R|||0|0|0|1|BAX|0|0|0|100|SEK|156614|198433|lyfsjukr||||1500|0||Icepharma hf|Baxter|Sevóflúran||156614||156614|198433|
023708|J05AE0101|Invirase|filmhtfl|500|mg|120|stk|1|glas||J05AE01|01.01.2006||R|||0|1|0|1|ROC|0|0|0|100|DKK|57858|74494|lyfsjukr||||120|0|33,3300|Icepharma hf|Roche|Saquínavír||57858||57858|74494|
023968|G04BE0302|Revatio|filmhtfl|20|mg|90|stk|1|ţpakki||G04BE03|01.08.2006||R|||0|1|0|1|IPI|0|0|0|100|DKK|78332|100189|lyfsjukr||||90|0|36,0000|Icepharma hf|Pfizer Limited|Síldenafíl||78332||78332|100189|
024018|N04BA0204|Sinemet 25/100|töflur|125|mg|100|stk|1|glas|25+100 mg|N04BA02|01.10.1985||R|||0|0|E|0|MSD|0|0|0|100|DKK|2995|5076|lyfalmen||||100|0|16,6667|Vistor hf|M.S.D.|Levódópa og dópadekarboxýl­asa­hemill||2995||2995|5076|
024024|J01AA1201|Tygacil|irs|50|mg|10|hgl|1|pakki||J01AA12|01.02.2007||R|||0|0|0|1|WTE|0|0|0|100|DKK|79110|101166|lyfsjukr||||10|0|5,0000|Icepharma hf|Wyeth Europe|Tigecýklín||79110||79110|101166|
024056|N02AB0301|Durogesic|forđapl|12|mcg/klst|5|stk|1|ţpakki||N02AB03|01.02.2006||R|||1|0|E|0|JAS|0|0|0|100|SEK|2593|4526|lyfalmen||||5|0|3,6000|Vistor hf|Janssen-Cilag AB|Fentanýl||2593||2593|4526|
024090|N04BD0201|Azilect|töflur|1|mg|30|stk|1|glas||N04BD02|01.10.2005||R|||0|0|E|0|TPG|0|0|0|100|DKK|19791|27383|lyfalmen||||30|0|30,0000|Lundbeck Export A/S|Teva Pharma GmbH|Rasagilín||19791||19791|27383|
024135|B05BB0119|Ringer-Acetat Baxter Viaflo|irl|||1000|ml|10|pokar|lausn|B05BB01|01.10.2005||R|||0|0|0|1|BAM|0|0|0|100|SEK|1830|2641|lyfsjukr||||10000|0||Icepharma hf|Baxter Medical AB|Elektrólýtar||1830||1830|2641|
024151|B05BA1020|StructoKabiven elektrolyfri|irl|1100|kcal|986|ml|4|pokar|fleyti|B05BA10|01.03.2010||R|||0|0|0|1|FRP|0|0|0|100|DKK|23153|30940|lyfsjukr||||3944|0||Icepharma hf|Fresenius Kabi|Blöndur||23153||23153|30940|
024185|N05AH0309|Kozylex|munndr.t|10|mg|28|stk|1|ţpakki||N05AH03|01.09.2011||R|||0|0|*|0|POF|0|1|0|100|XEU|14726|11736|lyfalmen|V0456|11063||28|0|28,0000|Portfarma ehf|Portfarma|Olanzapín||7864||7864|11736|
024200|N04BD0201|Azilect|töflur|1|mg|100|stk|1|ţpakki||N04BD02|01.10.2005||R|||0|0|E|0|TPG|0|0|0|100|DKK|65276|84467|lyfalmen||||100|0|100,0000|Lundbeck Export A/S|Teva Pharma GmbH|Rasagilín||65276||65276|84467|
024307|V01AA1105|Alutard SQ, hundahar|stl|||5|ml|4|hgl|byrjunarsett|V01AA11|01.07.1999||R|||0|1|E|0|ALK|0|0|0|100|DKK|24818|33692|lyfalmen||||20|0||Vistor hf|ALK-Abello A/S|dýr||24818||24818|33692|
024478|V04CL0016|Soluprick SQ ALK553 - hundahár|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|||0|0|0|0|ALK|0|0|0|100|DKK|7813|11667|lyfalmen||||2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7813||7813|11667|
024481|R03CC0301|Bricanyl|mixtúra|0,3|mg/ml|100|ml|1|fl||R03CC03|01.03.2006||R|||0|0|B|0|AZD|0|0|0|100|SEK|438|1578|lyfalmen||||100|0|2,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||438||438|1578|
024482|V04CL0017|Soluprick SQ ALK555 - kattahár|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|||0|0|0|0|ALK|0|0|0|100|DKK|7813|11667|lyfalmen||||2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7813||7813|11667|
024504|V04CL0003|Soluprick SQ ALK106 - Rauđölur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|||0|0|0|0|ALK|0|0|0|100|DKK|13164|19066|lyfalmen||||2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||13164||13164|19066|
024526|V04CL0006|Soluprick SQ ALK113 - Hesliviđur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|||0|0|0|0|ALK|0|0|0|100|DKK|13187|19095|lyfalmen||||2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||13187||13187|19095|
024565|V04CL0009|Soluprick SQ ALK218 - Hávingull|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|||0|0|0|0|ALK|0|0|0|100|DKK|13322|19264|lyfalmen||||2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||13322||13322|19264|
024583|V04CL0011|Soluprick SQ ALK225 - Vallarfoxgras|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|||0|0|0|0|ALK|0|0|0|100|DKK|5633|8685|lyfalmen||||2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||5633||5633|8685|
024590|M05BA0802|Aclasta|irl|5|mg|100|ml|1|fl|lausn|M05BA08|01.07.2005||R|||0|1|0|0|NOE|0|0|0|100|DKK|71574|92371|lyfalmen||||100|0|1,2500|Vistor hf|Novartis Europharm Ltd|Zoledronsýra||71574||71574|92371|
024600|V04CL0013|Soluprick SQ ALK231 - Rúgur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|||0|0|0|0|ALK|0|0|0|100|DKK|13322|19264|lyfalmen||||2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||13322||13322|19264|
024603|V04CL0001|Soluprick  Negativ Kontrol|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|||0|0|0|0|ALK|0|0|0|100|DKK|1604|3173|lyfalmen||||2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||1604||1604|3173|
024622|V04CL0005|Soluprick SQ ALK108 - Birkifrjó|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|||0|0|0|0|ALK|0|0|0|100|DKK|5633|8685|lyfalmen||||2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||5633||5633|8685|
024644|V04CL0015|Soluprick SQ ALK552 - Hrossavćrur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|||0|0|0|0|ALK|0|0|0|100|DKK|7813|11667|lyfalmen||||2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7813||7813|11667|
024670|V04CL0014|Soluprick SQ ALK504 - Rykmaur|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|||0|0|0|0|ALK|0|0|0|100|DKK|7813|11667|lyfalmen||||2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7813||7813|11667|
024681|V04CL0002|Soluprick  Positiv Kontrol|lausn|10|HEP|2|ml|1|hgl||V04CL|01.04.2006||R|||0|0|0|0|ALK|0|0|0|100|DKK|1604|3173|lyfalmen||||2|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||1604||1604|3173|
024991|M01AE0111|Burana|filmhtfl|600|mg|30|stk|1|ţpakki||M01AE01|01.06.2012||R|||0|0|E|0|OPF|0|0|1|100|XEU|385|1506|lyfalmen|V0563|1506||30|0|15,0000|Portfarma ehf|Orion Corporation|Íbúprófen||385||385|1506|
025009|M01AE0111|Burana|filmhtfl|400|mg|30|stk|1|ţpakki||M01AE01|01.07.2012||L|||0|0|0|0|OPF|0|0|1|100|IKR|||lyflausa||||30|0|10,0000|Portfarma ehf|Orion Corporation|Íbúprófen||||||
025020|M01AE0111|Burana|filmhtfl|400|mg|100|stk|1|glas||M01AE01|01.06.2012||R|||0|0|E|0|OPF|0|0|1|100|XEU|772|2035|lyfalmen|V0562|2035||100|0|33,3300|Portfarma ehf|Orion Corporation|Íbúprófen||772||772|2035|
025053|M01AE0111|Burana|filmhtfl|600|mg|100|stk|1|glas||M01AE01|01.06.2012||R|||0|0|E|0|OPF|0|0|1|100|XEU|937|2261|lyfalmen|V0564|2261||100|0|50,0000|Portfarma ehf|Orion Corporation|Íbúprófen||937||937|2261|
025142|D07AB0202|Locoid Crelo|lausn|1|mg/g|30|g|1|glas|á húđ|D07AB02|01.04.1994||R|||0|0|B|0|ASP|0|0|1|100|XEU|649|1867|lyfalmen||||30|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||649||649|1867|
025155|V01AA1105|Alutard SQ, hundahar|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|||0|1|E|0|ALK|0|0|0|100|DKK|19869|27481|lyfalmen||||5|0||Vistor hf|ALK-Abello A/S|dýr||19869||19869|27481|
025174|D07AB0202|Locoid Crelo|lausn|1|mg/g|100|g|1|glas|á húđ|D07AB02|01.04.1994||R|||0|0|B|0|ASP|0|0|1|100|XEU|1977|3683|lyfalmen||||100|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||1977||1977|3683|
025262|V01AA1105|Alutard SQ, hundahar|stl|0,01|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|||0|1|E|0|ALK|0|0|0|100|DKK|19869|27481|lyfalmen||||5|0||Vistor hf|ALK-Abello A/S|dýr||19869||19869|27481|
025306|M05BB0301|Fosavance|töflur|||12|stk|1|ţpakki|70mg+70mcg|M05BB03|01.10.2006||R|||0|0|0|0|MSD|0|0|0|100|DKK|14109|20252|lyfalmen||||12|0|84,0000|Vistor hf|M.S.D.|Alendrónsýra og kólekalsíferól||14109||14109|20252|
025317|J05AF1001|Baraclude|filmhtfl|1|mg|30|stk|1|ţpakki||J05AF10|01.09.2007||R|||0|1|0|1|BSP|0|0|0|100|DKK|85905|109693|lyfsjukr||||30|0|60,0000|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Entecavír||85905||85905|109693|
025323|J05AF1001|Baraclude|filmhtfl|0,5|mg|30|stk|1|ţpakki||J05AF10|01.09.2007||R|||0|1|0|1|BSP|0|0|0|100|DKK|80239|102582|lyfsjukr||||30|0|30,0000|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Entecavír||80239||80239|102582|
025388|QM01AC0601|Metacam|stl|5|mg/ml|20|ml|1|hgl||QM01AC06|01.10.2006||R|||0|0|0|0|BOI|1|0|0|100|DKK|9846|19078|vetalmen||||20|0||Vistor hf|Boehringer Ingelheim|||9846||9846|19078|
025425|V01AA0217|Grazax 75.000 SQ-T|lausnart|75000|ein|30|stk|1|ţpakki|frostţurrkađar|V01AA02|01.02.2008||R|||0|1|0|0|ALK|0|0|0|100|DKK|17043|23934|lyfalmen||||30|0||Vistor hf|ALK-Abello A/S|grasfrjó||17043||17043|23934|
025444|C09CA0301|Diovan|filmhtfl|320|mg|98|stk|1|ţpakki|filmuhúđađar töflur|C09CA03|01.04.2007||R|||0|0|0|0|NOH|0|0|0|100|DKK|20229|27933|lyfalmen||||98|0|392,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||20229||20229|27933|
025455|C09CA0301|Diovan|töflur|320|mg|28|stk|1|ţpakki|filmuhúđađar töflur|C09CA03|01.04.2007||R|||0|0|0|0|NOH|0|0|0|100|DKK|6471|9831|lyfalmen||||28|0|112,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||6471||6471|9831|
025458|A10BX0203|Repaglinide Portfarma|töflur|0,5|mg|90|stk|1|ţpakki||A10BX02|01.01.2012||R|||0|0|*|0|POF|0|0|0|100|DKK|2368|2979|lyfalmen|V0462|2977||90|0|11,2500|Portfarma ehf|Portfarma|Repaglíníđ||1462||1462|2979|
025469|A10BX0203|Repaglinide Portfarma|töflur|1|mg|90|stk|1|ţpakki||A10BX02|01.01.2012||R|||0|0|*|0|POF|0|0|0|100|DKK|2577|3114|lyfalmen|V0471|3113||90|0|22,5000|Portfarma ehf|Portfarma|Repaglíníđ||1561||1561|3114|
025578|S01EC0302|Trusopt (D.A.C.)|augndr|20|mg/ml|5|ml|1|glas||S01EC03|01.04.2010||R|||0|0|*|0|DAC|0|0|0|100|DKK|1936|3627|lyfalmen|V0369|3019||5|0|16,6667|D.A.C. ehf|D.A.C. ehf|Dorzólamíđ||1936||1936|3627|
025588|M05BA0602|Bonviva|filmhtfl|150|mg|1|stk|1|ţpakki||M05BA06|01.01.2006||R|||0|0|0|0|RRL|0|0|0|100|DKK|5391|8354|lyfalmen|V0205|1661||1|0|30,0000|Icepharma hf|Roche Registration Limited|Íbandrónsýra||5391||5391|8354|
025599|M05BA0602|Bonviva|filmhtfl|150|mg|3|stk|1|ţpakki||M05BA06|01.01.2006||R|||0|0|0|0|RRL|0|0|0|100|DKK|14449|20679|lyfalmen|V0205|4984||3|0|90,0000|Icepharma hf|Roche Registration Limited|Íbandrónsýra||14449||14449|20679|
025632|A10BX0203|Repaglinide Portfarma|töflur|2|mg|90|stk|1|ţpakki||A10BX02|01.01.2012||R|||0|0|*|0|POF|0|0|0|100|DKK|2770|3380|lyfalmen|V0472|3378||90|0|45,0000|Portfarma ehf|Portfarma|Repaglíníđ||1755||1755|3380|
025736|V01AA0217|Grazax 75.000 SQ-T|lausnart|75000|ein|100|stk|1|ţpakki|frostţurrkađar|V01AA02|01.02.2008||R|||0|1|0|0|ALK|0|0|0|100|DKK|54746|71251|lyfalmen||||100|0||Vistor hf|ALK-Abello A/S|grasfrjó||54746||54746|71251|
025747|C01BB0101|Xylocard  100 mg/ 5 ml|stl|20|mg/ml|5|ml|5|gl-lyk||C01BB01|01.12.2006||R|||0|0|0|1|AZD|0|0|0|100|SEK|7459|10765|lyfsjukr||||25|0|0,1667|Vistor hf|AstraZeneca A/S DK|Lídókaín||7459||7459|10765|
025841|V01AA1106|Alutard SQ, kattahar|stl|||5|ml|4|hgl|byrjunarsett|V01AA11|01.07.1999||R|||0|1|E|0|ALK|0|0|0|100|DKK|24818|33692|lyfalmen||||20|0||Vistor hf|ALK-Abello A/S|dýr||24818||24818|33692|
025917|L04AX0201|Thalidomide Celgene|hylki|50|mg|28|stk|1|ţpakki|hart|L04AX02|01.09.2011||R|||0|1|0|1|CEE|0|0|0|100|XEU|59028|75963|lyfsjukr||||28|0|14,0000|Celgene Europe ltd|Celgene Europe ltd|Thalidómíde||||59028|75963|
025941|R03DC0302|Montelukast Portfarma|tuggutfl|4|mg|98|stk|1|ţpakki||R03DC03|01.01.2012||R|||0|0|B|0|POF|0|0|0|100|XEU|13686|19721|lyfalmen|V0492|19721||98|0|39,2000|Portfarma ehf|Portfarma|Montelúkast||13686||13686|19721|
025958|M01AE0218|Naproxen Mylan|töflur|250|mg|100|stk|1|glas||M01AE02|01.01.1991||R|||0|0|E|0|MYL|0|0|1|100|SEK|1016|2369|lyfalmen||||100|0|50,0000|Actavis Group PTC ehf|Mylan AB|Naproxen||1016||1016|2369|
025963|R03DC0302|Montelukast Portfarma|tuggutfl|5|mg|98|stk|1|ţpakki||R03DC03|01.01.2012||R|||0|0|B|0|POF|0|0|0|100|XEU|16600|19721|lyfalmen|V0491|19721||98|0|49,0000|Portfarma ehf|Portfarma|Montelúkast||13686||13686|19721|
025965|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|1|l|1|fl||QP54AA01|01.04.1992||R|||0|0|0|0|MEF|0|0|0|100|XEU|4824|8415|vetorma||||1|0||Vistor hf|Merial (MSD)|||4824||4824|8415|
025976|M01AE0218|Naproxen Mylan|töflur|500|mg|25|stk|1|glas||M01AE02|01.12.2009||R|||0|0|E|0|MYL|0|0|1|100|SEK|527|1700|lyfalmen||||25|0|25,0000|Actavis Group PTC ehf|Mylan AB|Naproxen||527||527|1700|
025986|R03DC0302|Montelukast Portfarma|filmhtfl|10|mg|98|stk|1|ţpakki||R03DC03|01.11.2011||R|||0|0|B|0|POF|0|0|0|100|XEU|13999|10767|lyfalmen|V0490|10747||98|0|98,0000|Portfarma ehf|Portfarma|Montelúkast||7155||7155|10767|
025994|M01AE0218|Naproxen Mylan|töflur|500|mg|100|stk|1|glas||M01AE02|01.01.1991||R|||0|0|E|0|MYL|0|0|1|100|SEK|2698|3534|lyfalmen|V0427|3534||100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Naproxen||1868||1868|3534|
025997|A07DA0302|Loperamid Portfarma|töflur|2|mg|20|stk|1|ţpakki||A07DA03|01.05.2011||L|||0|0|0|0|POF|0|0|0|100|IKR|||lyflausa||||20|0|4,0000|Portfarma ehf|Portfarma|Lóperamíđ||||||
026000|QS02CA0301|Easotic|eyrnadr|||10|ml|1|fl|dreifa|QS02CA03|01.04.2012||R|||0|0|0|0|VIR|0|0|0|100|SEK|2683|5324|vetalmen||||10|0||Vistor hf|Virbac S.A|Hýdrókortisón,miconazol,gentamicin||2683||2683|5324|
026019|A07DA0302|Loperamid Portfarma|töflur|2|mg|100|stk|1|ţpakki||A07DA03|01.07.2011||R|||0|0|E|0|POF|0|0|0|100|IKR|820|2101|lyfalmen|V0447|2101||100|0|20,0000|Portfarma ehf|Portfarma|Lóperamíđ||820||820|2101|
026021|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|2,5|l|1|fl||QP54AA01|01.04.1992||R|||0|0|0|0|MEF|0|0|0|100|XEU|9504|16579|vetorma||||2|0||Vistor hf|Merial (MSD)|||9504||9504|16579|
026086|N05AH0309|Kozylex|munndr.t|15|mg|28|stk|1|ţpakki||N05AH03|01.11.2011||R|||0|0|*|0|POF|0|1|0|100|XEU|23695|20433|lyfalmen|V0475|20433||28|0|42,0000|Portfarma ehf|Portfarma|Olanzapín||14253||14253|20433|
026096|V01AA1106|Alutard SQ, kattahar|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|||0|1|E|0|ALK|0|0|0|100|DKK|19869|27481|lyfalmen||||5|0||Vistor hf|ALK-Abello A/S|dýr||19869||19869|27481|
026101|L01CA0501|Javlor|irţ|25|mg/ml|2|ml|1|hgl|lausn|L01CA05|01.12.2010||R|||0|1|0|1|PFM|0|0|0|100|DKK|43825|56883|lyfsjukr||||2|0||Vistor hf|Pierre Fabre Médicament|Vínflúnín||43825||43825|56883|
026114|L01CA0501|Javlor|irţ|25|mg/ml|10|ml|1|hgl|lausn|L01CA05|01.12.2010||R|||0|1|0|1|PFM|0|0|0|100|DKK|219150|276916|lyfsjukr||||10|0||Vistor hf|Pierre Fabre Médicament|Vínflúnín||219150||219150|276916|
026569|R02AA0305|Strepsils Cool|sogtfl|||24|stk|1|ţpakki||R02AA03|01.09.2010||L|||0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa||||24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól||||||
026571|N03AX1801|Vimpat|filmhtfl|50|mg|14|stk|1|ţpakki||N03AX18|01.12.2009||R|||0|0|E|0|UCB|0|0|0|100|DKK|1867|3533|lyfalmen||||14|0|2,3300|Vistor hf|U.C.B|Lacosamíđ||||1867|3533|
026582|N03AX1801|Vimpat|filmhtfl|50|mg|56|stk|1|ţpakki||N03AX18|01.12.2009||R|||0|0|E|0|UCB|0|0|0|100|DKK|7075|10657|lyfalmen||||56|0|9,3300|Vistor hf|U.C.B|Lacosamíđ||||7075|10657|
026593|N03AX1801|Vimpat|filmhtfl|100|mg|14|stk|1|ţpakki||N03AX18|01.12.2009||R|||0|0|E|0|UCB|0|0|0|100|DKK|3688|6024|lyfalmen||||14|0|4,6700|Vistor hf|U.C.B|Lacosamíđ||||3688|6024|
026605|N03AX1801|Vimpat|filmhtfl|100|mg|56|stk|1|ţpakki||N03AX18|01.12.2009||R|||0|0|E|0|UCB|0|0|0|100|DKK|14610|20881|lyfalmen||||56|0|18,6700|Vistor hf|U.C.B|Lacosamíđ||||14610|20881|
026627|N03AX1801|Vimpat|filmhtfl|150|mg|56|stk|1|ţpakki||N03AX18|01.12.2009||R|||0|0|E|0|UCB|0|0|0|100|DKK|21893|30021|lyfalmen||||56|0|28,0000|Vistor hf|U.C.B|Lacosamíđ||||21893|30021|
026638|N03AX1801|Vimpat|filmhtfl|200|mg|56|stk|1|ţpakki||N03AX18|01.12.2009||R|||0|0|E|0|UCB|0|0|0|100|DKK|29176|39161|lyfalmen||||56|0|37,3300|Vistor hf|U.C.B|Lacosamíđ||||29176|39161|
026682|J01XE0101|Furadantin|töflur|50|mg|100|stk|1|glas||J01XE01|01.03.2004||R|||0|0|0|0|REP|0|0|1|100|SEK|1466|2984|lyfalmen||||100|0|25,0000|Vistor hf|Recip AB|Nítrófúrantóín||1466||1466|2984|
026698|A02BC0110|Omeprazol ratiopharm|sţ-hylki|20|mg|14|stk|1|glas|hart|A02BC01|01.02.2012||L|||0|0|0|0|RAT|0|0|0|100|IKR|||lyflausa||||14|0|14,0000|LYFIS ehf|ratiopharm GmbH|Ómeprazól||||||
026946|J01CA0412|Amoxicillin Mylan (D.A.C.)|hylki|500|mg|30|stk|1|glas||J01CA04|01.07.2011||R|||0|0|0|0|DAC|0|0|1|100|SEK|1636|3217|lyfalmen|V0160|3217||30|0|15,0000|D.A.C. ehf|D.A.C. ehf|Amoxicillín||1636||1636|3217|
026957|J01CA0412|Amoxicillin Mylan (D.A.C.)|hylki|500|mg|20|stk|1|glas||J01CA04|01.05.2011||R|||0|0|0|0|DAC|0|0|1|100|SEK|1163|2508|lyfalmen|V0159|2508||20|0|10,0000|D.A.C. ehf|D.A.C. ehf|Amoxicillín||1118||1118|2508|
027094|J01XE0101|Furadantin|töflur|5|mg|50|stk|1|glas||J01XE01|01.03.2004||R|||0|0|0|0|REP|0|0|1|100|SEK|436|1575|lyfalmen||||50|0|1,2500|Vistor hf|Recip AB|Nítrófúrantóín||436||436|1575|
027144|M01CC0101|Atamir|hylki|150|mg|50|stk|1|ţpakki||M01CC01|01.06.1982||R|||0|0|B|0|SGM|0|0|0|100|DKK|2774|4774|lyfalmen|V0199|3570||50|0|15,0000|Swedish Orphan International AB|Sandoz GmbH (S)|Penicillamín||2774||2774|4774|
027202|S01ED5111|Azarga|augndr|15|mg/ml|5|ml|1|glas|10+5 mg/ml|S01ED51|01.10.2009||R|||0|0|*|0|ALA|0|0|0|100|USD|2603|4540|lyfalmen||||5|0|25,0000|Vistor hf|Alcon Laboratories Ltd.|Tímólól í blöndum||2603||2603|4540|
027235|G03HA0104|Cyproteron Mylan|töflur|50|mg|50|stk|1|glas||G03HA01|01.04.1997||R|||0|0|*|0|MYL|0|0|0|100|SEK|7168|10784|lyfalmen||||50|0|25,0000|Actavis Group PTC ehf|Mylan AB|Cýpróterón||7168||7168|10784|
027281|N06DA0204|Donepezil Actavis|filmhtfl|5|mg|100|stk|1|ţpakki||N06DA02|01.05.2009||R|||0|0|E|0|ACA|0|0|0|100|XEU|30297|20321|lyfalmen|V0341|17601||100|0|66,6600|Actavis Group hf|Actavis hf|Dónepezíl||14164||14164|20321|
027305|N06DA0204|Donepezil Actavis|filmhtfl|10|mg|100|stk|1|ţpakki||N06DA02|01.05.2009||R|||0|0|E|0|ACA|0|0|0|100|XEU|34001|21287|lyfalmen|V0342|19088||100|0|133,3300|Actavis Group hf|Actavis hf|Dónepezíl||14934||14934|21287|
027586|N03AX1501|Zonegran|hylki|25|mg|56|stk|1|ţpakki||N03AX15|01.03.2007||R|||0|0|E|0|EIS|0|0|0|100|SEK|7405|11109|lyfalmen||||56|0|7,0000|Vistor hf|Eisai Ltd|Zonisamíđ||7405||7405|11109|
027595|N03AX1501|Zonegran|hylki|50|mg|56|stk|1|ţpakki||N03AX15|01.03.2007||R|||0|0|E|0|EIS|0|0|0|100|SEK|9758|14327|lyfalmen||||56|0|14,0000|Vistor hf|Eisai Ltd|Zonisamíđ||9758||9758|14327|
027649|H03AA0105|Levaxin|töflur|0,05|mg|100|stk|1|glas||H03AA01|01.04.2004||R|||0|0|B|0|NYG|0|0|0|100|DKK|863|2159|lyfalmen|V0153|2105||100|0|33,3300|Gróco ehf|Nycomed Danmark A/S|Levótýroxínnatríum||863||863|2159|
027656|H03AA0105|Levaxin|töflur|0,1|mg|100|stk|1|glas||H03AA01|01.03.2003||R|||0|0|B|0|NYG|0|0|0|100|DKK|863|2159|lyfalmen|V0154|1957||100|0|66,6667|Gróco ehf|Nycomed Danmark A/S|Levótýroxínnatríum||863||863|2159|
027795|J02AC0401|Noxafil|mixtúra|40|mg/ml|105|ml|1|fl||J02AC04|01.08.2006||R|||0|1|0|1|SPE|0|0|0|100|DKK|103267|131483|lyfsjukr||||105|0|5,2500|Vistor hf|SP Europe|Posacónazól||103267||103267|131483|
027968|N05AX1201|Abilify|munndr.t|10|mg|28|stk|1|ţpakki||N05AX12|01.01.2007||R|||0|0|0|0|OTS|0|1|0|100|DKK|21071|28989|lyfalmen||||28|0|18,6670|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||21071||21071|28989|
027976|N05AH0307|Zypadhera|sts|210|mg|1|hgl|1|pakki|+leysir|N05AH03|01.02.2010||R|||0|0|0|1|ELD|0|1|0|100|XEU|32745|42977|lyfsjukr||||1|0|21,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||||32745|42977|
027977|N05AX1201|Abilify|munndr.t|15|mg|28|stk|1|ţpakki||N05AX12|01.01.2007||R|||0|0|0|0|OTS|0|1|0|100|DKK|24353|33108|lyfalmen||||28|0|28,0000|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||24353||24353|33108|
027988|N05AH0307|Zypadhera|sts|300|mg|1|hgl|1|pakki|+leysir|N05AH03|01.02.2010||R|||0|0|0|1|ELD|0|1|0|100|XEU|48249|62435|lyfsjukr||||1|0|30,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||48249||48249|62435|
027999|N05AH0307|Zypadhera|sts|405|mg|1|hgl|1|pakki|+leysir|N05AH03|01.02.2010||R|||0|0|0|1|ELD|0|1|0|100|XEU|60780|78161|lyfsjukr||||1|0|40,5000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||||60780|78161|
028045|G03AB0001|Qlaira|töflur|||84|stk|1|ţpakki|3x28 stk|G03AB|01.11.2009||R|||0|0|0|0|BAP|0|0|0|100|SEK|5113|7973|lyfalmen||||84|0|84,0000|Icepharma hf|Bayer Schering Pharma AG|Kaflaskipt lyf, prógestógen og östrógen||5113||5113|7973|
028112|R06AX2602|Nefoxef|filmhtfl|120|mg|30|stk|1|ţpakki||R06AX26|01.07.2008||L|||0|0|0|0|MYL|0|0|1|100|IKR|||lyflausa||||30|0|30,0000|Actavis Group PTC ehf|Mylan AB|Fexófenadín||||||
028121|A10BD0701|Janumet|filmhtfl|1050|mg|196|stk|1|ţpakki|50/1000mg|A10BD07|01.01.2010||R|||0|0|*|0|MSD|0|0|0|100|DKK|24940|33845|lyfalmen|V0386|33845||196|0|98,0000|Vistor hf|M.S.D.|Metforminum og sitagliptinum||24940||24940|33845|
028124|R06AX2602|Nefoxef|filmhtfl|120|mg|100|stk|1|ţpakki||R06AX26|01.07.2008||R|||0|0|E|0|MYL|0|0|1|100|SEK|3655|4778|lyfalmen|V0364|4778||100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Fexófenadín||2777||2777|4778|
028168|C09XA5201|Rasilez HCT|filmhtfl|162,5|mg|28|stk|1|ţpakki|150/12,5 mg|C09XA52|01.06.2009||R|||0|0|0|0|NOE|0|0|0|100|DKK|4040|6505|lyfalmen||||28|0|28,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren og ţvagrćsilyf||||4040|6505|
028177|C10AD5201|Tredaptive|töflur|1020|mg|98|stk|2|ţpakki|1000+20 mg|C10AD52|01.12.2009||R|||0|0|0|0|MSD|0|0|0|100|DKK|19297|26763|lyfalmen|V0120|26763||196|0||Vistor hf|M.S.D.|Nikótínsýra og afleiđur-Nikótínsýra í blöndum||||19297|26763|
028268|R03DX0501|Xolair|stl|150|mg|1|áf.spr|1|pakki||R03DX05|01.04.2011||R|||0|1|0|1|NOE|0|0|0|100|DKK|58252|74989|lyfsjukr||||1|0|9,3800|Vistor hf|Novartis Europharm Ltd|Omalizúmab||58252||58252|74989|
028314|J07AP0301|Typhim Vi|stl|25|mcg/spr|0,5|ml|1|áf.spr|m/ ađsk. nál|J07AP03|01.05.2008||R|||0|0|0|0|SPM|0|0|0|100|XEU|2592|4525|lyfalmen||||0|0||Icepharma hf|Sanofi Pasteur MSD|Taugaveiki, hreinsađir  mótefnavakar||2592||2592|4525|
028351|J07BL0101|Stamaril|sts|||0,5|ml|10|hgl|+ 10 áf.spr. međ leysi|J07BL01|01.01.1996||R|||0|0|0|0|SPM|0|0|0|100|XEU|21764|29859|lyfalmen||||5|0||Icepharma hf|Sanofi Pasteur MSD|Gulusótt, veikluđ veira||21764||21764|29859|
028360|J07BG0101|Rabies - Imovax|bóluefni|||1|ml|1|hgl||J07BG01|01.01.1996||R|||0|0|0|0|MEX|0|0|0|100|XEU|8328|12371|lyfalmen||||1|0||Icepharma hf|Aventis Pasteur MSD A/S|Hundaćđi, dauđ veira||8328||8328|12371|
028387|M03BX0105|Baklofen Mylan|töflur|25|mg|50|stk|1|glas|0|M03BX01|01.10.2008||R|||0|0|E|0|MYL|0|0|1|100|SEK|1912|3594|lyfalmen|V0202|3594||50|0|25,0000|Actavis Group PTC ehf|Mylan AB|Baklófen||1912||1912|3594|
028405|M01AE0217|Naproxen-E Mylan|sh-tfl|500|mg|50|stk|1|plglas||M01AE02|01.07.1993||R|||0|0|E|0|MYL|0|0|1|100|SEK|2144|3912|lyfalmen|V0428|3396||50|0|50,0000|Actavis Group PTC ehf|Mylan AB|Naproxen||2144||2144|3912|
028498|C08DB0102|Cardizem Retard|forđatfl|120|mg|60|stk|1|glas||C08DB01|01.04.1987||R|||0|0|B|0|FRO|0|0|0|100|DKK|5404|8371|lyfalmen||||60|0|30,0000|Vistor hf|Ferrosan A/S|Diltíazem||5404||5404|8371|
028575|N03AX0901|Lamictal|dreifit.|5|mg|56|stk|1|ţpakki||N03AX09|01.05.2009||R|||0|0|E|0|GSK|0|0|0|100|IKR|1278|2727|lyfalmen||||56|0|0,9334|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||||1278|2727|
028586|N03AX0901|Lamictal|dreifit.|100|mg|98|stk|1|ţpakki||N03AX09|01.05.2009||R|||0|0|E|0|GSK|0|0|0|100|IKR|5812|6720|lyfalmen|V0245|5473||98|0|32,6667|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||4197||4197|6720|
028598|N03AX0901|Lamictal|dreifit.|200|mg|98|stk|1|ţpakki||N03AX09|01.05.2009||R|||0|0|E|0|GSK|0|0|0|100|IKR|10358|11162|lyfalmen|V0232|10441||98|0|65,3333|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||7444||7444|11162|
028599|N04BC0503|Pramipexole Portfarma|töflur|0,088|mg|30|stk|1|ţpakki||N04BC05|01.02.2010||R|||0|0|E|0|POF|0|0|0|100|XEU|817|1150|lyfalmen|V0266|1138||30|0|1,0600|Portfarma ehf|Portfarma|Pramipexól||125||125|1150|
028606|QN05CM1801|Dexdomitor|stl|0,5|mg/ml|10|ml|1|hgl||QN05CM18|01.11.2007||R|||0|0|0|0|OCO|1|0|0|100|DKK|8171|15862|vetalmen||||10|0||Icepharma hf|Orion Corporation (I)|||8171||8171|15862|
028609|R03DC0302|Montelukast Portfarma|filmhtfl|10|mg|28|stk|1|ţpakki||R03DC03|01.10.2011||R|||0|0|B|0|POF|0|0|0|100|XEU|4704|7414|lyfalmen||||28|0|28,0000|Portfarma ehf|Portfarma|Montelúkast||4704||4704|7414|
028610|N04BC0503|Pramipexole Portfarma|töflur|0,18|mg|100|stk|1|ţpakki||N04BC05|01.02.2010||R|||0|0|E|0|POF|0|0|0|100|XEU|5316|2956|lyfalmen|V0267|2863||100|0|7,2000|Portfarma ehf|Portfarma|Pramipexól||1445||1445|2956|
028622|N04BC0503|Pramipexole Portfarma|töflur|0,7|mg|100|stk|1|ţpakki||N04BC05|01.02.2010||R|||0|0|E|0|POF|0|0|0|100|XEU|19167|10204|lyfalmen|V0269|10204||100|0|28,0000|Portfarma ehf|Portfarma|Pramipexól||6744||6744|10204|
028761|A03FA0101|Primperan|stl|5|mg/ml|2|ml|12|lykjur||A03FA01|01.10.1995|30.04.2012|R|||0|0|E|0|SNO|0|0|1|100|NOK|971|2307|lyfalmen||||24|0|4,0000|Vistor hf|Sanofi-aventis Norge AS|Metóklópramíđ||971||971|2307|
028907|J02AC0103|Fluconazole Portfarma|hylki|50|mg|7|stk|1|ţpakki||J02AC01|01.05.2010||R|||0|0|0|0|POF|0|0|1|100|IKR|1362|2842|lyfalmen|V0179|1824||7|0|1,7500|Portfarma ehf|Portfarma|Flúkónazól||1362||1362|2842|
028918|J02AC0103|Fluconazole Portfarma|hylki|50|mg|30|stk|1|ţpakki||J02AC01|01.05.2010||R|||0|0|0|0|POF|0|0|1|100|IKR|4998|7816|lyfalmen|V0179|7816||30|0|7,5000|Portfarma ehf|Portfarma|Flúkónazól||4998||4998|7816|
028929|J02AC0103|Fluconazole Portfarma|hylki|150|mg|1|stk|1|ţpakki||J02AC01|01.05.2010||R|||0|0|0|0|POF|0|0|1|100|IKR|577|1768|lyfalmen|V0180|875||1|0|0,7500|Portfarma ehf|Portfarma|Flúkónazól||577||577|1768|
028940|J02AC0103|Fluconazole Portfarma|hylki|150|mg|2|stk|1|ţpakki||J02AC01|01.05.2010||R|||0|0|0|0|POF|0|0|1|100|IKR|563|1749|lyfalmen|V0180|1749||2|0|1,5000|Portfarma ehf|Portfarma|Flúkónazól||563||563|1749|
028953|J02AC0103|Fluconazole Portfarma|hylki|150|mg|4|stk|1|ţpakki||J02AC01|01.05.2010||R|||0|0|0|0|POF|0|0|1|100|IKR|2031|3757|lyfalmen|V0180|3498||4|0|3,0000|Portfarma ehf|Portfarma|Flúkónazól||2031||2031|3757|
029066|R01AD0801|Flixonase|nefúđi|50|mcg/sk|16|ml|1|stauk|120 sk|R01AD08|01.04.1992||R|||0|0|E|0|GSK|0|0|1|100|GBP|1157|2562|lyfalmen||||16|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||||1157|2562|
029078|N06AX2201|Valdoxan|filmhtfl|25|mg|28|stk|1|ţpakki||N06AX22|01.01.2010||R|||0|0|0|0|SEV|0|1|0|100|DKK|7800|11649|lyfalmen||||28|0|28,0000|Icepharma hf|Servier|Agómelatín||7800||7800|11649|
029100|N06AX2201|Valdoxan|filmhtfl|25|mg|84|stk|1|ţpakki||N06AX22|01.01.2010||R|||0|0|0|0|SEV|0|1|0|100|DKK|22249|30468|lyfalmen||||84|0|84,0000|Icepharma hf|Servier|Agómelatín||22249||22249|30468|
029198|R06AX2201|Kestine|filmhtfl|20|mg|30|stk|1|ţpakki||R06AX22|01.06.2012||R|||0|0|E|0|APS|0|0|1|100|DKK|2977|5051|lyfalmen||||30|0|60,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín||2977||2977|5051|
029287|C03DB0105|Amiloride|töflur|5|mg|28|stk|1|ţpakki||C03DB01|01.04.2009||R|||0|0|E|0|AUK|0|0|0|100|GBP|270|1348|lyfalmen||||28|0|14,0000|Actavis Group hf|Actavis UK Ltd.|Amiloridhýdróklóríđ||||270|1348|
029361|C10AA0103|Zocor (Lyfjaver)|töflur|20|mg|98|stk|1|ţpakki||C10AA01|01.09.2005||R|||0|0|0|0|LVR|0|0|0|100|XEU|7761|9462|lyfalmen|V0109|2300||98|0|65,3400|Lyfjaver ehf|Lyfjaver ehf|Simvastatín||6201||6201|9462|
029429|L01XX4101|Halaven|stl|0,44|mg/ml|2|ml|1|hgl|lausn|L01XX41|01.11.2011||R|||0|1|0|1|EIS|0|0|0|100|SEK|65740|84386|lyfsjukr||||2|0||Vistor hf|Eisai Ltd|Eribulin||65740||65740|84386|
029517|L01BB0503|Fludarabin Actavis|sts/irs|25|mg/ml|50|mg|1|hgl||L01BB05|01.04.2009||R|||0|1|0|1|AGP|0|0|0|100|XEU|23125|30904|lyfsjukr||||50|0||Actavis Group hf|Actavis Group PTC ehf|Flúdarabín||23125||23125|30904|
029528|L01CA0402 |Vinorelbin Actavis|irţ|10|mg/ml|5|ml|1|hgl||L01CA04|01.04.2009||R|||0|1|0|1|AGP|0|0|0|100|XEU|5979|8629|lyfsjukr||||5|0||Actavis Group hf|Actavis Group PTC ehf|Vínorelbín||5979||5979|8629|
029574|L01XX1904|Irinotecan Actavis|irţ|20|mg/ml|5|ml|1|hgl|lausn|L01XX19|01.04.2009||R|||0|1|0|1|AGT|0|0|0|100|XEU|4593|6629|lyfsjukr||||5|0||Actavis Group hf|Actavis Group hf|Írinótekan||4593||4593|6629|
029695|C09DA0601|Atacand Plus|töflur|44,5|mg|28|stk|1|ţpakki|32+12,5 mg|C09DA06|01.02.2010||R|||0|0|0|0|AZD|0|0|0|100|SEK|5194|8084|lyfalmen||||28|0|28,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og ţvagrćsilyf||||5194|8084|
029706|C09DA0601|Atacand Plus|töflur|44,5|mg|98|stk|1|ţpakki|32+12,5 mg|C09DA06|01.02.2010||R|||0|0|0|0|AZD|0|0|0|100|SEK|16312|23017|lyfalmen||||98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og ţvagrćsilyf||||16312|23017|
029717|C09DA0601|Atacand Plus|töflur|57|mg|28|stk|1|ţpakki|32+25 mg|C09DA06|01.02.2010||R|||0|0|0|0|AZD|0|0|0|100|SEK|5194|8084|lyfalmen||||28|0|28,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og ţvagrćsilyf||||5194|8084|
029729|C09DA0601|Atacand Plus|töflur|57|mg|98|stk|1|ţpakki|32+25 mg|C09DA06|01.02.2010||R|||0|0|0|0|AZD|0|0|0|100|SEK|16312|23017|lyfalmen||||98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og ţvagrćsilyf||||16312|23017|
029800|J01AA0208|Oracea|hylki|40|mg|56|stk|1|ţpakki|međ br.losunarhrađa|J01AA02|01.12.2011||R|||0|0|0|0|GAN|0|0|1|100|SEK|6608|10018|lyfalmen||||56|0|22,4000|Icepharma hf|Galderma Nordic AB|Doxýcýklín||6608||6608|10018|
029811|B02BX0401|Nplate|sts|250|mcg|1|hgl|1|pakki||B02BX04|01.04.2010||R|||0|1|0|1|AEU|0|0|0|100|DKK|103176|131368|lyfsjukr||||1|0|8,3300|Vistor hf|Amgen Europe B.V.|Romiplóstím||103176||103176|131368|
029822|B02BX0401|Nplate|sts|500|mcg|1|hgl|1|pakki||B02BX04|01.04.2010||R|||0|1|0|1|AEU|0|0|0|100|DKK|206350|260852|lyfsjukr||||1|0|16,6600|Vistor hf|Amgen Europe B.V.|Romiplóstím||206350||206350|260852|
029860|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|30|stk|1|ţpakki||N07BA01|01.05.2006||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín||||||
029869|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|105|stk|1|ţpakki||N07BA01|01.05.2006||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||105|0|7,0000|Vistor hf|McNeil Denmark ApS|Nikótín||||||
029878|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|210|stk|1|ţpakki||N07BA01|01.05.2006||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín||||||
029887|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|30|stk|1|ţpakki||N07BA01|01.05.2006||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||30|0|4,0000|Vistor hf|McNeil Denmark ApS|Nikótín||||||
029896|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|105|stk|1|ţpakki||N07BA01|01.05.2006||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||105|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín||||||
029905|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|210|stk|1|ţpakki||N07BA01|01.05.2006||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín||||||
030313|G04CA0206|Tamsulosin Portfarma|forđahlk|0,4|mg|90|stk|1|ţpakki||G04CA02|01.05.2011||R|||0|0|E|0|POF|0|0|0|100|SEK|4916|3997|lyfalmen|V0148|3997||90|0|90,0000|Portfarma ehf|Portfarma|Tamsúlósín||2206||2206|3997|
030315|N03AX1501|Zonegran|hylki|100|mg|98|stk|1|ţpakki||N03AX15|01.03.2007||R|||0|0|E|0|EIS|0|0|0|100|SEK|23191|31650|lyfalmen||||98|0|49,0000|Vistor hf|Eisai Ltd|Zonisamíđ||23191||23191|31650|
030588|M01AX0501|Glucomed|töflur|625|mg|60|stk|1|ţpakki||M01AX05|01.07.2006||L|||0|0|0|0|LEX|0|0|1|100|IKR|||lyflausa||||60|0|52,8000|Icepharma hf|Laboratories Expansvience|Glúkósamín||||||
030627|N05AH0201|Leponex|töflur|100|mg|100|stk|1|glas||N05AH02|01.04.1993||R|||0|0|*|0|NOH|0|1|0|100|DKK|9497|13970|lyfalmen|V0277|13969||100|0|33,3333|Vistor hf|Novartis Healthcare A/S-|Klózapín||9497||9497|13970|
030635|N05AH0201|Leponex|töflur|25|mg|100|stk|1|glas||N05AH02|01.04.1993||R|||0|0|0|0|NOH|0|1|0|100|DKK|3029|5122|lyfalmen||||100|0|8,3333|Vistor hf|Novartis Healthcare A/S-|Klózapín||3029||3029|5122|
030754|V03AN0102|Lyfjasurefni Strandmřllen|lyfjagas|100|%|770|l|1|hylki|kćlt|V03AN01|01.03.2009||L|||0|0|0|0|STM|0|0|0|100|IKR|||lyflausa||||770|0||Strandmöllen A/S|Strandmöllen A/S|Súrefni||||||
030765|V03AN0102|Lyfjasurefni Strandmřllen|lyfjagas|100|%|11000|l|1|hylki|kćlt|V03AN01|01.03.2009||L|||0|0|0|0|STM|0|0|0|100|IKR|||lyflausa||||11000|0||Strandmöllen A/S|Strandmöllen A/S|Súrefni||||||
030822|QI02AB0001|Startvac|stl|||2|ml|20|glös|fleyti|QI02AB|01.05.2010||R|||0|0|0|0|LHS|0|0|0|100|XEU|16552|28874|vetorma||||40|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Óvirkar bakteríur í bóluefnum||||16552|28874|
030940|C07AB0210|Metoprolol Mylan|töflur|50|mg|100|stk|1|glas||C07AB02|01.10.1995||R|||0|0|B|0|MYL|0|0|0|100|SEK|1417|2917|lyfalmen|V0051|2917||100|0|33,3333|Actavis Group PTC ehf|Mylan AB|Metóprólól||1417||1417|2917|
031039|C07AB0210|Metoprolol Mylan|töflur|100|mg|100|stk|1|glas||C07AB02|01.10.1995||R|||0|0|B|0|MYL|0|0|0|100|SEK|2239|4042|lyfalmen||||100|0|66,6667|Actavis Group PTC ehf|Mylan AB|Metóprólól||2239||2239|4042|
031070|A04AD0101|Scopoderm|forđapl|1|mg/72kls|2|stk|1|pakki||A04AD01|01.07.1985||L|||0|0|0|0|NEH|0|0|1|100|IKR|||lyflausa||||2|0|2,0000|Artasan ehf|Novartis Healthcare A/S|Skópólamín||||||
031088|A10AB0401|Humalog|stl|100|ae/ml|10|ml|1|hgl||A10AB04|01.01.1997||R|||0|0|*|0|ELD|0|0|0|100|XEU|3237|5407|lyfalmen||||10|0|25,0000|Icepharma hf|Eli Lilly Nederland B.V.|Insúlín lispró||3237||3237|5407|
031314|L01AX0301|Temodal|hylki|20|mg|20|sk-pokar|1|pakki||L01AX03|01.01.2010||R|||0|1|0|1|SCP|0|0|0|100|DKK|67447|86528|lyfsjukr||||20|0||Vistor hf|Schering-Plough|Temozolomid||67447||67447|86528|
031325|L01AX0301|Temodal|hylki|100|mg|5|sk-pokar|1|pakki||L01AX03|01.01.2010||R|||0|1|0|1|SCP|0|0|0|100|DKK|82173|105010|lyfsjukr||||5|0||Vistor hf|Schering-Plough|Temozolomid||82173||82173|105010|
031394|L01AX0301|Temodal|hylki|250|mg|5|sk-pokar|1|pakki||L01AX03|01.01.2010||R|||0|1|0|1|SCP|0|0|0|100|DKK|181167|229247|lyfsjukr||||5|0||Vistor hf|Schering-Plough|Temozolomid||181167||181167|229247|
031773|C01DA0801|Sorbangil|töflur|20|mg|100|stk|1|glas||C01DA08|01.01.1985||R|||0|0|B|0|REP|0|0|0|100|SEK|2151|3921|lyfalmen||||100|0|33,3333|Vistor hf|Recip AB|Ísósorbíđ dínítrat||2151||2151|3921|
031849|A10AB0503|NovoRapid Penfill|stl|100|ein/ml|3|ml|5|rörlyk||A10AB05|01.07.2002||R|||0|0|*|0|NAS|0|0|0|100|DKK|6111|9338|lyfalmen||||15|0|37,5000|Vistor hf|Novo-Nordisk A/S|Insúlín aspart||6111||6111|9338|
031942|H01BA0401|Glypressin|sts|1|mg/hgl|1|mg|5|hgl|og leysir|H01BA04|01.01.1998||R|||0|0|0|1|FEL|0|0|0|100|DKK|23935|31921|lyfsjukr||||5|0|0,4200|Vistor hf|Ferring Lćgemidler A/S|Terlípressín||23935||23935|31921|
031971|C07AA0705|Sotalol Mylan|töflur|160|mg|100|stk|1|plglas||C07AA07|01.01.1994||R|||0|0|B|0|MYL|0|0|0|100|SEK|2052|3786|lyfalmen||||100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Sótalól||2052||2052|3786|
032122|N01AX1302|Lyfjatviköfnunarefnisoxid Strandmöllen|lyfjagas|100|%|4|l|1|hylki||N01AX13|01.02.2009||R|||0|0|0|1|STM|0|0|0|100|DKK|9914|14308|lyfsjukr||||4|0||Strandmöllen A/S|Strandmöllen A/S|di-Nitrogen oxíđ||||9914|14308|
032145|N01AX1302|Lyfjatviköfnunarefnisoxid Strandmöllen|lyfjagas|100|%|10|l|1|hylki||N01AX13|01.02.2009||R|||0|0|0|1|STM|0|0|0|100|DKK|14490|20067|lyfsjukr||||10|0||Strandmöllen A/S|Strandmöllen A/S|di-Nitrogen oxíđ||||14490|20067|
032179|N01AX1302|Lyfjatviköfnunarefnisoxid Strandmöllen|lyfjagas|100|%|50|l|1|hylki||N01AX13|01.02.2009||R|||0|0|0|1|STM|0|0|0|100|DKK|50136|64803|lyfsjukr||||50|0||Strandmöllen A/S|Strandmöllen A/S|di-Nitrogen oxíđ||||50136|64803|
032190|V03AN0102|Lyfjasurefni Strandmřllen|lyfjagas|100|%|1|l|1|hylki|undir ţrýstingi|V03AN01|01.01.2009||L|||0|0|0|0|STM|0|0|0|100|IKR|||lyflausa||||1|0||Strandmöllen A/S|Strandmöllen A/S|Súrefni||||||
032202|V03AN0102|Lyfjasurefni Strandmřllen|lyfjagas|100|%|2|l|1|hylki|undir ţrýstingi|V03AN01|01.01.2009||L|||0|0|0|0|STM|0|0|0|100|IKR|||lyflausa||||2|0||Strandmöllen A/S|Strandmöllen A/S|Súrefni||||||
032236|V03AN0102|Lyfjasurefni Strandmřllen|lyfjagas|100|%|4|l|1|hylki|undir ţrýstingi|V03AN01|01.01.2009||L|||0|0|0|0|STM|0|0|0|100|IKR|||lyflausa||||4|0||Strandmöllen A/S|Strandmöllen A/S|Súrefni||||||
032247|V03AN0102|Lyfjasurefni Strandmřllen|lyfjagas|100|%|5|l|1|hylki|undir ţrýstingi|V03AN01|01.01.2009||L|||0|0|0|0|STM|0|0|0|100|IKR|||lyflausa||||5|0||Strandmöllen A/S|Strandmöllen A/S|Súrefni||||||
032258|V03AN0102|Lyfjasurefni Strandmřllen|lyfjagas|100|%|10|l|1|hylki|undir ţrýstingi|V03AN01|01.01.2009||L|||0|0|0|0|STM|0|0|0|100|IKR|||lyflausa||||10|0||Strandmöllen A/S|Strandmöllen A/S|Súrefni||||||
032270|V03AN0102|Lyfjasurefni Strandmřllen|lyfjagas|100|%|20|l|1|hylki|undir ţrýstingi|V03AN01|01.01.2009||L|||0|0|0|0|STM|0|0|0|100|IKR|||lyflausa||||20|0||Strandmöllen A/S|Strandmöllen A/S|Súrefni||||||
032281|V03AN0102|Lyfjasurefni Strandmřllen|lyfjagas|100|%|50|l|1|hylki|undir ţrýstingi|V03AN01|01.01.2009||L|||0|0|0|0|STM|0|0|0|100|IKR|||lyflausa||||50|0||Strandmöllen A/S|Strandmöllen A/S|Súrefni||||||
032304|V03AN0102|Lyfjasurefni Strandmřllen|lyfjagas|100|%|50|l|12|hylki|undir ţrýstingi|V03AN01|01.01.2009||L|||0|0|0|0|STM|0|0|0|100|IKR|||lyflausa||||600|0||Strandmöllen A/S|Strandmöllen A/S|Súrefni||||||
032523|N05AX1201|Abilify|mixtúra|1|mg/ml|150|ml|1|fl||N05AX12|01.02.2007||R|||0|0|*|0|OTS|0|1|0|100|DKK|21725|29810|lyfalmen||||150|0|10,0000|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||21725||21725|29810|
032649|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|50|ml|1|hgl|plast|QP54AA01|01.01.1985||R|||0|0|0|0|MEF|1|0|0|100|XEU|3904|6810|vetorma||||50|0||Vistor hf|Merial (MSD)|||3904||3904|6810|
032664|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|200|ml|1|fl||QP54AA01|01.01.1985||R|||0|0|0|0|MEF|1|0|0|100|XEU|15235|26577|vetorma||||200|0||Vistor hf|Merial (MSD)|||15235||15235|26577|
033124|L02BX0201|Firmagon|sts|80|mg|1|hgl|1|pakki|leysir|L02BX02|01.11.2010||R|||0|1|*|0|FER|0|0|0|100|DKK|22020|30180|lyfalmen||||1|0|29,6300|Vistor hf|Ferring|Degarelix||||22020|30180|
033135|L02BX0201|Firmagon|sts|120|mg|2|hgl|1|pakki|leysir|L02BX02|01.11.2010||R|||0|1|*|0|FER|0|0|0|100|DKK|43917|57661|lyfalmen||||2|0|88,8900|Vistor hf|Ferring|Degarelix||||43917|57661|
033193|QP54AA0105|Noromectin|pasta|18,7|mg/g|7,49|g|1|áf.spr|Fyrir hesta|QP54AA01|01.11.2011||L|||0|0|0|0|NOB|1|0|0|100|XEU|1258|2195|vetorma||||7|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|||||1258|2195|
033201|QJ01DD9001|Eficur vet.|stl|50|mg/ml|100|ml|1|hgl||QJ01DD90|01.02.2010||R|||0|0|0|0|LHS|0|0|0|100|XEU|9420|18260|vetalmen||||100|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Ceftiofurhydróklóríđ||||9420|18260|
033251|S01CA0102|Tobradex|augndr|||5|ml|1|glas|3+1 mg/ml|S01CA01|01.06.2007||R|||0|0|E|0|ALC|0|0|1|100|USD|1339|2811|lyfalmen||||5|0||K.Pétursson hf|Alcon|Dexametasón||1339||1339|2811|
033777|L02BG0404|Letromal|filmhtfl|2,5|mg|100|stk|1|ţpakki||L02BG04|01.04.2011||R|||0|0|*|0|WIH|0|0|0|100|XEU|47925|29623|lyfalmen|V0185|27712||100|0|100,0000|Portfarma ehf|Williams & Halls|Letrózól||21576||21576|29623|
033884|J05AE1001|Prezista|filmhtfl|400|mg|60|stk|1|plglas||J05AE10|01.11.2009||R|||0|1|0|1|JCI|0|0|0|100|SEK|82516|105440|lyfsjukr||||60|0|20,0000|Vistor hf|Janssen-Cilag International N.V.|Darunavír||82516||82516|105440|
033895|J05AE1001|Prezista|filmhtfl|600|mg|60|stk|1|plglas||J05AE10|01.11.2009||R|||0|1|0|1|JCI|0|0|0|100|SEK|107630|136958|lyfsjukr||||60|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Darunavír||107630||107630|136958|
034033|QJ01MA9001|Baytril vet.|töflur|50|mg|10|stk|1|ţpakki||QJ01MA90|01.03.2009||R|||0|0|0|0|BAN|0|0|0|100|DKK|2555|5079|vetalmen||||10|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||||2555|5079|
034157|J07AM5104|Diftavax|bóluefni|||0,5|ml|1|spr|einnota sprauta|J07AM51|01.01.2000||R|||0|0|0|0|SPM|0|0|1|100|XEU|768|2029|lyfalmen||||0|0||Icepharma hf|Sanofi Pasteur MSD|Stífkrampatoxóíđ í blöndum međ barnaveikistoxóíđum||768||768|2029|
034401|J06BA0208|Privigen|irl|100|mg/ml|25|ml|1|hgl||J06BA02|01.10.2009||R|||0|0|0|1|CSB|0|0|0|100|SEK|23742|31679|lyfsjukr||||25|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í ćđ||23742||23742|31679|
034423|J07BA0201|Ixiaro|stl|6|mcg|0,5|ml|1|spr|dreifa|J07BA02|01.01.2012||R|||0|0|0|0|IAG|0|0|0|100|SEK|15365|21828|lyfalmen||||0|0||Intercell AG|Intercell AG|Japönsk heilabólguveira óvirk||15365||15365|21828|
034468|B01AC2201|Efient|filmhtfl|5|mg|28|stk|1|ţpakki||B01AC22|01.12.2009||R|||0|0|E|0|ELD|0|0|0|100|XEU|8361|12416|lyfalmen||||28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Prasugrel||||8361|12416|
034479|B01AC2201|Efient|filmhtfl|10|mg|28|stk|1|ţpakki||B01AC22|01.12.2009||R|||0|0|E|0|ELD|0|0|0|100|XEU|8361|12416|lyfalmen||||28|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|Prasugrel||||8361|12416|
034494|N05CM1801|Dexdor|irţ|100|mcg/ml|10|ml|4|hgl|lausn|N05CM18|01.03.2012||R|||0|1|0|1|ORC|0|0|0|100|DKK|79076|101123|lyfsjukr||||40|0||Vistor hf|Orion Corporation|Dexmedetómid||79076||79076|101123|
034934|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|20|sk-hyl||S01BC03|01.04.1996||R|||0|0|E|0|NOH|0|0|1|100|DKK|1888|3562|lyfalmen|V0367|2703||6|0||Vistor hf|Novartis Healthcare A/S-|Díklófenak||1888||1888|3562|
034983|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|40|sk-hyl||S01BC03|01.04.1996||R|||0|0|E|0|NOH|0|0|1|100|DKK|3237|5407|lyfalmen|V0367|5407||12|0||Vistor hf|Novartis Healthcare A/S-|Díklófenak||3237||3237|5407|
034988|L03AB0702|Rebif|stl|44|mcg/lykj|0,5|ml|4|rörlyk||L03AB07|01.03.2010||R|||0|1|0|1|MSE|0|0|0|100|SEK|177592|224760|lyfsjukr||||2|0|40,9300|Icepharma hf|Merck Serono Europe Ltd|Interferón beta-1a||177592||177592|224760|
035024|V03AB1402|Protaminsulfat Leo Pharma|stl|10|mg/ml|5|ml|5|hgl||V03AB14|01.06.2007||R|||0|0|0|1|LEP|0|0|0|100|DKK|7691|11100|lyfsjukr||||25|0||Vistor hf|LEO Pharma A/S|Prótamín||7691||7691|11100|
035113|B05XA0501|Addex-Magnesium|irţ|1|mmol/ml|10|ml|10|plhgl||B05XA05|01.03.2010||R|||0|0|0|1|FRP|0|0|0|100|DKK|2336|3371|lyfsjukr||||100|0||Icepharma hf|Fresenius Kabi|Magnesíum súlfat||2336||2336|3371|
035212|A07EC0202|Pentasa|forđatfl|500|mg|300|stk|1|ţpakki||A07EC02|01.04.1992||R|||0|0|B|0|FER|0|0|0|100|DKK|16486|23235|lyfalmen||||300|0|100,0000|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||16486||16486|23235|
035444|C09CA0601|Atacand|töflur|16|mg|28|stk|1|ţpakki||C09CA06|01.02.2010||R|||0|0|0|0|AZD|0|0|0|100|SEK|3649|5971|lyfalmen|V0079|5971||28|0|56,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||||3649|5971|
035494|C07AB0211|Metoprolol ratiopharm|forđatfl|23,75|mg|100|stk|1|ţpakki||C07AB02|01.05.2012||R|||0|0|B|0|RGM|0|0|0|100|XEU|1047|2411|lyfalmen||||100|0|15,8300|Medical ehf|ratiopharm GmbH|Metóprólól||1047||1047|2411|30.06.2012
035515|N03AX0903|Lamotrin|dreifit.|50|mg|56|stk|1|ţpakki||N03AX09|01.11.2005||R|||0|0|E|0|ACA|0|0|0|100|IKR|1844|2856|lyfalmen|V0244|2828||56|0|9,3300|Actavis Group hf|Actavis hf|Lamótrigín||1372||1372|2856|
035528|C07AB0211|Metoprolol ratiopharm|forđatfl|47,5|mg|100|stk|1|ţpakki||C07AB02|01.06.2012||R|||0|0|B|0|RGM|0|0|0|100|XEU|1372|2690|lyfalmen|V0048|2690||100|0|31,6600|Medical ehf|ratiopharm GmbH|Metóprólól||1251||1251|2690|
035542|S01LA0301|Macugen|stl|0,3|mg/spr|1|spr|1|pakki|lausn|S01LA03|01.06.2006||R|||0|1|0|1|PER|0|0|0|100|DKK|124059|157577|lyfsjukr||||1|0||Icepharma hf|Pfizer ApS|Pegaptaníb||124059||124059|157577|
035563|C07AB0211|Metoprolol ratiopharm|forđatfl|95|mg|100|stk|1|ţpakki||C07AB02|01.05.2012||R|||0|0|B|0|RGM|0|0|0|100|XEU|2450|4330|lyfalmen|V0049|4330||100|0|63,3300|Medical ehf|ratiopharm GmbH|Metóprólól||2450||2450|4330|
035568|C09CA0601|Atacand|töflur|16|mg|98|stk|1|ţpakki||C09CA06|01.02.2010||R|||0|0|0|0|AZD|0|0|0|100|SEK|10464|5199|lyfalmen|V0080|5199||98|0|196,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||3085||3085|5199|
035597|C07AB0211|Metoprolol ratiopharm|forđatfl|190|mg|100|stk|1|ţpakki||C07AB02|01.06.2012||R|||0|0|B|0|RGM|0|0|0|100|XEU|5353|7577|lyfalmen|V0054|7577||100|0|126,6600|Medical ehf|ratiopharm GmbH|Metóprólól||4823||4823|7577|
036062|V03AE0202|Renvela|filmhtfl|800|mg|180|stk|1|pakki||V03AE02|01.04.2010||R|||0|0|0|0|GZE|0|0|0|100|XEU|31445|38211|lyfalmen||||180|0|22,5000|Vistor hf|Genzyme Europe B.V.|Sevelamer||28419||28419|38211|
036108|L03AB0702|Rebif|stl|22|mcg/lykj|0,5|ml|4|rörlyk||L03AB07|01.03.2010||R|||0|1|0|1|MSE|0|0|0|100|SEK|145615|184629|lyfsjukr||||2|0|20,4700|Icepharma hf|Merck Serono Europe Ltd|Interferón beta-1a||145615||145615|184629|
036145|M01AC0202|Tilcotil|töflur|20|mg|60|stk|1|glas||M01AC02|01.04.1988||R|||0|0|E|0|MAS|0|0|1|100|SEK|6084|9302|lyfalmen||||60|0|60,0000|Vistor hf|Meda AS|Tenoxíkam||6084||6084|9302|
036152|C09CA0601|Atacand|töflur|8|mg|28|stk|1|ţpakki||C09CA06|01.02.2010||R|||0|0|0|0|AZD|0|0|0|100|SEK|2986|5064|lyfalmen||||28|0|28,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||2986||2986|5064|
036228|C09CA0601|Atacand|töflur|8|mg|98|stk|1|ţpakki||C09CA06|01.02.2010||R|||0|0|0|0|AZD|0|0|0|100|SEK|8696|5199|lyfalmen|V0081|5199||98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||3085||3085|5199|
036290|J05AE0301|Norvir|filmhtfl|100|mg|30|stk|1|glas||J05AE03|01.10.2010||R|||0|1|0|1|ABL|0|0|0|100|DKK|6259|9033|lyfsjukr||||30|0|2,5000|Vistor hf|Abbott Laboratories A/S|Ritonavír||6259||6259|9033|
036332|L01XE0401|Sutent|hylki|12,5|mg|30|stk|1|glas||L01XE04|01.10.2006||R|||0|1|0|1|IPI|0|0|0|100|DKK|203012|256663|lyfsjukr||||30|0||Icepharma hf|Pfizer Limited|Sunitíníb||203012||203012|256663|
036341|L01XE0401|Sutent|hylki|25|mg|30|stk|1|glas||L01XE04|01.10.2006||R|||0|1|0|1|IPI|0|0|0|100|DKK|404925|510063|lyfsjukr||||30|0||Icepharma hf|Pfizer Limited|Sunitíníb||404925||404925|510063|
036351|L01XE0401|Sutent|hylki|50|mg|30|stk|1|glas||L01XE04|01.10.2006||R|||0|1|0|1|IPI|0|0|0|100|DKK|808147|1016107|lyfsjukr||||30|0||Icepharma hf|Pfizer Limited|Sunitíníb||808147||808147|1016107|
036442|J01CE0204|Kaavepenin|töflur|800|mg|20|stk|1|ţpakki||J01CE02|01.01.1988||R|||0|0|0|0|REP|0|0|1|100|SEK|832|2117|lyfalmen||||20|0|8,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||832||832|2117|
036517|J01CE0204|Kaavepenin|mixt.kyr|100|mg/ml|60|ml|1|glas||J01CE02|01.07.1992||R|||0|0|0|0|REP|0|0|1|100|SEK|1463|2980|lyfalmen||||60|0|3,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||1463||1463|2980|
036541|A03AX1301|Minifom|dropar|||30|ml|1|glas|+drteljari|A03AX13|01.12.1975||L|||0|0|0|0|GSC|0|0|0|100|IKR|||lyflausa||||30|0|6,0000|GlaxoSmithKline ehf|GlaxoSmithKline CH AB c/o GSK CH A/S|Silíkonsambönd||||||
036616|J01CE0204|Kaavepenin|mixt.kyr|100|mg/ml|125|ml|1|glas||J01CE02|01.07.1992||R|||0|0|0|0|REP|0|0|1|100|SEK|2888|4930|lyfalmen||||125|0|6,2500|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||2888||2888|4930|
036665|J01CE0204|Kaavepenin|töflur|800|mg|30|stk|1|ţpakki||J01CE02|01.01.1988||R|||0|0|0|0|REP|0|0|1|100|SEK|876|2177|lyfalmen||||30|0|12,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||876||876|2177|
037287|N04BC0404|Requip Depot|forđatfl|2|mg|84|stk|1|plglas||N04BC04|01.09.2008||R|||0|0|E|0|GSK|0|0|0|100|GBP|12873|18701|lyfalmen||||84|0|28,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||12873||12873|18701|
037305|N04BC0404|Requip Depot|forđatfl|4|mg|84|stk|1|plglas||N04BC04|01.09.2008||R|||0|0|E|0|GSK|0|0|0|100|GBP|23632|32203|lyfalmen||||84|0|56,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||23632||23632|32203|
037323|N04BC0404|Requip Depot|forđatfl|8|mg|84|stk|1|plglas||N04BC04|01.09.2008||R|||0|0|E|0|GSK|0|0|0|100|GBP|46215|60545|lyfalmen||||84|0|112,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||46215||46215|60545|
037358|N04BA0201|Madopar|töflur|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.07.1990||R|||0|0|E|0|ROC|0|0|0|100|DKK|2593|4526|lyfalmen|V0434|4526||100|0|16,6667|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||2593||2593|4526|
037531|D07AC1301|Elocon|húđlausn|0,1|%|30|ml|1|glas||D07AC13|01.01.2009||R|||0|0|B|0|SPL|0|0|1|100|DKK|1186|2601|lyfalmen||||30|0||Vistor hf|Schering-Plough Europe|Mómetasón||1186||1186|2601|
037846|A12BA0101|Kaleorid|forđatfl|750|mg|100|stk|1|glas||A12BA01|01.12.1972||L|||0|0|E|0|LEP|0|0|0|100|DKK|||lyfalmen||||100|0|25,0000|Vistor hf|LEO Pharma A/S|Kalíumklóríđ|||||2292|
037853|A12BA0101|Kaleorid|forđatfl|750|mg|250|stk|1|glas||A12BA01|01.12.1972||L|||0|0|E|0|LEP|0|0|0|100|DKK|||lyfalmen||||250|0|62,5000|Vistor hf|LEO Pharma A/S|Kalíumklóríđ|||||3733|
037895|C09CA0601|Atacand|töflur|4|mg|98|stk|1|ţpakki||C09CA06|01.02.2010||R|||0|0|0|0|AZD|0|0|0|100|SEK|8569|12701|lyfalmen||||98|0|49,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||||8569|12701|
038174|N06AB0501|Seroxat|töflur|20|mg|20|stk|1|ţpakki||N06AB05|01.04.1993||R|||0|0|B|0|GSK|0|1|0|100|IKR|664|1499|lyfalmen||||20|0|20,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Paroxetín||380||380|1499|
038257|N06AB0501|Seroxat|töflur|20|mg|60|stk|1|ţpakki||N06AB05|01.04.1993||R|||0|0|B|0|GSK|0|1|0|100|IKR|1766|2374|lyfalmen|V0321|1796||60|0|60,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Paroxetín||1020||1020|2374|
038448|N06AB0501|Seroxat|töflur|20|mg|100|stk|1|ţpakki||N06AB05|01.04.1993||R|||0|0|B|0|GSK|0|1|0|100|IKR|2667|3155|lyfalmen|V0321|2993||100|0|100,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Paroxetín||1591||1591|3155|
038513|D06BA0101|Flamazine|krem|10|mg/g|50|g|1|túpa||D06BA01|01.10.1988||R|||0|0|0|0|SON|0|0|1|100|DKK|1074|2448|lyfalmen||||50|0||Icepharma hf|Smith & Nephew|Silfursúlfadíazín||1074||1074|2448|
038554|C09CA0601|Atacand|töflur|4|mg|28|stk|1|ţpakki||C09CA06|01.02.2010||R|||0|0|0|0|AZD|0|0|0|100|SEK|2631|4578|lyfalmen||||28|0|14,0000|Vistor hf|AstraZeneca A/S DK|Candesartan||2631||2631|4578|
038607|L03AA1301|Neulasta|stl|6|mg/penna|0,6|ml|1|penni|áfylltur penni, lausn|L03AA13|01.07.2006||R|||0|1|0|1|AEU|0|0|0|100|DKK|180099|227907|lyfsjukr||||1|0|20,0000|Vistor hf|Amgen Europe B.V.|Pegfilgrastím||180099||180099|227907|
038689|L04AB0101|Enbrel|sts|25|mg|4|hgl|1|pakki|+ leysir|L04AB01|01.04.2010||R|||0|1|0|1|WTE|0|0|0|100|DKK|77842|99574|lyfsjukr||||4|0|14,2900|Icepharma hf|Wyeth Europe|Etanercept||77842||77842|99574|
039005|L01XA0301|Eloxatin|irţ|5|mg/ml|10|ml|1|hgl||L01XA03|01.03.2007||R|||0|1|0|1|SNO|0|0|0|100|NOK|42737|55517|lyfsjukr||||10|0||Vistor hf|Sanofi-aventis Norge AS|Oxalíplatín||42737||42737|55517|
039014|L01XA0301|Eloxatin|irţ|5|mg/ml|20|ml|1|hgl||L01XA03|01.03.2007||R|||0|1|0|1|SNO|0|0|0|100|NOK|71442|91542|lyfsjukr||||20|0||Vistor hf|Sanofi-aventis Norge AS|Oxalíplatín||71442||71442|91542|
039141|B01AX0601 |Xarelto|filmhtfl|15|mg|42|stk|1|ţpakki||B01AX06|01.05.2012||R|||0|0|E|0|BAP|0|0|0|100|SEK|15910|22512|lyfalmen|V0031|20960||42|0|63,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaroxaban||||15910|22512|
039430|J07AL5201|Synflorix|stl|||0,5|ml|1|áf.spr|m.nál, dreifa|J07AL52|01.04.2012||R|||0|0|0|0|GLB|0|0|0|100|GBP|7507|11137|lyfalmen||||0|0||GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|Lungnabólga a.v.pneumok.Hreins pneumok polysakk móte.v Hae||7426||7426|11137|
039575|D01AE1503|Lamisil (D.A.C.)|krem|10|mg/g|15|g|1|túpa||D01AE15|01.05.2009||L|||0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa||||15|0||D.A.C. ehf|D.A.C. ehf|Terbínafín||||||
039631|C01BD0701|Multaq|filmhtfl|400|mg|20|stk|1|ţpakki||C01BD07|01.08.2010||R|||0|1|0|0|SAA|0|0|0|100|NOK|4754|7482|lyfalmen||||20|0|10,0000|Vistor hf|Sanofi - Aventis|Dronedarón||||4754|7482|
039643|C01BD0701|Multaq|filmhtfl|400|mg|100|stk|1|ţpakki||C01BD07|01.08.2010||R|||0|1|0|0|SAA|0|0|0|100|NOK|23294|31779|lyfalmen||||100|0|50,0000|Vistor hf|Sanofi - Aventis|Dronedarón||||23294|31779|
039676|N06AX0307|Mianserin Mylan|filmhtfl|30|mg|100|stk|1|glas||N06AX03|01.06.2010||R|||0|0|B|0|MYL|0|1|0|100|SEK|3379|5601|lyfalmen||||100|0|50,0000|Actavis Group PTC ehf|Mylan AB|Míanserín||3379||3379|5601|
039698|C07AB0311|Atenolol Mylan|töflur|25|mg|98|stk|1|ţpakki||C07AB03|01.04.1992||R|||0|0|B|0|MYL|0|0|0|100|SEK|584|1626|lyfalmen|V0541|1598||98|0|32,6667|Actavis Group PTC ehf|Mylan AB|Atenólól||473||473|1626|
039709|C07AB0311|Atenolol Mylan|töflur|50|mg|98|stk|1|ţpakki||C07AB03|01.01.1991||R|||0|0|B|0|MYL|0|0|0|100|SEK|657|1678|lyfalmen|V0542|1649||98|0|65,3333|Actavis Group PTC ehf|Mylan AB|Atenólól||511||511|1678|
039776|J01FA1001|Zitromax|mixtúrud|40|mg/ml|15|ml|1|glas||J01FA10|01.07.1994||R|||0|0|0|0|PER|0|0|1|100|DKK|1330|2798|lyfalmen||||15|0|2,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||1330||1330|2798|
039784|J01FA1001|Zitromax|mixtúrud|40|mg/ml|22,5|ml|1|glas||J01FA10|01.01.1995||R|||0|0|0|0|PER|0|0|1|100|DKK|1918|3603|lyfalmen||||22|0|3,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||1918||1918|3603|
039909|L01AA0101|Sendoxan|sts|200|mg|1|stk|1|hgl||L01AA01|01.07.1992||R|||0|1|0|1|BAM|0|0|0|100|SEK|486|701|lyfsjukr||||1|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíđ||486||486|701|
039935|C10AA0105|Simvastatin Actavis|filmhtfl|40|mg|98|stk|1|ţpakki||C10AA01|01.06.2009||R|||0|0|E|0|AGP|0|0|0|100|IKR|1630|3049|lyfalmen|V0110|3029||98|0|130,6700|Actavis Group hf|Actavis Group PTC ehf|Simvastatín||1513||1513|3049|
039957|J05AB1104|Valaciclovir Actavis|filmhtfl|500|mg|42|stk|1|ţpakki||J05AB11|01.01.2010||R|||0|0|E|0|AGP|0|0|1|100|GBP|9007|9353|lyfalmen|V0182|9254||42|0|7,0000|Actavis Group hf|Actavis Group PTC ehf|Valacíklóvír||6122||6122|9353|
039958|L01AA0101|Sendoxan|sts|500|mg|1|stk|1|hgl||L01AA01|01.01.1988||R|||0|1|0|1|BAM|0|0|0|100|SEK|664|958|lyfsjukr||||1|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíđ||664||664|958|
039968|J05AB1104|Valaciclovir Actavis|filmhtfl|500|mg|10|stk|1|ţpakki||J05AB11|01.01.2010||R|||0|0|E|0|AGP|0|0|1|100|GBP|1951|2291|lyfalmen|V0033|2127||10|0|1,6667|Actavis Group hf|Actavis Group PTC ehf|Valacíklóvír||959||959|2291|
040089|L01AA0101|Sendoxan|sts|1|g|1|stk|1|hgl||L01AA01|01.07.1994||R|||0|1|0|1|BAM|0|0|0|100|SEK|1352|1951|lyfsjukr||||1|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíđ||1352||1352|1951|
040426|R06AX2703|Desloratadine Actavis|filmhtfl|5|mg|30|stk|1|ţpakki||R06AX27|01.05.2012||R|||0|0|E|0|APC|0|0|1|100|XEU|1341|2813|lyfalmen|V0366|2813||30|0|30,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Deslóratadín||1341||1341|2813|
040543|S01XA2012|Dacriosol|augndr|3|mg/ml|15|ml|1|glas||S01XA20|01.03.2000||L|||0|0|E|0|SAL|0|0|0|100|IKR|||lyfalmen||||15|0||Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Gervitár og ađrar óvirkar samsetningar|||||1723|
040822|C10AA0504|Atorvastatin Portfarma|filmhtfl|10|mg|100|stk|1|ţpakki||C10AA05|01.06.2006||R|||0|0|E|0|POF|0|0|0|100|IKR|4539|2527|lyfalmen|V0112|2527||100|0|50,0000|Portfarma ehf|Portfarma|Atorvastatín||1132||1132|2527|
041423|G03AA1203|Yasminelle|töflur|||63|stk|1|ţpakki|3+0,02 mg|G03AA12|01.12.2006||R|||0|0|0|0|BYP|0|0|0|100|SEK|3379|5601|lyfalmen||||63|0|84,0000|Icepharma hf|Bayer Pharma AG|Dróspírenón og östrógen||3379||3379|5601|
041704|QI09AX0001|Improvac|stl|300|mcg|20|ml|12|fl||QI09AX00|01.08.2010||R|||0|0|0|0|IPF|1|0|0|100|DKK|28821|50277|vetorma||||240|0||Icepharma hf|Pfizer Limited|GnRF hliđstćđa samtengd próteini||||28821|50277|
041749|QI04AB0101|Lambivac, vet.|stl|126|Lf/ml|100|ml|1|fl|dreifa|QI04AB01|01.04.2007||R|||0|0|0|0|INI|0|0|0|100|DKK|4514|7874|vetorma||||100|0||Icepharma hf|Intervet International B.V.|||4514||4514|7874|
041795|M02AA1503|Voltaren Emulgel (D.A.C.)|hlaup|11,6|mg/g|100|g|1|túpa||M02AA15|01.05.2009||L|||0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa||||100|0||D.A.C. ehf|D.A.C. ehf|Díklófenak||||||
041898|N06AX0307|Mianserin Mylan|filmhtfl|10|mg|90|stk|1|ţpakki||N06AX03|01.06.2008||R|||0|0|B|0|MYL|0|1|0|100|SEK|1209|2633|lyfalmen||||90|0|15,0000|Actavis Group PTC ehf|Mylan AB|Míanserín||||1209|2633|
041938|A02BC0508|Esomeprazol Actavis|sţ-hylki|40|mg|28|stk|1|ţpakki|hart|A02BC05|01.03.2012||R|||0|0|0|0|APC|0|0|0|100|XEU|4125|1874|lyfalmen|V0005|1835||28|0|37,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Esómeprazól||654||654|1874|
041996|A06AG1101|Microlax|innhl|||5|ml|4|túpa||A06AG11|01.12.1972||L|||0|0|0|0|MCN|0|0|0|100|IKR|||lyflausa||||20|0|4,0000|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, ţ.m.t. í blöndum||||||
042036|C07AB0205|Seloken|stl|1|mg/ml|5|ml|5|lykjur||C07AB02|01.01.1985||R|||0|0|B|0|AZD|0|0|0|100|SEK|1554|3105|lyfalmen||||25|0|0,1667|Vistor hf|AstraZeneca A/S DK|Metóprólól||1554||1554|3105|
042101|N01BB0902|Naropin|irl|2|mg/ml|100|ml|5|plpok||N01BB09|01.05.1998||R|||0|0|0|1|AZD|0|0|0|100|SEK|13077|18294|lyfsjukr||||500|0||Vistor hf|AstraZeneca A/S DK|Rópívakaín||13077||13077|18294|
042305|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|1000|ml|10|plpok|Freeflex umbúđir|B05BA03|01.05.2007||R|||0|0|0|1|FRP|0|0|0|100|DKK|2606|3761|lyfsjukr||||10000|0||Icepharma hf|Fresenius Kabi|Kolvetni||2606||2606|3761|
042314|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|500|ml|15|plpok|Freeflex umbúđir|B05BA03|01.05.2007||R|||0|0|0|1|FRP|0|0|0|100|DKK|3150|4546|lyfsjukr||||7500|0||Icepharma hf|Fresenius Kabi|Kolvetni||3150||3150|4546|
042323|B05BA0311|Glucos Fresenius Kabi|irl|200|mg/ml|1000|ml|10|plpok|Freeflex umbúđir|B05BA03|01.05.2007||R|||0|0|0|1|FRP|0|0|0|100|DKK|4460|6437|lyfsjukr||||10000|0||Icepharma hf|Fresenius Kabi|Kolvetni||4460||4460|6437|
042332|B05BA0311|Glucos Fresenius Kabi|irl|200|mg/ml|500|ml|15|plpok|Freeflex umbúđir|B05BA03|01.05.2007||R|||0|0|0|1|FRP|0|0|0|100|DKK|4571|6597|lyfsjukr||||7500|0||Icepharma hf|Fresenius Kabi|Kolvetni||4571||4571|6597|
042357|N07BA0141|Nicotinell Fruktsmak (D.A.C.)|tyggigúm|2|mg|204|stk|1|ţpakki||N07BA01|01.05.2009||L|||0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa||||204|0|13,6000|D.A.C. ehf|D.A.C. ehf|Nikótín||||||
042360|B05BA0311|Glucos Fresenius Kabi|irl|500|mg/ml|500|ml|15|plpok|Freeflex umbúđir|B05BA03|01.05.2007||R|||0|0|0|1|FRP|0|0|0|100|DKK|5823|8404|lyfsjukr||||7500|0||Icepharma hf|Fresenius Kabi|Kolvetni||5823||5823|8404|
042368|A06AB0602|Senokot|töflur|7,5|mg|500|stk|1|glas||A06AB06|01.04.2009|31.05.2012|R|||0|0|0|0|REB|0|0|0|100|GBP|2431|4304|lyfalmen||||500|0||Icepharma hf|Reckitt Benckiser Healthcare Ltd.|Senna||||2431|4304|
042369|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|100|ml|40|plpok|Excel umbúđir|B05BA03|01.03.2007||R|||0|0|0|1|FRP|0|0|0|100|DKK|7186|10371|lyfsjukr||||4000|0||Icepharma hf|Fresenius Kabi|Kolvetni||7186||7186|10371|
042378|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|250|ml|20|plpok|Freeflex umbúđir|B05BA03|01.03.2010||R|||0|0|0|1|FRP|0|0|0|100|DKK|3894|5620|lyfsjukr||||5000|0||Icepharma hf|Fresenius Kabi|Kolvetni||3894||3894|5620|
042387|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|500|ml|15|plpok|Freeflex umbúđir|B05BA03|01.05.2007||R|||0|0|0|1|FRP|0|0|0|100|DKK|2981|4302|lyfsjukr||||7500|0||Icepharma hf|Fresenius Kabi|Kolvetni||2981||2981|4302|
042396|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|1000|ml|10|plpok|Freeflex umbúđir|B05BA03|01.05.2007||R|||0|0|0|1|FRP|0|0|0|100|DKK|2278|3288|lyfsjukr||||10000|0||Icepharma hf|Fresenius Kabi|Kolvetni||2278||2278|3288|
042405|B05BB0213|Kalium-Natrium-Glucose "Fresenius Kabi"|irl|||1000|ml|10|plpok|Freeflex umbúđir|B05BB02|01.05.2007||R|||0|0|0|1|FRP|0|0|0|100|DKK|2851|4115|lyfsjukr||||10000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum međ kol­vetnum||2851||2851|4115|
042451|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|250|ml|20|plpok|Freeflex umbúđir|B05BB01|01.03.2010||R|||0|0|0|1|FRP|0|0|0|100|DKK|3742|5401|lyfsjukr||||5000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||3742||3742|5401|
042460|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|500|ml|15|plpok|Freeflex umbúđir|B05BB01|01.05.2007||R|||0|0|0|1|FRP|0|0|0|100|DKK|2556|3689|lyfsjukr||||7500|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||2556||2556|3689|
042469|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|1000|ml|10|plpok|Freeflex umbúđir|B05BB01|01.05.2007||R|||0|0|0|1|FRP|0|0|0|100|DKK|1841|2657|lyfsjukr||||10000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||1841||1841|2657|
042478|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|100|ml|40|plpok|Excel umbúđir|B05BB01|01.03.2007||R|||0|0|0|1|FRP|0|0|0|100|DKK|6249|9019|lyfsjukr||||4000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||6249||6249|9019|
042524|B05BB0115|Ringer-acetat Fresenius Kabi|irl|||1000|ml|10|plpok|Freeflex umbúđir|B05BB01|01.05.2007||R|||0|0|0|1|FRP|0|0|0|100|DKK|2085|3009|lyfsjukr||||10000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||2085||2085|3009|
042549|J07BF0301|Imovax Polio|bóluefni|||0,5|ml|1|dćla|einnota|J07BF03|01.01.1996||R|||0|0|0|0|SPM|0|0|0|100|XEU|792|2062|lyfalmen||||0|0||Icepharma hf|Sanofi Pasteur MSD|Mćnusótt, dauđ veira||792||792|2062|
042551|B05BB0209|Glucos 100 mg/ml med Na40 + K20 Fres|irl|||1000|ml|10|plpok||B05BB02|01.04.2009||R|||0|0|0|1|FRP|0|0|0|100|DKK|2952|4260|lyfsjukr||||10000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum međ kol­vetnum||2952||2952|4260|
042556|J07BF0301|Imovax Polio|bóluefni|||0,5|ml|20|dćlur|einnota|J07BF03|01.01.1996||R|||0|0|0|0|SPM|0|0|0|100|XEU|15140|21546|lyfalmen||||10|0||Icepharma hf|Sanofi Pasteur MSD|Mćnusótt, dauđ veira||15140||15140|21546|
042561|QM01AH9201|Trocoxil|tuggutfl|6|mg|2|stk|1|ţpakki||QM01AH92|01.12.2010||R|||0|0|0|0|IPF|0|0|0|100|DKK|1377|2739|vetalmen||||2|0||Icepharma hf|Pfizer Limited|Mavakoxíb||1377||1377|2739|
042573|QM01AH9201|Trocoxil|tuggutfl|20|mg|2|stk|1|ţpakki||QM01AH92|01.12.2010||R|||0|0|0|0|IPF|0|0|0|100|DKK|2053|4084|vetalmen||||2|0||Icepharma hf|Pfizer Limited|Mavakoxíb||2053||2053|4084|
042584|QM01AH9201|Trocoxil|tuggutfl|30|mg|2|stk|1|ţpakki||QM01AH92|01.12.2010||R|||0|0|0|0|IPF|0|0|0|100|DKK|2753|5459|vetalmen||||2|0||Icepharma hf|Pfizer Limited|Mavakoxíb||2753||2753|5459|
042595|QM01AH9201|Trocoxil|tuggutfl|75|mg|2|stk|1|ţpakki||QM01AH92|01.12.2010||R|||0|0|0|0|IPF|0|0|0|100|DKK|5507|10747|vetalmen||||2|0||Icepharma hf|Pfizer Limited|Mavakoxíb||5507||5507|10747|
042607|QM01AH9201|Trocoxil|tuggutfl|95|mg|2|stk|1|ţpakki||QM01AH92|01.12.2010||R|||0|0|0|0|IPF|0|0|0|100|DKK|6332|12331|vetalmen||||2|0||Icepharma hf|Pfizer Limited|Mavakoxíb||6332||6332|12331|
042615|B05BB0210|Rehydrex m. gl. 25 mg/ml Fresenius Kabi|irl|||1000|ml|10|plpok|Freeflex umbúđir|B05BB02|01.05.2007||R|||0|0|0|1|FRP|0|0|0|100|DKK|2485|3586|lyfsjukr||||10000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum međ kol­vetnum||2485||2485|3586|
042669|V07AB13|Sterilt vatten/vann/vand  Fresenius Kabi|leysir|||100|ml|40|plastl|fyrir stungulyf|V07AB|01.04.2008||L|||0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa||||4000|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar||||||
043232|N05CD0306|Flunitrazepam Mylan|töflur|1|mg|30|stk|1|ţpakki||N05CD03|01.10.1992||R|||1|0|0|0|MYL|0|0|0|100|SEK|540|1718|lyfalmen||||30|0|30,0000|Actavis Group PTC ehf|Mylan AB|Flúnítrazepam||540||540|1718|
043257|N01BB0902|Naropin|stl/irl|2|mg/ml|20|ml|5|plastl||N01BB09|01.05.1998||R|||0|0|0|1|AZD|0|0|0|100|SEK|3239|4675|lyfsjukr||||100|0||Vistor hf|AstraZeneca A/S DK|Rópívakaín||3239||3239|4675|
043345|N03AX1405|Matever|filmhtfl|1000|mg|100|stk|1|ţpakki||N03AX14|01.02.2012||R|||0|0|0|0|PSA|0|0|0|100|XEU|24475|22980|lyfalmen|V0516|20556||100|0|66,6700|Portfarma ehf|Pharmathen S.A.|Levetíracetam||16283||16283|22980|
043379|R03AC1201|Serevent|innúđal|25|mcg/sk|120|sk|1|stauk|HFA 134a|R03AC12|01.04.2007||R|||0|0|B|0|GSK|0|0|1|100|GBP|5194|6256|lyfalmen||||120|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról||3858||3858|6256|
043547|N01BB0902|Naropin|stl|7,5|mg/ml|20|ml|5|plastl||N01BB09|01.05.1998||R|||0|0|0|1|AZD|0|0|0|100|SEK|5989|8644|lyfsjukr||||100|0||Vistor hf|AstraZeneca A/S DK|Rópívakaín||5989||5989|8644|
043729|N05CD0503|Halcion|töflur|0,125|mg|30|stk|1|ţpakki||N05CD05|01.12.1983||R|||0|0|0|0|PER|0|0|1|100|DKK|579|1771|lyfalmen||||30|0|15,0000|Icepharma hf|Pfizer ApS|Tríazólam||579||579|1771|
043745|G03CA0401|Ovestin|töflur|2|mg|30|stk|1|ţpakki||G03CA04|01.07.1989||R|||0|0|E|0|ORG|0|0|0|100|DKK|1258|2700|lyfalmen||||30|0|30,0000|Vistor hf|N.V. Organon|Estríól||1258||1258|2700|
043919|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|10|ml|20|lykjur|fyrir stl|V07AB|01.07.1995||L|||0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa||||200|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar||||||
043935|V07AB13|Sterilt vatten/vann/vand  Fresenius Kabi|leysir|||10|ml|20|plastl|fyrir stungulyf|V07AB|01.10.1994||L|||0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa||||200|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar||||||
043988|B03AA0705|Ferrous Sulphate|töflur|200|mg|100|stk|1|glas|sykurhúđađar|B03AA07|01.09.2009||L|||0|0|0|0|AUK|0|0|1|100|IKR|||lyflausa||||100|0|32,5000|Actavis Group hf|Actavis UK Ltd.|Ferrósúlfat||||||
044360|B03AC0203|Venofer (Lyfjaver)|stl|20|mg/ml|5|ml|5|lykjur||B03AC02|01.05.2006||R|||0|0|E|0|LVR|0|0|1|100|CHF|13427|19396|lyfalmen|V0034|19396||25|0|5,0000|Lyfjaver ehf|Lyfjaver ehf|Járnoxíđ (sykurflétta)||13427||13427|19396|
044580|L01XE1001|Afinitor|töflur|5|mg|30|stk|1|ţpakki||L01XE10|01.09.2011||R|||0|1|0|1|NOE|0|0|0|100|DKK|391191|492827|lyfsjukr||||30|0||Vistor hf|Novartis Europharm Ltd|Everolímus||||391191|492827|
044591|L01XE1001|Afinitor|töflur|10|mg|30|stk|1|ţpakki||L01XE10|01.09.2011||R|||0|1|0|1|NOE|0|0|0|100|DKK|552040|694693|lyfsjukr||||30|0||Vistor hf|Novartis Europharm Ltd|Everolímus||||552040|694693|
044739|N04BC0502|Sifrol|forđatfl|0,52|mg|100|stk|1|pakki||N04BC05|01.02.2010||R|||0|0|E|0|BII|0|0|0|100|DKK|23756|32359|lyfalmen||||100|0|20,8000|Vistor hf|Boehringer Ingelheim International|Pramipexól||23756||23756|32359|
044752|N04BC0502|Sifrol|forđatfl|2,1|mg|100|stk|1|pakki||N04BC05|01.02.2010||R|||0|0|E|0|BII|0|0|0|100|DKK|90741|116425|lyfalmen||||100|0|84,0000|Vistor hf|Boehringer Ingelheim International|Pramipexól||90741||90741|116425|
044763|N04BC0502|Sifrol|forđatfl|0,52|mg|10|stk|1|pakki||N04BC05|01.02.2010||R|||0|0|E|0|BII|0|0|0|100|DKK|2749|4739|lyfalmen||||10|0|2,0800|Vistor hf|Boehringer Ingelheim International|Pramipexól||2749||2749|4739|
044888|QN05CM9001|Domosedan, vet.|munnh.hl|7,6|mg/ml|3|ml|1|áf.spr|munnsk.dćla|QN05CM90|01.01.2012||R|||0|0|0|0|OCO|0|0|0|100|DKK|2141|4259|vetalmen||||3|0||Icepharma hf|Orion Corporation (I)|||2141||2141|4259|
045385|J07BF0301|Imovax Polio|bóluefni|||0,5|ml|10|dćlur|einnota|J07BF03|01.01.1996||R|||0|0|0|0|SPM|0|0|0|100|XEU|7569|11333|lyfalmen||||5|0||Icepharma hf|Sanofi Pasteur MSD|Mćnusótt, dauđ veira||7569||7569|11333|
045510|C10AA0105|Simvastatin Actavis|filmhtfl|20|mg|98|stk|1|ţpakki||C10AA01|01.06.2009||R|||0|0|E|0|AGP|0|0|0|100|IKR|1050|2300|lyfalmen|V0109|2300||98|0|65,3400|Actavis Group hf|Actavis Group PTC ehf|Simvastatín||966||966|2300|
045533|C10AA0105|Simvastatin Actavis|filmhtfl|10|mg|98|stk|1|ţpakki||C10AA01|01.06.2009||R|||0|0|E|0|AGP|0|0|0|100|IKR|868|2095|lyfalmen|V0108|2095||98|0|32,6700|Actavis Group hf|Actavis Group PTC ehf|Simvastatín||816||816|2095|
045588|J01DC0204 |Cefuroxim Villerton|sts|750|mg/hgl|10|hgl|1|pakki||J01DC02|01.05.2009||R|||0|0|0|1|VIL|0|0|0|100|NOK|2991|4317|lyfsjukr||||10|0|2,5000|Lyfjaver ehf|Villerton Invest AS|Cefúroxím||2991||2991|4317|
045599|J01DC0204 |Cefuroxim Villerton|sts|1500|mg/hgl|10|hgl|1|pakki||J01DC02|01.05.2009||R|||0|0|0|1|VIL|0|0|0|100|NOK|5983|8635|lyfsjukr||||10|0|5,0000|Lyfjaver ehf|Villerton Invest AS|Cefúroxím||5983||5983|8635|
045634|N02AA5907|Pinex Comp Forte|eţ-stíll|530|mg|10|stk|1|pakki|30+500 mg|N02AA59|01.01.2011||R|||0|0|0|0|AGT|0|0|1|100|XEU|385|1506|lyfalmen||||10|0|3,3333|Actavis Group hf|Actavis Group hf|Kódein í blöndum nema međ geđlyfjum||385||385|1506|
046077|QJ01DD9101|Convenia|sts|80|mg/ml|10|ml|1|hgl|+leysir, lausn|QJ01DD91|01.01.2008||R|||0|0|0|0|PFV|0|0|0|100|DKK|21711|41861|vetalmen||||10|0||Icepharma hf|Pfizer vet.|||21711||21711|41861|
046269|C09AA0502|Ramil|töflur|2,5|mg|100|stk|1|ţpakki||C09AA05|01.03.2006||R|||0|0|B|0|ACA|0|0|0|100|XEU|1053|2419|lyfalmen||||100|0|100,0000|Actavis Group hf|Actavis hf|Ramipríl||1053||1053|2419|
046396|A04AA0102|Ondansetron Vian|stl|2|mg/ml|2|ml|5|lykjur||A04AA01|01.02.2008||R|||0|0|E|0|VIS|0|0|0|100|DKK|4037|6501|lyfalmen|V0382|6501||10|0|1,2500|Icepharma hf|Vian SA|Ondansetrón||4037||4037|6501|
046405|A10BB1202|Glimeryl|töflur|1|mg|90|stk|1|ţpakki||A10BB12|01.05.2006||R|||0|0|*|0|ACA|0|0|0|100|XEU|694|1928|lyfalmen|V0021|1928||90|0|45,0000|Actavis Group hf|Actavis hf|Glímepíríđ||694||694|1928|
046414|A10BB1202|Glimeryl|töflur|2|mg|90|stk|1|ţpakki||A10BB12|01.05.2006||R|||0|0|*|0|ACA|0|0|0|100|XEU|1139|2537|lyfalmen|V0022|2537||90|0|90,0000|Actavis Group hf|Actavis hf|Glímepíríđ||1139||1139|2537|
046423|A10BB1202|Glimeryl|töflur|3|mg|90|stk|1|ţpakki||A10BB12|01.05.2006||R|||0|0|*|0|ACA|0|0|0|100|XEU|1433|2939|lyfalmen|V0023|2939||90|0|135,0000|Actavis Group hf|Actavis hf|Glímepíríđ||1433||1433|2939|
046687|A04AA0102|Ondansetron Vian|stl|2|mg/ml|4|ml|5|lykjur||A04AA01|01.02.2008||R|||0|0|E|0|VIS|0|0|0|100|DKK|6723|10176|lyfalmen|V0383|10176||20|0|2,5000|Icepharma hf|Vian SA|Ondansetrón||6723||6723|10176|
046745|N04BC0405|Ropinirol Portfarma|filmhtfl|0,5|mg|84|stk|1|ţpakki||N04BC04|01.02.2012||R|||0|0|E|0|POF|0|0|0|100|GBP|5335|6546|lyfalmen|V0530|6546||84|0|7,0000|Portfarma ehf|Portfarma|Rópíníról||4070||4070|6546|
046767|N04BC0405|Ropinirol Portfarma|filmhtfl|2|mg|84|stk|1|ţpakki||N04BC04|01.02.2012||R|||0|0|E|0|POF|0|0|0|100|GBP|6693|7769|lyfalmen|V0531|7769||84|0|28,0000|Portfarma ehf|Portfarma|Rópíníról||4964||4964|7769|
046779|N05AH0308|Lazapix|filmhtfl|15|mg|28|stk|1|ţpakki||N05AH03|01.09.2011||R|||0|0|*|0|POF|0|1|0|100|XEU|10678|11297|lyfalmen|V0283|9719||28|0|42,0000|Portfarma ehf|Portfarma|Olanzapín||7543||7543|11297|
046812|M05BA0603|Ibandronic acid Portfarma|filmhtfl|150|mg|3|stk|1|ţpakki||M05BA06|01.02.2012||R|||0|0|0|0|POF|0|0|0|100|XEU|11093|4984|lyfalmen|V0205|4984||3|0|90,0000|Portfarma ehf|Portfarma|Íbandrónsýra||2928||2928|4984|
046823|N05AH0308|Lazapix|filmhtfl|5|mg|28|stk|1|ţpakki||N05AH03|01.09.2011||R|||0|0|*|0|POF|0|1|0|100|XEU|3446|2625|lyfalmen|V0279|2529||28|0|14,0000|Portfarma ehf|Portfarma|Olanzapín||1203||1203|2625|
047159|C07AA0705|Sotalol Mylan|töflur|40|mg|100|stk|1|glas||C07AA07|01.01.1994||R|||0|0|B|0|MYL|0|0|0|100|SEK|1036|2396|lyfalmen||||100|0|25,0000|Actavis Group PTC ehf|Mylan AB|Sótalól||1036||1036|2396|
047442|N01AX1301|Niontix|lyfjagas|100|%|10|l|1|hylki||N01AX13|01.06.2008||R|||0|0|0|1|AGA|0|0|0|100|IKR|13388|18684|lyfsjukr||||10|0||Ísaga ehf|AGA AB|di-Nitrogen oxíđ||13388||13388|18684|
047460|N01AX1301|Niontix|lyfjagas|100|%|50|l|1|hylki||N01AX13|01.06.2008||R|||0|0|0|1|AGA|0|0|0|100|IKR|47555|61564|lyfsjukr||||50|0||Ísaga ehf|AGA AB|di-Nitrogen oxíđ||47555||47555|61564|
047560|L04AB0101|Enbrel|stl|50|mg|4|áf.spr|1|pakki|lausn|L04AB01|01.05.2008||R|||0|1|0|1|WTE|0|0|0|100|DKK|150895|191256|lyfsjukr||||4|0|28,5800|Icepharma hf|Wyeth Europe|Etanercept||150895||150895|191256|
047941|N03AX2101|Trobalt|filmhtfl|300|mg|84|stk|1|ţpakki||N03AX21|01.12.2011||R|||0|0|E|0|GGL|0|0|0|100|GBP|27147|36615|lyfalmen||||84|0||GlaxoSmithKline ehf|Glaxo Group Limited|Retigabín||27147||27147|36615|
047986|L02BB0305|Bicalutamide Portfarma|filmhtfl|50|mg|30|stk|1|ţpakki||L02BB03|01.02.2011||R|||0|0|*|0|POF|0|0|0|100|XEU|12918|10122|lyfalmen|V0420|10122||30|0|30,0000|Portfarma ehf|Portfarma|Bíkalútamíđ||6684||6684|10122|
047998|L02BB0305|Bicalutamide Portfarma|filmhtfl|150|mg|30|stk|1|ţpakki||L02BB03|01.02.2011||R|||0|0|*|0|POF|0|0|0|100|XEU|24464|21543|lyfalmen|V0421|21543||30|0|90,0000|Portfarma ehf|Portfarma|Bíkalútamíđ||15138||15138|21543|
048015|B05AA0111|Albumin Baxter|irl|50|g/líter|250|ml|1|hgl||B05AA01|01.06.2007||R|||0|0|0|1|BAM|0|0|0|100|SEK|5383|7769|lyfsjukr||||250|0||Icepharma hf|Baxter Medical AB|Albúmín||5383||5383|7769|
048028|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|100|ml|50|pokar|Freeflex umbúđir|B05BB01|01.12.2011||R|||0|0|0|1|FRP|0|0|0|100|DKK|8982|12963|lyfsjukr||||5000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||8982||8982|12963|
048043|B05AA0111|Albumin Baxter|irl|200|g/líter|100|ml|1|hgl||B05AA01|01.06.2007||R|||0|0|0|1|BAM|0|0|0|100|SEK|8497|12263|lyfsjukr||||100|0||Icepharma hf|Baxter Medical AB|Albúmín||8497||8497|12263|
048100|N06AB1004|Esopram|töflur|5|mg|100|stk|1|ţpakki||N06AB10|01.04.2010||R|||0|0|B|0|APC|0|1|0|100|XEU|2767|3335|lyfalmen|V0324|3335||100|0|50,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||1722||1722|3335|
048111|N06AB1004|Esopram|töflur|10|mg|28|stk|1|ţpakki||N06AB10|01.04.2010||R|||0|0|0|0|APC|0|1|0|100|XEU|2570|3672|lyfalmen|V0035|3672||28|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||1969||1969|3672|
048122|N06AB1004|Esopram|töflur|10|mg|100|stk|1|plglas||N06AB10|01.04.2010||R|||0|0|B|0|APC|0|1|0|100|XEU|7978|5635|lyfalmen|V0325|5635||100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||3404||3404|5635|
048144|N06AB1004|Esopram|töflur|15|mg|100|stk|1|plglas||N06AB10|01.04.2010||R|||0|0|B|0|APC|0|1|0|100|XEU|7837|5399|lyfalmen|V0326|5399||100|0|150,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||3231||3231|5399|
048155|N06AB1004|Esopram|töflur|20|mg|28|stk|1|ţpakki||N06AB10|01.04.2010||R|||0|0|0|0|APC|0|1|0|100|XEU|4020|4556|lyfalmen|V0246|4556||28|0|56,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||2615||2615|4556|
048166|N06AB1004|Esopram|töflur|20|mg|100|stk|1|plglas||N06AB10|01.04.2010||R|||0|0|B|0|APC|0|1|0|100|XEU|15673|5399|lyfalmen|V0327|5399||100|0|200,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Escítalópram||3231||3231|5399|
048199|A03CA0201|Librax|töflur|||100|stk|1|glas||A03CA02|01.12.1972||R|||0|0|E|0|MAB|0|0|0|100|DKK|1202|2623|lyfalmen||||100|0||Vistor hf|Meda AB|Klídín og geđlyf||1202||1202|2623|
048297|C09DA0101|Cozaar Comp|filmhtfl|112,5|mg|98|stk|1|ţpakki|100+12,5 mg|C09DA01|01.06.2007||R|||0|0|0|0|MSD|0|0|0|100|DKK|14281|20468|lyfalmen||||98|0|98,0000|Vistor hf|M.S.D.|Lósartan og ţvagrćsilyf||14281||14281|20468|
048355|C01DA0801|Sorbangil|töflur|40|mg|100|stk|1|glas||C01DA08|01.10.1988||R|||0|0|B|0|REP|0|0|0|100|SEK|4198|6722|lyfalmen||||100|0|66,6667|Vistor hf|Recip AB|Ísósorbíđ dínítrat||4198||4198|6722|
048447|G03AA0901|Marvelon|töflur|||63|stk|1|ţpakki||G03AA09|01.07.1986||R|||0|0|0|0|ORG|0|0|0|100|DKK|1843|3500|lyfalmen||||63|0|84,0000|Vistor hf|N.V. Organon|Desógestrel og östrógen||1843||1843|3500|
048488|L04AA0601|Cellcept|töflur|500|mg|150|stk|1|ţpakki||L04AA06|01.03.1999||R|||0|1|*|0|ROC|0|0|0|100|DKK|63326|78535|lyfalmen|V0187|44261||150|0|37,5000|Icepharma hf|Roche|Mýcófenólsýra||60550||60550|78535|
048505|L03AX1601|Mozobil|stl|20|mg/ml|1,2|ml|1|hgl|lausn|L03AX16|01.07.2010||R|||0|1|0|1|GZE|0|0|0|100|XEU|1011668|1271526|lyfsjukr||||1|0|1,4300|Vistor hf|Genzyme Europe B.V.|Plerixaforum||1011668||1011668|1271526|
048744|N02BE0101|Panodil|töflur|500|mg|100|stk|1|glas||N02BE01|01.03.1984||R|||0|0|0|0|GSH|0|0|1|100|DKK|495|1656|lyfalmen|V0230|1562||100|0|16,6667|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól||495||495|1656|
049015|A02BA0201|Asyran|töflur|300|mg|100|stk|1|ţpakki||A02BA02|01.10.1987||R|||0|0|E|0|ACA|0|0|0|100|XEU|2506|4407|lyfalmen||||100|0|100,0000|Actavis Group hf|Actavis hf|Ranitidín||2506||2506|4407|
049169|M05BA0602|Bonviva|stl|1|mg/ml|3|ml|1|spr||M05BA06|01.10.2006||R|||0|0|0|0|RRL|0|0|0|100|DKK|17812|24899|lyfalmen||||3|0|0,5000|Icepharma hf|Roche Registration Limited|Íbandrónsýra||17812||17812|24899|
049395|B01AC0701|Persantin|töflur|100|mg|100|stk|1|glas||B01AC07|01.10.1985||R|||0|0|E|0|BOI|0|0|0|100|DKK|2462|4347|lyfalmen||||100|0|25,0000|Vistor hf|Boehringer Ingelheim|Dípýrídamól||2462||2462|4347|
049551|D01AE1601|Loceryl|lakk|50|mg/ml|5|ml|1|glas||D01AE16|01.10.1992||R|||0|0|0|0|GAN|0|0|1|100|CHF|6854|10355|lyfalmen||||5|0||Icepharma hf|Galderma Nordic AB|Amorolfín||6854||6854|10355|
049561|C10AA0104|Simvastatin (Portfarma)|filmhtfl|10|mg|98|stk|1|ţpakki||C10AA01|01.07.2006||R|||0|0|E|0|POF|0|0|0|100|IKR|1059|2095|lyfalmen|V0108|2095||98|0|32,6667|Portfarma ehf|Portfarma|Simvastatín||816||816|2095|
049579|C10AA0104|Simvastatin (Portfarma)|filmhtfl|20|mg|98|stk|1|ţpakki||C10AA01|01.07.2006||R|||0|0|E|0|POF|0|0|0|100|IKR|1154|2300|lyfalmen|V0109|2300||98|0|65,3400|Portfarma ehf|Portfarma|Simvastatín||966||966|2300|
049597|C10AA0104|Simvastatin (Portfarma)|filmhtfl|40|mg|100|stk|1|ţpakki||C10AA01|01.07.2006||R|||0|0|E|0|POF|0|0|0|100|IKR|1827|3091|lyfalmen|V0110|3091||100|0|133,3333|Portfarma ehf|Portfarma|Simvastatín||1544||1544|3091|
049650|D01BA0201|Lamisil|töflur|250|mg|28|stk|1|ţpakki||D01BA02|01.04.1993||R|||0|0|0|0|NOH|0|0|0|100|IKR|8006|4999|lyfalmen|V0123|4575||28|0|28,0000|Vistor hf|Novartis Healthcare A/S-|Terbínafín||2939||2939|4999|
049678|C09AA0502|Ramil|töflur|5|mg|100|stk|1|ţpakki||C09AA05|01.04.2006||R|||0|0|B|0|ACA|0|0|0|100|XEU|1225|2640|lyfalmen|V0496|2640||100|0|200,0000|Actavis Group hf|Actavis hf|Ramipríl||1214||1214|2640|
049684|D01AE1501|Lamisil|krem|10|mg/g|30|g|1|túpa||D01AE15|01.04.1993||L|||0|0|0|0|NHE|0|0|1|100|DKK|||lyflausa||||30|0||Artasan ehf|Novartis Healthcare A/S-A|Terbínafín||||||
049687|C09AA0502|Ramil|töflur|10|mg|100|stk|1|ţpakki||C09AA05|01.08.2005||R|||0|0|B|0|ACA|0|0|0|100|XEU|2524|3704|lyfalmen||||100|0|400,0000|Actavis Group hf|Actavis hf|Ramipríl||1992||1992|3704|
049834|N02BE0113|Pinex Junior|eţ-stíll|125|mg|10|stk|1|ţpakki||N02BE01|01.12.2011||L|||0|0|0|0|AGT|0|0|1|100|IKR|||lyflausa||||10|0|0,4167|Actavis Group hf|Actavis Group hf|Paracetamól||||||
049845|N02BE0113|Pinex Junior|eţ-stíll|250|mg|10|stk|1|ţpakki||N02BE01|01.12.2011||L|||0|0|0|0|AGT|0|0|1|100|IKR|||lyflausa||||10|0|0,8333|Actavis Group hf|Actavis Group hf|Paracetamól||||||
049856|N02BE0114|Pinex|eţ-stíll|500|mg|10|stk|1|pakki||N02BE01|01.01.2012||L|||0|0|0|0|AGT|0|0|1|100|IKR|||lyfalmen||||10|0|1,6667|Actavis Group hf|Actavis Group hf|Paracetamól|||||1417|
049908|L04AA0601|Cellcept|hylki|250|mg|300|stk|1|ţpakki||L04AA06|01.03.1999||R|||0|1|*|0|ROC|0|0|0|100|DKK|63326|82019|lyfalmen|V0470|77214||300|0|37,5000|Icepharma hf|Roche|Mýcófenólsýra||63326||63326|82019|
050342|L01XE0501|Nexavar|filmhtfl|200|mg|112|stk|1|ţpakki||L01XE05|01.12.2006||R|||0|1|0|1|BAP|0|0|0|100|SEK|576379|725238|lyfsjukr||||112|0||Icepharma hf|Bayer Schering Pharma AG|Sorafeníb||576379||576379|725238|
050438|L04AA2701|Gilenya|hylki|0,5|mg|7|stk|1|ţpakki||L04AA27|01.09.2011||R|||0|1|0|1|NOE|0|0|0|100|DKK|73733|94417|lyfsjukr||||7|0|7,0000|Vistor hf|Novartis Europharm Ltd|Fingolimod||||73733|94417|
050483|A02BC0507|Esomeprazole Portfarma|sţ-tfl|40|mg|56|stk|1|ţpakki||A02BC05|01.11.2011||R|||0|0|0|0|POF|0|0|0|100|XEU|7711|3265|lyfalmen|V0012|3141||56|0|74,6700|Portfarma ehf|Portfarma|Esómeprazól||1671||1671|3265|
050510|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|28|stk|1|ţpakki||A02BC01|01.05.2010||L|||0|0|0|0|AGT|0|0|0|100|IKR|||lyflausa||||28|0|28,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||||||
050605|N03AX1601|Lyrica|hylki|225|mg|14|stk|1|ţpakki||N03AX16|01.04.2007||R|||0|0|0|0|PER|0|0|0|100|DKK|3401|5631|lyfalmen||||14|0|10,5000|Icepharma hf|Pfizer ApS|Pregabalín||3401||3401|5631|
050614|N03AX1601|Lyrica|hylki|225|mg|56|stk|1|ţpakki||N03AX16|01.04.2007||R|||0|0|0|0|PER|0|0|0|100|DKK|13322|19264|lyfalmen||||56|0|42,0000|Icepharma hf|Pfizer ApS|Pregabalín||13322||13322|19264|
050660|C02CA0402|Carduran Retard|forđatfl|4|mg|100|stk|1|ţpakki||C02CA04|01.01.2007||R|||0|0|E|0|PER|0|0|0|100|DKK|5655|5273|lyfalmen|V0042|4752||100|0|100,0000|Icepharma hf|Pfizer ApS|Doxazósín||3139||3139|5273|
050679|A02BC0108|Omeprazol Actavis|sh-hylki|10|mg|100|stk|1|glas||A02BC01|01.09.2010||R|||0|0|0|0|AGT|0|0|0|100|XEU|5006|7126|lyfalmen|V0002|7126||100|0|50,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||4494||4494|7126|
050691|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|100|stk|1|glas||A02BC01|01.09.2010||R|||0|0|E|0|AGT|0|0|0|100|XEU|4811|4802|lyfalmen|V0006|4674||100|0|100,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||2795||2795|4802|
050702|A02BC0108|Omeprazol Actavis|sh-hylki|40|mg|100|stk|1|plglas||A02BC01|01.08.2010||R|||0|0|E|0|AGT|0|0|0|100|XEU|11495|5605|lyfalmen||||100|0|200,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||3382||3382|5605|
051029|N03AG0102|Orfiril|sh-tfl|150|mg|100|stk|1|glas||N03AG01|01.10.1995||R|||0|0|E|0|DEA|0|0|0|100|XEU|1745|3366|lyfalmen||||100|0|10,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||1745||1745|3366|
051076|D05AX5202|Daivobet (D.A.C.)|smyrsli|||60|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.01.2007||R|||0|0|B|0|DAC|0|0|0|100|DKK|7084|8745|lyfalmen||||60|0||D.A.C. ehf|D.A.C. ehf|Kalcípótríól í blöndum||5677||5677|8745|
051110|N03AG0102|Orfiril|sh-tfl|300|mg|100|stk|1|glas||N03AG01|01.10.1995||R|||0|0|E|0|DEA|0|0|0|100|XEU|1803|3445|lyfalmen||||100|0|20,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||1803||1803|3445|
051349|R06AX2602|Nefoxef|filmhtfl|180|mg|30|stk|1|ţpakki||R06AX26|01.07.2008||R|||0|0|E|0|MYL|0|0|1|100|SEK|1450|2607|lyfalmen|V0363|2607||30|0|45,0000|Actavis Group PTC ehf|Mylan AB|Fexófenadín||1190||1190|2607|
051358|R06AX2602|Nefoxef|töflur|180|mg|100|stk|1|ţpakki||R06AX26|01.07.2008||R|||0|0|E|0|MYL|0|0|1|100|SEK|3944|5527|lyfalmen|V0365|5527||100|0|150,0000|Actavis Group PTC ehf|Mylan AB|Fexófenadín||3325||3325|5527|
051550|N03AX1401|Keppra|irţ|100|mg/ml|5|ml|10|hgl||N03AX14|01.02.2007||R|||0|0|0|1|UCB|0|0|0|100|DKK|31168|40998|lyfsjukr||||50|0|3,3300|Vistor hf|U.C.B|Levetíracetam||31168||31168|40998|
051732|C08CA0104|Amlódipín Portfarma|töflur|5|mg|100|stk|1|ţpakki||C08CA01|01.12.2006||R|||0|0|B|0|POF|0|0|0|100|XEU|1614|1801|lyfalmen|V0056|1801||100|0|100,0000|Portfarma ehf|Portfarma|Amlódipín||601||601|1801|
051750|C08CA0104|Amlódipín Portfarma|töflur|10|mg|100|stk|1|ţpakki||C08CA01|01.12.2006||R|||0|0|B|0|POF|0|0|0|100|XEU|2732|2231|lyfalmen|V0057|2231||100|0|200,0000|Portfarma ehf|Portfarma|Amlódipín||915||915|2231|
051761|R03AC0302|Bricanyl Turbuhaler|innönddu|0,5|mg/sk|100|sk|1|stauk||R03AC03|01.07.2012||R|||0|0|B|0|AZD|0|0|1|100|SEK|1001|2348|lyfalmen||||100|0|25,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||1001||1001|2348|
052286|N05BA1205|Alprazolam Mylan|töflur|0,25|mg|20|stk|1|ţpakki||N05BA12|01.10.2009||R|||0|0|0|0|MYL|0|0|0|100|SEK|217|1276|lyfalmen|V0047|1276||20|0|5,0000|Actavis Group PTC ehf|Mylan AB|Alprazólam||217||217|1276|
052297|N05BA1205|Alprazolam Mylan|töflur|0,25|mg|50|stk|1|ţpakki||N05BA12|01.10.2009||R|||0|0|0|0|MYL|0|0|0|100|SEK|512|1679|lyfalmen|V0305|1001||50|0|12,5000|Actavis Group PTC ehf|Mylan AB|Alprazólam||512||512|1679|
052305|L01XE0601|Sprycel|filmhtfl|20|mg|60|stk|1|glas||L01XE06|01.09.2007||R|||0|1|0|1|BSP|0|0|0|100|DKK|352709|444532|lyfsjukr||||60|0||Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Dasatíníb||352709||352709|444532|
052309|N05BA1205|Alprazolam Mylan|töflur|0,5|mg|20|stk|1|ţpakki||N05BA12|01.07.2009||R|||0|0|0|0|MYL|0|0|1|100|SEK|363|1475|lyfalmen|V0439|1475||20|0|10,0000|Actavis Group PTC ehf|Mylan AB|Alprazólam||||363|1475|
052320|N05BA1205|Alprazolam Mylan|töflur|0,5|mg|50|stk|1|ţpakki||N05BA12|01.10.2009||R|||0|0|0|0|MYL|0|0|0|100|SEK|1165|2573|lyfalmen||||50|0|25,0000|Actavis Group PTC ehf|Mylan AB|Alprazólam||1165||1165|2573|
052331|N05BA1205|Alprazolam Mylan|töflur|0,25|mg|100|stk|1|glas||N05BA12|01.08.2009||R|||0|0|0|0|MYL|0|0|0|100|SEK|747|2001|lyfalmen|V0305|2001||100|0|25,0000|Actavis Group PTC ehf|Mylan AB|Alprazólam||747||747|2001|
052333|L01XE0601|Sprycel|filmhtfl|50|mg|60|stk|1|glas||L01XE06|01.09.2007||R|||0|1|0|1|BSP|0|0|0|100|DKK|736809|926578|lyfsjukr||||60|0||Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Dasatíníb||736809||736809|926578|
052360|L01XE0601|Sprycel|filmhtfl|70|mg|60|stk|1|glas||L01XE06|01.09.2007||R|||0|1|0|1|BSP|0|0|0|100|DKK|653046|821455|lyfsjukr||||60|0||Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Dasatíníb||653046||653046|821455|
052405|S01ED5112|Ganfort|augndr|5,3|mg/ml|3|ml|1|glas||S01ED51|01.01.2010||R|||0|0|*|0|ALL|0|0|0|100|SEK|3838|6229|lyfalmen||||3|0|30,0000|Vistor hf|Allergan|Tímólól í blöndum||3838||3838|6229|
052478|D06BB0305|Zovirax (D.A.C.)|krem|50|mg/g|2|g|1|túpa|+sk.dćla|D06BB03|01.03.2007||L|||0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa||||2|0||D.A.C. ehf|D.A.C. ehf|Acíklóvír||||||
052505|B05BA1014|Kabiven|irl|1900|kcal|2053|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|||0|0|0|1|FRP|0|0|0|100|DKK|38146|49756|lyfsjukr||||8212|0||Icepharma hf|Fresenius Kabi|Blöndur||38146||38146|49756|
052515|B05BA1014|Kabiven|irl|2300|kcal|2566|ml|3|pokar||B05BA10|01.03.2007||R|||0|0|0|1|FRP|0|0|0|100|DKK|31010|40800|lyfsjukr||||7698|0||Icepharma hf|Fresenius Kabi|Blöndur||31010||31010|40800|
052524|B05BA1010|Kabiven Peripheral|irl|1400|kcal|1920|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|||0|0|0|1|FRP|0|0|0|100|DKK|32737|42967|lyfsjukr||||7680|0||Icepharma hf|Fresenius Kabi|Blöndur||32737||32737|42967|
052533|B05BA1010|Kabiven Peripheral|irl|1700|kcal|2400|ml|3|pokar|fleyti|B05BA10|01.03.2007||R|||0|0|0|1|FRP|0|0|0|100|DKK|27389|36256|lyfsjukr||||7200|0||Icepharma hf|Fresenius Kabi|Blöndur||27389||27389|36256|
052542|B05BA1015|StructoKabiven|irl|2100|kcal|1970|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|||0|0|0|1|FRP|0|0|0|100|DKK|36834|48109|lyfsjukr||||7880|0||Icepharma hf|Fresenius Kabi|Blöndur||36834||36834|48109|
052560|B05BA1019|StructoKabiven Perifer|irl|1300|kcal|1904|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|||0|0|0|1|FRP|0|0|0|100|DKK|34203|44807|lyfsjukr||||7616|0||Icepharma hf|Fresenius Kabi|Blöndur||34203||34203|44807|
052838|A10BX0701|Victoza|stl|6|mg/ml|3|ml|2|lyfjap|lausn,áfylltur lyfjapenni|A10BX07|01.01.2012||R|||0|0|*|0|NAS|0|0|0|100|DKK|15922|22527|lyfalmen||||6|0|30,0000|Vistor hf|Novo-Nordisk A/S|Liraglútíđ||15922||15922|22527|
052979|J01CF0103|Dicloxacillin Arrow|hylki|250|mg|30|stk|1|ţpakki||J01CF01|01.06.2012||R|||0|0|0|0|PCO|0|0|1|100|DKK|1977|3631|lyfalmen||||30|1|3,7500|Distica|Distica - óskráđ lyf|Díkloxacillín||1939||1939|3631|
053006|N05CF0204|Zolpidem Mylan|filmhtfl|10|mg|100|stk|1|ţpakki||N05CF02|01.11.2006||R|||0|0|0|0|MYL|0|0|0|100|SEK|2423|4117|lyfalmen|V0313|4117||100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Zolpidem||2294||2294|4117|
053025|G03HB0102|Diane mite|töflur|||63|stk|1|ţpakki||G03HB01|01.07.1989||R|||0|0|0|0|BAP|0|0|0|100|SEK|2279|4096|lyfalmen||||63|0|84,0000|Icepharma hf|Bayer Schering Pharma AG|Cýpróterón og östrógen||2279||2279|4096|
053043|J05AE0601|Kaletra|filmhtfl|250|mg|120|stk|1|glös|200+50 mg|J05AE06|01.11.2006||R|||0|1|0|1|ABT|0|0|0|100|DKK|64137|82374|lyfsjukr||||120|0|30,0000|Vistor hf|Abbott Laboratories Ltd|Lopinavír||64137||64137|82374|
053055|C01BA0302|Durbis Retard|forđatfl|250|mg|100|stk|1|ţpakki||C01BA03|01.05.1983||R|||0|0|B|0|SNO|0|0|0|100|NOK|5748|8842|lyfalmen||||100|0|62,5000|Vistor hf|Sanofi-aventis Norge AS|Dísópýramíđ||5748||5748|8842|
053231|J07BB0201|Fluarix|bóluefni|||0,5|ml|10|spr|einnotaspr|J07BB02|01.10.1994||R|||0|0|0|0|GSK|0|0|0|100|GBP|6503|9875|lyfalmen||||5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Inflúensa, hreinsađir  mótefnavakar||6503||6503|9875|
053371|L04AA1301|Arava|töflur|10|mg|100|stk|1|glas||L04AA13|01.11.2000||R|||0|1|*|0|SDE|0|0|0|100|NOK|40565|53454|lyfalmen|V0453|44547||100|0|50,0000|Vistor hf|Sanofi - aventis Deutschland GmbH|Leflúnómíđ||40565||40565|53454|
053413|L04AA1301|Arava|töflur|20|mg|100|stk|1|glas||L04AA13|01.11.2000||R|||0|1|*|0|SDE|0|0|0|100|NOK|34050|45278|lyfalmen|V0454|40155||100|0|100,0000|Vistor hf|Sanofi - aventis Deutschland GmbH|Leflúnómíđ||34050||34050|45278|
053689|N05CF0204|Zolpidem Mylan|filmhtfl|10|mg|20|stk|1|ţpakki||N05CF02|01.11.2006||R|||0|0|0|0|MYL|0|0|1|100|SEK|645|1757|lyfalmen|V0060|1757||20|0|20,0000|Actavis Group PTC ehf|Mylan AB|Zolpidem||569||569|1757|
053905|N02AA0305|Hydromorphone Hydrochloride Inj. USP|stl|20|mg/ml|1|ml|10|lykjur||N02AA03|01.05.2006||R|||1|0|0|0|MAP|0|0|0|100|GBP|16615|23397|lyfalmen||||10|0|50,0000|Icepharma hf|Martindale Pharmaceuticals|Hýdrómorphón||16615||16615|23397|
053932|N05AX1201|Abilify|stl|7,5|mg/ml|1,33|ml|1|hgl||N05AX12|01.01.2010||R|||0|0|0|0|OTS|0|1|0|100|DKK|1595|3161|lyfalmen||||1|0|0,6650|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||1595||1595|3161|
053991|D10AF0101|Dalacin|lausn|10|mg/ml|30|ml|1|glas|Áburđur, lausn|D10AF01|01.07.1985||R|||0|0|0|0|PER|0|0|0|100|DKK|1189|2605|lyfalmen||||30|0||Icepharma hf|Pfizer ApS|Klindamýcín||1189||1189|2605|
054054|R03DC0303|Montelukast Actavis|filmhtfl|10|mg|100|stk|1|ţpakki||R03DC03|01.11.2011||R|||0|0|B|0|AGP|0|0|0|100|XEU|8034|10966|lyfalmen|V0490|10966||100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Montelúkast||7301||7301|10966|
054213|J07AG0101|Act-Hib|bóluefni|34|mcg/hgl|0,5|ml|1|hgl|+ leysir (10+24 mcg)|J07AG01|01.07.1994||R|||0|0|0|0|MEX|0|0|0|100|XEU|2683|4649|lyfalmen||||0|0||Icepharma hf|Aventis Pasteur MSD A/S|Haemophilus influenzae B||2683||2683|4649|
054247|R01AA0503|Nezeril|nefdr|0,25|mg/ml|0,1|ml|20|sk-hyl||R01AA05|01.01.1987||L|||0|0|0|0|GSC|0|0|1|100|IKR|||lyflausa||||2|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline CH AB c/o GSK CH A/S|Oxýmetazólín||||||
054278|D01AE1502|Lamisil Once|húđlausn|1|%|4|g|1|túpa||D01AE15|01.12.2006||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||4|0||Artasan ehf|Novartis Healthcare A/S-A|Terbínafín||||||
054321|J01CA0801|Selexid|filmhtfl|400|mg|15|stk|1|ţpakki||J01CA08|01.04.2012||R|||0|0|0|0|LEP|0|0|1|100|DKK|2812|4826|lyfalmen||||15|0|10,0000|Vistor hf|LEO Pharma A/S|Pívmecillínam||2812||2812|4826|
054332|J01CA0801|Selexid|filmhtfl|400|mg|20|stk|1|ţpakki||J01CA08|01.04.2012||R|||0|0|0|0|LEP|0|0|1|100|DKK|3877|6282|lyfalmen||||20|0|13,3300|Vistor hf|LEO Pharma A/S|Pívmecillínam||3877||3877|6282|
054369|J05AB0402|Copegus|filmhtfl|400|mg|56|stk|1|plglas||J05AB04|01.05.2007||R|||0|1|0|1|ROA|0|0|0|100|DKK|66583|85444|lyfsjukr||||56|0|22,4000|Icepharma hf|Roche A.S.|Ribavirin||66583||66583|85444|
054376|B05AA0113|Albunorm 20%|irl|200|g/líter|100|ml|1|fl|lausn|B05AA01|01.06.2012||R|||0|0|0|1|OCT|0|0|0|100|DKK|10150|14621|lyfsjukr||||100|0||Vistor hf|Octapharma AB|Albúmín||10150||10150|14621|
054403|R01AA0503|Nezeril|nefdr|0,5|mg/ml|0,1|ml|20|sk-hyl||R01AA05|01.01.1987||L|||0|0|0|0|GSC|0|0|1|100|IKR|||lyflausa||||2|0|2,5000|GlaxoSmithKline ehf|GlaxoSmithKline CH AB c/o GSK CH A/S|Oxýmetazólín||||||
054533|N05BB0101|Atarax|mixtúra|2|mg/ml|200|ml|1|glas||N05BB01|01.10.1994||R|||0|0|0|0|UCN|0|0|1|100|SEK|1113|2501|lyfalmen||||200|0|5,3333|Vistor hf|UCB Nordic A/S|Hýdroxýzín||1113||1113|2501|
054552|N06AB0308|Fluoxetin Actavis|lausnart|20|mg|30|stk|1|ţpakki||N06AB03|01.10.2006||R|||0|0|0|0|ACA|0|1|0|100|XEU|1779|3412|lyfalmen||||30|0|30,0000|Actavis Group hf|Actavis hf|Flúoxetín||1779||1779|3412|30.06.2012
054594|QN02AE0101|Vetergesic vet.|stl|300|mcg/ml|10|ml|1|hgl|lausn|QN02AE01|01.10.2010||R|||1|0|0|0|REB|0|0|0|100|DKK|4947|9672|vetalmen||||10|0||Icepharma hf|Reckitt Benckiser Healthcare Ltd.|Buprenorphinhýdróklóríđ||||4947|9672|
054650|QG03DA0202|Veramix, vet.|sk-svamp|60|mg|1|stk|20|stk||QG03DA02|01.12.1978||R|||0|0|0|0|PAL|1|0|0|100|DKK|8011|13975|vetorma||||20|0||Icepharma hf|Pfizer Oy Animal Health|||8011||8011|13975|
055164|S01AX2201|Vigamox|augndr|5|mg/ml|5|ml|1|glas|án rotvarnar|S01AX22|01.08.2010||R|||0|0|0|0|ALA|0|0|1|100|USD|1852|3512|lyfalmen||||5|0||Vistor hf|Alcon Laboratories Ltd.|Moxífloxasín hýdróklóríđ||||1852|3512|
055186|J01FA0103|Ery-Max|sh-hylki|250|mg|20|stk|1|glas||J01FA01|01.01.1986||R|||0|0|0|0|REP|0|0|1|100|SEK|795|2066|lyfalmen||||20|0|5,0000|Vistor hf|Recip AB|Erýtrómýcín||795||795|2066|
055277|N02AA0101|Contalgin|forđatfl|60|mg|100|stk|1|ţpakki||N02AA01|01.10.1995||R|||1|0|E|0|PER|0|0|0|100|DKK|9597|14107|lyfalmen||||100|0|60,0000|Icepharma hf|Pfizer ApS|Morfín||9597||9597|14107|
055481|A02BC0402|Rabeprazol Actavis|sh-tfl|10|mg|56|stk|1|ţpakki||A02BC04|01.06.2011||R|||0|0|E|0|APC|0|0|0|100|XEU|2239|3150|lyfalmen|V0467|3139||56|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||1587||1587|3150|
055749|N07BA0107|Nicotinell Mint|munnstfl|1|mg|36|stk|1|pakki||N07BA01|01.06.2000||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||36|0|1,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
055939|N07BA0107|Nicotinell Mint|munnstfl|1|mg|96|stk|1|pakki||N07BA01|01.06.2000||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||96|0|3,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
056015|C10AA0503|Atacor|filmhtfl|10|mg|100|stk|1|glas||C10AA05|01.06.2006||R|||0|0|E|0|ACA|0|0|0|100|IKR|4539|2527|lyfalmen|V0112|2527||100|0|50,0000|Actavis Group hf|Actavis hf|Atorvastatín||1132||1132|2527|
056024|C10AA0503|Atacor|filmhtfl|20|mg|100|stk|1|glas||C10AA05|01.06.2006||R|||0|0|E|0|ACA|0|0|0|100|IKR|6185|3246|lyfalmen|V0113|3246||100|0|100,0000|Actavis Group hf|Actavis hf|Atorvastatín||1657||1657|3246|
056033|C10AA0503|Atacor|filmhtfl|40|mg|100|stk|1|glas||C10AA05|01.06.2006||R|||0|0|0|0|ACA|0|0|0|100|IKR|7867|6047|lyfalmen|V0114|6047||100|0|200,0000|Actavis Group hf|Actavis hf|Atorvastatín||3705||3705|6047|
056183|B01AC2401|Brilique|filmhtfl|90|mg|100|stk|1|ţpakki||B01AC24|01.06.2011||R|||0|0|E|0|AZA|0|0|0|100|SEK|18647|25947|lyfalmen|V0459|24917||100|0|50,0000|Vistor hf|AstraZeneca AB|Ticagrelor||18647||18647|25947|
056442|QG03DA0401|Prid alpha|sk-innl|1,55|g|10|stk|1|pakki||QG03DA04|01.04.2011||R|||0|0|0|0|CES|1|0|0|100|XEU|28026|48890|vetorma||||10|0||Icepharma hf|Ceva Sante Animale|Prógesterón||28026||28026|48890|
056523|J01FA0103|Ery-Max|sh-hylki|250|mg|40|stk|1|glas||J01FA01|01.01.1986||R|||0|0|0|0|REP|0|0|1|100|SEK|1293|2748|lyfalmen||||40|0|10,0000|Vistor hf|Recip AB|Erýtrómýcín||1293||1293|2748|
056664|N06AX1608|Venlafaxin Actavis|forđahlk|75|mg|100|stk|1|glas|Til skömmtunar|N06AX16|01.10.2011||R|||0|0|B|0|AGP|0|0|0|100|XEU|3864|6265|lyfalmen||||100|0|75,0000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||||3864|6265|
056675|N06AX1608|Venlafaxin Actavis|forđahlk|150|mg|100|stk|1|glas|til skömmtunar|N06AX16|01.10.2011||R|||0|0|B|0|AGP|0|0|0|100|XEU|3864|6265|lyfalmen||||100|0|150,0000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||||3864|6265|
056915|L04AA2301|Tysabri|irţ|300|mg/hgl|15|ml|1|hgl|lausn|L04AA23|01.09.2007||R|||0|1|0|1|EPI|0|0|0|100|XEU|241729|305252|lyfsjukr||||15|0|30,0000|Icepharma hf|Elan Pharma International|Natalizumab||241729||241729|305252|
056961|J05AF0702|Viread (Paranova)|filmhtfl|245|mg|30|stk|1|plglas||J05AF07|01.05.2008||R|||0|1|0|1|POF|0|0|0|100|DKK|60432|77725|lyfsjukr||||30|0|30,0000|Portfarma ehf|Portfarma|Tenófóvír dísóproxíl||60432||60432|77725|
057026|C09DA0601|Atacand Plus|töflur|28,5|mg|28|stk|1|ţpakki|16 + 12,5 mg|C09DA06|01.02.2010||R|||0|0|0|0|AZD|0|0|0|100|SEK|3791|6165|lyfalmen||||28|0|28,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og ţvagrćsilyf||||3791|6165|30.04.2012
057042|C09DA0601|Atacand Plus|töflur|28,5|mg|98|stk|1|ţpakki|16 + 12,5 mg|C09DA06|01.02.2010||R|||0|0|0|0|AZD|0|0|0|100|SEK|11609|5199|lyfalmen|V0095|5199||98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Candesartan og ţvagrćsilyf||3085||3085|5199|
057307|H01CB0201|Sandostatin|stl|200|mcg/ml|5|ml|1|hgl||H01CB02|01.01.1991||R|||0|1|0|1|NOH|0|0|0|100|DKK|12236|17239|lyfsjukr||||5|0|1,4300|Vistor hf|Novartis Healthcare A/S-|Oktreótíđ||12236||12236|17239|
057349|H01CB0201|Sandostatin|stl|100|mcg/ml|1|ml|5|lykjur||H01CB02|01.01.1991||R|||0|1|0|1|NOH|0|0|0|100|DKK|7036|10155|lyfsjukr||||5|0|0,7100|Vistor hf|Novartis Healthcare A/S-|Oktreótíđ||7036||7036|10155|
057367|J06BA0207|Kiovig|irl|100|mg/ml|300|ml|1|hgl|lausn|J06BA02|01.10.2011||R|||0|0|0|1|BAA|0|0|0|100|SEK|247888|312982|lyfsjukr||||300|0||Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í ćđ||247888||247888|312982|
057401|N06DA0404|Galantamine Portfarma|forđahlk|16|mg|84|stk|1|ţpakki||N06DA04|01.12.2011||R|||0|0|E|0|POF|0|0|0|100|SEK|23727|27702|lyfalmen|V0350|27702||84|0|84,0000|Portfarma ehf|Portfarma|Galantamín||20045||20045|27702|
057422|B05XA3102|Tracel|irţ|||10|ml|20|plastl||B05XA31|01.01.1987||R|||0|0|0|1|FRP|0|0|0|100|DKK|5090|7346|lyfsjukr||||200|0||Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum međ öđrum efnum||5090||5090|7346|
057455|H01CB0201|Sandostatin|stl|50|mcg/ml|1|ml|5|lykjur||H01CB02|01.01.1991||R|||0|1|0|1|NOH|0|0|0|100|DKK|3879|5598|lyfsjukr||||5|0|0,3600|Vistor hf|Novartis Healthcare A/S-|Oktreótíđ||3879||3879|5598|
057492|L01XC1001|Arzerra|irţ|20|mg/ml|50|ml|1|hgl|1000 mg pr. hgl.|L01XC10|01.03.2012||R|||0|1|0|1|GGL|0|0|0|100|GBP|378939|477451|lyfsjukr||||50|0||GlaxoSmithKline ehf|Glaxo Group Limited|Ofatúmúmabi||378939||378939|477451|
057556|L02BX0301|Zytiga|töflur|250|mg|120|stk|1|glas||L02BX03|01.12.2011||R|||0|1|0|1|JAS|0|0|0|100|SEK|555779|699385|lyfsjukr||||120|0||Vistor hf|Janssen-Cilag AB|Abírateron||555779||555779|699385|
057703|J01DD0401|Rocephalin|irţ|2|g|5|hgl|1|pakki|lausn|J01DD04|01.10.1985||R|||0|0|0|1|ROC|0|0|0|100|DKK|25791|34250|lyfsjukr||||5|0|5,0000|Icepharma hf|Roche|Ceftríaxón||25791||25791|34250|
058014|N07BA0301|Champix|filmhtfl|1|mg|112|stk|1|ţpakki||N07BA03|01.03.2009||R|||0|0|0|0|IPI|0|0|1|100|DKK|20995|28894|lyfalmen||||112|0|56,0000|Icepharma hf|Pfizer Limited|Vareniclin||||20995|28894|
058164|A03BB0101|Buscopan|stl|20|mg/ml|1|ml|5|lykjur||A03BB01|01.10.1995||R|||0|0|E|0|BOI|0|0|0|100|DKK|444|1586|lyfalmen||||5|0|1,6667|Vistor hf|Boehringer Ingelheim|Bútýlskópólamín||444||444|1586|
058272|L01XE1101|Votrient|filmhtfl|200|mg|30|stk|1|glas||L01XE11|01.02.2011||R|||0|1|0|1|GGL|0|0|0|100|GBP|137087|173927|lyfsjukr||||30|0||GlaxoSmithKline ehf|Glaxo Group Limited|Pazópaníb||137087||137087|173927|
058283|QI01AD040|Avipro Thymovac|frţlyf|||500|sk|10|pakkar||QI01AD04|01.07.2009||R|||0|0|0|0|LOH|0|0|0|100|XEU|168379|293729|vetorma||||5000|0||Icepharma hf|Lohmann Animal Health|||||168379|293729|
058294|QI01AD040|Avipro Thymovac|frţlyf|||1000|sk|10|pakkar||QI01AD04|01.07.2009||R|||0|0|0|0|LOH|0|0|0|100|XEU|255784|446202|vetorma||||10000|0||Icepharma hf|Lohmann Animal Health|||||255784|446202|
058397|J07BM0101|Gardasil|stl|||0,5|ml|1|áf.spr|dreifa|J07BM01|01.01.2007||R|||0|0|0|0|SPM|0|0|0|100|XEU|18080|25236|lyfalmen||||0|0||Icepharma hf|Sanofi Pasteur MSD|Papillomavírus (manna gerđ 6, 11, 16, 18)||18080||18080|25236|
058503|J01EA0107|Trimetoprim Meda|mixtúra|10|mg/ml|100|ml|1|fl|dreifa|J01EA01|01.01.2004||R|||0|0|0|0|REP|0|0|1|100|SEK|1046|2410|lyfalmen||||100|0|2,5000|Vistor hf|Recip AB|Trímetóprím||1046||1046|2410|
058506|J05AF1001|Baraclude|mixtúra|0,05|mg/ml|210|ml|1|fl||J05AF10|01.09.2007||R|||0|1|0|1|BSP|0|0|0|100|DKK|104407|132913|lyfsjukr||||210|0|21,0000|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Entecavír||104407||104407|132913|
058609|N05AX1302|Xeplion|stl|50|mg|1|stk|1|áf.spr|forđadreifa|N05AX13|01.04.2012||R|||0|0|0|0|JCI|0|1|0|100|SEK|42457|55829|lyfalmen||||1|0|20,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||42457||42457|55829|
058735|C03CA0105|Lasix Retard|forđahlk|30|mg|100|stk|1|ţpakki||C03CA01|01.10.1995||R|||0|0|E|0|SNO|0|0|0|100|NOK|1298|2754|lyfalmen||||100|0|75,0000|Vistor hf|Sanofi-aventis Norge AS|Fúrósemíđ||1298||1298|2754|
058768|C03CA0105|Lasix Retard|forđahlk|60|mg|100|stk|1|ţpakki||C03CA01|01.10.1995||R|||0|0|E|0|SNO|0|0|0|100|NOK|2421|4291|lyfalmen||||100|0|150,0000|Vistor hf|Sanofi-aventis Norge AS|Fúrósemíđ||2421||2421|4291|
058958|J07CA0601|Infanrix-Polio + Hib|bóluefni|||0,5|ml|1|dćla|einnota dćla|J07CA06|01.03.1999||R|||0|0|0|0|GSK|0|0|0|100|GBP|4600|7271|lyfalmen||||0|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|barnaveiki, haemophilus influenza B, kíghósti, mćnusótt, stí||4600||4600|7271|
059070|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|56|stk|1|ţpakki||A02BC01|01.05.2011||R|||0|0|E|0|AGT|0|0|0|100|XEU|2576|3150|lyfalmen|V0006|2617||56|0|56,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||1587||1587|3150|
059204|C01DA0801|Sorbangil|töflur|5|mg|250|stk|1|plglas||C01DA08|01.04.2004||R|||0|0|B|0|REP|0|0|0|100|SEK|1540|3086|lyfalmen||||250|0|20,8300|Vistor hf|Recip AB|Ísósorbíđ dínítrat||1540||1540|3086|
059295|S01AA0104|Kloramfenikol - Lyfjaver|augnsm|1|%|5|g|1|túpa||S01AA01|01.06.2012||R|||0|0|E|0|LAL|0|0|1|100|IKR|2297|4121|lyfalmen||||5|1||Lyfjaver ehf|Lyfjaver ehf|Klóramfeníkól||2297||2297|4121|
059569|L02AE0203|Eligard|sts|45|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.05.2008||R|||0|1|*|0|ASP|0|0|0|100|XEU|103048|131870|lyfalmen||||2|0|311,1900|Vistor hf|Astellas Pharma A/S|Leuprórelín||103048||103048|131870|
059659|J07CA0601|Infanrix-Polio + Hib|bóluefni|||0,5|ml|10|spr||J07CA06|01.01.2007||R|||0|0|0|0|GSK|0|0|0|100|GBP|35122|46623|lyfalmen||||5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|barnaveiki, haemophilus influenza B, kíghósti, mćnusótt, stí||35122||35122|46623|
059687|J05AR0302|Truvada (Paranova)|filmhtfl|445|mg|30|stk|1|plglas|200+245 mg|J05AR03|01.05.2008||R|||0|1|0|1|POF|0|0|0|100|DKK|94289|120215|lyfsjukr||||30|0|30,0000|Portfarma ehf|Portfarma|Tenófóvír dísóproxíl og emtrícítabín||94289||94289|120215|
059767|N03AF0401|Zebinix|töflur|800|mg|30|stk|1|ţpakki||N03AF04|01.03.2010||R|||0|0|E|0|BPC|0|0|0|100|SEK|41464|47795|lyfalmen||||30|0|30,0000|Vistor hf|Bial-Portela & C.S.A.|Eslícarbazepín||36056||36056|47795|
059870|L04AD0201|Advagraf|forđahlk|3|mg|50|stk|1|ţpakki||L04AD02|01.11.2010||R|||0|1|*|0|APE|0|0|0|100|XEU|57148|74266|lyfalmen||||50|0|30,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||57148||57148|74266|
060560|V03AC0301|Exjade|dreifit.|500|mg|84|stk|1|ţpakki||V03AC03|01.03.2007||R|||0|1|0|0|NOE|0|0|0|100|DKK|392149|494692|lyfalmen||||84|0||Vistor hf|Novartis Europharm Ltd|Deferasírox||392149||392149|494692|
060569|V03AC0301|Exjade|dreifit.|250|mg|84|stk|1|ţpakki||V03AC03|01.03.2007||R|||0|1|0|0|NOE|0|0|0|100|DKK|196091|248639|lyfalmen||||84|0||Vistor hf|Novartis Europharm Ltd|Deferasírox||196091||196091|248639|
060848|N06AA0402|Anafranil Retard|forđatfl|75|mg|100|stk|1|ţpakki||N06AA04|01.10.1989||R|||0|0|B|0|NOH|0|1|0|100|DKK|5867|9005|lyfalmen||||100|0|75,0000|Vistor hf|Novartis Healthcare A/S-|Klómípramín||5867||5867|9005|
061414|QA04AD901|Cerenia|töflur|60|mg|4|stk|1|ţpakki||QA04AD90|01.02.2009||R|||0|0|0|0|PFA|0|0|0|100|DKK|2859|5662|vetalmen||||4|0||Icepharma hf|Pfizer Animal Health|||||2859|5662|
061442|QA04AD901|Cerenia|töflur|24|mg|4|stk|1|ţpakki||QA04AD90|01.02.2009||R|||0|0|0|0|PFA|0|0|0|100|DKK|1498|2980|vetalmen||||4|0||Icepharma hf|Pfizer Animal Health|||||1498|2980|
061451|QA04AD901|Cerenia|stl|10|mg/ml|20|ml|1|hgl|lausn|QA04AD90|01.02.2009||R|||0|0|0|0|PFA|1|0|0|100|DKK|8850|17166|vetalmen||||20|0||Icepharma hf|Pfizer Animal Health|||||8850|17166|
061460|G03CX0102|Livial (D.A.C.)|töflur|2,5|mg|84|stk|1|ţpakki||G03CX01|01.04.2010||R|||0|0|E|0|DAC|0|0|0|100|DKK|7269|10923|lyfalmen|V0133|10923||84|0|84,0000|D.A.C. ehf|D.A.C. ehf|Tíbólón||7269||7269|10923|
061465|M02AA0701|Felden gel|hlaup|5|mg/g|50|g|1|glas||M02AA07|01.04.1996||L|||0|0|0|0|PER|0|0|1|100|IKR|||lyflausa||||50|0||Icepharma hf|Pfizer ApS|Píroxíkam||||||
061481|G03CX0101|Livial|töflur|2,5|mg|84|stk|1|ţpakki||G03CX01|01.07.1998||R|||0|0|E|0|ORG|0|0|0|100|DKK|7270|10924|lyfalmen|V0133|10923||84|0|84,0000|Vistor hf|N.V. Organon|Tíbólón||7270||7270|10924|
061580|QP52AF0201|Banminth, vet.|pasta|11,4|g/skdćla|26|g|1|spr||QP52AF02|01.04.1992||L|||0|0|0|0|PAL|0|0|0|100|DKK|1771|3089|vetorma||||26|0||Icepharma hf|Pfizer Oy Animal Health|||||1771|3089|
061715|L01XE0901|Torisel|irţ|25|mg/ml|1|hgl|1|pakki||L01XE09|01.05.2008||R|||0|1|0|1|WTE|0|0|0|100|DKK|166392|210704|lyfsjukr||||1|0||Icepharma hf|Wyeth Europe|Temsirolímus||166392||166392|210704|
061937|L04AD0101|Sandimmun|irţ|50|mg/ml|1|ml|10|lykjur||L04AD01|01.10.1985||R|||0|0|0|1|NOH|0|0|0|100|DKK|4619|6666|lyfsjukr||||10|0|2,0000|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||4619||4619|6666|
061961|J01XX0901|Cubicin|sts/irs|350|mg|1|hgl|1|pakki|lausn|J01XX09|01.04.2007||R|||0|1|0|1|NOE|0|0|0|100|DKK|16495|22584|lyfsjukr||||1|0|1,2500|Vistor hf|Novartis Europharm Ltd|Daptomýcín||16495||16495|22584|
061970|J01XX0901|Cubicin|sts/irs|500|mg|1|hgl|1|pakki|lausn|J01XX09|01.04.2007||R|||0|1|0|1|NOE|0|0|0|100|DKK|23223|31027|lyfsjukr||||1|0|1,7900|Vistor hf|Novartis Europharm Ltd|Daptomýcín||23223||23223|31027|
062117|N05BA1204|Tafil Retard|forđatfl|0,5|mg|30|stk|1|ţpakki||N05BA12|01.04.1996||R|||0|0|0|0|PER|0|0|1|100|DKK|477|1631|lyfalmen||||30|0|15,0000|Icepharma hf|Pfizer ApS|Alprazólam||477||477|1631|
062341|L04AA0604|Mykofenolatmofetil Actavis|filmhtfl|500|mg|150|stk|1|ţpakki||L04AA06|01.08.2010||R|||0|1|*|0|AGP|0|0|0|100|XEU|61897|44261|lyfalmen|V0187|44261||150|0|37,5000|Actavis Group hf|Actavis Group PTC ehf|Mýcófenólsýra||33240||33240|44261|
062387|N04BC0502|Sifrol|forđatfl|0,26|mg|10|stk|1|pakki||N04BC05|01.02.2010||R|||0|0|E|0|BII|0|0|0|100|DKK|1716|3326|lyfalmen||||10|0|1,0400|Vistor hf|Boehringer Ingelheim International|Pramipexól||1716||1716|3326|
062638|L01BA0105|Methotrexate Wyeth Lederle|stl/irl|25|mg/ml|20|ml|1|hgl||L01BA01|01.10.1985||R|||0|1|0|1|PER|0|0|0|100|DKK|6923|9992|lyfsjukr||||20|0||Icepharma hf|Pfizer ApS|Metótrexat||6923||6923|9992|
062661|L01BA0105|Methotrexate Wyeth Lederle|stl/irl|25|mg/ml|1|ml|1|hgl||L01BA01|01.10.1985||R|||0|1|0|1|PER|0|0|0|100|DKK|472|681|lyfsjukr||||1|0||Icepharma hf|Pfizer ApS|Metótrexat||472||472|681|
062704|R02AA0305|Strepsils Cool|sogtfl|||36|stk|1|ţpakki||R02AA03|01.09.2010||L|||0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa||||36|0|6,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól||||||
062729|N05BA1204|Tafil Retard|forđatfl|0,5|mg|60|stk|1|ţpakki||N05BA12|01.04.1996||R|||0|0|0|0|PER|0|0|0|100|DKK|964|2298|lyfalmen||||60|0|30,0000|Icepharma hf|Pfizer ApS|Alprazólam||964||964|2298|
062737|B03BA0102|Betolvex|töflur|1|mg|100|stk|1|glas||B03BA01|01.03.2008||R|||0|0|E|0|AGT|0|0|1|100|XEU|1919|3604|lyfalmen||||100|0|100,0000|Actavis Group hf|Actavis Group hf|Cyanocobalamin||1919||1919|3604|
062745|QP53AF0102|Sebacil vet.|húđlausn|500|mg/ml|1000|ml|1|fl||QP53AF01|01.05.2005||R|||0|0|0|0|BAN|0|0|0|100|DKK|18731|32675|vetorma||||1000|0||Icepharma hf|Bayer Animal Health GmbH|||18731||18731|32675|
062761|L03AA0202|Zarzio|stl/irl|30|millj ae|0,5|ml|5|áf.spr|lausn|L03AA02|01.04.2011||R|||0|1|0|1|SAR|0|0|0|100|SEK|40953|53279|lyfsjukr||||2|0|4,2900|Artasan ehf|Sandoz GmbH (A)|Fílgrastím||40953||40953|53279|
062772|L03AA0202|Zarzio|stl/irl|48|millj ae|0,5|ml|5|áf.spr|lausn|L03AA02|01.04.2011||R|||0|1|0|1|SAR|0|0|0|100|SEK|50001|64634|lyfsjukr||||2|0|6,8600|Artasan ehf|Sandoz GmbH (A)|Fílgrastím||50001||50001|64634|
062987|J07BM0201|Cervarix|stl|||0,5|ml|1|áf.spr|dreifa|J07BM02|01.11.2007||R|||0|0|0|0|GLB|0|0|0|100|GBP|17411|17170|lyfalmen||||0|0||GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|Papillomavírus (manna gerđ 16, 18)||11836||11836|17170|
063057|J05AB0901|Famvir|töflur|125|mg|10|stk|1|ţpakki||J05AB09|01.10.1995||R|||0|0|E|0|NOH|0|0|1|100|DKK|4379|6969|lyfalmen||||10|0|1,6667|Vistor hf|Novartis Healthcare A/S-|Famcíclóvír||4379||4379|6969|
063661|A06AD1107|Medilax|mixtúra|667|mg/ml|500|ml|1|plastf||A06AD11|01.06.2007||L|||0|0|0|0|MET|0|0|0|100|DKK|||lyfalmen||||500|0|49,7761|Vistor hf|Medic Team|Laktúlósa|||||3027|
063697|D01BA0203|Terbinafin Actavis|töflur|250|mg|28|stk|1|ţpakki||D01BA02|01.11.2006||R|||0|0|0|0|ACA|0|0|0|100|XEU|2632|4577|lyfalmen|V0123|4575||28|0|28,0000|Actavis Group hf|Actavis hf|Terbínafín||2630||2630|4577|
063715|R06AX2702|Aerius (D.A.C.)|töflur|5|mg|100|stk|1|ţpakki||R06AX27|01.07.2011||R|||0|0|E|0|DAC|0|0|1|100|XEU|4695|6437|lyfalmen|V0458|6437||100|0|100,0000|D.A.C. ehf|D.A.C. ehf|Deslóratadín||3990||3990|6437|
063818|J06BB0102|Rhesonativ|stl|625|ae/ml|2|ml|1|lykja||J06BB01|01.05.2008||R|||0|0|0|1|OCT|0|0|0|100|DKK|8094|11682|lyfsjukr||||2|0||Vistor hf|Octapharma AB|And-D(rh) immúnóglóbúlín||8094||8094|11682|
063923|QP54AB5207|Equest Pramox vet|hlaup|||11,8|g|1|sk-dćl|19,5mg/g+121,7mg/g|QP54AB52|01.12.2006||R|||0|0|0|0|PAS|0|0|0|100|XEU|2631|4590|vetorma||||12|0||Vistor hf|Pfizer Oy Animal Health|||2631||2631|4590|
063941|N05BA1204|Tafil Retard|forđatfl|1|mg|30|stk|1|ţpakki||N05BA12|01.04.1996||R|||0|0|0|0|PER|0|0|1|100|DKK|1012|2363|lyfalmen||||30|0|30,0000|Icepharma hf|Pfizer ApS|Alprazólam||1012||1012|2363|
063958|N05BA1204|Tafil Retard|forđatfl|1|mg|60|stk|1|ţpakki||N05BA12|01.04.1996||R|||0|0|0|0|PER|0|0|0|100|DKK|2120|3879|lyfalmen||||60|0|60,0000|Icepharma hf|Pfizer ApS|Alprazólam||2120||2120|3879|
064069|B01AC2101|Remodulin|irl|2,5|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|||0|1|0|1|UTE|0|0|0|100|XEU|1125946|1414945|lyfsjukr||||20|0|11,6300|Icepharma hf|United Therapeutics Europe Ltd.|Treprostiníl natríum||||1125946|1414945|
064106|B01AC2101|Remodulin|irl|1|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|||0|1|0|1|UTE|0|0|0|100|XEU|450378|567107|lyfsjukr||||20|0|4,6500|Icepharma hf|United Therapeutics Europe Ltd.|Treprostiníl natríum||||450378|567107|
064170|N05BA1204|Tafil Retard|forđatfl|2|mg|30|stk|1|ţpakki||N05BA12|01.04.1996||R|||0|0|0|0|PER|0|0|1|100|DKK|2226|4024|lyfalmen||||30|0|60,0000|Icepharma hf|Pfizer ApS|Alprazólam||2226||2226|4024|
064224|B01AC2101|Remodulin|irl|10|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|||0|1|0|1|UTE|0|0|0|100|XEU|4503784|5654131|lyfsjukr||||20|0|46,5100|Icepharma hf|United Therapeutics Europe Ltd.|Treprostiníl natríum||||4503784|5654131|
064233|B01AC2101|Remodulin|irl|5|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|||0|1|0|1|UTE|0|0|0|100|XEU|2251893|2828008|lyfsjukr||||20|0|23,2600|Icepharma hf|United Therapeutics Europe Ltd.|Treprostiníl natríum||||2251893|2828008|
064732|A03BB0101|Buscopan|húđuđtfl|10|mg|100|stk|1|ţpakki||A03BB01|01.03.2012||R|||0|0|E|0|BOI|0|0|0|100|DKK|2185|3968|lyfalmen||||100|0|16,6700|Vistor hf|Boehringer Ingelheim|Bútýlskópólamín||2185||2185|3968|
064733|J07BB0203|Vaxigrip|bóluefni|||0,5|ml|1|spr|einnotaspr|J07BB02|01.10.1985||R|||0|0|0|0|SPM|0|0|0|100|XEU|854|2147|lyfalmen||||0|0||Icepharma hf|Sanofi Pasteur MSD|Inflúensa, hreinsađir  mótefnavakar||854||854|2147|
064742|B02BD0101|Octaplex|irs|500|ae|1|hgl|1|pakki|+leysir,lausn|B02BD01|01.12.2011||R|||0|0|0|1|OCT|0|0|0|100|DKK|60889|78298|lyfsjukr||||1|0|1,4300|Vistor hf|Octapharma AB|Storkuţćttir lX,ll,Vll,X||60889||60889|78298|
065032|D10AF5101|Duac|hlaup|||25|g|1|túpa|50 mg/g + 10 mg/g|D10AF51|01.01.2007||R|||0|0|0|0|SLL|0|0|0|100|DKK|2031|3757|lyfalmen||||25|0||Vistor hf|Stiefel Laboratories (Ireland) Ltd.|Klindamýcín í blöndum||2031||2031|3757|
065314|G01AF0201|Canesten|sk-tfl|100|mg|6|stk|1|pakki|+stjaka|G01AF02|01.12.1982||L|||0|0|0|0|BAE|0|0|0|100|IKR|||lyflausa||||6|0|6,0000|Icepharma hf|Bayer AB|Klótrímazól||||||
065332|G01AF0201|Canesten|sk-tfl|500|mg|1|stk|1|pakki|+stjaka|G01AF02|01.04.1985||L|||0|0|0|0|BAE|0|0|0|100|IKR|||lyflausa||||1|0|5,0000|Icepharma hf|Bayer AB|Klótrímazól||||||
065441|V08AB0901|Visipaque|stl|320|mg J/ml|20|ml|10|glhgl||V08AB09|01.12.2009||R|||0|0|0|1|GEH|0|0|0|100|NOK|15947|21896|lyfsjukr||||200|0||Icepharma hf|GE Healthcare AS|Jódixanól||15947||15947|21896|
065706|S01EE0101|Xalatan|augndr|50|mcg/sk|2,5|ml|1|glas||S01EE01|01.10.1999||R|||0|0|*|0|PER|0|0|0|100|DKK|2604|3835|lyfalmen|V0376|2211||2|0|25,0000|Icepharma hf|Pfizer ApS|Latanóprost||2088||2088|3835|
065711|L02AE0306|Zoladex (Lyfjaver)|vefjalyf|10,8|mg|1|stk|1|áf.spr|+ dćla|L02AE03|01.06.2011||R|||0|1|*|0|LVR|0|0|0|100|SEK|61893|77809|lyfalmen|V0451|77809||1|0|83,7209|Lyfjaver ehf|Lyfjaver ehf|Góserelín||59971||59971|77809|
065722|S01EE0101|Xalatan|augndr|50|mcg/ml|7,5|ml|1|pakki|3 glös í pakka|S01EE01|01.05.2009||R|||0|0|*|0|PER|0|0|0|100|DKK|7805|11188|lyfalmen|V0376|6634||8|0|75,0000|Icepharma hf|Pfizer ApS|Latanóprost||7463||7463|11188|
065729|N07BA0142|Nicorette Invisi|forđapl|15|mg/16kls|14|stk|1|ţpakki||N07BA01|01.03.2010||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||14|0|15,0000|Vistor hf|McNeil Denmark ApS|Nikótín||||||
065740|N07BA0142|Nicorette Invisi|forđapl|15|mg/16kls|7|stk|1|ţpakki||N07BA01|01.03.2010||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||7|0|7,5000|Vistor hf|McNeil Denmark ApS|Nikótín||||||
065752|N07BA0142|Nicorette Invisi|forđapl|10|mg/16kls|14|stk|1|ţpakki||N07BA01|01.03.2010||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||14|0|10,0000|Vistor hf|McNeil Denmark ApS|Nikótín||||||
065775|N07BA0142|Nicorette Invisi|forđapl|25|mg/16kls|14|stk|1|ţpakki||N07BA01|01.03.2010||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||14|0|25,0000|Vistor hf|McNeil Denmark ApS|Nikótín||||||
065786|N07BA0142|Nicorette Invisi|forđapl|25|mg/16kls|7|stk|1|ţpakki||N07BA01|01.03.2010||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||7|0|12,5000|Vistor hf|McNeil Denmark ApS|Nikótín||||||
065870|V08AB0201|Omnipaque|stl|180|mg J/ml|10|ml|10|glhgl||V08AB02|01.12.2009||R|||0|0|0|1|GEH|0|0|0|100|NOK|4945|7137|lyfsjukr||||100|0||Icepharma hf|GE Healthcare AS|Jóhexól||4945||4945|7137|
066195|QM01AC0605|Melovem|stl|5|mg/ml|100|ml|1|hgl||QM01AC06|01.08.2011||R|||0|0|0|0|DOR|1|0|0|100|DKK|4248|8329|vetalmen||||100|0||Icepharma hf|Dopharma Reserch B.V|||4248||4248|8329|
066278|R03BB0403|Spiriva Respimat|innöndl|2,5|mcg/sk|60|skammtar|1|pakki|lausn|R03BB04|01.04.2008||R|||0|0|0|0|BII|0|0|0|100|DKK|6950|10486|lyfalmen||||60|0|30,0000|Vistor hf|Boehringer Ingelheim International |Tíótrópíumbrómíđ||6950||6950|10486|
066287|B05AA0704|Voluven|irl|60|mg/ml|500|ml|20|pokar|Freeflex umbúđir|B05AA07|01.05.2008||R|||0|0|0|1|FRP|0|0|0|100|DKK|34238|44851|lyfsjukr||||10000|0||Icepharma hf|Fresenius Kabi|Hýdróxyetýl sterkja||34238||34238|44851|
066399|N07BA0106|Nicotinell|forđapl|7|mg/sólh|21|stk|1|pakki||N07BA01|01.04.1992||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||21|0|10,5000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
066407|N07BA0106|Nicotinell|forđapl|14|mg/sólh|21|stk|1|pakki||N07BA01|01.04.1992||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||21|0|21,0000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
066411|A01AA0101|Duraphat|tannpast|5|mg/ml|51|g|1|túpa||A01AA01|01.04.2011||R|||0|0|0|0|GOG|0|0|1|100|DKK|881|2184|lyfalmen||||51|0||Icepharma hf|Colgate Palmolive A/S|Natríumflúoríđ||881||881|2184|
066423|N07BA0106|Nicotinell|forđapl|21|mg/sólh|21|stk|1|pakki||N07BA01|01.04.1992||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||21|0|31,5000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
066688|V08AB0201|Omnipaque|stl|240|mg J/ml|20|ml|6|glerfl||V08AB02|01.12.1983||R|||0|0|0|1|GEH|0|0|0|100|IKR|4575|6603|lyfsjukr||||120|0||Icepharma hf|GE Healthcare AS|Jóhexól||4575||4575|6603|
066751|C01BD0103|Cordarone (D.A.C.)|töflur|100|mg|30|stk|1|ţpakki||C01BD01|01.11.2006||R|||0|0|B|0|DAC|0|0|0|100|NOK|1577|3136|lyfalmen|V0036|3136||30|0|15,0000|D.A.C. ehf|D.A.C. ehf|Amíódarón||1577||1577|3136|
066862|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|14|stk|1|ţpakki||A02BC01|01.05.2010||L|||0|0|0|0|AGT|0|0|0|100|IKR|||lyflausa||||14|0|14,0000|Actavis Group hf|Actavis Group hf|Ómeprazól||||||
066897|L01CD0104|Paclitaxel Actavis|irţ|6|mg/ml|50|ml|1|hgl|lausn|L01CD01|01.06.2010||R|||0|1|0|1|AGP|0|0|0|100|XEU|15869|21798|lyfsjukr||||50|0||Actavis Group hf|Actavis Group PTC ehf|Paklítaxel||15869||15869|21798|
067001|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|100|ml|50|pokar|Freeflex umbúđir|B05BA03|01.12.2011||R|||0|0|0|1|FRP|0|0|0|100|DKK|8983|12965|lyfsjukr||||5000|0||Icepharma hf|Fresenius Kabi|Kolvetni||8983||8983|12965|
067587|N05BB0101|Atarax|töflur|25|mg|100|stk|1|ţpakki||N05BB01|01.07.1994||R|||0|0|0|0|UCN|0|0|0|100|SEK|1484|3009|lyfalmen||||100|0|33,3333|Vistor hf|UCB Nordic A/S|Hýdroxýzín||1484||1484|3009|
067748|S01EE0104|Latanoprost Actavis|augndr|50|mcg/ml|2,5|ml|1|glas||S01EE01|01.09.2010||R|||0|0|*|0|APC|0|0|0|100|DKK|1929|2618|lyfalmen|V0376|2211||2|0|25,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Latanóprost||1198||1198|2618|
067751|J02AC0102|Candizol|hylki|50|mg|7|stk|1|glas||J02AC01|01.12.1998||R|||0|0|0|0|ACA|0|0|1|100|IKR|1567|2842|lyfalmen|V0179|1824||7|0|1,7500|Actavis Group hf|Actavis hf|Flúkónazól||1362||1362|2842|
067769|J02AC0102|Candizol|hylki|50|mg|30|stk|1|glas||J02AC01|01.12.1998||R|||0|0|0|0|ACA|0|0|1|100|IKR|5748|7816|lyfalmen|V0179|7816||30|0|7,5000|Actavis Group hf|Actavis hf|Flúkónazól||4998||4998|7816|
067785|J02AC0102|Candizol|hylki|150|mg|1|stk|1|glas||J02AC01|01.12.1998||R|||0|0|0|0|ACA|0|0|1|100|IKR|664|1768|lyfalmen|V0180|875||1|0|0,7500|Actavis Group hf|Actavis hf|Flúkónazól||577||577|1768|
067793|J02AC0102|Candizol|hylki|150|mg|2|stk|1|glas||J02AC01|01.12.1998||R|||0|0|0|0|ACA|0|0|1|100|IKR|612|1749|lyfalmen|V0180|1749||2|0|1,5000|Actavis Group hf|Actavis hf|Flúkónazól||563||563|1749|
067801|J02AC0102|Candizol|hylki|150|mg|4|stk|1|glas||J02AC01|01.12.1998||R|||0|0|0|0|ACA|0|0|1|100|IKR|2031|3757|lyfalmen|V0180|3498||4|0|3,0000|Actavis Group hf|Actavis hf|Flúkónazól||2031||2031|3757|
067827|J02AC0102|Candizol|hylki|200|mg|30|stk|1|glas||J02AC01|01.12.1998||R|||0|0|0|0|ACA|0|0|1|100|IKR|14199|13974|lyfalmen|V0419|13974||30|0|30,0000|Actavis Group hf|Actavis hf|Flúkónazól||9500||9500|13974|
068043|R01AA0704|Otrivin ukonserveret|nefúđi|1|mg/ml|10|ml|2|glas|sk-úđari|R01AA07|01.02.2010||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||20|0|25,0000|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín||||||
068312|QN01AX0302|Narketan, vet.|stl|100|mg/ml|50|ml|1|hgl||QN01AX03|01.01.1991||R|||1|0|0|0|VEQ|1|0|0|100|XEU|6331|12329|vetalmen||||50|0||Icepharma hf|Vétoquinol AG|||6331||6331|12329|
068358|L01XC1001|Arzerra|irţ|20|mg/ml|5|ml|3|hgl|100 mg pr. hgl.|L01XC10|01.03.2012||R|||0|1|0|1|GGL|0|0|0|100|GBP|113682|144553|lyfsjukr||||15|0||GlaxoSmithKline ehf|Glaxo Group Limited|Ofatúmúmabi||113682||113682|144553|
068381|B02BX0501|Revolade|filmhtfl|25|mg|14|stk|1|ţpakki||B02BX05|01.04.2011||R|||0|1|0|1|GTS|0|0|0|100|GBP|83626|106833|lyfsjukr||||14|0|7,0000|GlaxoSmithKline ehf|GlaxoSmithKline Trading Services Ltd.|Eltrombópag||83626||83626|106833|
068437|C01BC0401|Tambocor|töflur|100|mg|20|stk|1|ţpakki||C01BC04|01.04.1987||R|||0|1|B|0|MEB|0|0|0|100|SEK|1817|3464|lyfalmen||||20|0|10,0000|Vistor hf|Meda AB (V)|Flekaíníđ||1817||1817|3464|
068445|C01BC0401|Tambocor|töflur|100|mg|100|stk|1|ţpakki||C01BC04|01.04.1987||R|||0|1|B|0|MEB|0|0|0|100|SEK|6017|9210|lyfalmen||||100|0|50,0000|Vistor hf|Meda AB (V)|Flekaíníđ||6017||6017|9210|
068698|N06DA0206|Donepezil Medical|filmhtfl|10|mg|98|stk|1|ţpakki||N06DA02|01.04.2012||R|||0|0|E|0|MED|0|0|0|100|XEU|27476|18706|lyfalmen|V0342|18706||98|0|130,6600|Medical ehf|Medical ehf|Dónepezíl||12877||12877|18706|
068896|B05XA0303|Natriumklorid B.Braun|irţ|1|mmol/ml|20|ml|20|plastl||B05XA03|01.09.2010||R|||0|0|0|1|BRA|0|0|0|100|XEU|2608|3764|lyfsjukr||||400|0||Actavis Group hf|Braun|Natríumklóríđ||2608||2608|3764|
068905|B05XA0103|Kaliumklorid B.Braun|irţ|1|mmol/ml|20|ml|20|plastl||B05XA01|01.09.2010||R|||0|0|0|1|BRA|0|0|0|100|XEU|3246|4685|lyfsjukr||||400|0||Actavis Group hf|Braun|Kalíumklóríđ||3246||3246|4685|
068923|V07AB1001|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|10|ml|20|lykjur|leysir f.stungulyf|V07AB|01.01.2009||L|||0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa||||200|0||Actavis Group hf|Braun|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar||||||
068933|V07AB1001|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|20|ml|20|lykjur|leysir f.stungulyf|V07AB|01.01.2009||L|||0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa||||400|0||Actavis Group hf|Braun|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar||||||
068951|V07AB09|Sterilt Vann B. Braun|leysir|||10|ml|20|lykja|leysir f.stungulyf|V07AB|01.01.2009||L|||0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa||||200|0||Actavis Group hf|Braun|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar||||||
068960|V07AB09|Sterilt Vann B. Braun|leysir|||20|ml|20|lykja|leysir f.stungulyf|V07AB|01.01.2009||L|||0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa||||400|0||Actavis Group hf|Braun|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar||||||
069799|D01AE1501|Lamisil|krem|10|mg/g|15|g|1|túpa||D01AE15|01.04.1993||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||15|0||Artasan ehf|Novartis Healthcare A/S-A|Terbínafín||||||
069850|C09AA0210|Enalapril LYFIS|töflur|5|mg|100|stk|1|ţpakki||C09AA02|01.06.2011||R|||0|0|B|0|LYF|0|0|0|100|XEU|446|1397|lyfalmen|V0448|1397||100|0|50,0000|LYFIS ehf|LYFIS ehf|Enalapríl||306||306|1397|
070020|N05AX0803|Risperdal Consta|sts|25|mg|1|hgl|1|pakki|+ leysir|N05AX08|01.04.2010||R|||0|0|*|0|JAS|0|1|0|100|SEK|18736|26059|lyfalmen||||1|0|9,2600|Vistor hf|Janssen-Cilag AB|Risperídón||||18736|26059|
070031|N05AX0803|Risperdal Consta|sts|37,5|mg|1|hgl|1|pakki|+ leysir|N05AX08|01.04.2010||R|||0|0|*|0|JAS|0|1|0|100|SEK|27099|36554|lyfalmen||||1|0|13,8900|Vistor hf|Janssen-Cilag AB|Risperídón||||27099|36554|
070042|N05AX0803|Risperdal Consta|sts|50|mg|1|hgl|1|pakki|+ leysir|N05AX08|01.04.2010||R|||0|0|*|0|JAS|0|1|0|100|SEK|35095|46589|lyfalmen||||1|0|18,5200|Vistor hf|Janssen-Cilag AB|Risperídón||||35095|46589|
070342|V08AB0201|Omnipaque|stl|350|mg J/ml|100|ml|10|glerfl||V08AB02|01.12.1983||R|||0|0|0|1|GEH|0|0|0|100|NOK|48316|62519|lyfsjukr||||1000|0||Icepharma hf|GE Healthcare AS|Jóhexól||48316||48316|62519|
070557|QH01BB0203|Partoxin vet.|stl|17|mcg|10|ml|10|hgl||QH01BB02|01.12.2006||R|||0|0|0|0|PAB|1|0|0|100|IKR|10511|20355|vetalmen||||100|0||Vistor hf|Pharmaxim AB|||10511||10511|20355|
070797|N05AX0801|Risperdal|mixtúra|1|mg/ml|100|ml|1|fl|međ skammtasprautu|N05AX08|01.01.1997||R|||0|0|*|0|JAS|0|1|0|100|SEK|12735|18528|lyfalmen||||100|0|20,0000|Vistor hf|Janssen-Cilag AB|Risperídón||12735||12735|18528|
071076|QA12CE9902|Selevitan, vet.|kyrni|||1250|g|1|plbrús||QA12CE99|01.12.2006||R|||0|0|0|0|PAB|0|0|0|100|SEK|6399|12460|vetalmen||||1250|0||Vistor hf|Pharmaxim AB|||6399||6399|12460|
071134|N05AN0104|Litiumsitrat Actavis|töflur|500|mg|100|stk|1|glas||N05AN01|01.10.1995||R|||0|0|*|0|ACA|0|1|0|100|XEU|723|1968|lyfalmen||||100|0|22,1631|Actavis Group hf|Actavis hf|Litíum||723||723|1968|
071223|N02BG0801|Prialt|irl|100|mcg/ml|1|ml|1|hgl||N02BG08|01.06.2007||R|||0|1|0|1|EIS|0|0|0|100|SEK|67568|86680|lyfsjukr||||1|0|8,3300|Vistor hf|Eisai Ltd|Ziconotíđ||67568||67568|86680|
071232|N02BG0801|Prialt|irl|100|mcg/ml|5|ml|1|hgl||N02BG08|01.06.2007||R|||0|1|0|1|EIS|0|0|0|100|SEK|337841|425873|lyfsjukr||||5|0|41,6500|Vistor hf|Eisai Ltd|Ziconotíđ||337841||337841|425873|
071591|N05AH0405|Seroquel Prolong|forđatfl|150|mg|30|stk|1|ţpakki||N05AH04|01.10.2011||R|||0|0|0|0|ASA|0|1|0|100|SEK|8783|12994|lyfalmen||||30|0|11,2500|Vistor hf|Astra Zeneca A/S|Quetíapín||||8783|12994|
071611|G04BE0305|Vizarsin (Lyfis)|filmhtfl|100|mg|12|stk|1|pakki||G04BE03|01.08.2010||R|||0|0|0|0|LYF|0|0|0|100|XEU|11276|9709|lyfalmen|V0144|9188||12|0|24,0000|Lyfis ehf|Lyfis ehf|Síldenafíl||6382||6382|9709|
071975|L01BB0501|Fludara|filmhtfl|10|mg|20|stk|1|ţpakki||L01BB05|01.09.2011||R|||0|1|0|1|GZE|0|0|0|100|SEK|91024|116118|lyfsjukr||||20|0||Vistor hf|Genzyme Europe B.V.|Flúdarabín||||91024|116118|
072044|B01AC0402|Grepid|töflur|75|mg|30|stk|1|ţpakki||B01AC04|01.01.2010||R|||0|0|E|0|PSA|0|0|0|100|XEU|3270|2324|lyfalmen|V0009|2158||30|0|30,0000|Portfarma ehf|Pharmathen S.A.|Klópídógrel||983||983|2324|
072132|QN05CM9001|Domosedan, vet.|stl|10|mg/ml|5|ml|1|hgl||QN05CM90|01.01.1991||R|||0|0|0|0|ORF|1|0|0|100|DKK|7301|14192|vetalmen||||5|0||Vistor hf|Orion-Farmos|||7301||7301|14192|
072233|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|300|stk|1|ţpakki||N07BA01|01.02.2010||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||300|0|20,0000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
072380|B01AC0402|Grepid|töflur|75|mg|100|stk|1|ţpakki||B01AC04|01.12.2009||R|||0|0|E|0|PSA|0|0|0|100|XEU|10281|9167|lyfalmen|V0029|8509||100|0|100,0000|Portfarma ehf|Pharmathen S.A.|Klópídógrel||5986||5986|9167|
072520|V01AA1104|Alutard SQ, hrossavćrur|stl|0,01|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|||0|1|E|0|ALK|0|0|0|100|DKK|19869|27481|lyfalmen||||5|0||Vistor hf|ALK-Abello A/S|dýr||19869||19869|27481|
072641|V04CX0001|Lung test gas CO (HE) Aga|lyfjagas|0,28|%|20|l|1|hylki|undir ţrýstingi|V04CX|01.05.2012||R|||0|0|0|1|AGA|0|0|0|100|IKR|143477|181946|lyfsjukr||||20|0||Ísaga ehf|AGA AB|Carbon monoxide||143477||143477|181946|
072654|V04CX0002|Lung test gas CO (C2H2/CH4) Aga|lyfjagas|0,3|%|20|l|1|hylki|undir ţrýstingi|V04CX|01.05.2012||R|||0|0|0|1|AGA|0|0|0|100|IKR|143477|181946|lyfsjukr||||20|0||Ísaga ehf|AGA AB|Carbon monoxide||143477||143477|181946|
072751|N01AH0301|Sufenta|stl|5|mcg/ml|2|ml|5|lykjur||N01AH03|01.06.2000||R|||1|0|0|1|JAS|0|0|0|100|SEK|663|957|lyfsjukr||||10|0||Vistor hf|Janssen-Cilag AB|Súfentaníl||663||663|957|
072770|L04AB0401|Humira|stl|40|mg/penna|0,8|ml|2|pennar||L04AB04|01.06.2007||R|||0|1|0|1|ABB|0|0|0|100|DKK|154076|195248|lyfsjukr||||2|0|27,5900|Vistor hf|Abbott|Adalimumab||154076||154076|195248|
072978|A10BX0401|Byetta|stl|5|mcg/sk|1,2|ml|1|penni|lausn|A10BX04|01.05.2007||R|||0|0|*|0|ELD|0|0|0|100|XEU|17133|24047|lyfalmen||||1|0|20,0000|Icepharma hf|Eli Lilly Nederland B.V.|Exenatíđ||17133||17133|24047|
072996|A10BX0401|Byetta|stl|10|mcg/sk|2,4|ml|1|penni|lausn|A10BX04|01.05.2007||R|||0|0|*|0|ELD|0|0|0|100|XEU|17133|24047|lyfalmen||||2|0|40,0000|Icepharma hf|Eli Lilly Nederland B.V.|Exenatíđ||17133||17133|24047|
073027|J05AG0401|Intelence|töflur|200|mg|60|stk|1|glas||J05AG04|01.04.2012||R|||0|1|0|1|JCI|0|0|0|100|SEK|75924|97167|lyfsjukr||||60|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Etravírín||75924||75924|97167|
073205|N05AF0103|Fluanxol Mite|filmhtfl|0,5|mg|100|stk|1|glas||N05AF01|01.12.1972||R|||0|0|*|0|LBK|0|1|0|100|DKK|1096|2478|lyfalmen||||100|0|8,3333|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||1096||1096|2478|
073559|G04CA5201|Duodart|hylki|0,9|mg|30|stk|1|glas|0,5 mg + 0,4 mg|G04CA52|01.12.2010||R|||0|0|E|0|GSK|0|0|0|100|GBP|4016|6473|lyfalmen||||30|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Dútasteríđ og tamsúlósínhýdroklóríđ||4016||4016|6473|
073684|N05AF0103|Fluanxol Mite|filmhtfl|1|mg|100|stk|1|glas||N05AF01|01.12.1972||R|||0|0|*|0|LBK|0|1|0|100|DKK|1706|3313|lyfalmen||||100|0|16,6667|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||1706||1706|3313|
073708|L02BG0405|Letrozol Actavis|filmhtfl|2,5|mg|100|stk|1|ţpakki||L02BG04|01.09.2011||R|||0|0|*|0|AGP|0|0|0|100|XEU|53062|31687|lyfalmen|V0185|27712||100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Letrózól||23221||23221|31687|
073776|C09AA0210|Enalapril LYFIS|töflur|10|mg|100|stk|1|ţpakki||C09AA02|01.06.2011||R|||0|0|B|0|LYF|0|0|0|100|XEU|742|1599|lyfalmen|V0066|1599||100|0|100,0000|LYFIS ehf|LYFIS ehf|Enalapríl||453||453|1599|
073825|N05BA1203|Tafil|töflur|0,25|mg|20|stk|1|ţpakki||N05BA12|01.04.1987||R|||0|0|0|0|PER|0|0|1|100|DKK|317|1413|lyfalmen|V0047|1276||20|0|5,0000|Icepharma hf|Pfizer ApS|Alprazólam||317||317|1413|
073833|N05BA1203|Tafil|töflur|0,25|mg|50|stk|1|ţpakki||N05BA12|01.04.1987||R|||0|0|0|0|PER|0|0|0|100|DKK|780|2046|lyfalmen|V0305|1001||50|0|12,5000|Icepharma hf|Pfizer ApS|Alprazólam||780||780|2046|
073841|N05BA1203|Tafil|töflur|0,25|mg|100|stk|1|ţpakki||N05BA12|01.04.1987||R|||0|0|0|0|PER|0|0|0|100|DKK|996|2341|lyfalmen|V0305|2001||100|0|25,0000|Icepharma hf|Pfizer ApS|Alprazólam||996||996|2341|
073858|N05BA1203|Tafil|töflur|0,5|mg|20|stk|1|ţpakki||N05BA12|01.04.1987||R|||0|0|0|0|PER|0|0|1|100|DKK|536|1712|lyfalmen|V0439|1475||20|0|10,0000|Icepharma hf|Pfizer ApS|Alprazólam||536||536|1712|
073874|N05BA1203|Tafil|töflur|0,5|mg|100|stk|1|ţpakki||N05BA12|01.04.1987||R|||0|0|0|0|PER|0|0|0|100|DKK|1457|2972|lyfalmen||||100|0|50,0000|Icepharma hf|Pfizer ApS|Alprazólam||1457||1457|2972|
073935|QP54AA0302|Noromectin Drench|mixtúra|0,8|mg/ml|1|l|1|fl|lausn|QP54AA03|01.11.2011||R|||0|0|0|0|NOB|1|0|0|100|XEU|3859|6732|vetorma||||1|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|||3859||3859|6732|
073947|L04AX0102|Imurel|töflur|25|mg|50|stk|1|ţpakki||L04AX01|01.12.2010||R|||0|0|*|0|AEG|0|0|0|100|GBP|1427|2931|lyfalmen||||50|0|8,3333|GlaxoSmithKline ehf|Aspen Europe GmbH|Azatíóprín||1427||1427|2931|
074016|G04BE0303|Viagra (D.A.C.)|filmhtfl|25|mg|4|stk|1|ţpakki||G04BE03|01.12.2009||R|||0|0|0|0|DAC|0|0|0|100|DKK|4825|7579|lyfalmen|V0142|7579||4|0|2,0000|D.A.C. ehf|D.A.C. ehf|Síldenafíl||4825||4825|7579|
074042|C09DB0101|Exforge|filmhtfl|85|mg|28|stk|1|pakki||C09DB01|01.04.2007||R|||0|0|0|0|NOE|0|0|0|100|DKK|3731|6083|lyfalmen||||28|0|28,0000|Vistor hf|Novartis Europharm Ltd|Valsartín og amlódipín||3731||3731|6083|
074060|C09DB0101|Exforge|filmhtfl|165|mg|28|stk|1|pakki||C09DB01|01.04.2007|30.06.2012|R|||0|0|0|0|NOE|0|0|0|100|DKK|4839|7598|lyfalmen||||28|0|28,0000|Vistor hf|Novartis Europharm Ltd|Valsartín og amlódipín||4839||4839|7598|
074083|B03BB0106|Folic Acid (D.A.C.)|töflur|5|mg|28|stk|1|ţpakki||B03BB01|01.03.2011||R|||0|0|E|0|DAC|0|0|1|100|GBP|430|1562|lyfalmen|V0391|1562||28|0|350,0000|D.A.C. ehf|D.A.C. ehf|Fólínsýra||426||426|1562|
074443|V08CA0301|Omniscan|stl|0,5|mmol/ml|5|ml|10|hgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|||0|0|0|1|GEH|0|0|0|100|NOK|18257|24795|lyfsjukr||||50|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||18257||18257|24795|
074468|N05BA0105|Stesolid|töflur|5|mg|25|stk|1|glas||N05BA01|01.12.1972||R|||0|0|0|0|AGT|0|0|1|100|DKK|498|1660|lyfalmen||||25|0|12,5000|Actavis Group hf|Actavis Group hf|Díazepam||498||498|1660|
074484|N05BA0105|Stesolid|töflur|5|mg|50|stk|1|glas||N05BA01|01.12.1980||R|||0|0|0|0|AGT|0|0|1|100|DKK|712|1953|lyfalmen||||50|0|25,0000|Actavis Group hf|Actavis Group hf|Díazepam||712||712|1953|
074492|N05BA0105|Stesolid|töflur|5|mg|100|stk|1|glas||N05BA01|01.08.2011||R|||0|0|0|0|AGT|0|0|0|100|DKK|1119|2510|lyfalmen||||100|0|50,0000|Actavis Group hf|Actavis Group hf|Díazepam||1119||1119|2510|
074617|QI06AA0402|Fel-O-Vax PCT vet.|bóluefni|||1|ml|25|spr|áfyllt sprauta|QI06AA04|01.06.2000||R|||0|0|0|0|SCA|1|0|0|100|DKK|21514|37530|vetorma||||25|0||Vistor hf|Scan Vet Animal Health AS|||21514||21514|37530|
074667|N06AA0905|Amitriptyline|filmhtfl|10|mg|98|stk|1|ţpakki||N06AA09|01.03.2011||R|||0|0|B|0|AUK|0|1|0|100|GBP|440|1581|lyfalmen|V0510|1553||98|0|13,0700|Actavis Group hf|Actavis UK Ltd.|Amitriptýlín||440||440|1581|
074679|N06AA0905|Amitriptyline|filmhtfl|25|mg|98|stk|1|ţpakki||N06AA09|01.02.2011||R|||0|0|B|0|AUK|0|1|0|100|GBP|803|2034|lyfalmen|V0512|2028||98|0|32,6600|Actavis Group hf|Actavis UK Ltd.|Amitriptýlín||771||771|2034|
074758|C01AA0503|Lanoxin|mixtúra|50|mcg/ml|60|ml|1|glas||C01AA05|01.12.2010||R|||0|0|B|0|AEG|0|0|0|100|GBP|1017|2370|lyfalmen||||60|0|12,0000|GlaxoSmithKline ehf|Aspen Europe GmbH|Digoxín||1017||1017|2370|
074782|C01AA0503|Lanoxin|töflur|0,25|mg|100|stk|1|glas||C01AA05|01.09.2010||R|||0|0|B|0|APT|0|0|0|100|GBP|543|1722|lyfalmen||||100|0|100,0000|GlaxoSmithKline ehf|Aspen Pharma Trading Limited|Digoxín||543||543|1722|
074922|R06AX2601|Telfast|töflur|120|mg|30|stk|1|ţpakki||R06AX26|01.11.1999|30.04.2012|R|||0|0|E|0|SNO|0|0|1|100|NOK|1678|2585|lyfalmen||||30|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||1174||1174|2585|
075009|L04AX0102|Imurel|töflur|50|mg|100|stk|1|ţpakki||L04AX01|01.08.2011||R|||0|0|*|0|AEG|0|0|0|100|GBP|2718|4650|lyfalmen||||100|0|33,3333|GlaxoSmithKline ehf|Aspen Europe GmbH|Azatíóprín||2684||2684|4650|
075031|R03AC1801|Onbrez Breezhaler|innönddu|150|mcg|30|hylki|1|pakki||R03AC18|01.03.2010||R|||0|0|0|0|NOE|0|0|1|100|DKK|5080|7928|lyfalmen||||30|0|30,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||5080||5080|7928|
075042|R03AC1801|Onbrez Breezhaler|innönddu|150|mcg|90|hylki|1|pakki||R03AC18|01.03.2010||R|||0|0|0|0|NOE|0|0|1|100|DKK|15239|21670|lyfalmen||||90|0|90,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||15239||15239|21670|
075044|J02AB0201|Fungoral|töflur|200|mg|10|stk|1|ţpakki||J02AB02|01.01.1985||R|||0|0|0|0|JAS|0|0|1|100|SEK|1802|3444|lyfalmen||||10|0|10,0000|Vistor hf|Janssen-Cilag AB|Ketókónazól||1802||1802|3444|
075064|R03AC1801|Onbrez Breezhaler|innönddu|300|mcg|30|hylki|1|pakki||R03AC18|01.03.2010||R|||0|0|0|0|NOE|0|0|1|100|DKK|5080|7928|lyfalmen||||30|0|60,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||5080||5080|7928|
075069|R06AX2601|Telfast|töflur|180|mg|30|stk|1|ţpakki||R06AX26|01.11.1999||R|||0|0|E|0|SNO|0|0|1|100|NOK|2039|2839|lyfalmen|V0363|2607||30|0|45,0000|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||1360||1360|2839|
075075|R03AC1801|Onbrez Breezhaler|innönddu|300|mcg|90|hylki|1|pakki||R03AC18|01.03.2010||R|||0|0|0|0|NOE|0|0|1|100|DKK|15239|21670|lyfalmen||||90|0|180,0000|Vistor hf|Novartis Europharm Ltd|Indacaterol||15239||15239|21670|
075078|N07BA0131|Nicorette Microtab Classic|tungur.t|2|mg|90|stk|1|ţpakki||N07BA01|01.10.2008||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||90|0|6,0000|Vistor hf|McNeil Denmark ApS|Nikótín||||||
075087|N02BE5102|Parkodin|töflur|510|mg|300|stk|1|plglas|10+500 mg|N02BE51|01.07.2007||R|||1|0|0|0|ACA|0|0|1|100|XEU|1938|3630|lyfalmen||||300|0|50,0000|Actavis Group hf|Actavis hf|Paracetamól í blöndum nema međ geđlyfjum (psycholeptica)||1938||1938|3630|
075096|N02AA5902|Parkodin forte|töflur|530|mg|300|stk|1|plglas|30+500 mg|N02AA59|01.07.2007||R|||1|0|0|0|ACA|0|0|1|100|NOK|3200|5356|lyfalmen||||300|0|100,0000|Actavis Group hf|Actavis hf|Kódein í blöndum nema međ geđlyfjum||3200||3200|5356|
075187|A06AD0001|Moviprep|mixtduft|||4|pokar|1|pakki||A06AD|01.09.2011||R|||0|0|0|0|NBV|0|0|0|100|XEU|2701|4674|lyfalmen||||4|0||Norgine BV|Norgine BV|Hćgđalyf međ osmótíska verkun||||2701|4674|
075288|N05AX1203|Abilify (Lyfjaver)|töflur|5|mg|56|stk|1|ţpakki||N05AX12|01.12.2009||R|||0|0|*|0|LVR|0|1|0|100|DKK|35925|47631|lyfalmen||||56|0|18,6670|Lyfjaver ehf|Lyfjaver ehf|Aripiprazól||35925||35925|47631|30.04.2012
075299|M01AH0103|Celebra (Lyfjaver)|hylki|100|mg|100|stk|1|ţpakki||M01AH01|01.12.2009||R|||0|0|E|0|LVR|0|0|1|100|DKK|7352|11036|lyfalmen||||100|0|50,0000|Lyfjaver ehf|Lyfjaver ehf|Celekoxíb||7352||7352|11036|30.04.2012
075310|M01AH0103|Celebra (Lyfjaver)|hylki|200|mg|100|stk|1|ţpakki||M01AH01|01.12.2009||R|||0|0|E|0|LVR|0|0|1|100|DKK|13798|19862|lyfalmen|V0196|19862||100|0|100,0000|Lyfjaver ehf|Lyfjaver ehf|Celekoxíb||13798||13798|19862|
075356|G04BD0703|Detrusitol SR (Lyfjaver)|forđahlk|4|mg|84|stk|1|ţpakki||G04BD07|01.07.2011||R|||0|0|E|0|LVR|0|0|0|100|DKK|18549|25824|lyfalmen||||84|0|84,0000|Lyfjaver ehf|Lyfjaver ehf|Tólteródín||||18549|25824|
075382|V04CL0030|Soluprick SQ, rauđölur|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|||0|0|E|0|ALK|0|0|0|100|DKK|7714|11531|lyfalmen||||3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7714||7714|11531|
075391|N05AL0502|Solian (Lyfjaver)|töflur|200|mg|90|stk|1|ţpakki||N05AL05|01.12.2009||R|||0|0|*|0|LVR|0|1|0|100|NOK|20527|28307|lyfalmen||||90|0|45,0000|Lyfjaver ehf|Lyfjaver ehf|Amísúlpríđ||20527||20527|28307|30.04.2012
075402|N05AL0502|Solian (Lyfjaver)|töflur|50|mg|90|stk|1|ţpakki||N05AL05|01.12.2009||R|||0|0|*|0|LVR|0|1|0|100|NOK|6823|10312|lyfalmen||||90|0|11,2500|Lyfjaver ehf|Lyfjaver ehf|Amísúlpríđ||6823||6823|10312|30.04.2012
075408|V04CL0022|Soluprick SQ, graölur|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|||0|0|E|0|ALK|0|0|0|100|DKK|7714|11531|lyfalmen||||3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7714||7714|11531|
075413|G04BD0802|Vesicare (Lyfjaver)|filmhtfl|10|mg|90|stk|1|ţpakki||G04BD08|01.05.2012||R|||0|0|E|0|LVR|0|0|0|100|XEU|20672|28489|lyfalmen|V0441|28489||90|0|180,0000|Lyfjaver ehf|Lyfjaver ehf|Sólífenacín||20672||20672|28489|
075424|V04CL0019|Soluprick SQ, birkifrjo|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|||0|0|E|0|ALK|0|0|0|100|DKK|7714|11531|lyfalmen||||3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7714||7714|11531|
075425|G04BD0802|Vesicare (Lyfjaver)|filmhtfl|5|mg|90|stk|1|ţpakki||G04BD08|01.05.2012||R|||0|0|E|0|LVR|0|0|0|100|XEU|16831|23668|lyfalmen|V0440|23668||90|0|90,0000|Lyfjaver ehf|Lyfjaver ehf|Sólífenacín||16831||16831|23668|
075440|V04CL0026|Soluprick SQ, hesliviđur|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|||0|0|E|0|ALK|0|0|0|100|DKK|7714|11531|lyfalmen||||3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7714||7714|11531|
075451|G04CB0103|Finasteride Portfarma|filmhtfl|5|mg|98|stk|1|ţpakki||G04CB01|01.05.2011||R|||0|0|E|0|POF|0|0|0|100|XEU|4253|5620|lyfalmen|V0445|5620||98|0|98,0000|Portfarma ehf|Portfarma|Fínasteríđ||3393||3393|5620|
075465|V04CL0024|Soluprick SQ, haliđagras|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|||0|0|E|0|ALK|0|0|0|100|DKK|7714|11531|lyfalmen||||3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7714||7714|11531|
075470|L01CD0201|Taxotere|irţ|20|mg|1|ml|1|hgl|lausn|L01CD02|01.06.2010||R|||0|1|0|1|AVS|0|0|0|100|NOK|32306|42427|lyfsjukr||||1|0||Vistor hf|Aventis Pharma SA|Docetaxel||32306||32306|42427|
075482|L01CD0201|Taxotere|irţ|80|mg|4|ml|1|hgl|lausn|L01CD02|01.06.2010||R|||0|1|0|1|AVS|0|0|0|100|NOK|121255|154058|lyfsjukr||||4|0||Vistor hf|Aventis Pharma SA|Docetaxel||121255||121255|154058|
075507|V04CL0018|Soluprick SQ, axhnođapunktur|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|||0|0|E|0|ALK|0|0|0|100|DKK|7714|11531|lyfalmen||||3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7714||7714|11531|
075523|V04CL0025|Soluprick SQ, havingull|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|||0|0|E|0|ALK|0|0|0|100|DKK|7714|11531|lyfalmen||||3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7714||7714|11531|
075549|V04CL0033|Soluprick SQ, vallarrygresi|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|||0|0|E|0|ALK|0|0|0|100|DKK|7714|11531|lyfalmen||||3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7714||7714|11531|
075564|V04CL0032|Soluprick SQ, vallarfoxgras|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|||0|0|E|0|ALK|0|0|0|100|DKK|7714|11531|lyfalmen||||3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7714||7714|11531|
075580|V04CL0034|Soluprick SQ, vallarsveifgras|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|||0|0|E|0|ALK|0|0|0|100|DKK|7714|11531|lyfalmen||||3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7714||7714|11531|
075606|V04CL0031|Soluprick SQ, rugur|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|||0|0|E|0|ALK|0|0|0|100|DKK|7714|11531|lyfalmen||||3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7714||7714|11531|
075663|V04CL0021|Soluprick SQ, derm.pter.|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|||0|0|E|0|ALK|0|0|0|100|DKK|7714|11531|lyfalmen||||3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7714||7714|11531|
075689|V04CL0027|Soluprick SQ, hrossavćrur|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|||0|0|E|0|ALK|0|0|0|100|DKK|7714|11531|lyfalmen||||3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7714||7714|11531|
075705|V04CL0028|Soluprick SQ, hundahar|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|||0|0|E|0|ALK|0|0|0|100|DKK|7714|11531|lyfalmen||||3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7714||7714|11531|
075721|V04CL0029|Soluprick SQ, kattahar|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|||0|0|E|0|ALK|0|0|0|100|DKK|7714|11531|lyfalmen||||3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7714||7714|11531|
075724|B02BD0901|BeneFIX|sts|||1000|ae|1|hgl|+leysir|B02BD09|01.02.2004||R|||0|1|0|1|WTE|0|0|0|100|DKK|101667|129475|lyfsjukr||||1000|0|2,2200|Icepharma hf|Wyeth Europe|Storkuţáttur IX||101667||101667|129475|
075777|QG03DA0201|Perlutex, vet.|töflur|5|mg|20|stk|1|ţpakki||QG03DA02|01.03.2011||R|||0|0|0|0|DEC|0|0|0|100|DKK|994|1977|vetalmen||||20|0||Vistor hf|Dechra Veterinary Products A/S|||994||994|1977|
075869|B05DB0005|Balance|kviđ.sk|1,5|%|5000|ml|2|pokar|lausn|B05DB|01.11.2009||R|||0|0|0|1|FMC|0|0|0|100|XEU|6053|8736|lyfsjukr||||10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||6053||6053|8736|
075888|B05DB0005|Balance|kviđ.sk|2,3|%|5000|ml|2|pokar|lausn|B05DB|01.11.2009||R|||0|0|0|1|FMC|0|0|0|100|XEU|6053|8736|lyfsjukr||||10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||6053||6053|8736|
075906|B05DB0005|Balance|kviđ.sk|4,25|%|5000|ml|2|pokar|lausn|B05DB|01.11.2009||R|||0|0|0|1|FMC|0|0|0|100|XEU|6073|8765|lyfsjukr||||10000|0||Icepharma hf|Fresenius Medical Care Deutschland GmbH|Hýpertónískar lausnir||6073||6073|8765|
075936|P01BC0104|Quinine Sulphate Actavis|filmhtfl|200|mg|28|stk|1|ţpakki||P01BC01|01.07.2010||R|||0|0|0|0|AUK|0|0|0|100|GBP|471|1623|lyfalmen||||28|0|3,7300|Actavis Group hf|Actavis UK Ltd.|Kínín||471||471|1623|
075947|J01EE0107|Trimezol|töflur|480|mg|20|stk|1|ţpakki|80+400 mg|J01EE01|01.12.2009||R|||0|0|0|0|AEA|0|0|1|100|XEU|466|1616|lyfalmen||||20|0|5,0000|Actavis hf|Actavis EAD|Súlfametoxazól og trímetóprím||466||466|1616|
075991|C09AA0210|Enalapril LYFIS|töflur|20|mg|100|stk|1|ţpakki||C09AA02|01.06.2011||R|||0|0|B|0|LYF|0|0|0|100|XEU|925|1887|lyfalmen|V0449|1887||100|0|200,0000|LYFIS ehf|LYFIS ehf|Enalapríl||664||664|1887|
076024|A10BH0101|Januvia|filmhtfl|100|mg|28|stk|1|ţpakki||A10BH01|01.01.2010||R|||0|0|*|0|MSD|0|0|0|100|DKK|6808|10292|lyfalmen||||28|0|28,0000|Vistor hf|M.S.D.|Sítagliptín||6808||6808|10292|
076033|A10BH0101|Januvia|filmhtfl|100|mg|98|stk|1|ţpakki||A10BH01|01.11.2007||R|||0|0|*|0|MSD|0|0|0|100|DKK|23186|31644|lyfalmen||||98|0|98,0000|Vistor hf|M.S.D.|Sítagliptín||23186||23186|31644|
076361|V03AN0101|Conoxia|innö.gas|100|%|2|l|1|hylki|MO2LIV|V03AN01|01.12.2009||L|||0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa||||2|0||Ísaga ehf|AGA AB|Súrefni||||||
076369|N05AX0805|Risperidon Portfarma|filmhtfl|0,5|mg|20|stk|1|ţpakki||N05AX08|01.07.2007||R|||0|0|0|0|POF|0|1|0|100|IKR|445|1588|lyfalmen|V0045|1588||20|0|2,0000|Portfarma ehf|Portfarma|Risperídón||445||445|1588|
076378|N05AX0805|Risperidon Portfarma|filmhtfl|0,5|mg|60|stk|1|ţpakki||N05AX08|01.07.2007||R|||0|0|*|0|POF|0|1|0|100|IKR|1986|3099|lyfalmen|V0290|3099||60|0|6,0000|Portfarma ehf|Portfarma|Risperídón||1550||1550|3099|
076387|N05AX0805|Risperidon Portfarma|filmhtfl|1|mg|60|stk|1|ţpakki||N05AX08|01.07.2007||R|||0|0|*|0|POF|0|1|0|100|IKR|1946|3373|lyfalmen|V0291|3373||60|0|12,0000|Portfarma ehf|Portfarma|Risperídón||1750||1750|3373|
076533|N05AB0301|Trilafon|filmhtfl|2|mg|100|stk|1|ţpakki||N05AB03|01.04.2009||R|||0|0|*|0|SPL|0|1|0|100|DKK|916|2232|lyfalmen||||100|0|6,6667|Vistor hf|Schering-Plough Europe|Perfenazín||916||916|2232|
076542|N05AB0301|Trilafon|filmhtfl|4|mg|100|stk|1|ţpakki||N05AB03|01.04.2009||R|||0|0|*|0|SPL|0|1|0|100|DKK|1281|2731|lyfalmen||||100|0|13,3333|Vistor hf|Schering-Plough Europe|Perfenazín||||1281|2731|
076551|N05AB0301|Trilafon|filmhtfl|8|mg|100|stk|1|ţpakki||N05AB03|01.04.2009||R|||0|0|*|0|SPL|0|1|0|100|DKK|1826|3477|lyfalmen||||100|0|26,6667|Vistor hf|Schering-Plough Europe|Perfenazín||||1826|3477|
076752|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|100|ml|1|hgl|plast|QP54AA01|01.01.1985||R|||0|0|0|0|MEF|1|0|0|100|XEU|7390|12891|vetorma||||100|0||Vistor hf|Merial (MSD)|||7390||7390|12891|
076814|J07AL5201|Synflorix|stl|||0,5|ml|1|áf.spr|dreifa|J07AL52|01.12.2009||R|||0|0|0|0|GLB|0|0|0|100|GBP|7507|11137|lyfalmen||||0|0||GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|Lungnabólga a.v.pneumok.Hreins pneumok polysakk móte.v Hae||7426||7426|11137|
076871|G01AF0202|Canesten (D.A.C.)|sk-tfl|500|mg|1|stk|1|pakki|+stjaka|G01AF02|01.12.2009||L|||0|0|0|0|DAC|0|0|0|100|IKR|||lyflausa||||1|0|5,0000|D.A.C. ehf|D.A.C. ehf|Klótrímazól||||||
077420|N02BE5102|Parkodin|töflur|510|mg|30|stk|1|pakki|ţp 10+500 mg|N02BE51|01.01.1985||R|||0|0|0|0|ACA|0|0|1|100|XEU|238|1304|lyfalmen||||30|0|5,0000|Actavis Group hf|Actavis hf|Paracetamól í blöndum nema međ geđlyfjum (psycholeptica)||238||238|1304|
077446|N02BE5102|Parkodin|töflur|510|mg|100|stk|1|pakki|ţp 10+500 mg|N02BE51|01.01.1985||R|||0|0|0|0|ACA|0|0|1|100|XEU|703|1941|lyfalmen||||100|0|16,6667|Actavis Group hf|Actavis hf|Paracetamól í blöndum nema međ geđlyfjum (psycholeptica)||703||703|1941|
077821|B01AC0403|Clopidogrel Actavis|filmhtfl|75|mg|100|stk|1|glas||B01AC04|01.07.2010||R|||0|0|E|0|APC|0|0|0|100|XEU|10281|9167|lyfalmen|V0029|8509||100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Klópídógrel||5986||5986|9167|
077875|A02BA0205|Zantac|stl|25|mg/ml|2|ml|5|lykjur||A02BA02|01.10.1987||R|||0|0|E|0|GSK|0|0|0|100|GBP|841|2129|lyfalmen||||10|0|0,8333|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ranitidín||841||841|2129|
078182|D01AC0302|Pevaryl (D.A.C.)|krem|10|mg/g|30|g|1|túpa||D01AC03|01.12.2009||L|||0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa||||30|0||D.A.C. ehf|D.A.C. ehf|Ekónazól||||||
078193|D01AC0102|Canesten (D.A.C.)|krem|1|%|20|g|1|túpa||D01AC01|01.12.2009||L|||0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa||||20|0||D.A.C. ehf|D.A.C. ehf|Klótrímazól||||||
078239|S01GX0202|Livostin (D.A.C.)|augndr|0,5|mg/ml|4|ml|1|glas||S01GX02|01.12.2009||L|||0|0|0|0|DAC|0|0|0|100|IKR|||lyflausa||||4|0||D.A.C. ehf|D.A.C. ehf|Levókabastín||||||
078250|D01AC0803|Fungoral (D.A.C.)|sápa|20|mg/ml|120|ml|1|plastf||D01AC08|01.12.2009||L|||0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa||||120|0||D.A.C. ehf|D.A.C. ehf|Ketókónazól||||||
078307|J02AC0103|Fluconazole Portfarma|hylki|200|mg|28|stk|1|ţpakki||J02AC01|01.12.2010||R|||0|0|0|0|POF|0|0|1|100|IKR|11524|13974|lyfalmen|V0419|13042||28|0|28,0000|Portfarma ehf|Portfarma|Flúkónazól||9500||9500|13974|
078568|J01CE0204|Kaavepenin|töflur|250|mg|20|stk|1|ţpakki||J01CE02|01.10.1985||R|||0|0|0|0|REP|0|0|1|100|SEK|540|1718|lyfalmen||||20|0|2,5000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||540||540|1718|
078576|J01CE0204|Kaavepenin|töflur|250|mg|40|stk|1|ţpakki||J01CE02|01.10.1985||R|||0|0|0|0|REP|0|0|1|100|SEK|822|2103|lyfalmen||||40|0|5,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||822||822|2103|
078688|N01BB0204|Lidokain FarmaPlus|stl|10|mg/ml|20|ml|5|hgl|međ rotvörn|N01BB02|01.04.2012||R|||0|0|0|0|FPL|0|0|1|100|XEU|1444|2954|lyfalmen|V0560|2954||100|0||FarmaPlus AS|FarmaPlus AS|Lídókaín||1444||1444|2954|
078699|N01BB0204|Lidokain FarmaPlus|stl|20|mg/ml|20|ml|5|hgl|međ rotvörn|N01BB02|01.04.2012||R|||0|0|0|0|FPL|0|0|1|100|XEU|2065|3804|lyfalmen|V0561|3804||100|0||FarmaPlus AS|FarmaPlus AS|Lídókaín||2065||2065|3804|
078933|L03AB0801|Betaferon|sts|8|mi.ae/ml|15|spr|1|pakki|+leysir|L03AB08|01.01.2002||R|||0|1|0|1|SAG|0|0|0|100|SEK|125421|159286|lyfsjukr||||15|0|30,0000|Icepharma hf|Schering AG|Interferón beta-1b||125421||125421|159286|
079061|C09CA0101|Cozaar|töflur|50|mg|98|stk|1|ţpakki||C09CA01|01.01.1995||R|||0|0|0|0|MSD|0|0|0|100|DKK|9232|6276|lyfalmen|V0069|2518||98|0|98,0000|Vistor hf|M.S.D.|Lósartan||3872||3872|6276|
079103|L01AA0601|Holoxan|sts/irs|500|mg|1|stk|1|hgl||L01AA06|01.07.1998||R|||0|1|0|1|BAM|0|0|0|100|SEK|2816|4064|lyfsjukr||||1|0||Icepharma hf|Baxter Medical AB|Ífosfamíđ||2816||2816|4064|
079111|L01AA0601|Holoxan|sts/irs|1|g|1|stk|1|hgl||L01AA06|01.07.1998||R|||0|1|0|1|BAM|0|0|0|100|SEK|4771|6886|lyfsjukr||||1|0||Icepharma hf|Baxter Medical AB|Ífosfamíđ||4771||4771|6886|
079129|L01AA0601|Holoxan|sts/irs|2|g|1|stk|1|hgl||L01AA06|01.07.1998||R|||0|1|0|1|BAM|0|0|0|100|SEK|8873|12806|lyfsjukr||||1|0||Icepharma hf|Baxter Medical AB|Ífosfamíđ||8873||8873|12806|
079202|J05AH0201|Tamiflu|hylki|75|mg|10|stk|1|ţpakki||J05AH02|01.11.2002||R|||0|0|0|0|RRL|0|0|0|100|DKK|3783|6154|lyfalmen||||10|0|5,0000|Icepharma hf|Roche Registration Limited|Oseltamivír||3783||3783|6154|
079269|N05AB0302|Trilafon decanoat|stl|108,2|mg/ml|1|ml|10|lykjur||N05AB03|01.01.1988||R|||0|0|*|0|SPL|0|1|0|100|DKK|19112|26531|lyfalmen||||10|0|154,5714|Vistor hf|Schering-Plough Europe|Perfenazín||19112||19112|26531|
079358|N07BA0143|Nicotinell IceMint|tyggigúm|4|mg|24|stk|1|ţpakki||N07BA01|01.05.2010||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||24|0|3,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
079370|N07BA0143|Nicotinell IceMint|tyggigúm|4|mg|96|stk|1|ţpakki||N07BA01|01.05.2010||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||96|0|12,8000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
079381|N07BA0143|Nicotinell IceMint|tyggigúm|4|mg|204|stk|1|ţpakki||N07BA01|01.05.2010||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||204|0|27,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
079495|N06AB0308|Fluoxetin Actavis|lausnart|20|mg|100|stk|1|ţpakki||N06AB03|01.05.2010||R|||0|0|B|0|ACA|0|1|0|100|XEU|3611|5919|lyfalmen||||100|0|100,0000|Actavis Group hf|Actavis hf|Flúoxetín||3611||3611|5919|
079749|J01CF0101|Diclocil|sts/irs|1|g|1|stk|5|hgl||J01CF01|01.04.1987||R|||0|0|0|1|BRS|0|0|0|100|DKK|2146|3097|lyfsjukr||||5|0|2,5000|Vistor hf|Bristol-Myers Squibb|Díkloxacillín||2146||2146|3097|
080106|J01MA0203|Siprox|töflur|250|mg|10|stk|1|ţpakki||J01MA02|01.10.1992||R|||0|0|0|0|ACA|0|0|1|100|IKR|393|1517|lyfalmen|V0176|1517||10|0|2,5000|Actavis Group hf|Actavis hf|Cíprófloxacín||393||393|1517|
080115|J01MA0203|Siprox|töflur|250|mg|20|stk|1|ţpakki||J01MA02|01.10.1992||R|||0|0|0|0|ACA|0|0|1|100|IKR|638|1852|lyfalmen|V0418|1852||20|0|5,0000|Actavis Group hf|Actavis hf|Cíprófloxacín||638||638|1852|
080124|J01MA0203|Siprox|töflur|500|mg|10|stk|1|ţpakki||J01MA02|01.05.2008||R|||0|0|0|0|ACA|0|0|1|100|IKR|647|1864|lyfalmen|V0177|1864||10|0|5,0000|Actavis Group hf|Actavis hf|Cíprófloxacín||647||647|1864|
080133|J01MA0203|Siprox|töflur|500|mg|20|stk|1|ţpakki||J01MA02|01.01.1994||R|||0|0|0|0|ACA|0|0|1|100|IKR|1168|2577|lyfalmen|V0411|2577||20|0|10,0000|Actavis Group hf|Actavis hf|Cíprófloxacín||1168||1168|2577|
080145|QG02AD9002|Genestran|stl|75|mcg/ml|20|ml|1|hgl|lausn|QG02AD90|01.11.2011||R|||0|0|0|0|ANI|1|0|0|100|IKR|4985|9745|vetalmen||||20|0||Dýraheilsa ehf|aniMedica GmbH|||4985||4985|9745|
080156|QN02AF0101|Morphasol handa hundum og köttum|stl|4|mg/ml|10|ml|1|hgl||QN02AF01|01.06.2010||R|||0|0|0|0|ANI|1|0|0|100|XEU|4145|8132|vetalmen||||10|0||Dýraheilsa ehf|aniMedica GmbH|Bútorfanóltartrat||||4145|8132|
080331|L02BB0306|Bicalutamid LYFIS|filmhtfl|150|mg|30|stk|1|ţpakki||L02BB03|01.06.2012||R|||0|0|*|0|LYF|0|0|0|100|XEU|18206|22407|lyfalmen|V0421|21543||30|0|90,0000|LYFIS ehf|LYFIS ehf|Bíkalútamíđ||15826||15826|22407|
080424|G01AF0502|Pevaryl Depot|sk-stíll|150|mg|1|stk|1|still||G01AF05|01.04.1989||L|||0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa||||1|0|1,5000|Vistor hf|McNeil Sweden AB|Ekónazól||||||
080447|QP52AA5103|Drontal Vet.|filmhtfl|250|mg|24|stk|1|ţpakki|230+20 mg|QP52AA51|01.11.2011||R|||0|0|0|0|BAN|1|0|0|100|DKK|10573|18444|vetorma||||24|0||Icepharma hf|Bayer Animal Health GmbH|||10573||10573|18444|
080470|L02BG0406|Letrozole Bluefish|filmhtfl|2,5|mg|30|stk|1|ţpakki||L02BG04|01.03.2012||R|||0|0|*|0|RAT|0|0|0|100|XEU|17131|10204|lyfalmen|V0170|10204||30|0|30,0000|LYFIS ehf|ratiopharm GmbH|Letrózól||6744||6744|10204|
080482|L02BG0406|Letrozole Bluefish|filmhtfl|2,5|mg|100|stk|1|ţpakki||L02BG04|01.03.2012||R|||0|0|*|0|RAT|0|0|0|100|XEU|37855|27712|lyfalmen|V0185|27712||100|0|100,0000|LYFIS ehf|ratiopharm GmbH|Letrózól||20053||20053|27712|
080507|N06AA1001|Noritren|töflur|50|mg|100|stk|1|glas||N06AA10|01.04.1986||R|||0|0|B|0|LBK|0|1|0|100|DKK|2328|4163|lyfalmen||||100|0|66,6667|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||2328||2328|4163|
080524|N06AX1202|Wellbutrin Retard|töflur|300|mg|30|stk|1|ţpakki|m/br. losunarhrađa|N06AX12|01.07.2007||R|||0|0|0|0|GSK|0|1|1|100|GBP|6313|9615|lyfalmen||||30|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Bupropionum||6313||6313|9615|
080538|G04BE0306|Sildenafil Actavis|filmhtfl|50|mg|4|stk|1|pakki||G04BE03|01.08.2010||R|||0|0|0|0|AGP|0|0|0|100|XEU|2741|3649|lyfalmen|V0143|2523||4|0|4,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||1952||1952|3649|
080542|N06AX1202|Wellbutrin Retard|töflur|150|mg|30|stk|1|ţpakki|m/br. losunarhrađa|N06AX12|01.07.2007||R|||0|0|0|0|GSK|0|1|1|100|GBP|3278|5463|lyfalmen||||30|0|15,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Bupropionum||3278||3278|5463|
080549|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|500|ml|1|fl||QP54AA01|01.01.1985||R|||0|0|0|0|MEF|1|0|0|100|XEU|35270|61527|vetorma||||500|0||Vistor hf|Merial (MSD)|||35270||35270|61527|
080550|G04BE0306|Sildenafil Actavis|filmhtfl|50|mg|12|stk|1|pakki||G04BE03|01.08.2010||R|||0|0|0|0|AGP|0|0|0|100|XEU|7747|7570|lyfalmen|V0143|7570||12|0|12,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||4818||4818|7570|
080561|G04BE0306|Sildenafil Actavis|filmhtfl|100|mg|4|stk|1|pakki||G04BE03|01.08.2010||R|||0|0|0|0|AGP|0|0|0|100|XEU|3026|3748|lyfalmen|V0144|3063||4|0|8,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||2024||2024|3748|
080564|L01DB0601|Zavedos|sts|5|mg|1|stk|1|hgl||L01DB06|01.01.1992||R|||0|1|0|1|PER|0|0|0|100|DKK|15490|21322|lyfsjukr||||1|0||Icepharma hf|Pfizer ApS|Ídarúbicín||15490||15490|21322|
080573|G04BE0306|Sildenafil Actavis|filmhtfl|100|mg|12|stk|1|pakki||G04BE03|01.08.2010||R|||0|0|0|0|AGP|0|0|0|100|XEU|11277|11323|lyfalmen|V0144|9188||12|0|24,0000|Actavis Group hf|Actavis Group PTC ehf|Síldenafíl||7562||7562|11323|
080820|L01DB0601|Zavedos|sts|10|mg|1|stk|1|hgl||L01DB06|01.01.1992||R|||0|1|0|1|PER|0|0|0|100|DKK|30538|40208|lyfsjukr||||1|0||Icepharma hf|Pfizer ApS|Ídarúbicín||30538||30538|40208|
081315|M09AX0101|Artzal|stl|10|mg/ml|2,5|ml|5|dćlur|einnota dćlur plast|M09AX01|01.07.2012||R|||0|0|E|0|ASA|0|0|0|100|SEK|38005|50241|lyfalmen|V0209|50241||12|0|34,7222|Vistor hf|Astra Zeneca A/S|Natríumhýalúrónat||38005||38005|50241|
081525|V03AN0101|Conoxia|innö.gas|100|%|10|l|1|hylki|MO10|V03AN01|01.04.2007||L|||0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa||||10|0||Ísaga ehf|AGA AB|Súrefni||||||
081534|V03AN0101|Conoxia|innö.gas|100|%|20|l|1|hylki|MO20|V03AN01|01.04.2007||L|||0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa||||20|0||Ísaga ehf|AGA AB|Súrefni||||||
081543|V03AN0101|Conoxia|innö.gas|100|%|50|l|1|hylki|Mo50|V03AN01|01.04.2007||L|||0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa||||50|0||Ísaga ehf|AGA AB|Súrefni||||||
081552|V03AN0101|Conoxia|innö.gas|100|%|5|l|1|hylki|MO5|V03AN01|01.04.2007||L|||0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa||||5|0||Ísaga ehf|AGA AB|Súrefni||||||
081561|V03AN0101|Conoxia|innö.gas|100|%|50|l|12|hylki|MS5I|V03AN01|01.04.2007||L|||0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa||||600|0||Ísaga ehf|AGA AB|Súrefni||||||
081589|V03AN0101|Conoxia|innö.gas|100|%|1|l|1|hylki|MO1|V03AN01|01.04.2007||L|||0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa||||1|0||Ísaga ehf|AGA AB|Súrefni||||||
081613|N07BA0143|Nicotinell IceMint|tyggigúm|2|mg|24|stk|1|ţpakki||N07BA01|01.05.2010||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||24|0|1,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
081624|N07BA0143|Nicotinell IceMint|tyggigúm|2|mg|96|stk|1|ţpakki||N07BA01|01.05.2010||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||96|0|6,4000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
081625|V03AN0101|Conoxia|innö.gas|100|%|2|l|1|hylki|MO2|V03AN01|01.04.2007||L|||0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa||||2|0||Ísaga ehf|AGA AB|Súrefni||||||
081634|V03AN0101|Conoxia|innö.gas|100|%|4|l|1|hylki|MO4b|V03AN01|01.04.2007||L|||0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa||||4|0||Ísaga ehf|AGA AB|Súrefni||||||
081635|N07BA0143|Nicotinell IceMint|tyggigúm|2|mg|204|stk|1|ţpakki||N07BA01|01.05.2010||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
081645|N03AX1405|Matever|filmhtfl|250|mg|100|stk|1|ţpakki||N03AX14|01.02.2012||R|||0|0|0|0|PSA|0|0|0|100|XEU|8303|7783|lyfalmen|V0515|6626||100|0|16,6700|Portfarma ehf|Pharmathen S.A.|Levetíracetam||4974||4974|7783|
081669|G03DA0404|Lutinus|sk-tafla|100|mg|21|stk|1|ţpakki||G03DA04|01.04.2011||R|||0|1|E|0|FEL|0|0|0|100|DKK|4773|7508|lyfalmen||||21|0|23,3300|Vistor hf|Ferring Lćgemidler A/S|Prógesterón||4773||4773|7508|
081671|V03AN0101|Conoxia|innö.gas|100|%|4|l|1|hylki|MO4|V03AN01|01.04.2007||L|||0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa||||4|0||Ísaga ehf|AGA AB|Súrefni||||||
081745|N05CD0801|Dormicum|stl|5|mg/ml|1|ml|10|lykjur||N05CD08|01.07.1985||R|||0|0|0|1|ROC|0|0|0|100|DKK|1891|2729|lyfsjukr||||10|0|3,3333|Icepharma hf|Roche|Mídazólam||1891||1891|2729|
081897|N05AH0305|Zyprexa Velotab (D.A.C.)|munndr.t|10|mg|28|stk|1|ţpakki||N05AH03|01.04.2010||R|||0|0|*|0|DAC|0|1|0|100|XEU|20218|15987|lyfalmen|V0456|11063||28|0|28,0000|D.A.C. ehf|D.A.C. ehf|Olanzapín||10971||10971|15987|
081987|A10AB0602|Apidra [Solostar]|stl|100|ein/ml|3|ml|5|lyfjap|áfylltir lyfjapennar|A10AB06|01.01.2008||R|||0|0|*|0|SAA|0|0|0|100|NOK|6074|9288|lyfalmen||||15|0|37,5000|Vistor hf|Sanofi - Aventis|Insúlín glúlisín||6074||6074|9288|
081996|A10AE0403|Lantus [SoloStar]|stl|100|ein/ml|3|ml|5|lyfjap|áfylltir lyfjapennar|A10AE04|01.01.2008||R|||0|0|*|0|SDE|0|0|0|100|NOK|9125|13461|lyfalmen||||15|0|37,5000|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||9125||9125|13461|
082021|L02BG0302|Anastrozol Actavis|filmhtfl|1|mg|98|stk|1|ţpakki||L02BG03|01.03.2011||R|||0|0|*|0|AGP|0|0|0|100|XEU|39202|20684|lyfalmen|V0184|18706||98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Anastrózól||14453||14453|20684|
082040|D07XC0101|Diprosalic|áburđur|||100|ml|1|glas||D07XC01|01.01.1987||R|||0|0|B|0|SPL|0|0|1|100|DKK|2322|4155|lyfalmen||||100|0||Vistor hf|Schering-Plough Europe|Betametasón||2322||2322|4155|
082233|V03AN0101|Conoxia|innö.gas|100|%|36|l|1|hylki|Hemlox|V03AN01|01.04.2007||L|||0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa||||36|0||Ísaga ehf|AGA AB|Súrefni||||||
082685|R03BA0502|Flixotide Diskus|innúđadu|250|mcg/sk|60|sk|1|pakki|í diskus-t|R03BA05|01.07.1995||R|||0|0|B|0|GSK|0|0|0|100|GBP|3378|5094|lyfalmen||||60|0|25,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||3008||3008|5094|
082719|R03BA0502|Flixotide Diskus|innúđadu|500|mcg/sk|60|sk|1|pakki|í diskus-t|R03BA05|01.07.1995||R|||0|0|B|0|GSK|0|0|0|100|GBP|5986|9167|lyfalmen||||60|0|50,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||5986||5986|9167|
082792|J01CA0411|Amoxicillin Mylan|mixt.kyr|50|mg/ml|125|ml|1|glas||J01CA04|01.07.1998||R|||0|0|0|0|MYL|0|0|1|100|SEK|942|2268|lyfalmen||||125|0|6,2500|Actavis Group PTC ehf|Mylan AB|Amoxicillín||942||942|2268|
082797|N02BE0117|Panodil Zapp|filmhtfl|500|mg|20|stk|1|ţpakki||N02BE01|01.02.2012||L|||0|0|0|0|GGK|0|0|1|100|IKR|||lyflausa||||20|0|3,3333|GlaxoSmithKline ehf|GlaxoSmithKline Consumer Healthcare A/S|Paracetamól||||||
082883|R03BA0201|Pulmicort|innúđal|0,125|mg/ml|20|plhylk|1|pakki|í vél|R03BA02|01.01.1997||R|||0|0|0|0|AZD|0|0|0|100|SEK|4795|7538|lyfalmen||||20|0|1,6700|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||4795||4795|7538|
082933|R03BA0201|Pulmicort|innúđal|0,25|mg/ml|20|plhylk|1|pakki|í vél|R03BA02|01.01.1997||R|||0|0|0|0|AZD|0|0|0|100|SEK|5668|8732|lyfalmen||||20|0|3,3300|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||5668||5668|8732|
082940|C09CA0602|Candpress|töflur|16|mg|100|stk|1|ţpakki||C09CA06|01.01.2012||R|||0|0|0|0|AGP|0|0|0|100|XEU|9273|13347|lyfalmen|V0080|5305||100|0|200,0000|Actavis Group hf|Actavis Group PTC ehf|Candesartan||9041||9041|13347|
082958|N06DA0301|Exelon|hylki|1,5|mg|56|stk|1|ţpakki||N06DA03|01.10.2008||R|||0|0|E|0|NOH|0|0|0|100|DKK|13568|19573|lyfalmen||||56|0|9,3350|Vistor hf|Novartis Healthcare A/S-|Rívastigmín||13568||13568|19573|
083113|L02BG0301|Arimidex|filmhtfl|1|mg|28|stk|1|ţpakki||L02BG03|01.03.1998||R|||0|0|*|0|AZA|0|0|0|100|SEK|19192|26631|lyfalmen|V0186|7570||28|0|28,0000|Vistor hf|AstraZeneca AB|Anastrózól||19192||19192|26631|
083121|N06DA0301|Exelon|hylki|3|mg|56|stk|1|ţpakki||N06DA03|01.10.2008||R|||0|0|E|0|NOH|0|0|0|100|DKK|14170|20328|lyfalmen|V0344|14180||56|0|18,6700|Vistor hf|Novartis Healthcare A/S-|Rívastigmín||14170||14170|20328|
083154|R03BA0201|Pulmicort|innúđal|0,5|mg/ml|20|plhylk|1|pakki|í vél|R03BA02|01.01.1997||R|||0|0|0|0|AZD|0|0|0|100|SEK|7490|11225|lyfalmen||||20|0|6,6700|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||7490||7490|11225|
083592|J05AE0301|Norvir|mixtúra|80|mg/ml|90|ml|5|glös||J05AE03|01.08.2003||R|||0|1|0|1|ABL|0|0|0|100|DKK|79187|101262|lyfsjukr||||450|0|30,0000|Vistor hf|Abbott Laboratories A/S|Ritonavír||79187||79187|101262|
083634|N06DA0301|Exelon|hylki|6|mg|112|stk|1|ţpakki||N06DA03|01.01.1999||R|||0|0|E|0|NOH|0|0|0|100|DKK|30749|41135|lyfalmen|V0346|30459||112|0|74,6667|Vistor hf|Novartis Healthcare A/S-|Rívastigmín||30749||30749|41135|
083980|L02AE0101|Suprefact|stl|1|mg/ml|5,5|ml|2|hgl||L02AE01|01.10.1987||R|||0|1|0|1|SNO|0|0|0|100|NOK|8694|12548|lyfsjukr||||11|0|7,3333|Vistor hf|Sanofi-aventis Norge AS|Búserelín||8694||8694|12548|
084097|C09CA0105|Losartan LYFIS|filmhtfl|50|mg|98|stk|1|ţpakki||C09CA01|01.05.2012||R|||0|0|B|0|LYF|0|0|0|100|XEU|2178|2518|lyfalmen|V0069|2518||98|0|98,0000|LYFIS ehf|LYFIS ehf|Lósartan||1125||1125|2518|
084160|C03CA0101|Furix|stl|10|mg/ml|2|ml|5|lykjur||C03CA01|01.03.2003||R|||0|0|E|0|NYG|0|0|0|100|DKK|277|1358|lyfalmen||||10|0|2,5000|Gróco ehf|Nycomed Danmark A/S|Fúrósemíđ||277||277|1358|
084376|C03CA0101|Furix|stl|10|mg/ml|4|ml|5|lykjur||C03CA01|01.03.2003||R|||0|0|E|0|NYG|0|0|0|100|DKK|535|1711|lyfalmen||||20|0|5,0000|Gróco ehf|Nycomed Danmark A/S|Fúrósemíđ||535||535|1711|
084591|L04AB0101|Enbrel|stl|25|mg|4|áf.spr|1|pakki|lausn|L04AB01|01.04.2012||R|||0|1|0|1|IPI|0|0|0|100|DKK|75458|96582|lyfsjukr||||4|0|14,2900|Icepharma hf|Pfizer Limited|Etanercept||75458||75458|96582|
084669|B03XA0301|Mircera|stl|150|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|||0|1|0|1|RRL|0|0|0|100|DKK|63122|81101|lyfsjukr||||0|0|37,5000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||63122||63122|81101|
084678|B03XA0301|Mircera|stl|200|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|||0|1|0|1|RRL|0|0|0|100|DKK|82289|105155|lyfsjukr||||0|0|50,0000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||82289||82289|105155|
084687|B03XA0301|Mircera|stl|250|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|||0|1|0|1|RRL|0|0|0|100|DKK|101803|129645|lyfsjukr||||0|0|62,5000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||101803||101803|129645|
084696|B03XA0301|Mircera|stl|50|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|||0|1|0|1|RRL|0|0|0|100|DKK|21041|28289|lyfsjukr||||0|0|12,5000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||21041||21041|28289|
084705|B03XA0301|Mircera|stl|75|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|||0|1|0|1|RRL|0|0|0|100|DKK|32863|43126|lyfsjukr||||0|0|18,7500|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||32863||32863|43126|
084714|B03XA0301|Mircera|stl|100|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|||0|1|0|1|RRL|0|0|0|100|DKK|42081|54694|lyfsjukr||||0|0|25,0000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||42081||42081|54694|
084751|B03XA0301|Mircera|stl|30|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.05.2009||R|||0|1|0|1|RRL|0|0|0|100|DKK|13032|18238|lyfsjukr||||0|0|7,5000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||||13032|18238|
084778|B03XA0301|Mircera|stl|120|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.05.2009||R|||0|1|0|1|RRL|0|0|0|100|DKK|49679|64230|lyfsjukr||||0|0|30,0000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||||49679|64230|
084787|B03XA0301|Mircera|stl|360|mcg/spr|0,6|ml|1|áf.spr||B03XA03|01.05.2009||R|||0|1|0|1|RRL|0|0|0|100|DKK|153006|193905|lyfsjukr||||1|0|90,0000|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||||153006|193905|
084878|N03AF0301|Inovelon|filmhtfl|100|mg|10|stk|1|ţpakki||N03AF03|01.09.2007||R|||0|1|E|0|EIS|0|0|0|100|SEK|957|2288|lyfalmen||||10|0|0,7100|Vistor hf|Eisai Ltd|Rúfínamíđ||957||957|2288|
084887|N03AF0301|Inovelon|filmhtfl|200|mg|60|stk|1|ţpakki||N03AF03|01.09.2007||R|||0|1|E|0|EIS|0|0|0|100|SEK|11350|16505|lyfalmen||||60|0|8,5700|Vistor hf|Eisai Ltd|Rúfínamíđ||11350||11350|16505|
084896|N03AF0301|Inovelon|filmhtfl|400|mg|100|stk|1|ţpakki||N03AF03|01.09.2007||R|||0|1|E|0|EIS|0|0|0|100|SEK|36937|48901|lyfalmen||||100|0|28,5700|Vistor hf|Eisai Ltd|Rúfínamíđ||36937||36937|48901|
085068|N02AA0101|Contalgin|forđatfl|100|mg|100|stk|1|ţpakki||N02AA01|01.10.1985||R|||1|0|E|0|PER|0|0|0|100|DKK|15952|22565|lyfalmen||||100|0|100,0000|Icepharma hf|Pfizer ApS|Morfín||15952||15952|22565|
085184|L01XD0301|Metvix|krem|160|mg/g|2|g|1|túpa||L01XD03|01.09.2010||R|||0|1|*|0|GAN|0|0|0|100|NOK|45093|59137|lyfalmen||||2|0||Icepharma hf|Galderma Nordic AB|Metýlamínólevúlínat||45093||45093|59137|
085205|S01AX1901|Oftaquix|augndr|5|mg/ml|0,5|ml|30|sk-hyl||S01AX19|01.03.2008||R|||0|0|0|0|SAO|0|0|1|100|XEU|2698|4670|lyfalmen||||15|0||Icepharma hf|Santen Oy|Levófloxacín||2698||2698|4670|
085316|N06DA0301|Exelon|hylki|4,5|mg|112|stk|1|ţpakki||N06DA03|01.01.1999||R|||0|0|E|0|NOH|0|0|0|100|DKK|30749|41135|lyfalmen|V0345|30459||112|0|56,0000|Vistor hf|Novartis Healthcare A/S-|Rívastigmín||30749||30749|41135|
085407|R03AC0206|Ventoline|lausn|1|mg/ml|20|lykjur|1|pakki|f. vél|R03AC02|01.04.1992||R|||0|0|0|0|GSK|0|0|1|100|GBP|832|2117|lyfalmen||||20|0|5,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salbútamól||832||832|2117|
085542|G03GA0202|Menopur|sts|||75|ae|5|hgl|+ leysir|G03GA02|01.03.2001||R|||0|1|E|0|FEL|0|0|0|100|DKK|20925|28806|lyfalmen|V0412|24038||375|0|12,5000|Vistor hf|Ferring Lćgemidler A/S|Menótrópín||20925||20925|28806|
085551|G03GA0202|Menopur|sts|||75|ae|10|hgl|+ leysir|G03GA02|01.03.2001||R|||0|1|E|0|FEL|0|0|0|100|DKK|36279|48075|lyfalmen|V0412|48075||750|0|25,0000|Vistor hf|Ferring Lćgemidler A/S|Menótrópín||36279||36279|48075|
085770|G04BE0804|Adcirca|filmhtfl|20|mg|56|stk|1|ţpakki||G04BE08|01.12.2010||R|||0|1|0|1|ELD|0|0|0|100|XEU|96771|123330|lyfsjukr||||56|0|112,0000|Icepharma hf|Eli Lilly Nederland B.V.|Tadalafíl||96771||96771|123330|
085804|M05BX0401|Prolia|stl|60|mg/ml|1|ml|1|áf.spr|lausn|M05BX04|01.10.2010||R|||0|0|0|0|AEU|0|0|0|100|DKK|41079|54099|lyfalmen||||1|0|181,8100|Vistor hf|Amgen Europe B.V.|Denosúmab||41079||41079|54099|
085838|S01EE0301|Lumigan|augndr|0,1|mg/ml|3|ml|1|glös|lausn|S01EE03|01.10.2011||R|||0|0|*|0|API|0|0|0|100|SEK|2993|5073|lyfalmen|V0465|4360||3|0|30,0000|Vistor hf|Allergan Pharmaceuticals Ireland|Bimatóprost||2993||2993|5073|
085849|S01EE0301|Lumigan|augndr|0,1|mg/ml|3|ml|3|glös|lausn|S01EE03|01.10.2011||R|||0|0|*|0|API|0|0|0|100|SEK|8846|13080|lyfalmen|V0465|13080||9|0|90,0000|Vistor hf|Allergan Pharmaceuticals Ireland|Bimatóprost||8846||8846|13080|
085969|R06AX2601|Telfast|töflur|120|mg|100|stk|1|ţpakki||R06AX26|01.11.1999||R|||0|0|E|0|SNO|0|0|1|100|NOK|4236|5319|lyfalmen|V0364|4778||100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||3173||3173|5319|
086108|R06AX2601|Telfast|töflur|180|mg|100|stk|1|ţpakki||R06AX26|01.11.1999||R|||0|0|E|0|SNO|0|0|1|100|NOK|5736|6176|lyfalmen|V0365|5527||100|0|150,0000|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||3799||3799|6176|
086207|J01DD0202|Fortum|sts|1|g/hgl|5|hgl|1|pakki||J01DD02|01.08.2002||R|||0|0|0|1|GSK|0|0|0|100|GBP|8755|12636|lyfsjukr||||5|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ceftazidím||8755||8755|12636|
086231|J01DD0202|Fortum|sts|2|g/hgl|5|hgl|1|pakki||J01DD02|01.08.2002||R|||0|0|0|1|GSK|0|0|0|100|GBP|15219|20982|lyfsjukr||||5|0|2,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ceftazidím||15219||15219|20982|
086368|G03GA0202|Menopur|sts|||600|ae|1|hgl|+ leysir|G03GA02|01.04.2011||R|||0|1|E|0|FEL|0|0|0|100|DKK|31095|41569|lyfalmen||||600|0|20,0000|Vistor hf|Ferring Lćgemidler A/S|Menótrópín||31095||31095|41569|
086380|G03GA0202|Menopur|sts|||1200|ae|1|hgl|+ leysir|G03GA02|01.04.2011||R|||0|1|E|0|FEL|0|0|0|100|DKK|62190|80594|lyfalmen||||1200|0|40,0000|Vistor hf|Ferring Lćgemidler A/S|Menótrópín||62190||62190|80594|
086434|L04AA2401|Orencia|stl/irţ|250|mg/hgl|1|hgl|1|hgl|+ sprauta|L04AA24|01.02.2008||R|||0|1|0|1|BSP|0|0|0|100|DKK|55179|71132|lyfsjukr||||1|0|9,2600|Vistor hf|Bristol-Myers Squibb Pharma (UK) Ltd |Abatacept||55179||55179|71132|
086969|J05AB1401|Valcyte|mixtúrud|50|mg/ml|100|ml|1|glerfl|lausn|J05AB14|01.09.2009||R|||0|0|0|1|ROA|0|0|0|100|DKK|51750|66829|lyfsjukr||||100|0|5,5000|Icepharma hf|Roche A.S.|Valgancíklóvír||51750||51750|66829|
087114|G03CX0101|Livial|töflur|2,5|mg|28|stk|1|ţpakki||G03CX01|01.07.1998||R|||0|0|E|0|ORG|0|0|0|100|DKK|3070|5179|lyfalmen||||28|0|28,0000|Vistor hf|N.V. Organon|Tíbólón||3070||3070|5179|
087215|A03AX1335|Imogaze|hylki|240|mg|30|stk|1|ţpakki|mjúk hylki|A03AX13|01.12.2008||L|||0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa||||30|0|14,4000|Vistor hf|McNeil Sweden AB|Silíkonsambönd||||||
087260|J05AX0901|Celsentri|filmhtfl|150|mg|60|stk|1|ţpakki||J05AX09|01.04.2008||R|||0|1|0|1|VII|0|0|0|100|DKK|165672|209801|lyfsjukr||||60|0|15,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Maravíroc||165672||165672|209801|
087304|N05CF0101|Imovane|töflur|7,5|mg|10|stk|1|ţpakki||N05CF01|01.10.1995||R|||0|0|0|0|SNO|0|0|1|100|NOK|303|1393|lyfalmen|V0312|448||10|0|10,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||303||303|1393|
087312|N05CF0101|Imovane|töflur|7,5|mg|30|stk|1|ţpakki||N05CF01|01.10.1995||R|||0|0|0|0|SNO|0|0|0|100|NOK|267|1344|lyfalmen|V0312|1344||30|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||267||267|1344|
087320|N05CF0101|Imovane|töflur|7,5|mg|100|stk|1|ţpakki||N05CF01|01.10.1995||R|||0|0|0|0|SNO|0|0|0|100|NOK|2245|4050|lyfalmen||||100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||2245||2245|4050|
087445|A02BX1301|Gaviscon|mixtúra|||500|ml|1|glas||A02BX13|01.08.1984||L|||0|0|0|0|NDR|0|0|0|100|IKR|||lyfalmen||||500|0||Vistor hf|Nordic Drugs AB|Algínsýra|||||3586|
087759|G03GB0202|Pergotime|töflur|50|mg|5|stk|1|ţpakki||G03GB02|01.07.1986||R|||0|0|E|0|MEC|0|0|0|100|SEK|891|2198|lyfalmen||||5|0|27,7778|Icepharma hf|Merck AB|Klómífen||891||891|2198|
087788|B01AC0403|Clopidogrel Actavis|filmhtfl|75|mg|28|stk|1|ţpakki||B01AC04|01.11.2010||R|||0|0|E|0|APC|0|0|0|100|XEU|3595|2283|lyfalmen|V0009|2014||28|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Klópídógrel||953||953|2283|
087832|L02BB0304|Bicalutamid Actavis|filmhtfl|50|mg|30|stk|1|ţpakki||L02BB03|01.09.2007||R|||0|0|*|0|AGP|0|0|0|100|XEU|11019|11325|lyfalmen|V0420|10122||30|0|30,0000|Actavis Group hf|Actavis Group PTC ehf|Bíkalútamíđ||7563||7563|11325|
087867|QP52AA5108|Prazitel Plus|töflur|||104|stk|1|ţpakki|50/144/150|QP52AA51|01.07.2010||R|||0|0|0|0|CHP|0|0|0|100|XEU|32308|56360|vetorma||||104|0||Icepharma hf|Chanelle Pharmaceuticals|||32308||32308|56360|
087932|A02BX1301|Gaviscon|tuggutfl|||20|stk|1|ţpakki||A02BX13|01.10.1993||L|||0|0|0|0|NDR|0|0|0|100|IKR|||lyflausa||||20|0||Vistor hf|Nordic Drugs AB|Algínsýra||||||
087969|QD07AC0001|Cortavance|húđúđi|0,584|mg/ml|76|ml|1|fl|lausn|QD07AC|01.04.2012||R|||0|0|0|0|VIR|0|0|0|100|DKK|4575|8957|vetalmen||||76|0||Vistor hf|Virbac S.A|Hýdrókortisón aceponat||4575||4575|8957|
088026|QG03DA0402|Prid delta|sk-innl|1,55|g|10|stk|1|pakki||QG03DA04|01.02.2012||R|||0|0|0|0|CES|1|0|0|100|SEK|28462|49651|vetorma||||10|0||Icepharma hf|Ceva Sante Animale|Prógesterón||28462||28462|49651|
088261|R01AD1201|Avamys|nefúđi|27,5|mcg/sk|120|sk|1|glas||R01AD12|01.04.2008||R|||0|0|E|0|GGL|0|0|1|100|GBP|1422|2924|lyfalmen||||120|0|30,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Flútíkasón fúróat||1422||1422|2924|
088310|M01AX0101|Relifex|lausnart|1|g|20|stk|1|ţpakki||M01AX01|01.04.1995||R|||0|0|E|0|MAB|0|0|1|100|SEK|1552|3102|lyfalmen||||20|0|20,0000|Vistor hf|Meda AB|Nabúmeton||1552||1552|3102|
088328|M01AX0101|Relifex|lausnart|1|g|100|stk|1|ţpakki||M01AX01|01.04.1995||R|||0|0|E|0|MAB|0|0|1|100|SEK|5989|9172|lyfalmen||||100|0|100,0000|Vistor hf|Meda AB|Nabúmeton||5989||5989|9172|
088393|A03FA0101|Primperan|eţ-stíll|20|mg|6|stk|1|pakki||A03FA01|01.10.1995||R|||0|0|E|0|SNO|0|0|1|100|NOK|411|1541|lyfalmen||||6|0|4,0000|Vistor hf|Sanofi-aventis Norge AS|Metóklópramíđ||411||411|1541|
088696|D05AX5201|Daivobet|hlaup|||30|g|1|fl|50 mcg/g+0,5 mg/g|D05AX52|01.04.2012||R|||0|0|B|0|LEP|0|0|0|100|DKK|5214|8111|lyfalmen||||30|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||5214||5214|8111|
088705|D05AX5201|Daivobet|hlaup|||60|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.02.2011||R|||0|0|B|0|LEP|0|0|0|100|DKK|10073|14758|lyfalmen||||60|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||10073||10073|14758|
088714|D05AX5201|Daivobet|hlaup|||60|g|2|fl|50 mcg/g+0,5 mg/g|D05AX52|01.04.2012||R|||0|0|B|0|LEP|0|0|0|100|DKK|15455|21941|lyfalmen||||120|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||15455||15455|21941|
088723|L01XE0701|Tyverb|filmhtfl|250|mg|70|stk|1|ţpakki||L01XE07|01.11.2008||R|||0|1|0|1|GGL|0|0|0|100|GBP|178960|226477|lyfsjukr||||70|0||GlaxoSmithKline ehf|Glaxo Group Limited|Labatinibum||||178960|226477|
088814|L02BB0304|Bicalutamid Actavis|filmhtfl|150|mg|30|stk|1|ţpakki||L02BB03|01.12.2008||R|||0|0|*|0|AGP|0|0|0|100|XEU|23379|23706|lyfalmen|V0421|21543||30|0|90,0000|Actavis Group hf|Actavis Group PTC ehf|Bíkalútamíđ||16861||16861|23706|
088964|S01EE0103|Latanoprost Portfarma|augndr|50|mcg/ml|7,5|ml|1|pakki|3 glös í pakka|S01EE01|01.08.2010||R|||0|0|*|0|POF|0|0|0|100|DKK|6558|6634|lyfalmen|V0376|6634||8|0|75,0000|Portfarma ehf|Portfarma|Latanóprost||4134||4134|6634|
088975|G03AA1005|Harmonet|töflur|||63|stk|1|ţpakki|20+75 mcg|G03AA10|01.10.2011||R|||0|0|0|0|PER|0|0|0|100|DKK|1801|3443|lyfalmen||||63|0|84,0000|Icepharma hf|Pfizer ApS|Gestóden og östrógen||1801||1801|3443|
089094|A02BX1301|Gaviscon|tuggutfl|||120|stk|1|ţpakki||A02BX13|01.01.1989||L|||0|0|0|0|NDR|0|0|0|100|IKR|||lyfalmen||||120|0||Vistor hf|Nordic Drugs AB|Algínsýra|||||5674|
089114|J05AX0901|Celsentri|filmhtfl|300|mg|60|stk|1|ţpakki||J05AX09|01.04.2008||R|||0|1|0|1|VII|0|0|0|100|DKK|165672|209801|lyfsjukr||||60|0|30,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Maravíroc||165672||165672|209801|
089156|A03AA0406|Mebeverin Dura|filmhtfl|135|mg|100|stk|1|ţpakki||A03AA04|01.07.2010||R|||0|0|E|0|MYD|0|0|0|100|SEK|4069|6545|lyfalmen||||100|0|45,0000|Actavis Group PTC ehf|Mylan dura GmbH|Mebeverín||4069||4069|6545|
089281|R06AX1305|Loratadin LYFIS|töflur|10|mg|10|stk|1|ţpakki||R06AX13|01.05.2012||L|||0|0|0|0|LYF|0|0|1|100|IKR|||lyflausa||||10|0|10,0000|LYFIS ehf|LYFIS ehf|Lóratadín||||||
089293|R06AX1305|Loratadin LYFIS|töflur|10|mg|30|stk|1|ţpakki||R06AX13|01.05.2012||L|||0|0|0|0|LYF|0|0|1|100|IKR|||lyflausa||||30|0|30,0000|LYFIS ehf|LYFIS ehf|Lóratadín||||||
089304|R06AX1305|Loratadin LYFIS|töflur|10|mg|100|stk|1|ţpakki||R06AX13|01.05.2012||R|||0|0|E|0|LYF|0|0|1|100|XEU|1659|2321|lyfalmen|V0362|2321||100|0|100,0000|LYFIS ehf|LYFIS ehf|Lóratadín||981||981|2321|
090159|C08DB0101|Cardizem|töflur|60|mg|100|stk|1|glas||C08DB01|01.10.1995||R|||0|0|B|0|FRO|0|0|0|100|DKK|2390|4248|lyfalmen||||100|0|25,0000|Vistor hf|Ferrosan A/S|Diltíazem||2390||2390|4248|
090229|J01DB0101|Keflex|töflur|500|mg|20|stk|1|ţpakki||J01DB01|01.07.2011||R|||0|0|0|0|PAD|0|0|1|100|DKK|1635|3215|lyfalmen||||20|0|5,0000|Icepharma hf|PharmaCoDane ApS|Cefalexín||1635||1635|3215|
090240|J01DB0101|Keflex|töflur|500|mg|40|stk|1|ţpakki||J01DB01|01.05.2011||R|||0|0|0|0|PAD|0|0|1|100|DKK|3246|5419|lyfalmen||||40|0|10,0000|Icepharma hf|PharmaCoDane ApS|Cefalexín||3246||3246|5419|
090320|J01DB0101|Keflex|mixt.kyr|50|mg/ml|100|ml|1|fl|dreifa|J01DB01|01.03.2012||R|||0|0|0|0|PAD|0|0|1|100|DKK|975|2313|lyfalmen||||100|0|2,5000|Icepharma hf|PharmaCoDane ApS|Cefalexín||975||975|2313|
090354|J01DB0401|Kefzol|sts|1|g|10|stk|1|hgl||J01DB04|01.06.2011||R|||0|0|0|1|NOM|0|0|0|100|DKK|5975|8623|lyfsjukr||||10|0|3,3333|Icepharma hf|NordMedica ApS|Cefazólín||5975||5975|8623|
090662|R01AD1101|Nasacort|nefúđi|55|mcg/sk|16,5|ml|1|stauk|120 sk|R01AD11|01.11.1998||R|||0|0|E|0|SNO|0|0|1|100|NOK|1848|3507|lyfalmen||||16|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Tríamcínólón||1848||1848|3507|
090688|A06AB0602|Senokot|töflur|7,5|mg|60|stk|1|ţpakki||A06AB06|01.10.1990|31.05.2012|R|||0|0|0|0|REB|0|0|0|100|GBP|933|2255|lyfalmen||||60|0||Icepharma hf|Reckitt Benckiser Healthcare Ltd.|Senna||933||933|2255|
090979|S01JA0101|Anatera|stl|100|mg/ml|5|ml|12|hgl|lausn|S01JA01|01.10.2011||R|||0|1|0|1|ACK|0|0|0|100|USD|17437|23766|lyfsjukr||||60|0||Vistor hf|Alcon Denmark A/S|Flúorescein||||17437|23766|
091266|V03AF0401|Isovorin|stl|10|mg/ml|2,5|ml|1|hgl||V03AF04|01.04.2012||R|||0|0|0|1|PER|0|0|0|100|DKK|2932|4232|lyfsjukr||||2|0|0,8333|Icepharma hf|Pfizer ApS|Kalsíumlevófólínat||2932||2932|4232|
091277|V03AF0401|Isovorin|stl|10|mg/ml|5|ml|1|hgl||V03AF04|01.04.2012||R|||0|0|0|1|PER|0|0|0|100|DKK|5068|7314|lyfsjukr||||5|0|1,6667|Icepharma hf|Pfizer ApS|Kalsíumlevófólínat||5068||5068|7314|
091289|V03AF0401|Isovorin|stl|10|mg/ml|17,5|ml|1|hgl||V03AF04|01.04.2012||R|||0|0|0|1|PER|0|0|0|100|DKK|14871|20546|lyfsjukr||||18|0|5,8333|Icepharma hf|Pfizer ApS|Kalsíumlevófólínat||14871||14871|20546|
091345|N06BA0403|Ritalin Uno|hylki|10|mg|30|stk|1|glas||N06BA04|01.03.2011||R|||1|0|0|0|NOH|0|0|0|100|DKK|3452|5701|lyfalmen||||30|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Metýlfenídat||3452||3452|5701|
091649|L01DB0105|Doxorubicin Actavis|sts|10|mg|1|stk|1|hgl|lausn|L01DB01|01.12.2011||R|||0|1|0|1|APC|0|0|0|100|XEU|1840|2656|lyfsjukr||||1|0||Actavis Group PTC ehf|Actavis Group PTC ehf|Doxórúbicín||||1840|2656|
091662|L01DB0105|Doxorubicin Actavis|sts|50|mg|1|stk|1|hgl|lausn|L01DB01|01.12.2011||R|||0|1|0|1|APC|0|0|0|100|XEU|7528|10865|lyfsjukr||||1|0||Actavis Group PTC ehf|Actavis Group PTC ehf|Doxórúbicín||||7528|10865|
091736|S01BA0102|Opnol|augndr|1|mg/ml|30|sk-hyl|1|pakki|lausn|S01BA01|01.05.2011||R|||0|0|E|0|CHA|0|0|1|100|DKK|4073|6551|lyfalmen||||30|0||Vistor hf|CCS Healthcare AB|Dexametasón||4073||4073|6551|
091751|A10BB1201|Amaryl|töflur|1|mg|90|stk|1|ţpakki||A10BB12|01.09.1997||R|||0|0|*|0|AVP|0|0|0|100|NOK|1309|2646|lyfalmen|V0021|1928||90|0|45,0000|Vistor hf|Aventis Pharma |Glímepíríđ||1219||1219|2646|
091769|A10BB1201|Amaryl|töflur|2|mg|90|stk|1|ţpakki||A10BB12|01.09.1997||R|||0|0|*|0|AVP|0|0|0|100|NOK|2263|3619|lyfalmen|V0022|2537||90|0|90,0000|Vistor hf|Aventis Pharma |Glímepíríđ||1930||1930|3619|
091872|C07AA0512|Pranolol|töflur|80|mg|100|stk|1|glas||C07AA05|01.12.2011||R|||0|0|B|0|AGT|0|0|0|100|XEU|640|1854|lyfalmen||||100|0|50,0000|Actavis Group hf|Actavis Group hf|Própranólól||640||640|1854|
092005|N06AB1001|Cipralex|dropar|20|mg/ml|15|ml|1|glerfl||N06AB10|01.04.2009||R|||0|0|0|0|LBK|0|0|0|100|DKK|3968|6407|lyfalmen||||15|0|30,0000|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||||3968|6407|
092130|QJ01CA0401|Clamoxyl, vet.|töflur|200|mg|100|stk|1|ţpakki||QJ01CA04|01.10.1987||R|||0|0|0|0|PAL|1|0|0|100|DKK|9405|18232|vetalmen||||100|0||Icepharma hf|Pfizer Oy Animal Health|||9405||9405|18232|
092241|J01AA0209|Doxycyclin Actavis Disper|töflur|100|mg|8|stk|1|ţpakki|0|J01AA02|01.02.2012||R|||0|0|0|0|AGT|0|0|1|100|XEU|457|1604|lyfalmen||||8|0|8,0000|Actavis Group hf|Actavis Group hf|Doxýcýklín||457||457|1604|
092361|B01AC0401|Plavix|töflur|75|mg|28|stk|1|ţpakki||B01AC04|01.12.1999||R|||0|0|E|0|SBM|0|0|0|100|NOK|8228|11156|lyfalmen|V0009|2014||28|0|28,0000|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Klópídógrel||7440||7440|11156|
092553|N07BA0144|Nicorette Whitemint|tyggigúm|2|mg|30|stk|1|ţpakki||N07BA01|01.08.2010||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||30|0|2,0000|Vistor hf|McNeil Denmark ApS|Nikótín||||||
092575|N07BA0144|Nicorette Whitemint|tyggigúm|2|mg|210|stk|1|ţpakki||N07BA01|01.08.2010||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||210|0|14,0000|Vistor hf|McNeil Denmark ApS|Nikótín||||||
092586|N07BA0144|Nicorette Whitemint|tyggigúm|4|mg|30|stk|1|ţpakki||N07BA01|01.08.2010||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||30|0|4,0000|Vistor hf|McNeil Denmark ApS|Nikótín||||||
092609|N07BA0144|Nicorette Whitemint|tyggigúm|4|mg|210|stk|1|ţpakki||N07BA01|01.08.2010||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||210|0|28,0000|Vistor hf|McNeil Denmark ApS|Nikótín||||||
092655|G03CA0310|Vagifem|sk-tfl|10|mcg|18|stk|1|pakki||G03CA03|01.03.2011||R|||0|0|E|0|NAS|0|0|0|100|DKK|2330|4166|lyfalmen||||18|0|7,2000|Vistor hf|Novo-Nordisk A/S|Estradíól||2330||2330|4166|
092750|N05AH0203|Leponex (D.A.C.)|töflur|100|mg|100|stk|1|glas||N05AH02|01.05.2007||R|||0|0|*|0|DAC|0|1|0|100|DKK|9496|13969|lyfalmen|V0277|13969||100|0|33,3333|D.A.C. ehf|D.A.C. ehf|Klózapín||9496||9496|13969|
092787|C09DA0306|Diovan Comp 320/25 mg|filmhtfl|345|mg|98|stk|1|ţpakki|320/25 mg|C09DA03|01.11.2008||R|||0|0|0|0|NOH|0|0|0|100|DKK|24584|33398|lyfalmen||||98|0|98,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan og ţvagrćsilyf||24584||24584|33398|
092879|M01AB0103|Indometacin Actavis|hylki|25|mg|28|stk|1|ţpakki||M01AB01|01.03.2010||R|||0|0|E|0|AUK|0|0|1|100|GBP|458|1605|lyfalmen||||28|0|7,0000|Actavis Group hf|Actavis UK Ltd.|Indómetacín||458||458|1605|
092891|M01AB0103|Indometacin Actavis|hylki|50|mg|28|stk|1|ţpakki||M01AB01|01.03.2010||R|||0|0|E|0|AUK|0|0|1|100|GBP|596|1794|lyfalmen||||28|0|14,0000|Actavis Group hf|Actavis UK Ltd.|Indómetacín||596||596|1794|
092958|M05BA0408|Ostacid|töflur|70|mg|12|stk|1|ţpakki||M05BA04|01.05.2010||R|||0|0|E|0|POF|0|0|0|100|XEU|3430|3746|lyfalmen|V0203|3746||12|0|84,0000|Portfarma ehf|Portfarma|Alendrónsýra||2023||2023|3746|
093016|N02AA0504|OxyNorm Dispersa|munndr.t|5|mg|28|stk|1|ţpakki||N02AA05|01.10.2011||R|||1|0|0|0|NOR|0|0|0|100|DKK|1176|2588|lyfalmen||||28|0|1,8700|Icepharma hf|Norpharma a/s|Oxýcódon||||1176|2588|
093027|N02AA0504|OxyNorm Dispersa|munndr.t|10|mg|28|stk|1|ţpakki||N02AA05|01.10.2011||R|||1|0|0|0|NOR|0|0|0|100|DKK|2699|4671|lyfalmen||||28|0|3,7300|Icepharma hf|Norpharma a/s|Oxýcódon||||2699|4671|
093038|N02AA0504|OxyNorm Dispersa|munndr.t|20|mg|28|stk|1|ţpakki||N02AA05|01.10.2011||R|||1|0|0|0|NOR|0|0|0|100|DKK|5246|8155|lyfalmen||||28|0|7,4700|Icepharma hf|Norpharma a/s|Oxýcódon||||5246|8155|
093260|N02CC0101|Imigran|stl|12|mg/ml|0,5|ml|2|spr|+ penni|N02CC01|01.10.1992||R|||0|0|E|0|GSK|0|0|0|100|GBP|7250|10897|lyfalmen||||1|0|2,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Súmatriptan||7250||7250|10897|
093343|C09CA0301|Diovan|mixtúra|3|mg/ml|160|ml|1|fl|lausn|C09CA03|01.03.2012||R|||0|0|B|0|NOH|0|0|0|100|DKK|1504|3036|lyfalmen||||160|0|6,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan||1504||1504|3036|
093617|QG03DA0202|Veramix, vet.|sk-svamp|60|mg|1|stk|100|stk||QG03DA02|01.10.1991||R|||0|0|0|0|PAL|1|0|0|100|DKK|27106|47285|vetorma||||100|0||Icepharma hf|Pfizer Oy Animal Health|||27106||27106|47285|
093736|L02AE0305|Zoladex LA (D.A.C.)|vefjalyf|10,8|mg|1|stk|1|áf.spr||L02AE03|01.06.2010||R|||0|1|*|0|DAC|0|0|0|100|SEK|61893|79009|lyfalmen|V0451|77809||1|0|83,7209|D.A.C. ehf|D.A.C. ehf|Góserelín||60927||60927|79009|
093747|C09AA0503|Ramipril Actavis (DAC)|töflur|5|mg|100|stk|1|ţpakki||C09AA05|01.11.2011||R|||0|0|B|0|DAC|0|0|0|100|XEU|1214|2640|lyfalmen|V0496|2640||100|0|200,0000|D.A.C. ehf|D.A.C. ehf|Ramipríl||1214||1214|2640|
093757|N02AA0501|Oxycontin|forđatfl|80|mg|28|stk|1|ţpakki||N02AA05|01.04.2003||R|||1|0|E|0|NOP|0|0|0|100|DKK|16531|23292|lyfalmen||||28|0|29,8700|Icepharma hf|Norpharma |Oxýcódon||16531||16531|23292|
093770|L02AE0304|Zoladex (D.A.C.)|vefjalyf|3,6|mg|1|stk|1|áf.spr||L02AE03|01.06.2010||R|||0|1|*|0|DAC|0|0|0|100|SEK|22942|31337|lyfalmen|V0183|31337||1|0|27,9070|D.A.C. ehf|D.A.C. ehf|Góserelín||22942||22942|31337|
093799|N02AA0501|Oxycontin|forđatfl|80|mg|98|stk|1|ţpakki||N02AA05|01.04.2003||R|||1|0|E|0|NOP|0|0|0|100|DKK|46650|61091|lyfalmen||||98|0|104,5300|Icepharma hf|Norpharma |Oxýcódon||46650||46650|61091|
093827|L04AC0501|Stelara|stl|45|mg/spr|0,5|ml|1|áf.spr||L04AC05|01.04.2011||R|||0|1|0|1|JCI|0|0|0|100|SEK|557451|701484|lyfsjukr||||0|0|83,3300|Vistor hf|Janssen-Cilag International N.V.|Ustekinumabi||557451||557451|701484|
093838|L04AC0501|Stelara|stl|90|mg/spr|1|ml|1|áf.spr||L04AC05|01.05.2011||R|||0|1|0|1|JCI|0|0|0|100|SEK|600346|755317|lyfsjukr||||1|0|166,6700|Vistor hf|Janssen-Cilag International N.V.|Ustekinumabi||600346||600346|755317|
094111|N02CC0501|Almogran|töflur|12,5|mg|6|stk|1|ţpakki|filmuhúđađar töflur|N02CC05|01.07.2010||R|||0|0|E|0|ALM|0|0|0|100|SEK|5179|8064|lyfalmen|V0236|7652||6|0|6,0000|Vistor hf|Almirall S.A.|Almótriptan||5179||5179|8064|
094122|N02CC0501|Almogran|töflur|12,5|mg|9|stk|1|ţpakki|filmuhúđađar töflur|N02CC05|01.07.2010||R|||0|0|E|0|ALM|0|0|0|100|SEK|7675|11478|lyfalmen|V0236|11478||9|0|9,0000|Vistor hf|Almirall S.A.|Almótriptan||7675||7675|11478|
094132|QM01AC0604|Metacam fyrir ketti|mixtúra|0,5|mg/ml|15|ml|1|fl||QM01AC06|01.01.2009||R|||0|0|0|0|BOI|0|0|0|100|DKK|1826|3632|vetalmen||||15|0||Vistor hf|Boehringer Ingelheim|||1826||1826|3632|
094287|L04AD0201|Advagraf|forđahlk|0,5|mg|50|stk|1|ţpakki||L04AD02|01.10.2007||R|||0|1|*|0|APE|0|0|0|100|XEU|13298|19234|lyfalmen||||50|0|5,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||13298||13298|19234|
094296|L04AD0201|Advagraf|forđahlk|1|mg|50|stk|1|ţpakki||L04AD02|01.10.2007||R|||0|1|*|0|APE|0|0|0|100|XEU|19049|26452|lyfalmen||||50|0|10,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||19049||19049|26452|
094305|L04AD0201|Advagraf|forđahlk|5|mg|50|stk|1|ţpakki||L04AD02|01.10.2007||R|||0|1|*|0|APE|0|0|0|100|XEU|85715|110117|lyfalmen||||50|0|50,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||85715||85715|110117|
094801|J05AR0401|Trizivir|filmhtfl|750|mg|60|stk|1|ţpakki|300+150+300 mg|J05AR04|01.08.2003||R|||0|1|0|1|VII|0|0|0|100|GBP|85345|108990|lyfsjukr||||60|0|30,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Zídóvúdín, lamívúdín og abacavír||85345||85345|108990|
094812|N01BX0403|Qutenza|plástur|179|mg|1|plástur|1|pakki||N01BX04|01.01.2011||R|||0|0|0|0|APE|0|0|1|100|XEU|48436|63332|lyfalmen||||1|0||Vistor hf|Astellas Phama Europe B.V.|Capsaicin||||48436|63332|
094834|QI09AB0801|Suiseng Vet|stl|||50|ml|1|hgl|dreifa|QI09AB08|01.05.2010||R|||0|0|0|0|LHS|0|0|0|100|XEU|6608|11527|vetorma||||50|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Bakteríubólefni gegn Escherichia coli + Clostridium||6608||6608|11527|
095208|G04BX0101|Emgesan|töflur|250|mg|100|stk|1|glas||G04BX01|01.03.2001||R|||0|0|0|0|PCO|0|0|0|100|IKR|1577|3136|lyfalmen||||100|1|50,0000|Distica|Distica - óskráđ lyf|Magnesíum hýdroxíđ||1577||1577|3136|
095418|G04BE0305|Vizarsin (Lyfis)|filmhtfl|50|mg|8|stk|1|pakki||G04BE03|01.02.2011||R|||0|0|0|0|LYF|0|0|0|100|XEU|5163|5359|lyfalmen|V0143|5047||8|0|8,0000|Lyfis ehf|Lyfis ehf|Síldenafíl||3202||3202|5359|
095588|N07BB0101|Antabus|freyđit|400|mg|50|stk|1|glas||N07BB01|01.12.1972||R|||0|0|E|0|AGT|0|0|0|100|DKK|5932|9094|lyfalmen||||50|0|100,0000|Actavis Group hf|Actavis Group hf|Dísúlfíram||5932||5932|9094|
095652|N05AX1301|Invega|forđatfl|3|mg|28|stk|1|ţpakki||N05AX13|01.02.2008||R|||0|0|0|0|JCI|0|1|0|100|SEK|18103|25264|lyfalmen||||28|0|14,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||18103||18103|25264|
095680|N05AX1301|Invega|forđatfl|6|mg|28|stk|1|ţpakki||N05AX13|01.02.2008||R|||0|0|0|0|JCI|0|1|0|100|SEK|18103|25264|lyfalmen||||28|0|28,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||18103||18103|25264|
095692|J01MA0204|Ciprofloxacin Portfarma|irl|2|mg/ml|100|ml|1|hgl||J01MA02|01.12.2010||R|||0|0|0|0|POF|0|0|0|100|XEU|1961|3661|lyfalmen||||100|0|0,4000|Portfarma ehf|Portfarma|Cíprófloxacín||1961||1961|3661|
095704|J01MA0204|Ciprofloxacin Portfarma|irl|2|mg/ml|200|ml|1|hgl||J01MA02|01.12.2010||R|||0|0|0|0|POF|0|0|0|100|XEU|3071|5180|lyfalmen||||200|0|0,8000|Portfarma ehf|Portfarma|Cíprófloxacín||3071||3071|5180|
095707|N05AX1301|Invega|forđatfl|9|mg|28|stk|1|ţpakki||N05AX13|01.02.2008||R|||0|0|0|0|JCI|0|1|0|100|SEK|18103|25264|lyfalmen||||28|0|42,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||18103||18103|25264|
095715|J02AC0103|Fluconazole Portfarma|irl|2|mg/ml|50|ml|1|hgl|lausn|J02AC01|01.10.2011||R|||0|0|0|1|POF|0|0|0|100|XEU|2574|3715|lyfsjukr||||50|0|0,5000|Portfarma ehf|Portfarma|Flúkónazól||||2574|3715|
095726|J02AC0103|Fluconazole Portfarma|irl|2|mg/ml|100|ml|1|hgl||J02AC01|01.09.2011||R|||0|0|0|1|POF|0|0|0|100|XEU|3562|5141|lyfsjukr||||100|0|1,0000|Portfarma ehf|Portfarma|Flúkónazól||||3562|5141|
095748|N02AX0212|Tramadol Actavis|hylki|50|mg|100|stk|1|glas||N02AX02|01.09.2011||R|||0|0|E|0|AGP|0|0|1|100|XEU|1088|1515|lyfalmen|V0225|1515||100|0|16,6700|Actavis Group hf|Actavis Group PTC ehf|Tramadól||392||392|1515|
095924|QM01AE9102|Canidryl|töflur|20|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|||0|0|0|0|CHD|0|0|0|100|XEU|3721|7317|vetalmen||||100|0||Dýraheilsa/Icevet ehf|Chanelle Pharmaceuticals (D)|||3721||3721|7317|
095933|QM01AE9102|Canidryl|töflur|50|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|||0|0|0|0|CHD|0|0|0|100|XEU|4910|9600|vetalmen||||100|0||Dýraheilsa/Icevet ehf|Chanelle Pharmaceuticals (D)|||4910||4910|9600|
095942|QM01AE9102|Canidryl|töflur|100|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|||0|0|0|0|CHD|0|0|0|100|XEU|8942|17343|vetalmen||||100|0||Dýraheilsa/Icevet ehf|Chanelle Pharmaceuticals (D)|||8942||8942|17343|
096115|V03AF0101|Uromitexan|stl|100|mg/ml|4|ml|15|lykjur||V03AF01|01.10.1990||R|||0|0|0|1|BAM|0|0|0|100|SEK|2410|3478|lyfsjukr||||60|0||Icepharma hf|Baxter Medical AB|Mesna||2410||2410|3478|
096169|J06BA0103|Gammanorm|stl|165|mg/ml|10|ml|1|hgl|0|J06BA01|01.10.2008||R|||0|0|0|1|OCT|0|0|0|100|DKK|13100|18323|lyfsjukr||||10|0||Vistor hf|Octapharma AB|Immúnóglóbúlín, normal, manna, sem ekki eru gefin í ćđ||13100||13100|18323|
096178|J06BA0103|Gammanorm|stl|165|mg/ml|10|ml|10|hgl|0|J06BA01|01.10.2008||R|||0|0|0|1|OCT|0|0|0|100|DKK|102414|130412|lyfsjukr||||100|0||Vistor hf|Octapharma AB|Immúnóglóbúlín, normal, manna, sem ekki eru gefin í ćđ||102414||102414|130412|
096203|C09DA0107|Losartan HCT Bluefish|filmhtfl|62,5|mg|98|stk|1|ţpakki|50+12,5 mg|C09DA01|01.05.2012||R|||0|0|B|0|BLP|0|0|0|100|XEU|2448|2997|lyfalmen|V0088|2997||98|0|98,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Lósartan og ţvagrćsilyf||1475||1475|2997|
096227|C09DA0107|Losartan HCT Bluefish|filmhtfl|125|mg|98|stk|1|ţpakki|100+25 mg|C09DA01|01.05.2012||R|||0|0|B|0|BLP|0|0|0|100|XEU|2548|3031|lyfalmen|V0089|3031||98|0|98,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Lósartan og ţvagrćsilyf||1500||1500|3031|
096251|D06AX1301|Altargo|smyrsli|1|%|5|g|1|túpa||D06AX13|01.11.2007||R|||0|0|0|0|GGL|0|0|1|100|GBP|2149|3919|lyfalmen||||5|0||GlaxoSmithKline ehf|Glaxo Group Limited|Retapamúlín||2149||2149|3919|
096260|N06DA0301|Exelon|forđapl|4,6|mg/sólh|30|pokar|1|pakki||N06DA03|01.01.2008||R|||0|0|E|0|NOE|0|0|0|100|DKK|16472|23218|lyfalmen||||30|0|14,5300|Vistor hf|Novartis Europharm Ltd|Rívastigmín||16472||16472|23218|
096488|L04AX0401|Revlimid|hylki|5|mg|21|stk|1|ţpakki|hart|L04AX04|01.03.2009||R|||0|1|0|1|CEE|0|0|0|100|XEU|700881|881488|lyfsjukr||||21|0|10,5000|Celgene Europe ltd|Celgene Europe ltd|Lenalídómíd||700881||700881|881488|
096497|L04AX0401|Revlimid|hylki|10|mg|21|stk|1|ţpakki|hart|L04AX04|01.03.2009||R|||0|1|0|1|CEE|0|0|0|100|XEU|742971|934311|lyfsjukr||||21|0|21,0000|Celgene Europe ltd|Celgene Europe ltd|Lenalídómíd||742971||742971|934311|
096506|L04AX0401|Revlimid|hylki|15|mg|21|stk|1|ţpakki|hart|L04AX04|01.03.2009||R|||0|1|0|1|CEE|0|0|0|100|XEU|781423|982568|lyfsjukr||||21|0|31,5000|Celgene Europe ltd|Celgene Europe ltd|Lenalídómíd||781423||781423|982568|
096515|L04AX0401|Revlimid|hylki|25|mg|21|stk|1|ţpakki|hart|L04AX04|01.03.2009||R|||0|1|0|1|CEE|0|0|0|100|XEU|857585|1078152|lyfsjukr||||21|0|52,5000|Celgene Europe ltd|Celgene Europe ltd|Lenalídómíd||857585||857585|1078152|
096679|N06DA0301|Exelon|forđapl|9,5|mg/sólh|30|pokar|1|pakki||N06DA03|01.01.2008||R|||0|0|E|0|NOE|0|0|0|100|DKK|16472|23218|lyfalmen||||30|0|30,0000|Vistor hf|Novartis Europharm Ltd|Rívastigmín||16472||16472|23218|
096685|C03BA1102|Natrilix Retard|forđatfl|1,5|mg|30|stk|1|ţpakki||C03BA11|01.03.1999||R|||0|0|E|0|SEV|0|0|0|100|DKK|1345|2819|lyfalmen||||30|0|18,0000|Icepharma hf|Servier|Indapamíđ||1345||1345|2819|
096688|N06DA0301|Exelon|forđapl|9,5|mg/sólh|60|pokar|1|pakki||N06DA03|01.01.2008||R|||0|0|E|0|NOE|0|0|0|100|DKK|32946|43892|lyfalmen||||60|0|60,0000|Vistor hf|Novartis Europharm Ltd|Rívastigmín||32946||32946|43892|
096768|L02AE0102|Suprecur|nefúđi|0,15|mg/sk|10|g|2|fl|lausn|L02AE01|01.01.2012||R|||0|1|E|0|SNO|0|0|0|100|NOK|19230|26679|lyfalmen||||20|0|16,6700|Vistor hf|Sanofi-aventis Norge AS|Búserelín||19230||19230|26679|
096896|J02AX0601|Ecalta|irs|100|mg/hgl|1|hgl|1|pakki|+ leysir, lausn|J02AX06|01.03.2008||R|||0|1|0|1|IPI|0|0|0|100|DKK|90844|115892|lyfsjukr||||1|0|1,0000|Icepharma hf|Pfizer Limited|Anidulafungin||90844||90844|115892|
097033|B05AA0706|Tetraspan|irl|60|mg/ml|500|ml|20|pokar|Freeflex umbúđir|B05AA07|01.04.2010||R|||0|0|0|1|BRA|0|0|0|100|XEU|27799|36770|lyfsjukr||||10000|0||Actavis Group hf|Braun|Hýdróxyetýl sterkja||27799||27799|36770|
097092|QN02AF0102|Alvegesic vet.|stl|10|mg/ml|10|ml|1|hgl||QN02AF01|01.08.2010||R|||0|0|0|0|AUW|1|0|0|100|XEU|8257|16027|vetalmen||||10|0||Icepharma hf|ALVETRA u. WERFFTt GmbH|Bútorfanóltartrat||||8257|16027|
097269|J01FF0103|Dalacin (D.A.C.)|hylki|300|mg|20|stk|1|ţpakki||J01FF01|01.06.2007||R|||0|0|0|0|DAC|0|0|1|100|DKK|2243|4028|lyfalmen|V0461|4028||20|0|5,0000|D.A.C. ehf|D.A.C. ehf|Klindamýcín||2229||2229|4028|
097288|R06AX2701|Aerius|mixtúra|0,5|mg/ml|120|ml|1|fl||R06AX27|01.10.2008||R|||0|0|E|0|SCP|0|0|1|100|DKK|1128|2522|lyfalmen||||120|0|12,0000|Vistor hf|Schering-Plough|Deslóratadín||1128||1128|2522|
097531|N06AX1602|Efexor Depot|forđahlk|75|mg|98|stk|1|ţpakki||N06AX16|01.07.2012||R|||0|0|0|0|PER|0|1|0|100|DKK|11359|16517|lyfalmen|V0334|6140||98|0|73,5000|Icepharma hf|Pfizer ApS|Venlafaxín||11359||11359|16517|
097577|N06AX1602|Efexor Depot|forđahlk|150|mg|98|stk|1|ţpakki||N06AX16|01.09.2011||R|||0|0|0|0|PER|0|1|0|100|DKK|21567|29612|lyfalmen|V0335|6140||98|0|147,0000|Icepharma hf|Pfizer ApS|Venlafaxín||||21567|29612|
097599|N05BA0603|Temesta|töflur|1|mg|100|stk|1|ţpakki||N05BA06|01.02.2012||R|||0|0|0|0|PCO|0|0|1|100|DKK|2481|4373|lyfalmen||||100|1|40,0000|Distica|Distica - óskráđ lyf|Lórazepam||2481||2481|4373|
097881|A10BB1201|Amaryl|töflur|3|mg|90|stk|1|ţpakki||A10BB12|01.09.1997||R|||0|0|*|0|AVP|0|0|0|100|NOK|3248|4470|lyfalmen|V0023|2939||90|0|135,0000|Vistor hf|Aventis Pharma |Glímepíríđ||2552||2552|4470|
097887|N02CC0104|Sumacta|húđuđtfl|50|mg|12|stk|1|ţpakki||N02CC01|01.11.2007||R|||0|0|E|0|AGP|0|0|0|100|IKR|2738|3057|lyfalmen|V0233|2887||12|0|12,0000|Actavis Group hf|Actavis Group PTC ehf|Súmatriptan||1519||1519|3057|
097896|N02CC0104|Sumacta|húđuđtfl|100|mg|6|stk|1|ţpakki||N02CC01|01.11.2007||R|||0|0|E|0|AGP|0|0|0|100|IKR|1917|2655|lyfalmen|V0234|2492||6|0|12,0000|Actavis Group hf|Actavis Group PTC ehf|Súmatriptan||1225||1225|2655|
097905|N06AX1104|Miron Smelt|munndr.t|15|mg|30|stk|1|ţpakki||N06AX11|01.11.2007||R|||0|0|B|0|AGP|0|1|0|100|XEU|1121|2492|lyfalmen|V0329|2492||30|0|15,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||1106||1106|2492|
098059|C09CA0303|Valpress|filmhtfl|80|mg|98|stk|1|ţpakki||C09CA03|01.12.2007||R|||0|0|B|0|ACA|0|0|0|100|XEU|6710|3481|lyfalmen|V0072|3213||98|0|98,0000|Actavis Group hf|Actavis hf|Valsartan||1829||1829|3481|
098068|C09CA0303|Valpress|filmhtfl|160|mg|98|stk|1|ţpakki||C09CA03|01.12.2007||R|||0|0|B|0|ACA|0|0|0|100|XEU|8598|3562|lyfalmen|V0073|3293||98|0|196,0000|Actavis Group hf|Actavis hf|Valsartan||1888||1888|3562|
098233|D07AC0401|Synalar|krem|0,25|mg/g|30|g|1|túpa||D07AC04|01.04.1998||R|||0|0|B|0|BIG|0|0|1|100|SEK|608|1811|lyfalmen||||30|0||Icepharma hf|Bioglan AB|Flúócínólón||608||608|1811|
098245|D07AC0401|Synalar|smyrsli|0,25|mg/g|30|g|1|túpa||D07AC04|01.08.2011||R|||0|0|B|0|BIG|0|0|1|100|SEK|608|1811|lyfalmen||||30|0||Icepharma hf|Bioglan AB|Flúócínólón||608||608|1811|
098290|D08AC0202|Hibitane|sk-krem|10|mg/ml|250|ml|1|glas||D08AC02|01.06.2011||L|||0|0|0|0|BIG|0|0|0|100|IKR|||lyflausa||||250|0||Icepharma hf|Bioglan AB|Klórhexidín||||||
098378|N03AX0904|Lamotrigin ratiopharm|dreifit.|25|mg|50|stk|1|ţpakki||N03AX09|01.05.2012||R|||0|0|E|0|RGM|0|0|0|100|XEU|1012|2135|lyfalmen|V0243|2135||50|0|4,1600|Medical ehf|ratiopharm GmbH|Lamótrigín||845||845|2135|
098387|N03AX0904|Lamotrigin ratiopharm|dreifit.|50|mg|50|stk|1|ţpakki||N03AX09|01.05.2012||R|||0|0|E|0|RGM|0|0|0|100|XEU|1725|2525|lyfalmen|V0244|2525||50|0|8,3300|Medical ehf|ratiopharm GmbH|Lamótrigín||1130||1130|2525|
098405|N03AX0904|Lamotrigin ratiopharm|dreifit.|100|mg|100|stk|1|ţpakki||N03AX09|01.05.2012||R|||0|0|E|0|RGM|0|0|0|100|XEU|4870|5585|lyfalmen|V0245|5585||100|0|33,3300|Medical ehf|ratiopharm GmbH|Lamótrigín||3367||3367|5585|
098423|N03AX0904|Lamotrigin ratiopharm|dreifit.|200|mg|100|stk|1|ţpakki||N03AX09|01.05.2012||R|||0|0|E|0|RGM|0|0|0|100|XEU|8725|10654|lyfalmen|V0232|10654||100|0|66,6600|Medical ehf|ratiopharm GmbH|Lamótrigín||7073||7073|10654|
098713|V03AB2502|Flumazenil B. Braun|stl|0,1|mg/ml|5|ml|5|lykjur||V03AB25|01.04.2011||R|||0|0|0|1|BRA|0|0|0|100|XEU|19038|25775|lyfsjukr||||25|0||Actavis Group hf|Braun|Flúmazeníl||19038||19038|25775|
098722|J07BM0101|Gardasil|stl|||0,5|ml|1|áf.spr|dreifa|J07BM01|01.08.2008||R|||0|0|0|0|SPM|0|0|0|100|XEU|17896|25005|lyfalmen||||0|0||Icepharma hf|Sanofi Pasteur MSD|Papillomavírus (manna gerđ 6, 11, 16, 18)||17896||17896|25005|
099204|L02BA0301|Faslodex|stl|250|mg/spr|5|ml|2|spr||L02BA03|01.12.2010||R|||0|1|0|1|ASZ|0|0|0|100|SEK|99005|126134|lyfsjukr||||10|0|60,2400|Vistor hf|AstraZeneca UK Ltd|Fulvestrant||99005||99005|126134|
099476|N05AH0406|Quetiapin Mylan|filmhtfl|25|mg|100|stk|1|ţpakki||N05AH04|01.03.2008||R|||0|0|0|0|MYL|0|1|0|100|SEK|6128|9362|lyfalmen|V0284|3750||100|0|6,2500|Actavis Group PTC ehf|Mylan AB|Quetíapín||6128||6128|9362|
099485|N05AH0406|Quetiapin Mylan|filmhtfl|100|mg|100|stk|1|ţpakki||N05AH04|01.03.2008||R|||0|0|0|0|MYL|0|1|0|100|SEK|14070|20106|lyfalmen|V0285|14998||100|0|25,0000|Actavis Group PTC ehf|Mylan AB|Quetíapín||13993||13993|20106|
099494|N05AH0406|Quetiapin Mylan|filmhtfl|200|mg|100|stk|1|ţpakki||N05AH04|01.03.2008||R|||0|0|*|0|MYL|0|1|0|100|SEK|23001|27950|lyfalmen|V0286|27950||100|0|50,0000|Actavis Group PTC ehf|Mylan AB|Quetíapín||20243||20243|27950|
099705|D08AG0201|Betadine|áburđur|100|mg/ml|500|ml|1|brusar|vatnsl|D08AG02|01.04.1985||L|||0|0|0|0|NOR|0|0|0|100|IKR|||lyflausa||||500|0||Icepharma hf|Norpharma a/s|Jođ/pólývídón||||||
099721|D08AG0201|Betadine|lyf.sápa|75|mg/ml|500|ml|1|brusar||D08AG02|01.04.1985||L|||0|0|0|0|NOR|0|0|0|100|IKR|||lyflausa||||500|0||Icepharma hf|Norpharma a/s|Jođ/pólývídón||||||
099835|N03AX1107|Topiramat Actavis|filmhtfl|25|mg|60|stk|1|plglas||N03AX11|01.08.2010||R|||0|0|E|0|AGP|0|0|0|100|XEU|2995|4054|lyfalmen|V0247|4054||60|0|5,0000|Actavis Group hf|Actavis Group PTC ehf|Tópíramat||2248||2248|4054|
099847|N03AX1107|Topiramat Actavis|filmhtfl|50|mg|60|stk|1|plglas||N03AX11|01.09.2010||R|||0|0|E|0|AGP|0|0|0|100|XEU|4142|6173|lyfalmen|V0248|6173||60|0|10,0000|Actavis Group hf|Actavis Group PTC ehf|Tópíramat||3797||3797|6173|
099858|N03AX1107|Topiramat Actavis|filmhtfl|100|mg|60|stk|1|plglas||N03AX11|01.08.2010||R|||0|0|E|0|AGP|0|0|0|100|XEU|8413|10327|lyfalmen|V0249|10327||60|0|20,0000|Actavis Group hf|Actavis Group PTC ehf|Tópíramat||6834||6834|10327|
099902|H02AB0605|Prednisolone Actavis|töflur|5|mg|98|stk|1|ţpakki||H02AB06|01.01.2011||R|||0|0|B|0|AUK|0|0|1|100|GBP|743|1995|lyfalmen|V0414|1995||98|0|49,0000|Actavis Group hf|Actavis UK Ltd.|Prednisólón||743||743|1995|
100291|G04BE0801|Cialis|filmhtfl|2,5|mg|28|stk|1|ţpakki||G04BE08|01.11.2008||R|||0|0|0|0|LIL|0|0|0|100|XEU|13408|19372|lyfalmen||||28|0|7,0000|Icepharma hf|Lilly ICOS Limited|Tadalafíl||||13408|19372|
100300|G04BE0801|Cialis|filmhtfl|5|mg|28|stk|1|ţpakki||G04BE08|01.11.2008||R|||0|0|0|0|LIL|0|0|0|100|XEU|13408|19372|lyfalmen||||28|0|14,0000|Icepharma hf|Lilly ICOS Limited|Tadalafíl||||13408|19372|
100428|N06AX1103|Miron|filmhtfl|15|mg|100|stk|1|plglas||N06AX11|01.01.2012||R|||0|0|B|0|ACA|0|1|0|100|XEU|1935|3626|lyfalmen||||100|0|50,0000|Actavis Group hf|Actavis hf|Mirtazapín||1935||1935|3626|
101106|N03AX1201|Neurontin|filmhtfl|600|mg|100|stk|1|ţpakki||N03AX12|01.03.2009||R|||0|0|E|0|PER|0|0|0|100|DKK|12821|13572|lyfalmen||||100|0|33,3300|Icepharma hf|Pfizer ApS|Gabapentín||9206||9206|13572|
101115|N03AX1201|Neurontin|filmhtfl|800|mg|100|stk|1|ţpakki||N03AX12|01.03.2009||R|||0|0|E|0|PER|0|0|0|100|DKK|17733|24800|lyfalmen||||100|0|44,4400|Icepharma hf|Pfizer ApS|Gabapentín||17733||17733|24800|
101691|C08CA0502|Adalat Oros|forđatfl|20|mg|28|stk|1|ţpakki||C08CA05|01.10.1999||R|||0|0|B|0|BAP|0|0|0|100|SEK|2011|3730|lyfalmen||||28|0|18,6667|Icepharma hf|Bayer Schering Pharma AG|Nífedipín||2011||2011|3730|
101709|C08CA0502|Adalat Oros|forđatfl|20|mg|98|stk|1|ţpakki||C08CA05|01.10.1999||R|||0|0|B|0|BAP|0|0|0|100|SEK|6492|9860|lyfalmen||||98|0|65,3333|Icepharma hf|Bayer Schering Pharma AG|Nífedipín||6492||6492|9860|
101742|N06AX1104|Miron Smelt|munndr.t|30|mg|30|stk|1|ţpakki||N06AX11|01.11.2007||R|||0|0|0|0|AGP|0|1|0|100|XEU|1382|2869|lyfalmen|V0330|2869||30|0|30,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||1382||1382|2869|
101751|N06AX1104|Miron Smelt|munndr.t|30|mg|96|stk|1|ţpakki||N06AX11|01.11.2007||R|||0|0|B|0|AGP|0|1|0|100|XEU|3144|5280|lyfalmen|V0331|5280||96|0|96,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||3144||3144|5280|
101756|C09DA0106|Lopress Comp|filmhtfl|62,5|mg|100|stk|1|glas|50+12,5 mg|C09DA01|01.11.2010||R|||0|0|B|0|APC|0|0|0|100|XEU|3944|3266|lyfalmen|V0088|3058||100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Lósartan og ţvagrćsilyf||1672||1672|3266|
101760|N06AX1104|Miron Smelt|munndr.t|45|mg|96|stk|1|ţpakki||N06AX11|01.12.2011||R|||0|0|0|0|AGP|0|1|0|100|XEU|5630|8680|lyfalmen|V0332|8680||96|0|144,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||5630||5630|8680|
101767|C09DA0106|Lopress Comp|filmhtfl|125|mg|100|stk|1|glas|100+25 mg|C09DA01|01.11.2010||R|||0|0|B|0|APC|0|0|0|100|XEU|4575|3434|lyfalmen|V0089|3093||100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Lósartan og ţvagrćsilyf||1795||1795|3434|
101769|N02AX0211|Nobligan Retard (D.A.C.)|forđatfl|150|mg|100|stk|1|ţpakki||N02AX02|01.09.2007||R|||0|0|E|0|DAC|0|0|1|100|DKK|5250|8161|lyfalmen|V0227|7593||100|0|50,0000|D.A.C. ehf|D.A.C. ehf|Tramadól||5250||5250|8161|
101823|QM01AC0602|Metacam fyrir hesta|mixtúra|15|mg/ml|250|ml|1|fl||QM01AC06|01.02.2009||R|||0|0|0|0|BOI|0|0|0|100|SEK|17482|33741|vetalmen||||250|0||Vistor hf|Boehringer Ingelheim|||||17482|33741|
101825|A09AA0206|Creon 10.000|sh-hylki|150|mg|100|stk|1|plglas||A09AA02|01.09.2011||R|||0|0|E|0|APR|0|0|0|100|DKK|3272|5455|lyfalmen||||100|0|16,6700|Vistor hf|Abbott Products GmbH|Hvatablöndur (lípasi, próteasi o.s.frv.)||||3272|5455|
101893|G03DB0801|Visanne|töflur|2|mg|28|stk|1|ţpakki||G03DB08|01.05.2012||R|||0|0|0|0|BAB|0|0|0|100|SEK|6800|10281|lyfalmen||||28|0|28,0000|Icepharma hf|Bayer AB|Díenógest||6800||6800|10281|
101904|G03DB0801|Visanne|töflur|2|mg|84|stk|1|ţpakki||G03DB08|01.05.2012||R|||0|0|0|0|BAB|0|0|0|100|SEK|20397|28143|lyfalmen||||84|0|84,0000|Icepharma hf|Bayer AB|Díenógest||20397||20397|28143|
102871|C01DA1401|Imdur|forđatfl|60|mg|98|stk|1|ţpakki||C01DA14|01.07.1989||R|||0|0|B|0|AZD|0|0|0|100|SEK|3772|6139|lyfalmen|V0041|3630||98|0|147,0000|Vistor hf|AstraZeneca A/S DK|Ísósorbíđ mónónítrat||3772||3772|6139|
102905|N01AX1001|Diprivan|stl|10|mg/ml|50|ml|1|dćla|einnota dćla|N01AX10|01.01.1994||R|||0|0|0|1|AZA|0|0|0|100|SEK|1890|2728|lyfsjukr||||50|0||Vistor hf|AstraZeneca AB|Própófól||1890||1890|2728|
102939|N01AX1001|Diprivan|stl|20|mg/ml|50|ml|1|dćla|einnota dćla|N01AX10|01.01.1988||R|||0|0|0|1|AZA|0|0|0|100|SEK|3073|4435|lyfsjukr||||50|0||Vistor hf|AstraZeneca AB|Própófól||3073||3073|4435|
103633|C09DA0105|Presmin Combo|filmhtfl|62,5|mg|98|stk|1|ţpakki|50+12,5 mg|C09DA01|01.02.2008||R|||0|0|B|0|POF|0|0|0|100|XEU|3542|3266|lyfalmen|V0088|2997||98|0|98,0000|Portfarma ehf|Portfarma|Lósartan og ţvagrćsilyf||1672||1672|3266|
103642|C09DA0105|Presmin Combo|filmhtfl|125|mg|98|stk|1|ţpakki|100+25 mg|C09DA01|01.02.2008||R|||0|0|B|0|POF|0|0|0|100|XEU|4483|3434|lyfalmen|V0089|3031||98|0|98,0000|Portfarma ehf|Portfarma|Lósartan og ţvagrćsilyf||1795||1795|3434|
103651|C09CA0104|Presmin|filmhtfl|50|mg|98|stk|1|ţpakki||C09CA01|01.02.2008||R|||0|0|B|0|POF|0|0|0|100|XEU|3026|2786|lyfalmen|V0069|2518||98|0|98,0000|Portfarma ehf|Portfarma|Lósartan||1321||1321|2786|
103660|J05AB1103|Valaciklovir Portfarma|töflur|500|mg|10|stk|1|ţpakki||J05AB11|01.02.2008||R|||0|0|E|0|POF|0|0|1|100|GBP|2684|2127|lyfalmen|V0033|2127||10|0|1,6667|Portfarma ehf|Portfarma|Valacíklóvír||839||839|2127|
103669|J05AB1103|Valaciklovir Portfarma|töflur|500|mg|40|stk|1|ţpakki||J05AB11|01.02.2008||R|||0|0|E|0|POF|0|0|1|100|GBP|10616|8813|lyfalmen|V0182|8813||40|0|6,6700|Portfarma ehf|Portfarma|Valacíklóvír||5727||5727|8813|
103678|N06AX1604|Venlafaxin (Portfarma)|forđahlk|75|mg|100|stk|1|ţpakki||N06AX16|01.12.2007||R|||0|0|B|0|POF|0|1|0|100|XEU|4504|6265|lyfalmen|V0334|6265||100|0|75,0000|Portfarma ehf|Portfarma|Venlafaxín||3864||3864|6265|
103687|N06AX1604|Venlafaxin (Portfarma)|forđahlk|150|mg|100|stk|1|ţpakki||N06AX16|01.12.2007||R|||0|0|B|0|POF|0|1|0|100|XEU|7229|6265|lyfalmen|V0335|6265||100|0|150,0000|Portfarma ehf|Portfarma|Venlafaxín||3864||3864|6265|
103937|A06AG0201|Toilax|innhl|2|mg/ml|5|ml|5|túpa||A06AG02|01.12.1975||L|||0|0|0|0|ERC|0|0|0|100|DKK|||lyfalmen||||25|0|5,0000|Vistor hf|Orion Pharma|Bisakódýl|||||1930|
103952|A06AG0201|Toilax|innhl/tf|||1|stk|1|pakki|túpa+4 tfl|A06AG02|01.12.1972||L|||0|0|0|0|ERC|0|0|0|100|IKR|||lyflausa||||1|0|1,0000|Vistor hf|Orion Pharma|Bisakódýl||||||
104026|V08AB0901|Visipaque|stl|270|mg J/ml|20|ml|10|glhgl||V08AB09|01.12.2009||R|||0|0|0|1|GEH|0|0|0|100|NOK|14081|19554|lyfsjukr||||200|0||Icepharma hf|GE Healthcare AS|Jódixanól||14081||14081|19554|
104047|C09CA0304|Valsartan LYFIS|filmhtfl|160|mg|98|stk|1|ţpakki||C09CA03|01.06.2012||R|||0|0|B|0|LYF|0|0|0|100|XEU|3114|3293|lyfalmen|V0073|3293||98|0|196,0000|LYFIS ehf|LYFIS ehf|Valsartan||1692||1692|3293|
104471|H01BA0201|Minirin|nefdr|0,1|mg/ml|2,5|ml|1|glas|+2 slöngur|H01BA02|01.01.1988||R|||0|0|E|0|FEL|0|0|0|100|DKK|3213|5374|lyfalmen||||2|0|10,0000|Vistor hf|Ferring Lćgemidler A/S|Desmópressín||3213||3213|5374|
104498|N05CH0101|Circadin|forđatfl|2|mg|21|stk|1|ţpakki||N05CH01|01.11.2007||R|||0|0|0|0|NEU|0|0|1|100|DKK|2210|4002|lyfalmen||||21|0|21,0000|Gróco ehf|Neurim Pharmaceuticals EEC Ltd|Melatonin||2210||2210|4002|
104760|A07EC0202|Pentasa|eţ-stíll|1|g|28|stk|1|pakki||A07EC02|01.07.1991||R|||0|0|B|0|FER|0|0|0|100|DKK|8471|12567|lyfalmen||||28|0|18,6667|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||8471||8471|12567|
104836|A07EC0202|Pentasa|innhl|10|mg/ml|100|ml|7|stk||A07EC02|01.01.1990||R|||0|0|B|0|FER|0|0|0|100|DKK|4757|7486|lyfalmen|V0017|7486||700|0|4,6667|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||4757||4757|7486|
104851|A07EC0202|Pentasa|forđatfl|500|mg|100|stk|1|ţpakki||A07EC02|01.04.1992||R|||0|0|B|0|FER|0|0|0|100|DKK|5384|8344|lyfalmen||||100|0|33,3333|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||5384||5384|8344|
104959|B03XA0201|Aranesp|stl|100|mcg/spr|0,5|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|||0|1|0|1|AMG|0|0|0|100|DKK|131553|166982|lyfsjukr||||2|0|88,8900|Vistor hf|Amgen|Darbepóetín alfa||||131553|166982|
105278|A02BC0505|Nexium (D.A.C.)|sh-tfl|20|mg|28|stk|1|veski||A02BC05|01.09.2007||R|||0|0|0|0|DAC|0|0|0|100|SEK|4347|6032|lyfalmen|V0004|1730||28|0|18,6700|D.A.C. ehf|D.A.C. ehf|Esómeprazól||3694||3694|6032|
105297|A02BC0505|Nexium (D.A.C.)|sh-tfl|20|mg|100|stk|1|glas||A02BC05|01.09.2007||R|||0|0|0|0|DAC|0|0|0|100|SEK|13228|16361|lyfalmen|V0011|5609||100|0|66,6700|D.A.C. ehf|D.A.C. ehf|Esómeprazól||11245||11245|16361|
105306|A02BC0505|Nexium (D.A.C.)|sh-tfl|40|mg|100|stk|1|glas||A02BC05|01.09.2007||R|||0|0|0|0|DAC|0|0|0|100|SEK|17591|19435|lyfalmen|V0012|5609||100|0|133,3300|D.A.C. ehf|D.A.C. ehf|Esómeprazól||13458||13458|19435|
105315|G03AA0705|Microgynon (D.A.C.)|töflur|||63|stk|1|ţpakki||G03AA07|01.05.2009||R|||0|0|0|0|DAC|0|0|0|100|SEK|1238|2672|lyfalmen|V0545|2672||63|0|84,0000|D.A.C. ehf|D.A.C. ehf|Levónorgestrel og östrógen||1238||1238|2672|
105586|C09XA0201|Rasilez|filmhtfl|150|mg|28|stk|1|ţpakki||C09XA02|01.01.2008||R|||0|0|0|0|NOE|0|0|0|100|DKK|4040|6505|lyfalmen||||28|0|28,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren||4040||4040|6505|
105597|C09XA0201|Rasilez|filmhtfl|150|mg|98|stk|1|ţpakki|2 x 49 töflur|C09XA02|01.01.2008||R|||0|0|0|0|NOE|0|0|0|100|DKK|14044|20170|lyfalmen||||98|0|98,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren||14044||14044|20170|
105608|C09XA0201|Rasilez|filmhtfl|300|mg|28|stk|1|ţpakki||C09XA02|01.01.2008||R|||0|0|0|0|NOE|0|0|0|100|DKK|4656|7348|lyfalmen||||28|0|56,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren||4656||4656|7348|
105620|C09XA0201|Rasilez|filmhtfl|300|mg|98|stk|1|ţpakki|2 x 49 töflur|C09XA02|01.01.2008||R|||0|0|0|0|NOE|0|0|0|100|DKK|16198|22874|lyfalmen||||98|0|196,0000|Vistor hf|Novartis Europharm Ltd|Aliskiren||16198||16198|22874|
105785|N01BB0301|Carbocain|stl|10|mg/ml|20|ml|5|hgl||N01BB03|01.02.2003||R|||0|0|0|0|AZD|0|0|1|100|SEK|2452|4333|lyfalmen||||100|0||Vistor hf|AstraZeneca A/S DK|Mepívakaín||2452||2452|4333|
105796|N01BB0301|Carbocain|stl|20|mg/ml|20|ml|5|hgl||N01BB03|01.02.2003||R|||0|0|0|0|AZD|0|0|1|100|SEK|2899|4945|lyfalmen||||100|0||Vistor hf|AstraZeneca A/S DK|Mepívakaín||2899||2899|4945|
106006|J05AH0201|Tamiflu|hylki|30|mg|10|stk|1|ţpakki||J05AH02|01.11.2011||R|||0|0|0|0|RRL|0|0|0|100|DKK|1885|3557|lyfalmen||||10|0|2,0000|Icepharma hf|Roche Registration Limited|Oseltamivír||1885||1885|3557|
106017|J05AH0201|Tamiflu|hylki|45|mg|10|stk|1|ţpakki||J05AH02|01.11.2011||R|||0|0|0|0|RRL|0|0|0|100|DKK|3770|6136|lyfalmen||||10|0|3,0000|Icepharma hf|Roche Registration Limited|Oseltamivír||3770||3770|6136|
106021|J01FA0901|Klacid|töflur|250|mg|14|stk|1|ţpakki||J01FA09|01.04.1992||R|||0|0|0|0|ABS|0|0|1|100|DKK|2728|4711|lyfalmen||||14|0|7,0000|Vistor hf|Abbott Scandinavia AB|Klaritrómýcín||2728||2728|4711|
106567|J05AB0102|Zovir|irs|500|mg/hgl|5|hgl|1|pakki||J05AB01|01.01.1995||R|||0|0|0|1|GSK|0|0|0|100|GBP|19725|26637|lyfsjukr||||5|0|0,6250|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||19725||19725|26637|
106898|J05AB0102|Zovir|irs|250|mg/hgl|5|hgl|1|pakki||J05AB01|01.07.1989||R|||0|0|0|1|GSK|0|0|0|100|GBP|10908|15572|lyfsjukr||||5|0|0,3125|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||10908||10908|15572|
107092|N05AH0311|Olanzapine Ranbaxy|töflur|2,5|mg|28|stk|1|ţpakki||N05AH03|01.12.2011||R|||0|0|*|0|RAN|0|1|0|100|XEU|2069|1857|lyfalmen|V0278|1857||28|0|7,0000|Artasan ehf|Ranbaxy (UK) Ltd|Olanzapín||642||642|1857|
107138|C07AG0203|Carvedilol Actavis|filmhtfl|6,25|mg|100|stk|1|ţpakki||C07AG02|01.05.2012||R|||0|0|B|0|ADG|0|0|0|100|XEU|1297|2753|lyfalmen||||100|0|16,6600|Actavis Group hf|Actavis Deutchland GmbH & Co. KG|Carvedílól||1297||1297|2753|
107203|R06AX2201|Kestine|filmhtfl|10|mg|30|stk|1|ţpakki||R06AX22|01.06.2012||L|||0|0|0|0|APS|0|0|1|100|IKR|||lyflausa||||30|0|30,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín||||||
107219|A07EC0102|Salazopyrin EN|sh-tfl|500|mg|100|stk|1|glas||A07EC01|01.04.1987||R|||0|0|B|0|PER|0|0|0|100|DKK|1608|3179|lyfalmen||||100|0|25,0000|Icepharma hf|Pfizer ApS|Súlfasalazín||1608||1608|3179|
107594|QP54AA0104|Bimectin Horse Oral Paste|pasta|18,7|mg/g|6,42|g|1|áf.spr||QP54AA01|01.04.2008||L|||0|0|0|0|CRO|0|0|0|100|XEU|1574|2746|vetorma||||6|0||Portfarma ehf|Cross Vetpharm Group Ltd.|||||1574|2746|
107607|A02BA0201|Asyran|töflur|150|mg|60|stk|1|ţpakki||A02BA02|01.07.1986||R|||0|0|E|0|ACA|0|0|0|100|XEU|944|2270|lyfalmen||||60|0|30,0000|Actavis Group hf|Actavis hf|Ranitidín||944||944|2270|
108308|C08CA0501|Adalat|töflur|10|mg|100|stk|1|ţpakki||C08CA05|01.01.1991||R|||0|0|B|0|BAP|0|0|0|100|SEK|2869|4904|lyfalmen||||100|0|33,3333|Icepharma hf|Bayer Schering Pharma AG|Nífedipín||2869||2869|4904|
108540|A10BH0201|Galvus|töflur|50|mg|30|stk|1|ţpakki||A10BH02|01.09.2008||R|||0|0|*|0|NOE|0|0|0|100|DKK|3373|5593|lyfalmen||||30|0|15,0000|Vistor hf|Novartis Europharm Ltd|Vildagliptín||3373||3373|5593|
108562|A10BH0201|Galvus|töflur|50|mg|90|stk|1|ţpakki||A10BH02|01.09.2008||R|||0|0|*|0|NOE|0|0|0|100|DKK|10012|14675|lyfalmen||||90|0|45,0000|Vistor hf|Novartis Europharm Ltd|Vildagliptín||10012||10012|14675|
108802|N05AH0310|Zalasta (LYFIS)|töflur|10|mg|56|stk|1|ţpakki||N05AH03|01.10.2011||R|||0|0|*|0|LYF|0|1|0|100|XEU|14047|7836|lyfalmen|V0282|7774||56|0|56,0000|LYFIS ehf|LYFIS ehf|Olanzapín||5013||5013|7836|
108845|R01AD0501|Rhinocort Aqua|nefúđi|32|mcg/sk|120|sk|1|fl||R01AD05|01.10.1988||R|||0|0|E|0|AZD|0|0|1|100|SEK|1186|2601|lyfalmen||||120|0|19,2000|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||1186||1186|2601|
108852|R01AD0501|Rhinocort Aqua|nefúđi|64|mcg/sk|120|sk|1|fl||R01AD05|01.10.1988||R|||0|0|E|0|AZD|0|0|1|100|SEK|1645|3229|lyfalmen|V0443|3228||120|0|38,4000|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||1645||1645|3229|
109357|A02BC0508|Esomeprazol Actavis|sţ-hylki|20|mg|28|stk|1|ţpakki|hart|A02BC05|01.03.2012||R|||0|0|0|0|APC|0|0|0|100|XEU|2234|1730|lyfalmen|V0004|1730||28|0|18,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Esómeprazól||549||549|1730|
109421|V01AA0303|Alutard SQ, derm.farinae|stl|||5|ml|4|hgl|byrjunarsett|V01AA03|01.07.1999||R|||0|1|E|0|ALK|0|0|0|100|DKK|24818|33692|lyfalmen||||20|0||Vistor hf|ALK-Abello A/S|rykmaurar||24818||24818|33692|
109439|V01AA0303|Alutard SQ, derm.farinae|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA03|01.07.1999||R|||0|1|E|0|ALK|0|0|0|100|DKK|19869|27481|lyfalmen||||5|0||Vistor hf|ALK-Abello A/S|rykmaurar||19869||19869|27481|
109462|V04CL0020|Soluprick SQ, derm.farinae|lausn|10|HEP|3|ml|1|hgl||V04CL|01.07.1999||R|||0|0|E|0|ALK|0|0|0|100|DKK|7714|11531|lyfalmen||||3|0||Vistor hf|ALK-Abello A/S|Ofnćmisvakar (allergenar) til greiningar á ofnćmissjúkdómum||7714||7714|11531|
109678|N02BE0107|Paratabs|töflur|500|mg|20|stk|1|ţpakki||N02BE01|01.12.1983||L|||0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa||||20|0|3,3333|Actavis Group hf|Actavis hf|Paracetamól||||||
109728|N02BE0107|Paratabs|töflur|500|mg|30|stk|1|ţpakki||N02BE01|01.07.1992||L|||0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa||||30|0|5,0000|Actavis Group hf|Actavis hf|Paracetamól||||||
109751|N02BE0107|Paratabs|töflur|500|mg|100|stk|1|ţpakki||N02BE01|01.11.1981||R|||0|0|0|0|ACA|0|0|1|100|XEU|426|1562|lyfalmen|V0230|1562||100|0|16,6667|Actavis Group hf|Actavis hf|Paracetamól||426||426|1562|
110080|S01ED0105|Optimol|augndr|5|mg/ml|5|ml|1|glas||S01ED01|01.01.1987||R|||0|0|*|0|SAO|0|0|0|100|XEU|529|1703|lyfalmen||||5|0|25,0000|Icepharma hf|Santen Oy|Tímólól||529||529|1703|
110242|V03AN0101|Conoxia|innö.gas|100|%|3|l|1|hylki|MO3LIV|V03AN01|01.04.2008||L|||0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa||||3|0||Ísaga ehf|AGA AB|Súrefni||||||
110395|G03AA0902|Mercilon|töflur|||63|stk|1|ţpakki||G03AA09|01.07.1990||R|||0|0|0|0|ORG|0|0|0|100|DKK|1574|3132|lyfalmen||||63|0|84,0000|Vistor hf|N.V. Organon|Desógestrel og östrógen||1574||1574|3132|
110635|C08DA0104|Veraloc Retard|forđatfl|200|mg|100|stk|1|glas||C08DA01|01.10.1988||R|||0|0|B|0|ORC|0|0|0|100|DKK|4024|6484|lyfalmen||||100|0|83,3333|Vistor hf|Orion Corporation|Verapamíl||4024||4024|6484|
110750|J05AX0801|Isentress|filmhtfl|400|mg|60|stk|1|glas||J05AX08|01.04.2012||R|||0|1|0|1|MLD|0|0|0|100|DKK|115346|146642|lyfsjukr||||60|0|30,0000|Vistor hf|Merck Sharp & Dohme Limited|Raltegravír||115346||115346|146642|
111479|S01ED5113|Dorzolamide/Timolol Portfarma|augndr|5|mg/ml|5|ml|3|glas|+ dorzólamid 20 mg/ml|S01ED51|01.11.2011||R|||0|0|*|0|POF|0|0|0|100|XEU|5992|7452|lyfalmen|V0373|7452||15|0|75,0000|Portfarma ehf|Portfarma|Tímólól í blöndum||4732||4732|7452|
111955|N02BE0101|Panodil|töflur|1|g|100|stk|1|glas||N02BE01|01.05.2003||R|||0|0|0|0|GSH|0|0|1|100|DKK|766|2027|lyfalmen||||100|0|33,3300|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól||766||766|2027|
112022|G03AC0802|Implanon NXT|vefjalyf|68|mg|1|stk|1|pakki||G03AC08|01.02.2011||R|||0|0|0|0|ORG|0|0|0|100|DKK|22237|30453|lyfalmen||||1|0|1000,0000|Vistor hf|N.V. Organon|Etónógestrel||22237||22237|30453|
112641|M05BA0407|Alendronat Ranbaxy|töflur|70|mg|12|stk|1|ţpakki||M05BA04|01.04.2009||R|||0|0|E|0|RAN|0|0|0|100|XEU|8383|3876|lyfalmen|V0203|3746||12|0|84,0000|Artasan ehf|Ranbaxy (UK) Ltd|Alendrónsýra||2118||2118|3876|
113394|A10BD0801|Eucreas|filmhtfl|900|mg|60|stk|1|ţpakki|50mg/850mg|A10BD08|01.11.2008||R|||0|0|*|0|NOE|0|0|0|100|DKK|8698|12877|lyfalmen|V0024|11664||60|0|30,0000|Vistor hf|Novartis Europharm Ltd|Metforminum og vildagliptinum||8698||8698|12877|
113403|A10BD0801|Eucreas|filmhtfl|900|mg|180|stk|1|ţpakki|50mg/850mg|A10BD08|01.11.2008||R|||0|0|*|0|NOE|0|0|0|100|DKK|25855|34993|lyfalmen|V0024|34993||180|0|90,0000|Vistor hf|Novartis Europharm Ltd|Metforminum og vildagliptinum||25855||25855|34993|
113412|A10BD0801|Eucreas|filmhtfl|1050|mg|60|stk|1|ţpakki|50mg/1000mg|A10BD08|01.11.2008||R|||0|0|*|0|NOE|0|0|0|100|DKK|8811|13032|lyfalmen|V0025|11790||60|0|30,0000|Vistor hf|Novartis Europharm Ltd|Metforminum og vildagliptinum||8811||8811|13032|
113415|B01AB0501|Klexane|stl|100|mg/ml|0,2|ml|10|stk|einnota dćla|B01AB05|01.10.1995||R|||0|0|E|0|SNO|0|0|1|100|NOK|3888|6297|lyfalmen||||2|0|10,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||3888||3888|6297|
113421|A10BD0801|Eucreas|filmhtfl|1050|mg|180|stk|1|ţpakki|50mg/1000mg|A10BD08|01.11.2008||R|||0|0|*|0|NOE|0|0|0|100|DKK|26156|35371|lyfalmen|V0025|35371||180|0|90,0000|Vistor hf|Novartis Europharm Ltd|Metforminum og vildagliptinum||26156||26156|35371|
113704|B01AB0501|Klexane|stl|100|mg/ml|0,4|ml|10|stk|einnota dćla|B01AB05|01.10.1995||R|||0|0|E|0|SNO|0|0|1|100|NOK|6662|10092|lyfalmen||||4|0|20,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||6662||6662|10092|
113818|L01XE0801|Tasigna|hylki|200|mg|112|stk|1|ţpakki||L01XE08|01.06.2008||R|||0|1|0|1|NOE|0|0|0|100|DKK|681311|856928|lyfsjukr||||112|0||Vistor hf|Novartis Europharm Ltd|Nilotiníb||681311||681311|856928|
113894|J01CE0204|Kaavepenin|töflur|1|g|20|stk|1|ţpakki||J01CE02|01.10.1985||R|||0|0|0|0|REP|0|0|1|100|SEK|725|1971|lyfalmen||||20|0|10,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||725||725|1971|
113902|J01CE0204|Kaavepenin|töflur|1|g|30|stk|1|ţpakki||J01CE02|01.10.1985||R|||0|0|0|0|REP|0|0|1|100|SEK|921|2239|lyfalmen||||30|0|15,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||921||921|2239|
113910|J01CE0204|Kaavepenin|töflur|1|g|40|stk|1|ţpakki||J01CE02|01.10.1985||R|||0|0|0|0|REP|0|0|1|100|SEK|1405|2901|lyfalmen||||40|0|20,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||1405||1405|2901|
114033|R03AC0210|Ventolin Diskus|innúđadu|200|mcg/sk|60|skammtar|1|stk|Diskus tćki|R03AC02|01.03.1999||R|||0|0|B|0|GSK|0|0|1|100|GBP|1013|2365|lyfalmen||||60|0|15,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salbútamól||1013||1013|2365|
114328|L01AX0303|Temomedac|hylki|100|mg|5|stk|1|glas||L01AX03|01.04.2011||R|||0|1|0|1|WIL|0|0|0|100|XEU|53574|69118|lyfsjukr||||5|0||Williams & Halls efh|medac Gesellschaft|Temozolomid||53574||53574|69118|
114440|M01AH0501|Arcoxia|filmhtfl|30|mg|28|stk|1|ţpakki||M01AH05|01.01.2010||R|||0|0|E|0|MSD|0|0|1|100|DKK|4224|6757|lyfalmen||||28|0|14,0000|Vistor hf|M.S.D.|Etoríkoxíb||4224||4224|6757|
114447|S01ED5101|Cosopt|augndr|5|mg/ml|5|ml|1|glas|+ dorzólamíđ 20 mg|S01ED51|01.03.1999||R|||0|0|*|0|MSD|0|0|0|100|DKK|2410|4276|lyfalmen|V0373|2484||5|0|25,0000|Vistor hf|M.S.D.|Tímólól í blöndum||2410||2410|4276|
114512|D06BB0401|Condyline|áburđur|5|mg/ml|3,5|ml|1|glas|til penslu|D06BB04|01.11.2010||R|||0|0|0|0|GAN|0|0|1|100|XEU|2258|4068|lyfalmen||||4|0||Icepharma hf|Galderma Nordic AB|Pódófýllótoxín||2258||2258|4068|
114664|D10AD5301|Epiduo|hlaup|||30|g|1|túpa|0,1% / 2,5%|D10AD53|01.12.2011|30.06.2012|R|||0|0|0|0|GAN|0|0|0|100|SEK|3275|5459|lyfalmen||||30|0||Icepharma hf|Galderma Nordic AB|Adapalen og benzóýl peroxíđ||3275||3275|5459|
114675|D10AD5301|Epiduo|hlaup|||60|g|1|túpa|0,1% / 2,5%|D10AD53|01.12.2011||R|||0|0|0|0|GAN|0|0|0|100|SEK|6285|9576|lyfalmen||||60|0||Icepharma hf|Galderma Nordic AB|Adapalen og benzóýl peroxíđ||6285||6285|9576|
115163|B01AE0701|Pradaxa|hylki|75|mg|10|stk|1|ţpakki|hart|B01AE07|01.01.2009||R|||0|0|E|0|BII|0|0|0|100|DKK|1947|3642|lyfalmen||||10|0|3,4100|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||1947||1947|3642|
115241|V03AB1504|Naloxon B. Braun|stl|0,4|mg/ml|1|ml|10|lykjur||V03AB15|01.09.2010||R|||0|0|0|1|BRA|0|0|0|100|IKR|9164|13226|lyfsjukr||||10|0||Actavis Group hf|Braun|Naloxón||9164||9164|13226|
115285|J01CA0411|Amoxicillin Mylan|töflur|750|mg|20|stk|1|ţpakki||J01CA04|01.10.1998||R|||0|0|0|0|MYL|0|0|1|100|SEK|1583|3144|lyfalmen||||20|0|15,0000|Actavis Group PTC ehf|Mylan AB|Amoxicillín||1583||1583|3144|
115330|B01AE0701|Pradaxa|hylki|75|mg|60|stk|1|ţpakki|hart|B01AE07|01.01.2009||R|||0|0|E|0|BII|0|0|0|100|DKK|11680|16957|lyfalmen||||60|0|20,4600|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||11680||11680|16957|
115341|B01AE0701|Pradaxa|hylki|110|mg|10|stk|1|ţpakki|hart|B01AE07|01.01.2009||R|||0|0|E|0|BII|0|0|0|100|DKK|1947|3642|lyfalmen||||10|0|5,0000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||1947||1947|3642|
115364|B01AE0701|Pradaxa|hylki|110|mg|60|stk|1|ţpakki|hart|B01AE07|01.01.2009||R|||0|0|E|0|BII|0|0|0|100|DKK|11680|16957|lyfalmen||||60|0|30,0000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||11680||11680|16957|
115642|S01EC0301|Trusopt|augndr|20|mg/ml|5|ml|1|glas||S01EC03|01.04.1996||R|||0|0|*|0|MSD|0|0|0|100|DKK|1939|3631|lyfalmen|V0369|3019||5|0|16,6667|Vistor hf|M.S.D.|Dorzólamíđ||1939||1939|3631|
115931|R03AC1202|Serevent Diskus|innúđadu|50|mcg/sk|60|sk|1|pakki||R03AC12|01.01.1995||R|||0|0|B|0|GSK|0|0|1|100|GBP|3918|6339|lyfalmen||||60|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról||3918||3918|6339|
115980|P03AX0301|Prioderm|húđlausn|5|mg/ml|55|ml|1|glas||P03AX03|01.12.1983||L|||0|0|0|0|NOP|0|0|0|100|IKR|||lyflausa||||55|0||Icepharma hf|Norpharma |Malatíón||||||
116004|J01DC0202|Zinacef|sts|1,5|g|5|hgl|1|pakki||J01DC02|01.06.2005||R|||0|0|0|1|GSK|0|0|0|100|GBP|3935|5679|lyfsjukr||||5|0|2,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Cefúroxím||3935||3935|5679|
116046|J01DC0202|Zinacef|sts|750|mg|1|stk|5|hgl||J01DC02|01.09.1983||R|||0|0|0|1|GSK|0|0|0|100|GBP|2057|2969|lyfsjukr||||5|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Cefúroxím||2057||2057|2969|
116198|C08CA0105|Amlodipin Bluefish|töflur|5|mg|100|stk|1|ţpakki||C08CA01|01.03.2012||R|||0|0|B|0|BLP|0|0|0|100|XEU|1208|1801|lyfalmen|V0056|1801||100|0|100,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Amlódipín||601||601|1801|
116220|C08CA0105|Amlodipin Bluefish|töflur|10|mg|100|stk|1|ţpakki||C08CA01|01.03.2012||R|||0|0|B|0|BLP|0|0|0|100|XEU|1912|2231|lyfalmen|V0057|2231||100|0|200,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Amlódipín||915||915|2231|
116244|D11AF01|Verucid|áburđur|||10|ml|1|glas||D11AF|01.11.1981||L|||0|0|0|0|GAN|0|0|0|100|IKR|||lyflausa||||10|0||Icepharma hf|Galderma Nordic AB|Lyf viđ vörtum og líkţornum||||||
116327|D07AC1301|Elocon|krem|0,1|%|100|g|1|túpa||D07AC13|01.04.2009||R|||0|0|B|0|SPL|0|0|1|100|DKK|2656|4612|lyfalmen||||100|0||Vistor hf|Schering-Plough Europe|Mómetasón||2656||2656|4612|
116418|D07AC1301|Elocon|smyrsli|0,1|%|100|g|1|túpa||D07AC13|01.04.2009||R|||0|0|B|0|SPL|0|0|1|100|DKK|3052|5154|lyfalmen||||100|0||Vistor hf|Schering-Plough Europe|Mómetasón||3052||3052|5154|
116551|M01AE0102|Ibufen|töflur|200|mg|20|stk|1|ţpakki||M01AE01|01.12.2008||L|||0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa||||20|0|3,3333|Actavis Group hf|Actavis hf|Íbúprófen||||||
116573|M01AE0102|Ibufen|töflur|400|mg|30|stk|1|ţpakki||M01AE01|01.05.2008||L|||0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa||||30|0|10,0000|Actavis Group hf|Actavis hf|Íbúprófen||||||
116584|M01AE0102|Ibufen|töflur|400|mg|100|stk|1|ţpakki||M01AE01|01.08.2008||R|||0|0|E|0|ACA|0|0|1|100|XEU|774|2038|lyfalmen|V0562|2035||100|0|33,3333|Actavis Group hf|Actavis hf|Íbúprófen||774||774|2038|
116595|M01AE0102|Ibufen|töflur|600|mg|30|stk|1|ţpakki||M01AE01|01.07.2008||R|||0|0|E|0|ACA|0|0|1|100|XEU|385|1506|lyfalmen|V0563|1506||30|0|15,0000|Actavis Group hf|Actavis hf|Íbúprófen||385||385|1506|
116606|M01AE0102|Ibufen|töflur|600|mg|100|stk|1|ţpakki||M01AE01|01.05.2008||R|||0|0|E|0|ACA|0|0|1|100|XEU|938|2262|lyfalmen|V0564|2261||100|0|50,0000|Actavis Group hf|Actavis hf|Íbúprófen||938||938|2262|
116694|G04BD1101|Toviaz|forđatfl|4|mg|84|stk|1|ţpakki||G04BD11|01.11.2008||R|||0|0|E|0|IPI|0|0|0|100|DKK|18105|25267|lyfalmen||||84|0|84,0000|Icepharma hf|Pfizer Limited|Fesóteródín||18105||18105|25267|
116697|C09CA0602|Candpress|töflur|8|mg|100|stk|1|ţpakki||C09CA06|01.01.2012||R|||0|0|0|0|AGP|0|0|0|100|XEU|7706|10942|lyfalmen|V0081|5305||100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Candesartan||7283||7283|10942|
116705|G04BD1101|Toviaz|forđatfl|4|mg|28|stk|1|ţpakki||G04BD11|01.11.2008||R|||0|0|E|0|IPI|0|0|0|100|DKK|6169|9418|lyfalmen||||28|0|28,0000|Icepharma hf|Pfizer Limited|Fesóteródín||6169||6169|9418|
116716|G04BD1101|Toviaz|forđatfl|8|mg|28|stk|1|ţpakki||G04BD11|01.11.2008||R|||0|0|E|0|IPI|0|0|0|100|DKK|6625|10042|lyfalmen||||28|0|56,0000|Icepharma hf|Pfizer Limited|Fesóteródín||6625||6625|10042|
116727|G04BD1101|Toviaz|forđatfl|8|mg|84|stk|1|ţpakki||G04BD11|01.11.2008||R|||0|0|E|0|IPI|0|0|0|100|DKK|19558|27090|lyfalmen||||84|0|168,0000|Icepharma hf|Pfizer Limited|Fesóteródín||19558||19558|27090|
116928|J07AL0202|Prevenar 13|stl|2,2|mcg|0,5|ml|1|áf.spr||J07AL02|01.04.2010||R|||0|0|0|0|WLV|0|0|0|100|DKK|8438|12522|lyfalmen||||0|0||Icepharma hf|Wyeth Lederle Vaccines SA|Hreinsuđ pneumococca poly­sakkaríđ mótefnavakar (cojugated)||8438||8438|12522|
117408|QA12AX0001|Calcimag vet. Kela|irl|||500|ml|12|plastf||QA12AX00|01.04.2004||R|||0|0|0|0|KEL|1|0|0|100|NOK|10902|21106|vetalmen||||6000|0||Icepharma hf|Kela Laboratoria NV|||10902||10902|21106|
117515|M01AE0303|Orudis|forđahlk|200|mg|100|stk|1|glas||M01AE03|01.10.1995||R|||0|0|E|0|SNO|0|0|1|100|NOK|3344|5553|lyfalmen||||100|0|133,3333|Vistor hf|Sanofi-aventis Norge AS|Ketóprófen||3344||3344|5553|
117531|N04BA0201|Madopar|hylki|250|mg|100|stk|1|glas|200+50 mg|N04BA02|01.07.1974||R|||0|0|E|0|ROC|0|0|0|100|DKK|4635|7319|lyfalmen|V0435|7213||100|0|33,3333|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||4635||4635|7319|
117550|N05AH0405|Seroquel Prolong|forđatfl|50|mg|100|stk|1|ţpakki||N05AH04|01.12.2008||R|||0|0|0|0|ASZ|0|1|0|100|SEK|14944|21300|lyfalmen||||100|0|12,5000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||14944|21300|
117561|N05AH0405|Seroquel Prolong|forđatfl|200|mg|100|stk|1|ţpakki||N05AH04|01.12.2008||R|||0|0|0|0|ASZ|0|1|0|100|SEK|26413|35693|lyfalmen||||100|0|50,0000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||26413|35693|
117564|N04BA0201|Madopar|hylki|62,5|mg|100|stk|1|glas|50+12.5 mg|N04BA02|01.06.1981||R|||0|0|E|0|ROC|0|0|0|100|DKK|1643|3226|lyfalmen||||100|0|8,3333|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||1643||1643|3226|
117573|N05AH0405|Seroquel Prolong|forđatfl|300|mg|10|stk|1|ţpakki||N05AH04|01.12.2008||R|||0|0|0|0|ASZ|0|1|0|100|SEK|4567|7226|lyfalmen||||10|0|7,5000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||4567|7226|
117584|N05AH0405|Seroquel Prolong|forđatfl|300|mg|100|stk|1|ţpakki||N05AH04|01.12.2008||R|||0|0|0|0|ASZ|0|1|0|100|SEK|45671|59862|lyfalmen||||100|0|75,0000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||45671|59862|
117595|N05AH0405|Seroquel Prolong|forđatfl|400|mg|100|stk|1|ţpakki||N05AH04|01.12.2008||R|||0|0|0|0|ASZ|0|1|0|100|SEK|52825|68841|lyfalmen||||100|0|100,0000|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||52825|68841|
117676|L01DB0103|Caelyx|irţ|2|mg/ml|10|ml|1|hgl||L01DB01|01.01.2011||R|||0|1|0|1|JCI|0|0|0|100|SEK|67211|86232|lyfsjukr||||10|0||Vistor hf|Janssen-Cilag International N.V.|Doxórúbicín||67211||67211|86232|
117770|QP51AJ0101|Baycox Vet.|mixtúra|50|mg/ml|250|ml|1|fl||QP51AJ01|01.12.2005||R|||0|0|0|0|BAN|0|0|0|100|DKK|9938|17336|vetorma||||250|0||Icepharma hf|Bayer Animal Health GmbH|||9938||9938|17336|
117788|C08CA0502|Adalat Oros|forđatfl|30|mg|28|stk|1|ţpakki||C08CA05|01.07.1994||R|||0|0|B|0|BAP|0|0|0|100|SEK|2342|4183|lyfalmen||||28|0|28,0000|Icepharma hf|Bayer Schering Pharma AG|Nífedipín||2342||2342|4183|
117796|C08CA0502|Adalat Oros|forđatfl|30|mg|98|stk|1|ţpakki||C08CA05|01.07.1994||R|||0|0|B|0|BAP|0|0|0|100|SEK|5599|8638|lyfalmen||||98|0|98,0000|Icepharma hf|Bayer Schering Pharma AG|Nífedipín||5599||5599|8638|
117820|C08CA0502|Adalat Oros|forđatfl|60|mg|98|stk|1|ţpakki||C08CA05|01.07.1994||R|||0|0|B|0|BAP|0|0|0|100|SEK|8384|12448|lyfalmen||||98|0|196,0000|Icepharma hf|Bayer Schering Pharma AG|Nífedipín||8384||8384|12448|
117929|QA12AA0001|Calci-kel vet. Kela|irl|20,8|mg/ml|100|ml|12|fl||QA12AA00|01.04.2004||R|||0|0|0|0|KEL|0|0|0|100|NOK|7615|14795|vetalmen||||1200|0||Icepharma hf|Kela Laboratoria NV|||7615||7615|14795|
117937|QA12AA0001|Calci-kel vet. Kela|irl|20,8|mg/ml|500|ml|12|plastf||QA12AA00|01.04.2004||R|||0|0|0|0|KEL|0|0|0|100|NOK|13356|25818|vetalmen||||6000|0||Icepharma hf|Kela Laboratoria NV|||13356||13356|25818|
118020|N05AH0306|Olanzapin Actavis|filmhtfl|2,5|mg|28|stk|1|ţpakki||N05AH03|01.05.2008||R|||0|0|*|0|AGP|0|1|0|100|XEU|4076|1994|lyfalmen|V0278|1857||28|0|7,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||742||742|1994|
118043|N05AH0306|Olanzapin Actavis|filmhtfl|5|mg|28|stk|1|ţpakki||N05AH03|01.04.2008||R|||0|0|*|0|AGP|0|1|0|100|XEU|5794|2625|lyfalmen|V0279|2529||28|0|14,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||1203||1203|2625|
118076|N05AH0306|Olanzapin Actavis|filmhtfl|10|mg|56|stk|1|ţpakki||N05AH03|01.03.2008||R|||0|0|*|0|AGP|0|1|0|100|XEU|22471|8363|lyfalmen|V0282|7774||56|0|56,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||5398||5398|8363|
118087|N05AH0306|Olanzapin Actavis|filmhtfl|15|mg|28|stk|1|ţpakki||N05AH03|01.04.2008||R|||0|0|*|0|AGP|0|1|0|100|XEU|17166|10600|lyfalmen|V0283|9719||28|0|42,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||7033||7033|10600|
118158|J01DC0203|Zinnat|mixt.kyr|25|mg/ml|100|ml|1|glas||J01DC02|01.10.1990||R|||0|0|0|0|GSK|0|0|1|100|GBP|2343|4184|lyfalmen||||100|0|5,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Cefúroxím||2343||2343|4184|
118231|N01AX1301|Niontix|lyfjagas|100|%|4|l|1|hylki||N01AX13|01.06.2008||R|||0|0|0|1|AGA|0|0|0|100|IKR|9512|13728|lyfsjukr||||4|0||Ísaga ehf|AGA AB|di-Nitrogen oxíđ||9512||9512|13728|
118307|A02BA0201|Asyran|töflur|150|mg|30|stk|1|ţpakki||A02BA02|01.04.1994||L|||0|0|0|0|ACA|0|0|0|100|IKR|||lyflausa||||30|0|15,0000|Actavis Group hf|Actavis hf|Ranitidín||||||
118406|A02BA0201|Asyran|töflur|300|mg|30|stk|1|ţpakki||A02BA02|01.04.1994||R|||0|0|E|0|ACA|0|0|0|100|XEU|955|2285|lyfalmen||||30|0|30,0000|Actavis Group hf|Actavis hf|Ranitidín||955||955|2285|
118484|N05AH0306|Olanzapin Actavis|filmhtfl|7,5|mg|56|stk|1|ţpakki||N05AH03|01.04.2008||R|||0|0|*|0|AGP|0|1|0|100|XEU|17666|10007|lyfalmen|V0280|9315||56|0|42,0000|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||6600||6600|10007|
118570|A07EC0203|Pentasa Sachets|forđakyr|1|g|50|stk|1|pakki||A07EC02|01.04.1998||R|||0|0|B|0|FER|0|0|0|100|DKK|7701|11513|lyfalmen|V0015|10739||50|0|33,3333|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||7701||7701|11513|
118612|A07EC0203|Pentasa Sachets|forđakyr|1|g|150|stk|1|pakki|3 x 50 stk|A07EC02|01.04.1998||R|||0|0|B|0|FER|0|0|0|100|DKK|23644|32218|lyfalmen|V0015|32218||150|0|100,0000|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||23644||23644|32218|
118674|N05AH0204|Leponex (Lyfjaver)|töflur|25|mg|100|stk|1|glas||N05AH02|01.05.2008||R|||0|0|*|0|LVR|0|1|0|100|DKK|3110|5233|lyfalmen||||100|0|8,3333|Lyfjaver ehf|Lyfjaver ehf|Klózapín||3110||3110|5233|30.04.2012
118685|N05AH0204|Leponex (Lyfjaver)|töflur|100|mg|100|stk|1|glas||N05AH02|01.05.2008||R|||0|0|*|0|LVR|0|1|0|100|DKK|9752|14319|lyfalmen||||100|0|33,3333|Lyfjaver ehf|Lyfjaver ehf|Klózapín||9752||9752|14319|30.04.2012
118793|C01AA0504|Lanoxin mite|töflur|62,5|mcg|120|stk|1|ţpakki||C01AA05|01.12.2010||R|||0|0|B|0|AEG|0|0|0|100|XEU|499|1662|lyfalmen||||120|0|30,0000|GlaxoSmithKline ehf|Aspen Europe GmbH|Digoxín||499||499|1662|
119031|L01XC0801|Vectibix|irţ|20|mg/ml|5|ml|1|hgl|lausn|L01XC08|01.06.2008||R|||0|1|0|1|AEU|0|0|0|100|DKK|79102|101156|lyfsjukr||||5|0||Vistor hf|Amgen Europe B.V.|Panitúmúmab||79102||79102|101156|
119962|M01AE0109|Ibuprofen Portfarma|filmhtfl|400|mg|30|stk|1|ţpakki||M01AE01|01.03.2008||L|||0|0|0|0|POF|0|0|1|100|IKR|||lyflausa||||30|0|10,0000|Portfarma ehf|Portfarma|Íbúprófen||||||
119984|C02KX0201|Volibris|filmhtfl|5|mg|30|stk|1|ţpakki||C02KX02|01.12.2008||R|||0|1|0|1|GGL|0|0|0|100|GBP|469932|591647|lyfsjukr||||30|0|20,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Ambrisentanum||469932||469932|591647|
120007|C02KX0201|Volibris|filmhtfl|10|mg|30|stk|1|ţpakki||C02KX02|01.12.2008||R|||0|1|0|1|GGL|0|0|0|100|GBP|469932|591647|lyfsjukr||||30|0|40,0000|GlaxoSmithKline ehf|Glaxo Group Limited|Ambrisentanum||469932||469932|591647|
120022|S01FA0401|Cyclogyl 1 %|augndr|10|mg/ml|10|ml|1|glas||S01FA04|01.10.2003||R|||0|0|E|0|SAL|0|0|0|100|USD|1035|2395|lyfalmen||||10|0||Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Cýklópentólat||1035||1035|2395|
120062|L01BA0401|Alimta|irţ|100|mg/hgl|1|hgl|1|pakki||L01BA04|01.11.2008||R|||0|1|0|1|LIL|0|0|0|100|XEU|49124|63533|lyfsjukr||||1|0||Icepharma hf|Lilly ICOS Limited|Pemetrexed||49124||49124|63533|
120392|M01AE0110|Ibuprofen Actavis|filmhtfl|200|mg|24|stk|1|ţpakki||M01AE01|01.01.2012||L|||0|0|0|0|AHF|0|0|1|100|IKR|||lyflausa||||24|0|4,0000|Actavis Group PTC ehf|Actavis Group hf|Íbúprófen||||||
120798|H01AC0111|Omnitrope|stl|6,7|mg/ml|1,5|ml|1|rörlyk|lausn|H01AC01|01.04.2012||R|||0|1|0|1|SDG|0|0|0|100|DKK|32503|42674|lyfsjukr||||2|0|15,0000|Artasan ehf|Sandoz GmbH (Kundl)|Sómatrópín||32503||32503|42674|
120973|N03AX1402|Keppra (Lyfjaver)|filmhtfl|500|mg|100|stk|1|ţpakki||N03AX14|01.05.2008||R|||0|0|0|0|LVR|0|0|0|100|DKK|18224|25416|lyfalmen|V0253|10136||100|0|33,3300|Lyfjaver ehf|Lyfjaver ehf|Levetíracetam||18224||18224|25416|
121164|A02BC0501|Nexium|mixt.kyr|10|mg|28|sk-pokar|1|pakki|dreifa|A02BC05|01.04.2009||R|||0|0|0|0|AZD|0|0|0|100|SEK|5685|8756|lyfalmen||||28|0|9,3300|Vistor hf|AstraZeneca A/S DK|Esómeprazól||5685||5685|8756|
121286|M03AC0901|Esmeron|stl|10|mg/ml|5|ml|10|hgl||M03AC09|01.04.2009||R|||0|0|0|1|ORG|0|0|0|100|DKK|9697|13995|lyfsjukr||||50|0||Vistor hf|N.V. Organon|Rókúrón, brómíđ||9697||9697|13995|
121327|R03AC0204|Ventolin|innúđal|0,1|mg/sk|200|sk|1|stauk||R03AC02|01.12.1972||R|||0|0|B|0|GSK|0|0|1|100|GBP|473|1626|lyfalmen||||200|0|25,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salbútamól||473||473|1626|
121550|A02BC0507|Esomeprazole Portfarma|sţ-tfl|20|mg|98|stk|1|ţpakki||A02BC05|01.11.2011||R|||0|0|E|0|POF|0|0|0|100|XEU|8220|5660|lyfalmen|V0011|5497||98|0|65,3300|Portfarma ehf|Portfarma|Esómeprazól||3422||3422|5660|
121562|B03BB0104|Folic Acid|töflur|5|mg|28|stk|1|ţpakki||B03BB01|01.01.2008||R|||0|0|E|0|AUK|0|0|1|100|GBP|430|1563|lyfalmen|V0391|1562||28|0|350,0000|Actavis Group hf|Actavis UK Ltd.|Fólínsýra||427||427|1563|
121582|N06AA0401|Anafranil|töflur|25|mg|100|stk|1|ţpakki||N06AA04|01.03.1977||R|||0|0|B|0|NOH|0|1|0|100|DKK|1802|3444|lyfalmen|V0314|2298||100|0|25,0000|Vistor hf|Novartis Healthcare A/S-|Klómípramín||1802||1802|3444|
121691|H02AB0605|Prednisolone Actavis|töflur|1|mg|28|stk|1|ţpakki||H02AB06|01.01.2011||R|||0|0|B|0|AUK|0|0|1|100|GBP|287|1372|lyfalmen||||28|0|2,8000|Actavis Group hf|Actavis UK Ltd.|Prednisólón||287||287|1372|
122411|QI09AA0701|Ingelvac CircoFLEX|stl|||50|ml|1|hgl|dreifa|QI09AA07|01.12.2010||R|||0|0|0|0|BIV|0|0|0|100|IKR|9600|16747|vetorma||||50|0||Vistor hf|Boehringer Ingelheim Vetmedica GmbH|Porcine circovirus Type ORF-2 protein||9600||9600|16747|
123216|N05BA0105|Stesolid|eţ-stíll|5|mg|10|stk|1|pakki||N05BA01|01.07.2005||R|||0|0|0|0|AGT|0|0|1|100|DKK|564|1750|lyfalmen||||10|0|5,0000|Actavis Group hf|Actavis Group hf|Díazepam||564||564|1750|
123224|N05BA0105|Stesolid|eţ-stíll|10|mg|10|stk|1|pakki||N05BA01|01.07.2005||R|||0|0|0|0|AGT|0|0|1|100|DKK|879|2181|lyfalmen||||10|0|10,0000|Actavis Group hf|Actavis Group hf|Díazepam||879||879|2181|
123256|QP52AA5104|Zantel|töflur|550|mg|100|stk|1|ţpakki|50+500 mg|QP52AA51|01.07.2011||R|||0|0|0|0|ICE|0|0|0|100|USD|28405|49551|vetorma||||100|0||Icepharma hf|Icepharma hf|||28405||28405|49551|
123806|C07AA0512|Pranolol|töflur|20|mg|100|stk|1|glas||C07AA05|01.09.2011||R|||0|0|B|0|AGT|0|0|0|100|XEU|250|1321|lyfalmen||||100|0|12,5000|Actavis Group hf|Actavis Group hf|Própranólól||||250|1321|
123992|N07XX0201|Rilutek|töflur|50|mg|56|stk|1|ţpakki||N07XX02|01.05.1998||R|||0|0|E|0|AVS|0|0|0|100|NOK|47271|61870|lyfalmen||||56|0|28,0000|Vistor hf|Aventis Pharma SA|Rílúzól||47271||47271|61870|
124020|QM01AC0603|Rheumocam|mixtúra|1,5|mg/ml|42|ml|1|plastf||QM01AC06|01.08.2009||R|||0|0|0|0|CHP|0|0|0|100|XEU|1859|3698|vetalmen||||42|0||Icepharma hf|Chanelle Pharmaceuticals|||||1859|3698|
124119|B01AC0401|Plavix|töflur|300|mg|30|stk|1|ţpakki||B01AC04|01.09.2009||R|||0|0|0|0|SBM|0|0|0|100|NOK|39455|52061|lyfalmen||||30|0|120,0000|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Klópídógrel||||39455|52061|
124207|N02CC0105|Sumatriptan Bluefish|töflur|100|mg|6|stk|1|ţpakki||N02CC01|01.04.2012||R|||0|0|E|0|BLP|0|0|0|100|XEU|1949|2492|lyfalmen|V0234|2492||6|0|12,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Súmatriptan||1106||1106|2492|
124251|N02CC0105|Sumatriptan Bluefish|töflur|50|mg|12|stk|1|ţpakki||N02CC01|01.04.2012||R|||0|0|E|0|BLP|0|0|0|100|XEU|2784|2887|lyfalmen|V0233|2887||12|0|12,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Súmatriptan||1395||1395|2887|
124354|G02AB0101|Methergin|töflur|0,125|mg|30|stk|1|ţpakki||G02AB01|01.03.1980||R|||0|0|E|0|NOH|0|0|0|100|DKK|1023|2378|lyfalmen||||30|0|18,7500|Vistor hf|Novartis Healthcare A/S-|Metýlergómetrín||1023||1023|2378|
124727|C09AA0201|Daren|töflur|10|mg|30|stk|1|ţpakki||C09AA02|01.01.1994||R|||0|0|B|0|ACA|0|0|0|100|XEU|522|1693|lyfalmen||||30|0|30,0000|Actavis Group hf|Actavis hf|Enalapríl||522||522|1693|
124870|S01ED5110|Duotrav|augndr|||2,5|ml|3|glas|40 mcg/ml+5 mg/ml|S01ED51|01.10.2011||R|||0|0|*|0|ALC|0|0|0|100|USD|11101|16165|lyfalmen|V0464|16165||8|0|75,0000|K.Pétursson hf|Alcon|Tímólól í blöndum||11101||11101|16165|
124936|N07BC0101|Subutex|tungur.t|2|mg|7|stk|1|ţpakki||N07BC01|01.11.1999||R|||1|0|0|1|RBP|0|0|0|100|DKK|1302|1879|lyfsjukr||||7|0|1,7500|Vistor hf|RB Pharmaceuticals Limited|Búprenorfín||1302||1302|1879|
125054|C09AA0201|Daren|töflur|10|mg|100|stk|1|ţpakki||C09AA02|01.01.1994||R|||0|0|B|0|ACA|0|0|0|100|XEU|858|1599|lyfalmen|V0066|1599||100|0|100,0000|Actavis Group hf|Actavis hf|Enalapríl||453||453|1599|
126253|N04BA0302|Stalevo (Lyfjaver)|filmhtfl|387,5|mg|100|stk|1|glas|150+37,5+200mg|N04BA03|01.05.2008||R|||0|0|E|0|LVR|0|0|0|100|DKK|15412|21887|lyfalmen||||100|0|33,3300|Lyfjaver ehf|Lyfjaver ehf|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||15412||15412|21887|31.05.2012
126326|A07DA0301|Imodium|töflur|2|mg|16|stk|1|ţpakki||A07DA03|01.10.1991||L|||0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa||||16|0|3,2000|Vistor hf|McNeil Sweden AB|Lóperamíđ||||||
126374|L01XX1702|Hycamtin|hylki|1|mg|10|stk|1|ţpakki|hart|L01XX17|01.11.2008||R|||0|1|0|1|SKB|0|0|0|100|GBP|119644|152036|lyfsjukr||||10|0||GlaxoSmithKline ehf|SmithKline Beecham Ltd|Tópótecan||||119644|152036|
126385|L01XX1702|Hycamtin|hylki|0,25|mg|10|stk|1|ţpakki|hart|L01XX17|01.11.2008||R|||0|1|0|1|SKB|0|0|0|100|GBP|30705|40417|lyfsjukr||||10|0||GlaxoSmithKline ehf|SmithKline Beecham Ltd|Tópótecan||||30705|40417|
126540|J01GB0303|Gentacoll|vefjasv|1,3|mg/fercm|1|stk|1|pakki|10X10 cm|J01GB03|01.10.1995||R|||0|0|0|1|INN|0|0|0|100|XEU|25871|34351|lyfsjukr||||1|0|0,5417|Innocoll Pharmaceuticals Ltd.|Innocoll Pharmaceuticals Ltd.|Gentamícín||25871||25871|34351|
126649|J01GB0303|Gentacoll|vefjasv|1,3|mg/fercm|1|stk|1|pakki|5X5 cm|J01GB03|01.10.1995||R|||0|0|0|1|INN|0|0|0|100|XEU|8623|12445|lyfsjukr||||1|0|0,1354|Innocoll Pharmaceuticals Ltd.|Innocoll Pharmaceuticals Ltd.|Gentamícín||8623||8623|12445|
126684|J06BA0208|Privigen|irl|100|mg/ml|50|ml|1|hgl||J06BA02|01.10.2009||R|||0|0|0|1|CSB|0|0|0|100|SEK|47463|61449|lyfsjukr||||50|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í ćđ||47463||47463|61449|
126695|J06BA0208|Privigen|irl|100|mg/ml|100|ml|1|hgl||J06BA02|01.10.2009||R|||0|0|0|1|CSB|0|0|0|100|SEK|94951|121046|lyfsjukr||||100|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í ćđ||94951||94951|121046|
126707|J06BA0208|Privigen|irl|100|mg/ml|200|ml|1|hgl||J06BA02|01.10.2009||R|||0|0|0|1|CSB|0|0|0|100|SEK|189835|240125|lyfsjukr||||200|0||Icepharma hf|CSL Behring GmbH|Immúnóglóbúlín, normal, manna, gefin í ćđ||189835||189835|240125|
126926|B01AX0601 |Xarelto|filmhtfl|15|mg|100|stk|1|ţpakki||B01AX06|01.05.2012||R|||0|0|E|0|BAP|0|0|0|100|SEK|37737|49905|lyfalmen|V0031|49905||100|0|150,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaroxaban||||37737|49905|
126953|A07DA0301|Imodium|töflur|2|mg|100|stk|1|ţpakki||A07DA03|01.10.1991||R|||0|0|E|0|MCS|0|0|0|100|SEK|1043|2406|lyfalmen|V0447|2101||100|0|20,0000|Vistor hf|McNeil Sweden AB|Lóperamíđ||1043||1043|2406|
127383|R02AA0302|Strepsils med honning og citron|sogtfl|||36|stk|1|ţpakki||R02AA03|01.01.2009||L|||0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa||||36|0|6,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól||||||
128058|N05AH0301|Zyprexa|húđuđtfl|5|mg|28|stk|1|ţpakki||N05AH03|01.03.1998||R|||0|0|*|0|ELD|0|1|0|100|XEU|8892|6308|lyfalmen|V0279|2529||28|0|14,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||3896||3896|6308|
128131|QG51BE0002|Sulfa-Streptocillin vet.|legstíl|||30|stk|1|ţpakki||QG51BE00|01.03.2009||R|||0|0|0|0|BID|1|0|0|100|DKK|12568|24305|vetalmen||||30|0||Vistor hf|Boehringer Ingelheim Danmark|||12568||12568|24305|
128348|C03AB0102|Centyl mite med kaliumklorid|töflur|||100|stk|1|glas||C03AB01|01.05.1999||R|||0|0|E|0|LEP|0|0|0|100|DKK|1260|2703|lyfalmen||||100|0|50,0000|Vistor hf|LEO Pharma A/S|Bendróflúmetíazíđ og kalíum||1260||1260|2703|
128777|N02BA5102|Treo|freyđit|||60|stk|1|glas||N02BA51|01.07.1988||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||60|0|10,0000|Vistor hf|McNeil Denmark ApS|Acetýlsalicýlsýra í blöndum, ţó ekki međ geđlyfjum (psychole||||||
128934|V03AF0101|Uromitexan|stl|100|mg/ml|10|ml|10|lykjur||V03AF01|01.10.1990||R|||0|0|0|1|BAM|0|0|0|100|SEK|4016|5796|lyfsjukr||||100|0||Icepharma hf|Baxter Medical AB|Mesna||4016||4016|5796|
129098|N05AH0301|Zyprexa|húđuđtfl|7,5|mg|56|stk|1|ţpakki||N05AH03|01.03.1998||R|||0|0|0|0|ELD|0|1|0|100|XEU|32060|30621|lyfalmen|V0280|9315||56|0|42,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||22371||22371|30621|
129106|N05AH0301|Zyprexa|húđuđtfl|10|mg|56|stk|1|ţpakki||N05AH03|01.03.1998||R|||0|0|*|0|ELD|0|1|0|100|XEU|34845|23598|lyfalmen|V0282|7774||56|0|56,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||16775||16775|23598|
129158|H02AB0605|Prednisolone Actavis|töflur|5|mg|28|stk|1|ţpakki||H02AB06|01.02.2011||R|||0|0|B|0|AUK|0|0|1|100|GBP|241|1309|lyfalmen||||28|0|14,0000|Actavis Group hf|Actavis UK Ltd.|Prednisólón||241||241|1309|
129668|A02AH0002|Natriumbikarbonat|töflur|1|g|100|stk|1|glas||A02AH00|01.08.2005||L|||0|0|0|0|REP|0|0|0|100|SEK|||lyfalmen||||100|0||Vistor hf|Recip AB|Natríumhýdrógenkarbonat|||||3231|
129817|R03BB0101|Atrovent|innúđal|0,25|mg/ml|60|plastl|1|pakki|í vél|R03BB01|01.04.1989||R|||0|0|B|0|BOI|0|0|0|100|DKK|4478|7105|lyfalmen||||60|0|100,0000|Vistor hf|Boehringer Ingelheim|Ípratrópíumbrómíđ||4478||4478|7105|
130013|N05AH0401|Seroquel|töflur|100|mg|100|stk|1|ţpakki||N05AH04|01.09.1998||R|||0|0|0|0|AZA|0|1|0|100|SEK|18696|23018|lyfalmen|V0285|14998||100|0|25,0000|Vistor hf|AstraZeneca AB|Quetíapín||16313||16313|23018|
130021|N05AH0401|Seroquel|töflur|200|mg|100|stk|1|ţpakki||N05AH04|01.09.1998||R|||0|0|0|0|AZA|0|1|0|100|SEK|29594|34956|lyfalmen|V0286|27950||100|0|50,0000|Vistor hf|AstraZeneca AB|Quetíapín||25825||25825|34956|
130286|C01CA2406|Adrenalin Mylan|stl|1|mg/ml|1|ml|10|gl-lyk||C01CA24|01.06.2009||R|||0|0|0|0|MYL|0|0|1|100|SEK|2350|4194|lyfalmen||||10|0|20,0000|Actavis Group PTC ehf|Mylan AB|Adrenalín tartrat||2350||2350|4194|
130397|QH01CA9301|Suprelorin|vefjalyf|4,7|mg|2|stk|1|pakki|fyrir hunda|QH01CA93|01.05.2012||R|||0|0|0|0|VIR|1|0|0|100|DKK|14292|27615|vetalmen||||2|0||Vistor hf|Virbac S.A|Deslorelín||14292||14292|27615|
130575|C03CA0101|Furix|stl|10|mg/ml|25|ml|5|lykjur||C03CA01|01.03.2003||R|||0|0|E|0|NYG|0|0|0|100|DKK|4086|6568|lyfalmen||||125|0|31,2500|Gróco ehf|Nycomed Danmark A/S|Fúrósemíđ||4086||4086|6568|
130591|A03BA0103|Atropin Mylan|stl|0,5|mg/ml|1|ml|10|gl-lyk||A03BA01|01.06.2009||R|||0|0|0|0|MYL|0|0|1|100|SEK|1837|3492|lyfalmen||||10|0|3,3400|Actavis Group PTC ehf|Mylan AB|Atrópínsúlfat||1837||1837|3492|
130596|N07BA0301|Champix|filmhtfl|||53|stk|1|ţpakki|0,5 mg og 1 mg|N07BA03|01.02.2009||R|||0|0|0|0|IPI|0|0|1|100|DKK|11628|16885|lyfalmen||||53|0|23,7500|Icepharma hf|Pfizer Limited|Vareniclin||||11628|16885|
130772|QI10AB0201|Alpha Ject 3000|stl|||500|ml|1|plpoki||QI10AB02|01.05.2009||R|||0|0|0|0|PHA|0|0|0|100|NOK|66738|108883|veteldis||||500|0||Vistor hf|PHARMAQ AS|Aeromónas+Vibrio||||66738|108883|
131136|C01CA2601|Efedrin Mylan|stl|50|mg/ml|1|ml|10|gl-lyk||C01CA26|01.06.2009||R|||0|0|0|0|MYL|0|0|0|100|SEK|3368|5586|lyfalmen||||10|0|10,0000|Actavis Group PTC ehf|Mylan AB|Efedrínhýdróklóríđ||||3368|5586|
131334|N03AB0205|Fenantoin Recip|töflur|100|mg|100|stk|1|glas||N03AB02|01.06.2004||R|||0|0|E|0|REP|0|0|0|100|SEK|475|1629|lyfalmen||||100|0|33,3333|Vistor hf|Recip AB|Fenýtóín||475||475|1629|
131383|N03AA0204|Fenemal Recip|töflur|15|mg|100|stk|1|glas||N03AA02|01.06.2004||R|||0|0|E|0|REP|0|0|0|100|SEK|748|2002|lyfalmen||||100|0|15,0000|Vistor hf|Recip AB|Fenemal||748||748|2002|
131417|N03AA0204|Fenemal Recip|töflur|50|mg|100|stk|1|glas||N03AA02|01.06.2004||R|||0|0|E|0|REP|0|0|0|100|SEK|997|2343|lyfalmen||||100|0|50,0000|Vistor hf|Recip AB|Fenemal||997||997|2343|
131441|N03AA0204|Fenemal Recip|töflur|100|mg|100|stk|1|glas||N03AA02|01.06.2004||R|||0|0|E|0|REP|0|0|0|100|SEK|1104|2489|lyfalmen||||100|0|100,0000|Vistor hf|Recip AB|Fenemal||1104||1104|2489|
131450|B01AC0405|Clopidogrel Qualigen (Lyfjaver)|filmhtfl|75|mg|28|stk|1|ţpakki||B01AC04|01.07.2011||R|||0|0|E|0|LVR|0|0|0|100|XEU|2663|2961|lyfalmen|V0009|2014||28|0|28,0000|Lyfjaver ehf|Lyfjaver ehf|Klópídógrel||1449||1449|2961|
131565|G03CA0306|Evorel|forđapl|100|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993||R|||0|0|E|0|JAS|0|0|0|100|SEK|5687|8758|lyfalmen|V0132|8758||26|0|182,0000|Vistor hf|Janssen-Cilag AB|Estradíól||5687||5687|8758|
131740|N07BA0132|Nicorette Microtab Lemon|tungur.t|2|mg|90|stk|1|ţpakki||N07BA01|01.10.2008||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||90|0|6,0000|Vistor hf|McNeil Denmark ApS|Nikótín||||||
131817|B01AX0601 |Xarelto|filmhtfl|10|mg|10|stk|1|ţpakki||B01AX06|01.05.2009||R|||0|0|E|0|BAP|0|0|0|100|SEK|3763|6126|lyfalmen|V0032|5474||10|0|10,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaroxaban||3763||3763|6126|
131828|B01AX0601 |Xarelto|filmhtfl|10|mg|30|stk|1|ţpakki||B01AX06|01.05.2009||R|||0|0|E|0|BAP|0|0|0|100|SEK|11290|16423|lyfalmen|V0032|16423||30|0|30,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaroxaban||11290||11290|16423|
131840|B01AX0601 |Xarelto|filmhtfl|10|mg|100|stk|1|ţpakki||B01AX06|01.05.2009||R|||0|0|E|0|BAP|0|0|0|100|SEK|37487|49591|lyfalmen||||100|0|100,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaroxaban||37487||37487|49591|
132229|N06AA0905|Amitriptyline|töflur|10|mg|28|stk|1|ţpakki||N06AA09|01.04.2008||R|||0|0|B|0|AUK|0|1|0|100|GBP|268|1262|lyfalmen||||28|0|3,7300|Actavis Group hf|Actavis UK Ltd.|Amitriptýlín||207||207|1262|
132260|N06DA0404|Galantamine Portfarma|forđahlk|8|mg|28|stk|1|ţpakki||N06DA04|01.12.2011||R|||0|0|E|0|POF|0|0|0|100|SEK|8040|10772|lyfalmen|V0348|10772||28|0|14,0000|Portfarma ehf|Portfarma|Galantamín||7159||7159|10772|
132361|C09DA0309|Valpress Comp|filmhtfl|172,5|mg|98|stk|1|ţpakki||C09DA03|01.10.2008||R|||0|0|0|0|AGP|0|0|0|100|XEU|9452|4092|lyfalmen||||98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Valsartan og ţvagrćsilyf||2276||2276|4092|
132372|C09DA0309|Valpress Comp|filmhtfl|92,5|mg|98|stk|1|ţpakki||C09DA03|01.10.2008||R|||0|0|0|0|AGP|0|0|0|100|XEU|7575|4092|lyfalmen||||98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Valsartan og ţvagrćsilyf||2276||2276|4092|
132662|R05DA0403|Kodein Recip|töflur|25|mg|100|stk|1|glas||R05DA04|01.08.2005||R|||1|0|E|0|REP|0|0|1|100|SEK|1493|3021|lyfalmen||||100|0|25,0000|Vistor hf|Recip AB|Kódein||1493||1493|3021|
132663|N06BA0402|Concerta|forđatfl|27|mg|30|stk|1|glas||N06BA04|01.02.2009||R|||1|0|0|0|JAS|0|0|0|100|SEK|7812|11665|lyfalmen||||30|0|27,0000|Vistor hf|Janssen-Cilag AB|Metýlfenídat||7812||7812|11665|
132761|D08AG0201|Betadine|áburđur|100|mg/ml|8|ml|1|glas||D08AG02|01.01.1986||L|||0|0|0|0|NOR|0|0|0|100|IKR|||lyflausa||||8|0||Icepharma hf|Norpharma a/s|Jođ/pólývídón||||||
132845|S01HA0401|Alcaine|augndr|5|mg/ml|15|ml|1|glas||S01HA04|01.09.2003||R|||0|0|0|0|SAL|0|0|0|100|USD|1180|2593|lyfalmen||||15|0||Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Proxýmetakaín||1180||1180|2593|
132852|A07BA0104|Kolsuspension|mixtúra|150|mg/ml|100|ml|1|fl|dreifa|A07BA01|01.08.2005||L|||0|0|0|0|ABI|0|0|0|100|IKR|||lyflausa||||100|0|3,0000|Vistor hf|Abigo Medical AB|Lyfjakol||||||
132902|G03AB0402|Trinovum 28|töflur|||84|stk|1|ţpakki||G03AB04|01.01.1993||R|||0|0|0|0|JAS|0|0|0|100|SEK|1390|2880|lyfalmen||||84|0|84,0000|Vistor hf|Janssen-Cilag AB|Noretísterón og östrógen||1390||1390|2880|
133097|M03AX0104|NeuroBloc|stl|5000|ein/ml|0,5|ml|1|hgl||M03AX01|01.02.2009||R|||0|1|0|1|EIS|0|0|0|100|SEK|28417|37546|lyfsjukr||||0|0||Vistor hf|Eisai Ltd|Clostridium botulinum toxín-A||28417||28417|37546|
133109|M03AX0104|NeuroBloc|stl|5000|ein/ml|1|ml|1|hgl||M03AX01|01.02.2009||R|||0|1|0|1|EIS|0|0|0|100|SEK|37799|49320|lyfsjukr||||1|0||Vistor hf|Eisai Ltd|Clostridium botulinum toxín-A||37799||37799|49320|
133120|M03AX0104|NeuroBloc|stl|5000|ein/ml|2|ml|1|hgl||M03AX01|01.02.2009||R|||0|1|0|1|EIS|0|0|0|100|SEK|49390|63867|lyfsjukr||||2|0||Vistor hf|Eisai Ltd|Clostridium botulinum toxín-A||||49390|63867|
133508|A06AD6501|Moxalole|mixtduft|13,8|g|8|pokar|1|pakki||A06AD65|01.05.2011||L|||0|0|0|0|MEB|0|0|0|100|IKR|||lyflausa||||8|0||Vistor hf|Meda AB (V)|Makrógól 3350||||||
133530|A06AD6501|Moxalole|mixtduft|13,8|g|20|pokar|1|pakki||A06AD65|01.05.2011||L|||0|0|0|0|MEB|0|0|0|100|IKR|||lyflausa||||20|0||Vistor hf|Meda AB (V)|Makrógól 3350||||||
133552|A06AD6501|Moxalole|mixtduft|13,8|g|50|pokar|1|pakki||A06AD65|01.05.2011||L|||0|0|0|0|MEB|0|0|0|100|IKR|||lyflausa||||50|0||Vistor hf|Meda AB (V)|Makrógól 3350||||||
133736|J04AB0201|Rimactan|hylki|150|mg|100|stk|1|glas||J04AB02|01.04.1993||R|||0|0|E|0|SAD|0|0|0|100|DKK|8423|12501|lyfalmen||||100|0|25,0000|Icepharma hf|Sandoz GmbH|Rífampicín||8423||8423|12501|
134274|J02AC0302|Vfend (D.A.C.)|filmhtfl|200|mg|14|stk|1|ţpakki||J02AC03|01.05.2008||R|||0|0|0|1|DAC|0|0|0|100|DKK|94242|120156|lyfsjukr||||14|0|7,0000|D.A.C. ehf|D.A.C. ehf|Voricónazól||94242||94242|120156|
134338|J01FA0901|Klacid|mixt.kyr|50|mg/ml|50|ml|1|glas|pl.fl. m/sk.sprautu|J01FA09|01.07.1998||R|||0|0|0|0|ABS|0|0|1|100|DKK|1546|3094|lyfalmen||||50|0|5,0000|Vistor hf|Abbott Scandinavia AB|Klaritrómýcín||1546||1546|3094|
134352|S01EE0501|Taflotan|augndr|15|mcg/ml|0,3|ml|30|sk-hyl||S01EE05|01.03.2010||R|||0|0|*|0|SAO|0|0|0|100|XEU|4075|6553|lyfalmen|V0378|5959||9|0|30,0000|Icepharma hf|Santen Oy|Taflúprost||4075||4075|6553|
134374|S01EE0501|Taflotan|augndr|15|mcg/ml|0,3|ml|90|sk-hyl||S01EE05|01.06.2010||R|||0|0|*|0|SAO|0|0|0|100|XEU|12216|17876|lyfalmen|V0378|17876||27|0|90,0000|Icepharma hf|Santen Oy|Taflúprost||12216||12216|17876|
134520|L01DB0302 |Epirubicin Actavis|stl|2|mg/ml|25|ml|1|hgl||L01DB03|01.04.2009||R|||0|1|0|1|AGT|0|0|0|100|XEU|4813|6946|lyfsjukr||||25|0||Actavis Group hf|Actavis Group hf|Epírúbicín||4813||4813|6946|
134642|J05AE0801|Reyataz|hylki|300|mg|30|stk|1|plglas||J05AE08|01.01.2010||R|||0|1|0|1|BRS|0|0|0|100|DKK|71732|91906|lyfsjukr||||30|0|30,0000|Vistor hf|Bristol-Myers Squibb|Atazanavír||71732||71732|91906|
134862|J05AR0601|Atripla|filmhtfl|||30|stk|1|glas|600+200+245 mg|J05AR06|01.07.2008||R|||0|1|0|1|GSI|0|0|0|100|DKK|132909|168683|lyfsjukr||||30|0|30,0000|Lyfjaver ehf|Gilead Science International (L)|Emtrícítabín, tenófóvír dísóproxíl og efavírenz||132909||132909|168683|
135111|H01AC0101|Genotropin|sts|12|mg|1|rörlyk|1|pakki|tvíhólfa|H01AC01|01.04.1992||R|||0|1|0|1|PER|0|0|0|100|DKK|54028|69688|lyfsjukr||||1|0|18,0000|Icepharma hf|Pfizer ApS|Sómatrópín||54028||54028|69688|
135289|C07AG0203|Carvedilol Actavis|filmhtfl|12,5|mg|100|stk|1|ţpakki||C07AG02|01.07.2011||R|||0|0|B|0|ADG|0|0|0|100|XEU|2167|3943|lyfalmen||||100|0|33,3333|Actavis Group hf|Actavis Deutchland GmbH & Co. KG|Carvedílól||2167||2167|3943|
135319|C08DA0108|Verapamil Mylan|töflur|80|mg|100|stk|1|glas||C08DA01|01.01.1990||R|||0|0|B|0|MYL|0|0|0|100|SEK|1016|2369|lyfalmen||||100|0|33,3333|Actavis Group PTC ehf|Mylan AB|Verapamíl||1016||1016|2369|
135434|R03BA0502|Flixotide Diskus|innúđadu|100|mcg/sk|60|sk|1|pakki|í diskus-t|R03BA05|01.07.1995||R|||0|0|0|0|GSK|0|0|0|100|GBP|2368|4218|lyfalmen||||60|0|10,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||2368||2368|4218|
136168|G03AB0401|Trinovum|töflur|||63|stk|1|ţpakki||G03AB04|01.10.1988||R|||0|0|0|0|JAS|0|0|0|100|SEK|1673|3267|lyfalmen||||63|0|84,0000|Vistor hf|Janssen-Cilag AB|Noretísterón og östrógen||1673||1673|3267|
136200|J04AC0102|Tibinide|töflur|300|mg|100|stk|1|glas||J04AC01|01.07.2005||R|||0|0|0|0|REP|0|0|0|100|SEK|6971|10515|lyfalmen||||100|0|100,0000|Vistor hf|Recip AB|Ísóníazíđ||6971||6971|10515|
136281|L04AB0101|Enbrel|sts|25|mg|4|hgl|1|pakki|+ leysir|L04AB01|01.03.2012||R|||0|1|0|1|IPI|0|0|0|100|DKK|75458|96582|lyfsjukr||||4|0|14,2900|Icepharma hf|Pfizer Limited|Etanercept||75458||75458|96582|
136964|L01CD0103|Paclitaxel Hospira|irţ|6|mg/ml|5|ml|1|hgl||L01CD01|01.10.2005||R|||0|1|0|1|HUK|0|0|0|100|SEK|2281|3292|lyfsjukr||||5|0||Icepharma hf|Hospira UK Ltd|Paklítaxel||2281||2281|3292|
136975|L01CD0103|Paclitaxel Hospira|irţ|6|mg/ml|16,7|ml|1|hgl|lausn|L01CD01|01.10.2005||R|||0|1|0|1|HUK|0|0|0|100|SEK|7143|10309|lyfsjukr||||17|0||Icepharma hf|Hospira UK Ltd|Paklítaxel||7143||7143|10309|
136987|L01CD0103|Paclitaxel Hospira|irţ|6|mg/ml|25|ml|1|hgl|lausn|L01CD01|01.10.2005||R|||0|1|0|1|HUK|0|0|0|100|SEK|5265|7599|lyfsjukr||||25|0||Icepharma hf|Hospira UK Ltd|Paklítaxel||5265||5265|7599|
136998|L01CD0103|Paclitaxel Hospira|irţ|6|mg/ml|50|ml|1|hgl|lausn|L01CD01|01.10.2005||R|||0|1|0|1|HUK|0|0|0|100|SEK|8207|11845|lyfsjukr||||50|0||Icepharma hf|Hospira UK Ltd|Paklítaxel||8207||8207|11845|
137110|L01XA0302|Oxaliplatin Hospira|irţ|5|mg/ml|20|ml|1|hgl||L01XA03|01.06.2011||R|||0|1|0|1|HOP|0|0|0|100|XEU|6037|8713|lyfsjukr||||20|0||Icepharma hf|Hospira Nordic AB|Oxalíplatín||6037||6037|8713|
137513|S01XA2011|Oculac|augndr|||10|ml|1|glas|međ rotvörn|S01XA20|01.10.1999||L|||0|0|E|0|ACK|0|0|0|100|DKK|||lyfalmen||||10|0||Vistor hf|Alcon Denmark A/S|Gervitár og ađrar óvirkar samsetningar|||||1690|
137521|S01XA2011|Oculac|augndr|||0,4|ml|20|sk-hyl|án rotvarnar|S01XA20|01.10.1999||L|||0|0|E|0|ACK|0|0|0|100|DKK|||lyfalmen||||8|0||Vistor hf|Alcon Denmark A/S|Gervitár og ađrar óvirkar samsetningar|||||2076|
137809|M05BA0302|Pamidronatdinatrium Hospira|irţ|3|mg/ml|5|ml|5|hgl|lausn|M05BA03|01.05.2005||R|||0|0|0|1|MAY|0|0|0|100|SEK|20995|28231|lyfsjukr||||25|0|1,2500|Icepharma hf|Mayne Pharma Plc|Pamídrónsýra||20995||20995|28231|
137820|M05BA0302|Pamidronatdinatrium Hospira|irţ|3|mg/ml|10|ml|1|hgl|lausn |M05BA03|01.05.2005||R|||0|0|0|1|MAY|0|0|0|100|XEU|6387|9218|lyfsjukr||||10|0|0,5000|Icepharma hf|Mayne Pharma Plc|Pamídrónsýra||6387||6387|9218|
137831|M05BA0302|Pamidronatdinatrium Hospira|irţ|6|mg/ml|10|ml|1|hgl|lausn|M05BA03|01.05.2005||R|||0|0|0|1|MAY|0|0|0|100|XEU|10722|15339|lyfsjukr||||10|0|1,0000|Icepharma hf|Mayne Pharma Plc|Pamídrónsýra||10722||10722|15339|
137842|M05BA0302|Pamidronatdinatrium Hospira|irţ|9|mg/ml|10|ml|1|hgl|lausn|M05BA03|01.05.2005||R|||0|0|0|1|MAY|0|0|0|100|SEK|6026|8697|lyfsjukr||||10|0|1,5000|Icepharma hf|Mayne Pharma Plc|Pamídrónsýra||6026||6026|8697|
137992|J01XA0106|Vancomycin Hospira|irs|500|mg/hgl|500|mg|1|hgl||J01XA01|01.04.1997||R|||0|0|0|1|HOS|0|0|0|100|XEU|756|1091|lyfsjukr||||500|0|0,2500|Icepharma hf|Hospira Enterprises B.V. (I)|Vankómýcín||756||756|1091|
138073|J01XA0106|Vancomycin Hospira|irs|1|g/hgl|1|g|1|hgl||J01XA01|01.04.1997||R|||0|0|0|1|HOS|0|0|0|100|DKK|1541|2224|lyfsjukr||||1|0|0,5000|Icepharma hf|Hospira Enterprises B.V. (I)|Vankómýcín||1541||1541|2224|
138594|S01ED0105|Optimol|augndr|5|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED01|01.01.1995||R|||0|0|*|0|SAO|0|0|0|100|XEU|1723|3336|lyfalmen||||15|0|60,0000|Icepharma hf|Santen Oy|Tímólól||1723||1723|3336|
139050|S01ED5115|Arzotilol|augndr|5|mg/ml|5|ml|3|glös|+ dorzólamíđ 20 mg|S01ED51|01.01.2012||R|||0|0|*|0|APC|0|0|0|100|XEU|4798|7452|lyfalmen|V0373|7452||15|0|75,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Tímólól í blöndum||4732||4732|7452|
139840|R06AA0401|Tavegyl|töflur|1|mg|100|stk|1|ţpakki||R06AA04|01.08.1981||L|||0|0|0|0|NEH|0|0|1|100|IKR|||lyflausa||||100|0|50,0000|Artasan ehf|Novartis Healthcare A/S|Klemastín||||||
140130|V03AB3501|Bridion|stl|100|mg/ml|2|ml|10|hgl||V03AB35|01.04.2009||R|||0|1|0|1|ORG|0|0|0|100|DKK|139543|177009|lyfsjukr||||20|0||Vistor hf|N.V. Organon|Sugammadex||139543||139543|177009|
140141|V03AB3501|Bridion|stl|100|mg/ml|5|ml|10|hgl||V03AB35|01.04.2009||R|||0|1|0|1|ORG|0|0|0|100|DKK|348745|439557|lyfsjukr||||50|0||Vistor hf|N.V. Organon|Sugammadex||348745||348745|439557|
140327|N04BC0502|Sifrol|töflur|0,088|mg|30|stk|1|ţpakki||N04BC05|01.05.2005||R|||0|0|E|0|BII|0|0|0|100|DKK|1478|3001|lyfalmen|V0266|1138||30|0|1,0600|Vistor hf|Boehringer Ingelheim International |Pramipexól||1478||1478|3001|
140442|N05AF0503|Cisordinol-Acutard|stl|50|mg/ml|1|ml|10|lykjur||N05AF05|01.01.1991||R|||0|0|0|1|LBK|0|1|0|100|DKK|11955|16886|lyfsjukr||||10|0|16,6700|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||11955||11955|16886|
140566|H01BB0201|Syntocinon|stl|10|ae/ml|1|ml|5|lykjur||H01BB02|01.12.1972||R|||0|0|0|1|DES|0|0|0|100|DKK|648|935|lyfsjukr||||5|0|3,3333|Swedish Orphan Biovitrum A/S|Defiante Farmaceutica S.A.|Oxýtócín||648||648|935|
140729|QN01AX0001|Finquel, vet|duft|100|%|1000|g|1|fl|bađlausn handa fiskum|QN01AX|01.01.2012||R|||0|0|0|0|SRR|1|0|0|100|NOK|96678|185809|vetalmen||||1000|0||Scan Aqua AS|Scan Aqua AS|Tricaine mesylate||96678||96678|185809|
140954|N07BA0103|Nicorette|nefúđi|10|mg/ml|10|ml|1|glas||N07BA01|01.04.1994||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||10|0|3,3300|Vistor hf|McNeil Denmark ApS|Nikótín||||||
141044|H02AB0401|Depo-Medrol|stl|40|mg/ml|2|ml|1|spr|einnotaspr|H02AB04|01.04.1994||R|||0|0|B|0|PER|0|0|1|100|DKK|1262|2705|lyfalmen|V0413|2419||2|0|4,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||1262||1262|2705|
141197|N02BE0112|Perfalgan (D.A.C.)|irl|10|mg/ml|100|ml|12|hgl||N02BE01|01.05.2008||R|||0|0|0|1|DAC|0|0|0|100|DKK|4501|6320|lyfsjukr||||1200|0|4,0000|D.A.C. ehf|D.A.C. ehf|Paracetamól||4379||4379|6320|
141219|J02AC0302|Vfend (D.A.C.)|irs|200|mg|1|hgl|1|pakki||J02AC03|01.05.2008||R|||0|0|0|1|DAC|0|0|0|100|DKK|21377|28711|lyfsjukr||||1|0|0,5000|D.A.C. ehf|D.A.C. ehf|Voricónazól||21377||21377|28711|
141388|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|500|ml|20|pokar|Freeflex umbúđir|B05BB01|01.12.2011||R|||0|0|0|1|FRP|0|0|0|100|DKK|3919|5656|lyfsjukr||||10000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||3919||3919|5656|
141432|N04BC0502|Sifrol|töflur|0,18|mg|30|stk|1|ţpakki||N04BC05|01.05.2005||R|||0|0|E|0|BII|0|0|0|100|DKK|2793|4800|lyfalmen||||30|0|2,1600|Vistor hf|Boehringer Ingelheim International |Pramipexól||2793||2793|4800|
141438|G03GA0502|Gonal-f|stl|300|ae/penna|0,5|ml|1|penni|(22 mcg) áfylltur penni|G03GA05|01.01.2012||R|||0|1|E|0|MSE|0|0|0|100|SEK|20397|28143|lyfalmen||||0|0|4,0000|Icepharma hf|Merck Serono Europe Ltd|Follitrópín alfa||20397||20397|28143|
141684|G03AA1205|Yaz|filmhtfl|||84|stk|1|ţpakki|0,02mg/3mg|G03AA12|01.02.2009||R|||0|0|0|0|BAB|0|0|0|100|SEK|4757|7486|lyfalmen||||84|0|84,0000|Icepharma hf|Bayer AB|Dróspírenón og östrógen||4757||4757|7486|
141945|N04BC0502|Sifrol|töflur|0,18|mg|100|stk|1|ţpakki||N04BC05|01.05.2005||R|||0|0|E|0|BII|0|0|0|100|DKK|8755|12955|lyfalmen|V0267|2863||100|0|7,2000|Vistor hf|Boehringer Ingelheim International|Pramipexól||8755||8755|12955|
142034|M01AE0218|Naproxen Mylan|töflur|500|mg|100|stk|1|glas||M01AE02|01.07.2012||R|||0|0|E|0|MYL|0|0|1|100|SEK|2698|4670|lyfalmen|V0427|3534||100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Naproxen||||2698|4670|
142299|C01BD0101|Cordarone|stl|50|mg/ml|3|ml|10|lykjur||C01BD01|01.04.1987||R|||0|0|0|1|SNO|0|0|0|100|NOK|3387|4888|lyfsjukr||||30|0|7,5000|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||3387||3387|4888|
142307|C01BD0101|Cordarone|töflur|200|mg|30|stk|1|ţpakki||C01BD01|01.04.1987||R|||0|0|B|0|SNO|0|0|0|100|NOK|1110|2497|lyfalmen||||30|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||1110||1110|2497|
142323|J01XX0501|Haiprex|töflur|1|g|100|stk|1|glas||J01XX05|01.10.1995||R|||0|0|0|0|MEB|0|0|1|100|SEK|2895|4939|lyfalmen||||100|0|50,0000|Vistor hf|Meda AB (V)|Metenamín||2895||2895|4939|
143339|H02AB0403|Solu-Medrol|sts|125|mg|1|stk|1|hgl|Act-O-Vial|H02AB04|01.07.1974||R|||0|0|B|0|PER|0|0|1|100|DKK|1469|2988|lyfalmen||||1|0|6,2500|Icepharma hf|Pfizer ApS|Metýlprednisólón||1469||1469|2988|
143347|H02AB0403|Solu-Medrol|sts|500|mg|1|stk|1|hgl|+ leysir|H02AB04|01.07.1974||R|||0|0|0|1|PER|0|0|0|100|DKK|2307|3330|lyfsjukr||||1|0|25,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||2307||2307|3330|
143511|J07BC2002|Twinrix Paediatric|bóluefni|||0,5|ml|1|dćla|einnota dćla|J07BC20|01.01.1999||R|||0|0|0|0|GLB|0|0|0|100|GBP|4020|6478|lyfalmen||||0|0||GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|Lifrarbólgubóluefni (hepatitis)-Blöndur||4020||4020|6478|
143586|S01FA0601|Mydriacyl 1 %|augndr|10|mg/ml|15|ml|1|glas||S01FA06|01.09.2003||R|||0|0|0|0|SAL|0|0|0|100|USD|975|2313|lyfalmen||||15|0||Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Trópíkamíđ||975||975|2313|
143602|J01FA1001|Zitromax|töflur|500|mg|2|stk|1|ţpakki||J01FA10|01.11.1998||R|||0|0|0|0|PER|0|0|1|100|DKK|1499|3029|lyfalmen||||2|0|3,3333|Icepharma hf|Pfizer ApS|Azitrómýcín||1499||1499|3029|
143610|N02CX0201|Catapresan|töflur|25|mcg|100|stk|1|ţpakki||N02CX02|01.04.1974||R|||0|0|E|0|BOI|0|0|0|100|DKK|1351|2827|lyfalmen||||100|0|25,0000|Vistor hf|Boehringer Ingelheim|Klónidín||1351||1351|2827|
143631|A10BD0701|Janumet|filmhtfl|1050|mg|56|stk|1|ţpakki|50/1000mg|A10BD07|01.03.2009||R|||0|0|*|0|MSD|0|0|0|100|DKK|8571|12704|lyfalmen|V0386|9670||56|0|28,0000|Vistor hf|M.S.D.|Metforminum og sitagliptinum||8571||8571|12704|
143727|D07AB0201|Locoid|smyrsli|1|mg/g|30|g|1|túpa||D07AB02|01.07.1985||R|||0|0|B|0|ASP|0|0|1|100|XEU|614|1819|lyfalmen||||30|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||614||614|1819|
143800|N05AN0101|Litarex|forđatfl|564|mg|100|stk|1|glas||N05AN01|01.04.1974||R|||0|0|*|0|AGT|0|1|0|100|DKK|1224|2653|lyfalmen||||100|0|25,0000|Actavis Group hf|Actavis Group hf|Litíum||1224||1224|2653|
143891|J01FA1001|Zitromax|töflur|500|mg|3|stk|1|ţpakki||J01FA10|01.11.1998||R|||0|0|0|0|PER|0|0|1|100|DKK|2060|3797|lyfalmen|V0174|3797||3|0|5,0000|Icepharma hf|Pfizer ApS|Azitrómýcín||2060||2060|3797|
144030|N04BA0207|Sinemet depot mite|forđatfl|125|mg|100|stk|1|glas|25+100 mg|N04BA02|01.04.1992||R|||0|0|E|0|MSD|0|0|0|100|DKK|2124|3884|lyfalmen||||100|0|16,6667|Vistor hf|M.S.D.|Levódópa og dópadekarboxýl­asa­hemill||2124||2124|3884|
144035|N05AH0501|Sycrest|tungur.t|10|mg|60|stk|1|ţpakki||N05AH05|01.10.2011||R|||0|0|0|0|ORR|0|1|0|100|DKK|23358|31859|lyfalmen||||60|0|30,0000|Lundbeck Export A/S|N.V. Organon|Asenapíne||23358||23358|31859|
144139|H01AC0106|Norditropin Simplexx|stl|10|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.02.2000||R|||0|1|0|1|NAS|0|0|0|100|DKK|82029|104829|lyfsjukr||||2|0|22,5000|Vistor hf|Novo-Nordisk A/S|Sómatrópín||82029||82029|104829|
144436|H01AC0106|Norditropin Simplexx|stl|6,7|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.02.2000||R|||0|1|0|1|NAS|0|0|0|100|DKK|61309|78825|lyfsjukr||||2|0|15,0000|Vistor hf|Novo-Nordisk A/S|Sómatrópín||61309||61309|78825|
144725|H01AC0106|Norditropin Simplexx|stl|3,3|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.02.2000||R|||0|1|0|1|NAS|0|0|0|100|DKK|38094|49690|lyfsjukr||||2|0|7,5000|Vistor hf|Novo-Nordisk A/S|Sómatrópín||38094||38094|49690|
144808|D07AB0201|Locoid|lausn|1|mg/ml|30|ml|1|glas||D07AB02|01.10.1986||R|||0|0|B|0|ASP|0|0|1|100|XEU|663|1886|lyfalmen||||30|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||663||663|1886|
144964|N05BA0205|Risolid|filmhtfl|10|mg|24|stk|1|plglas||N05BA02|01.04.2008|30.06.2012|R|||0|0|0|0|AGT|0|0|1|100|XEU|332|1433|lyfalmen||||24|0|8,0000|Actavis Group hf|Actavis Group hf|Klórdíazepoxíđ||332||332|1433|
144980|N05BA0205|Risolid|filmhtfl|25|mg|24|stk|1|plglas||N05BA02|01.04.2008|30.06.2012|R|||0|0|0|0|AGT|0|0|1|100|XEU|551|1733|lyfalmen||||24|0|20,0000|Actavis Group hf|Actavis Group hf|Klórdíazepoxíđ||551||551|1733|
145077|L04AB0201|Remicade|irs|100|mg|1|hgl|1|pakki||L04AB02|01.06.2011||R|||0|1|0|1|CEO|0|0|0|100|DKK|86744|110746|lyfsjukr||||1|0|26,6700|Vistor hf|Centocor B.V.|Infliximab||86744||86744|110746|
145508|D07AC0104|Diproderm|krem|0,5|mg/g|100|g|1|túpa||D07AC01|01.03.1977||R|||0|0|B|0|SPL|0|0|1|100|DKK|2257|4066|lyfalmen||||100|0||Vistor hf|Schering-Plough Europe|Betametasón||2257||2257|4066|
145607|P02CX0101|Vanquin|töflur|50|mg|8|stk|1|ţpakki||P02CX01|01.12.1972||L|||0|0|0|0|REP|0|0|0|100|IKR|||lyflausa||||8|0||Vistor hf|Recip AB|Pýrvín||||||
145631|P02CX0101|Vanquin|töflur|50|mg|32|stk|1|ţpakki||P02CX01|01.01.1995||L|||0|0|0|0|REP|0|0|0|100|IKR|||lyflausa||||32|0||Vistor hf|Recip AB|Pýrvín||||||
145698|N05AH0301|Zyprexa|húđuđtfl|10|mg|28|stk|1|ţpakki||N05AH03|01.03.1998||R|||0|0|0|0|ELD|0|1|0|100|XEU|20858|20285|lyfalmen||||28|0|28,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||14135||14135|20285|
146082|L04AA2601|Benlysta|irs|120|mg/hgl|1|hgl|1|pakki|lausn|L04AA26|01.12.2011||R|||0|1|0|1|GGL|0|0|0|100|GBP|32385|42526|lyfsjukr||||1|0||GlaxoSmithKline ehf|Glaxo Group Limited|Belimumab||32385||32385|42526|
146207|L01XX1903|Irinotecan Hospira|irţ|20|mg/ml|2|ml|1|hgl|lausn|L01XX19|01.03.2009||R|||0|1|0|1|HUK|0|0|0|100|XEU|3084|4451|lyfsjukr||||2|0||Icepharma hf|Hospira UK Ltd|Írinótekan||3084||3084|4451|
146218|L01XX1903|Irinotecan Hospira|irţ|20|mg/ml|5|ml|1|hgl|lausn|L01XX19|01.03.2009||R|||0|1|0|1|HUK|0|0|0|100|XEU|6265|9042|lyfsjukr||||5|0||Icepharma hf|Hospira UK Ltd|Írinótekan||6265||6265|9042|
146473|N06BA0901|Strattera|hylki|80|mg|28|stk|1|glas|hart|N06BA09|01.01.2010||R|||0|1|0|0|ELI|0|0|0|100|XEU|18257|25458|lyfalmen||||28|0|28,0000|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||18257||18257|25458|
146530|P01AB0102|Flagyl|töflur|400|mg|10|stk|1|ţpakki||P01AB01|01.10.1995||R|||0|0|0|0|SNO|0|0|1|100|NOK|904|2216|lyfalmen|V0351|1119||10|0|2,0000|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||904||904|2216|
147241|L01BC0102|Arabine|stl/irl|100|mg/ml|1|ml|5|hgl||L01BC01|01.03.2009||R|||0|1|0|1|HOP|0|0|0|100|XEU|2557|3690|lyfsjukr||||5|0||Icepharma hf|Hospira Nordic AB|Cýtarabín||2557||2557|3690|
147252|L01BC0102|Arabine|stl/irl|100|mg/ml|10|ml|1|hgl||L01BC01|01.03.2009||R|||0|1|0|1|HOP|0|0|0|100|XEU|1584|2286|lyfsjukr||||10|0||Icepharma hf|Hospira Nordic AB|Cýtarabín||1584||1584|2286|
147343|A02BC0109|Omeprazol Pensa (Lyfjaver)|sţ-hylki|20|mg|28|stk|1|ţpakki||A02BC01|01.02.2012||L|||0|0|0|0|LVR|0|0|0|100|IKR|||lyflausa||||28|0|28,0000|Lyfjaver ehf|Lyfjaver ehf|Ómeprazól||||||
148213|R05CB1301|Pulmozyme|innúđal|1|mg/ml|2,5|ml|30|lykjur||R05CB13|01.01.1997||R|||0|0|0|0|ROA|0|0|1|100|DKK|114989|146856|lyfalmen||||75|0|30,0000|Icepharma hf|Roche A.S.|Dornase alfa||114989||114989|146856|
148363|D11AH0401|Toctino|hylki|10|mg|30|stk|1|ţpakki|mjúk|D11AH04|01.03.2012||R|||0|1|0|0|BLT|0|0|0|100|DKK|84864|109049|lyfalmen||||30|0||Icepharma hf|Basilea Medical Ltd.|Alítretínóín||84864||84864|109049|
148374|D11AH0401|Toctino|hylki|30|mg|30|stk|1|ţpakki|mjúk|D11AH04|01.03.2012||R|||0|1|0|0|BLT|0|0|0|100|DKK|84864|109049|lyfalmen||||30|0||Icepharma hf|Basilea Medical Ltd.|Alítretínóín||84864||84864|109049|
148452|N04AA0201|Akineton|töflur|2|mg|100|stk|1|ţpakki||N04AA02|01.11.2005||R|||0|0|*|0|LFS|0|1|0|100|DKK|869|2168|lyfalmen||||100|0|20,0000|Vistor hf|Laboratorio Farmaceutico (S.I.T.)|Bíperíden||869||869|2168|
148642|N01AX6301|Livopan|lyfjagas|||5|l|1|hylki|50% + 50%|N01AX63|01.05.2012||R|||0|0|0|1|AGA|0|0|0|100|IKR|62097|79814|lyfsjukr||||5|0||Ísaga ehf|AGA AB|Tvínituroxíđ og súrefni||62097||62097|79814|
148741|L01CA0207|Vincristine Hospira|stl|1|mg/ml|1|ml|5|hgl||L01CA02|01.01.1991||R|||0|1|0|1|HOP|0|0|0|100|SEK|6359|9178|lyfsjukr||||5|0||Icepharma hf|Hospira Nordic AB|Vínkristín||6359||6359|9178|
148752|L01CA0207|Vincristine Hospira|stl|1|mg/ml|2|ml|5|hgl||L01CA02|01.07.2004||R|||0|1|0|1|HOP|0|0|0|100|SEK|13330|18612|lyfsjukr||||10|0||Icepharma hf|Hospira Nordic AB|Vínkristín||13330||13330|18612|
148917|L01BA0301|Tomudex|irs|2|mg/hgl|1|hgl|1|pakki||L01BA03|01.03.1998||R|||0|1|0|1|HOS|0|0|0|100|SEK|28516|37670|lyfsjukr||||1|0||Icepharma hf|Hospira Enterprises B.V. (I)|Raltítrexed||28516||28516|37670|
148999|QN05CM9201|Rompun, vet.|stl|20|mg/ml|25|ml|1|hgl||QN05CM92|01.12.1972||R|||0|0|0|0|BAN|1|0|0|100|DKK|3703|7283|vetalmen||||25|0||Icepharma hf|Bayer Animal Health GmbH|||3703||3703|7283|
149146|N05AG0201|Orap|töflur|1|mg|75|stk|1|ţpakki||N05AG02|01.03.2004||R|||0|0|0|0|PCO|0|1|0|100|SEK|2122|3882|lyfalmen||||75|1|18,7500|Distica|Distica - óskráđ lyf|Pímózíđ||2122||2122|3882|
149375|S01EE0103|Latanoprost Portfarma|augndr|50|mcg/ml|2,5|ml|1|glas||S01EE01|01.03.2010||R|||0|0|*|0|POF|0|0|0|100|DKK|2217|2618|lyfalmen|V0376|2211||2|0|25,0000|Portfarma ehf|Portfarma|Latanóprost||1198||1198|2618|
150243|J04AB0201|Rimactan|hylki|300|mg|100|stk|1|glas||J04AB02|01.04.1993||R|||0|0|E|0|SAD|0|0|0|100|DKK|16435|23171|lyfalmen|V0571|23171||100|0|50,0000|Icepharma hf|Sandoz GmbH|Rífampicín||16435||16435|23171|
150521|B03XA0201|Aranesp|stl|40|mcg/spr|0,4|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|||0|1|0|1|AMG|0|0|0|100|DKK|53450|68962|lyfsjukr||||2|0|35,5600|Vistor hf|Amgen|Darbepóetín alfa||||53450|68962|
150539|C10AD5201|Tredaptive|töflur|1020|mg|28|stk|1|ţpakki|1000+20 mg|C10AD52|01.12.2009||R|||0|0|0|0|MSD|0|0|0|100|DKK|3861|6261|lyfalmen||||28|0||Vistor hf|M.S.D.|Nikótínsýra og afleiđur-Nikótínsýra í blöndum||||3861|6261|
150550|C10AD5201|Tredaptive|töflur|1020|mg|56|stk|1|ţpakki|1000+20 mg|C10AD52|01.12.2009||R|||0|0|0|0|MSD|0|0|0|100|DKK|6405|9741|lyfalmen|V0120|7647||56|0||Vistor hf|M.S.D.|Nikótínsýra og afleiđur-Nikótínsýra í blöndum||||6405|9741|
150996|J07AH0401|Mencevax ACWY|stl|50|mcg|0,5|ml|1|hgl||J07AH04|01.11.2008||R|||0|0|0|0|GSK|0|0|0|100|GBP|3840|6232|lyfalmen||||0|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Hreinsađir fjórgildir meningókokka polysakkaríđ mótefnavakar||||3840|6232|
151191|N05AF0102|Fluanxol Depot|stl|20|mg/ml|1|ml|10|lykjur||N05AF01|01.03.1977||R|||0|0|*|0|LBK|0|1|0|100|DKK|6694|10136|lyfalmen||||10|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||6694||6694|10136|
151217|G01AF0102|Flagyl|sk-stíll|500|mg|10|stk|1|pakki|+ hanskar|G01AF01|01.10.1995||R|||0|0|E|0|SNO|0|0|0|100|NOK|1218|2645|lyfalmen||||10|0|10,0000|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||1218||1218|2645|
151518|N06DX0101|Ebixa|filmhtfl|20|mg|28|stk|1|ţpakki||N06DX01|01.11.2008||R|||0|0|E|0|LBK|0|0|0|100|DKK|16257|22948|lyfalmen||||28|0|28,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||||16257|22948|
151529|N06DX0101|Ebixa|filmhtfl|20|mg|98|stk|1|ţpakki||N06DX01|01.11.2008||R|||0|0|E|0|LBK|0|0|0|100|DKK|50196|62539|lyfalmen||||98|0|98,0000|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||47804||47804|62539|
151627|G03GA0801|Ovitrelle|stl|250|mcg/spr|0,5|ml|1|pakki|lausn,áf.lyfjap.+ spr.nál|G03GA08|01.04.2012||R|||0|1|E|0|MSE|0|0|0|100|SEK|5132|7999|lyfalmen||||0|0|1,0000|Icepharma hf|Merck Serono Europe Ltd|Chóríógónadótrópín alfa||5132||5132|7999|
151640|G04CA0204|Tamsulogen|hylki|0,4|mg|90|stk|1|ţpakki|međ br. losunarhrađa|G04CA02|01.05.2006||R|||0|0|E|0|MYL|0|0|0|100|SEK|5402|4113|lyfalmen|V0148|3997||90|0|90,0000|Actavis Group PTC ehf|Mylan AB|Tamsúlósín||2291||2291|4113|
151928|N06AA1201|Sinquan|hylki|25|mg|100|stk|1|ţpakki||N06AA12|01.12.1972||R|||0|0|B|0|PER|0|1|0|100|DKK|1606|3176|lyfalmen||||100|0|25,0000|Icepharma hf|Pfizer ApS|Doxepín||1606||1606|3176|
151975|A02BC0110|Omeprazol ratiopharm|sţ-hylki|20|mg|100|stk|1|glas|hart|A02BC01|01.02.2012||R|||0|0|E|0|RAT|0|0|0|100|XEU|4566|4802|lyfalmen|V0006|4674||100|0|100,0000|LYFIS ehf|ratiopharm GmbH|Ómeprazól||2795||2795|4802|
152223|M03BX0103|Lioresal|stl|50|mcg/ml|1|ml|5|lykjur|stl.intrathecal.|M03BX01|01.10.1995||R|||0|0|0|1|NOH|0|0|0|100|DKK|2048|2956|lyfsjukr||||5|0|0,4500|Vistor hf|Novartis Healthcare A/S-|Baklófen||2048||2048|2956|
152318|D01BA0204|Terbinafine (D.A.C.)|töflur|250|mg|28|stk|1|ţpakki||D01BA02|01.12.2010||R|||0|0|0|0|DAC|0|0|0|100|XEU|2632|4575|lyfalmen|V0123|4575||28|0|28,0000|D.A.C. ehf|D.A.C. ehf|Terbínafín||2629||2629|4575|
152348|M02AA0701|Felden gel|hlaup|5|mg/g|25|g|1|glas||M02AA07|01.04.1996||L|||0|0|0|0|PER|0|0|1|100|IKR|||lyflausa||||25|0||Icepharma hf|Pfizer ApS|Píroxíkam||||||
152397|R03BA0202|Pulmicort Turbuhaler|innúđadu|100|mcg/sk|200|sk|1|stauk||R03BA02|01.04.1991||R|||0|0|B|0|AZD|0|0|0|100|SEK|3940|6369|lyfalmen||||200|0|25,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||3940||3940|6369|
152413|R03BA0202|Pulmicort Turbuhaler|innúđadu|200|mcg/sk|200|sk|1|stauk||R03BA02|01.10.1989||R|||0|0|B|0|AZD|0|0|0|100|SEK|5758|8856|lyfalmen||||200|0|50,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||5758||5758|8856|
152421|R03BA0202|Pulmicort Turbuhaler|innúđadu|400|mcg/sk|200|sk|1|stauk||R03BA02|01.10.1989||R|||0|0|B|0|ASZ|0|0|0|100|SEK|10564|15430|lyfalmen||||200|0|100,0000|Vistor hf|AstraZeneca UK Ltd|Búdesóníđ||10564||10564|15430|
152635|B01AC0601|Hjartamagnyl|sţ-tfl|75|mg|100|stk|1|glas||B01AC06|01.06.2012||L|||0|0|0|0|AGP|0|0|0|100|IKR|||lyflausa||||100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Asetýlsalicýlsýra||||||
152663|N04BC0504|Oprymea (Lyfis)|töflur|0,7|mg|100|stk|1|ţpakki||N04BC05|01.07.2010||R|||0|0|E|0|LYF|0|0|0|100|XEU|19166|10204|lyfalmen|V0269|10204||100|0|28,0000|Lyfis ehf|Lyfis ehf|Pramipexól||6744||6744|10204|
152991|J02AC0201|Sporanox|hylki|100|mg|4|stk|1|ţpakki|hart|J02AC02|01.01.1995||R|||0|0|0|0|JAS|0|0|1|100|SEK|1258|2700|lyfalmen|V0181|1466||4|0|2,0000|Vistor hf|Janssen-Cilag AB|Ítracónazól||1258||1258|2700|
153080|R06AE0704|Histasin|töflur|10|mg|10|stk|1|ţpakki||R06AE07|01.01.1998||L|||0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa||||10|0|10,0000|Actavis Group hf|Actavis hf|Cetirizín||||||
153122|N01BB5203|Xylocain adrenalin|stl|10|mg/ml|20|ml|5|hgl|(10mg+5míkróg)/ml|N01BB52|01.10.1995||R|||0|0|0|0|AZD|0|0|1|100|SEK|1803|3445|lyfalmen||||100|0||Vistor hf|AstraZeneca A/S DK|Lídókaín í blöndum||1803||1803|3445|
153197|R06AE0704|Histasin|töflur|10|mg|30|stk|1|ţpakki||R06AE07|01.01.1998||L|||0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa||||30|0|30,0000|Actavis Group hf|Actavis hf|Cetirizín||||||
153222|B03XA0201|Aranesp|stl|30|mcg/spr|0,3|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|||0|1|0|1|AMG|0|0|0|100|DKK|40594|52828|lyfsjukr||||1|0|26,6700|Vistor hf|Amgen|Darbepóetín alfa||||40594|52828|
153254|N01BB0203|Xylocain|stl|20|mg/ml|20|ml|5|hgl|međ rotvörn|N01BB02|01.03.2003||R|||0|0|0|0|AZD|0|0|1|100|SEK|2276|4092|lyfalmen|V0561|3804||100|0||Vistor hf|AstraZeneca A/S DK|Lídókaín||2276||2276|4092|
153270|N01BB0203|Xylocain|stl|10|mg/ml|20|ml|5|hgl|međ rotvörn|N01BB02|01.03.2003||R|||0|0|0|0|AZD|0|0|1|100|SEK|1592|3157|lyfalmen|V0560|2954||100|0||Vistor hf|AstraZeneca A/S DK|Lídókaín||1592||1592|3157|
153288|R06AE0704|Histasin|töflur|10|mg|100|stk|1|ţpakki||R06AE07|01.01.1998||R|||0|0|E|0|ACA|0|0|1|100|XEU|2331|4168|lyfalmen||||100|0|100,0000|Actavis Group hf|Actavis hf|Cetirizín||2331||2331|4168|
153379|J02AA0104|AmBisome|irs|50|mg/hgl|10|hgl|1|pakki||J02AA01|01.07.2001||R|||0|0|0|1|GIS|0|0|0|100|DKK|233585|295032|lyfsjukr||||10|0|14,2857|Gilead Sience Sweden AB|Gilead Science International ltd.|Amfóterícín||233585||233585|295032|
153417|C07AA0512|Pranolol|töflur|40|mg|100|stk|1|glas||C07AA05|01.10.2011||R|||0|0|B|0|AGT|0|0|0|100|XEU|555|1738|lyfalmen||||100|0|25,0000|Actavis Group hf|Actavis Group hf|Própranólól||||555|1738|
153507|L02BG0602|Exemestan Actavis|filmhtfl|25|mg|100|stk|1|ţpakki||L02BG06|01.08.2011||R|||0|0|*|0|APC|0|0|0|100|XEU|35776|47444|lyfalmen|V0452|47444||100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Exemestan||35776||35776|47444|
153536|J02AC0201|Sporanox|hylki|100|mg|15|stk|1|ţpakki|hart|J02AC02|01.04.1995||R|||0|0|0|0|JAS|0|0|1|100|SEK|4346|6924|lyfalmen|V0181|5496||15|0|7,5000|Vistor hf|Janssen-Cilag AB|Ítracónazól||4346||4346|6924|
153553|N05BA0205|Risolid|filmhtfl|10|mg|24|stk|1|glas||N05BA02|01.07.2012||R|||0|0|0|0|AGT|0|0|1|100|XEU|327|1426|lyfalmen||||24|0|8,0000|Actavis Group hf|Actavis Group hf|Klórdíazepoxíđ||327||327|1426|
153564|N05BA0205|Risolid|filmhtfl|25|mg|24|stk|1|glas||N05BA02|01.07.2012||R|||0|0|0|0|AGT|0|0|1|100|XEU|541|1719|lyfalmen||||24|0|20,0000|Actavis Group hf|Actavis Group hf|Klórdíazepoxíđ||541||541|1719|
153601|B03BA0302|Vibeden|stl|1|mg/ml|1|ml|1|lykja||B03BA03|01.06.2010||R|||0|0|E|0|SHS|0|0|1|100|DKK|1603|3172|lyfalmen||||1|0|50,0000|Artasan ehf|Sandoz A/S|Hýdroxókóbalamín||1603||1603|3172|
154475|D05AX5203|Xamiol|hlaup|||60|g|1|plastf|50 mcg/g+0,5 mg/g|D05AX52|01.05.2009||R|||0|0|B|0|LEP|0|0|0|100|DKK|8265|12285|lyfalmen||||60|0||Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||8265||8265|12285|
154480|R06AX2201|Kestine|filmhtfl|20|mg|100|stk|1|ţpakki||R06AX22|01.06.2012||R|||0|0|E|0|APS|0|0|1|100|DKK|9618|14136|lyfalmen||||100|0|200,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín||9618||9618|14136|
154484|G04CA0102|Xatral Uno|forđatfl|10|mg|30|stk|1|ţpakki||G04CA01|01.01.2003|31.05.2012|R|||0|0|E|0|SNO|0|0|0|100|NOK|3512|5783|lyfalmen||||30|0|40,0000|Vistor hf|Sanofi-aventis Norge AS|Alfúzósín||3512||3512|5783|
154591|M01AB5501|Arthrotec|töflur|50,2|mg|20|stk|1|pakki|ţp (0,2+50 mg)|M01AB55|01.04.1993||R|||0|0|E|0|PER|0|0|1|100|DKK|1079|2455|lyfalmen||||20|0|10,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||1079||1079|2455|
154618|B05BA1021|SmofKabiven|irl|1100|kcal|986|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|||0|0|0|1|FRP|0|0|0|100|DKK|29769|39243|lyfsjukr||||3944|0||Icepharma hf|Fresenius Kabi|Blöndur||29769||29769|39243|
154629|B05BA1021|SmofKabiven|irl|1600|kcal|1477|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|||0|0|0|1|FRP|0|0|0|100|DKK|39001|50829|lyfsjukr||||5908|0||Icepharma hf|Fresenius Kabi|Blöndur||39001||39001|50829|
154640|B05BA1021|SmofKabiven|irl|2200|kcal|1970|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|||0|0|0|1|FRP|0|0|0|100|DKK|42851|55661|lyfsjukr||||7880|0||Icepharma hf|Fresenius Kabi|Blöndur||42851||42851|55661|
154662|B05BA1022|SmofKabiven Elektrolytfri|irl|1100|kcal|986|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|||0|0|0|1|FRP|0|0|0|100|DKK|31715|41685|lyfsjukr||||3944|0||Icepharma hf|Fresenius Kabi|Blöndur||31715||31715|41685|
154673|B05BA1022|SmofKabiven Elektrolytfri|irl|1600|kcal|1477|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|||0|0|0|1|FRP|0|0|0|100|DKK|39014|50845|lyfsjukr||||5908|0||Icepharma hf|Fresenius Kabi|Blöndur||39014||39014|50845|
154706|B05BA1023|SmofKabiven Perifer|irl|800|kcal|1206|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|||0|0|0|1|FRP|0|0|0|100|DKK|27949|36958|lyfsjukr||||4824|0||Icepharma hf|Fresenius Kabi|Blöndur||27949||27949|36958|
154708|M01AB5501|Arthrotec|töflur|50,2|mg|100|stk|1|pakki|ţp (0,2+50 mg)|M01AB55|01.04.1993||R|||0|0|E|0|PER|0|0|1|100|DKK|3870|6273|lyfalmen||||100|0|50,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||3870||3870|6273|
154717|B05BA1023|SmofKabiven Perifer|irl|1300|kcal|1904|ml|4|pokar|fleyti|B05BA10|01.08.2011||R|||0|0|0|1|FRP|0|0|0|100|DKK|36443|47618|lyfsjukr||||7616|0||Icepharma hf|Fresenius Kabi|Blöndur||36443||36443|47618|
154728|N06AX1608|Venlafaxin Actavis|forđahlk|75|mg|28|stk|1|ţpakki|hart|N06AX16|01.08.2009||R|||0|0|0|0|AGP|0|0|0|100|XEU|1552|3102|lyfalmen|V0259|3102||28|0|21,0000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||1552||1552|3102|
154732|G04CA0102|Xatral Uno|forđatfl|10|mg|90|stk|1|ţpakki||G04CA01|01.01.2003||R|||0|0|E|0|SNO|0|0|0|100|NOK|7624|11408|lyfalmen|V0550|7805||90|0|120,0000|Vistor hf|Sanofi-aventis Norge AS|Alfúzósín||7624||7624|11408|
154739|N06AX1608|Venlafaxin Actavis|forđahlk|75|mg|98|stk|1|ţpakki|hart|N06AX16|01.08.2009||R|||0|0|B|0|AGP|0|0|0|100|XEU|4414|6158|lyfalmen|V0334|6140||98|0|73,5000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||3786||3786|6158|
154750|N06AX1608|Venlafaxin Actavis|forđahlk|150|mg|28|stk|1|ţpakki|hart|N06AX16|01.08.2009||R|||0|0|0|0|AGP|0|0|0|100|XEU|2432|2489|lyfalmen|V0265|2489||28|0|42,0000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||1104||1104|2489|
154761|N06AX1608|Venlafaxin Actavis|forđahlk|150|mg|98|stk|1|ţpakki|hart|N06AX16|01.08.2009||R|||0|0|B|0|AGP|0|0|0|100|XEU|7084|6158|lyfalmen|V0335|6140||98|0|147,0000|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||3786||3786|6158|
154952|L04AX0501|Esbriet|hylki|267|mg|252|stk|1|ţpakki|hart|L04AX05|01.07.2012||R|||0|1|0|0|INT|0|0|0|100|DKK|459413|579108|lyfalmen||||252|0||Vistor hf|InterMune Europe Ltd.|Pírfenidon||459413||459413|579108|
155085|L01AA0201|Leukeran|töflur|2|mg|25|stk|1|glas||L01AA02|01.06.2001||R|||0|0|*|0|AUG|0|0|0|100|XEU|1603|3172|lyfalmen||||25|0||Aspen Europe GmbH|Aspen Europe GmbH|Chlorambucíl||1603||1603|3172|
155219|N03AX1106|Topiramate Portfarma|filmhtfl|25|mg|60|stk|1|ţpakki||N03AX11|01.04.2010||R|||0|0|E|0|POF|0|0|0|100|XEU|2256|4054|lyfalmen|V0247|4054||60|0|5,0000|Portfarma ehf|Portfarma|Tópíramat||2248||2248|4054|
155230|N03AX1106|Topiramate Portfarma|filmhtfl|50|mg|60|stk|1|ţpakki||N03AX11|01.04.2010||R|||0|0|E|0|POF|0|0|0|100|XEU|3803|6173|lyfalmen|V0248|6173||60|0|10,0000|Portfarma ehf|Portfarma|Tópíramat||3797||3797|6173|
155241|N03AX1106|Topiramate Portfarma|filmhtfl|100|mg|60|stk|1|ţpakki||N03AX11|01.04.2010||R|||0|0|E|0|POF|0|0|0|100|XEU|6837|10327|lyfalmen|V0249|10327||60|0|20,0000|Portfarma ehf|Portfarma|Tópíramat||6834||6834|10327|
155390|N05AF0301|Truxal|töflur|50|mg|100|stk|1|glas||N05AF03|01.12.1972||R|||0|0|*|0|LBK|0|1|0|100|DKK|1554|3105|lyfalmen||||100|0|16,6667|Lundbeck Export A/S|H. Lundbeck A/S|Klórprótixen||1554||1554|3105|
155432|N05AF0301|Truxal|töflur|15|mg|100|stk|1|glas||N05AF03|01.12.1972||R|||0|0|*|0|LBK|0|1|0|100|DKK|665|1889|lyfalmen||||100|0|5,0000|Lundbeck Export A/S|H. Lundbeck A/S|Klórprótixen||665||665|1889|
155648|J02AC0201|Sporanox|hylki|100|mg|28|stk|1|ţpakki|hart|J02AC02|01.04.1995||R|||0|0|0|0|JAS|0|0|1|100|SEK|6785|10260|lyfalmen|V0181|10260||28|0|14,0000|Vistor hf|Janssen-Cilag AB|Ítracónazól||6785||6785|10260|
156505|A08AB0101|Xenical|hylki|120|mg|42|stk|1|ţpakki||A08AB01|01.07.1999|30.04.2012|R|||0|0|0|0|ROC|0|0|0|100|DKK|6632|10051|lyfalmen||||42|0|14,0000|Icepharma hf|Roche|Orlístat||6632||6632|10051|
156506|A10AB0405|Humalog KwikPen|stl|100|ae/ml|3|ml|5|rörlyk||A10AB04|01.05.2011||R|||0|0|*|0|ELD|0|0|0|100|XEU|5974|9151|lyfalmen||||15|0|37,5000|Icepharma hf|Eli Lilly Nederland B.V.|Insúlín lispró||5974||5974|9151|
156517|A10AD0403|Humalog Mix25 KwikPen|stl|100|ae/ml|3|ml|5|rörlyk||A10AD04|01.05.2011||R|||0|0|*|0|ELD|0|0|0|100|XEU|6025|9221|lyfalmen||||15|0|37,5000|Icepharma hf|Eli Lilly Nederland B.V.|Insulín lispro||6025||6025|9221|
156528|J01XE0101|Furadantin|töflur|50|mg|15|stk|1|ţpakki||J01XE01|01.08.2010||R|||0|0|0|0|REP|0|0|1|100|SEK|437|1577|lyfalmen||||15|0|3,7500|Vistor hf|Recip AB|Nítrófúrantóín||437||437|1577|
156563|L01XA0210|Carboplatin Hospira|irţ|10|mg/ml|15|ml|1|hgl||L01XA02|01.04.1992||R|||0|1|0|1|HOP|0|0|0|100|XEU|2397|3459|lyfsjukr||||15|0||Icepharma hf|Hospira Nordic AB|Karbóplatín||2397||2397|3459|
156574|L01XA0210|Carboplatin Hospira|irţ|10|mg/ml|5|ml|1|hgl||L01XA02|01.04.1992||R|||0|1|0|1|HOP|0|0|0|100|XEU|1405|2028|lyfsjukr||||5|0||Icepharma hf|Hospira Nordic AB|Karbóplatín||1405||1405|2028|
156585|L01XA0210|Carboplatin Hospira|irţ|10|mg/ml|45|ml|1|hgl||L01XA02|01.04.1992||R|||0|1|0|1|HOP|0|0|0|100|XEU|6565|9475|lyfsjukr||||45|0||Icepharma hf|Hospira Nordic AB|Karbóplatín||6565||6565|9475|
156596|A08AB0101|Xenical|hylki|120|mg|84|stk|1|ţpakki||A08AB01|01.07.1999||R|||0|0|0|0|ROC|0|0|0|100|DKK|9665|14200|lyfalmen||||84|0|28,0000|Icepharma hf|Roche|Orlístat||9665||9665|14200|
156597|L01XA0210|Carboplatin Hospira|irţ|10|mg/ml|60|ml|1|hgl||L01XA02|01.04.2007||R|||0|1|0|1|HOP|0|0|0|100|XEU|8793|12690|lyfsjukr||||60|0||Icepharma hf|Hospira Nordic AB|Karbóplatín||8793||8793|12690|
156661|P02CA0101|Vermox|töflur|100|mg|6|stk|1|ţpakki||P02CA01|01.12.1982||R|||0|0|0|0|JAS|0|0|0|100|SEK|877|2179|lyfalmen||||6|0|3,0000|Vistor hf|Janssen-Cilag AB|Mebendazól||877||877|2179|
157047|N07BA0146|Nicotinell Tropical Fruit|tyggigúm|2|mg|24|stk|1|ţpakki||N07BA01|01.11.2011||L|||0|0|0|0|NOS|0|0|1|100|IKR|||lyflausa||||24|0|1,6000|Artasan ehf|Novartis Healthcare A/S|Nikótín||||||
157206|QP52AF0201|Banminth, vet.|pasta|11,4|g/skdćla|26|g|10|spr||QP52AF02|01.04.1992||R|||0|0|0|0|PAL|0|0|0|100|DKK|7446|12989|vetorma||||260|0||Icepharma hf|Pfizer Oy Animal Health|||7446||7446|12989|
157741|N05AH0311|Olanzapine Ranbaxy|töflur|5|mg|28|stk|1|ţpakki||N05AH03|01.12.2011||R|||0|0|*|0|RAN|0|1|0|100|XEU|2768|2529|lyfalmen|V0279|2529||28|0|14,0000|Artasan ehf|Ranbaxy (UK) Ltd|Olanzapín||1133||1133|2529|
157863|N03AF0104|Tegretol|töflur|200|mg|100|stk|1|ţpakki||N03AF01|01.01.2010||R|||0|0|E|0|NOH|0|0|0|100|DKK|1557|3109|lyfalmen|V0239|3109||100|0|20,0000|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||1557||1557|3109|
158163|N05AH0405|Seroquel Prolong|forđatfl|50|mg|10|stk|1|ţpakki||N05AH04|01.10.2011||R|||0|0|0|0|ASA|0|1|0|100|SEK|1589|3153|lyfalmen||||10|0|1,2500|Vistor hf|Astra Zeneca A/S|Quetíapín||||1589|3153|
158185|N05AH0405|Seroquel Prolong|forđatfl|150|mg|100|stk|1|ţpakki||N05AH04|01.10.2011||R|||0|0|0|0|ASA|0|1|0|100|SEK|29277|39288|lyfalmen||||100|0|37,5000|Vistor hf|Astra Zeneca A/S|Quetíapín||||29277|39288|
158287|N03AF0104|Tegretol|töflur|200|mg|50|stk|1|ţpakki||N03AF01|01.12.1972||R|||0|0|E|0|NOH|0|0|0|100|DKK|971|2307|lyfalmen|V0239|1555||50|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||971||971|2307|
158431|B02BD0801|NovoSeven|sts|1|mg|1|hgl|1|pakki|+leysir, lausn|B02BD08|01.04.2009||R|||0|1|0|1|NAS|0|0|0|100|DKK|105642|134463|lyfsjukr||||1|0|0,0200|Vistor hf|Novo-Nordisk A/S|Eptacog alfa (virkjađ)||||105642|134463|
158442|B02BD0801|NovoSeven|sts|2|mg|1|hgl|1|pakki|+leysir, lausn|B02BD08|01.04.2009||R|||0|1|0|1|NAS|0|0|0|100|DKK|211285|267045|lyfsjukr||||1|0|0,0400|Vistor hf|Novo-Nordisk A/S|Eptacog alfa (virkjađ)||||211285|267045|
158453|B02BD0801|NovoSeven|sts|5|mg|1|hgl|1|pakki|+leysir, lausn|B02BD08|01.04.2009||R|||0|1|0|1|NAS|0|0|0|100|DKK|599092|753743|lyfsjukr||||1|0|0,1000|Vistor hf|Novo-Nordisk A/S|Eptacog alfa (virkjađ)||||599092|753743|
158608|J02AX0501|Mycamine|irs|50|mg|1|hgl|1|pakki||J02AX05|01.03.2009||R|||0|1|0|1|APG|0|0|0|100|XEU|53882|69504|lyfsjukr||||1|0|0,5000|Vistor hf|Astellas Pharma GmbH|Micafungin||||53882|69504|
158619|J02AX0501|Mycamine|irs|100|mg|1|hgl|1|pakki||J02AX05|01.03.2009||R|||0|1|0|1|APG|0|0|0|100|XEU|76864|98347|lyfsjukr||||1|0|1,0000|Vistor hf|Astellas Pharma GmbH|Micafungin||76864||76864|98347|
158683|H01BB0201|Syntocinon|nefúđi|6,7|mcg/sk|5|ml|1|stauk||H01BB02|01.07.1988||R|||0|0|E|0|DES|0|0|0|100|DKK|837|2124|lyfalmen||||5|0|13,3333|Swedish Orphan Biovitrum A/S|Defiante Farmaceutica S.A.|Oxýtócín||837||837|2124|
158725|M01AB0516|Diklofenak Mylan|sţ-tfl|50|mg|100|stk|1|ţpakki||M01AB05|01.12.2008||R|||0|0|E|0|MYL|0|0|1|100|SEK|1038|2399|lyfalmen|V0469|2399||100|0|50,0000|Actavis Group PTC ehf|Mylan AB|Díklófenak||||1038|2399|
159107|N02AB0303|Fentanyl Actavis|forđapl|25|mcg/klst|5|stk|1|ţpakki||N02AB03|01.12.2008||R|||1|0|E|0|AGP|0|0|0|100|XEU|3438|5682|lyfalmen|V0219|5682||5|0|7,5000|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||3438||3438|5682|
159118|N02AB0303|Fentanyl Actavis|forđapl|50|mcg/klst|5|stk|1|ţpakki||N02AB03|01.12.2008||R|||1|0|E|0|AGP|0|0|0|100|XEU|5920|9077|lyfalmen|V0220|9077||5|0|15,0000|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||5920||5920|9077|
159130|N02AB0303|Fentanyl Actavis|forđapl|75|mcg/klst|5|stk|1|ţpakki||N02AB03|01.12.2008||R|||1|0|E|0|AGP|0|0|0|100|XEU|7679|11483|lyfalmen|V0221|11483||5|0|22,5000|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||7679||7679|11483|
159141|N02AB0303|Fentanyl Actavis|forđapl|100|mcg/klst|5|stk|1|ţpakki||N02AB03|01.12.2008||R|||1|0|E|0|AGP|0|0|0|100|XEU|8948|13219|lyfalmen|V0223|13219||5|0|30,0000|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||8948||8948|13219|
159517|N06AB0401|Cipramil|töflur|20|mg|56|stk|1|ţpakki||N06AB04|01.04.1993||R|||0|0|B|0|LBK|0|1|0|100|DKK|5297|4750|lyfalmen|V0318|2506||56|0|56,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||2757||2757|4750|
159533|L02BG0601|Aromasin|töflur|25|mg|30|stk|1|ţpakki||L02BG06|01.06.2001||R|||0|0|*|0|PER|0|0|0|100|DKK|20736|28569|lyfalmen||||30|0|30,0000|Icepharma hf|Pfizer ApS|Exemestan||20736||20736|28569|
159541|N06AB0401|Cipramil|töflur|40|mg|56|stk|1|ţpakki||N06AB04|01.04.1993||R|||0|0|0|0|LBK|0|1|0|100|DKK|13583|12597|lyfalmen|V0320|4154||56|0|112,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||8493||8493|12597|
159558|N06AB0401|Cipramil|töflur|10|mg|28|stk|1|ţpakki||N06AB04|01.04.1993||R|||0|0|0|0|LBK|0|1|0|100|DKK|1921|2682|lyfalmen|V0062|2040||28|0|14,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||1245||1245|2682|
159632|N06AB0401|Cipramil|töflur|20|mg|28|stk|1|ţpakki||N06AB04|01.04.1993||R|||0|0|0|0|LBK|0|1|0|100|DKK|3325|3761|lyfalmen|V0067|1921||28|0|28,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||2034||2034|3761|
159640|N06AB0401|Cipramil|töflur|40|mg|28|stk|1|ţpakki||N06AB04|01.04.1993||R|||0|0|0|0|LBK|0|1|0|100|DKK|6852|4998|lyfalmen|V0071|2164||28|0|56,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||2938||2938|4998|
159672|R05CB0105|Acetylcystein Mylan|freyđit|200|mg|25|stk|1|pakki||R05CB01|01.03.2010||R|||0|0|E|0|MYL|0|0|1|100|SEK|469|1620|lyfalmen||||25|0|10,0000|Actavis Group PTC ehf|Mylan AB|Acetýlcýstein||469||469|1620|
159683|R05CB0105|Acetylcystein Mylan|freyđit|200|mg|100|stk|1|pakki||R05CB01|01.03.2010||R|||0|0|E|0|MYL|0|0|1|100|SEK|1614|3187|lyfalmen||||100|0|40,0000|Actavis Group PTC ehf|Mylan AB|Acetýlcýstein||1614||1614|3187|
159772|B01AD0701|Rapilysin|sts|10|ae/hgl|2|hgl|1|pakki|+ leysir|B01AD07|01.02.2002||R|||0|0|0|1|APC|0|0|0|100|DKK|102978|131120|lyfsjukr||||2|0|1,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Reteplasi||102978||102978|131120|
159973|QM01AG9002|Flunixin|stl|50|mg/ml|50|ml|1|hgl|nautg,hesta og svín|QM01AG90|01.11.2011||R|||0|0|0|0|NOB|1|0|0|100|XEU|4287|8404|vetalmen||||50|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|||4287||4287|8404|
160279|A02BC0402|Rabeprazol Actavis|sh-tfl|20|mg|56|stk|1|ţpakki||A02BC04|01.05.2011||R|||0|0|E|0|APC|0|0|0|100|XEU|2254|3150|lyfalmen|V0010|3139||56|0|56,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||1587||1587|3150|
160325|N05BA0105|Stesolid|stl|5|mg/ml|2|ml|25|lykjur||N05BA01|01.04.1974||R|||0|0|0|1|AGT|0|0|0|100|DKK|2322|3351|lyfsjukr||||50|0|25,0000|Actavis Group hf|Actavis Group hf|Díazepam||2322||2322|3351|
160408|V08CA0301|Omniscan|stl|0,5|mmol/ml|10|ml|10|plhgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|||0|0|0|1|GEH|0|0|0|100|NOK|37585|49052|lyfsjukr||||100|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||37585||37585|49052|
160457|V08CA0301|Omniscan|stl|0,5|mmol/ml|15|ml|10|plhgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|||0|0|0|1|GEH|0|0|0|100|NOK|54724|70561|lyfsjukr||||150|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||54724||54724|70561|
160523|N05AB0401|Stemetil|töflur|5|mg|100|stk|1|ţpakki||N05AB04|01.06.1981||R|||0|0|*|0|SNO|0|1|0|100|NOK|1031|2389|lyfalmen||||100|0|5,0000|Vistor hf|Sanofi-aventis Norge AS|Próklórperazín||1031||1031|2389|
160531|C10AC0101|Questran|skammtar|4|g|50|skammtar|1|pakki||C10AC01|01.04.1988||R|||0|0|0|0|BRS|0|0|0|100|DKK|2419|4288|lyfalmen||||50|0|14,2857|Vistor hf|Bristol-Myers Squibb|Kólestýramín||2419||2419|4288|
160622|V08CA0301|Omniscan|stl|0,5|mmol/ml|20|ml|10|plhgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|||0|0|0|1|GEH|0|0|0|100|NOK|73006|93505|lyfsjukr||||200|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||73006||73006|93505|
160852|R01AX0301|Atrovent|nefúđi|21|mcg/sk|15|ml|1|glas|180 sk, lausn|R01AX03|01.09.2009||R|||0|0|E|0|BOI|0|0|1|100|DKK|1229|2660|lyfalmen||||15|0|15,7500|Vistor hf|Boehringer Ingelheim|Ípratrópínbrómíđ||1229||1229|2660|
161065|J05AG0401|Intelence|töflur|100|mg|120|stk|1|glas||J05AG04|01.02.2009||R|||0|1|0|1|JCI|0|0|0|100|SEK|75924|97167|lyfsjukr||||120|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Etravírín||75924||75924|97167|
161075|H02AB0403|Solu-Medrol|sts|40|mg|1|stk|1|hgl|Act-O-Vial|H02AB04|01.08.1980||R|||0|0|B|0|PER|0|0|1|100|DKK|607|1809|lyfalmen||||1|0|2,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||607||607|1809|
161091|H02AB0901|Solu-Cortef|sts|250|mg|1|stk|1|hgl|Act-O-Vial|H02AB09|01.12.1972||R|||0|0|0|1|PER|0|0|0|100|DKK|942|1360|lyfsjukr||||1|0|8,3333|Icepharma hf|Pfizer ApS|Hýdrókortisón||942||942|1360|
161117|H02AB0901|Solu-Cortef|sts|100|mg|1|stk|5|hgl|Act-O-Vial |H02AB09|01.08.1998||R|||0|0|0|1|PER|0|0|0|100|DKK|855|1234|lyfsjukr||||5|0|16,6667|Icepharma hf|Pfizer ApS|Hýdrókortisón||855||855|1234|
161125|H02AB0901|Solu-Cortef|sts|100|mg|1|stk|1|hgl|Act-O-Vial|H02AB09|01.12.1972||R|||0|0|B|0|PER|0|0|1|100|DKK|620|1827|lyfalmen||||1|0|3,3333|Icepharma hf|Pfizer ApS|Hýdrókortisón||620||620|1827|
161133|G03CA0306|Evorel|forđapl|75|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993||R|||0|0|E|0|JAS|0|0|0|100|SEK|5053|7891|lyfalmen|V0131|7891||26|0|136,5000|Vistor hf|Janssen-Cilag AB|Estradíól||5053||5053|7891|
161547|L02BG0601|Aromasin|töflur|25|mg|100|stk|1|ţpakki||L02BG06|01.06.2001||R|||0|0|*|0|PER|0|0|0|100|DKK|61669|79940|lyfalmen|V0452|47444||100|0|100,0000|Icepharma hf|Pfizer ApS|Exemestan||61669||61669|79940|
161870|N07BC5101|Suboxone|tungur.t|10|mg|28|stk|1|ţpakki|8+2 mg|N07BC51|01.08.2011||R|||1|1|0|1|RBP|0|0|0|100|DKK|14533|20007|lyfsjukr||||28|0|28,0000|Vistor hf|RB Pharmaceuticals Limited|Búprenorfín í blöndum||14442||14442|20007|
162080|H01AC0111|Omnitrope|stl|6,7|mg/ml|1,5|ml|5|rörlyk|lausn|H01AC01|01.04.2012||R|||0|1|0|1|SDG|0|0|0|100|DKK|162515|205839|lyfsjukr||||8|0|75,0000|Artasan ehf|Sandoz GmbH (Kundl)|Sómatrópín||162515||162515|205839|
162115|N06AA0906|Saroten|töflur|25|mg|100|stk|1|glas||N06AA09|01.12.2011||R|||0|0|B|0|LBK|0|1|0|100|DKK|797|2069|lyfalmen|V0512|2069||100|0|33,3300|Lundbeck Export A/S|H. Lundbeck A/S|Amitriptýlín||797||797|2069|
162149|N06AA0906|Saroten|töflur|10|mg|100|stk|1|glas||N06AA09|01.12.2011||R|||0|0|B|0|LBK|0|1|0|100|DKK|443|1585|lyfalmen|V0510|1585||100|0|13,3300|Lundbeck Export A/S|H. Lundbeck A/S|Amitriptýlín||443||443|1585|
162354|A07EC0101|Salazopyrin|töflur|500|mg|100|stk|1|glas||A07EC01|01.12.1972||R|||0|0|B|0|PER|0|0|0|100|DKK|1963|3664|lyfalmen||||100|0|25,0000|Icepharma hf|Pfizer ApS|Súlfasalazín||1963||1963|3664|
162778|QN05CM9002|Detonervin, vet.|stl|10|mg/ml|5|ml|1|hgl|f.hesta og nautgr.|QN05CM90|01.12.2011||R|||0|0|0|0|LEV|1|0|0|100|XEU|5552|10833|vetalmen||||5|0||Le Vet B.V.|Le Vet B.V.|||||5552|10833|
162808|C01DA1404|Fem-Mono Retard|forđatfl|60|mg|100|stk|1|ţpakki||C01DA14|01.03.2012||R|||0|0|B|0|GUK|0|0|0|100|SEK|1992|3704|lyfalmen|V0041|3704||100|0|150,0000|Actavis Group PTC ehf|Generics UK Ltd.|Ísósorbíđ mónónítrat||1992||1992|3704|
162903|S01ED5115|Arzotilol|augndr|5|mg/ml|5|ml|1|glas|+ dorzólamíđ 20 mg|S01ED51|01.01.2012||R|||0|0|*|0|APC|0|0|0|100|XEU|1674|3198|lyfalmen|V0373|2484||5|0|25,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Tímólól í blöndum||1622||1622|3198|
162929|G04CA0205|Ranomax|forđahlk|0,4|mg|100|stk|1|ţpakki||G04CA02|01.04.2009||R|||0|0|E|0|RAN|0|0|0|100|XEU|4851|4541|lyfalmen|V0148|4441||100|0|100,0000|Artasan ehf|Ranbaxy (UK) Ltd|Tamsúlósín||2604||2604|4541|
162933|R03BA0501|Flixotide|innúđal|50|mcg/sk|120|sk|1|stauk||R03BA05|01.07.1994||R|||0|0|B|0|GSK|0|0|0|100|GBP|2368|4218|lyfalmen||||120|0|20,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||2368||2368|4218|
163089|N06BA0401|Ritalin|töflur|10|mg|30|stk|1|ţpakki||N06BA04|01.12.1972||R|||1|0|0|0|NOH|0|0|0|100|DKK|1172|2582|lyfalmen||||30|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Metýlfenídat||1172||1172|2582|
163246|P01AB0102|Flagyl|töflur|400|mg|30|stk|1|ţpakki||P01AB01|01.10.1995||R|||0|0|0|0|SNO|0|0|1|100|NOK|1738|3356|lyfalmen|V0351|3356||30|0|6,0000|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||1738||1738|3356|
163274|C03AA0304|Dehydratin Neo|töflur|25|mg|20|stk|1|pakki||C03AA03|01.02.2009||R|||0|0|E|0|AEA|0|0|0|100|XEU|207|1262|lyfalmen||||20|0|20,0000|Actavis hf|Actavis EAD|hýdróklórtíazíđ||||207|1262|
163493|R03BA0501|Flixotide|innúđal|125|mcg/sk|120|sk|1|stauk||R03BA05|01.07.1994||R|||0|0|B|0|GSK|0|0|0|100|GBP|3501|5094|lyfalmen||||120|0|25,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||3008||3008|5094|
163709|V03AE0101|Resonium|duft|||454|g|1|stauk||V03AE01|01.01.2000||R|||0|0|0|0|PCO|0|0|0|100|IKR|8140|12114|lyfalmen||||454|1|10,0800|Distica|Distica - óskráđ lyf|Pólýstýren súlfónat||8140||8140|12114|
164119|J05AE1101|Incivo|filmhtfl|375|mg|42|stk|1|glas||J05AE11|01.02.2012||R|||0|1|0|1|JCI|0|0|0|100|SEK|350937|442308|lyfsjukr||||42|0||Vistor hf|Janssen-Cilag International N.V.|Telaprevír||350937||350937|442308|
164251|L01BB0201|Puri-nethol|töflur|50|mg|25|stk|1|glas||L01BB02|01.06.2001||R|||0|0|*|0|AUG|0|0|0|100|XEU|3531|5809|lyfalmen||||25|0||Aspen Europe GmbH|Aspen Europe GmbH|Merkaptópúrín||3531||3531|5809|
164256|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|500|ml|20|pokar|Freeflex umbúđir|B05BA03|01.12.2011||R|||0|0|0|1|FRP|0|0|0|100|DKK|3974|5735|lyfsjukr||||10000|0||Icepharma hf|Fresenius Kabi|Kolvetni||3974||3974|5735|
164807|N04BD0105|Selegilin Mylan|töflur|5|mg|100|stk|1|glas||N04BD01|01.10.1995||R|||0|0|E|0|MYL|0|0|0|100|SEK|3029|5122|lyfalmen||||100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Selegilín||||3029|5122|
164818|N04BD0105|Selegilin Mylan|töflur|10|mg|100|stk|1|glas||N04BD01|01.05.2010||R|||0|0|E|0|MYL|0|0|0|100|SEK|9986|14639|lyfalmen||||100|0|200,0000|Actavis Group PTC ehf|Mylan AB|Selegilín||9986||9986|14639|
164829|N06AA0406|Klomipramin Mylan|töflur|10|mg|100|stk|1|glas||N06AA04|01.10.2010||R|||0|0|B|0|MYL|0|1|0|100|SEK|1045|2408|lyfalmen||||100|0|10,0000|Actavis Group PTC ehf|Mylan AB|Klómípramín||1045||1045|2408|
164840|N06AA0406|Klomipramin Mylan|töflur|25|mg|100|stk|1|glas||N06AA04|01.10.1992||R|||0|0|B|0|MYL|0|1|0|100|SEK|964|2298|lyfalmen|V0314|2298||100|0|25,0000|Actavis Group PTC ehf|Mylan AB|Klómípramín||||964|2298|
164871|A07EC0204|Asacol|eţ-stíll|500|mg|60|stk|1|pakki||A07EC02|01.01.2000||R|||0|0|B|0|TIL|0|0|0|100|SEK|7399|11100|lyfalmen|V0014|11100||60|0|20,0000|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||7399||7399|11100|
165001|C05AA0102|Proctosedyl|eţ-stíll|||12|stk|1|pakki||C05AA01|01.12.1972||L|||0|0|0|0|SNO|0|0|0|100|IKR|||lyflausa||||12|0||Vistor hf|Sanofi-aventis Norge AS|Hýdrókortisón||||||
165019|C05AA0102|Proctosedyl|eţ-smyr|||30|g|1|túpa||C05AA01|01.03.1981||L|||0|0|0|0|SNO|0|0|0|100|IKR|||lyflausa||||30|0||Vistor hf|Sanofi-aventis Norge AS|Hýdrókortisón||||||
165175|N05BA0205|Risolid|filmhtfl|10|mg|100|stk|1|glas||N05BA02|01.03.2012||R|||0|0|0|0|AGT|0|0|1|100|XEU|855|2148|lyfalmen||||100|0|33,3300|Actavis Group hf|Actavis Group hf|Klórdíazepoxíđ||855||855|2148|
165306|QN05CM9501|Dorbene vet.|stl|1|mg/ml|10|mg|1|hgl||QN05CM95|01.05.2009||R|||0|0|0|0|LAS|1|0|0|100|XEU|7063|13735|vetalmen||||10|0||Dýraheilsa ehf|Laboratorios SYVA S.A.|||7063||7063|13735|
165431|C08CA0202|Plendil|forđatfl|2,5|mg|98|stk|1|ţpakki||C08CA02|01.01.1992||R|||0|0|B|0|AZD|0|0|0|100|SEK|4538|7187|lyfalmen||||98|0|49,0000|Vistor hf|AstraZeneca A/S DK|Felódipín||4538||4538|7187|
165449|C08CA0202|Plendil|forđatfl|10|mg|98|stk|1|ţpakki||C08CA02|01.10.1995||R|||0|0|B|0|AZD|0|0|0|100|SEK|5125|7990|lyfalmen|V0059|4004||98|0|196,0000|Vistor hf|AstraZeneca A/S DK|Felódipín||5125||5125|7990|
165548|C08CA0202|Plendil|forđatfl|5|mg|98|stk|1|ţpakki||C08CA02|01.10.1995||R|||0|0|B|0|AZD|0|0|0|100|SEK|3308|5504|lyfalmen|V0058|2882||98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Felódipín||3308||3308|5504|
165603|H01AC0104|Saizen|sts|8|mg/ml|1,5|ml|5|rörlyk||H01AC01|01.05.2011||R|||0|1|0|1|EMA|0|0|0|100|SEK|269349|339915|lyfsjukr||||8|0|90,0000|Icepharma hf|E. Merck AB|Sómatrópín||269349||269349|339915|
165662|V08CA0301|Omniscan|stl|0,5|mmol/ml|10|ml|10|gl-hgl|röntgenskuggaefni fyrir MRT|V08CA03|01.12.2010||R|||0|0|0|1|GEH|0|0|0|100|NOK|37585|49052|lyfsjukr||||100|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||37585||37585|49052|
165670|V08CA0301|Omniscan|stl|0,5|mmol/ml|15|ml|10|gl-hgl|röntgenskuggaefni fyrir MRT|V08CA03|01.12.2010||R|||0|0|0|1|GEH|0|0|0|100|NOK|54724|70561|lyfsjukr||||150|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||54724||54724|70561|
165761|R06AE0501|Postafen|töflur|25|mg|100|stk|1|ţpakki||R06AE05|01.12.1972||R|||0|0|E|0|UCN|0|0|1|100|SEK|709|1949|lyfalmen||||100|0|50,0000|Vistor hf|UCB Nordic A/S|Meklózín||709||709|1949|
165779|R06AE0501|Postafen|töflur|25|mg|25|stk|1|ţpakki||R06AE05|01.12.1972||R|||0|0|E|0|UCN|0|0|1|100|SEK|205|1259|lyfalmen||||25|0|12,5000|Vistor hf|UCB Nordic A/S|Meklózín||205||205|1259|
165787|R06AE0501|Postafen|töflur|25|mg|10|stk|1|ţpakki||R06AE05|01.12.1972||L|||0|0|0|0|UCN|0|0|1|100|IKR|||lyflausa||||10|0|5,0000|Vistor hf|UCB Nordic A/S|Meklózín||||||
165791|N06DA0206|Donepezil Medical|filmhtfl|5|mg|98|stk|1|ţpakki||N06DA02|01.04.2012||R|||0|0|E|0|MED|0|0|0|100|XEU|24871|17249|lyfalmen|V0341|17249||98|0|65,3300|Medical ehf|Medical ehf|Dónepezíl||11894||11894|17249|
165859|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|500|ml|20|pokar|Freeflex umbúđir|B05BA03|01.12.2011||R|||0|0|0|1|FRP|0|0|0|100|DKK|4199|6060|lyfsjukr||||10000|0||Icepharma hf|Fresenius Kabi|Kolvetni||4199||4199|6060|
165878|V08CA0301|Omniscan|stl|0,5|mmol/ml|20|ml|10|gl-hgl|röntgenskuggaefni fyrir MRT|V08CA03|01.12.2010||R|||0|0|0|1|GEH|0|0|0|100|NOK|73006|93505|lyfsjukr||||200|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||73006||73006|93505|
165894|V08CA0301|Omniscan|stl|0,5|mmol/ml|50|ml|10|plhgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|||0|0|0|1|GEH|0|0|0|100|NOK|247479|312469|lyfsjukr||||500|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||247479||247479|312469|
166008|QJ51RC2202|Nafpenzal vet.|spenalyf|||3|g|20|spr||QJ51RC22|01.02.2010||R|||0|0|0|0|INI|0|0|0|100|DKK|4793|9376|vetalmen||||60|0||Icepharma hf|Intervet International B.V.|||||4793|9376|
166157|P01BA0201|Plaquenil|töflur|200|mg|100|stk|1|ţpakki||P01BA02|01.12.1972||R|||0|0|B|0|SNO|0|0|0|100|NOK|1962|3663|lyfalmen||||100|0|38,7597|Vistor hf|Sanofi-aventis Norge AS|Hydroxýklórókín||1962||1962|3663|
166165|H01CA0201|Synarela|nefúđi|200|mcg/sk|8|ml|1|stauk|60 sk|H01CA02|01.04.1992||R|||0|1|E|0|PER|0|0|0|100|DKK|15563|22077|lyfalmen||||8|0|30,0000|Icepharma hf|Pfizer ApS|Nafarelín||15563||15563|22077|
166351|M01AE0217|Naproxen-E Mylan|sh-tfl|250|mg|100|stk|1|glas||M01AE02|01.07.1993||R|||0|0|E|0|MYL|0|0|1|100|SEK|2245|4050|lyfalmen||||100|0|50,0000|Actavis Group PTC ehf|Mylan AB|Naproxen||2245||2245|4050|
166362|M01AE0217|Naproxen-E Mylan|sh-tfl|500|mg|100|stk|1|glas||M01AE02|01.07.1993||R|||0|0|E|0|MYL|0|0|1|100|SEK|4249|6791|lyfalmen|V0428|6791||100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Naproxen||4249||4249|6791|
166709|G04CA0103|Alfuzosin Ranbaxy|forđatfl|10|mg|90|stk|1|ţpakki||G04CA01|01.07.2009||R|||0|0|E|0|RAN|0|0|0|100|XEU|4990|7805|lyfalmen|V0550|7805||90|0|120,0000|Artasan ehf|Ranbaxy (UK) Ltd|Alfúzósín||4990||4990|7805|
166858|M09AB0201|Xiapex|sts|0,9|mg/hgl|1|hgl|1|stk|+ leysir|M09AB02|01.09.2011||R|||0|1|E|0|IPI|0|0|0|100|DKK|133912|170605|lyfalmen||||1|0||Icepharma hf|Pfizer Limited|Clostridíum||133912||133912|170605|
166869|N02BA0110|Aspirin Actavis|töflur|300|mg|100|stk|1|glas||N02BA01|01.11.2010||L|||0|0|0|0|AUK|0|0|1|100|IKR|||lyflausa||||100|0|10,0000|Actavis Group hf|Actavis UK Ltd.|Acetýlsalicýlsýra||||||
167319|N06AX1608|Venlafaxin Actavis|forđahlk|37,5|mg|7|stk|1|ţpakki|hart|N06AX16|01.08.2009||R|||0|0|0|0|AGP|0|0|0|100|XEU|459|1607|lyfalmen|V0333|1607||7|0|2,6300|Actavis Group hf|Actavis Group PTC ehf|Venlafaxín||459||459|1607|
168275|M04AA0104|Allopurinol|töflur|100|mg|100|stk|1|ţpakki||M04AA01|01.06.2009||R|||0|0|E|0|AUK|0|0|0|100|GBP|659|1880|lyfalmen||||100|0|25,0000|Actavis Group hf|Actavis UK Ltd.|Allópúrinol||||659|1880|
168309|A02BC0306|Lanser|sţ-hylki|30|mg|98|stk|1|ţpakki||A02BC03|01.08.2009||R|||0|0|E|0|AGP|0|0|0|100|XEU|4829|5497|lyfalmen||||98|0|98,0000|Actavis Group hf|Actavis Group PTC ehf|Lansóprazól||3303||3303|5497|
168740|N03AF0105|Tegretol Retard|forđatfl|200|mg|200|stk|1|ţpakki||N03AF01|01.07.1988||R|||0|0|E|0|NOH|0|0|0|100|DKK|3126|5255|lyfalmen|V0240|5254||200|0|40,0000|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||3126||3126|5255|
168815|N03AF0105|Tegretol Retard|forđatfl|400|mg|30|stk|1|ţpakki||N03AF01|01.07.1988|30.06.2012|R|||0|0|E|0|NOH|0|0|0|100|DKK|1261|2704|lyfalmen||||30|0|12,0000|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||1261||1261|2704|
168971|N03AF0105|Tegretol Retard|forđatfl|400|mg|200|stk|1|ţpakki||N03AF01|01.07.1988||R|||0|0|E|0|NOH|0|0|0|100|DKK|5770|8872|lyfalmen|V0433|8869||200|0|80,0000|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||5770||5770|8872|
168997|L01CA0401|Navelbine|irţ|10|mg/ml|1|ml|10|hgl||L01CA04|01.03.1998||R|||0|1|0|1|PFP|0|0|0|100|SEK|54569|70367|lyfsjukr||||10|0||Vistor hf|Pierre Fabre Pharma|Vínorelbín||54569||54569|70367|
169433|L01CA0401|Navelbine|irţ|10|mg/ml|5|ml|10|hgl||L01CA04|01.03.1998||R|||0|1|0|1|PFP|0|0|0|100|SEK|237254|299636|lyfsjukr||||50|0||Vistor hf|Pierre Fabre Pharma|Vínorelbín||237254||237254|299636|
169557|J05AB0601|Cymevene|irs|500|mg|5|hgl|1|pakki|+innr.sía|J05AB06|01.10.1995||R|||0|0|0|1|ROA|0|0|0|100|DKK|22226|29776|lyfsjukr||||5|0|5,0000|Icepharma hf|Roche A.S.|Gancíklóvír||22226||22226|29776|
169664|J07BK0101|Varilrix|bóluefni|||0,5|ml|1|hgl|ţurrefni + 0.5 ml leysir|J07BK01|01.10.1995||R|||0|0|0|0|GSK|0|0|0|100|GBP|5643|8698|lyfalmen||||0|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Hlaupabóla, veikluđ veira||5643||5643|8698|
169729|D10BA0105|Isotretinoin Portfarma|hylki|10|mg|30|stk|1|ţpakki||D10BA01|01.10.2009||R|||0|1|C|0|POF|0|0|0|30|IKR|1407|2827|lyfalmen|V0124|2827||30|0|10,0000|Portfarma ehf|Portfarma|Ísótretínóín||1351||1351|2827|
169740|D10BA0105|Isotretinoin Portfarma|hylki|20|mg|30|stk|1|ţpakki||D10BA01|01.10.2009||R|||0|1|C|0|POF|0|0|0|30|IKR|2450|4196|lyfalmen|V0125|4196||30|0|20,0000|Portfarma ehf|Portfarma|Ísótretínóín||2352||2352|4196|
169751|J01MA0204|Ciprofloxacin Portfarma|filmhtfl|500|mg|20|stk|1|ţpakki||J01MA02|01.06.2009||R|||0|0|0|0|POF|0|0|1|100|IKR|1168|2577|lyfalmen|V0411|2577||20|0|10,0000|Portfarma ehf|Portfarma|Cíprófloxacín||1168||1168|2577|
169762|J01MA0204|Ciprofloxacin Portfarma|filmhtfl|500|mg|10|stk|1|ţpakki||J01MA02|01.06.2009||R|||0|0|0|0|POF|0|0|1|100|IKR|647|1864|lyfalmen|V0177|1864||10|0|5,0000|Portfarma ehf|Portfarma|Cíprófloxacín||647||647|1864|
169773|J01MA0204|Ciprofloxacin Portfarma|filmhtfl|250|mg|20|stk|1|ţpakki||J01MA02|01.06.2009||R|||0|0|0|0|POF|0|0|1|100|IKR|638|1852|lyfalmen|V0418|1852||20|0|5,0000|Portfarma ehf|Portfarma|Cíprófloxacín||638||638|1852|
169784|J01MA0204|Ciprofloxacin Portfarma|filmhtfl|250|mg|10|stk|1|ţpakki||J01MA02|01.06.2009||R|||0|0|0|0|POF|0|0|1|100|IKR|393|1517|lyfalmen|V0176|1517||10|0|2,5000|Portfarma ehf|Portfarma|Cíprófloxacín||393||393|1517|
169912|N01BB0102|Marcain|stl|2,5|mg/ml|20|ml|5|gl-hgl|án rotv|N01BB01|01.03.2003||R|||0|0|0|0|AZD|0|0|1|100|SEK|2985|5062|lyfalmen||||100|0||Vistor hf|AstraZeneca A/S DK|Búpívakaín||2985||2985|5062|
169920|N01BB0102|Marcain|stl|5|mg/ml|20|ml|5|gl-hgl|án rotv|N01BB01|01.03.2003||R|||0|0|0|0|AZD|0|0|1|100|SEK|3213|5374|lyfalmen||||100|0||Vistor hf|AstraZeneca A/S DK|Búpívakaín||3213||3213|5374|
170062|L04AC0701|RoActemra|irţ|20|mg/ml|4|ml|1|hgl||L04AC07|01.07.2009||R|||0|1|0|1|RRL|0|0|0|100|DKK|24881|33108|lyfsjukr||||4|0|4,0000|Icepharma hf|Roche Registration Limited|Tocilizúmabi||||24881|33108|
170085|L04AC0701|RoActemra|irţ|20|mg/ml|10|ml|1|hgl||L04AC07|01.07.2009||R|||0|1|0|1|RRL|0|0|0|100|DKK|61752|79381|lyfsjukr||||10|0|10,0000|Icepharma hf|Roche Registration Limited|Tocilizúmabi||||61752|79381|
170092|J07BC2001|Twinrix Adult|bóluefni|||1|ml|1|dćla|einnota dćla|J07BC20|01.01.1999||R|||0|0|0|0|GLB|0|0|0|100|GBP|6066|9277|lyfalmen||||1|0||GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|Lifrarbólgubóluefni (hepatitis)-Blöndur||6066||6066|9277|
170107|L04AC0701|RoActemra|irţ|20|mg/ml|20|ml|1|hgl||L04AC07|01.07.2009||R|||0|1|0|1|RRL|0|0|0|100|DKK|116725|148372|lyfsjukr||||20|0|20,0000|Icepharma hf|Roche Registration Limited|Tocilizúmabi||116725||116725|148372|
170505|J04AB0201|Rimactan|hylki|300|mg|100|stk|1|glas||J04AB02|01.07.2012||R|||0|0|E|0|SAD|0|0|0|100|DKK|16435|23171|lyfalmen|V0571|23171||100|0|50,0000|Icepharma hf|Sandoz GmbH|Rífampicín||16435||16435|23171|
170514|C01BC0301|Rytmonorm|töflur|150|mg|100|stk|1|ţpakki||C01BC03|01.04.1996||R|||0|1|B|0|ABS|0|0|0|100|DKK|3995|6444|lyfalmen||||100|0|50,0000|Vistor hf|Abbott Scandinavia AB|Própafenón||3995||3995|6444|
170548|C01BC0301|Rytmonorm|töflur|300|mg|100|stk|1|ţpakki||C01BC03|01.04.1996||R|||0|1|B|0|ABS|0|0|0|100|DKK|6993|10545|lyfalmen||||100|0|100,0000|Vistor hf|Abbott Scandinavia AB|Própafenón||6993||6993|10545|
170555|N01BB5301|Carbocain adrenalin|stl|10|mg/ml|20|ml|5|hgl|10 mg+5 míkróg/ml|N01BB53|01.12.1982||R|||0|0|0|0|AZD|0|0|1|100|SEK|2443|4321|lyfalmen||||100|0||Vistor hf|AstraZeneca A/S DK|Mepívakaín í blöndum||2443||2443|4321|
170628|J01GB0304|Gentamicin B. Braun|irl|1|mg/ml|80|ml|20|fl|.|J01GB03|01.04.2011||R|||0|0|0|1|BRA|0|0|0|100|XEU|11681|16542|lyfsjukr||||1600|0|6,6700|Actavis Group hf|Braun|Gentamícín||11681||11681|16542|
170640|J01GB0304|Gentamicin B. Braun|irl|3|mg/ml|80|ml|20|fl||J01GB03|01.04.2011||R|||0|0|0|1|BRA|0|0|0|100|XEU|28099|37147|lyfsjukr||||1600|0|20,0000|Actavis Group hf|Braun|Gentamícín||28099||28099|37147|
170651|J01GB0304|Gentamicin B. Braun|irl|3|mg/ml|120|ml|20|fl||J01GB03|01.04.2011||R|||0|0|0|1|BRA|0|0|0|100|XEU|42148|54778|lyfsjukr||||2400|0|30,0000|Actavis Group hf|Braun|Gentamícín||42148||42148|54778|
170697|M05BA0406|Alendronat Actavis|töflur|70|mg|12|stk|1|ţpakki||M05BA04|01.06.2009||R|||0|0|E|0|AGP|0|0|0|100|XEU|3430|3746|lyfalmen|V0203|3746||12|0|84,0000|Actavis Group hf|Actavis Group PTC ehf|Alendrónsýra||2023||2023|3746|
170763|M05BA0706|Risedronate sodium Portfarma|filmhtfl|35|mg|12|stk|1|ţpakki||M05BA07|01.03.2011||R|||0|0|E|0|POF|0|0|0|100|IKR|12363|4397|lyfalmen|V0207|3640||12|0|84,0000|Portfarma ehf|Portfarma|Rísedrónsýru||2499||2499|4397|
170997|L01BC0701|Vidaza|irţ|25|mg/ml|4|ml|1|hgl||L01BC07|01.09.2009||R|||0|1|0|1|CEE|0|0|0|100|XEU|58830|75714|lyfsjukr||||4|0||Celgene Europe ltd|Celgene Europe ltd|Azasitidín||58830||58830|75714|
171404|QS02CA0102|Canaural|eyrnadr|||25|ml|1|glas|handa hundum|QS02CA01|01.01.2012||R|||0|0|0|0|DEC|1|0|0|100|DKK|2162|4301|vetalmen||||25|0||Vistor hf|Dechra Veterinary Products A/S|||2162||2162|4301|
171603|N01BB5101|Marcain adrenalin|stl|2,5|mg/ml|20|ml|5|hgl||N01BB51|01.12.1982||R|||0|0|0|0|AZD|0|0|1|100|SEK|3701|6042|lyfalmen||||100|0||Vistor hf|AstraZeneca A/S DK|Búpívakaín í blöndum||3701||3701|6042|
171611|N01BB5101|Marcain adrenalin|stl|5|mg/ml|20|ml|5|hgl||N01BB51|01.12.1982||R|||0|0|0|0|AZD|0|0|1|100|SEK|3987|6433|lyfalmen||||100|0||Vistor hf|AstraZeneca A/S DK|Búpívakaín í blöndum||3987||3987|6433|
171777|H03BB0101|Neo-Mercazole|töflur|5|mg|100|stk|1|glas||H03BB01|01.08.2005||R|||0|0|B|0|LDR|0|0|0|100|NOK|1613|3185|lyfalmen||||100|1|33,3333|Parlogis hf|Parlogis - óskráđ lyf|Karbímazól||1613||1613|3185|
171793|N03AX1101|Topimax|töflur|25|mg|60|stk|1|ţpakki||N03AX11|01.01.2003||R|||0|0|E|0|JAS|0|0|0|100|SEK|4518|7159|lyfalmen|V0247|4054||60|0|5,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||4518||4518|7159|
171876|N03AX1101|Topimax|töflur|50|mg|60|stk|1|ţpakki||N03AX11|01.01.2003||R|||0|0|E|0|JAS|0|0|0|100|SEK|7437|11152|lyfalmen|V0248|6173||60|0|10,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||7437||7437|11152|
171991|V08CA0101|Magnevist|stl|469|mg/ml|15|ml|5|spr|röntgenskuggaefni|V08CA01|01.04.2007||R|||0|0|0|1|BAP|0|0|0|100|SEK|42978|55820|lyfsjukr||||75|0||Icepharma hf|Bayer Schering Pharma AG|Gadópentetat||42978||42978|55820|
172049|V08CA0101|Magnevist|stl|469|mg/ml|10|ml|5|spr|röntgenskuggaefni|V08CA01|01.04.2007||R|||0|0|0|1|BAP|0|0|0|100|SEK|28652|37841|lyfsjukr||||50|0||Icepharma hf|Bayer Schering Pharma AG|Gadópentetat||28652||28652|37841|
172353|N03AX1101|Topimax|töflur|100|mg|60|stk|1|ţpakki||N03AX11|01.01.2003||R|||0|0|E|0|JAS|0|0|0|100|SEK|13430|19400|lyfalmen|V0249|10327||60|0|20,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||13430||13430|19400|
172395|N03AX1101|Topimax|töflur|200|mg|60|stk|1|ţpakki||N03AX11|01.01.2003||R|||0|0|E|0|JAS|0|0|0|100|SEK|25204|34176|lyfalmen||||60|0|40,0000|Vistor hf|Janssen-Cilag AB|Tópíramat||25204||25204|34176|
172411|V08CA0101|Magnevist|stl|469|mg/ml|20|ml|5|spr|röntgenskuggaefni|V08CA01|01.04.2007||R|||0|0|0|1|BAP|0|0|0|100|SEK|65900|84587|lyfsjukr||||100|0||Icepharma hf|Bayer Schering Pharma AG|Gadópentetat||65900||65900|84587|
172482|N06DA0303|Nimvastid (Lyfis)|hylki|6|mg|112|stk|1|ţpakki||N06DA03|01.04.2011||R|||0|0|E|0|LYF|0|0|0|100|XEU|30664|30459|lyfalmen|V0346|30459||112|0|74,6700|Lyfis ehf|Lyfis ehf|Rívastigmín||22242||22242|30459|
172619|L01AB0101|Myleran|filmhtfl|2|mg|100|stk|1|glas||L01AB01|01.06.2001||R|||0|1|*|0|AUG|0|0|0|100|XEU|3567|5858|lyfalmen||||100|0||Aspen Europe GmbH|Aspen Europe GmbH|Búsúlfan||3567||3567|5858|
172627|C07FB0202|Logimax forte|forđatfl|105|mg|98|stk|1|pakki|ţp 10 + 95 mg|C07FB02|01.07.1999||R|||0|0|B|0|AZD|0|0|0|100|SEK|11758|17063|lyfalmen||||98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Metóprólól og önnur blóđţrýstingslćkkandi lyf||11758||11758|17063|
172684|N02AA0303|Palladon|forđahlk|4|mg|56|stk|1|ţpakki||N02AA03|01.09.2000||R|||1|0|E|0|NOP|0|0|0|100|DKK|6517|9894|lyfalmen||||56|0|11,2000|Icepharma hf|Norpharma |Hýdrómorphón||6517||6517|9894|
172692|N02AA0303|Palladon|forđahlk|8|mg|56|stk|1|ţpakki||N02AA03|01.09.2000||R|||1|0|E|0|NOP|0|0|0|100|DKK|12107|17739|lyfalmen||||56|0|22,4000|Icepharma hf|Norpharma |Hýdrómorphón||12107||12107|17739|
172759|N02AA0303|Palladon|forđahlk|16|mg|56|stk|1|ţpakki||N02AA03|01.09.2000||R|||1|0|E|0|NOP|0|0|0|100|DKK|21005|28906|lyfalmen||||56|0|44,8000|Icepharma hf|Norpharma |Hýdrómorphón||21005||21005|28906|
172794|M05BA0707|Risedronato Semanal Qualigen (Lyfjaver)|filmhtfl|35|mg|4|stk|1|ţpakki||M05BA07|01.05.2011||R|||0|0|0|0|LVR|0|0|0|100|IKR|830|2114|lyfalmen|V0207|1213||4|0|28,0000|Lyfjaver ehf|Lyfjaver ehf|Rísedrónsýru||830||830|2114|
172916|N02AA0303|Palladon|forđahlk|24|mg|56|stk|1|ţpakki||N02AA03|01.09.2000||R|||1|0|E|0|NOP|0|0|0|100|DKK|27393|36923|lyfalmen||||56|0|67,2000|Icepharma hf|Norpharma |Hýdrómorphón||27393||27393|36923|
173088|N05CD0202|Mogadon|töflur|5|mg|50|stk|1|ţpakki||N05CD02|01.12.1972||R|||0|0|0|0|MAB|0|0|1|100|DKK|439|1579|lyfalmen||||50|0|50,0000|Vistor hf|Meda AB|Nítrazepam||439||439|1579|
173310|N05BE0108|Buspiron Mylan|töflur|5|mg|100|stk|1|ţpakki||N05BE01|01.04.1995||R|||0|0|E|0|MYL|0|0|1|100|SEK|2914|4965|lyfalmen||||100|0|16,6667|Actavis Group PTC ehf|Mylan AB|Búspírón hýdróklóríđ||2914||2914|4965|
173344|A06AG1101|Microlax|innhl|||5|ml|12|túpa||A06AG11|01.12.1972||L|||0|0|0|0|MCN|0|0|0|100|DKK|||lyfalmen||||60|0|12,0000|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, ţ.m.t. í blöndum|||||3637|
173518|N05BE0108|Buspiron Mylan|töflur|10|mg|100|stk|1|ţpakki||N05BE01|01.04.1995||R|||0|0|E|0|MYL|0|0|1|100|SEK|6220|9488|lyfalmen||||100|0|33,3333|Actavis Group PTC ehf|Mylan AB|Búspírón hýdróklóríđ||6220||6220|9488|
173750|B03XA0201|Aranesp|stl|10|mcg/spr|0,4|ml|4|spr|áfylltar spr.međ nálarvörn|B03XA02|01.08.2011||R|||0|1|0|1|AMG|0|0|0|100|DKK|17020|23111|lyfsjukr||||2|0|8,8900|Vistor hf|Amgen|Darbepóetín alfa||16915||16915|23111|
173856|N05CF0105|Zopiklon Mylan|töflur|5|mg|30|stk|1|ţpakki||N05CF01|01.10.2001||R|||0|0|0|0|MYL|0|0|1|100|SEK|357|1467|lyfalmen||||30|0|20,0000|Actavis Group PTC ehf|Mylan AB|Zópíklón||357||357|1467|
173942|H01AC0111|Omnitrope|stl|3,3|mg/ml|1,5|ml|1|rörlyk|lausn|H01AC01|01.04.2012||R|||0|1|0|1|SDG|0|0|0|100|DKK|16252|22279|lyfsjukr||||2|0|7,5000|Artasan ehf|Sandoz GmbH (Kundl)|Sómatrópín||16252||16252|22279|
173955|N05BA0106|Stesolid Novum|stl|5|mg/ml|2|ml|10|lykjur||N05BA01|01.07.1985||R|||0|0|0|1|AGT|0|0|0|100|DKK|1410|2035|lyfsjukr||||20|0|10,0000|Actavis Group hf|Actavis Group hf|Díazepam||1410||1410|2035|
174300|J01CE0204|Kaavepenin|töflur|800|mg|14|stk|1|ţpakki||J01CE02|01.01.1989||R|||0|0|0|0|REP|0|0|1|100|SEK|682|1912|lyfalmen||||14|0|5,6000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||682||682|1912|
174359|J01CE0204|Kaavepenin|töflur|1|g|14|stk|1|ţpakki||J01CE02|01.01.1989||R|||0|0|0|0|REP|0|0|1|100|SEK|698|1934|lyfalmen||||14|0|7,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||698||698|1934|
174433|S01EA0501|Alphagan|augndr|2|mg/ml|5|ml|1|glas||S01EA05|01.04.2009||R|||0|0|*|0|ALL|0|0|0|100|SEK|1802|3444|lyfalmen|V0368|2736||5|0|25,0000|Vistor hf|Allergan|Brímónidín||1802||1802|3444|
174615|N05CF0105|Zopiklon Mylan|töflur|7,5|mg|30|stk|1|ţpakki||N05CF01|01.09.1999||R|||0|0|0|0|MYL|0|0|0|100|SEK|276|1356|lyfalmen||||30|0|30,0000|Actavis Group PTC ehf|Mylan AB|Zópíklón||||276|1356|31.05.2012
174664|S01EA0501|Alphagan|augndr|2|mg/ml|5|ml|3|glös||S01EA05|01.04.2009||R|||0|0|*|0|ALL|0|0|0|100|SEK|5284|8207|lyfalmen|V0368|8207||15|0|75,0000|Vistor hf|Allergan|Brímónidín||5284||5284|8207|
175612|J05AB1101|Valtrex|töflur|500|mg|10|stk|1|ţpakki||J05AB11|01.10.1996||R|||0|0|E|0|GSK|0|0|1|100|GBP|2683|2291|lyfalmen|V0033|2127||10|0|1,6667|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Valacíklóvír||959||959|2291|
176214|N05AH0301|Zyprexa|húđuđtfl|2,5|mg|28|stk|1|ţpakki||N05AH03|01.01.1999||R|||0|0|0|0|ELD|0|1|0|100|XEU|6775|5047|lyfalmen|V0278|1857||28|0|7,0000|Icepharma hf|Eli Lilly Nederland B.V.|Olanzapín||2974||2974|5047|
178004|H02AB0801|Kenalog|stl|40|mg/ml|1|ml|1|hgl||H02AB08|01.02.2002||R|||0|0|E|0|PCO|0|0|1|100|IKR|723|1968|lyfalmen||||1|1|5,3330|Distica|Distica - óskráđ lyf|Tríamcínólón||723||723|1968|
179157|L04AB0601|Simponi|stl|50|mg|1|spr|1|spr|áfyllt sprauta|L04AB06|01.06.2011||R|||0|1|0|1|CEO|0|0|0|100|DKK|170981|216464|lyfsjukr||||1|0|30,1200|Vistor hf|Centocor B.V.|Golimumab||170981||170981|216464|
179171|N01AH0601|Remifentanil Actavis|sts/irs|2|mg|5|hgl|1|pakki|ţykkni,lausn|N01AH06|01.02.2012|30.06.2012|R|||1|0|0|1|AGP|0|0|0|100|XEU|5479|7908|lyfsjukr||||5|0||Actavis Group hf|Actavis Group PTC ehf|Remífentaníl||5479||5479|7908|
179333|R02AA0304|Strepsils Menthol|sogtfl|||24|stk|1|ţpakki||R02AA03|01.12.2005||L|||0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa||||24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól||||||
179364|N03AX1406|Zelta|filmhtfl|500|mg|100|stk|1|ţpakki||N03AX14|01.04.2012||R|||0|0|0|0|LYF|0|0|0|100|XEU|13124|10136|lyfalmen|V0253|10136||100|0|33,3300|LYFIS ehf|LYFIS ehf|Levetíracetam||6694||6694|10136|
179552|B01AX0601 |Xarelto|filmhtfl|15|mg|28|stk|1|ţpakki||B01AX06|01.05.2012||R|||0|0|E|0|BAP|0|0|0|100|SEK|10607|15489|lyfalmen||||28|0|42,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaroxaban||||10607|15489|
180130|L01AX0303|Temomedac|hylki|250|mg|5|stk|1|glas||L01AX03|01.04.2011||R|||0|1|0|1|WIL|0|0|0|100|XEU|132989|168784|lyfsjukr||||5|0||Williams & Halls efh|medac Gesellschaft|Temozolomid||132989||132989|168784|
180166|A07EC0301|Dipentum|hylki|250|mg|100|stk|1|glas||A07EC03|01.01.1990||R|||0|0|B|0|UCB|0|0|0|100|DKK|5740|8831|lyfalmen||||100|0|25,0000|Vistor hf|U.C.B|Olsalazín||5740||5740|8831|
180539|R01AA0705|Otrivin Menthol ukonserveret|nefúđi|1|mg/ml|10|ml|1|glas|sk-úđari|R01AA07|01.05.2001||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||10|0|12,5000|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín||||||
180729|S03CA0401|Hydrocortison m.Terram.|aug.eydr|||5|ml|1|túpa|+ Polymyxin B|S03CA04|01.11.1981||R|||0|0|E|0|PER|0|0|1|100|DKK|817|2097|lyfalmen||||5|0||Icepharma hf|Pfizer ApS|Hýdrókortisón og sýkingalyf||817||817|2097|
181255|G01AF0201|Canesten|sk-krem|10|mg/g|50|g|1|sett|+stjaka|G01AF02|01.12.1982||L|||0|0|0|0|BAE|0|0|0|100|IKR|||lyflausa||||50|0|5,0000|Icepharma hf|Bayer AB|Klótrímazól||||||
181552|QJ51DA3201|Pathozone, vet.|spenalyf|250|mg/dćlu|10|ml|10|dćlur|dćla + rýja|QJ51DA32|01.10.1995||R|||0|0|0|0|PFV|0|0|0|100|DKK|8244|16002|vetalmen||||100|0||Icepharma hf|Pfizer vet.|||8244||8244|16002|
181750|L01BA0105|Methotrexate Wyeth Lederle|irţ|100|mg/ml|10|ml|1|hgl||L01BA01|01.04.1991||R|||0|1|0|1|PER|0|0|0|100|DKK|10022|14460|lyfsjukr||||10|0||Icepharma hf|Pfizer ApS|Metótrexat||10022||10022|14460|
182170|QM01AG9001|Finadyne, vet.|kyrni|25|mg/g|10|g|10|skammt||QM01AG90|01.01.1991||R|||0|0|0|0|IBV|0|0|0|100|SEK|5938|11574|vetalmen||||100|0||Vistor hf|Intervet International BV|||5938||5938|11574|
183327|QM01AG9001|Finadyne, vet.|stl|50|mg/ml|50|ml|1|hgl||QM01AG90|01.07.1992||R|||0|0|0|0|IBV|1|0|0|100|DKK|5527|10785|vetalmen||||50|0||Vistor hf|Intervet International BV|||5527||5527|10785|
183660|C01CA2407|Jext|stl|300|mcg|1|stk|1|pakki|áfylltur penni|C01CA24|01.10.2011||R|||0|0|B|0|ALK|0|0|1|100|DKK|5934|9096|lyfalmen||||1|0|0,6000|Vistor hf|ALK-Abello A/S|Adrenalín tartrat||||5934|9096|
183735|J05AE1101|Incivo|filmhtfl|375|mg|168|stk|1|pakki||J05AE11|01.03.2012||R|||0|1|0|1|JCI|0|0|0|100|SEK|1403740|1763576|lyfsjukr||||168|0||Vistor hf|Janssen-Cilag International N.V.|Telaprevír||1403740||1403740|1763576|
183871|H02AA0201|Florinef|töflur|0,1|mg|100|stk|1|glas||H02AA02|01.12.1972||R|||0|0|B|0|BRS|0|0|0|100|DKK|1218|2645|lyfalmen||||100|0|100,0000|Vistor hf|Bristol-Myers Squibb|Flúdrókortisón||1218||1218|2645|
183947|P01AB0102|Flagyl|töflur|200|mg|21|stk|1|ţpakki||P01AB01|01.10.1995||R|||0|0|0|0|SNO|0|0|1|100|NOK|862|2158|lyfalmen||||21|0|2,1000|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||862||862|2158|
184176|J01CR0201|Amoksiklav|mixtúrud|31,25|mg/ml|100|ml|1|glas|25+6.25 mg/ml|J01CR02|01.01.1996||R|||0|0|0|0|LPM|0|0|1|100|XEU|500|1663|lyfalmen||||100|0|2,5000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||500||500|1663|
184192|J01CR0201|Amoksiklav|mixtúrud|62,5|mg/ml|100|ml|1|glas|50+12.5 mg/ml|J01CR02|01.01.1996||R|||0|0|0|0|LPM|0|0|1|100|IKR|1643|2121|lyfalmen||||100|0|5,0000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||835||835|2121|
184200|J01CR0201|Amoksiklav|töflur|375|mg|15|stk|1|glas|250+125 mg|J01CR02|01.01.1996||R|||0|0|0|0|LPM|0|0|1|100|XEU|634|1846|lyfalmen||||15|0|3,7500|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||634||634|1846|
184234|A07EC0204|Asacol|innhl|10|mg/ml|100|ml|7|stk||A07EC02|01.02.2000||R|||0|0|B|0|TIL|0|0|0|100|SEK|4980|7791|lyfalmen|V0017|7486||700|0|4,6667|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||4980||4980|7791|
184259|L02BG0401|Femar|töflur|2,5|mg|30|stk|1|ţpakki||L02BG04|01.03.1998||R|||0|0|*|0|NOH|0|0|0|100|DKK|22273|30498|lyfalmen|V0170|10204||30|0|30,0000|Vistor hf|Novartis Healthcare A/S-|Letrózól||22273||22273|30498|
184275|L02BG0401|Femar|töflur|2,5|mg|100|stk|1|ţpakki||L02BG04|01.03.1998||R|||0|0|*|0|NOH|0|0|0|100|DKK|56606|73586|lyfalmen|V0185|27712||100|0|100,0000|Vistor hf|Novartis Healthcare A/S-|Letrózól||56606||56606|73586|
184341|J01CR0201|Amoksiklav|töflur|625|mg|16|stk|1|glas|500+125 mg|J01CR02|01.01.1996||R|||0|0|0|0|LPM|0|0|1|100|XEU|1206|2629|lyfalmen||||16|0|8,0000|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||1206||1206|2629|
184432|N02CC0302|Zomig Rapimelt|munnltfl|2,5|mg|6|stk|1|ţpakki||N02CC03|01.05.2001||R|||0|0|E|0|AZA|0|0|0|100|SEK|5386|8347|lyfalmen|V0235|7889||6|0|6,0000|Vistor hf|AstraZeneca AB|Zolmítriptan||5386||5386|8347|
188631|N03AG0102|Orfiril|mixtúra|60|mg/ml|250|ml|1|glas||N03AG01|01.10.1995||R|||0|0|E|0|DEA|0|0|0|100|XEU|2996|5077|lyfalmen||||250|0|10,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||2996||2996|5077|
188987|S01EC0101|Diamox|töflur|250|mg|100|stk|1|glas||S01EC01|01.12.1972||R|||0|0|*|0|GPL|0|0|0|100|USD|2121|3880|lyfalmen||||100|0|33,3333|Icepharma hf|Goldshield Pharmaceuticals Ltd|Acetazólamíđ||2121||2121|3880|
189175|V03AC0101|Desferal|irs|500|mg|10|hgl|1|pakki|lausn|V03AC01|01.04.2007||R|||0|0|0|1|NOH|0|0|0|100|DKK|7339|10592|lyfsjukr||||10|0||Vistor hf|Novartis Healthcare A/S-|Deferoxamín||7339||7339|10592|
189506|H02AB0401|Depo-Medrol|stl|40|mg/ml|5|ml|1|hgl||H02AB04|01.12.1972||R|||0|0|B|0|PER|0|0|1|100|DKK|2557|4477|lyfalmen||||5|0|10,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||2557||2557|4477|
189514|H02AB0401|Depo-Medrol|stl|40|mg/ml|2|ml|1|hgl||H02AB04|01.12.1972||R|||0|0|B|0|PER|0|0|1|100|DKK|1053|2419|lyfalmen|V0413|2419||2|0|4,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||1053||1053|2419|
189522|H02AB0401|Depo-Medrol|stl|40|mg/ml|1|ml|1|hgl||H02AB04|01.12.1972||R|||0|0|B|0|PER|0|0|1|100|DKK|509|1675|lyfalmen||||1|0|2,0000|Icepharma hf|Pfizer ApS|Metýlprednisólón||509||509|1675|
189627|L01BA0108|Methotrexate Pfizer|stl/irl|25|mg/ml|1|ml|1|hgl||L01BA01|01.11.2011||R|||0|1|0|1|PER|0|0|0|100|DKK|472|681|lyfsjukr||||1|0||Icepharma hf|Pfizer ApS|Metótrexat||472||472|681|
190702|M01AB0101|Confortid|eţ-stíll|100|mg|10|stk|1|pakki||M01AB01|01.01.2012||R|||0|0|E|0|AGT|0|0|1|100|DKK|1022|2377|lyfalmen||||10|0|10,0000|Actavis Group hf|Actavis Group hf|Indómetacín||1022||1022|2377|
191064|B05XC03|Vitalipid Infant|irţ|||10|ml|10|lykjur||B05XC|01.10.1985||R|||0|0|0|1|FRP|0|0|0|100|DKK|3959|5714|lyfsjukr||||100|0||Icepharma hf|Fresenius Kabi|Vítamín||3959||3959|5714|
191247|B05XC02|Vitalipid Adult|irţ|||10|ml|10|lykjur||B05XC|01.10.1985||R|||0|0|0|1|FRP|0|0|0|100|DKK|3771|5442|lyfsjukr||||100|0||Icepharma hf|Fresenius Kabi|Vítamín||3771||3771|5442|
191254|B05XC01|Soluvit|irs|||10|ml|10|hgl||B05XC|01.10.1985||R|||0|0|0|1|FRP|0|0|0|100|DKK|3891|5616|lyfsjukr||||100|0||Icepharma hf|Fresenius Kabi|Vítamín||3891||3891|5616|
191403|R01AA0503|Nezeril|nefúđi|0,25|mg/ml|7,5|ml|1|glas|sk-úđari|R01AA05|01.10.1994||L|||0|0|0|0|GSC|0|0|1|100|IKR|||lyflausa||||8|0|4,6875|GlaxoSmithKline ehf|GlaxoSmithKline CH AB c/o GSK CH A/S|Oxýmetazólín||||||
191916|S01AA0101|Chloromycetin|augnsm|10|mg/g|4|g|1|túpa||S01AA01|01.12.1972||R|||0|0|E|0|PER|0|0|1|100|DKK|534|1709|lyfalmen||||4|0||Icepharma hf|Pfizer ApS|Klóramfeníkól||534||534|1709|
192456|N06AX1104|Miron Smelt|munndr.t|15|mg|96|stk|1|ţpakki||N06AX11|01.12.2011||R|||0|0|B|0|AGP|0|1|0|100|XEU|3916|6336|lyfalmen||||96|0|48,0000|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||3916||3916|6336|
192617|C03AB0101|Centyl med kaliumklorid|sh-tfl|||100|stk|1|glas||C03AB01|01.12.1972||R|||0|0|E|0|LEP|0|0|0|100|DKK|1647|3232|lyfalmen||||100|0|100,0000|Vistor hf|LEO Pharma A/S|Bendróflúmetíazíđ og kalíum||1647||1647|3232|
192625|C03AB0101|Centyl med kaliumklorid|sh-tfl|||25|stk|1|glas||C03AB01|01.12.1972||R|||0|0|E|0|LEP|0|0|0|100|DKK|459|1607|lyfalmen||||25|0|25,0000|Vistor hf|LEO Pharma A/S|Bendróflúmetíazíđ og kalíum||459||459|1607|
193821|A12AA0601|Calcium-Sandoz|freyđit|500|mg|20|stk|1|glas||A12AA06|01.12.1972||L|||0|0|0|0|SAN|0|0|0|100|IKR|||lyfalmen||||20|0|7,5500|Vistor hf|Sandoz A/S|Kalsíumlaktóglúkónat|||||2233|
194209|L01BA0105|Methotrexate Wyeth Lederle|stl/irl|25|mg/ml|2|ml|1|hgl||L01BA01|01.10.1985||R|||0|1|0|1|PER|0|0|0|100|DKK|1091|1575|lyfsjukr||||2|0||Icepharma hf|Pfizer ApS|Metótrexat||1091||1091|1575|
195040|C07AB0311|Atenolol Mylan|töflur|25|mg|250|stk|1|glas||C07AB03|01.07.2009||R|||0|0|B|0|MYL|0|0|0|100|SEK|1855|3516|lyfalmen||||250|0|83,3300|Actavis Group PTC ehf|Mylan AB|Atenólól||1855||1855|3516|
195149|B03BA0201|Betolvex|stl|1|mg/ml|1|ml|5|lykjur||B03BA02|01.11.1981||R|||0|0|E|0|AGT|0|0|1|100|DKK|2532|4443|lyfalmen||||5|0|250,0000|Actavis Group hf|Actavis Group hf|Cýanókóbalamíntannín-komplex||2532||2532|4443|
195156|B03BA0201|Betolvex|stl|1|mg/ml|1|ml|1|lykja||B03BA02|01.12.1972||R|||0|0|E|0|AGT|0|0|1|100|DKK|805|2080|lyfalmen||||1|0|50,0000|Actavis Group hf|Actavis Group hf|Cýanókóbalamíntannín-komplex||805||805|2080|
195472|A02BC0507|Esomeprazole Portfarma|sţ-tfl|40|mg|98|stk|1|ţpakki||A02BC05|01.11.2011||R|||0|0|E|0|POF|0|0|0|100|XEU|14001|5660|lyfalmen|V0012|5497||98|0|130,6700|Portfarma ehf|Portfarma|Esómeprazól||3422||3422|5660|
195583|H01AC0104|Saizen|sts|8|mg/ml|2,5|ml|1|rörlyk||H01AC01|01.05.2011||R|||0|1|0|1|EMA|0|0|0|100|SEK|89783|114560|lyfsjukr||||2|0|30,0000|Icepharma hf|E. Merck AB|Sómatrópín||89783||89783|114560|
195587|L04AB0601|Simponi|stl|50|mg|1|áf-penni|1|penni|áfylltur penni|L04AB06|01.06.2011||R|||0|1|0|1|CEO|0|0|0|100|DKK|170981|216464|lyfsjukr||||1|0|30,1200|Vistor hf|Centocor B.V.|Golimumab||170981||170981|216464|
195669|D01AC2002|Pevisone|krem|||15|g|1|túpa||D01AC20|01.10.1988||R|||0|0|0|0|JAS|0|0|1|100|SEK|764|2024|lyfalmen||||15|0||Vistor hf|Janssen-Cilag AB|Blöndur||764||764|2024|
195768|R01BA0101|Rinexin|forđatfl|50|mg|30|stk|1|ţpakki||R01BA01|01.03.1981||R|||0|0|E|0|REP|0|0|1|100|SEK|391|1514|lyfalmen||||30|0|15,0000|Vistor hf|Recip AB|Fenýlprópanólamín||391||391|1514|
195776|R01BA0101|Rinexin|forđatfl|50|mg|100|stk|1|glas||R01BA01|01.03.1981||R|||0|0|E|0|REP|0|0|1|100|SEK|829|2113|lyfalmen||||100|0|50,0000|Vistor hf|Recip AB|Fenýlprópanólamín||829||829|2113|
196022|C07AB0311|Atenolol Mylan|töflur|50|mg|250|stk|1|glas||C07AB03|01.07.2009||R|||0|0|B|0|MYL|0|0|0|100|SEK|2370|4221|lyfalmen||||250|0|166,6700|Actavis Group PTC ehf|Mylan AB|Atenólól||2370||2370|4221|
196121|G03AB0302|Triquilar|töflur|80|mcg|63|stk|1|pakki|ţp, 50+30 míkróg etc.|G03AB03|01.01.1985||R|||0|0|0|0|BAP|0|0|0|100|SEK|1476|2998|lyfalmen||||63|0|84,0000|Icepharma hf|Bayer Schering Pharma AG|Levónorgestrel og östrógen||1476||1476|2998|
196327|N07BA0145|Nicorette Freshdrops|munnstfl|2|mg|24|stk|1|ţpakki||N07BA01|01.12.2010||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||24|0|1,6000|Vistor hf|McNeil Denmark ApS|Nikótín||||||
196551|N02BE0114|Pinex|mixtúra|24|mg/ml|100|ml|1|fl||N02BE01|01.07.2012||L|||0|0|0|0|APC|0|0|1|100|IKR|||lyflausa||||100|0|0,8000|Actavis Group PTC ehf|Actavis Group PTC ehf|Paracetamól||||||
196851|C07AG0101|Trandate|stl|5|mg/ml|20|ml|5|lykjur||C07AG01|01.05.2012||R|||0|0|B|0|AUG|0|0|0|100|GBP|6218|9485|lyfalmen||||100|0|0,8333|Aspen Europe GmbH|Aspen Europe GmbH|Labetalól||6218||6218|9485|
196913|B03XA0201|Aranesp|stl|20|mcg/spr|0,5|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|||0|1|0|1|AMG|0|0|0|100|DKK|27234|36061|lyfsjukr||||2|0|17,7800|Vistor hf|Amgen|Darbepóetín alfa||||27234|36061|
197103|QH01CA9001|Receptal, vet.|stl|4|mcg/ml|10|ml|1|hgl||QH01CA90|01.07.1998||R|||0|0|0|0|INI|1|0|0|100|DKK|2620|5203|vetalmen||||10|0||Icepharma hf|Intervet International B.V.|||2620||2620|5203|
197657|N05BA1203|Tafil|töflur|1|mg|20|stk|1|ţpakki||N05BA12|01.10.1990||R|||0|0|0|0|PER|0|0|1|100|DKK|872|2172|lyfalmen||||20|0|20,0000|Icepharma hf|Pfizer ApS|Alprazólam||872||872|2172|
197673|N05BA1203|Tafil|töflur|1|mg|100|stk|1|ţpakki||N05BA12|01.10.1990||R|||0|0|0|0|PER|0|0|0|100|DKK|2856|4886|lyfalmen||||100|0|100,0000|Icepharma hf|Pfizer ApS|Alprazólam||2856||2856|4886|
197848|N01BB0203|Xylocain|hlaup|20|mg/ml|10|g|10|plspr||N01BB02|01.10.2003||R|||0|0|0|0|AZD|0|0|1|100|SEK|2193|3979|lyfalmen||||100|0||Vistor hf|AstraZeneca A/S DK|Lídókaín||2193||2193|3979|
198580|L01AA0301|Alkeran|töflur|2|mg|25|stk|1|glas||L01AA03|01.06.2001||R|||0|1|*|0|AUG|0|0|0|100|XEU|2155|3927|lyfalmen||||25|0||Aspen Europe GmbH|Aspen Europe GmbH|Melphalan||2155||2155|3927|
198648|L01BC0203|Flurablastin|stl|50|mg/ml|20|ml|10|hgl||L01BC02|01.04.1991||R|||0|1|0|1|PER|0|0|0|100|DKK|7309|10549|lyfsjukr||||200|0||Icepharma hf|Pfizer ApS|Flúóróúracíl||7309||7309|10549|
198861|N04AA0201|Akineton|stl|5|mg/ml|1|ml|5|lykjur||N04AA02|01.12.1975||R|||0|0|0|1|LFS|0|1|0|100|DKK|415|599|lyfsjukr||||5|0|2,5000|Vistor hf|Laboratorio Farmaceutico (S.I.T.)|Bíperíden||415||415|599|
199091|L01XX1101|Estracyt|hylki|140|mg|100|stk|1|glas||L01XX11|01.12.1978||R|||0|0|*|0|PER|0|0|0|100|DKK|36732|48644|lyfalmen||||100|0||Icepharma hf|Pfizer ApS|Estramústín||36732||36732|48644|
199272|N03AX1404|Levetiracetam Actavis|filmhtfl|250|mg|100|stk|1|ţpakki||N03AX14|01.12.2011||R|||0|0|0|0|APC|0|0|0|100|XEU|8660|7783|lyfalmen|V0515|6626||100|0|16,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Levetíracetam||4974||4974|7783|
199539|N05CD0503|Halcion|töflur|0,25|mg|30|stk|1|ţpakki||N05CD05|01.11.1981||R|||0|0|0|0|PER|0|0|1|100|DKK|644|1860|lyfalmen||||30|0|30,0000|Icepharma hf|Pfizer ApS|Tríazólam||644||644|1860|
199584|A02BC0508|Esomeprazol Actavis|sţ-hylki|20|mg|98|stk|1|glas|hart|A02BC05|01.03.2012||R|||0|0|E|0|APC|0|0|0|100|XEU|8288|5497|lyfalmen|V0011|5497||98|0|65,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Esómeprazól||3303||3303|5497|
199692|B03XA0201|Aranesp|stl|300|mcg/spr|0,6|ml|1|áf.spr|nálavörn|B03XA02|01.11.2010||R|||0|1|0|1|AMG|0|0|0|100|DKK|95925|122268|lyfsjukr||||1|0|66,6700|Vistor hf|Amgen|Darbepóetín alfa||||95925|122268|
199737|G02CB0301|Dostinex|töflur|0,5|mg|8|stk|1|glas||G02CB03|01.07.1993||R|||0|0|E|0|PER|0|0|0|100|DKK|4756|7485|lyfalmen|V0126|7485||8|0|8,0000|Icepharma hf|Pfizer ApS|Kabególín||4756||4756|7485|
199836|B01AC1301|ReoPro|stl|2|mg/ml|5|ml|1|hgl||B01AC13|01.09.1997||R|||0|0|0|1|JAB|0|0|0|100|XEU|57198|73666|lyfsjukr||||5|0|0,4000|Janssen Biologics B.V.|Janssen Biologics B.V.|Abciximab||57198||57198|73666|
199940|L01XC1101|Yervoy|stţ|5|mg/ml|40|ml|1|hgl|lausn|L01XC11|01.05.2012||R|||0|1|0|1|BMS|0|0|0|100|DKK|2786661|3499142|lyfsjukr||||40|0||Vistor hf|Bristol-Myers Squibb Pharma EEIG|Ipilimumab||2786661||2786661|3499142|
300373|A05AA0201|Destolit|töflur|150|mg|60|stk|1|glas||A05AA02|01.01.1998||R|||0|0|E|0|PCO|0|0|0|100|GBP|5661|8542|lyfalmen||||60|1|12,0000|Distica|Distica - óskráđ lyf|Úrsódeoxýkól sýra||5529||5529|8542|
370007|B02BA0102|Konakion Novum|stl|10|mg/ml|0,2|ml|5|lykjur||B02BA01|01.10.1995||R|||0|0|0|1|ROC|0|0|0|100|DKK|687|992|lyfsjukr||||1|0|0,5000|Icepharma hf|Roche|Fýtómenadíón||687||687|992|
370173|QH01CA9301|Suprelorin|vefjalyf|9,4|mg|2|stk|1|pakki|fyrir hunda|QH01CA93|01.05.2012||R|||0|0|0|0|VIR|1|0|0|100|DKK|31566|60784|vetalmen||||2|0||Vistor hf|Virbac S.A|Deslorelín||31566||31566|60784|
370434|A02BC0508|Esomeprazol Actavis|sţ-hylki|40|mg|98|stk|1|glas|hart|A02BC05|01.03.2012||R|||0|0|E|0|APC|0|0|0|100|XEU|12508|5497|lyfalmen|V0012|5497||98|0|130,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Esómeprazól||3303||3303|5497|
370940|J01DB0401|Kefzol|sts|1|g|1|stk|1|hgl||J01DB04|01.07.1995||R|||0|0|0|1|NOM|0|0|0|100|DKK|598|863|lyfsjukr||||1|0|0,3333|Icepharma hf|NordMedica ApS|Cefazólín||598||598|863|
371583|A06AG1001|Klyx|innhl|||240|ml|1|fl||A06AG10|01.12.1978||L|||0|0|0|0|FEL|0|0|0|100|IKR|||lyflausa||||240|0|1,0000|Vistor hf|Ferring Lćgemidler A/S|Dókúsatnatríum, ţ.m.t. í blöndum||||||
371609|A06AG1001|Klyx|innhl|||120|ml|1|fl||A06AG10|01.12.1978||L|||0|0|0|0|FEL|0|0|0|100|IKR|||lyflausa||||120|0|1,0000|Vistor hf|Ferring Lćgemidler A/S|Dókúsatnatríum, ţ.m.t. í blöndum||||||
371617|A06AG1001|Klyx|innhl|||120|ml|10|fl||A06AG10|01.12.1978||L|||0|0|0|0|FEL|0|0|0|100|SEK|||lyfalmen||||1200|0|10,0000|Vistor hf|Ferring Lćgemidler A/S|Dókúsatnatríum, ţ.m.t. í blöndum|||||10035|
371658|A02BA0201|Asyran|töflur|150|mg|10|stk|1|ţpakki||A02BA02|01.10.1995||L|||0|0|0|0|ACA|0|0|0|100|IKR|||lyflausa||||10|0|5,0000|Actavis Group hf|Actavis hf|Ranitidín||||||
372045|N05AL0501|Solian|töflur|50|mg|90|stk|1|ţpakki||N05AL05|01.01.2005||R|||0|0|0|0|SNO|0|1|0|100|NOK|6571|9968|lyfalmen||||90|0|11,2500|Vistor hf|Sanofi-aventis Norge AS|Amísúlpríđ||6571||6571|9968|
372151|N04BA0209|Madopar Quick "125"|lausnart|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.11.2000||R|||0|0|E|0|ROC|0|0|0|100|DKK|3726|6076|lyfalmen||||100|0|16,6667|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||3726||3726|6076|
372177|N07BA0103|Nicorette|innsogsl|10|mg|42|rör|1|pakki|ţp+munnstk|N07BA01|01.09.1977||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||42|0|7,0000|Vistor hf|McNeil Denmark ApS|Nikótín||||||
372185|N07BA0103|Nicorette|innsogsl|10|mg|18|rör|1|pakki|ţp+munnstk|N07BA01|01.09.1977||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||18|0|3,0000|Vistor hf|McNeil Denmark ApS|Nikótín||||||
373001|G03AB0501|Gracial|töflur|||66|stk|1|pakki|ţp 3 x (15+7 stk)|G03AB05|01.07.1998||R|||0|0|0|0|ORG|0|0|0|100|DKK|2555|4474|lyfalmen||||66|0|66,0000|Vistor hf|N.V. Organon|Desógestrel og östrógen||2555||2555|4474|
373241|N05AL0501|Solian|töflur|200|mg|90|stk|1|ţpakki||N05AL05|01.01.2005||R|||0|0|0|0|SNO|0|1|0|100|NOK|19767|27353|lyfalmen||||90|0|45,0000|Vistor hf|Sanofi-aventis Norge AS|Amísúlpríđ||19767||19767|27353|
373324|R03AK0602|Seretide Diskus|innúđadu|150|mcg/sk|60|sk|1|pakki|50+100 mcg, discus|R03AK06|01.05.2000||R|||0|0|B|0|GSK|0|0|0|100|GBP|4337|6912|lyfalmen||||60|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||4337||4337|6912|
373340|R03AK0602|Seretide Diskus|innúđadu|300|mcg/sk|60|sk|1|pakki|50+250 mcg, discus|R03AK06|01.05.2000||R|||0|0|0|0|GSK|0|0|0|100|GBP|7163|10778|lyfalmen|V0436|10776||60|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||7163||7163|10778|
373365|R03AK0602|Seretide Diskus|innúđadu|550|mcg/sk|60|sk|1|pakki|50+500 mcg, discus|R03AK06|01.05.2000||R|||0|0|0|0|GSK|0|0|0|100|GBP|9888|14505|lyfalmen|V0437|14505||60|0|30,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||9888||9888|14505|
373853|L02BB0307|Bicalutamid Medical|filmhtfl|50|mg|30|stk|1|ţpakki||L02BB03|01.06.2012||R|||0|0|*|0|MED|0|0|0|100|XEU|7563|10256|lyfalmen|V0420|10122||30|0|30,0000|Medical ehf|Medical ehf|Bíkalútamíđ||6782||6782|10256|
373951|G02CB0301|Dostinex|töflur|0,5|mg|2|stk|1|glas||G02CB03|01.04.1998||R|||0|0|E|0|PER|0|0|0|100|DKK|1610|3181|lyfalmen|V0126|1871||2|0|2,0000|Icepharma hf|Pfizer ApS|Kabególín||1610||1610|3181|
374143|L01XE1201|Caprelsa|filmhtfl|100|mg|30|stk|1|ţpakki||L01XE12|01.07.2012||R|||0|1|0|1|AZA|0|0|0|100|SEK|392838|494894|lyfsjukr||||30|0||Vistor hf|AstraZeneca AB|Vandetaníb||392838||392838|494894|
374231|A10BA0201|Glucophage|töflur|500|mg|100|stk|1|ţpakki||A10BA02|01.01.1987||R|||0|0|*|0|MCK|0|0|0|100|SEK|690|1923|lyfalmen|V0500|1671||100|0|25,0000|Icepharma hf|Merck Santé s.a.s.|Metformín||690||690|1923|
374251|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|250|ml|30|pokar|Freeflex umbúđir|B05BA03|01.12.2011||R|||0|0|0|1|FRP|0|0|0|100|DKK|5841|8430|lyfsjukr||||7500|0||Icepharma hf|Fresenius Kabi|Kolvetni||5841||5841|8430|
374348|G04CA0201|Omnic|forđahlk|0,4|mg|30|stk|1|ţpakki||G04CA02|01.08.1998||R|||0|0|E|0|ASP|0|0|0|100|XEU|4676|7375|lyfalmen||||30|0|30,0000|Vistor hf|Astellas Pharma A/S|Tamsúlósín||4676||4676|7375|
374397|J05AB1101|Valtrex|töflur|250|mg|60|stk|1|ţpakki||J05AB11|01.01.2003||R|||0|0|E|0|GSK|0|0|1|100|GBP|12096|17726|lyfalmen||||60|0|5,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Valacíklóvír||12096||12096|17726|
374504|G01AF0502|Pevaryl Depot|krem/sti|||15|g|1|sett|kr.+1sk-stíll m.forđaverkun|G01AF05|01.01.1997||L|||0|0|0|0|MCS|0|0|0|100|IKR|||lyflausa||||15|0|1,5000|Vistor hf|McNeil Sweden AB|Ekónazól||||||
374587|B01AB0501|Klexane|stl|100|mg/ml|0,6|ml|10|lykjur|einnota dćla|B01AB05|01.01.1993||R|||0|0|E|0|SNO|0|0|1|100|NOK|9322|13731|lyfalmen||||6|0|30,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||9322||9322|13731|
374595|B01AB0501|Klexane|stl|100|mg/ml|0,8|ml|10|lykjur|einnota dćla|B01AB05|01.01.1993||R|||0|0|E|0|SNO|0|0|1|100|NOK|11063|16113|lyfalmen||||8|0|40,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||11063||11063|16113|
374603|B01AB0501|Klexane|stl|100|mg/ml|1|ml|10|lykjur|einnota dćla|B01AB05|01.01.1993||R|||0|0|E|0|SNO|0|0|1|100|NOK|12925|18766|lyfalmen||||10|0|50,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||12925||12925|18766|
376246|B01AC2401|Brilique|filmhtfl|90|mg|168|stk|1|ţpakki||B01AC24|01.06.2011||R|||0|0|E|0|AZA|0|0|0|100|SEK|31327|41861|lyfalmen|V0459|41861||168|0|84,0000|Vistor hf|AstraZeneca AB|Ticagrelor||31327||31327|41861|
376509|L04AD0202|Prograf|hylki|1|mg|50|stk|1|ţpakki||L04AD02|01.06.2010||R|||0|1|*|0|ASP|0|0|0|100|XEU|20666|28481|lyfalmen||||50|0|10,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||20666||20666|28481|
376533|L04AD0202|Prograf|hylki|5|mg|50|stk|1|ţpakki||L04AD02|01.06.2010||R|||0|1|*|0|ASP|0|0|0|100|XEU|94698|121391|lyfalmen||||50|0|50,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||94698||94698|121391|
377242|J01FA0901|Klacid|töflur|500|mg|14|stk|1|ţpakki||J01FA09|01.04.1992||R|||0|0|0|0|ABS|0|0|1|100|DKK|4368|6954|lyfalmen||||14|0|14,0000|Vistor hf|Abbott Scandinavia AB|Klaritrómýcín||4368||4368|6954|
377333|J05AB1101|Valtrex|töflur|500|mg|42|stk|1|ţpakki||J05AB11|01.10.1996||R|||0|0|E|0|GSK|0|0|1|100|GBP|11715|9353|lyfalmen|V0182|9254||42|0|7,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Valacíklóvír||6122||6122|9353|
379570|L04AB0101|Enbrel|stl|50|mg|4|pennar|1|pakki|lausn|L04AB01|01.03.2012||R|||0|1|0|1|IPI|0|0|0|100|DKK|150895|191256|lyfsjukr||||4|0|28,5800|Icepharma hf|Pfizer Limited|Etanercept||150895||150895|191256|
379669|H01CB0202|Sandostatin Lar|sts|10|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|||0|1|0|1|NOH|0|0|0|100|DKK|117161|148920|lyfsjukr||||2|0|14,2900|Vistor hf|Novartis Healthcare A/S-|Oktreótíđ||117161||117161|148920|
379677|H01CB0202|Sandostatin Lar|sts|20|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|||0|1|0|1|NOH|0|0|0|100|DKK|165072|209048|lyfsjukr||||2|0|28,5700|Vistor hf|Novartis Healthcare A/S-|Oktreótíđ||165072||165072|209048|
379685|H01CB0202|Sandostatin Lar|sts|30|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|||0|1|0|1|NOH|0|0|0|100|DKK|209001|264179|lyfsjukr||||2|0|42,8600|Vistor hf|Novartis Healthcare A/S-|Oktreótíđ||209001||209001|264179|
379875|N05BA0105|Stesolid|innhl|5|mg/2.5ml|2,5|ml|5|túpa||N05BA01|01.10.1995||R|||0|0|0|0|AGT|0|0|1|100|DKK|1538|3083|lyfalmen||||12|0|2,5000|Actavis Group hf|Actavis Group hf|Díazepam||1538||1538|3083|
379883|N05BA0105|Stesolid|innhl|10|mg/2.5ml|2,5|ml|5|túpa||N05BA01|01.10.1995||R|||0|0|0|0|AGT|0|0|1|100|DKK|1901|3579|lyfalmen||||12|0|5,0000|Actavis Group hf|Actavis Group hf|Díazepam||1901||1901|3579|
380276|N03AX1406|Zelta|filmhtfl|250|mg|100|stk|1|ţpakki||N03AX14|01.04.2012||R|||0|0|0|0|LYF|0|0|0|100|XEU|8518|6626|lyfalmen|V0515|6626||100|0|16,6700|LYFIS ehf|LYFIS ehf|Levetíracetam||4128||4128|6626|
381005|N07BA0146|Nicotinell Tropical Fruit|tyggigúm|2|mg|204|stk|1|ţpakki||N07BA01|01.11.2011||L|||0|0|0|0|NOS|0|0|1|100|IKR|||lyflausa||||204|0|13,6000|Artasan ehf|Novartis Healthcare A/S|Nikótín||||||
381194|A10AD0401|Humalog Mix25 100 E/ml Pen|stl|100|ae/ml|3|ml|5|pennar||A10AD04|01.09.1999||R|||0|0|*|0|ELD|0|0|0|100|XEU|5692|8765|lyfalmen||||15|0|37,5000|Icepharma hf|Eli Lilly Nederland B.V.|Insulín lispro||5692||5692|8765|
381505|G04BE0305|Vizarsin (Lyfis)|filmhtfl|50|mg|12|stk|1|pakki||G04BE03|01.08.2010||R|||0|0|0|0|LYF|0|0|0|100|XEU|7746|7570|lyfalmen|V0143|7570||12|0|12,0000|Lyfis ehf|Lyfis ehf|Síldenafíl||4818||4818|7570|
383000|R03CC1201|Bambec|töflur|10|mg|100|stk|1|glas||R03CC12|01.10.1991||R|||0|0|B|0|AZD|0|0|0|100|SEK|7053|10627|lyfalmen||||100|0|50,0000|Vistor hf|AstraZeneca A/S DK|Bambúteról||7053||7053|10627|
383117|QP52AA5103|Drontal Vet.|töflur|250|mg|2|stk|1|ţpakki|230+20 mg|QP52AA51|01.06.2000||L|||0|0|0|0|BAN|0|0|0|100|DKK|1311|2287|vetorma||||2|0||Icepharma hf|Bayer Animal Health GmbH|||||1311|2287|
383133|QP52AA5103|Drontal Vet.|töflur|250|mg|20|stk|1|ţpakki|230+20 mg|QP52AA51|01.06.2000||R|||0|0|0|0|BAN|0|0|0|100|DKK|7896|13774|vetorma||||20|0||Icepharma hf|Bayer Animal Health GmbH|||7896||7896|13774|
383257|D01AC0802|Dermatin|sápa|20|mg/ml|60|ml|1|glas||D01AC08|01.07.1998||L|||0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa||||60|0||Actavis Group hf|Actavis hf|Ketókónazól||||||
383265|D01AC0802|Dermatin|sápa|20|mg/ml|120|ml|1|glas||D01AC08|01.07.1998||L|||0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa||||120|0||Actavis Group hf|Actavis hf|Ketókónazól||||||
386278|G04BE0305|Vizarsin (Lyfis)|filmhtfl|100|mg|8|stk|1|pakki||G04BE03|01.02.2011||R|||0|0|0|0|LYF|0|0|0|100|XEU|6264|6125|lyfalmen|V0144|6125||8|0|16,0000|Lyfis ehf|Lyfis ehf|Síldenafíl||3762||3762|6125|
386953|L02BG0301|Arimidex|filmhtfl|1|mg|98|stk|1|ţpakki||L02BG03|01.03.1998||R|||0|0|*|0|AZA|0|0|0|100|SEK|58236|75631|lyfalmen|V0184|18706||98|0|98,0000|Vistor hf|AstraZeneca AB|Anastrózól||58236||58236|75631|
387662|QA12CC0202|Magnesiumsulfat Icepharma vet.|stl|200|mg/ml|100|ml|1|plhgl||QA12CC02|01.07.1996||R|||0|0|0|0|ICE|0|0|0|100|XEU|744|1480|vetalmen||||100|0||Icepharma hf|Icepharma hf|||744||744|1480|
387746|J02AA0101|Abelcet|irţ|5|mg/ml|20|ml|10|hgl|+ síunálar|J02AA01|01.04.1996||R|||0|0|0|1|CEP|0|0|0|100|DKK|204865|258988|lyfsjukr||||200|0|28,5714|Icepharma hf|Cephalon France (I)|Amfóterícín||204865||204865|258988|
388256|N01BB2001|Emla|krem|||5|g|5|túpa|+12 umbúđ.|N01BB20|01.01.1987||R|||0|0|0|0|AZD|0|0|1|100|SEK|3353|5566|lyfalmen||||25|0||Vistor hf|AstraZeneca A/S DK|Blöndur||3353||3353|5566|
388264|N01BB2001|Emla|krem|||30|g|1|túpa||N01BB20|01.01.1987||R|||0|0|0|0|AZD|0|0|1|100|SEK|4226|6760|lyfalmen||||30|0||Vistor hf|AstraZeneca A/S DK|Blöndur||4226||4226|6760|
388272|N01BB2001|Emla|plástur|||2|stk|1|pakki||N01BB20|01.04.1994||L|||0|0|0|0|AZD|0|0|1|100|IKR|||lyflausa||||2|0||Vistor hf|AstraZeneca A/S DK|Blöndur||||||
388280|N01BB2001|Emla|plástur|||20|stk|1|pakki||N01BB20|01.04.1994||R|||0|0|0|0|AZD|0|0|1|100|SEK|8200|12196|lyfalmen||||20|0||Vistor hf|AstraZeneca A/S DK|Blöndur||8200||8200|12196|
388482|A02BC0402|Rabeprazol Actavis|sh-tfl|10|mg|28|stk|1|ţpakki||A02BC04|01.06.2011||R|||0|0|E|0|APC|0|0|0|100|XEU|816|1584|lyfalmen|V0466|1584||28|0|14,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||442||442|1584|
389106|G03FA0103|Femanor|töflur|||84|stk|1|pakki|ţp 2+1 mg |G03FA01|01.08.1998||R|||0|0|E|0|BIP|0|0|0|100|DKK|2426|4298|lyfalmen|V0410|4298||84|0|84,0000|Vistor hf|BioPhausia AB|Noretísterón og östrógen||2426||2426|4298|
389122|G03FB0503|Femasekvens|töflur|||84|stk|1|pakki|ţp samsett pk. |G03FB05|01.08.1998||R|||0|0|E|0|BIP|0|0|0|100|DKK|2216|4010|lyfalmen||||84|0|84,0000|Vistor hf|BioPhausia AB|Noretísterón og östrógen||2216||2216|4010|
389155|G03CA0312|Femanest|töflur|2|mg|84|stk|1|ţpakki||G03CA03|01.05.1997||R|||0|0|E|0|BIP|0|0|0|100|DKK|703|1941|lyfalmen|V0128|1941||84|0|84,0000|Vistor hf|BioPhausia AB|Estradíól||703||703|1941|
389171|G03CA0312|Femanest|töflur|1|mg|84|stk|1|ţpakki||G03CA03|01.05.1997||R|||0|0|E|0|BIP|0|0|0|100|DKK|651|1869|lyfalmen||||84|0|42,0000|Vistor hf|BioPhausia AB|Estradíól||651||651|1869|
389395|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|10|sk-hyl|einnota hylki|S01BC03|01.04.1996||R|||0|0|E|0|NOH|0|0|1|100|DKK|991|2335|lyfalmen|V0367|1352||3|0||Vistor hf|Novartis Healthcare A/S-|Díklófenak||991||991|2335|
389414|G04BE0305|Vizarsin (Lyfis)|filmhtfl|50|mg|4|stk|1|pakki||G04BE03|01.08.2010||R|||0|0|0|0|LYF|0|0|0|100|XEU|2740|3649|lyfalmen|V0143|2523||4|0|4,0000|Lyfis ehf|Lyfis ehf|Síldenafíl||1952||1952|3649|
389443|N04BC0504|Oprymea (Lyfis)|töflur|0,18|mg|100|stk|1|ţpakki||N04BC05|01.07.2010||R|||0|0|E|0|LYF|0|0|0|100|XEU|5315|2863|lyfalmen|V0267|2863||100|0|7,2000|Lyfis ehf|Lyfis ehf|Pramipexól||1377||1377|2863|
389637|G03GA0502|Gonal-f|stl|900|ae/penna|1,5|ml|1|penni|áfylltur penni (66 mcg)|G03GA05|01.01.2012||R|||0|1|E|0|MSE|0|0|0|100|SEK|58781|76315|lyfalmen||||2|0|12,0000|Icepharma hf|Merck Serono Europe Ltd|Follitrópín alfa||58781||58781|76315|
389944|L04AD0201|Advagraf|forđahlk|1|mg|50|stk|1|ţpakki||L04AD02|01.03.2012||R|||0|1|*|0|APE|0|0|0|100|XEU|19049|26452|lyfalmen||||50|0|10,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||19049||19049|26452|
390699|N05CM1801|Dexdor|irţ|100|mcg/ml|2|ml|25|lykjur|lausn|N05CM18|01.03.2012||R|||0|1|0|1|ORC|0|0|0|100|DKK|83915|107196|lyfsjukr||||50|0||Vistor hf|Orion Corporation|Dexmedetómid||83915||83915|107196|
390757|A07AA0201|Mycostatin|mixtúra|100000|ae/ml|100|ml|1|glas||A07AA02|01.04.1974||R|||0|0|E|0|BRS|0|0|1|100|DKK|2988|5066|lyfalmen||||100|0|6,6667|Vistor hf|Bristol-Myers Squibb|Nýstatín||2988||2988|5066|
390971|M01AH0101|Celebra|hylki|100|mg|100|stk|1|ţpakki||M01AH01|01.07.2002||R|||0|0|E|0|PER|0|0|1|100|DKK|7160|10773|lyfalmen||||100|0|50,0000|Icepharma hf|Pfizer ApS|Celekoxíb||7160||7160|10773|
390997|M01AH0101|Celebra|hylki|200|mg|20|stk|1|ţpakki||M01AH01|01.07.2002||R|||0|0|E|0|PER|0|0|1|100|DKK|2828|4847|lyfalmen|V0037|4847||20|0|20,0000|Icepharma hf|Pfizer ApS|Celekoxíb||2828||2828|4847|
391010|G03GA0502|Gonal-f|stl|450|ae/penna|0,75|ml|1|penni|áfylltur penni (33 mcg)|G03GA05|01.01.2012||R|||0|1|E|0|MSE|0|0|0|100|SEK|30566|40905|lyfalmen||||1|0|6,0000|Icepharma hf|Merck Serono Europe Ltd|Follitrópín alfa||30566||30566|40905|
391268|M01AH0101|Celebra|hylki|200|mg|100|stk|1|ţpakki||M01AH01|01.07.2002||R|||0|0|E|0|PER|0|0|1|100|DKK|13799|19863|lyfalmen|V0196|19862||100|0|100,0000|Icepharma hf|Pfizer ApS|Celekoxíb||13799||13799|19863|
391730|N01BB0203|Xylocain|úđalyf|100|mg/ml|50|ml|1|glas|+ sk-úđari|N01BB02|01.10.1990||R|||0|0|0|0|AZD|0|0|1|100|SEK|2700|4672|lyfalmen||||50|0||Vistor hf|AstraZeneca A/S DK|Lídókaín||2700||2700|4672|
392225|V08CA0301|Omniscan|stl|0,5|mmol/ml|50|ml|10|plastf|röntgenskuggaefni fyrir MRT|V08CA03|01.12.2010||R|||0|0|0|1|GEH|0|0|0|100|NOK|247479|312469|lyfsjukr||||500|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||247479||247479|312469|
392563|A04AA0103|Zofran|mixtúra|0,8|mg/ml|50|ml|1|fl||A04AA01|01.08.2009||R|||0|0|E|0|PCO|0|0|0|100|IKR|12000|17605|lyfalmen||||50|1|2,5000|Distica|Distica - óskráđ lyf|Ondansetrón||||12000|17605|
393918|QJ51CF0204|Orbenin vet.|spenalyf|500|mg/dćlu|1|stk|24|spr||QJ51CF02|01.09.1983||R|||0|0|0|0|PAL|0|0|0|100|DKK|5750|11213|vetalmen||||24|0||Icepharma hf|Pfizer Oy Animal Health|||5750||5750|11213|
393934|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|204|stk|1|ţpakki||N07BA01|01.06.1998||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
393942|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|204|stk|1|ţpakki||N07BA01|01.06.1998||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||204|0|27,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
393959|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|204|stk|1|ţpakki||N07BA01|01.06.1998||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||204|0|13,6000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
394010|N06AB1005|Escitalopram LYFIS|filmhtfl|20|mg|100|stk|1|ţpakki||N06AB10|01.02.2012||R|||0|0|B|0|LYF|0|1|0|100|XEU|4829|5399|lyfalmen|V0327|5399||100|0|200,0000|LYFIS ehf|LYFIS ehf|Escítalópram||3231||3231|5399|
394262|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|204|stk|1|ţpakki||N07BA01|01.06.1998||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||204|0|27,2000|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||||
395522|B03XA0201|Aranesp|stl|500|mcg/spr|1|ml|1|spr|áfyllt spr.međ nálarvörn|B03XA02|01.08.2011||R|||0|1|0|1|AMG|0|0|0|100|DKK|152131|191616|lyfsjukr||||1|0|111,1100|Vistor hf|Amgen|Darbepóetín alfa||151182||151182|191616|
395886|R03AK0704|Symbicort Turbuhaler (Lyfjaver)|innúđadu|164,5|mcg/sk|360|sk|1|pakki|160+4,5 mcg/sk|R03AK07|01.05.2011||R|||0|0|0|0|LVR|0|0|0|100|SEK|28251|37499|lyfalmen|V0356|37499||360|0|90,0000|Lyfjaver ehf|Lyfjaver ehf|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||27852||27852|37499|
395954|V08CA0101|Magnevist|stl|469|mg/ml|30|ml|10|hgl|röntgenskuggaefni|V08CA01|01.04.2007||R|||0|0|0|1|BAP|0|0|0|100|SEK|171913|217633|lyfsjukr||||300|0||Icepharma hf|Bayer Schering Pharma AG|Gadópentetat||171913||171913|217633|
396318|R06AX2201|Kestine|filmhtfl|10|mg|100|stk|1|ţpakki||R06AX22|01.06.2012||R|||0|0|E|0|APS|0|0|1|100|DKK|4144|6648|lyfalmen||||100|0|100,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín||4144||4144|6648|
397494|L01XC0601|Erbitux|irl|5|mg/ml|20|ml|1|hgl|lausn|L01XC06|01.12.2011||R|||0|1|0|1|MKA|0|0|0|100|SEK|36675|47910|lyfsjukr||||20|0||Icepharma hf|Merck KgaA|Cetúxímab||36675||36675|47910|
397745|L01BC0601|Xeloda|töflur|150|mg|60|stk|1|ţpakki||L01BC06|01.01.2002||R|||0|1|0|1|ROC|0|0|0|100|DKK|10129|14594|lyfsjukr||||60|0||Icepharma hf|Roche|Capecitabín||10129||10129|14594|
397752|L01BC0601|Xeloda|töflur|500|mg|120|stk|1|ţpakki||L01BC06|01.01.2002||R|||0|1|0|1|ROC|0|0|0|100|DKK|58075|74767|lyfsjukr||||120|0||Icepharma hf|Roche|Capecitabín||58075||58075|74767|
397796|A06AB5801|Picoprep|mixtduft|||2|pokar|1|pakki|lausn|A06AB58|01.10.2011||L|||0|0|0|0|FEL|0|0|0|100|IKR|||lyflausa||||2|0||Vistor hf|Ferring Lćgemidler A/S|Natríumpicosúlfat||||||
398821|A02BC0506|Esomeprazole Krka (LYFIS)|sţ-hylki|40|mg|56|stk|1|ţpakki||A02BC05|01.08.2011||R|||0|0|0|0|LYF|0|0|0|100|XEU|7783|3482|lyfalmen|V0012|3141||56|0|74,6700|LYFIS ehf|LYFIS ehf|Esómeprazól||1830||1830|3482|
399241|B01AC0404|Clopidogrel Krka (Lyfis)|filmhtfl|75|mg|28|stk|1|ţpakki||B01AC04|01.07.2010||R|||0|0|E|0|LYF|0|0|0|100|XEU|3594|2014|lyfalmen|V0009|2014||28|0|28,0000|Lyfis ehf|Lyfis ehf|Klópídógrel||757||757|2014|
399510|N02AX0204|Tradolan|filmhtfl|50|mg|100|stk|1|ţpakki||N02AX02|01.05.2012||R|||0|0|E|0|GLP|0|0|1|100|SEK|399|1525|lyfalmen|V0225|1515||100|0|16,6700|Vistor hf|G.L.Pharma GmbH|Tramadól||399||399|1525|
399519|N03AX0901|Lamictal|dreifit.|50|mg|56|stk|1|ţpakki||N03AX09|01.03.1999||R|||0|0|E|0|GSK|0|0|0|100|IKR|2049|2856|lyfalmen|V0244|2828||56|0|9,3333|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||1372||1372|2856|
399733|B01AB0401|Fragmin|stl|25000|ae/ml|0,3|ml|10|áf.spr|7500 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.1993||R|||0|0|E|0|PER|0|0|1|100|DKK|9233|13609|lyfalmen||||3|0|30,0000|Icepharma hf|Pfizer ApS|Dalteparín||9233||9233|13609|
399746|L03AA0202|Zarzio|stl/irl|30|millj ae|0,5|ml|5|áf.spr|lausn|L03AA02|01.04.2011||R|||0|1|0|1|SAR|0|0|0|100|SEK|40953|53279|lyfsjukr||||2|0|4,2900|Artasan ehf|Sandoz GmbH (A)|Fílgrastím||40953||40953|53279|
399782|D06BB0601|Vectavir|krem|10|mg/g|2|g|1|túpa||D06BB06|01.04.1997||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||2|0||Artasan ehf|Novartis Healthcare A/S-A|Pencíklóvír||||||
399856|L03AB1101|Pegasys|stl|180|mcg/pen|0,5|ml|4|lyfjap|áfylltur lyfjapenni|L03AB11|01.05.2012||R|||0|1|0|1|RRL|0|0|0|100|DKK|116702|148344|lyfsjukr||||2|0|27,6900|Icepharma hf|Roche Registration Limited|Peginterferón alfa 2a||116702||116702|148344|
400044|S03CA0102|Sofradex|aug.eydr|||8|ml|1|glas||S03CA01|01.03.1980||R|||0|0|E|0|SNO|0|0|1|100|NOK|1547|3095|lyfalmen||||8|0||Vistor hf|Sanofi-aventis Norge AS|Dexametasón og sýkingalyf||1547||1547|3095|
400101|R05DB2002|Pektolin|mixtúra|||150|ml|1|glas||R05DB20|01.06.1981||L|||0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa||||150|0||Actavis Group hf|Actavis hf|Blöndur||||||
400143|C10AB0401|Lopid|hylki|300|mg|100|stk|1|ţpakki||C10AB04|01.04.1988||R|||0|0|0|0|PER|0|0|0|100|DKK|5272|8191|lyfalmen||||100|0|25,0000|Icepharma hf|Pfizer ApS|Gemfíbrózíl||5272||5272|8191|
400267|N05BA0402|Sobril|töflur|25|mg|25|stk|1|ţpakki||N05BA04|01.01.1985||R|||0|0|0|0|PER|0|0|1|100|DKK|229|1292|lyfalmen||||25|0|12,5000|Icepharma hf|Pfizer ApS|Oxazepam||229||229|1292|
400424|N05BA0402|Sobril|töflur|15|mg|100|stk|1|ţpakki||N05BA04|01.01.1985||R|||0|0|0|0|PER|0|0|0|100|DKK|415|1547|lyfalmen||||100|0|30,0000|Icepharma hf|Pfizer ApS|Oxazepam||415||415|1547|
400432|N05BA0402|Sobril|töflur|15|mg|25|stk|1|ţpakki||N05BA04|01.01.1985||R|||0|0|0|0|PER|0|0|1|100|DKK|198|1250|lyfalmen||||25|0|7,5000|Icepharma hf|Pfizer ApS|Oxazepam||198||198|1250|
401801|B01AC2401|Brilique|filmhtfl|90|mg|56|stk|1|ţpakki||B01AC24|01.06.2011||R|||0|0|E|0|AZA|0|0|0|100|SEK|10823|15784|lyfalmen|V0459|13954||56|0|28,0000|Vistor hf|AstraZeneca AB|Ticagrelor||10823||10823|15784|
401828|N06AA1001|Noritren|töflur|10|mg|100|stk|1|glas||N06AA10|01.01.1985||R|||0|0|B|0|LBK|0|1|0|100|DKK|776|2040|lyfalmen||||100|0|13,3333|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||776||776|2040|
401851|N06AA1001|Noritren|töflur|25|mg|100|stk|1|glas||N06AA10|01.01.1985||R|||0|0|B|0|LBK|0|1|0|100|DKK|1242|2678|lyfalmen||||100|0|33,3333|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||1242||1242|2678|
401877|C09AA0103|Katopril|töflur|25|mg|100|stk|1|pakki||C09AA01|01.10.1995||R|||0|0|B|0|ACA|0|0|0|100|XEU|1217|2644|lyfalmen||||100|0|50,0000|Actavis Group hf|Actavis hf|Kaptópríl||1217||1217|2644|
401901|C09AA0103|Katopril|töflur|50|mg|100|stk|1|pakki||C09AA01|01.10.1995||R|||0|0|B|0|ACA|0|0|0|100|XEU|1954|3652|lyfalmen||||100|0|100,0000|Actavis Group hf|Actavis hf|Kaptópríl||1954||1954|3652|
402651|J07BB0205|Influvac|bóluefni|||0,5|ml|1|spr|einnotaspr|J07BB02|01.12.1998||R|||0|0|0|0|AHP|0|0|0|100|XEU|666|1890|lyfalmen||||0|0||Vistor hf|Abbott Healthcare Products B.V.|Inflúensa, hreinsađir  mótefnavakar||666||666|1890|
402743|QJ01RA0102|Streptocillin, vet.|stl|||100|ml|1|hgl||QJ01RA01|01.11.1979||R|||0|0|0|0|BID|0|0|0|100|DKK|1709|3400|vetalmen||||100|0||Vistor hf|Boehringer Ingelheim Danmark|||1709||1709|3400|
403226|L04AA0605|Myfenax (Lyfis)|hylki|250|mg|100|stk|1|ţpakki||L04AA06|01.03.2011||R|||0|1|*|0|LYF|0|0|0|100|XEU|21036|25738|lyfalmen|V0470|25738||100|0|12,5000|Lyfis ehf|Lyfis ehf|Mýcófenólsýra||18480||18480|25738|
403444|QG02AD9001|Estrumat, vet.|stl|0,25|mg/ml|20|ml|1|hgl||QG02AD90|01.01.1991||R|||0|0|0|0|IBV|1|0|0|100|DKK|5258|10269|vetalmen||||20|0||Vistor hf|Intervet International BV|||5258||5258|10269|
403550|C08CA0302|Lomir Retard|forđahlk|2,5|mg|100|stk|1|ţpakki||C08CA03|01.10.1992||R|||0|0|B|0|NOH|0|0|0|100|DKK|6005|9193|lyfalmen||||100|0|50,0000|Vistor hf|Novartis Healthcare A/S-|Ísradipín||6005||6005|9193|
403856|L01BA0108|Methotrexate Pfizer|irţ|100|mg/ml|50|ml|1|hgl||L01BA01|01.10.2011||R|||0|1|0|1|PER|0|0|0|100|DKK|37831|49360|lyfsjukr||||50|0||Icepharma hf|Pfizer ApS|Metótrexat||||37831|49360|
403915|S01GX0101|Lomudal|augndr|20|mg/ml|13,5|ml|1|glas||S01GX01|01.07.1992||R|||0|0|E|0|SNO|0|0|0|100|NOK|1477|2999|lyfalmen||||14|0||Vistor hf|Sanofi-aventis Norge AS|Krómóglíkatsýra||1477||1477|2999|
404426|S01XA2019|Oftagel|augngel|2,5|mg/g|10|g|1|túpa||S01XA20|01.04.2004||L|||0|0|E|0|SAO|0|0|0|100|XEU|||lyfalmen||||10|0||Icepharma hf|Santen Oy|Gervitár og ađrar óvirkar samsetningar|||||1875|
404533|B01AD0201|Actilyse|sts/irs|50|mg|1|stk|1|hgl|+ leysir|B01AD02|01.07.1989||R|||0|0|0|1|BOI|0|0|0|100|DKK|66632|85506|lyfsjukr||||1|0|0,5000|Vistor hf|Boehringer Ingelheim|Alteplasi||66632||66632|85506|
404939|B02BA0102|Konakion Novum|stl|10|mg/ml|1|ml|5|lykjur||B02BA01|01.04.1991||R|||0|0|0|1|ROC|0|0|0|100|DKK|700|1010|lyfsjukr||||5|0|2,5000|Icepharma hf|Roche|Fýtómenadíón||700||700|1010|
405466|QM01AX9001|Cartrophen vet.|stl|100|mg/ml|10|ml|1|hgl|lausn f.hunda|QM01AX90|01.08.2011||R|||0|0|0|0|AEL|1|0|0|100|XEU|8295|16100|vetalmen||||10|0||Icepharma hf|Arthropharm Europe Limited|Pentosan Polysulfate Sodium||8295||8295|16100|
405589|J07BD5203|Priorix|bóluefni|||0,5|ml|1|hgl|+ einnota dćla|J07BD52|01.03.1999||R|||0|0|0|0|GSK|0|0|0|100|GBP|1883|3555|lyfalmen||||0|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|mislingar í blöndum međ hettusótt og rauđum hundum (veiklađa||1883||1883|3555|
405597|J07BD5203|Priorix|bóluefni|||0,5|ml|10|hgl||J07BD52|01.11.2001||R|||0|0|0|0|GSK|0|0|0|100|GBP|20074|27738|lyfalmen||||5|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|mislingar í blöndum međ hettusótt og rauđum hundum (veiklađa||20074||20074|27738|
405985|N05AE0301|Serdolect|filmhtfl|12|mg|28|stk|1|ţpakki||N05AE03|01.01.2006||R|||0|0|0|0|LBK|0|1|0|100|DKK|18545|25819|lyfalmen||||28|0|21,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||18545||18545|25819|
406025|V08AB0201|Omnipaque|stl|300|mg J/ml|50|ml|10|plastf||V08AB02|01.12.1983||R|||0|0|0|1|GEH|0|0|0|100|IKR|20662|27813|lyfsjukr||||500|0||Icepharma hf|GE Healthcare AS|Jóhexól||20662||20662|27813|
406033|N05AE0301|Serdolect|filmhtfl|16|mg|28|stk|1|ţpakki||N05AE03|01.01.2006||R|||0|0|0|0|LBK|0|1|0|100|DKK|21157|29097|lyfalmen||||28|0|28,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||21157||21157|29097|
406165|N05AE0301|Serdolect|filmhtfl|20|mg|28|stk|1|ţpakki||N05AE03|01.01.2006||R|||0|0|0|0|LBK|0|1|0|100|DKK|23189|31647|lyfalmen||||28|0|35,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||23189||23189|31647|
406322|N05AE0301|Serdolect|filmhtfl|4|mg|100|stk|1|glas||N05AE03|01.10.2006||R|||0|0|0|0|LBK|0|1|0|100|DKK|20918|28797|lyfalmen||||100|0|25,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||20918||20918|28797|
406355|V08AB0201|Omnipaque|stl|350|mg J/ml|50|ml|10|plastf||V08AB02|01.12.1983||R|||0|0|0|1|GEH|0|0|0|100|IKR|23122|30901|lyfsjukr||||500|0||Icepharma hf|GE Healthcare AS|Jóhexól||23122||23122|30901|
406371|N05AE0301|Serdolect|filmhtfl|12|mg|100|stk|1|glas||N05AE03|01.10.2006||R|||0|0|0|0|LBK|0|1|0|100|DKK|63071|81699|lyfalmen||||100|0|75,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||63071||63071|81699|
406389|N05AE0301|Serdolect|filmhtfl|16|mg|100|stk|1|glas||N05AE03|01.10.2006||R|||0|0|0|0|LBK|0|1|0|100|DKK|74039|95464|lyfalmen||||100|0|100,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||74039||74039|95464|
406397|N05AE0301|Serdolect|filmhtfl|20|mg|100|stk|1|glas||N05AE03|01.10.2006||R|||0|0|0|0|LBK|0|1|0|100|DKK|83944|107895|lyfalmen||||100|0|125,0000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||83944||83944|107895|
406462|N05AE0301|Serdolect|filmhtfl|4|mg|30|stk|1|ţpakki||N05AE03|01.01.2006||R|||0|0|0|0|LBK|0|1|0|100|DKK|6401|9735|lyfalmen||||30|0|7,5000|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||6401||6401|9735|
406894|H01AC0111|Omnitrope|stl|3,3|mg/ml|1,5|ml|5|rörlyk|lausn|H01AC01|01.04.2012||R|||0|1|0|1|SDG|0|0|0|100|DKK|81260|103864|lyfsjukr||||8|0|37,5000|Artasan ehf|Sandoz GmbH (Kundl)|Sómatrópín||81260||81260|103864|
407142|C09CA0304|Valsartan LYFIS|filmhtfl|80|mg|98|stk|1|ţpakki||C09CA03|01.06.2012||R|||0|0|B|0|LYF|0|0|0|100|XEU|3406|3213|lyfalmen|V0072|3213||98|0|98,0000|LYFIS ehf|LYFIS ehf|Valsartan||1633||1633|3213|
407395|N02CA7201|Anervan|töflur|160,5|mg|100|stk|1|pakki|ţp (0,5+10+50+100 mg)|N02CA72|01.10.1995||R|||0|0|E|0|REP|0|0|0|100|SEK|2209|4001|lyfalmen||||100|0|12,5000|Vistor hf|Recip AB|Ergotamínlyf í blöndum međ geđlyfjum (psycoleptica)||2209||2209|4001|
407981|N05BA0402|Sobril|töflur|10|mg|25|stk|1|ţpakki||N05BA04|01.01.1985||R|||0|0|0|0|PER|0|0|1|100|DKK|171|1213|lyfalmen||||25|0|5,0000|Icepharma hf|Pfizer ApS|Oxazepam||171||171|1213|
407999|N05BA0402|Sobril|töflur|10|mg|100|stk|1|ţpakki||N05BA04|01.01.1985||R|||0|0|0|0|PER|0|0|0|100|DKK|373|1489|lyfalmen||||100|0|20,0000|Icepharma hf|Pfizer ApS|Oxazepam||373||373|1489|
408740|D07AC0104|Diproderm|smyrsli|0,5|mg/g|100|g|1|túpa||D07AC01|01.03.1977||R|||0|0|B|0|SPL|0|0|1|100|DKK|2938|4998|lyfalmen||||100|0||Vistor hf|Schering-Plough Europe|Betametasón||2938||2938|4998|
408773|D07AC0104|Diproderm|áburđur|0,5|mg/ml|100|ml|1|glas||D07AC01|01.03.1977||R|||0|0|B|0|SPL|0|0|1|100|DKK|2303|4129|lyfalmen||||100|0||Vistor hf|Schering-Plough Europe|Betametasón||2303||2303|4129|
409078|J02AC0101|Diflucan|mixtúrud|10|mg/ml|35|ml|1|glas||J02AC01|01.07.1992||R|||0|0|0|0|PER|0|0|1|100|DKK|4371|6958|lyfalmen||||35|0|1,7500|Icepharma hf|Pfizer ApS|Flúkónazól||4371||4371|6958|
409417|C09CA0701|Micardis|töflur|80|mg|28|stk|1|ţpakki||C09CA07|01.02.2008||R|||0|0|0|0|BII|0|0|0|100|DKK|3802|6180|lyfalmen||||28|0|56,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan||3802||3802|6180|
409425|R01AD0502|Rhinocort Turbuhaler|nefúđad|100|mcg/sk|200|sk|1|stauk||R01AD05|01.01.1992||R|||0|0|E|0|AZD|0|0|1|100|SEK|4281|6835|lyfalmen||||200|0|100,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||4281||4281|6835|
409474|C09CA0701|Micardis|töflur|80|mg|98|stk|1|ţpakki||C09CA07|01.02.2008||R|||0|0|0|0|BII|0|0|0|100|DKK|12729|18520|lyfalmen||||98|0|196,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan||12729||12729|18520|
409516|C09CA0701|Micardis|töflur|40|mg|28|stk|1|ţpakki||C09CA07|01.02.2008||R|||0|0|0|0|BII|0|0|0|100|DKK|3036|5132|lyfalmen||||28|0|28,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan||3036||3036|5132|
409532|QN05AA0402|Plegicil vet.|stl|10|mg/ml|20|ml|6|hgl||QN05AA04|01.11.2007||R|||0|0|0|0|PAB|1|0|0|100|DKK|10833|20974|vetalmen||||120|0||Vistor hf|Pharmaxim AB|||10833||10833|20974|
409745|N05AX1302|Xeplion|stl|100|mg|1|stk|1|áf.spr|forđadreifa|N05AX13|01.04.2012||R|||0|0|0|0|JCI|0|1|0|100|SEK|78657|101260|lyfalmen||||1|0|40,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||78657||78657|101260|
409763|C09CA0701|Micardis|töflur|40|mg|98|stk|1|ţpakki||C09CA07|01.02.2008||R|||0|0|0|0|BII|0|0|0|100|DKK|10314|15088|lyfalmen||||98|0|98,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan||10314||10314|15088|
410639|P01BA0102|Klorokinfosfat Recip|filmhtfl|250|mg|20|stk|1|ţpakki||P01BA01|01.08.2005||R|||0|0|0|0|REP|0|0|0|100|SEK|1148|2549|lyfalmen||||20|0|6,2000|Vistor hf|Recip AB|Klórókín||1148||1148|2549|
410712|D10AD0102|Aberela|krem|0,05|%|30|g|1|túpa||D10AD01|01.10.2007||R|||0|0|0|0|JAS|0|0|0|100|SEK|784|2051|lyfalmen||||30|0||Vistor hf|Janssen-Cilag AB|Tretínóín||784||784|2051|
411033|M03BX0105|Baklofen Mylan|töflur|10|mg|50|stk|1|ţpakki||M03BX01|01.01.1990||R|||0|0|E|0|MYL|0|0|1|100|SEK|686|1917|lyfalmen||||50|0|10,0000|Actavis Group PTC ehf|Mylan AB|Baklófen||686||686|1917|
411389|N05CD0801|Dormicum|stl|5|mg/ml|10|ml|5|lykjur||N05CD08|01.10.1990||R|||0|0|0|1|ROC|0|0|0|100|DKK|4986|7196|lyfsjukr||||50|0|16,6667|Icepharma hf|Roche|Mídazólam||4986||4986|7196|
411827|J05AF0501|Epivir|töflur|150|mg|60|stk|1|glas||J05AF05|01.03.1999||R|||0|1|0|1|VII|0|0|0|100|GBP|26682|35368|lyfsjukr||||60|0|30,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Lamívúdín||26682||26682|35368|
411918|N02CC0101|Imigran|nefúđi|20|mg/sk|6|sk|1|pakki||N02CC01|01.07.2000||R|||0|0|E|0|GSK|0|0|0|100|GBP|7806|11657|lyfalmen||||6|0|6,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Súmatriptan||7806||7806|11657|
412049|L02AE0301|Zoladex|vefjalyf|3,6|mg|1|stk|1|áf.spr|+ dćla|L02AE03|01.01.1990||R|||0|1|*|0|AZA|0|0|0|100|SEK|22943|31339|lyfalmen|V0183|31337||1|0|27,9070|Vistor hf|AstraZeneca AB|Góserelín||22943||22943|31339|
412361|B01AB0501|Klexane|stl|100|mg/ml|3|ml|1|hgl|međ rotv.|B01AB05|01.02.1999||R|||0|0|0|1|SNO|0|0|0|100|NOK|3881|5601|lyfsjukr||||3|0|15,0000|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||3881||3881|5601|
412395|QM01AE0301|Romefen, vet.|stl|100|mg/ml|100|ml|1|hgl||QM01AE03|01.10.1995||R|||0|0|0|0|MER|1|0|0|100|DKK|8719|16914|vetalmen||||100|0||Vistor hf|Merial|||8719||8719|16914|
412547|L03AB0701|Avonex|stl|30|mcg/pen|0,5|ml|4|spr|lausn,áfylltur lyfjapenni|L03AB07|01.11.2011||R|||0|1|0|1|BIB|0|0|0|100|XEU|130550|165723|lyfsjukr||||2|0|27,9100|Icepharma hf|Biogen Idec Ltd|Interferón beta-1a||130550||130550|165723|
412581|N05AX1302|Xeplion|stl|75|mg|1|stk|1|áf.spr|forđadreifa|N05AX13|01.04.2012||R|||0|0|0|0|JCI|0|1|0|100|SEK|61175|79320|lyfalmen||||1|0|30,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||61175||61175|79320|
412825|L02BA0107|Tamoxifen Mylan|töflur|10|mg|100|stk|1|glas||L02BA01|01.01.1990||R|||0|0|*|0|MYL|0|0|0|100|SEK|3448|5696|lyfalmen||||100|0|50,0000|Actavis Group PTC ehf|Mylan AB|Tamoxífen||3448||3448|5696|
412924|L02BA0107|Tamoxifen Mylan|töflur|20|mg|100|stk|1|glas||L02BA01|01.01.2010||R|||0|0|*|0|MYL|0|0|0|100|SEK|4235|6772|lyfalmen||||100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Tamoxífen||4235||4235|6772|
414167|N06DA0205|Donesyn|filmhtfl|10|mg|98|stk|1|ţpakki||N06DA02|01.05.2011||R|||0|0|E|0|WIH|0|0|0|100|XEU|29039|19631|lyfalmen|V0342|18706||98|0|130,6700|Portfarma ehf|Williams & Halls|Dónepezíl||13614||13614|19631|
414680|C03BA1102|Natrilix Retard|forđatfl|1,5|mg|90|stk|1|ţpakki||C03BA11|01.03.1999||R|||0|0|E|0|SEV|0|0|0|100|DKK|3895|6307|lyfalmen||||90|0|54,0000|Icepharma hf|Servier|Indapamíđ||3895||3895|6307|
414789|N03AF0104|Tegretol|mixtúra|20|mg/ml|300|ml|1|glas||N03AF01|01.09.2007||R|||0|0|E|0|NOH|0|0|0|100|DKK|1352|2828|lyfalmen||||300|0|6,0000|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||1352||1352|2828|
415556|B03AC0204|Venofer  (D.A.C.)|stl|20|mg/ml|5|ml|5|hgl||B03AC02|01.03.2011||R|||0|0|E|0|DAC|0|0|1|100|CHF|15396|19450|lyfalmen|V0034|19396||25|0|5,0000|D.A.C. ehf|D.A.C. ehf|Járnoxíđ (sykurflétta)||13470||13470|19450|
415679|G03CA0310|Vagifem|sk-tfl|25|mcg|15|stk|1|pakki||G03CA03|01.01.1995||R|||0|0|E|0|NAS|0|0|0|100|DKK|1942|3635|lyfalmen||||15|0|15,0000|Vistor hf|Novo-Nordisk A/S|Estradíól||1942||1942|3635|
415946|N03AX1405|Matever|filmhtfl|500|mg|100|stk|1|ţpakki||N03AX14|01.02.2012||R|||0|0|0|0|PSA|0|0|0|100|XEU|13124|11656|lyfalmen|V0253|10136||100|0|33,3300|Portfarma ehf|Pharmathen S.A.|Levetíracetam||7805||7805|11656|
416446|C09DA0101|Cozaar Comp|filmhtfl|62,5|mg|98|stk|1|ţpakki|50+12,5 mg|C09DA01|01.09.1997||R|||0|0|0|0|MSD|0|0|0|100|DKK|9712|9739|lyfalmen|V0088|2997||98|0|98,0000|Vistor hf|M.S.D.|Lósartan og ţvagrćsilyf||6404||6404|9739|
416494|A02BC0507|Esomeprazole Portfarma|sţ-tfl|40|mg|28|stk|1|ţpakki||A02BC05|01.11.2011||R|||0|0|0|0|POF|0|0|0|100|XEU|4261|1835|lyfalmen|V0005|1835||28|0|37,3300|Portfarma ehf|Portfarma|Esómeprazól||626||626|1835|
416818|A02BA0205|Zantac|mixtúra|15|mg/ml|300|ml|1|glas||A02BA02|01.07.2000||R|||0|0|E|0|PCO|0|0|0|100|GBP|5346|8292|lyfalmen||||300|1|15,0000|Distica|Distica - óskráđ lyf|Ranitidín||5346||5346|8292|
416829|N07BC0101|Subutex|tungur.t|8|mg|7|stk|1|ţpakki||N07BC01|01.03.2011||R|||1|0|0|1|RBP|0|0|0|100|DKK|5015|7238|lyfsjukr||||7|0|7,0000|Vistor hf|RB Pharmaceuticals Limited|Búprenorfín||5015||5015|7238|
416859|A01AA0101|Duraphat|tannlakk|22,6|mg/ml|10|ml|1|túpa||A01AA01|01.10.1995||R|||0|0|E|0|GOG|0|0|1|100|XEU|2951|5016|lyfalmen||||10|0||Icepharma hf|Colgate Palmolive A/S|Natríumflúoríđ||2951||2951|5016|
416867|A01AA0101|Duraphat|tannlakk|22,6|mg/ml|30|ml|5|túpa||A01AA01|01.10.1988||R|||0|0|E|0|GOG|0|0|1|100|DKK|26587|35912|lyfalmen||||150|0||Icepharma hf|Colgate Palmolive A/S|Natríumflúoríđ||26587||26587|35912|
416883|D10AX0301|Skinoren|krem|200|mg/g|30|g|1|túpa||D10AX03|01.07.1991||R|||0|0|0|0|IGB|0|0|0|100|SEK|1243|2679|lyfalmen||||30|0||Icepharma hf|Intendis GmbH Berlin|Azelainsýra||1243||1243|2679|
417832|J05AF0601|Ziagen|filmhtfl|300|mg|60|stk|1|ţpakki||J05AF06|01.07.2005||R|||0|1|0|1|VII|0|0|0|100|GBP|43672|56691|lyfsjukr||||60|0|30,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Abacavír||43672||43672|56691|
417880|B02BD0901|BeneFIX|sts|||1000|ae|1|hgl|+leysir|B02BD09|01.07.2012||R|||0|1|0|1|IPI|0|0|0|100|DKK|101667|129475|lyfsjukr||||1000|0|2,2200|Icepharma hf|Pfizer Limited|Storkuţáttur IX||101667||101667|129475|
418043|B01AE0701|Pradaxa|hylki|150|mg|180|stk|1|ţpakki|hart|B01AE07|01.10.2011||R|||0|0|E|0|BII|0|0|0|100|DKK|35040|46520|lyfalmen|V0460|46520||180|0|122,7200|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||||35040|46520|
418483|A07EC0201|Mesasal|sh-tfl|250|mg|100|stk|1|ţpakki||A07EC02|01.10.1991||R|||0|0|B|0|SNO|0|0|0|100|NOK|5020|7846|lyfalmen||||100|0|16,6667|Vistor hf|Sanofi-aventis Norge AS|Mesalazín (5-amínósalicýlsýra)||5020||5020|7846|
418592|L04AC0301|Kineret|stl|100|mg/spr|0,67|ml|28|áf.spr||L04AC03|01.06.2012||R|||0|1|0|1|BIO|0|0|0|100|DKK|137771|174785|lyfsjukr||||19|0|28,0000|Swedish Orphan Biovitrum AB|Swedish Orphan Biovitrum AB|Anakinra||137771||137771|174785|
418665|D07XC0101|Diprosalic|smyrsli|||50|g|1|túpa||D07XC01|01.11.1979||R|||0|0|B|0|SPL|0|0|1|100|DKK|1637|3218|lyfalmen||||50|0||Vistor hf|Schering-Plough Europe|Betametasón||1637||1637|3218|
418731|A07EC0201|Mesasal|eţ-stíll|500|mg|60|stk|1|pakki||A07EC02|01.10.1991||R|||0|0|B|0|SNO|0|0|0|100|NOK|7647|11440|lyfalmen|V0014|11100||60|0|20,0000|Vistor hf|Sanofi-aventis Norge AS|Mesalazín (5-amínósalicýlsýra)||7647||7647|11440|
418950|N05AH0310|Zalasta (LYFIS)|munndr.t|15|mg|28|stk|1|ţpakki||N05AH03|01.02.2012||R|||0|0|*|0|LYF|0|1|0|100|XEU|24084|20997|lyfalmen|V0475|20433||28|0|42,0000|LYFIS ehf|LYFIS ehf|Olanzapín||14703||14703|20997|
418981|R06AX2703|Desloratadine Actavis|filmhtfl|5|mg|100|stk|1|ţpakki||R06AX27|01.05.2012||R|||0|0|E|0|APC|0|0|1|100|XEU|3990|6437|lyfalmen|V0458|6437||100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Deslóratadín||3990||3990|6437|
418988|QA07AA0101|Colinovina, vet.|mixtúra|200|mg/ml|200|ml|1|glas||QA07AA01|01.03.1981||R|||0|0|0|0|BID|0|0|0|100|DKK|2093|4163|vetalmen||||200|0||Vistor hf|Boehringer Ingelheim Danmark|||2093||2093|4163|
418996|QA07AA0101|Colinovina, vet.|mixtúra|200|mg/ml|200|ml|1|sett|+ dćla|QA07AA01|01.03.1981||R|||0|0|0|0|BID|0|0|0|100|DKK|2716|5388|vetalmen||||200|0||Vistor hf|Boehringer Ingelheim Danmark|||2716||2716|5388|
419242|A11CC0301|Etalpha|hylki|0,25|mcg|100|stk|1|ţpakki||A11CC03|01.11.1979||R|||0|0|B|0|LEP|0|0|0|100|DKK|3403|5634|lyfalmen||||100|0|25,0000|Vistor hf|LEO Pharma A/S|Alfakalsídól||3403||3403|5634|
419309|A11CC0301|Etalpha|hylki|1|mcg|100|stk|1|ţpakki||A11CC03|01.11.1979||R|||0|0|B|0|LEP|0|0|0|100|DKK|7277|10933|lyfalmen||||100|0|100,0000|Vistor hf|LEO Pharma A/S|Alfakalsídól||7277||7277|10933|
419820|J05AE0201|Crixivan|hylki|400|mg|180|stk|1|glas||J05AE02|01.04.1997||R|||0|1|0|1|MSD|0|0|0|100|DKK|53432|68940|lyfsjukr||||180|0|30,0000|Vistor hf|M.S.D.|Indínavír||53432||53432|68940|
419838|A16AA0401|Cystagon|hylki|150|mg|100|stk|1|glas||A16AA04|01.02.2008||R|||0|1|0|1|ORP|0|0|0|100|DKK|40545|52766|lyfsjukr||||100|0|7,5000|Swedish Orphan International AB|Orphan  Europe (S)|Mecaptamín||40545||40545|52766|
419945|D07AD0101|Dermovat|húđlausn|0,5|mg/ml|25|ml|1|glas|í hársvörđ|D07AD01|01.09.1982||R|||0|0|B|0|GSK|0|0|1|100|GBP|882|2185|lyfalmen||||25|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Klóbetasól||882||882|2185|
420117|B01AB0401|Fragmin|stl|10000|ae/ml|1|ml|10|lykjur||B01AB04|01.04.1993||R|||0|0|E|0|PER|0|0|1|100|DKK|12336|18027|lyfalmen||||10|0|40,0000|Icepharma hf|Pfizer ApS|Dalteparín||12336||12336|18027|
421180|C01BD0101|Cordarone|töflur|100|mg|30|stk|1|ţpakki||C01BD01|01.07.1989||R|||0|0|B|0|SNO|0|0|0|100|NOK|1578|3138|lyfalmen|V0036|3136||30|0|15,0000|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||1578||1578|3138|
422121|C07AB0205|Seloken|töflur|50|mg|100|stk|1|ţpakki||C07AB02|01.05.2009||R|||0|0|B|0|AZD|0|0|0|100|SEK|1529|3070|lyfalmen|V0051|2917||100|0|33,3300|Vistor hf|AstraZeneca A/S DK|Metóprólól||1529||1529|3070|
422246|C07AB0206|Seloken ZOC|forđatfl|95|mg|98|stk|1|ţpakki||C07AB02|01.07.1988||R|||0|0|B|0|AZD|0|0|0|100|SEK|3495|5760|lyfalmen|V0049|4243||98|0|62,0700|Vistor hf|AstraZeneca A/S DK|Metóprólól||3495||3495|5760|
422337|C07AB0206|Seloken ZOC|forđatfl|190|mg|98|stk|1|ţpakki||C07AB02|01.07.1988||R|||0|0|B|0|AZD|0|0|0|100|SEK|6023|9218|lyfalmen|V0054|7425||98|0|124,1300|Vistor hf|AstraZeneca A/S DK|Metóprólól||6023||6023|9218|
422474|B02BB0101|Riastap|sts/irs|1|g|1|hgl|1|pakki|lausn|B02BB01|01.12.2011||R|||0|1|0|1|CSB|0|0|0|100|SEK|74114|94896|lyfsjukr||||1|0|0,2000|Icepharma hf|CSL Behring GmbH|Manna Fíbrínógen||74114||74114|94896|
423527|A02BC0506|Esomeprazole Krka (LYFIS)|sţ-hylki|20|mg|56|stk|1|ţpakki||A02BC05|01.08.2011||R|||0|0|0|0|LYF|0|0|0|100|XEU|6924|3746|lyfalmen|V0011|3141||56|0|37,3300|LYFIS ehf|LYFIS ehf|Esómeprazól||2023||2023|3746|
423737|J01GB0304|Gentamicin B. Braun|irl|3|mg/ml|120|ml|10|fl||J01GB03|01.07.2012||R|||0|0|0|1|BRU|0|0|0|100|XEU|22327|29903|lyfsjukr||||1200|0|15,0000|Actavis Group hf|B.Braun Melsungen AG|Gentamícín||22327||22327|29903|
424960|QP52AC1302|Panacur, vet.|pasta|187,5|mg/g|24|g|1|sk-dćl||QP52AC13|01.05.1999||L|||0|0|0|0|INI|0|0|0|100|DKK|1659|2894|vetorma||||24|0||Icepharma hf|Intervet International B.V.|||||1659|2894|
425181|N05CD0306|Flunitrazepam Mylan|töflur|1|mg|100|stk|1|glas||N05CD03|01.10.1992||R|||1|0|0|0|MYL|0|0|0|100|SEK|815|2094|lyfalmen||||100|0|100,0000|Actavis Group PTC ehf|Mylan AB|Flúnítrazepam||815||815|2094|
425608|N07BC5101|Suboxone|tungur.t|2,5|mg|28|stk|1|ţpakki|2+0,5 mg|N07BC51|01.08.2011||R|||1|1|0|1|RBP|0|0|0|100|DKK|4883|7001|lyfsjukr||||28|0|7,0000|Vistor hf|RB Pharmaceuticals Limited|Búprenorfín í blöndum||4851||4851|7001|
425939|C09CA0102|Lopress|töflur|12,5|mg|100|stk|1|glas||C09CA01|01.06.2012||R|||0|0|B|0|ACA|0|0|0|100|SEK|2172|3950|lyfalmen||||100|0|25,0000|Actavis Group hf|Actavis hf|Lósartan||2172||2172|3950|
426122|R01AA0503|Nezeril|nefdr|0,1|mg/ml|0,1|ml|20|sk-hyl||R01AA05|01.01.1987||L|||0|0|0|0|GSC|0|0|1|100|IKR|||lyflausa||||2|0|0,5000|GlaxoSmithKline ehf|GlaxoSmithKline CH AB c/o GSK CH A/S|Oxýmetazólín||||||
426593|J01CE0204|Kaavepenin|töflur|500|mg|20|stk|1|ţpakki||J01CE02|01.10.1985||R|||0|0|0|0|REP|0|0|1|100|SEK|682|1912|lyfalmen||||20|0|5,0000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||682||682|1912|
426601|J01CE0204|Kaavepenin|töflur|500|mg|30|stk|1|ţpakki||J01CE02|01.10.1985||R|||0|0|0|0|REP|0|0|1|100|SEK|891|2198|lyfalmen||||30|0|7,5000|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||891||891|2198|
427765|A06AB0801|Laxoberal|dropar|7,5|mg/ml|30|ml|1|plglas||A06AB08|01.09.2008||L|||0|0|0|0|BII|0|0|0|100|IKR|||lyfalmen||||30|0|45,0000|Vistor hf|Boehringer Ingelheim International |Natríum pícósúlfat|||||2738|
428018|R06AX2201|Kestine|filmhtfl|10|mg|10|stk|1|ţpakki||R06AX22|01.06.2012||L|||0|0|0|0|APS|0|0|1|100|IKR|||lyflausa||||10|0|10,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín||||||
428441|D07AC1301|Elocon|krem|0,1|%|30|g|1|túpa||D07AC13|01.08.2008||R|||0|0|B|0|SPL|0|0|1|100|DKK|880|2183|lyfalmen||||30|0||Vistor hf|Schering-Plough Europe|Mómetasón||880||880|2183|
428524|D07AC1301|Elocon|smyrsli|0,1|%|30|g|1|túpa||D07AC13|01.08.2008||R|||0|0|B|0|SPL|0|0|1|100|DKK|1033|2392|lyfalmen||||30|0||Vistor hf|Schering-Plough Europe|Mómetasón||1033||1033|2392|
428579|L03AA0202|Zarzio|stl/irl|48|millj ae|0,5|ml|5|áf.spr|lausn|L03AA02|01.04.2011||R|||0|1|0|1|SAR|0|0|0|100|SEK|50001|64634|lyfsjukr||||2|0|6,8600|Artasan ehf|Sandoz GmbH (A)|Fílgrastím||50001||50001|64634|
428822|C10AA0504|Atorvastatin Portfarma|filmhtfl|20|mg|100|stk|1|ţpakki||C10AA05|01.06.2006||R|||0|0|E|0|POF|0|0|0|100|IKR|6185|3246|lyfalmen|V0113|3246||100|0|100,0000|Portfarma ehf|Portfarma|Atorvastatín||1657||1657|3246|
428828|N06DA0303|Nimvastid (Lyfis)|hylki|3|mg|112|stk|1|ţpakki||N06DA03|01.04.2011||R|||0|0|E|0|LYF|0|0|0|100|XEU|28201|28360|lyfalmen|V0344|28360||112|0|37,3300|Lyfis ehf|Lyfis ehf|Rívastigmín||20570||20570|28360|
429167|J07CA0602|Pentavac|bóluefni|||0,5|ml|1|hgl|+ dreifa í dćlu|J07CA06|01.10.1999||R|||0|0|0|0|SPM|0|0|0|100|XEU|4311|6876|lyfalmen||||0|0||Icepharma hf|Sanofi Pasteur MSD|barnaveiki, haemophilus influenza B, kíghósti, mćnusótt, stí||4311||4311|6876|
429225|J07CA0602|Pentavac|bóluefni|||0,5|ml|10|hgl||J07CA06|01.12.1999||R|||0|0|0|0|SPM|0|0|0|100|XEU|42418|55780|lyfalmen||||5|0||Icepharma hf|Sanofi Pasteur MSD|barnaveiki, haemophilus influenza B, kíghósti, mćnusótt, stí||42418||42418|55780|
429503|J02AC0401|Noxafil|mixtúra|40|mg/ml|105|ml|1|fl||J02AC04|01.07.2012||R|||0|1|0|1|MLD|0|0|0|100|DKK|103267|131483|lyfsjukr||||105|0|5,2500|Vistor hf|Merck Sharp & Dohme Limited|Posacónazól||103267||103267|131483|
429837|C03DA0101|Aldactone|töflur|100|mg|100|stk|1|ţpakki||C03DA01|01.11.1981||R|||0|0|E|0|PER|0|0|0|100|DKK|4180|6697|lyfalmen||||100|0|133,3333|Icepharma hf|Pfizer ApS|Spírónólaktón||4180||4180|6697|
430009|N01AH0102|Leptanal|stl|50|mcg/ml|10|ml|5|lykjur||N01AH01|01.10.1989||R|||1|0|0|1|JAS|0|0|0|100|SEK|1720|2482|lyfsjukr||||50|0||Vistor hf|Janssen-Cilag AB|Fentanýl||1720||1720|2482|
430074|N05CD0801|Dormicum|stl|1|mg/ml|5|ml|10|lykjur||N05CD08|01.07.1990||R|||0|0|0|1|ROC|0|0|0|100|DKK|1476|2130|lyfsjukr||||50|0|3,3333|Icepharma hf|Roche|Mídazólam||1476||1476|2130|
430157|QJ01EW1001|Tribrissen, vet.|stl|480|mg/ml|100|ml|1|hgl|80+400 mg/ml|QJ01EW10|01.10.1990||R|||0|0|0|0|IBV|0|0|0|100|DKK|4577|8961|vetalmen||||100|0||Vistor hf|Intervet International BV|||4577||4577|8961|
430281|L02BG0303|Astrozol|filmhtfl|1|mg|98|stk|1|ţpakki||L02BG03|01.08.2011||R|||0|0|*|0|WIH|0|0|0|100|XEU|29893|18952|lyfalmen|V0184|18706||98|0|98,0000|Portfarma ehf|Williams & Halls|Anastrózól||13073||13073|18952|
430417|N03AX2101|Trobalt|filmhtfl|400|mg|84|stk|1|ţpakki||N03AX21|01.12.2011||R|||0|0|E|0|GGL|0|0|0|100|GBP|35469|47059|lyfalmen||||84|0||GlaxoSmithKline ehf|Glaxo Group Limited|Retigabín||35469||35469|47059|
430521|G04BE0305|Vizarsin (Lyfis)|filmhtfl|100|mg|4|stk|1|pakki||G04BE03|01.08.2010||R|||0|0|0|0|LYF|0|0|0|100|XEU|3025|3748|lyfalmen|V0144|3063||4|0|8,0000|Lyfis ehf|Lyfis ehf|Síldenafíl||2024||2024|3748|
430710|J07AP0301|Typhim Vi|bóluefni|||0,5|ml|1|spr|einnotaspr|J07AP03|01.07.1994||R|||0|0|0|0|SPM|0|0|0|100|XEU|2502|4402|lyfalmen||||0|0||Icepharma hf|Sanofi Pasteur MSD|Taugaveiki, hreinsađir  mótefnavakar||2502||2502|4402|
431023|D06AX0101|Fucidin|smyrsli|20|mg/g|15|g|1|túpa||D06AX01|01.04.1989||R|||0|0|0|0|LEP|0|0|1|100|DKK|779|2045|lyfalmen||||15|0||Vistor hf|LEO Pharma A/S|Fúsidínsýra||779||779|2045|
431049|C01DA0801|Sorbangil|töflur|10|mg|100|stk|1|ţpakki||C01DA08|01.07.1989||R|||0|0|B|0|REP|0|0|0|100|SEK|1176|2588|lyfalmen||||100|0|16,6667|Vistor hf|Recip AB|Ísósorbíđ dínítrat||1176||1176|2588|
431495|L01CD0201|Taxotere|irţ|160|mg|8|ml|1|hgl|lausn|L01CD02|01.04.2011||R|||0|1|0|1|AVS|0|0|0|100|NOK|242512|306235|lyfsjukr||||8|0||Vistor hf|Aventis Pharma SA|Docetaxel||242512||242512|306235|
431759|M01AB5503|Arthrotec Forte|töflur|75,2|mg|20|stk|1|ţpakki|75+0,2 mg|M01AB55|01.09.2009||R|||0|0|E|0|PER|0|0|1|100|DKK|1446|2957|lyfalmen||||20|0|15,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||||1446|2957|
431783|M01AB5503|Arthrotec Forte|töflur|75,2|mg|100|stk|1|ţpakki|75+0,2 mg|M01AB55|01.09.2009||R|||0|0|E|0|PER|0|0|1|100|DKK|4903|7686|lyfalmen||||100|0|75,0000|Icepharma hf|Pfizer ApS|Díklófenaknatríum í blöndum||4903||4903|7686|
432665|M09AX0101|Artzal|stl|10|mg/ml|2,5|ml|5|dćlur|einnota dćlur plast|M09AX01|01.10.2011||R|||0|0|E|0|NDR|0|0|0|100|SEK|38005|50241|lyfalmen|V0209|50241||12|0|34,7222|Vistor hf|Nordic Drugs AB|Natríumhýalúrónat||||38005|50241|
432880|N02BE0107|Paratabs|töflur|500|mg|300|stk|1|glas|öryggislok|N02BE01|01.11.1981||R|||0|0|0|0|ACA|0|0|1|100|XEU|1173|2584|lyfalmen||||300|0|50,0000|Actavis Group hf|Actavis hf|Paracetamól||1173||1173|2584|
432972|QJ01CR0201|Combisyn|töflur|50|mg|100|stk|1|töflur||QJ01CR02|01.02.2012||R|||0|0|0|0|NOB|1|0|0|100|XEU|3784|7438|vetalmen||||100|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Amoxicillín og Clavulansýra||3784||3784|7438|
433250|N04BX0201|Comtess|töflur|200|mg|100|stk|1|glas||N04BX02|01.07.1999||R|||0|0|E|0|ORC|0|0|0|100|DKK|11313|16455|lyfalmen||||100|0|20,0000|Vistor hf|Orion Corporation|Entakapón||11313||11313|16455|
433292|N02AA0106|Contalgin Uno|forđahlk|30|mg|28|stk|1|ţpakki||N02AA01|01.05.1998||R|||1|0|E|0|PER|0|0|0|100|DKK|2646|4598|lyfalmen||||28|0|8,4000|Icepharma hf|Pfizer ApS|Morfín||2646||2646|4598|
433318|N02AA0106|Contalgin Uno|forđahlk|90|mg|28|stk|1|ţpakki||N02AA01|01.05.1998||R|||1|0|E|0|PER|0|0|0|100|DKK|5792|8902|lyfalmen||||28|0|25,2000|Icepharma hf|Pfizer ApS|Morfín||5792||5792|8902|
433342|N02AA0106|Contalgin Uno|forđahlk|150|mg|28|stk|1|ţpakki||N02AA01|01.05.1998||R|||1|0|E|0|PER|0|0|0|100|DKK|8841|13073|lyfalmen||||28|0|42,0000|Icepharma hf|Pfizer ApS|Morfín||8841||8841|13073|
433512|A02BC0507|Esomeprazole Portfarma|sţ-tfl|20|mg|7|stk|1|ţpakki||A02BC05|01.11.2011||R|||0|0|0|0|POF|0|0|0|100|XEU|609|1731|lyfalmen|V0004|432||7|0|4,6700|Portfarma ehf|Portfarma|Esómeprazól||550||550|1731|
434639|QP52AC1302|Panacur, vet.|töflur|250|mg|10|stk|1|ţpakki||QP52AC13|01.04.1992||L|||0|0|0|0|INI|0|0|0|100|DKK|1162|2027|vetorma||||10|0||Icepharma hf|Intervet International B.V.|||||1162|2027|
434670|D01AC2001|Daktacort|krem|||50|g|1|túpa||D01AC20|01.10.1988||R|||0|0|0|0|MCS|0|0|1|100|SEK|906|2218|lyfalmen||||50|0||Vistor hf|McNeil Sweden AB|Blöndur||906||906|2218|
434829|C01CA2404|EpiPen|stl|0,3|mg/sk|1|stk|1|pakki|einnota penni i.m.|C01CA24|01.07.2007||R|||0|0|B|0|MEB|0|0|1|100|DKK|5934|9096|lyfalmen||||1|0|0,6000|Vistor hf|Meda AB (V)|Adrenalín tartrat||5934||5934|9096|
434837|C01CA2405|EpiPen Junior|stl|0,15|mg/sk|1|stk|1|pakki|einnota penni i.m.|C01CA24|01.07.2007||R|||0|0|B|0|MEB|0|0|1|100|DKK|5934|9096|lyfalmen||||1|0|0,3000|Vistor hf|Meda AB (V)|Adrenalín tartrat||5934||5934|9096|
434852|N06AB0302|Fontex|dreifit.|20|mg|100|stk|1|pakki|ţp (10x10 stk)|N06AB03|01.06.1998||R|||0|0|0|0|ELI|0|1|0|100|XEU|10488|15326|lyfalmen||||100|0|100,0000|Icepharma hf|Eli Lilly Danmark A/S|Flúoxetín||10488||10488|15326|
435537|N02CC0301|Zomig|töflur|5|mg|6|stk|1|ţpakki||N02CC03|01.06.1999||R|||0|0|E|0|ASZ|0|0|0|100|SEK|6785|10260|lyfalmen||||6|0|12,0000|Vistor hf|AstraZeneca UK Ltd|Zolmítriptan||6785||6785|10260|
435594|N02CC0301|Zomig|töflur|2,5|mg|6|stk|1|ţpakki||N02CC03|01.11.1998||R|||0|0|E|0|ASZ|0|0|0|100|SEK|4708|7419|lyfalmen||||6|0|6,0000|Vistor hf|AstraZeneca UK Ltd|Zolmítriptan||4708||4708|7419|
435651|N05AH0401|Seroquel|töflur|25|mg|100|stk|1|ţpakki||N05AH04|01.09.1998||R|||0|0|0|0|AZA|0|1|0|100|SEK|8373|10970|lyfalmen|V0284|3750||100|0|6,2500|Vistor hf|AstraZeneca AB|Quetíapín||7304||7304|10970|
435817|N05AH0407|Quetiapina Qualigen (Lyfjaver)|töflur|25|mg|60|stk|1|ţpakki||N05AH04|01.06.2011||R|||0|0|*|0|LVR|0|1|0|100|IKR|929|2250|lyfalmen|V0284|2250||60|0|3,7500|Lyfjaver ehf|Lyfjaver ehf|Quetíapín||929||929|2250|
435974|C01DA0801|Sorbangil|töflur|10|mg|250|stk|1|plglas||C01DA08|01.04.2004||R|||0|0|B|0|REP|0|0|0|100|SEK|2833|4854|lyfalmen||||250|0|41,6700|Vistor hf|Recip AB|Ísósorbíđ dínítrat||2833||2833|4854|
436010|L01AA0901|Levact|irţ|2,5|mg/ml|100|mg|5|hgl|lausn|L01AA09|01.11.2011||R|||0|1|0|1|AST|0|0|0|100|DKK|241540|305015|lyfsjukr||||500|0||Icepharma hf|Astellas Pharma GmbH|Bentamustine||241540||241540|305015|
436022|C09DA0308|Diovan Comp 80 mg/12,5 mg|töflur|92,5|mg|28|stk|1|pakki||C09DA03|01.10.1999||R|||0|0|0|0|NOH|0|0|0|100|DKK|3618|5928|lyfalmen||||28|0|28,0000|Vistor hf|Novartis Healthcare A/S-|Valsartan og ţvagrćsilyf||3618||3618|5928|
436147|M01AE0217|Naproxen-E Mylan|sh-tfl|250|mg|20|stk|1|ţpakki||M01AE02|01.07.1993||L|||0|0|0|0|MYL|0|0|1|100|IKR|||lyflausa||||20|0|10,0000|Actavis Group PTC ehf|Mylan AB|Naproxen||||||
436410|D06AX0101|Fucidin|krem|20|mg/g|15|g|1|túpa||D06AX01|01.01.1989||R|||0|0|0|0|LEP|0|0|1|100|DKK|758|2016|lyfalmen||||15|0||Vistor hf|LEO Pharma A/S|Fúsidínsýra||758||758|2016|
436877|L01AA0901|Levact|irţ|2,5|mg/ml|25|mg|20|hgl|lausn|L01AA09|01.11.2011||R|||0|1|0|1|AST|0|0|0|100|DKK|247707|312755|lyfsjukr||||500|0||Icepharma hf|Astellas Pharma GmbH|Bentamustine||247707||247707|312755|
436915|N05AD0101|Haldol|töflur|1|mg|100|stk|1|ţpakki||N05AD01|01.12.1972||R|||0|0|*|0|JAS|0|1|0|100|SEK|967|2302|lyfalmen||||100|0|12,5000|Vistor hf|Janssen-Cilag AB|Halóperídól||967||967|2302|
436931|N05AD0101|Haldol|töflur|4|mg|100|stk|1|ţpakki||N05AD01|01.12.1972||R|||0|0|*|0|JAS|0|1|0|100|SEK|3539|5820|lyfalmen||||100|0|50,0000|Vistor hf|Janssen-Cilag AB|Halóperídól||3539||3539|5820|
437013|B01AC0404|Clopidogrel Krka (Lyfis)|filmhtfl|75|mg|100|stk|1|ţpakki||B01AC04|01.07.2010||R|||0|0|E|0|LYF|0|0|0|100|XEU|10280|8509|lyfalmen|V0029|8509||100|0|100,0000|Lyfis ehf|Lyfis ehf|Klópídógrel||5505||5505|8509|
437935|L01AA0901|Levact|irţ|2,5|mg/ml|25|mg|5|hgl|lausn|L01AA09|01.11.2011||R|||0|1|0|1|AST|0|0|0|100|DKK|69429|89016|lyfsjukr||||125|0||Icepharma hf|Astellas Pharma GmbH|Bentamustine||69429||69429|89016|
438225|N07XX0701|Fampyra|forđatfl|10|mg|28|stk|1|glas||N07XX07|01.12.2011||R|||0|1|0|1|BIB|0|0|0|100|XEU|33315|43693|lyfsjukr||||28|0|14,0000|Icepharma hf|Biogen Idec Ltd|Fampridine||33315||33315|43693|
438333|N06AX1602|Efexor Depot|forđahlk|150|mg|28|stk|1|ţpakki||N06AX16|01.10.1998||R|||0|0|0|0|PER|0|1|0|100|DKK|6306|9605|lyfalmen|V0265|2489||28|0|42,0000|Icepharma hf|Pfizer ApS|Venlafaxín||6306||6306|9605|
438416|S02CA0301|Ciproxin-Hydrocortison|eyrnadr|||10|ml|1|túpa|2 mg + 10 mg/ml|S02CA03|01.09.2002||R|||0|0|E|0|SAL|0|0|1|100|USD|1304|2763|lyfalmen||||10|0||Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Hýdrókortisón og sýkingalyf||1304||1304|2763|
438424|N06AX1602|Efexor Depot|forđahlk|75|mg|28|stk|1|ţpakki||N06AX16|01.10.1998||R|||0|0|0|0|PER|0|1|0|100|DKK|3304|5499|lyfalmen|V0259|3102||28|0|21,0000|Icepharma hf|Pfizer ApS|Venlafaxín||3304||3304|5499|
438432|N06AX1602|Efexor Depot|forđahlk|75|mg|98|stk|1|ţpakki||N06AX16|01.10.1998||R|||0|0|0|0|PER|0|1|0|100|DKK|11359|16517|lyfalmen|V0334|6140||98|0|73,5000|Icepharma hf|Pfizer ApS|Venlafaxín||11359||11359|16517|
438762|R06AX1301|Clarityn|töflur|10|mg|10|stk|1|ţpakki||R06AX13|01.07.1989||L|||0|0|0|0|SCP|0|0|1|100|IKR|||lyflausa||||10|0|10,0000|Vistor hf|Schering-Plough|Lóratadín||||||
438770|R06AX1301|Clarityn|töflur|10|mg|30|stk|1|ţpakki||R06AX13|01.07.1989||R|||0|0|0|0|SCP|0|0|1|100|DKK|1924|3611|lyfalmen||||30|0|30,0000|Vistor hf|Schering-Plough|Lóratadín||1924||1924|3611|
438788|R06AX1301|Clarityn|töflur|10|mg|100|stk|1|ţpakki||R06AX13|01.07.1989||R|||0|0|E|0|SCP|0|0|1|100|DKK|6059|9267|lyfalmen|V0362|2321||100|0|100,0000|Vistor hf|Schering-Plough|Lóratadín||6059||6059|9267|
438806|B03XA0201|Aranesp|stl|130|mcg/spr|0,65|ml|4|áf.spr|nálavörn|B03XA02|01.12.2010||R|||0|1|0|1|AMG|0|0|0|100|DKK|168341|213150|lyfsjukr||||3|0|115,5600|Vistor hf|Amgen|Darbepóetín alfa||168341||168341|213150|
439208|J01DC0203|Zinnat|töflur|250|mg|14|stk|1|ţpakki||J01DC02|01.10.1990||R|||0|0|0|0|GSK|0|0|1|100|GBP|2897|4942|lyfalmen||||14|0|7,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Cefúroxím||2897||2897|4942|
439489|C07FB0201|Logimax|forđatfl|55|mg|98|stk|1|pakki|ţp 5+50 mg|C07FB02|01.04.1997||R|||0|0|B|0|AZD|0|0|0|100|SEK|8651|12813|lyfalmen||||98|0|98,0000|Vistor hf|AstraZeneca A/S DK|Metóprólól og önnur blóđţrýstingslćkkandi lyf||8651||8651|12813|
439794|R01AA0704|Otrivin ukonserveret|nefúđi|1|mg/ml|10|ml|1|glas|sk-úđari|R01AA07|01.05.2001||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||10|0|12,5000|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín||||||
440099|J01CR0202|Augmentin|mixtduft|91,4|mg/ml|70|ml|1|glas|80+11,4 mg/ml|J01CR02|01.08.1998||R|||0|0|0|0|GSK|0|0|1|100|IKR|1066|2437|lyfalmen||||70|0|5,6000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||1066||1066|2437|
440677|J01CE0106|Penicillin Actavis|sts|600|mg/hgl|10|hgl|1|pakki|1 millj.ae|J01CE01|01.07.2004||R|||0|0|0|1|AGT|0|0|0|100|DKK|1515|2187|lyfsjukr||||10|0|1,6700|Actavis Group hf|Actavis Group hf|Benzýlpenicillín||1515||1515|2187|
440693|J01CE0106|Penicillin Actavis|sts|1,2|g/hgl|10|hgl|1|pakki|2 millj.ae|J01CE01|01.07.2004||R|||0|0|0|1|AGT|0|0|0|100|DKK|2391|3451|lyfsjukr||||10|0|3,3300|Actavis Group hf|Actavis Group hf|Benzýlpenicillín||2391||2391|3451|
441006|C03DA0101|Aldactone|töflur|25|mg|100|stk|1|ţpakki||C03DA01|01.12.1972||R|||0|0|E|0|PER|0|0|0|100|DKK|947|2274|lyfalmen|V0046|2274||100|0|33,3333|Icepharma hf|Pfizer ApS|Spírónólaktón||947||947|2274|
441279|D01AC2002|Pevisone|krem|||30|g|1|túpa||D01AC20|01.10.1988||R|||0|0|0|0|JAS|0|0|1|100|SEK|1271|2718|lyfalmen||||30|0||Vistor hf|Janssen-Cilag AB|Blöndur||1271||1271|2718|
441619|J05AR0801|Eviplera|filmhtfl|470|mg|30|stk|1|glas|200+25+245 mg|J05AR08|01.05.2012||R|||0|1|0|1|GIL|0|0|0|100|DKK|128206|162781|lyfsjukr||||30|0||Gilead Sience Sweden AB|Gilead Science International Limited|Emtrícítabín, rilpívírin og tenófóvír||128206||128206|162781|
441634|P03AC0401|Nix|hársápa|10|mg/ml|59|ml|1|pakki||P03AC04|01.01.1996||L|||0|0|0|0|ACH|0|0|0|100|IKR|||lyflausa||||59|0||Aco Hud Nordic AB|ACO Hud AB|Permetrín||||||
441949|G03DC0202|Primolut N|töflur|5|mg|30|stk|1|glas||G03DC02|01.12.1972||R|||0|0|E|0|BAP|0|0|0|100|SEK|1009|2359|lyfalmen||||30|0|30,0000|Icepharma hf|Bayer Schering Pharma AG|Noretísterón||1009||1009|2359|
442705|B01AE0701|Pradaxa|hylki|150|mg|60|stk|1|ţpakki|hart|B01AE07|01.10.2011||R|||0|0|E|0|BII|0|0|0|100|DKK|11680|16957|lyfalmen|V0460|15507||60|0|40,9000|Vistor hf|Boehringer Ingelheim International|Dabigatran etexílat||||11680|16957|
443135|H04AA0102|GlucaGen Hypokit|sts|1|mg|1|stk|1|hgl|dćla|H04AA01|01.01.1989||R|||0|0|*|0|NAS|0|0|1|100|DKK|3527|5804|lyfalmen||||1|0|1,0000|Vistor hf|Novo-Nordisk A/S|Glúkagon||3527||3527|5804|
443358|N02AA0101|Contalgin|forđatfl|200|mg|90|stk|1|ţpakki||N02AA01|01.04.1993||R|||1|0|E|0|PER|0|0|0|100|DKK|26891|36293|lyfalmen||||90|0|180,0000|Icepharma hf|Pfizer ApS|Morfín||26891||26891|36293|
444041|N05AH0501|Sycrest|tungur.t|10|mg|20|stk|1|ţpakki||N05AH05|01.10.2011||R|||0|0|0|0|ORR|0|1|0|100|DKK|7786|11630|lyfalmen||||20|0|10,0000|Lundbeck Export A/S|N.V. Organon|Asenapíne||7786||7786|11630|
444315|N06AB0302|Fontex|dreifit.|20|mg|30|stk|1|pakki|ţp (2 x 15 stk)|N06AB03|01.06.1998||R|||0|0|0|0|ELI|0|1|0|100|DKK|3196|5351|lyfalmen||||30|0|30,0000|Icepharma hf|Eli Lilly Danmark A/S|Flúoxetín||3196||3196|5351|
444430|N04BA0208|Madopar Quick "62,5"|lausnart|62,5|mg|100|stk|1|glas|50+12,5 mg|N04BA02|01.11.2000||R|||0|0|E|0|ROC|0|0|0|100|DKK|2327|4162|lyfalmen||||100|0|8,3333|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||2327||2327|4162|
445155|D07CA0102|Fucidin-Hydrocortison|krem|30|mg/g|30|g|1|túpa|20 + 10 mg|D07CA01|01.02.1998||R|||0|0|B|0|LEO|0|0|1|100|DKK|1624|3200|lyfalmen||||30|0||Vistor hf|LEO A/S|Hýdrókortisón og sýklalyf||1624||1624|3200|
446187|QA12CX9001|Tonophosphan, vet.|stl|200|mg/ml|50|ml|1|hgl||QA12CX90|01.12.1972||R|||0|0|0|0|INI|0|0|0|100|DKK|1479|2942|vetalmen||||50|0||Icepharma hf|Intervet International B.V.|||1479||1479|2942|
447052|B01AB0401|Fragmin|stl|25000|ae/ml|0,72|ml|5|áf.spr|18000 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.2008||R|||0|0|E|0|PER|0|0|0|100|DKK|10829|15792|lyfalmen||||4|0|36,0000|Icepharma hf|Pfizer ApS|Dalteparín||10829||10829|15792|
447110|B01AB0401|Fragmin|stl|25000|ae/ml|0,4|ml|5|áf.spr|10000 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.2008||R|||0|0|E|0|PER|0|0|0|100|DKK|6171|9421|lyfalmen||||2|0|20,0000|Icepharma hf|Pfizer ApS|Dalteparín||6171||6171|9421|
447136|B01AB0401|Fragmin|stl|25000|ae/ml|0,5|ml|5|áf.spr|12500 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.2008||R|||0|0|E|0|PER|0|0|0|100|DKK|7638|11427|lyfalmen||||2|0|25,0000|Icepharma hf|Pfizer ApS|Dalteparín||7638||7638|11427|
447151|B01AB0401|Fragmin|stl|25000|ae/ml|0,6|ml|5|áf.spr|15000 a.e. anti-Xa/ml/sprautu|B01AB04|01.04.2008||R|||0|0|E|0|PER|0|0|0|100|DKK|9090|13414|lyfalmen||||3|0|30,0000|Icepharma hf|Pfizer ApS|Dalteparín||9090||9090|13414|
448217|C05AA0801|Doloproct|eţ-stíll|||10|stk|1|pakki||C05AA08|01.01.1991||R|||0|0|0|0|IGB|0|0|0|100|SEK|639|1853|lyfalmen||||10|0||Icepharma hf|Intendis GmbH Berlin|Flúókortólón||639||639|1853|
448233|C05AA0801|Doloproct|eţ-krem|||30|g|1|túpa||C05AA08|01.01.1991||R|||0|0|0|0|IGB|0|0|0|100|SEK|1248|2686|lyfalmen||||30|0||Icepharma hf|Intendis GmbH Berlin|Flúókortólón||1248||1248|2686|
448688|M03BX0103|Lioresal|töflur|25|mg|50|stk|1|ţpakki||M03BX01|01.12.1972||R|||0|0|E|0|NOH|0|0|1|100|DKK|2165|3941|lyfalmen|V0202|3594||50|0|25,0000|Vistor hf|Novartis Healthcare A/S-|Baklófen||2165||2165|3941|
449470|B05BB0120|Natriumhydrogenkarbonat B.Braun|irl|500|mmól/l|0,25|l|1|fl|lausn|B05BB01|01.02.2012||R|||0|0|0|1|Bru|0|0|0|100|XEU|1170|1689|lyfsjukr||||0|0||Actavis Group hf|B.Braun Melsungen AG|Elektrólýtar||1170||1170|1689|
449611|C07AB0311|Atenolol Mylan|töflur|100|mg|98|stk|1|ţpakki||C07AB03|01.01.1991||R|||0|0|B|0|MYL|0|0|0|100|SEK|1410|2908|lyfalmen||||98|0|130,6667|Actavis Group PTC ehf|Mylan AB|Atenólól||1410||1410|2908|
449819|J01CE0106|Penicillin Actavis|sts|3|g/hgl|10|hgl|1|pakki|5 millj.ae|J01CE01|01.07.2004||R|||0|0|0|1|AGT|0|0|0|100|DKK|5671|8185|lyfsjukr||||10|0|8,3300|Actavis Group hf|Actavis Group hf|Benzýlpenicillín||5671||5671|8185|
449911|A10AC0110|Humulin NPH KwikPen|stl|100|ae/ml|3|ml|5|pennar|áfylltur penni|A10AC01|01.01.2012||R|||0|0|*|0|ELI|0|0|0|100|XEU|5494|8494|lyfalmen||||15|0|37,5000|Icepharma hf|Eli Lilly Danmark A/S|Insúlín (manna)||5494||5494|8494|
450009|QN51AA0101|Euthasol vet.|stl|400|mg/ml|100|ml|1|fl||QN51AA01|01.07.2012||R|||1|0|0|0|LEV|1|0|0|100|XEU|4764|9320|vetalmen||||100|0||Le Vet B.V.|Le Vet B.V.|Pentobarbital||4764||4764|9320|
450155|J01CR0202|Augmentin|töflur|1|g|12|stk|1|pakki|ţp 875+125 mg|J01CR02|01.01.1997||R|||0|0|0|0|GSK|0|0|1|100|IKR|1115|2382|lyfalmen|V0169|2367||12|0|10,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||1026||1026|2382|
450734|N05CF0201|Stilnoct|töflur|10|mg|20|stk|1|ţpakki||N05CF02|01.10.1992||R|||0|0|0|0|SNO|0|0|1|100|NOK|910|1779|lyfalmen|V0060|1757||20|0|20,0000|Vistor hf|Sanofi-aventis Norge AS|Zolpidem||585||585|1779|
450775|N05CF0201|Stilnoct|töflur|10|mg|100|stk|1|ţpakki||N05CF02|01.10.1992||R|||0|0|0|0|SNO|0|0|0|100|NOK|3158|4207|lyfalmen|V0313|4117||100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Zolpidem||2360||2360|4207|
450979|QP54AA0302|Noromectin Drench|mixtúra|0,8|mg/ml|2,5|l|1|fl||QP54AA03|01.11.2011||R|||0|0|0|0|NOB|1|0|0|100|XEU|7604|13265|vetorma||||2|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|||7604||7604|13265|
451153|V08CA0301|Omniscan|stl|0,5|mmol/ml|10|ml|10|spr|áfylltar sprautur|V08CA03|01.07.2003||R|||0|0|0|1|GEH|0|0|0|100|NOK|56920|73317|lyfsjukr||||100|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||56920||56920|73317|
451419|V08CA0301|Omniscan|stl|0,5|mmol/ml|15|ml|10|spr|áfylltar sprautur|V08CA03|01.07.2003||R|||0|0|0|1|GEH|0|0|0|100|NOK|85381|109036|lyfsjukr||||150|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||85381||85381|109036|
451476|V08CA0301|Omniscan|stl|0,5|mmol/ml|20|ml|10|spr|áfylltar sprautur|V08CA03|01.07.2003||R|||0|0|0|1|GEH|0|0|0|100|NOK|113840|144752|lyfsjukr||||200|0||Icepharma hf|GE Healthcare AS|Gadódíamíđ||113840||113840|144752|
451989|N06AB0401|Cipramil|töflur|30|mg|28|stk|1|ţpakki||N06AB04|01.11.1999||R|||0|0|0|0|LBK|0|1|0|100|DKK|5855|8187|lyfalmen||||28|0|42,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||5269||5269|8187|
451997|N06AB0401|Cipramil|töflur|30|mg|100|stk|1|glas||N06AB04|01.11.1999||R|||0|0|0|0|LBK|0|1|0|100|DKK|15462|21950|lyfalmen||||100|0|150,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||15462||15462|21950|
452022|D01AC0801|Fungoral|sápa|20|mg/ml|120|ml|1|fl||D01AC08|01.01.2012||L|||0|0|0|0|MCS|0|0|1|100|IKR|||lyflausa||||120|0||Vistor hf|McNeil Sweden AB|Ketókónazól||||||
452284|M01AB1501|Toradol|stl|30|mg/ml|1|ml|5|lykjur||M01AB15|01.04.1992||R|||0|0|E|0|ROA|0|0|1|100|DKK|1188|2604|lyfalmen||||5|0|5,0000|Icepharma hf|Roche A.S.|Ketórólak||1188||1188|2604|
452467|QI09AB0401|Rhiniseng|stl|||50|ml|1|hgl|dreifa|QI09AB04|01.03.2011||R|||0|0|0|0|LHS|0|0|0|100|XEU|11392|19873|vetorma||||50|0||Dýraheilsa ehf|Laboratorios Hipra S.A.|Óvirkar bakteríur í bóluefnum||11392||11392|19873|
452482|V07AB09|Sterilt Vann B. Braun|leysir|||100|ml|20|hgl|leysir f.stungulyf|V07AB|01.01.2009||L|||0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa||||2000|0||Actavis Group hf|Braun|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar||||||
452862|D06BB1001|Aldara|krem|50|mg/g|250|mg|12|stk|einnota pokar|D06BB10|01.03.2000||R|||0|0|0|0|LAB|0|0|1|100|SEK|12033|17647|lyfalmen||||3000|0||Vistor hf|Laboratories 3M Santé|Imikvímóđ||12033||12033|17647|
452896|A06AD1701|Phosphoral|mixtúra|||45|ml|2|fl||A06AD17|01.03.1999||R|||0|0|0|0|LCC|0|0|0|100|DKK|2398|4259|lyfalmen||||90|0||Clean Chemical Sweden AB|Laboratorios Casen-Fleet S.L.U.|Natríumfosföt||2398||2398|4259|
452904|N02AA0501|Oxycontin|forđatfl|10|mg|28|stk|1|ţpakki||N02AA05|01.04.2003||R|||1|0|E|0|NOP|0|0|0|100|DKK|2430|4303|lyfalmen||||28|0|3,7300|Icepharma hf|Norpharma |Oxýcódon||2430||2430|4303|
452920|N02AA0501|Oxycontin|forđatfl|10|mg|98|stk|1|ţpakki||N02AA05|01.04.2003||R|||1|0|E|0|NOP|0|0|0|100|DKK|7144|10752|lyfalmen||||98|0|13,0700|Icepharma hf|Norpharma |Oxýcódon||7144||7144|10752|
452995|N02AA0501|Oxycontin|forđatfl|20|mg|28|stk|1|ţpakki||N02AA05|01.04.2003||R|||1|0|E|0|NOP|0|0|0|100|DKK|4692|7397|lyfalmen||||28|0|7,4700|Icepharma hf|Norpharma |Oxýcódon||4692||4692|7397|
453126|QP54AA0101|Eqvalan, vet.|pasta|18,7|mg/g|6,4|g|1|sk-dćl||QP54AA01|01.01.1991||L|||0|0|0|0|MEF|0|0|0|100|XEU|1505|2625|vetorma||||6|0||Vistor hf|Merial (MSD)|||||1505|2625|
453175|N02AA0501|Oxycontin|forđatfl|20|mg|98|stk|1|ţpakki||N02AA05|01.04.2003||R|||1|0|E|0|NOP|0|0|0|100|DKK|13836|19909|lyfalmen||||98|0|26,1300|Icepharma hf|Norpharma |Oxýcódon||13836||13836|19909|
453498|N02AA0501|Oxycontin|forđatfl|40|mg|28|stk|1|ţpakki||N02AA05|01.04.2003||R|||1|0|E|0|NOP|0|0|0|100|DKK|8980|13263|lyfalmen||||28|0|14,9300|Icepharma hf|Norpharma |Oxýcódon||8980||8980|13263|
453571|N02AA0501|Oxycontin|forđatfl|40|mg|98|stk|1|ţpakki||N02AA05|01.04.2003||R|||1|0|E|0|NOP|0|0|0|100|DKK|25218|34194|lyfalmen||||98|0|52,2700|Icepharma hf|Norpharma|Oxýcódon||25218||25218|34194|
453753|N05AE0401|Zeldox|sts|20|mg/hgl|1|hgl|1|pakki|+leysir|N05AE04|01.03.2002||R|||0|0|0|1|PER|0|1|0|100|DKK|2817|4066|lyfsjukr||||1|0|0,5000|Icepharma hf|Pfizer ApS|Ziprasidon||2817||2817|4066|
453795|J07AL0102|Pneumo 23|bóluefni|||0,5|ml|1|dćla||J07AL01|01.09.2003||R|||0|0|0|0|SPM|0|0|0|100|XEU|2347|4189|lyfalmen||||0|0||Icepharma hf|Sanofi Pasteur MSD|Hreinsuđ pneumococca poly­sakkaríđ mótefnavakar||2347||2347|4189|
454439|N06DA0201|Aricept|töflur|5|mg|28|stk|1|ţpakki||N06DA02|01.09.1998||R|||0|0|E|0|PER|0|0|0|100|DKK|15694|22241|lyfalmen||||28|0|18,6667|Icepharma hf|Pfizer ApS|Dónepezíl||15694||15694|22241|
454454|N06DA0201|Aricept|töflur|5|mg|98|stk|1|ţpakki||N06DA02|01.09.1998||R|||0|0|E|0|PER|0|0|0|100|DKK|44523|39819|lyfalmen|V0341|17249||98|0|65,3333|Icepharma hf|Pfizer ApS|Dónepezíl||29700||29700|39819|
454491|A02BC0507|Esomeprazole Portfarma|sţ-tfl|20|mg|28|stk|1|ţpakki||A02BC05|01.11.2011||R|||0|0|0|0|POF|0|0|0|100|XEU|2163|1731|lyfalmen|V0004|1730||28|0|18,6700|Portfarma ehf|Portfarma|Esómeprazól||550||550|1731|
454678|N06DA0201|Aricept|töflur|10|mg|28|stk|1|ţpakki||N06DA02|01.09.1998||R|||0|0|E|0|PER|0|0|0|100|DKK|17617|24654|lyfalmen||||28|0|37,3333|Icepharma hf|Pfizer ApS|Dónepezíl||17617||17617|24654|
454686|N06DA0201|Aricept|töflur|10|mg|98|stk|1|ţpakki||N06DA02|01.09.1998||R|||0|0|E|0|PER|0|0|0|100|DKK|49054|44381|lyfalmen|V0342|18706||98|0|130,6667|Icepharma hf|Pfizer ApS|Dónepezíl||33335||33335|44381|
454819|N02BE0115|Paracet|eţ-stíll|60|mg|10|stk|1|pakki||N02BE01|01.07.2011||L|||0|0|0|0|AGP|0|0|1|100|IKR|||lyflausa||||10|0|0,2000|Actavis Group hf|Actavis Group PTC ehf|Paracetamól||||||
454850|L01XX1701|Hycamtin|irs|4|mg/hgl|1|hgl|1|pakki||L01XX17|01.02.1999||R|||0|1|0|1|SKB|0|0|0|100|GBP|56271|72503|lyfsjukr||||1|0||GlaxoSmithKline ehf|SmithKline Beecham Ltd|Tópótecan||56271||56271|72503|
454918|QJ01CE0902|Penovet, vet.|stl|300000|ae/ml|100|ml|1|hgl||QJ01CE09|01.10.1997||R|||0|0|0|0|BID|0|0|0|100|DKK|1175|2337|vetalmen||||100|0||Vistor hf|Boehringer Ingelheim Danmark|||1175||1175|2337|
455329|A10BF0101|Glucobay|töflur|50|mg|30|stk|1|ţpakki||A10BF01|01.12.1997||R|||0|0|*|0|BAP|0|0|0|100|SEK|1029|2387|lyfalmen||||30|0|5,0000|Icepharma hf|Bayer Schering Pharma AG|Acarbósa||1029||1029|2387|
455337|A10BF0101|Glucobay|töflur|50|mg|120|stk|1|ţpakki||A10BF01|01.12.1997||R|||0|0|*|0|BAP|0|0|0|100|SEK|3697|6036|lyfalmen||||120|0|20,0000|Icepharma hf|Bayer Schering Pharma AG|Acarbósa||3697||3697|6036|
455584|J05AB0901|Famvir|töflur|500|mg|21|stk|1|ţpakki||J05AB09|01.10.1995||R|||0|0|E|0|NOH|0|0|1|100|DKK|22437|30704|lyfalmen||||21|0|14,0000|Vistor hf|Novartis Healthcare A/S-|Famcíclóvír||22437||22437|30704|
455949|J01AA0207|Doxylin|töflur|100|mg|10|stk|1|ţpakki|0|J01AA02|01.10.2008||R|||0|0|0|0|AGT|0|0|1|100|XEU|940|2265|lyfalmen||||10|0|10,0000|Actavis Group hf|Actavis Group hf|Doxýcýklín||940||940|2265|
455956|J01AA0207|Doxylin|töflur|100|mg|15|stk|1|ţpakki||J01AA02|01.01.2009||R|||0|0|0|0|AGT|0|0|1|100|XEU|1064|2434|lyfalmen||||15|0|15,0000|Actavis Group hf|Actavis Group hf|Doxýcýklín||1064||1064|2434|
455972|J01AA0207|Doxylin|töflur|100|mg|30|stk|1|ţpakki|0|J01AA02|01.10.2008||R|||0|0|0|0|AGT|0|0|1|100|XEU|2206|3997|lyfalmen||||30|0|30,0000|Actavis Group hf|Actavis Group hf|Doxýcýklín||2206||2206|3997|
457726|A02BC0402|Rabeprazol Actavis|sh-tfl|20|mg|28|stk|1|ţpakki||A02BC04|01.05.2011||R|||0|0|E|0|APC|0|0|0|100|XEU|816|1584|lyfalmen|V0003|1584||28|0|28,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||442||442|1584|
458067|N05CM0201|Heminevrin|hylki|300|mg|25|stk|1|glas||N05CM02|01.12.1998||R|||0|0|0|0|CHE|0|0|1|100|SEK|1187|2603|lyfalmen||||25|0|5,0000|Vistor hf|CHEPLAPHARM Arzneimittel GmbH|Clómetíazól||1187||1187|2603|
458349|J01CA0801|Selexid|töflur|200|mg|20|stk|1|ţpakki||J01CA08|01.12.1980||R|||0|0|0|0|LEP|0|0|1|100|DKK|1475|2997|lyfalmen||||20|0|6,6667|Vistor hf|LEO Pharma A/S|Pívmecillínam||1475||1475|2997|
458356|J01CA0801|Selexid|töflur|200|mg|30|stk|1|ţpakki||J01CA08|01.12.1980|31.05.2012|R|||0|0|0|0|LEP|0|0|1|100|DKK|2224|4021|lyfalmen||||30|0|10,0000|Vistor hf|LEO Pharma A/S|Pívmecillínam||2224||2224|4021|
458422|J01CA0801|Selexid|töflur|200|mg|100|stk|1|ţpakki||J01CA08|01.12.2007|31.05.2012|R|||0|0|0|0|LEP|0|0|1|100|DKK|9199|13563|lyfalmen||||100|0|33,3333|Vistor hf|LEO Pharma A/S|Pívmecillínam||9199||9199|13563|
458737|B05DA0003|Dianeal PD4 Glucose Duo|kviđ.sk|13,6|mg/ml|2000|ml|5|pokar||B05DA00|01.03.1999|30.04.2012|R|||0|0|0|1|BAX|0|0|0|100|SEK|12959|18146|lyfsjukr||||10000|0||Icepharma hf|Baxter|Ísótónískar lausnir||12959||12959|18146|
458778|B05DB0003|Dianeal PD4 Glucose Duo|kviđ.sk|22,7|mg/ml|2000|ml|5|pokar||B05DB00|01.03.1999|30.04.2012|R|||0|0|0|1|BAX|0|0|0|100|SEK|12959|18146|lyfsjukr||||10000|0||Icepharma hf|Baxter|Hýpertónískar lausnir||12959||12959|18146|
458794|B05DB0003|Dianeal PD4 Glucose Duo|kviđ.sk|38,6|mg/ml|2000|ml|5|pokar||B05DB00|01.03.1999|30.04.2012|R|||0|0|0|1|BAX|0|0|0|100|SEK|12959|18146|lyfsjukr||||10000|0||Icepharma hf|Baxter|Hýpertónískar lausnir||12959||12959|18146|
458865|A07AA0906|Vancomycin Xellia|hylki|250|mg|28|stk|1|ţpakki|hart hylki|A07AA09|01.01.2011||R|||0|0|E|0|XEL|0|0|1|100|DKK|24780|33644|lyfalmen||||28|0|3,5000|Actavis Group hf|Xellia Pharmaceuticals ApS|Vankómýcín||24780||24780|33644|
459104|N05AH0310|Zalasta (LYFIS)|töflur|2,5|mg|28|stk|1|ţpakki||N05AH03|01.10.2011||R|||0|0|*|0|LYF|0|1|0|100|XEU|2536|1994|lyfalmen|V0278|1857||28|0|7,0000|LYFIS ehf|LYFIS ehf|Olanzapín||742||742|1994|
459354|J01FF0101|Dalacin|stl|150|mg/ml|2|ml|1|lykja||J01FF01|01.11.1979||R|||0|0|0|1|PER|0|0|0|100|DKK|876|1264|lyfsjukr||||2|0|0,1667|Icepharma hf|Pfizer ApS|Klindamýcín||876||876|1264|
459420|J01FF0101|Dalacin|stl|150|mg/ml|4|ml|1|lykja||J01FF01|01.11.1979||R|||0|0|0|1|PER|0|0|0|100|DKK|1605|2316|lyfsjukr||||4|0|0,3333|Icepharma hf|Pfizer ApS|Klindamýcín||1605||1605|2316|
459766|N05AH0501|Sycrest|tungur.t|5|mg|20|stk|1|ţpakki||N05AH05|01.10.2011||R|||0|0|0|0|ORR|0|1|0|100|DKK|7786|11630|lyfalmen||||20|0|5,0000|Lundbeck Export A/S|N.V. Organon|Asenapíne||7786||7786|11630|
459828|N07BA0145|Nicorette Freshdrops|munnstfl|2|mg|96|stk|1|ţpakki||N07BA01|01.12.2010||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||96|0|6,4000|Vistor hf|McNeil Denmark ApS|Nikótín||||||
459859|B02AA0201|Cyklokapron|töflur|500|mg|30|stk|1|ţpakki||B02AA02|01.04.1989||R|||0|0|E|0|MAS|0|0|1|100|SEK|2217|4012|lyfalmen||||30|0|7,5000|Vistor hf|Meda AS|Tranexamsýra||2217||2217|4012|
459867|B02AA0201|Cyklokapron|töflur|500|mg|60|stk|1|ţpakki||B02AA02|01.04.1989||R|||0|0|E|0|MAS|0|0|1|100|SEK|4500|7135|lyfalmen||||60|0|15,0000|Vistor hf|Meda AS|Tranexamsýra||4500||4500|7135|
460170|J07BC0202|Avaxim|bóluefni|||0,5|ml|1|dćla|einnota dćla|J07BC02|01.04.1998||R|||0|0|0|0|MEX|0|0|0|100|XEU|4104|6593|lyfalmen||||0|0||Icepharma hf|Aventis Pasteur MSD A/S|Lifrarbólga-A, dauđ veira (inactiv­ated whole virus)||4104||4104|6593|
460303|J01CA0406|Flemoxin Solutab|lausnart|750|mg|20|stk|1|ţpakki||J01CA04|01.07.1989||R|||0|0|0|0|ASP|0|0|1|100|XEU|575|1765|lyfalmen||||20|0|15,0000|Vistor hf|Astellas Pharma A/S|Amoxicillín||575||575|1765|
460826|QJ01CR0201|Combisyn|töflur|250|mg|100|stk|1|töflur||QJ01CR02|01.11.2011||R|||0|0|0|0|NOB|1|0|0|100|XEU|7273|14138|vetalmen||||100|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Amoxicillín og Clavulansýra||7273||7273|14138|
460972|J07BB0205|Influvac|bóluefni|||0,5|ml|10|spr|einnotaspr|J07BB02|01.12.1998||R|||0|0|0|0|AHP|0|0|0|100|XEU|5716|8798|lyfalmen||||5|0||Vistor hf|Abbott Healthcare Products B.V.|Inflúensa, hreinsađir  mótefnavakar||5716||5716|8798|
461731|N02BE5102|Parkodin|töflur|510|mg|10|stk|1|pakki|ţp 10+500 mg|N02BE51|01.01.1989||R|||0|0|0|0|ACA|0|0|1|100|XEU|192|1242|lyfalmen||||10|0|1,6667|Actavis Group hf|Actavis hf|Paracetamól í blöndum nema međ geđlyfjum (psycholeptica)||192||192|1242|
462028|D07AD0101|Dermovat|krem|0,5|mg/g|25|g|1|túpa||D07AD01|01.09.1982||R|||0|0|B|0|GSK|0|0|1|100|GBP|705|1943|lyfalmen||||25|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Klóbetasól||705||705|1943|
462044|D07AD0101|Dermovat|smyrsli|0,5|mg/g|25|g|1|túpa||D07AD01|01.09.1982||R|||0|0|B|0|GSK|0|0|1|100|GBP|705|1943|lyfalmen||||25|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Klóbetasól||705||705|1943|
462358|A07EA0601|Entocort|endaţ.dr|20|mcg/ml|7|stk|1|ţpakki|samsett pk|A07EA06|01.04.1993||R|||0|0|B|0|AZD|0|0|0|100|SEK|7699|11511|lyfalmen||||7|0|7,0000|Vistor hf|AstraZeneca A/S DK|Búdesóníđ||7699||7699|11511|
462813|A07AA0906|Vancomycin Xellia|hylki|125|mg|28|stk|1|ţpakki|hart hylki|A07AA09|01.01.2011||R|||0|0|E|0|XEL|0|0|1|100|DKK|12373|18073|lyfalmen||||28|0|1,7500|Actavis Group hf|Xellia Pharmaceuticals ApS|Vankómýcín||12373||12373|18073|
462986|QM01AE9101|Rimadyl vet.|stl|50|mg/ml|20|ml|1|hgl||QM01AE91|01.06.2000||R|||0|0|0|0|PAL|1|0|0|100|DKK|6861|13347|vetalmen||||20|0||Icepharma hf|Pfizer Oy Animal Health|||||6861|13347|
463490|N03AX2101|Trobalt|filmhtfl|100|mg|84|stk|1|ţpakki||N03AX21|01.12.2011||R|||0|0|E|0|GGL|0|0|0|100|GBP|9475|13940|lyfalmen||||84|0||GlaxoSmithKline ehf|Glaxo Group Limited|Retigabín||9475||9475|13940|
463612|QM01AE9101|Rimadyl vet.|töflur|50|mg|100|stk|1|pakki||QM01AE91|01.06.2000||R|||0|0|0|0|PAL|0|0|0|100|DKK|5473|10682|vetalmen||||100|0||Icepharma hf|Pfizer Oy Animal Health|||5473||5473|10682|
464164|N02BE0101|Panodil|töflur|500|mg|30|stk|1|ţpakki||N02BE01|01.04.1992||L|||0|0|0|0|GSH|0|0|1|100|IKR|||lyflausa||||30|0|5,0000|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól||||||
464370|N05AD0301|Buronil|töflur|25|mg|100|stk|1|glas||N05AD03|01.12.1972||R|||0|0|*|0|LPL|0|1|0|100|DKK|1811|3456|lyfalmen||||100|0|8,3333|Swedish Orphan Biovitrum A/S|Lundbeck Pharmaceuticals|Melperón||1811||1811|3456|
465065|S01EE0104|Latanoprost Actavis|augndr|50|mcg/ml|7,5|ml|1|pakki|3 glös í pakka|S01EE01|01.10.2011||R|||0|0|*|0|APC|0|0|0|100|DKK|4173|6634|lyfalmen|V0376|6634||8|0|75,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Latanóprost||4134||4134|6634|
465203|QJ01RA0103|Depomycine, vet.|stl|||100|ml|1|hgl||QJ01RA01|01.12.1982||R|||0|0|0|0|INI|0|0|0|100|DKK|1216|2419|vetalmen||||100|0||Icepharma hf|Intervet International B.V.|||1216||1216|2419|
465237|QJ01CR5001|Duplocillin L.A., vet.|stl|||100|ml|1|hgl||QJ01CR50|01.05.1983||R|||0|0|0|0|INI|1|0|0|100|DKK|1148|2284|vetalmen||||100|0||Icepharma hf|Intervet International B.V.|||1148||1148|2284|
465260|QJ01AA0603|Engemycin, vet.|stl|100|mg/ml|100|ml|1|hgl||QJ01AA06|01.12.1982||R|||0|0|0|0|INI|0|0|0|100|DKK|1231|2449|vetalmen||||100|0||Icepharma hf|Intervet International B.V.|||1231||1231|2449|
465278|QJ51RC2301|Nafpenzal DC,  vet.|spenalyf|||3|g|4|spr||QJ51RC23|01.04.1985||R|||0|0|0|0|INI|0|0|0|100|XEU|647|1287|vetalmen||||12|0||Icepharma hf|Intervet International B.V.|||647||647|1287|
466086|N02AA0101|Contalgin|forđatfl|10|mg|25|stk|1|ţpakki||N02AA01|01.07.1992||R|||1|0|E|0|PER|0|0|0|100|DKK|683|1913|lyfalmen||||25|0|2,5000|Icepharma hf|Pfizer ApS|Morfín||683||683|1913|
466094|N02AA0101|Contalgin|forđatfl|10|mg|100|stk|1|ţpakki||N02AA01|01.08.1984||R|||1|0|E|0|PER|0|0|0|100|DKK|2113|3869|lyfalmen||||100|0|10,0000|Icepharma hf|Pfizer ApS|Morfín||2113||2113|3869|
466169|N02AA0101|Contalgin|forđatfl|30|mg|25|stk|1|ţpakki||N02AA01|01.07.1992||R|||1|0|E|0|PER|0|0|0|100|DKK|1513|3049|lyfalmen||||25|0|7,5000|Icepharma hf|Pfizer ApS|Morfín||1513||1513|3049|
466219|N02AA0101|Contalgin|forđatfl|30|mg|100|stk|1|ţpakki||N02AA01|01.08.1984||R|||1|0|E|0|PER|0|0|0|100|DKK|5912|9066|lyfalmen||||100|0|30,0000|Icepharma hf|Pfizer ApS|Morfín||5912||5912|9066|
466466|N02AA0101|Contalgin|forđatfl|60|mg|25|stk|1|ţpakki||N02AA01|01.10.1995||R|||1|0|E|0|PER|0|0|0|100|DKK|2812|4826|lyfalmen||||25|0|15,0000|Icepharma hf|Pfizer ApS|Morfín||2812||2812|4826|
466482|L04AD0102|Sandimmun Neoral|hylki|25|mg|50|stk|1|ţpakki||L04AD01|01.07.1994||R|||0|0|*|0|NOH|0|0|0|100|DKK|8101|12061|lyfalmen||||50|0|5,0000|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||8101||8101|12061|
466680|N02AA0101|Contalgin|forđatfl|100|mg|25|stk|1|ţpakki||N02AA01|01.07.1992||R|||1|0|E|0|PER|0|0|0|100|DKK|4627|7308|lyfalmen||||25|0|25,0000|Icepharma hf|Pfizer ApS|Morfín||4627||4627|7308|
466813|N06AG0201|Aurorix|töflur|150|mg|100|stk|1|ţpakki||N06AG02|01.10.1990||R|||0|0|B|0|MAS|0|1|0|100|SEK|4594|7263|lyfalmen||||100|0|50,0000|Vistor hf|Meda AS|Móklóbemíđ||4594||4594|7263|
467191|L03AA0201|Neupogen|stl|0,6|mg/ml|0,5|ml|1|spr|áfyllt sprauta, lausn|L03AA02|01.02.2004||R|||0|1|0|1|AEU|0|0|0|100|DKK|15627|21494|lyfsjukr||||0|0|0,8600|Vistor hf|Amgen Europe B.V.|Fílgrastím||15627||15627|21494|
467258|L03AA0201|Neupogen|stl|0,96|mg/ml|0,5|ml|1|spr|áfyllt sprauta, lausn|L03AA02|01.02.2004||R|||0|1|0|1|AEU|0|0|0|100|DKK|23948|31937|lyfsjukr||||0|0|1,3700|Vistor hf|Amgen Europe B.V.|Fílgrastím||23948||23948|31937|
467480|L03AB0502|IntronA|stl|18|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.02.2001||R|||0|1|0|1|SCP|0|0|0|100|DKK|18915|25621|lyfsjukr||||1|0|9,0000|Vistor hf|Schering-Plough|Interferón alfa-2b||18915||18915|25621|
467498|L03AB0502|IntronA|stl|30|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.02.2001||R|||0|1|0|1|SCP|0|0|0|100|DKK|30507|40169|lyfsjukr||||1|0|15,0000|Vistor hf|Schering-Plough|Interferón alfa-2b||30507||30507|40169|
467514|L04AA1001|Rapamune|mixtúra|1|mg/ml|60|ml|1|fl||L04AA10|01.04.2004||R|||0|1|*|0|WTE|0|0|0|100|DKK|34664|46048|lyfalmen||||60|0|20,0000|Icepharma hf|Wyeth Europe|Sirolimus||34664||34664|46048|
467563|L04AD0102|Sandimmun Neoral|hylki|50|mg|50|stk|1|ţpakki||L04AD01|01.07.1994||R|||0|0|*|0|NOH|0|0|0|100|DKK|15804|22379|lyfalmen||||50|0|10,0000|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||15804||15804|22379|
467621|L03AB0502|IntronA|stl|60|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.02.2001||R|||0|1|0|1|SCP|0|0|0|100|DKK|56739|73090|lyfsjukr||||1|0|30,0000|Vistor hf|Schering-Plough|Interferón alfa-2b||56739||56739|73090|
467720|L04AD0102|Sandimmun Neoral|hylki|100|mg|50|stk|1|ţpakki||L04AD01|01.07.1994||R|||0|0|*|0|NOH|0|0|0|100|DKK|30091|40309|lyfalmen||||50|0|20,0000|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||30091||30091|40309|
467993|N05AD0101|Haldol|stl|5|mg/ml|1|ml|5|lykjur||N05AD01|01.08.2000||R|||0|0|0|1|JAS|0|1|0|100|SEK|511|738|lyfsjukr||||5|0|3,1250|Vistor hf|Janssen-Cilag AB|Halóperídól||511||511|738|
468082|N06AB0401|Cipramil|töflur|10|mg|100|stk|1|plglas||N06AB04|01.04.1993||R|||0|0|B|0|LBK|0|1|0|100|DKK|6558|6791|lyfalmen|V0317|4676||100|0|50,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||4249||4249|6791|
468116|N01AH0102|Leptanal|stl|50|mcg/ml|2|ml|5|lykjur||N01AH01|01.11.2001||R|||1|0|0|1|JAS|0|0|0|100|SEK|389|561|lyfsjukr||||10|0||Vistor hf|Janssen-Cilag AB|Fentanýl||389||389|561|
468124|N06AB0401|Cipramil|töflur|20|mg|100|stk|1|glas||N06AB04|01.04.1993||R|||0|0|B|0|LBK|0|1|0|100|DKK|9549|6470|lyfalmen|V0318|4475||100|0|100,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||4014||4014|6470|
468165|N06AB0401|Cipramil|töflur|40|mg|100|stk|1|glas||N06AB04|01.04.1993||R|||0|0|0|0|LBK|0|1|0|100|DKK|24128|13052|lyfalmen|V0320|7418||100|0|200,0000|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||8826||8826|13052|
468803|M05BA0705|Risedronat Actavis|filmhtfl|35|mg|12|stk|1|ţpakki||M05BA07|01.03.2011||R|||0|0|E|0|APC|0|0|0|100|IKR|4530|4397|lyfalmen|V0207|3640||12|0|84,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rísedrónsýru||2499||2499|4397|
468996|A02BC0402|Rabeprazol Actavis|sţ-tfl|10|mg|100|stk|1|glas||A02BC04|01.01.2012||R|||0|0|E|0|APC|0|0|0|100|XEU|4525|5605|lyfalmen|V0467|5605||100|0|50,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||3382||3382|5605|
469346|C10AB0401|Lopid|töflur|600|mg|98|stk|1|ţpakki||C10AB04|01.07.1991||R|||0|0|0|0|PER|0|0|0|100|DKK|5765|8865|lyfalmen||||98|0|49,0000|Icepharma hf|Pfizer ApS|Gemfíbrózíl||5765||5765|8865|
469480|B05BA0311|Glucos Fresenius Kabi|irl|500|mg/ml|500|ml|20|pokar|Freeflex umbúđir|B05BA03|01.12.2011||R|||0|0|0|1|FRP|0|0|0|100|DKK|7764|11205|lyfsjukr||||10000|0||Icepharma hf|Fresenius Kabi|Kolvetni||7764||7764|11205|
469817|N02AX0206|Nobligan Retard|forđatfl|200|mg|100|stk|1|pakki||N02AX02|01.05.2000||R|||0|0|E|0|GRU|0|0|1|100|DKK|6457|9812|lyfalmen|V0228|9784||100|0|66,6667|Icepharma hf|Grunenthal|Tramadól||6457||6457|9812|
469874|N02AX0206|Nobligan Retard|forđatfl|150|mg|100|stk|1|pakki||N02AX02|01.05.2000||R|||0|0|E|0|GRU|0|0|1|100|DKK|5250|8161|lyfalmen|V0227|7593||100|0|50,0000|Icepharma hf|Grunenthal|Tramadól||5250||5250|8161|
469932|N02AX0206|Nobligan Retard|forđatfl|100|mg|100|stk|1|pakki||N02AX02|01.05.2000||R|||0|0|E|0|GRU|0|0|1|100|DKK|3427|5667|lyfalmen|V0226|4969||100|0|33,3333|Icepharma hf|Grunenthal|Tramadól||3427||3427|5667|
470385|R03BA0501|Flixotide|innúđal|250|mcg/sk|120|sk|1|stauk||R03BA05|01.04.1995||R|||0|0|B|0|GSK|0|0|0|100|GBP|6206|9468|lyfalmen||||120|0|50,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||6206||6206|9468|
470397|N05CM1801|Dexdor|irţ|100|mcg/ml|4|ml|4|hgl|lausn|N05CM18|01.03.2012||R|||0|1|0|1|ORC|0|0|0|100|DKK|31630|41578|lyfsjukr||||16|0||Vistor hf|Orion Corporation|Dexmedetómid||31630||31630|41578|
470989|V08AB0201|Omnipaque|stl|180|mg J/ml|15|ml|10|plastf||V08AB02|01.01.2005||R|||0|0|0|1|GEH|0|0|0|100|NOK|7418|10706|lyfsjukr||||150|0||Icepharma hf|GE Healthcare AS|Jóhexól||7418||7418|10706|
471144|V08AB0201|Omnipaque|stl|240|mg J/ml|20|ml|10|plastf||V08AB02|01.10.1998||R|||0|0|0|1|GEH|0|0|0|100|NOK|9901|14290|lyfsjukr||||200|0||Icepharma hf|GE Healthcare AS|Jóhexól||9901||9901|14290|
471151|V08AB0201|Omnipaque|stl|300|mg J/ml|10|ml|10|plastf||V08AB02|01.06.2004||R|||0|0|0|1|GEH|0|0|0|100|IKR|4414|6371|lyfsjukr||||100|0||Icepharma hf|GE Healthcare AS|Jóhexól||4414||4414|6371|
471169|V08AB0201|Omnipaque|stl|300|mg J/ml|20|ml|10|plastf||V08AB02|01.10.1998||R|||0|0|0|1|GEH|0|0|0|100|NOK|9892|14277|lyfsjukr||||200|0||Icepharma hf|GE Healthcare AS|Jóhexól||9892||9892|14277|
471177|V08AB0201|Omnipaque|stl|350|mg J/ml|20|ml|10|plastf||V08AB02|01.10.1998||R|||0|0|0|1|GEH|0|0|0|100|NOK|14206|19711|lyfsjukr||||200|0||Icepharma hf|GE Healthcare AS|Jóhexól||14206||14206|19711|
471425|A10BB0701|Mindiab|töflur|5|mg|100|stk|1|ţpakki||A10BB07|01.07.1990||R|||0|0|*|0|PER|0|0|0|100|DKK|1246|2683|lyfalmen||||100|0|50,0000|Icepharma hf|Pfizer ApS|Glípízíđ||1246||1246|2683|
471821|QP52AC1302|Panacur, vet.|töflur|250|mg|20|stk|1|ţpakki||QP52AC13|01.04.1992||L|||0|0|0|0|INI|0|0|0|100|DKK|2175|3794|vetorma||||20|0||Icepharma hf|Intervet International B.V.|||||2175|3794|
471938|L01AA0101|Sendoxan|töflur|50|mg|100|stk|1|ţpakki||L01AA01|01.01.1988||R|||0|0|*|0|BAM|0|0|0|100|SEK|3367|5585|lyfalmen||||100|0||Icepharma hf|Baxter Medical AB|Cýklófosfamíđ||3367||3367|5585|
471953|QV03AB9001|Antisedan, vet.|stl|5|mg/ml|10|ml|1|hgl||QV03AB90|01.08.2006||R|||0|0|0|0|ORC|1|0|0|100|DKK|4872|9528|vetalmen||||10|0||Vistor hf|Orion Corporation|||4872||4872|9528|
472092|C07AB0206|Seloken ZOC|forđatfl|47,5|mg|98|stk|1|ţpakki||C07AB02|01.07.1989||R|||0|0|B|0|AZD|0|0|0|100|SEK|2147|3916|lyfalmen|V0048|2636||98|0|31,0300|Vistor hf|AstraZeneca A/S DK|Metóprólól||2147||2147|3916|
472099|R02AA0307|Strepsils Warm|sogtfl|||24|stk|1|ţpakki||R02AA03|01.08.2011||L|||0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa||||24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól||||||
472332|J07BC0201|Havrix|bóluefni|1440|ein/ml|0,5|ml|1|dćla|einnota dćla|J07BC02|01.10.1995||R|||0|0|0|0|GSK|0|0|0|100|GBP|3311|5508|lyfalmen||||0|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lifrarbólga-A, dauđ veira (inactiv­ated whole virus)||3311||3311|5508|
472599|A02BC0506|Esomeprazole Krka (LYFIS)|sţ-hylki|40|mg|98|stk|1|glas||A02BC05|01.08.2011||R|||0|0|E|0|LYF|0|0|0|100|XEU|14111|5659|lyfalmen|V0012|5497||98|0|130,6700|LYFIS ehf|LYFIS ehf|Esómeprazól||3421||3421|5659|
474007|B05AA0507|Promiten|stl|150|mg/ml|20|ml|20|lykjur|plastlykjur|B05AA05|01.03.1999||R|||0|0|0|1|MAB|0|0|0|100|SEK|15670|21548|lyfsjukr||||400|0||Vistor hf|Meda AB|Dextran||15670||15670|21548|
474043|N01AH0601|Remifentanil Actavis|sts/irs|2|mg|5|hgl|1|pakki|ţykkni,lausn|N01AH06|01.06.2012||R|||1|0|0|1|AGP|0|0|0|100|XEU|5385|7772|lyfsjukr||||5|0||Actavis Group hf|Actavis Group PTC ehf|Remífentaníl||5385||5385|7772|
474106|M02AA1301|Deep Relief|hlaup|5|%|50|g|1|túpa||M02AA13|01.06.2000||L|||0|0|0|0|MEN|0|0|1|100|IKR|||lyflausa||||50|0||Icepharma hf|Mentholatum Company Ltd.|Íbúprófen||||||
474114|N02CA7201|Anervan|töflur|160,5|mg|30|stk|1|pakki|ţp (0,5+10+50+100 mg)|N02CA72|01.10.1995||R|||0|0|E|0|REP|0|0|0|100|SEK|1033|2392|lyfalmen||||30|0|3,7500|Vistor hf|Recip AB|Ergotamínlyf í blöndum međ geđlyfjum (psycoleptica)||1033||1033|2392|
474197|M02AA1301|Deep Relief|hlaup|5|%|15|g|1|túpa||M02AA13|01.06.2000||L|||0|0|0|0|MEN|0|0|1|100|IKR|||lyflausa||||15|0||Icepharma hf|Mentholatum Company Ltd.|Íbúprófen||||||
474395|J05AG0101|Viramune|töflur|200|mg|60|stk|1|ţpakki||J05AG01|01.03.2007||R|||0|1|0|1|BII|0|0|0|100|DKK|37384|48799|lyfsjukr||||60|0|30,0000|Vistor hf|Boehringer Ingelheim International |Nevírapín||37384||37384|48799|
474431|N05AH0310|Zalasta (LYFIS)|munndr.t|10|mg|28|stk|1|ţpakki||N05AH03|01.02.2012||R|||0|0|*|0|LYF|0|1|0|100|XEU|14725|11063|lyfalmen|V0456|11063||28|0|28,0000|LYFIS ehf|LYFIS ehf|Olanzapín||7372||7372|11063|
474551|R01AD0901|Nasonex|nefúđi|50|mcg/sk|140|skammtar|1|úđagl|18 g í pakkn.|R01AD09|01.05.1998||R|||0|0|E|0|SPL|0|0|1|100|DKK|1894|3570|lyfalmen||||140|0|35,0000|Vistor hf|Schering-Plough Europe|Mómetasón||1894||1894|3570|
474608|QB03AC9001|Uniferon|stl|200|mg/ml|100|ml|12|hgl|lausn|QB03AC90|01.08.2011||R|||0|0|0|0|PHM|0|0|0|100|DKK|28283|54480|vetalmen||||1200|0||Icepharma hf|Pharmacosmos A/S|Járn hýdróxíđ||||28283|54480|
474657|N04BC0504|Oprymea (Lyfis)|töflur|0,088|mg|30|stk|1|ţpakki||N04BC05|01.07.2010||R|||0|0|E|0|LYF|0|0|0|100|XEU|816|1138|lyfalmen|V0266|1138||30|0|1,0600|Lyfis ehf|Lyfis ehf|Pramipexól||116||116|1138|
475434|B01AA0301|Kovar|töflur|2|mg|100|stk|1|glas||B01AA03|01.10.1995||R|||0|0|E|0|ACA|0|0|0|100|IKR|930|2251|lyfalmen||||100|0|26,6667|Actavis Group hf|Actavis hf|Warfarín||930||930|2251|
475467|G03CA0306|Evorel|forđapl|50|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993||R|||0|0|E|0|JAS|0|0|0|100|SEK|3224|5389|lyfalmen|V0130|5389||26|0|91,0000|Vistor hf|Janssen-Cilag AB|Estradíól||3224||3224|5389|
475491|N02AA5902|Parkodin forte|töflur|530|mg|20|stk|1|pakki|ţp 30+500 mg|N02AA59|01.04.1992||R|||0|0|0|0|ACA|0|0|1|100|NOK|296|1384|lyfalmen||||20|0|6,6667|Actavis Group hf|Actavis hf|Kódein í blöndum nema međ geđlyfjum||296||296|1384|
475533|N02AA5902|Parkodin forte|töflur|530|mg|30|stk|1|pakki|ţp 30+500 mg|N02AA59|01.04.1992||R|||0|0|0|0|ACA|0|0|1|100|NOK|362|1474|lyfalmen||||30|0|10,0000|Actavis Group hf|Actavis hf|Kódein í blöndum nema međ geđlyfjum||362||362|1474|
475715|N02AA5902|Parkodin forte|töflur|530|mg|100|stk|1|pakki|ţp 30+500 mg|N02AA59|01.04.1992||R|||1|0|0|0|ACA|0|0|1|100|NOK|1011|2362|lyfalmen||||100|0|33,3333|Actavis Group hf|Actavis hf|Kódein í blöndum nema međ geđlyfjum||1011||1011|2362|
475798|R03AC1302|Oxis Turbuhaler|innúđadu|4,5|mcg/sk|60|sk|1|stauk||R03AC13|01.10.1997||R|||0|0|0|0|AZD|0|0|1|100|SEK|3713|6058|lyfalmen||||60|0|11,2500|Vistor hf|AstraZeneca A/S DK|Formóteról||3713||3713|6058|
475822|R03AC1302|Oxis Turbuhaler|innúđadu|9|mcg/sk|60|sk|1|stauk||R03AC13|01.10.1997||R|||0|0|0|0|AZD|0|0|1|100|SEK|4891|7670|lyfalmen||||60|0|22,5000|Vistor hf|AstraZeneca A/S DK|Formóteról||4891||4891|7670|
475921|A10AB0404|Humalog Pen|stl|100|ae/ml|3|ml|5|pennar|einnota pennar|A10AB04|01.11.1999||R|||0|0|*|0|ELD|0|0|0|100|XEU|5694|8768|lyfalmen||||15|0|37,5000|Icepharma hf|Eli Lilly Nederland B.V.|Insúlín lispró||5694||5694|8768|
476093|A10AC0106|Humulin NPH Pen|stl|100|ae/ml|3|ml|5|pennar|Einnota pennar|A10AC01|01.06.1999||R|||0|0|*|0|ELI|0|0|0|100|XEU|6152|9395|lyfalmen||||15|0|37,5000|Icepharma hf|Eli Lilly Danmark A/S|Insúlín (manna)||6152||6152|9395|
476434|B03XA0201|Aranesp|stl|60|mcg/spr|0,3|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|||0|1|0|1|AMG|0|0|0|100|DKK|79277|101375|lyfsjukr||||1|0|53,3300|Vistor hf|Amgen|Darbepóetín alfa||||79277|101375|
476580|R03AC0206|Ventoline|lausn|2|mg/ml|20|lykjur|1|pakki|f. vél|R03AC02|01.04.1992||R|||0|0|0|0|GSK|0|0|1|100|GBP|1216|2642|lyfalmen||||20|0|10,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salbútamól||1216||1216|2642|
476736|N05AH0311|Olanzapine Ranbaxy|töflur|10|mg|56|stk|1|ţpakki||N05AH03|01.12.2011||R|||0|0|*|0|RAN|0|1|0|100|XEU|12113|7774|lyfalmen|V0282|7774||56|0|56,0000|Artasan ehf|Ranbaxy (UK) Ltd|Olanzapín||4967||4967|7774|
477059|P01BB5101|Malarone|filmhtfl|350|mg|12|stk|1|glas|250 + 100 mg|P01BB51|01.02.2006||R|||0|0|0|0|GSK|0|0|0|100|GBP|5453|8438|lyfalmen||||12|0|3,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Prógúaníl í blöndum||5453||5453|8438|
477547|V07AB0003|Sterilt vatten Fresenius Kabi|leysir|||20|ml|10|hgl|fyrir stungulyf|V07AB00|01.02.2007||L|||0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa||||200|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar||||||
477554|V07AB0003|Sterilt vatten Fresenius Kabi|leysir|||50|ml|10|hgl|fyrir stungulyf|V07AB00|01.02.2007||L|||0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa||||500|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar||||||
477752|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|20|ml|10|hgl|fyrir stungulyf|V07AB|01.08.2004||L|||0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa||||200|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar||||||
477760|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|50|ml|10|hgl|fyrir stungulyf|V07AB|01.08.2004||L|||0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa||||500|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar||||||
477786|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|100|ml|10|hgl|fyrir stungulyf|V07AB|01.08.2004||L|||0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa||||1000|0||Icepharma hf|Fresenius Kabi|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar||||||
478119|A10BA0202|Metformin Actavis|filmhtfl|500|mg|100|stk|1|glas||A10BA02|01.12.2011||R|||0|0|*|0|APC|0|0|0|100|XEU|506|1671|lyfalmen|V0500|1671||100|0|25,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Metformín||506||506|1671|
479407|L04AA1302|Leflunomide medac|filmhtfl|20|mg|100|stk|1|glas||L04AA13|01.07.2011||R|||0|1|*|0|WIL|0|0|0|100|XEU|29968|40155|lyfalmen|V0454|40155||100|0|100,0000|Williams & Halls efh|medac Gesellschaft|Leflúnómíđ||29968||29968|40155|
480863|G03XC0101|Evista|töflur|60|mg|28|stk|1|ţpakki||G03XC01|01.02.1999|31.05.2012|R|||0|0|E|0|DSG|0|0|0|100|SEK|4432|7042|lyfalmen||||28|0|28,0000|Icepharma hf|Daiichi Sankyo Europe GmbH|Raloxífen||4432||4432|7042|
480867|N06DA0205|Donesyn|filmhtfl|5|mg|98|stk|1|ţpakki||N06DA02|01.05.2011||R|||0|0|E|0|WIH|0|0|0|100|XEU|26733|18558|lyfalmen|V0341|17249||98|0|65,3333|Portfarma ehf|Williams & Halls|Dónepezíl||12759||12759|18558|
480897|G03XC0101|Evista|töflur|60|mg|84|stk|1|ţpakki||G03XC01|01.02.1999||R|||0|0|E|0|DSG|0|0|0|100|SEK|12811|18623|lyfalmen||||84|0|84,0000|Icepharma hf|Daiichi Sankyo Europe GmbH|Raloxífen||12811||12811|18623|
481176|N06AX1201|Zyban|forđatfl|150|mg|100|stk|1|ţpakki||N06AX12|01.09.2000||R|||0|0|0|0|GSK|0|1|1|100|GBP|14699|20992|lyfalmen||||100|0|50,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Bupropionum||14699||14699|20992|
481534|N02AX0204|Tradolan|filmhtfl|50|mg|20|stk|1|ţpakki||N02AX02|01.05.2012||R|||0|0|E|0|GLP|0|0|1|100|SEK|336|1439|lyfalmen|V0055|1276||20|0|3,3300|Vistor hf|G.L.Pharma GmbH|Tramadól||336||336|1439|
483217|B01AX0601 |Xarelto|filmhtfl|20|mg|98|stk|1|ţpakki||B01AX06|01.05.2012||R|||0|0|E|0|BAP|0|0|0|100|SEK|36984|48960|lyfalmen|V0030|48907||98|0|196,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaroxaban||||36984|48960|
483602|J02AC0101|Diflucan|irl|2|mg/ml|50|ml|1|fl||J02AC01|01.04.1990||R|||0|0|0|1|PER|0|0|0|100|DKK|2837|4095|lyfsjukr||||50|0|0,5000|Icepharma hf|Pfizer ApS|Flúkónazól||2837||2837|4095|
483663|B03BA0302|Vibeden|stl|1|mg/ml|1|ml|3|lykja||B03BA03|01.07.2012||R|||0|0|E|0|SHS|0|0|1|100|DKK|3616|5925|lyfalmen||||3|0|150,0000|Artasan ehf|Sandoz A/S|Hýdroxókóbalamín||3616||3616|5925|
483685|J02AC0101|Diflucan|irl|2|mg/ml|100|ml|1|hgl||J02AC01|01.03.2001||R|||0|0|0|1|PER|0|0|0|100|DKK|4896|7066|lyfsjukr||||100|0|1,0000|Icepharma hf|Pfizer ApS|Flúkónazól||4896||4896|7066|
483711|S01ED5114|Latanoprost/Timolol Portfarma|augndr|5,05|mg/ml|2,5|ml|1|glas|5mg/ml+50mcg/ml|S01ED51|01.01.2012||R|||0|0|*|0|POF|0|0|0|100|DKK|2480|4371|lyfalmen|V0374|4371||2|0|25,0000|Portfarma ehf|Portfarma|Tímólól í blöndum||2480||2480|4371|
483996|N02AX0212|Tramadol Actavis|hylki|50|mg|20|stk|1|ţpakki||N02AX02|01.09.2011||R|||0|0|E|0|AGP|0|0|1|100|XEU|297|1276|lyfalmen|V0055|1276||20|0|3,3300|Actavis Group hf|Actavis Group PTC ehf|Tramadól||217||217|1276|
484022|L02AE0401|Decapeptyl Depot|sts|3,75|mg|1|stk|3|spr|+ leysir|L02AE04|01.01.1995||R|||0|1|0|1|FER|0|0|0|100|DKK|58514|75318|lyfsjukr||||3|0|83,9552|Vistor hf|Ferring|Triptórelín||58514||58514|75318|
484238|D11AX1001|Propecia|töflur|1|mg|28|stk|1|ţpakki||D11AX10|01.08.1999||R|||0|0|0|0|MSD|0|0|0|100|DKK|6080|9296|lyfalmen||||28|0|28,0000|Vistor hf|M.S.D.|Fínasteríđ||6080||6080|9296|
484327|L03AA1301|Neulasta|stl|6|mg/spr|0,6|ml|1|spr|nálavörn|L03AA13|01.11.2010||R|||0|1|0|1|AEU|0|0|0|100|DKK|156608|198426|lyfsjukr||||1|0|20,0000|Vistor hf|Amgen Europe B.V.|Pegfilgrastím||156608||156608|198426|
484618|A01AD0201|Andolex|lausn|1,5|mg/ml|300|ml|1|glas|lausn til munnskolunar|A01AD02|01.01.1996||R|||0|0|E|0|MEB|0|0|1|100|SEK|1392|2883|lyfalmen||||300|0||Vistor hf|Meda AB (V)|Benzýdamín||1392||1392|2883|
484721|L04AD0201|Advagraf|forđahlk|3|mg|50|stk|1|ţpakki||L04AD02|01.03.2012||R|||0|1|*|0|APE|0|0|0|100|XEU|57147|74265|lyfalmen||||50|0|30,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||57147||57147|74265|
485006|S01BA0401|Ultracortenol|augnsm|5|mg/g|5|g|1|túpa||S01BA04|01.01.2012||R|||0|0|E|0|ANS|0|0|1|100|XEU|1268|2713|lyfalmen||||5|0||Anstalt zur gewerblichen Produktion|Anstalt zur gewerblichen Produktion|Prednisólón||1268||1268|2713|
486779|M01AE0218|Naproxen Mylan|töflur|250|mg|20|stk|1|ţpakki||M01AE02|01.04.1995||L|||0|0|0|0|MYL|0|0|1|100|IKR|||lyflausa||||20|0|10,0000|Actavis Group PTC ehf|Mylan AB|Naproxen||||||
486860|S01BA0101|Maxidex|augndr|1|mg/ml|5|ml|1|glas||S01BA01|01.01.1977||R|||0|0|E|0|SAL|0|0|1|100|USD|498|1660|lyfalmen||||5|0||Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Dexametasón||498||498|1660|
486886|S01CA0101|Maxitrol|augndr|||5|ml|1|glas||S01CA01|01.07.1990||R|||0|0|E|0|SAL|0|0|1|100|USD|711|1952|lyfalmen||||5|0||Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Dexametasón||711||711|1952|
487682|N06AB1005|Escitalopram LYFIS|filmhtfl|15|mg|100|stk|1|ţpakki||N06AB10|01.02.2012||R|||0|0|B|0|LYF|0|1|0|100|XEU|4829|5399|lyfalmen|V0326|5399||100|0|150,0000|LYFIS ehf|LYFIS ehf|Escítalópram||3231||3231|5399|
487796|L04AA1302|Leflunomide medac|töflur|10|mg|100|stk|1|glas||L04AA13|01.07.2011||R|||0|1|*|0|WIL|0|0|0|100|XEU|33468|44547|lyfalmen|V0453|44547||100|0|50,0000|Williams & Halls efh|medac Gesellschaft|Leflúnómíđ||33468||33468|44547|
488049|M01AX0101|Relifex|töflur|500|mg|20|stk|1|ţpakki||M01AX01|01.04.1995||R|||0|0|E|0|MAB|0|0|1|100|SEK|963|2296|lyfalmen||||20|0|10,0000|Vistor hf|Meda AB|Nabúmeton||963||963|2296|
488056|M01AX0101|Relifex|töflur|500|mg|60|stk|1|plglas||M01AX01|01.07.1998||R|||0|0|E|0|MAB|0|0|1|100|SEK|2676|4640|lyfalmen|V0198|3824||60|0|30,0000|Vistor hf|Meda AB|Nabúmeton||2676||2676|4640|
488767|D05BB0201|Neotigason|hylki|10|mg|50|stk|1|ţpakki||D05BB02|01.04.1992||R|||0|1|B|0|APC|0|0|0|100|DKK|6428|9772|lyfalmen||||50|0|14,2857|Actavis Group PTC ehf|Actavis Group PTC ehf|Acitretín||6428||6428|9772|
488791|D05BB0201|Neotigason|hylki|25|mg|50|stk|1|ţpakki||D05BB02|01.04.1992||R|||0|1|B|0|APC|0|0|0|100|DKK|11561|16794|lyfalmen||||50|0|35,7143|Actavis Group PTC ehf|Actavis Group PTC ehf|Acitretín||11561||11561|16794|
489259|B03XA0201|Aranesp|stl|80|mcg/spr|0,4|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|||0|1|0|1|AMG|0|0|0|100|DKK|105675|134505|lyfsjukr||||2|0|71,1100|Vistor hf|Amgen|Darbepóetín alfa||||105675|134505|
489591|M01AB0506|Voltaren Rapid|töflur|50|mg|10|stk|1|ţpakki||M01AB05|01.01.1996||R|||0|0|0|0|NOH|0|0|1|100|IKR|338|1242|lyfalmen|V0188|463||10|0|5,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||192||192|1242|
489609|M01AB0506|Voltaren Rapid|töflur|50|mg|30|stk|1|ţpakki||M01AB05|01.01.1996||R|||0|0|E|0|NOH|0|0|1|100|IKR|882|1618|lyfalmen|V0188|1389||30|0|15,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||467||467|1618|
490417|G03FB0504|Evorel Sequi|forđapl|||8|stk|1|pakki||G03FB05|01.08.1999||R|||0|0|E|0|JAS|0|0|0|100|SEK|2409|4274|lyfalmen||||8|0|28,0000|Vistor hf|Janssen-Cilag AB|Noretísterón og östrógen||2409||2409|4274|
490425|G03FA0104|Evorel Conti|forđapl|||8|stk|1|pakki||G03FA01|01.08.1999||R|||0|0|E|0|JAS|0|0|0|100|SEK|2538|4451|lyfalmen||||8|0|28,0000|Vistor hf|Janssen-Cilag AB|Noretísterón og östrógen||2538||2538|4451|
490797|C10AA0501|Zarator|töflur|10|mg|30|stk|1|ţpakki||C10AA05|01.03.1998||R|||0|0|0|0|PER|0|0|0|100|DKK|4047|6515|lyfalmen||||30|0|15,0000|Icepharma hf|Pfizer ApS|Atorvastatín||4047||4047|6515|
490805|C10AA0501|Zarator|töflur|10|mg|100|stk|1|ţpakki||C10AA05|01.03.1998||R|||0|0|0|0|PER|0|0|0|100|DKK|11078|10805|lyfalmen|V0112|2527||100|0|50,0000|Icepharma hf|Pfizer ApS|Atorvastatín||7183||7183|10805|
490813|C10AA0501|Zarator|töflur|20|mg|30|stk|1|ţpakki||C10AA05|01.03.1998||R|||0|0|0|0|PER|0|0|0|100|DKK|5381|8340|lyfalmen||||30|0|30,0000|Icepharma hf|Pfizer ApS|Atorvastatín||5381||5381|8340|
490821|C10AA0501|Zarator|töflur|20|mg|100|stk|1|ţpakki||C10AA05|01.03.1998||R|||0|0|0|0|PER|0|0|0|100|DKK|15721|14654|lyfalmen|V0113|3246||100|0|100,0000|Icepharma hf|Pfizer ApS|Atorvastatín||9997||9997|14654|
490854|C10AA0501|Zarator|töflur|40|mg|100|stk|1|ţpakki||C10AA05|01.03.1998||R|||0|0|0|0|PER|0|0|0|100|DKK|19995|18378|lyfalmen|V0114|6047||100|0|200,0000|Icepharma hf|Pfizer ApS|Atorvastatín||12616||12616|18378|
491860|L03AX0301|Oncotice|duft|500|millj ae|3|hgl|1|pakki|Fyrir ídreypivökva.|L03AX03|01.03.1999||R|||0|1|0|1|ORG|0|0|0|100|DKK|50516|65280|lyfsjukr||||3|0|20,8300|Vistor hf|N.V. Organon|BCG bóluefni||50516||50516|65280|
492405|N04BA0202|Madopar Depot|forđahlk|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.01.1991||R|||0|0|E|0|ROC|0|0|0|100|DKK|3359|5574|lyfalmen||||100|0|16,6667|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||3359||3359|5574|
492512|A02BC0102|Losec|sh-tfl|10|mg|14|stk|1|ţpakki||A02BC01|01.09.2009||L|||0|0|0|0|AZD|0|0|0|100|IKR|||lyflausa||||14|0|7,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól||||||
492520|A02BC0102|Losec|sh-tfl|10|mg|100|stk|1|glas||A02BC01|01.01.1999||R|||0|0|0|0|AZD|0|0|0|100|SEK|12725|18515|lyfalmen|V0002|7126||100|0|50,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól||12725||12725|18515|
492546|A02BC0102|Losec|sh-tfl|20|mg|14|stk|1|ţpakki||A02BC01|01.05.2009||L|||0|0|0|0|AZD|0|0|0|100|IKR|||lyflausa||||14|0|14,0000|Vistor hf|AstraZeneca A/S DK|Ómeprazól||||||
493113|R02AA0306|Strepsils Jordbćr Sukkerfri|sogtfl|||24|stk|1|ţpakki||R02AA03|01.09.2011||L|||0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa||||24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól||||||
493689|N03AX1404|Levetiracetam Actavis|filmhtfl|1000|mg|100|stk|1|ţpakki||N03AX14|01.12.2011||R|||0|0|0|0|APC|0|0|0|100|XEU|24475|22980|lyfalmen|V0516|20556||100|0|66,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Levetíracetam||16283||16283|22980|
494013|N06AA0601|Surmontil|töflur|25|mg|100|stk|1|glas||N06AA06|01.10.1995||R|||0|0|B|0|SNO|0|1|0|100|NOK|1457|2972|lyfalmen||||100|0|16,6667|Vistor hf|Sanofi-aventis Norge AS|Trímípramín||1457||1457|2972|
494138|N02CX0101|Sandomigrin|töflur|0,5|mg|100|stk|1|ţpakki||N02CX01|01.04.1974||R|||0|0|E|0|NOH|0|0|0|100|DKK|2525|4433|lyfalmen||||100|0|33,3333|Vistor hf|Novartis Healthcare A/S-|Pízótífen||2525||2525|4433|
494237|L01XC0201|MabThera|irţ|100|mg|10|ml|2|hgl|lausn|L01XC02|01.11.2003||R|||0|1|0|1|RRL|0|0|0|100|DKK|82700|105671|lyfsjukr||||20|0||Icepharma hf|Roche Registration Limited|Rítúxímab||82700||82700|105671|
494286|L01XC0201|MabThera|irţ|500|mg|50|ml|1|hgl|lausn|L01XC02|01.11.2003||R|||0|1|0|1|RRL|0|0|0|100|DKK|206749|261352|lyfsjukr||||50|0||Icepharma hf|Roche Registration Limited|Rítúxímab||206749||206749|261352|
494559|D10AF0101|Dalacin|fleyti|10|mg/ml|60|ml|1|glas|Áburđur, fleyti|D10AF01|01.10.1995||R|||0|0|0|0|PER|0|0|0|100|DKK|2060|3797|lyfalmen||||60|0||Icepharma hf|Pfizer ApS|Klindamýcín||2060||2060|3797|
494682|G03CA0320|Estrofem 2 mg|töflur|2|mg|84|stk|1|skífup||G03CA03|01.12.1980||R|||0|0|E|0|NAS|0|0|0|100|DKK|2311|4140|lyfalmen|V0128|1941||84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Estradíól||2311||2311|4140|
494724|G03FA0102|Kliogest|töflur|||84|stk|1|skífup||G03FA01|01.10.1986||R|||0|0|E|0|NAS|0|0|0|100|DKK|3359|5574|lyfalmen|V0410|4298||84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Noretísterón og östrógen||3359||3359|5574|
494831|B01AC0702|Persantin retard|forđahlk|200|mg|60|stk|1|glas|hart hylki|B01AC07|01.04.2006||R|||0|0|E|0|BII|0|0|0|100|DKK|1910|3592|lyfalmen||||60|0|30,0000|Vistor hf|Boehringer Ingelheim International |Dípýrídamól||1910||1910|3592|
495283|A04AA0101|Zofran|töflur|8|mg|15|stk|1|ţpakki||A04AA01|01.01.1991||R|||0|0|E|0|GSK|0|0|0|100|GBP|19596|8698|lyfalmen|V0384|8698||15|0|7,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ondansetrón||5643||5643|8698|
495382|A04AA0101|Zofran|stl|2|mg/ml|2|ml|5|lykjur||A04AA01|01.01.1991||R|||0|0|E|0|GSK|0|0|0|100|GBP|7622|8838|lyfalmen|V0382|6501||10|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ondansetrón||5745||5745|8838|
495390|A04AA0101|Zofran|stl|2|mg/ml|4|ml|5|lykjur||A04AA01|01.01.1991||R|||0|0|E|0|GSK|0|0|0|100|GBP|10889|10446|lyfalmen|V0383|10176||20|0|2,5000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ondansetrón||6921||6921|10446|
495820|J05AH0101|Relenza|innúđadu|5|mg/úđask|20|sk|1|stauk|+diskhaler|J05AH01|01.02.2000||R|||0|0|0|0|GSK|0|0|0|100|GBP|2990|5069|lyfalmen||||20|0|5,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Zanamivír||2990||2990|5069|
496040|N06DA0303|Nimvastid (Lyfis)|hylki|4,5|mg|112|stk|1|ţpakki||N06DA03|01.04.2011||R|||0|0|E|0|LYF|0|0|0|100|XEU|30664|30459|lyfalmen|V0345|30459||112|0|56,0000|Lyfis ehf|Lyfis ehf|Rívastigmín||22242||22242|30459|
496174|QJ01MA9001|Baytril vet.|töflur|150|mg|10|stk|1|ţpakki||QJ01MA90|01.03.2009||R|||0|0|0|0|BAN|0|0|0|100|DKK|4323|8473|vetalmen||||10|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||||4323|8473|
496547|C07AG0101|Trandate|stl|5|mg/ml|20|ml|5|lykjur||C07AG01|01.01.1985||R|||0|0|B|0|AUG|0|0|0|100|GBP|6218|9485|lyfalmen||||100|0|0,8333|Aspen Europe GmbH|Aspen Europe GmbH|Labetalól||6218||6218|9485|
496554|C07AG0101|Trandate|filmhtfl|100|mg|50|stk|1|glas||C07AG01|01.02.1982||R|||0|0|B|0|AUG|0|0|0|100|GBP|1091|2471|lyfalmen||||50|0|8,3333|Aspen Europe GmbH|Aspen Europe GmbH|Labetalól||1091||1091|2471|
496644|L03AB0103|Multiferon|stl|3|millj ae|0,5|ml|6|áf.spr|lausn|L03AB01|01.12.2011||R|||0|1|0|1|SOI|0|0|0|100|DKK|87943|112251|lyfsjukr||||3|0|9,0000|Swedish Orphan International AB|Swedish Orphan International AB|Interferón-alfa natural||87943||87943|112251|
496752|C07AG0101|Trandate|filmhtfl|200|mg|100|stk|1|glas||C07AG01|01.01.1986||R|||0|0|B|0|AUG|0|0|0|100|GBP|3422|5660|lyfalmen||||100|0|33,3333|Aspen Europe GmbH|Aspen Europe GmbH|Labetalól||3422||3422|5660|
496935|N02AG0201|Ketogan|eţ-stíll|||10|stk|1|pakki||N02AG02|01.07.1994||R|||1|0|E|0|PER|0|0|0|100|DKK|480|1636|lyfalmen||||10|0|4,0000|Icepharma hf|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||480||480|1636|
496950|N02AG0201|Ketogan|töflur|||20|stk|1|ţpakki|5 + 25 mg|N02AG02|01.07.1994||R|||1|0|E|0|PER|0|0|0|100|DKK|866|2164|lyfalmen||||20|0|4,0000|Icepharma hf|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||866||866|2164|
497099|N02AG0201|Ketogan|töflur|||100|stk|1|ţpakki|5 + 25 mg|N02AG02|01.07.1994||R|||1|0|E|0|PER|0|0|0|100|DKK|3302|5496|lyfalmen||||100|0|20,0000|Icepharma hf|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||3302||3302|5496|
497289|C09AA0201|Daren|töflur|5|mg|30|stk|1|ţpakki||C09AA02|01.07.1990||R|||0|0|B|0|ACA|0|0|0|100|XEU|347|1454|lyfalmen||||30|0|15,0000|Actavis Group hf|Actavis hf|Enalapríl||347||347|1454|
497297|C09AA0201|Daren|töflur|5|mg|100|stk|1|ţpakki||C09AA02|01.07.1990||R|||0|0|B|0|ACA|0|0|0|100|XEU|514|1397|lyfalmen|V0448|1397||100|0|50,0000|Actavis Group hf|Actavis hf|Enalapríl||306||306|1397|
497313|C09AA0201|Daren|töflur|20|mg|100|stk|1|ţpakki||C09AA02|01.07.1990||R|||0|0|B|0|ACA|0|0|0|100|XEU|1069|1887|lyfalmen|V0449|1887||100|0|200,0000|Actavis Group hf|Actavis hf|Enalapríl||664||664|1887|
497995|S01EC0303|Dorzolamide Portfarma|augndr|20|mg/ml|5|ml|1|glas||S01EC03|01.10.2011||R|||0|0|*|0|POF|0|0|0|100|XEU|1536|3019|lyfalmen|V0369|3019||5|0|16,6667|Portfarma ehf|Portfarma|Dorzólamíđ||1491||1491|3019|
498048|H02AB0103|Diprospan|stl|7|mg/ml|2|ml|1|hgl|5 + 2 mg/ml|H02AB01|01.09.2004||R|||0|0|B|0|SPL|0|0|1|100|DKK|1392|2883|lyfalmen||||2|0|9,3300|Vistor hf|Schering-Plough Europe|Betametasón||1392||1392|2883|
498964|N05AE0401|Zeldox|hylki|20|mg|56|stk|1|ţpakki|hart hylki|N05AE04|01.03.2002||R|||0|0|0|0|PER|0|1|0|100|DKK|17347|24316|lyfalmen||||56|0|14,0000|Icepharma hf|Pfizer ApS|Ziprasidon||17347||17347|24316|
498980|N05AE0401|Zeldox|hylki|40|mg|56|stk|1|ţpakki|hart hylki|N05AE04|01.03.2002||R|||0|0|0|0|PER|0|1|0|100|DKK|18504|25768|lyfalmen||||56|0|28,0000|Icepharma hf|Pfizer ApS|Ziprasidon||18504||18504|25768|
499004|N05AE0401|Zeldox|hylki|60|mg|56|stk|1|ţpakki|hart hylki|N05AE04|01.03.2002||R|||0|0|0|0|PER|0|1|0|100|DKK|23050|31473|lyfalmen||||56|0|42,0000|Icepharma hf|Pfizer ApS|Ziprasidon||23050||23050|31473|
499020|N05AE0401|Zeldox|hylki|80|mg|56|stk|1|ţpakki|hart hylki|N05AE04|01.03.2002||R|||0|0|0|0|PER|0|1|0|100|DKK|27847|37493|lyfalmen||||56|0|56,0000|Icepharma hf|Pfizer ApS|Ziprasidon||27847||27847|37493|
499273|B01AX0601 |Xarelto|filmhtfl|20|mg|28|stk|1|ţpakki||B01AX06|01.05.2012||R|||0|0|E|0|BAP|0|0|0|100|SEK|10607|15489|lyfalmen||||28|0|56,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaroxaban||||10607|15489|
501734|M01AB0508|Vostar-R|forđatfl|75|mg|100|stk|1|glas|0|M01AB05|01.03.2000||R|||0|0|E|0|ACA|0|0|1|100|XEU|2842|4867|lyfalmen||||100|0|75,0000|Actavis Group hf|Actavis hf|Díklófenak||2842||2842|4867|
502047|N04BA0201|Madopar|hylki|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.12.1983||R|||0|0|E|0|ROC|0|0|0|100|DKK|3131|5262|lyfalmen|V0434|4526||100|0|16,6667|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||3131||3131|5262|
502633|N06AA2101|Ludiomil|töflur|25|mg|100|stk|1|ţpakki||N06AA21|01.06.1977||R|||0|0|B|0|AML|0|1|0|100|DKK|3053|5155|lyfalmen||||100|0|25,0000|Vistor hf|Amdipharm Limited|Maprótilín||3053||3053|5155|
503151|L02AE0401|Decapeptyl Depot|sts|3,75|mg|1|stk|1|spr|+ leysir|L02AE04|01.01.1995||R|||0|1|0|1|FER|0|0|0|100|DKK|30790|40524|lyfsjukr||||1|0|27,9851|Vistor hf|Ferring|Triptórelín||30790||30790|40524|
503491|N06DA0303|Nimvastid (Lyfis)|hylki|1,5|mg|28|stk|1|ţpakki||N06DA03|01.04.2011||R|||0|0|E|0|LYF|0|0|0|100|XEU|6762|7226|lyfalmen||||28|0|4,6700|Lyfis ehf|Lyfis ehf|Rívastigmín||4567||4567|7226|
503795|M01AB0512|Voltaren Dolo|húđuđtfl|25|mg|20|stk|1|ţpakki||M01AB05|01.10.2011||L|||0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa||||20|0|5,0000|Artasan ehf|Novartis Healthcare A/S-A|Díklófenak||||||
504119|A10BB1202|Glimeryl|töflur|4|mg|90|stk|1|ţpakki||A10BB12|01.11.2011||R|||0|0|*|0|AGP|0|0|0|100|XEU|1688|3288|lyfalmen|V0494|3288||90|0|180,0000|Actavis Group hf|Actavis Group PTC ehf|Glímepíríđ||1688||1688|3288|
504191|N02BA5102|Treo|freyđit|||20|stk|1|glas||N02BA51|01.07.1988||L|||0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa||||20|0|3,3333|Vistor hf|McNeil Denmark ApS|Acetýlsalicýlsýra í blöndum, ţó ekki međ geđlyfjum (psychole||||||
504266|G03CA0401|Ovestin|töflur|1|mg|90|stk|1|ţpakki||G03CA04|01.01.1988||R|||0|0|E|0|ORG|0|0|0|100|DKK|2089|3837|lyfalmen||||90|0|45,0000|Vistor hf|N.V. Organon|Estríól||2089||2089|3837|
504878|N05BA0801|Lexotan|töflur|3|mg|100|stk|1|glas||N05BA08|01.01.1987||R|||0|0|0|0|ROC|0|0|1|100|DKK|1187|2603|lyfalmen||||100|0|30,0000|Icepharma hf|Roche|Brómazepam||1187||1187|2603|
505743|N06AA2101|Ludiomil|töflur|75|mg|100|stk|1|ţpakki||N06AA21|01.05.1978||R|||0|0|B|0|AML|0|1|0|100|DKK|8399|12468|lyfalmen||||100|0|75,0000|Vistor hf|Amdipharm Limited|Maprótilín||8399||8399|12468|
505834|L01DB0101|Adriamycin|stl|2|mg/ml|5|ml|1|plhgl||L01DB01|01.05.2008||R|||0|1|0|1|PER|0|0|0|100|DKK|1846|2664|lyfsjukr||||5|0||Icepharma hf|Pfizer ApS|Doxórúbicín||1846||1846|2664|
505875|L01DB0101|Adriamycin|stl|2|mg/ml|10|ml|1|plhgl||L01DB01|01.05.2008||R|||0|1|0|1|PER|0|0|0|100|DKK|3687|5321|lyfsjukr||||10|0||Icepharma hf|Pfizer ApS|Doxórúbicín||3687||3687|5321|
505883|L01DB0101|Adriamycin|stl|2|mg/ml|25|ml|1|plhgl||L01DB01|01.05.2008||R|||0|1|0|1|PER|0|0|0|100|DKK|8413|12142|lyfsjukr||||25|0||Icepharma hf|Pfizer ApS|Doxórúbicín||8413||8413|12142|
506972|N06AA1201|Sinquan|hylki|50|mg|100|stk|1|ţpakki||N06AA12|01.12.1972||R|||0|0|B|0|PER|0|1|0|100|DKK|2521|4428|lyfalmen||||100|0|50,0000|Icepharma hf|Pfizer ApS|Doxepín||2521||2521|4428|
506998|A06AB0202|Toilax|sh-tfl|5|mg|25|stk|1|ţpakki||A06AB02|01.12.1975||L|||0|0|0|0|ERC|0|0|0|100|IKR|||lyflausa||||25|0|12,5000|Vistor hf|Orion Pharma|Bisakódýl||||||
507004|A06AB0202|Toilax|sh-tfl|5|mg|100|stk|1|ţpakki||A06AB02|01.12.1975||R|||0|0|0|0|ERC|0|0|0|100|DKK|409|1538|lyfalmen||||100|0|50,0000|Vistor hf|Orion Pharma|Bisakódýl||409||409|1538|
507103|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|24|g|1|spr||QP52AF02|01.07.1995||L|||0|0|0|0|PAL|0|0|0|100|DKK|674|1176|vetorma||||24|0||Icepharma hf|Pfizer Oy Animal Health|||||674|1176|
507111|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|24|g|5|spr||QP52AF02|01.07.1995||L|||0|0|0|0|PAL|0|0|0|100|DKK|2865|4998|vetorma||||120|0||Icepharma hf|Pfizer Oy Animal Health|||||2865|4998|
507343|QP52AC1302|Panacur, vet.|mixtúra|100|mg/ml|1000|ml|1|fl||QP52AC13|01.12.1978||R|||0|0|0|0|INI|0|0|0|100|DKK|16450|28696|vetorma||||1000|0||Icepharma hf|Intervet International B.V.|||16450||16450|28696|
507582|QJ01EW1001|Tribrissen, vet.|stl|480|mg/ml|50|ml|1|hgl|80+400 mg/ml|QJ01EW10|01.06.1999|31.05.2012|R|||0|0|0|0|IBV|0|0|0|100|DKK|2667|5294|vetalmen||||50|0||Vistor hf|Intervet International BV|||2667||2667|5294|
508622|C08DA0103|Isoptin retard|forđatfl|240|mg|98|stk|1|ţpakki||C08DA01|01.10.1993||R|||0|0|B|0|ABS|0|0|0|100|DKK|2616|4557|lyfalmen||||98|0|98,0000|Vistor hf|Abbott Scandinavia AB|Verapamíl||2616||2616|4557|
508671|QJ01MA9001|Baytril vet.|mixtúra|25|mg/ml|100|ml|1|plastf||QJ01MA90|01.03.2009||R|||0|0|0|0|BAN|0|0|0|100|DKK|5227|10209|vetalmen||||100|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||||5227|10209|
508689|QJ01MA9001|Baytril vet.|stl|50|mg/ml|50|ml|1|hgl|lausn|QJ01MA90|01.01.2009||R|||0|0|0|0|BAN|0|0|0|100|DKK|4192|8222|vetalmen||||50|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||4192||4192|8222|
508705|QJ01MA9001|Baytril vet.|stl|100|mg/ml|100|ml|1|hgl|lausn|QJ01MA90|01.01.2009||R|||0|0|0|0|BAN|0|0|0|100|DKK|12970|25077|vetalmen||||100|0||Icepharma hf|Bayer Animal Health GmbH|Enrofloxacinum||12970||12970|25077|
508921|L01CD0401|Jevtana|irţ|60|mg|15|ml|1|hgl|+ leysir|L01CD04|01.08.2011||R|||0|1|0|1|SOF|0|0|0|100|NOK|745383|937338|lyfsjukr||||15|0||Vistor hf|SANOFI|Cabazitaxel||745383||745383|937338|
509042|N05AF0502|Cisordinol Depot|stl|200|mg/ml|1|ml|10|lykjur||N05AF05|01.03.1984||R|||0|0|*|0|LBK|0|1|0|100|DKK|9303|13705|lyfalmen||||10|0|133,3333|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||9303||9303|13705|
509273|G03CA0401|Ovestin|sk-krem|1|mg/g|15|g|1|túpa|+stjaka|G03CA04|01.01.1988||L|||0|0|E|0|ORG|0|0|0|100|DKK|||lyfalmen||||15|0|75,0000|Vistor hf|N.V. Organon|Estríól|||||2863|
509653|J05AR0101|Combivir|filmhtfl|450|mg|60|stk|1|ţpakki|150+300 mg|J05AR01|01.05.2004||R|||0|1|0|1|VII|0|0|0|100|GBP|50683|65490|lyfsjukr||||60|0|30,0000|GlaxoSmithKline ehf|ViiV Healthcare UK Ltd|Zídóvúdín og lamívúdín||50683||50683|65490|
510255|B03XA0103|NeoRecormon|stl|2000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|||0|1|0|1|ROC|0|0|0|100|DKK|17021|23244|lyfsjukr||||2|0|12,0000|Icepharma hf|Roche|Epóetín||17021||17021|23244|
510263|B03XA0103|NeoRecormon|stl|3000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|||0|1|0|1|ROC|0|0|0|100|DKK|25478|33857|lyfsjukr||||2|0|18,0000|Icepharma hf|Roche|Epóetín||25478||25478|33857|
510271|B03XA0103|NeoRecormon|stl|5000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|||0|1|0|1|ROC|0|0|0|100|DKK|41792|54331|lyfsjukr||||2|0|30,0000|Icepharma hf|Roche|Epóetín||41792||41792|54331|
510305|B03XA0103|NeoRecormon|stl|10000|ae/spr|0,6|ml|6|spr||B03XA01|01.02.2002||R|||0|1|0|1|ROC|0|0|0|100|DKK|82648|105606|lyfsjukr||||4|0|60,0000|Icepharma hf|Roche|Epóetín||82648||82648|105606|
510810|B03XA0201|Aranesp|stl|150|mcg/spr|0,3|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|||0|1|0|1|AMG|0|0|0|100|DKK|191898|242714|lyfsjukr||||1|0|133,3300|Vistor hf|Amgen|Darbepóetín alfa||||191898|242714|
510974|G04CB0102|Finol|töflur|5|mg|98|stk|1|glas||G04CB01|01.01.1998||R|||0|0|E|0|ACA|0|0|0|100|XEU|4253|5620|lyfalmen|V0445|5620||98|0|98,0000|Actavis Group hf|Actavis hf|Fínasteríđ||3393||3393|5620|
511071|C09CA0701|Micardis|töflur|20|mg|28|stk|1|ţpakki||C09CA07|01.03.2008||R|||0|0|0|0|BII|0|0|0|100|DKK|2772|4771|lyfalmen||||28|0|14,0000|Vistor hf|Boehringer Ingelheim International |Telmisartan||2772||2772|4771|
511245|N05AH0310|Zalasta (LYFIS)|munndr.t|20|mg|28|stk|1|ţpakki||N05AH03|01.02.2012||R|||0|0|*|0|LYF|0|1|0|100|XEU|37131|31565|lyfalmen|V0540|31565||28|0|56,0000|LYFIS ehf|LYFIS ehf|Olanzapín||23123||23123|31565|
511303|G03FB0501|Trisekvens|töflur|||84|stk|1|skífup||G03FB05|01.12.1980||R|||0|0|E|0|NAS|0|0|0|100|DKK|2754|4746|lyfalmen||||84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Noretísterón og östrógen||2754||2754|4746|
511493|B05AA0509|Rheomacrodex med NaCl|irl|100|mg/ml|500|ml|12|pokar||B05AA05|01.07.1991||R|||0|0|0|1|MAB|0|0|0|100|SEK|23572|31465|lyfsjukr||||6000|0||Vistor hf|Meda AB|Dextran||23572||23572|31465|
511501|B05AA0502|Macrodex 60 mg/ml med NaCl|irl|||500|ml|12|pokar||B05AA05|01.07.1991||R|||0|0|0|1|MAB|0|0|0|100|SEK|14746|20389|lyfsjukr||||6000|0||Vistor hf|Meda AB|Dextran||14746||14746|20389|
512192|N06AB1005|Escitalopram LYFIS|filmhtfl|10|mg|100|stk|1|ţpakki||N06AB10|01.02.2012||R|||0|0|B|0|LYF|0|1|0|100|XEU|4829|5635|lyfalmen|V0325|5635||100|0|100,0000|LYFIS ehf|LYFIS ehf|Escítalópram||3404||3404|5635|
512608|B05XA3101|Peditrace|irţ|||10|ml|10|hgl||B05XA31|01.07.1993||R|||0|0|0|1|FRP|0|0|0|100|DKK|5375|7757|lyfsjukr||||100|0||Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum međ öđrum efnum||5375||5375|7757|
513309|D04AB0101|Xylocain|smyrsli|5|%|35|g|1|pakki||D04AB01|01.09.2003||L|||0|0|0|0|AZD|0|0|1|100|IKR|||lyflausa||||35|0||Vistor hf|AstraZeneca A/S DK|Lídókaín||||||
513474|N05AH0501|Sycrest|tungur.t|5|mg|60|stk|1|ţpakki||N05AH05|01.10.2011||R|||0|0|0|0|ORR|0|1|0|100|DKK|23358|31859|lyfalmen||||60|0|15,0000|Lundbeck Export A/S|N.V. Organon|Asenapíne||23358||23358|31859|
513758|QJ01CR0201|Combisyn|stl|175|mg/ml|100|ml|1|hgl|140+35 mg/ml|QJ01CR02|01.11.2011||R|||0|0|0|0|NOB|1|0|0|100|XEU|2163|4303|vetalmen||||100|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|Amoxicillín og Clavulansýra||2163||2163|4303|
514265|R03AC0302|Bricanyl Turbuhaler|innúđadu|0,25|mg/sk|200|sk|1|stauk||R03AC03|01.07.1993||R|||0|0|B|0|AZD|0|0|1|100|SEK|2065|3804|lyfalmen||||200|0|25,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||2065||2065|3804|
514427|C07AG0203|Carvedilol Actavis|filmhtfl|25|mg|100|stk|1|ţpakki||C07AG02|01.07.2011||R|||0|0|B|0|ADG|0|0|0|100|XEU|3189|5341|lyfalmen||||100|0|66,6667|Actavis Group hf|Actavis Deutchland GmbH & Co. KG|Carvedílól||3189||3189|5341|
515049|N06AX1801|Edronax|töflur|4|mg|60|stk|1|ţpakki||N06AX18|01.06.2000||R|||0|0|B|0|PER|0|1|0|100|DKK|4517|4385|lyfalmen||||60|0|30,0000|Icepharma hf|Pfizer ApS|Reboxetin||2490||2490|4385|
515239|C01DA0205|Nitroglyserin DAK|tungur.t|0,25|mg|100|stk|1|glas||C01DA02|01.05.2011||L|||0|0|B|0|NYG|0|0|0|100|DKK|||lyfalmen||||100|0|10,0000|Gróco ehf|Nycomed Danmark A/S|Glýcerýltrínítrat|||||2605|
515247|C01DA0205|Nitroglyserin DAK|tungur.t|0,5|mg|100|stk|1|glas||C01DA02|01.05.2011||L|||0|0|B|0|NYG|0|0|0|100|DKK|||lyfalmen||||100|0|20,0000|Gróco ehf|Nycomed Danmark A/S|Glýcerýltrínítrat|||||2618|
517073|A02BC0402|Rabeprazol Actavis|sh-tfl|20|mg|120|stk|1|ţpakki||A02BC04|01.06.2011||R|||0|0|E|0|APC|0|0|0|100|XEU|5546|6727|lyfalmen|V0010|6727||120|0|120,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Rabeprazól||4202||4202|6727|
517714|A10BX0201|Novonorm|töflur|0,5|mg|90|stk|1|ţpakki||A10BX02|01.10.2000||R|||0|0|*|0|NAS|0|0|0|100|DKK|3022|5113|lyfalmen|V0462|2977||90|0|11,2500|Vistor hf|Novo-Nordisk A/S|Repaglíníđ||3022||3022|5113|
517755|A10BX0201|Novonorm|töflur|1|mg|90|stk|1|ţpakki||A10BX02|01.10.2000||R|||0|0|*|0|NAS|0|0|0|100|DKK|3290|5479|lyfalmen|V0471|3113||90|0|22,5000|Vistor hf|Novo-Nordisk A/S|Repaglíníđ||3290||3290|5479|
517813|A10BX0201|Novonorm|töflur|2|mg|90|stk|1|ţpakki||A10BX02|01.10.2000||R|||0|0|*|0|NAS|0|0|0|100|DKK|3538|5819|lyfalmen|V0472|3378||90|0|45,0000|Vistor hf|Novo-Nordisk A/S|Repaglíníđ||3538||3538|5819|
517990|R06AX2201|Kestine|filmhtfl|20|mg|10|stk|1|ţpakki||R06AX22|01.06.2012||L|||0|0|0|0|APS|0|0|1|100|IKR|||lyflausa||||10|0|20,0000|Vistor hf|Almirall-Prodesfarma S.A.|Ebastín||||||
518241|M01AB0509|Modifenac|forđahlk|75|mg|20|stk|1|ţpakki||M01AB05|01.11.2000||R|||0|0|E|0|AGT|0|0|1|100|DKK|939|2263|lyfalmen||||20|0|15,0000|Actavis Group hf|Actavis Group hf|Díklófenak||939||939|2263|
518258|M01AB0509|Modifenac|forđahlk|75|mg|100|stk|1|ţpakki|međ breyttan losunarhrađa|M01AB05|01.11.2000||R|||0|0|E|0|AGT|0|0|1|100|DKK|3459|5711|lyfalmen||||100|0|75,0000|Actavis Group hf|Actavis Group hf|Díklófenak||3459||3459|5711|
518332|G03AC0901|Cerazette|töflur|75|mcg|84|stk|1|ţpakki|3x28 stk|G03AC09|01.01.2001||R|||0|0|0|0|ORG|0|0|0|100|DKK|2132|3895|lyfalmen||||84|0|84,0000|Vistor hf|N.V. Organon|Desógestrel||2132||2132|3895|
518337|N05AH0407|Quetiapina Qualigen (Lyfjaver)|töflur|200|mg|60|stk|1|ţpakki||N05AH04|01.06.2011||R|||0|0|*|0|LVR|0|1|0|100|SEK|12890|17696|lyfalmen|V0286|16770||60|0|30,0000|Lyfjaver ehf|Lyfjaver ehf|Quetíapín||12072||12072|17696|
518944|J01CE0205|Kaavepenin Frukt|mixt.kyr|50|mg/ml|125|ml|1|glas||J01CE02|01.10.1985||R|||0|0|0|0|REP|0|0|1|100|SEK|1117|2507|lyfalmen||||125|0|3,1250|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||1117||1117|2507|
519463|J01EE0108|Eusaprim|mixtúra|48|mg/ml|100|ml|1|glas|8+40 mg/ml|J01EE01|01.07.2011||R|||0|0|0|0|AEG|0|0|1|100|SEK|1673|3267|lyfalmen||||100|0|2,5000|GlaxoSmithKline ehf|Aspen Europe GmbH|Súlfametoxazól og trímetóprím||1673||1673|3267|
519819|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|1|spr|einnota sprauta|M09AX01|01.01.2001||R|||0|0|E|0|NYG|0|0|0|100|DKK|7427|11139|lyfalmen|V0431|9670||2|0|5,7222|Gróco ehf|Nycomed Danmark A/S|Natríumhýalúrónat||7427||7427|11139|
520239|G04BE0301|Viagra|filmhtfl|25|mg|4|stk|1|pakki||G04BE03|01.07.1999||R|||0|0|0|0|PER|0|0|0|100|DKK|4923|7713|lyfalmen|V0142|7579||4|0|2,0000|Icepharma hf|Pfizer ApS|Síldenafíl||4923||4923|7713|
520288|G04BE0301|Viagra|filmhtfl|50|mg|4|stk|1|pakki||G04BE03|01.07.1999||R|||0|0|0|0|PER|0|0|0|100|DKK|5560|8585|lyfalmen|V0143|2523||4|0|4,0000|Icepharma hf|Pfizer ApS|Síldenafíl||5560||5560|8585|
520338|G04BE0301|Viagra|filmhtfl|50|mg|12|stk|1|pakki||G04BE03|01.07.1999||R|||0|0|0|0|PER|0|0|0|100|DKK|15666|22206|lyfalmen|V0143|7570||12|0|12,0000|Icepharma hf|Pfizer ApS|Síldenafíl||15666||15666|22206|
520346|G04BE0301|Viagra|filmhtfl|100|mg|4|stk|1|pakki||G04BE03|01.07.1999||R|||0|0|0|0|PER|0|0|0|100|DKK|5963|9136|lyfalmen|V0144|3063||4|0|8,0000|Icepharma hf|Pfizer ApS|Síldenafíl||5963||5963|9136|
520379|G04BE0301|Viagra|filmhtfl|100|mg|12|stk|1|pakki||G04BE03|01.07.1999||R|||0|0|0|0|PER|0|0|0|100|DKK|16499|23251|lyfalmen|V0144|9188||12|0|24,0000|Icepharma hf|Pfizer ApS|Síldenafíl||16499||16499|23251|
520502|C08CA0102|Amlo|töflur|5|mg|100|stk|1|plglas||C08CA01|01.03.1998||R|||0|0|B|0|ACA|0|0|0|100|IKR|1355|1815|lyfalmen|V0056|1801||100|0|100,0000|Actavis Group hf|Actavis hf|Amlódipín||611||611|1815|
520577|C08CA0102|Amlo|töflur|10|mg|100|stk|1|plglas||C08CA01|01.03.1998||R|||0|0|B|0|ACA|0|0|0|100|IKR|2163|2252|lyfalmen|V0057|2231||100|0|200,0000|Actavis Group hf|Actavis hf|Amlódipín||931||931|2252|
520759|M03BC5101|Norgesic|töflur|||30|stk|1|ţpakki||M03BC51|01.03.1981||R|||0|0|E|0|MEB|0|0|1|100|SEK|360|1471|lyfalmen||||30|0|7,5000|Vistor hf|Meda AB (V)|Orfenadrín í blöndum||360||360|1471|
520874|C01DA0205|Nitroglyserin DAK|tungur.t|0,25|mg|25|stk|1|glas||C01DA02|01.05.2011||L|||0|0|B|0|NYG|0|0|0|100|DKK|||lyfalmen||||25|0|2,5000|Gróco ehf|Nycomed Danmark A/S|Glýcerýltrínítrat|||||1731|
520882|C01DA0205|Nitroglyserin DAK|tungur.t|0,5|mg|25|stk|1|glas||C01DA02|01.05.2011||L|||0|0|B|0|NYG|0|0|0|100|DKK|||lyfalmen||||25|0|5,0000|Gróco ehf|Nycomed Danmark A/S|Glýcerýltrínítrat|||||1741|
521203|N04BC0502|Sifrol|töflur|0,7|mg|100|stk|1|ţpakki||N04BC05|01.05.2005||R|||0|0|E|0|BII|0|0|0|100|DKK|32794|43702|lyfalmen|V0269|10204||100|0|28,0000|Vistor hf|Boehringer Ingelheim International|Pramipexól||32794||32794|43702|
521954|N03AX2101|Trobalt|filmhtfl|200|mg|84|stk|1|ţpakki||N03AX21|01.12.2011||R|||0|0|E|0|GGL|0|0|0|100|GBP|18505|25769|lyfalmen||||84|0||GlaxoSmithKline ehf|Glaxo Group Limited|Retigabín||18505||18505|25769|
521966|A10BX0202|Repaglinid Krka (LYFIS)|töflur|1|mg|90|stk|1|ţpakki||A10BX02|01.11.2011||R|||0|0|*|0|LYF|0|0|0|100|XEU|3080|3113|lyfalmen|V0471|3113||90|0|22,5000|LYFIS ehf|LYFIS ehf|Repaglíníđ||1560||1560|3113|
522003|QJ01RA0102|Streptocillin, vet.|spenalyf|||8|g|40|spr||QJ01RA01|01.12.1982||R|||0|0|0|0|BID|0|0|0|100|DKK|8580|16647|vetalmen||||320|0||Vistor hf|Boehringer Ingelheim Danmark|||8580||8580|16647|
522599|J07CA0202|Tetravac|bóluefni|||0,5|ml|1|spr|einnota dćla|J07CA02|01.10.1999||R|||0|0|0|0|SPM|0|0|0|100|XEU|2332|4169|lyfalmen||||0|0||Icepharma hf|Sanofi Pasteur MSD|barnaveiki, kíghósti, mćnusótt, stífkrampi||2332||2332|4169|
522706|L04AC0201|Simulect|sts|20|mg|1|hgl|1|pakki|+leysir|L04AC02|01.06.2004||R|||0|1|0|1|NOE|0|0|0|100|DKK|190219|240607|lyfsjukr||||1|0|0,5000|Vistor hf|Novartis Europharm Ltd|Basiliximab||190219||190219|240607|
522730|N02AX0204|Tradolan|töflur|50|mg|20|stk|1|ţpakki||N02AX02|01.08.1998||R|||0|0|E|0|GLP|0|0|1|100|SEK|336|1439|lyfalmen|V0055|1276||20|0|3,3300|Vistor hf|G.L.Pharma GmbH|Tramadól||336||336|1439|
522771|N02AX0204|Tradolan|töflur|50|mg|100|stk|1|ţpakki||N02AX02|01.08.1998||R|||0|0|E|0|GLP|0|0|1|100|SEK|399|1525|lyfalmen|V0225|1515||100|0|16,6700|Vistor hf|G.L.Pharma GmbH|Tramadól||399||399|1525|
522797|N02AX0204|Tradolan|töflur|50|mg|250|stk|1|ţpakki||N02AX02|01.08.1998||R|||0|0|E|0|GLP|0|0|1|100|DKK|2832|4853|lyfalmen||||250|0|41,6700|Vistor hf|G.L.Pharma GmbH|Tramadól||2832||2832|4853|
522813|N02AX0204|Tradolan|stl|50|mg/ml|2|ml|5|lykjur||N02AX02|01.08.1998||R|||0|0|E|0|GLP|0|0|1|100|DKK|403|1530|lyfalmen||||10|0|1,6667|Vistor hf|G.L.Pharma GmbH|Tramadól||403||403|1530|
523043|N02AA5902|Parkodin forte|töflur|530|mg|40|stk|1|pakki|ţp 30+500 mg|N02AA59|01.11.1998||R|||0|0|0|0|ACA|0|0|1|100|NOK|462|1611|lyfalmen||||40|0|13,3333|Actavis Group hf|Actavis hf|Kódein í blöndum nema međ geđlyfjum||462||462|1611|
523274|S01XA2008|Artelac|augndr|||10|ml|1|glas|plastglas|S01XA20|01.05.1998||L|||0|0|E|0|GEM|0|0|0|100|IKR|||lyfalmen||||10|0||Actavis Group hf|Gerhard Mann|Gervitár og ađrar óvirkar samsetningar|||||1395|
523779|R06AD0201|Phenergan|töflur|25|mg|100|stk|1|ţpakki||R06AD02|01.10.1995||R|||0|0|E|0|SNO|0|0|1|100|NOK|1307|2767|lyfalmen||||100|0|100,0000|Vistor hf|Sanofi-aventis Norge AS|Prómetazín||1307||1307|2767|
524215|C01DA1401|Imdur|forđatfl|30|mg|28|stk|1|ţpakki||C01DA14|01.07.1993||R|||0|0|B|0|AZD|0|0|0|100|SEK|450|1594|lyfalmen||||28|0|21,0000|Vistor hf|AstraZeneca A/S DK|Ísósorbíđ mónónítrat||450||450|1594|
524223|C01DA1401|Imdur|forđatfl|30|mg|98|stk|1|ţpakki||C01DA14|01.07.1993||R|||0|0|B|0|AZD|0|0|0|100|SEK|2834|4856|lyfalmen||||98|0|73,5000|Vistor hf|AstraZeneca A/S DK|Ísósorbíđ mónónítrat||2834||2834|4856|
524276|A02BC0401|Pariet|sh-tfl|20|mg|98|stk|1|ţpakki||A02BC04|01.06.2011||R|||0|0|0|0|EIS|0|0|0|100|IKR|8619|5951|lyfalmen|V0010|5494||98|0|98,0000|Vistor hf|Eisai Ltd|Rabeprazól||3635||3635|5951|
524934|QM01AE9001|Quadrisol|hlaup|100|mg/ml|1|spr|1|pakki|f. hesta|QM01AE90|01.07.2010||R|||0|0|0|0|INI|0|0|0|100|DKK|1943|3865|vetalmen||||1|0||Icepharma hf|Intervet International B.V.|Vedaprófen||1943||1943|3865|
525014|M03BC5101|Norgesic|töflur|||100|stk|1|ţpakki||M03BC51|01.06.1981||R|||0|0|E|0|MEB|0|0|1|100|SEK|883|2187|lyfalmen||||100|0|25,0000|Vistor hf|Meda AB (V)|Orfenadrín í blöndum||883||883|2187|
525030|M01AB0505|Voltaren|stl|25|mg/ml|3|ml|5|lykjur|lausn|M01AB05|01.05.2007||R|||0|0|0|0|NOH|0|0|0|100|DKK|791|2061|lyfalmen||||15|0|3,7500|Vistor hf|Novartis Healthcare A/S-|Díklófenak||791||791|2061|
525076|A02BC0109|Omeprazol Pensa (Lyfjaver)|sţ-hylki|20|mg|100|stk|1|glas|hart|A02BC01|01.02.2012||R|||0|0|E|0|LVR|0|0|0|100|IKR|4621|4674|lyfalmen|V0006|4674||100|0|100,0000|Lyfjaver ehf|Lyfjaver ehf|Ómeprazól||2701||2701|4674|
525147|M01AB0504|Klofen-L|forđahlk|100|mg|30|stk|1|glas||M01AB05|01.01.1993||R|||0|0|E|0|ACA|0|0|1|100|XEU|1522|3061|lyfalmen||||30|0|30,0000|Actavis Group hf|Actavis hf|Díklófenak||1522||1522|3061|
525170|M01AB0504|Klofen-L|forđahlk|100|mg|100|stk|1|glas||M01AB05|01.01.1993||R|||0|0|E|0|ACA|0|0|1|100|XEU|5073|7919|lyfalmen||||100|0|100,0000|Actavis Group hf|Actavis hf|Díklófenak||5073||5073|7919|
525188|N06BA0701|Modiodal|töflur|100|mg|30|stk|1|ţpakki||N06BA07|01.03.2002||R|||0|0|0|0|CPA|0|0|0|100|DKK|11079|16134|lyfalmen||||30|0|10,0000|Vistor hf|Cephalon France (V)|Modafinil||11079||11079|16134|
525720|B01AX0601 |Xarelto|filmhtfl|20|mg|100|stk|1|ţpakki||B01AX06|01.05.2012||R|||0|0|E|0|BAP|0|0|0|100|SEK|37737|49905|lyfalmen|V0030|49905||100|0|200,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaroxaban||||37737|49905|
525857|B05XA0103|Kaliumklorid B.Braun|irţ|1|mmol/ml|50|ml|20|hgl||B05XA01|01.09.2010||R|||0|0|0|1|BRA|0|0|0|100|XEU|5532|7984|lyfsjukr||||1000|0||Actavis Group hf|Braun|Kalíumklóríđ||5532||5532|7984|
525865|B05XA0303|Natriumklorid B.Braun|irţ|1|mmol/ml|50|ml|20|hgl||B05XA03|01.09.2010||R|||0|0|0|1|BRA|0|0|0|100|XEU|5037|7270|lyfsjukr||||1000|0||Actavis Group hf|Braun|Natríumklóríđ||5037||5037|7270|
525998|V07AB1001|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|50|ml|20|hgl|leysir f.stungulyf|V07AB|01.01.2009||L|||0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa||||1000|0||Actavis Group hf|Braun|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar||||||
526004|V07AB09|Sterilt Vann B. Braun|leysir|||50|ml|20|hgl|leysir f.stungulyf|V07AB|01.01.2009||L|||0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa||||1000|0||Actavis Group hf|Braun|Leysi- og ţynningarvökvar, ţ.m.t. skolvökvar||||||
526368|N04BA0201|Madopar|töflur|250|mg|100|stk|1|glas|200+50 mg|N04BA02|01.11.1981||R|||0|0|E|0|ROC|0|0|0|100|DKK|4557|7213|lyfalmen|V0435|7213||100|0|33,3333|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||4557||4557|7213|
526376|N03AG0103|Orfiril Retard|forđatfl|300|mg|100|stk|1|glas||N03AG01|01.10.1995||R|||0|0|E|0|DEA|0|0|0|100|XEU|4236|6774|lyfalmen||||100|0|20,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||4236||4236|6774|
526384|QJ01EW1001|Tribrissen, vet.|pasta|400|mg/g|37,5|g|5|spr|til inntöku|QJ01EW10|01.03.2007||R|||0|0|0|0|IBV|0|0|0|100|DKK|6815|13258|vetalmen||||188|0||Vistor hf|Intervet International BV|||6815||6815|13258|
526798|N03AG0102|Orfiril|sh-tfl|600|mg|100|stk|1|glas||N03AG01|01.10.1995||R|||0|0|E|0|DEA|0|0|0|100|XEU|3623|5935|lyfalmen||||100|0|40,0000|Vistor hf|Desitin Artzneimittel|Valpróínsýra||3623||3623|5935|
527112|N02BE0116|Pinex Smelt|munndr.t|250|mg|20|stk|1|ţpakki||N02BE01|01.09.2011||L|||0|0|0|0|APC|0|0|1|100|IKR|||lyflausa||||20|0|1,6700|Actavis Group PTC ehf|Actavis Group PTC ehf|Paracetamól||||||
527143|J01XD0102|Flagyl|irl|5|g/1000ml|100|ml|20|pokar||J01XD01|01.12.1983||R|||0|0|0|1|SNO|0|0|0|100|NOK|15800|21712|lyfsjukr||||2000|0|6,6667|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||15800||15800|21712|
527523|S01GX0601|Emadine|augndr|0,5|mg/ml|5|ml|1|glas||S01GX06|01.05.2003||R|||0|0|E|0|ALC|0|0|0|100|USD|1317|2780|lyfalmen||||5|0||K.Pétursson hf|Alcon|Emedastín||1317||1317|2780|
528374|G03BA0307|Nebido|stl|250|mg/ml|4|ml|1|lykja||G03BA03|01.07.2012||R|||0|0|E|0|BGB|0|0|0|100|SEK|17393|24373|lyfalmen|V0546|24373||4|0|55,5600|Icepharma hf|Bayer Pharma AG|Testósterón||17393||17393|24373|
528472|R03AK0704|Symbicort Turbuhaler (Lyfjaver)|innúđadu|164,5|mcg/sk|120|sk|1|pakki|160+4,5 mcg/sk|R03AK07|01.05.2011||R|||0|0|0|0|LVR|0|0|0|100|SEK|9915|13680|lyfalmen|V0356|12500||120|0|30,0000|Lyfjaver ehf|Lyfjaver ehf|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||9285||9285|13680|
528584|A07EC0202|Pentasa|forđatfl|1|g|60|stk|1|ţpakki|6 x 10 stk|A07EC02|01.06.2012||R|||0|0|B|0|FEL|0|0|0|100|DKK|7027|10591|lyfalmen||||60|0|40,0000|Vistor hf|Ferring Lćgemidler A/S|Mesalazín (5-amínósalicýlsýra)||7027||7027|10591|
529289|R02AA0301|Strepsils|sogtfl|||24|stk|1|ţpakki||R02AA03|01.09.1982||L|||0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa||||24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól||||||
529438|QJ51RC2002|Ampiclox vet.|spenalyf|||3|g|24|spr|spenadćlur|QJ51RC20|01.06.1998||R|||0|0|0|0|PAL|0|0|0|100|DKK|4592|8990|vetalmen||||72|0||Icepharma hf|Pfizer Oy Animal Health|||4592||4592|8990|
529446|QJ01CA0401|Clamoxyl, vet.|töflur|40|mg|100|stk|1|ţpakki||QJ01CA04|01.10.1987||R|||0|0|0|0|PAL|0|0|0|100|DKK|4882|9547|vetalmen||||100|0||Icepharma hf|Pfizer Oy Animal Health|||4882||4882|9547|
529735|N03AB0501|Pro-Epanutin|irţ|50|mg/ml|10|ml|10|hgl||N03AB05|01.12.2001||R|||0|0|0|1|PER|0|0|0|100|DKK|70094|89850|lyfsjukr||||100|0|11,1000|Icepharma hf|Pfizer ApS|Fosfenýtóín||70094||70094|89850|
529852|L02BG0304|Anastrozole Bluefish|filmhtfl|1|mg|98|stk|1|ţpakki||L02BG03|01.03.2012||R|||0|0|*|0|BLP|0|0|0|100|XEU|29015|18706|lyfalmen|V0184|18706||98|0|98,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Anastrózól||12877||12877|18706|
530188|A06AD6502|Movicol|mixtduft|13,8|g|50|pokar|1|pakki||A06AD65|01.09.2011||L|||0|0|0|0|NOI|0|0|0|100|XEU|||lyfalmen||||50|0|25,0000|Artasan ehf|Norgine A/S|Makrógól 3350|||||6964|
530379|L02BG0304|Anastrozole Bluefish|filmhtfl|1|mg|28|stk|1|ţpakki||L02BG03|01.03.2012||R|||0|0|*|0|BLP|0|0|0|100|XEU|11982|7570|lyfalmen|V0186|7570||28|0|28,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Anastrózól||4818||4818|7570|
530741|G03FA0105|Activelle|töflur|||84|stk|1|pakki|ţp 1+0,5 mg|G03FA01|01.03.2000||R|||0|0|E|0|NAS|0|0|0|100|DKK|3170|5315|lyfalmen||||84|0|84,0000|Vistor hf|Novo-Nordisk A/S|Noretísterón og östrógen||3170||3170|5315|
530828|B05BA0311|Glucos Fresenius Kabi|irl|200|mg/ml|500|ml|20|pokar|Freeflex umbúđir|B05BA03|01.12.2011||R|||0|0|0|1|FRP|0|0|0|100|DKK|6094|8795|lyfsjukr||||10000|0||Icepharma hf|Fresenius Kabi|Kolvetni||6094||6094|8795|
531459|R03CC0303|Bricanyl Retard|forđatfl|7,5|mg|100|stk|1|glas||R03CC03|01.01.1985||R|||0|0|B|0|AZD|0|0|0|100|SEK|3002|5085|lyfalmen||||100|0|50,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||3002||3002|5085|
531913|J05AG0101|Viramune|mixtúra|10|mg/ml|240|ml|1|fl||J05AG01|01.03.2007||R|||0|1|0|1|BII|0|0|0|100|DKK|8379|12093|lyfsjukr||||240|0|6,0000|Vistor hf|Boehringer Ingelheim International |Nevírapín||8379||8379|12093|
532048|L04AA0605|Myfenax (Lyfis)|hylki|500|mg|50|stk|1|ţpakki||L04AA06|01.03.2011||R|||0|1|*|0|LYF|0|0|0|100|XEU|20631|16136|lyfalmen|V0187|14754||50|0|12,5000|Lyfis ehf|Lyfis ehf|Mýcófenólsýra||11080||11080|16136|
532374|P02CA0101|Vermox|mixtúra|20|mg/ml|30|ml|1|glas||P02CA01|01.12.1982||R|||0|0|0|0|JAS|0|0|0|100|SEK|664|1887|lyfalmen||||30|0|3,0000|Vistor hf|Janssen-Cilag AB|Mebendazól||664||664|1887|
532671|J01EA0107|Trimetoprim Meda|töflur|100|mg|30|stk|1|glas||J01EA01|01.03.2010||R|||0|0|0|0|MEB|0|0|1|100|SEK|351|1459|lyfalmen||||30|0|7,5000|Vistor hf|Meda AB (V)|Trímetóprím||351||351|1459|
532697|J01EA0107|Trimetoprim Meda|töflur|100|mg|100|stk|1|glas||J01EA01|01.03.2010||R|||0|0|0|0|MEB|0|0|1|100|SEK|1019|2373|lyfalmen||||100|0|25,0000|Vistor hf|Meda AB (V)|Trímetóprím||1019||1019|2373|
532705|J01EA0107|Trimetoprim Meda|töflur|160|mg|14|stk|1|glas||J01EA01|01.03.2010||R|||0|0|0|0|MEB|0|0|1|100|SEK|282|1365|lyfalmen||||14|0|5,6000|Vistor hf|Meda AB (V)|Trímetóprím||282||282|1365|
532721|J01EA0107|Trimetoprim Meda|töflur|160|mg|100|stk|1|glas||J01EA01|01.03.2010||R|||0|0|0|0|MEB|0|0|1|100|SEK|1795|3434|lyfalmen||||100|0|40,0000|Vistor hf|Meda AB (V)|Trímetóprím||1795||1795|3434|
533302|N05AH0310|Zalasta (LYFIS)|töflur|15|mg|28|stk|1|ţpakki||N05AH03|01.02.2012||R|||0|0|*|0|LYF|0|1|0|100|XEU|14743|9719|lyfalmen|V0283|9719||28|0|42,0000|LYFIS ehf|LYFIS ehf|Olanzapín||6389||6389|9719|
533737|R03CC0303|Bricanyl Retard|forđatfl|5|mg|100|stk|1|glas||R03CC03|01.04.1986||R|||0|0|B|0|AZD|0|0|0|100|SEK|2035|3763|lyfalmen||||100|0|33,3333|Vistor hf|AstraZeneca A/S DK|Terbútalín||2035||2035|3763|
534471|L04AA1001|Rapamune|filmhtfl|1|mg|100|stk|1|ţpakki||L04AA10|01.06.2012||R|||0|1|*|0|IPI|0|0|0|100|DKK|59996|77840|lyfalmen|V0567|77840||100|0|33,3300|Icepharma hf|Pfizer Limited|Sirolimus||59996||59996|77840|
535773|P03AA5401|Tenutex|áburđur|245|mg/g|100|g|1|túpa|(20 mg + 225 mg)/g|P03AA54|01.12.1997||L|||0|0|0|0|BIG|0|0|0|100|IKR|||lyflausa||||100|0||Icepharma hf|Bioglan AB|Dísúlfíram í blöndum||||||
535844|N05AH0310|Zalasta (LYFIS)|töflur|5|mg|28|stk|1|ţpakki||N05AH03|01.10.2011||R|||0|0|*|0|LYF|0|1|0|100|XEU|3317|2625|lyfalmen|V0279|2529||28|0|14,0000|LYFIS ehf|LYFIS ehf|Olanzapín||1203||1203|2625|
535898|G04BD0401|Ditropan|töflur|5|mg|84|stk|1|ţpakki||G04BD04|01.06.1998||R|||0|0|E|0|SNO|0|0|0|100|NOK|6763|10230|lyfalmen||||84|0|28,0000|Vistor hf|Sanofi-aventis Norge AS|Oxýbútýnín||6763||6763|10230|
536037|S01EB0105|Isopto Carpine|augndr|20|mg/ml|10|ml|1|glas||S01EB01|01.03.2000||R|||0|0|*|0|SAL|0|0|0|100|USD|464|1614|lyfalmen||||10|0|25,0000|Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Pílókarpín||464||464|1614|
536052|S01EB0105|Isopto Carpine|augndr|40|mg/ml|10|ml|1|glas||S01EB01|01.03.2000||R|||0|0|*|0|SAL|0|0|0|100|USD|592|1789|lyfalmen||||10|0|25,0000|Alcon Danmark A/S|S.A. Alcon - Couvreur N.V.|Pílókarpín||592||592|1789|
536115|C10AA0504|Atorvastatin Portfarma|filmhtfl|80|mg|100|stk|1|ţpakki||C10AA05|01.11.2011||R|||0|0|0|0|POF|0|0|0|100|IKR|12900|18735|lyfalmen|V0115|18735||100|0|400,0000|Portfarma ehf|Portfarma|Atorvastatín||12900||12900|18735|
536460|N05AX1302|Xeplion|stl|150|mg|1|stk|1|áf.spr|forđadreifa|N05AX13|01.04.2012||R|||0|0|0|0|JCI|0|1|0|100|SEK|109076|139436|lyfalmen||||1|0|60,0000|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||109076||109076|139436|
536840|N07XX0701|Fampyra|forđatfl|10|mg|56|stk|1|glas||N07XX07|01.12.2011||R|||0|1|0|1|BIB|0|0|0|100|XEU|66630|85503|lyfsjukr||||56|0|28,0000|Icepharma hf|Biogen Idec Ltd|Fampridine||66630||66630|85503|
537373|QP52AF0201|Banminth, vet.|pasta|115,3|mg/g|2|g|1|spr||QP52AF02|01.07.1995||L|||0|0|0|0|PAL|0|0|0|100|DKK|602|1050|vetorma||||2|0||Icepharma hf|Pfizer Oy Animal Health|||||602|1050|
537465|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|250|ml|30|pokar|Freeflex umbúđir|B05BB01|01.12.2011||R|||0|0|0|1|FRP|0|0|0|100|DKK|6454|9315|lyfsjukr||||7500|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||6454||6454|9315|
537811|G03CA0401|Ovestin|sk-stíll|0,5|mg|15|stk|1|pakki||G03CA04|01.01.1988||L|||0|0|E|0|ORG|0|0|0|100|DKK|||lyfalmen||||15|0|37,5000|Vistor hf|N.V. Organon|Estríól|||||2441|
538181|A02AD0106|Rennie|sog/tugg|||24|stk|1|ţpakki||A02AD01|01.10.1995||L|||0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa||||24|0|2,4000|Icepharma hf|Bayer AB|Blöndur saltsambanda||||||
538199|A02AD0106|Rennie|sog/tugg|||48|stk|1|ţpakki||A02AD01|01.10.1995||L|||0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa||||48|0|4,8000|Icepharma hf|Bayer AB|Blöndur saltsambanda||||||
538207|A02AD0106|Rennie|sog/tugg|||96|stk|1|ţpakki||A02AD01|01.10.1995||L|||0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa||||96|0|9,6000|Icepharma hf|Bayer AB|Blöndur saltsambanda||||||
538496|L03AB0702|Rebif|stl|22|mcg/spr|0,5|ml|12|spr|Áfylltar sprautur|L03AB07|01.05.1999||R|||0|1|0|1|MSE|0|0|0|100|SEK|136280|172914|lyfsjukr||||6|0|61,3953|Icepharma hf|Merck Serono Europe Ltd|Interferón beta-1a||136280||136280|172914|
539031|N03AG0401|Sabrilex|töflur|500|mg|100|stk|1|ţpakki||N03AG04|01.10.1992||R|||0|1|E|0|SNO|0|0|0|100|NOK|10842|15810|lyfalmen||||100|0|25,0000|Vistor hf|Sanofi-aventis Norge AS|Vígabatrín||10842||10842|15810|
539152|N05AH0407|Quetiapina Qualigen (Lyfjaver)|töflur|100|mg|60|stk|1|ţpakki||N05AH04|01.06.2011||R|||0|0|*|0|LVR|0|1|0|100|IKR|5863|8999|lyfalmen|V0285|8999||60|0|15,0000|Lyfjaver ehf|Lyfjaver ehf|Quetíapín||5863||5863|8999|
539551|N05BA0105|Stesolid|töflur|2|mg|25|stk|1|glas||N05BA01|01.12.1972||R|||0|0|0|0|AGT|0|0|1|100|DKK|225|1287|lyfalmen||||25|0|5,0000|Actavis Group hf|Actavis Group hf|Díazepam||225||225|1287|
539577|N05BA0105|Stesolid|töflur|2|mg|100|stk|1|glas||N05BA01|01.12.1972||R|||0|0|0|0|AGT|0|0|0|100|DKK|560|1745|lyfalmen||||100|0|20,0000|Actavis Group hf|Actavis Group hf|Díazepam||560||560|1745|
539783|D01AC2001|Daktacort|krem|||15|g|1|túpa||D01AC20|01.04.1986||L|||0|0|0|0|MCS|0|0|1|100|IKR|||lyflausa||||15|0||Vistor hf|McNeil Sweden AB|Blöndur||||||
539973|G01AA1001|Dalacin|sk-krem|20|mg/g|40|g|1|sett|+7 stjökur|G01AA10|01.10.1994||R|||0|0|E|0|PER|0|0|0|100|DKK|1835|3489|lyfalmen||||40|0|8,0000|Icepharma hf|Pfizer ApS|Klindamýcín||1835||1835|3489|
540070|D06BA0101|Flamazine|krem|10|mg/g|250|g|1|dos||D06BA01|01.10.1988||R|||0|0|0|0|SON|0|0|1|100|DKK|2850|4878|lyfalmen||||250|0||Icepharma hf|Smith & Nephew|Silfursúlfadíazín||2850||2850|4878|
540989|S01ED5101|Cosopt|augndr|5|mg/ml|5|ml|3|glös|+ dorzólamíđ 20 mg|S01ED51|01.07.2000||R|||0|0|*|0|MSD|0|0|0|100|DKK|6013|9204|lyfalmen|V0373|7452||15|0|75,0000|Vistor hf|M.S.D.|Tímólól í blöndum||6013||6013|9204|
541060|R03AC0302|Bricanyl Turbuhaler|innúđadu|0,5|mg/sk|200|sk|1|stauk||R03AC03|01.01.1989|30.06.2012|R|||0|0|B|0|AZD|0|0|1|100|SEK|2066|3805|lyfalmen||||200|0|50,0000|Vistor hf|AstraZeneca A/S DK|Terbútalín||2066||2066|3805|
541128|M01CC0101|Atamir|hylki|150|mg|200|stk|1|glas||M01CC01|01.09.1983||R|||0|0|B|0|SGM|0|0|0|100|DKK|9722|14278|lyfalmen|V0199|14278||200|0|60,0000|Swedish Orphan International AB|Sandoz GmbH (S)|Penicillamín||9722||9722|14278|
541136|M01CC0101|Atamir|hylki|250|mg|200|stk|1|plglas||M01CC01|12.10.2004||R|||0|0|B|0|SGM|0|0|0|100|DKK|15747|22308|lyfalmen|V0200|22308||200|0|100,0000|Swedish Orphan International AB|Sandoz GmbH (S)|Penicillamín||15747||15747|22308|
541169|R02AA0302|Strepsils med honning og citron|sogtfl|||24|stk|1|ţpakki||R02AA03|01.09.1982||L|||0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa||||24|0|4,0000|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól||||||
542216|J01GB0304|Gentamicin B. Braun|irl|1|mg/ml|80|ml|10|fl|.|J01GB03|01.08.2011||R|||0|0|0|1|BRA|0|0|0|100|XEU|5992|8648|lyfsjukr||||800|0|3,3300|Actavis Group hf|Braun|Gentamícín||5992||5992|8648|
542977|J04BA0201|Dapson|töflur|50|mg|100|stk|1|glas||J04BA02|01.05.1998||R|||0|1|E|0|LDR|0|0|0|100|IKR|4756|7485|lyfalmen||||100|1|100,0000|Parlogis hf|Parlogis - óskráđ lyf|Dapsón||4756||4756|7485|
543330|C07AA0302|Visken|töflur|10|mg|98|stk|1|ţpakki||C07AA03|01.12.1983||R|||0|0|B|0|NOH|0|0|0|100|DKK|2972|5044|lyfalmen||||98|0|65,3333|Vistor hf|Novartis Healthcare A/S-|Pindólól||2972||2972|5044|
543374|S01ED5113|Dorzolamide/Timolol Portfarma|augndr|5|mg/ml|5|ml|1|glas|+ dorzólamid 20mg/ml|S01ED51|01.11.2011||R|||0|0|*|0|POF|0|0|0|100|XEU|2259|3198|lyfalmen|V0373|2484||5|0|25,0000|Portfarma ehf|Portfarma|Tímólól í blöndum||1622||1622|3198|
543710|A06AC0101|Vi-Siblin|kyrni|610|mg/g|250|g|1|stauk||A06AC01|01.06.1999||L|||0|0|0|0|REP|0|0|0|100|IKR|||lyflausa||||250|0|21,7857|Vistor hf|Recip AB|Semen psyllii (ispaghula)||||||
543743|N05AH0310|Zalasta (LYFIS)|munndr.t|5|mg|28|stk|1|ţpakki||N05AH03|01.02.2012||R|||0|0|*|0|LYF|0|1|0|100|XEU|7520|5147|lyfalmen|V0457|5147||28|0|14,0000|LYFIS ehf|LYFIS ehf|Olanzapín||3047||3047|5147|
543744|R01AA0503|Nezeril|nefúđi|0,5|mg/ml|7,5|ml|1|glas|sk-úđari|R01AA05|01.10.1994||L|||0|0|0|0|GSC|0|0|1|100|IKR|||lyflausa||||8|0|9,3750|GlaxoSmithKline ehf|GlaxoSmithKline CH AB c/o GSK CH A/S|Oxýmetazólín||||||
543972|J05AE1201|Victrelis|hylki|200|mg|336|stk|1|ţpakki|hörđ|J05AE12|01.01.2012||R|||0|1|0|1|MLD|0|0|0|100|DKK|525117|660904|lyfsjukr||||336|0|28,0000|Vistor hf|Merck Sharp & Dohme Limited|Boceprevír||525117||525117|660904|
544429|L04AD0202|Prograf|hylki|0,5|mg|50|stk|1|ţpakki||L04AD02|01.06.2010||R|||0|1|*|0|ASP|0|0|0|100|XEU|13262|19189|lyfalmen||||50|0|5,0000|Vistor hf|Astellas Pharma A/S|Tacrolimus||13262||13262|19189|
544919|A02BC0507|Esomeprazole Portfarma|sţ-tfl|40|mg|7|stk|1|ţpakki||A02BC05|01.11.2011||R|||0|0|0|0|POF|0|0|0|100|XEU|996|2269|lyfalmen|V0005|459||7|0|9,3300|Portfarma ehf|Portfarma|Esómeprazól||943||943|2269|
545681|D06AX0901|Bactroban|smyrsli|20|mg/g|15|g|1|túpa||D06AX09|01.07.1994||R|||0|0|0|0|GSK|0|0|1|100|GBP|1032|2391|lyfalmen||||15|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Múpírócín||1032||1032|2391|
545814|N05AF0501|Cisordinol|töflur|2|mg|100|stk|1|glas||N05AF05|01.06.1984||R|||0|0|*|0|LBK|0|1|0|100|DKK|925|2244|lyfalmen||||100|0|6,6667|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||925||925|2244|
545848|N05AF0501|Cisordinol|töflur|10|mg|100|stk|1|glas||N05AF05|01.06.1984||R|||0|0|*|0|LBK|0|1|0|100|DKK|2283|4102|lyfalmen||||100|0|33,3333|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||2283||2283|4102|
545996|V01AA0507|Alutard SQ, birkifrjo|stl|||5|ml|4|hgl|byrjunarsett|V01AA05|01.07.1999||R|||0|1|E|0|ALK|0|0|0|100|DKK|30900|41325|lyfalmen||||20|0||Vistor hf|ALK-Abello A/S|trjáfrjó||30900||30900|41325|
546002|V01AA0507|Alutard SQ, birkifrjo|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA05|01.07.1999||R|||0|1|E|0|ALK|0|0|0|100|DKK|24914|33812|lyfalmen||||5|0||Vistor hf|ALK-Abello A/S|trjáfrjó||24914||24914|33812|
546044|V01AA0210|Alutard SQ, vallarfoxgras|stl|||5|ml|4|hgl|byrjunarsett|V01AA02|01.07.1999||R|||0|1|E|0|ALK|0|0|0|100|DKK|31082|41553|lyfalmen||||20|0||Vistor hf|ALK-Abello A/S|grasfrjó||31082||31082|41553|
546051|V01AA0210|Alutard SQ, vallarfoxgras|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA02|01.07.1999||R|||0|1|E|0|ALK|0|0|0|100|DKK|26406|35685|lyfalmen||||5|0||Vistor hf|ALK-Abello A/S|grasfrjó||26406||26406|35685|
546143|N02BE0108|Paratabs Retard|forđatfl|500|mg|30|stk|1|ţpakki||N02BE01|01.10.1993||L|||0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa||||30|0|5,0000|Actavis Group hf|Actavis hf|Paracetamól||||||
546168|N02BE0108|Paratabs Retard|forđatfl|500|mg|100|stk|1|glas||N02BE01|01.10.1993||R|||0|0|0|0|ACA|0|0|1|100|XEU|1163|2570|lyfalmen||||100|0|16,6667|Actavis Group hf|Actavis hf|Paracetamól||1163||1163|2570|
547612|A02BX0202|Antepsin|töflur|1|g|60|stk|1|ţpakki||A02BX02|01.01.1986||L|||0|0|0|0|ORC|0|0|0|100|IKR|||lyfalmen||||60|0|15,0000|Vistor hf|Orion Corporation|Súkralfat|||||4791|
547659|A02BC0506|Esomeprazole Krka (LYFIS)|sţ-hylki|20|mg|28|stk|1|ţpakki||A02BC05|01.08.2011||R|||0|0|0|0|LYF|0|0|0|100|XEU|3487|2158|lyfalmen|V0004|1730||28|0|18,6700|LYFIS ehf|LYFIS ehf|Esómeprazól||862||862|2158|
547687|B01AC1601|Integrilin|irl|0,75|mg/ml|100|ml|1|fl||B01AC16|01.07.2000||R|||0|1|0|1|GGL|0|0|0|100|GBP|10823|15465|lyfsjukr||||100|0|0,3800|GlaxoSmithKline ehf|Glaxo Group Limited|Eptifibatíđ||10823||10823|15465|
547695|B01AC1601|Integrilin|stl|2|mg/ml|10|ml|1|hgl||B01AC16|01.07.2000||R|||0|1|0|1|GGL|0|0|0|100|GBP|3567|5148|lyfsjukr||||10|0|0,1000|GlaxoSmithKline ehf|Glaxo Group Limited|Eptifibatíđ||3567||3567|5148|
547729|G03GA0601|Puregon|stl|100|ae/hgl|0,5|ml|1|hgl||G03GA06|01.01.2000||R|||0|1|E|0|ORG|0|0|0|100|DKK|7973|11886|lyfalmen||||0|0|1,3333|Vistor hf|N.V. Organon|Follitrópín beta||7973||7973|11886|
548120|C07AB0312|Atenolol LYFIS|filmhtfl|50|mg|100|stk|1|ţpakki||C07AB03|01.05.2012||R|||0|0|B|0|LYF|0|0|0|100|XEU|584|1683|lyfalmen|V0542|1683||100|0|66,6600|LYFIS ehf|LYFIS ehf|Atenólól||515||515|1683|
548776|M05BA0701|Optinate|filmhtfl|5|mg|28|stk|1|ţpakki||M05BA07|01.03.2001|30.04.2012|R|||0|0|0|0|SNO|0|0|0|100|NOK|5740|8831|lyfalmen||||28|0|28,0000|Vistor hf|Sanofi-aventis Norge AS|Rísedrónsýru||5740||5740|8831|
548784|M05BA0701|Optinate|filmhtfl|5|mg|84|stk|1|ţpakki||M05BA07|01.03.2001||R|||0|0|0|0|SNO|0|0|0|100|NOK|15906|22507|lyfalmen||||84|0|84,0000|Vistor hf|Sanofi-aventis Norge AS|Rísedrónsýru||15906||15906|22507|
549113|J06BB1601|Synagis|sts|50|mg/hgl|1|hgl|1|pakki||J06BB16|01.01.2004||R|||0|0|0|1|ABT|0|0|0|100|DKK|96660|123191|lyfsjukr||||1|0||Vistor hf|Abbott Laboratories Ltd|Palivisumab||96660||96660|123191|
549139|N05AD0102|Haldol Depot|stl|100|mg/ml|1|ml|5|lykjur||N05AD01|01.01.1987||R|||0|0|*|0|JAS|0|1|0|100|SEK|9587|14093|lyfalmen||||5|0|151,5152|Vistor hf|Janssen-Cilag AB|Halóperídól||9587||9587|14093|
549170|J06BB1601|Synagis|sts|100|mg/hgl|1|hgl|1|pakki||J06BB16|01.01.2004||R|||0|0|0|1|ABT|0|0|0|100|DKK|143135|181517|lyfsjukr||||1|0||Vistor hf|Abbott Laboratories Ltd|Palivisumab||143135||143135|181517|
549674|B01AX0601 |Xarelto|filmhtfl|15|mg|98|stk|1|ţpakki||B01AX06|01.05.2012||R|||0|0|E|0|BAP|0|0|0|100|SEK|36984|48960|lyfalmen|V0031|48907||98|0|147,0000|Icepharma hf|Bayer Schering Pharma AG|Rivaroxaban||||36984|48960|
550020|J07AP0302|Typherix|bóluefni|50|mcg/ml|0,5|ml|1|spr|einnota sprauta|J07AP03|01.10.2001||R|||0|0|0|0|GSK|0|0|0|100|GBP|2260|4070|lyfalmen||||0|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Taugaveiki, hreinsađir  mótefnavakar||2260||2260|4070|
550061|N02BE0102|Panodil Brus|freyđit|500|mg|24|stk|1|ţpakki||N02BE01|01.04.1992||L|||0|0|0|0|GSH|0|0|1|100|IKR|||lyfalmen||||24|0|4,0000|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól|||||1592|
550624|N02BE0103|Panodil Junior|mixtúra|24|mg/ml|60|ml|1|glas||N02BE01|01.11.1981||L|||0|0|0|0|GSH|0|0|1|100|IKR|||lyflausa||||60|0|0,4800|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól||||||
550731|N02BE0103|Panodil Junior|eţ-stíll|125|mg|10|stk|1|pakki||N02BE01|01.11.1981||L|||0|0|0|0|GSH|0|0|1|100|IKR|||lyflausa||||10|0|0,4167|GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Paracetamól||||||
551183|N05AH0310|Zalasta (LYFIS)|töflur|7,5|mg|56|stk|1|ţpakki||N05AH03|01.10.2011||R|||0|0|*|0|LYF|0|1|0|100|XEU|11511|9315|lyfalmen|V0280|9315||56|0|42,0000|LYFIS ehf|LYFIS ehf|Olanzapín||6094||6094|9315|
551408|N02CC0302|Zomig Rapimelt|munnltfl|2,5|mg|12|stk|1|ţpakki||N02CC03|01.05.2001||R|||0|0|E|0|AZA|0|0|0|100|SEK|10818|15777|lyfalmen|V0235|15777||12|0|12,0000|Vistor hf|AstraZeneca AB|Zolmítriptan||10818||10818|15777|
551572|H02AB0802|Lederspan|stl|20|mg/ml|1|ml|1|hgl|dreifa|H02AB08|01.11.2003||R|||0|0|B|0|MAB|0|0|1|100|SEK|1848|3507|lyfalmen||||1|0|2,6667|Vistor hf|Meda AB|Tríamcínólón||1848||1848|3507|
551606|M01AX0101|Relifex|töflur|500|mg|100|stk|1|ţpakki||M01AX01|01.04.1995||R|||0|0|E|0|MAB|0|0|1|100|SEK|3943|6373|lyfalmen|V0198|6373||100|0|50,0000|Vistor hf|Meda AB|Nabúmeton||3943||3943|6373|
551739|N02AA0102|Morfin|töflur|10|mg|20|stk|1|pakki||N02AA01|01.04.1999||R|||1|0|E|0|LDR|0|0|0|100|IKR|738|1988|lyfalmen||||20|1|2,0000|Parlogis hf|Parlogis - óskráđ lyf|Morfín||738||738|1988|
551846|A02BC0401|Pariet|sh-tfl|10|mg|28|stk|1|ţpakki||A02BC04|01.05.2001||R|||0|0|0|0|EIS|0|0|0|100|IKR|2157|1752|lyfalmen|V0466|1584||28|0|14,0000|Vistor hf|Eisai Ltd|Rabeprazól||565||565|1752|
551853|A02BC0401|Pariet|sh-tfl|10|mg|56|stk|1|ţpakki||A02BC04|01.05.2001||R|||0|0|0|0|EIS|0|0|0|100|IKR|3931|3432|lyfalmen|V0467|3139||56|0|28,0000|Vistor hf|Eisai Ltd|Rabeprazól||1793||1793|3432|
551879|A02BC0401|Pariet|sh-tfl|20|mg|14|stk|1|ţpakki||A02BC04|01.11.2001||R|||0|0|0|0|EIS|0|0|0|100|SEK|1459|2975|lyfalmen|V0003|792||14|0|14,0000|Vistor hf|Eisai Ltd|Rabeprazól||1459||1459|2975|
551929|A02BC0401|Pariet|sh-tfl|20|mg|28|stk|1|ţpakki||A02BC04|01.05.2001||R|||0|0|0|0|EIS|0|0|0|100|IKR|3631|1752|lyfalmen|V0003|1584||28|0|28,0000|Vistor hf|Eisai Ltd|Rabeprazól||565||565|1752|
551937|A02BC0401|Pariet|sh-tfl|20|mg|56|stk|1|ţpakki||A02BC04|01.05.2001||R|||0|0|0|0|EIS|0|0|0|100|IKR|7648|3432|lyfalmen|V0010|3139||56|0|56,0000|Vistor hf|Eisai Ltd|Rabeprazól||1793||1793|3432|
551989|N03AX1406|Zelta|filmhtfl|1000|mg|100|stk|1|ţpakki||N03AX14|01.04.2012||R|||0|0|0|0|LYF|0|0|0|100|XEU|24475|20556|lyfalmen|V0516|20556||100|0|66,6700|LYFIS ehf|LYFIS ehf|Levetíracetam||14351||14351|20556|
552224|C08CA0501|Adalat|töflur|20|mg|100|stk|1|ţpakki||C08CA05|01.04.1985||R|||0|0|B|0|BAP|0|0|0|100|SEK|3604|5909|lyfalmen||||100|0|66,6667|Icepharma hf|Bayer Schering Pharma AG|Nífedipín||3604||3604|5909|
552877|N05CF0105|Zopiklon Mylan|filmhtfl|7,5|mg|500|stk|1|plglas||N05CF01|01.07.2007||R|||0|0|0|0|MYL|0|0|0|100|SEK|5085|7935|lyfalmen||||500|0|500,0000|Actavis Group PTC ehf|Mylan AB|Zópíklón||5085||5085|7935|
552901|N03AF0201|Trileptal|filmhtfl|150|mg|100|stk|1|ţpakki||N03AF02|01.10.2000||R|||0|0|E|0|NOH|0|0|0|100|DKK|3364|5581|lyfalmen||||100|0|15,0000|Vistor hf|Novartis Healthcare A/S-|Oxkarbazepín||3364||3364|5581|
553206|N02CC0601|Relpax|filmhtfl|40|mg|18|stk|1|ţpakki||N02CC06|01.08.2009||R|||0|0|E|0|PER|0|0|0|100|DKK|12271|17945|lyfalmen|V0237|17945||18|0|18,0000|Icepharma hf|Pfizer ApS|Eletriptan||||12271|17945|
553339|N02CC0601|Relpax|filmhtfl|40|mg|6|stk|1|ţpakki||N02CC06|01.10.2001||R|||0|0|E|0|PER|0|0|0|100|DKK|4197|6720|lyfalmen|V0237|5982||6|0|6,0000|Icepharma hf|Pfizer ApS|Eletriptan||4197||4197|6720|
554154|QA12CE9902|Selevitan, vet.|stl|||100|ml|5|hgl||QA12CE99|01.05.1983||R|||0|0|0|0|BID|0|0|0|100|DKK|7778|15107|vetalmen||||500|0||Vistor hf|Boehringer Ingelheim Danmark|||7778||7778|15107|
556921|H01AC0104|Saizen|sts|5,83|mg/ml|1,03|ml|1|rörlyk||H01AC01|01.05.2011||R|||0|1|0|1|EMA|0|0|0|100|SEK|26957|35714|lyfsjukr||||1|0|9,0000|Icepharma hf|E. Merck AB|Sómatrópín||26957||26957|35714|
556936|N03AF0201|Trileptal|filmhtfl|300|mg|100|stk|1|ţpakki||N03AF02|01.02.2000||R|||0|0|E|0|NOH|0|0|0|100|DKK|4984|7797|lyfalmen||||100|0|30,0000|Vistor hf|Novartis Healthcare A/S-|Oxkarbazepín||4984||4984|7797|
556944|N03AF0201|Trileptal|filmhtfl|600|mg|50|stk|1|glas||N03AF02|01.02.2000||R|||0|0|E|0|NOH|0|0|0|100|DKK|6779|10252|lyfalmen|V0242|7136||50|0|30,0000|Vistor hf|Novartis Healthcare A/S-|Oxkarbazepín||6779||6779|10252|
556951|N03AF0201|Trileptal|filmhtfl|600|mg|100|stk|1|ţpakki||N03AF02|01.02.2000||R|||0|0|E|0|NOH|0|0|0|100|DKK|9717|14271|lyfalmen|V0242|14271||100|0|60,0000|Vistor hf|Novartis Healthcare A/S-|Oxkarbazepín||9717||9717|14271|
557546|D10AF0202|Zineryt|áburđur|||30|ml|1|glas|+ leysir|D10AF02|01.07.1985||R|||0|0|0|0|ASP|0|0|0|100|XEU|1628|3206|lyfalmen||||30|0||Vistor hf|Astellas Pharma A/S|Erýtrómýcín||1628||1628|3206|
558770|L04AA2701|Gilenya|hylki|0,5|mg|28|stk|1|ţpakki||L04AA27|01.09.2011||R|||0|1|0|1|NOE|0|0|0|100|DKK|286915|361961|lyfsjukr||||28|0|28,0000|Vistor hf|Novartis Europharm Ltd|Fingolimod||||286915|361961|
559013|C08DA0103|Isoptin retard|forđatfl|120|mg|28|stk|1|ţpakki||C08DA01|01.01.1995||R|||0|0|B|0|ABS|0|0|0|100|DKK|866|2164|lyfalmen||||28|0|14,0000|Vistor hf|Abbott Scandinavia AB|Verapamíl||866||866|2164|
559021|C08DA0103|Isoptin retard|forđatfl|120|mg|98|stk|1|ţpakki||C08DA01|01.01.1995||R|||0|0|B|0|ABS|0|0|0|100|DKK|1987|3697|lyfalmen||||98|0|49,0000|Vistor hf|Abbott Scandinavia AB|Verapamíl||1987||1987|3697|
559104|N02AX0201|Nobligan|eţ-stíll|100|mg|20|stk|1|pakki||N02AX02|01.04.1994||R|||0|0|E|0|GRU|0|0|1|100|DKK|674|1901|lyfalmen||||20|0|6,6667|Icepharma hf|Grunenthal|Tramadól||674||674|1901|
559286|C05BA0101|Hirudoid|krem|3|mg/g|100|g|1|túpa||C05BA01|01.08.1984||L|||0|0|0|0|STD|0|0|0|100|IKR|||lyflausa||||100|0||Icepharma hf|STADA Arzneimittel AG|Heparínóíđ||||||
559401|S01ED5104|Fotil|augndr|25|mg/ml|5|ml|1|glas|5+20 mg/ml|S01ED51|01.10.1995||R|||0|0|*|0|SAO|0|0|0|100|XEU|1594|3159|lyfalmen||||5|0|25,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||1594||1594|3159|
559476|C05BA0101|Hirudoid|hlaup|3|mg/g|100|g|1|túpa||C05BA01|01.08.1984||L|||0|0|0|0|STD|0|0|0|100|IKR|||lyflausa||||100|0||Icepharma hf|STADA Arzneimittel AG|Heparínóíđ||||||
559948|G03CA0303|Estring|sk-hring|7,5|mcg/sólh|1|stk|1|pakki||G03CA03|01.07.1994||R|||0|0|E|0|PER|0|0|0|100|DKK|5852|8984|lyfalmen||||1|0|90,0000|Icepharma hf|Pfizer ApS|Estradíól||5852||5852|8984|
559971|C01DA0201|Discotrine|forđapl|10|mg/sólh|30|stk|1|ţpakki||C01DA02|01.01.1994||R|||0|0|B|0|MEB|0|0|0|100|SEK|3530|5808|lyfalmen||||30|0|60,0000|Vistor hf|Meda AB (V)|Glýcerýltrínítrat||3530||3530|5808|
559989|N01AB0701|Suprane|innönd.l|||240|ml|1|fl||N01AB07|01.01.1995||R|||0|0|0|1|BAX|0|0|0|100|SEK|13374|18667|lyfsjukr||||240|0||Icepharma hf|Baxter|Desflúran||13374||13374|18667|
560060|S01XA2004|Vidisic|augngel|2|mg/g|10|g|1|túpa||S01XA20|01.04.1993||L|||0|0|E|0|GEM|0|0|0|100|XEU|||lyfalmen||||10|0||Actavis Group hf|Gerhard Mann|Gervitár og ađrar óvirkar samsetningar|||||1430|
560326|J05AB0102|Zovir|töflur|200|mg|25|stk|1|ţpakki||J05AB01|01.07.1989||R|||0|0|E|0|GSK|0|0|1|100|GBP|3224|5389|lyfalmen||||25|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||3224||3224|5389|
560367|D06BB0303|Zovir|krem|50|mg/g|2|g|1|túpa||D06BB03|01.07.1994||L|||0|0|0|0|GSH|0|0|1|100|IKR|||lyflausa||||2|0||GlaxoSmithKline ehf|GlaxoSmithKline CH A/S|Acíklóvír||||||
560375|S01AD0301|Zovir|augnsm|30|mg/g|4,5|g|1|túpa||S01AD03|01.01.1988||R|||0|0|E|0|GSK|0|0|1|100|GBP|1605|3174|lyfalmen||||4|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||1605||1605|3174|
560383|J05AB0102|Zovir|mixtúra|40|mg/ml|125|ml|1|glas||J05AB01|01.01.1995||R|||0|0|E|0|GSK|0|0|1|100|GBP|6145|9385|lyfalmen||||125|0|1,2500|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||6145||6145|9385|
560391|J05AB0102|Zovir|mixtúra|80|mg/ml|100|ml|1|glas||J05AB01|01.01.1995||R|||0|0|E|0|GSK|0|0|1|100|GBP|6664|10095|lyfalmen||||100|0|2,0000|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||6664||6664|10095|
560490|C01CX0801|Simdax|irţ|2,5|mg/ml|5|ml|1|lykja||C01CX08|01.09.2001||R|||0|1|0|1|ORC|0|0|0|100|DKK|102464|130475|lyfsjukr||||5|0|1,1400|Vistor hf|Orion Corporation|Levosimendan||102464||102464|130475|
560557|C01CX0801|Simdax|irţ|2,5|mg/ml|5|ml|4|lykjur||C01CX08|01.09.2001||R|||0|1|0|1|ORC|0|0|0|100|DKK|473867|596586|lyfsjukr||||20|0|4,5500|Vistor hf|Orion Corporation|Levosimendan||473867||473867|596586|
561145|N03AX2101|Trobalt|filmhtfl|150|mg|63|stk|1|ţpakki|21x50mg+42x100mg|N03AX21|01.12.2011||R|||0|0|E|0|GGL|0|0|0|100|GBP|5955|9125|lyfalmen||||63|0||GlaxoSmithKline ehf|Glaxo Group Limited|Retigabín||5955||5955|9125|
561159|S01ED5105|Fotil forte|augndr|45|mg/ml|5|ml|1|glas|5+40 mg/ml|S01ED51|01.10.1995||R|||0|0|*|0|SAO|0|0|0|100|XEU|1750|3373|lyfalmen||||5|0|25,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||1750||1750|3373|
562014|C09BA0201|Daraziđ|töflur|32,5|mg|100|stk|1|glas|20+12,5 mg|C09BA02|01.06.2011||R|||0|0|B|0|APC|0|0|0|100|XEU|2547|4463|lyfalmen||||100|0|100,0000|Actavis Group PTC ehf|Actavis Group PTC ehf|Enalapríl og ţvagrćsilyf||2547||2547|4463|
562668|L04AA2601|Benlysta|irs|400|mg/hgl|1|hgl|1|pakki|lausn|L04AA26|01.12.2011||R|||0|1|0|1|GGL|0|0|0|100|GBP|107949|137358|lyfsjukr||||1|0||GlaxoSmithKline ehf|Glaxo Group Limited|Belimumab||107949||107949|137358|
563111|L04AX0501|Esbriet|hylki|267|mg|63|stk|1|ţpakki|hart|L04AX05|01.07.2012||R|||0|1|0|0|INT|0|0|0|100|DKK|117332|149797|lyfalmen||||63|0||Vistor hf|InterMune Europe Ltd.|Pírfenidon||117332||117332|149797|
563346|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|3|spr|einnota sprauta|M09AX01|01.01.2001||R|||0|0|E|0|NYG|0|0|0|100|DKK|21633|29695|lyfalmen|V0431|29010||6|0|17,1667|Gróco ehf|Nycomed Danmark A/S|Natríumhýalúrónat||21633||21633|29695|
563361|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|5|spr|einnota sprauta|M09AX01|01.01.2001||R|||0|0|E|0|NYG|0|0|0|100|DKK|36498|48350|lyfalmen|V0431|48350||10|0|28,6111|Gróco ehf|Nycomed Danmark A/S|Natríumhýalúrónat||36498||36498|48350|
563379|D07AC1701|Cutivat|krem|0,5|mg/g|30|g|1|túpa||D07AC17|01.07.1995||R|||0|0|B|0|GSK|0|0|1|100|GBP|794|2065|lyfalmen||||30|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||794||794|2065|
563395|D07AC1701|Cutivat|smyrsli|50|mcg/g|30|g|1|túpa||D07AC17|01.07.1995||R|||0|0|B|0|GSK|0|0|1|100|GBP|717|1960|lyfalmen||||30|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||717||717|1960|
563502|N02AA0101|Contalgin|forđatfl|5|mg|100|stk|1|ţpakki||N02AA01|01.10.1993||R|||1|0|E|0|PER|0|0|0|100|DKK|1412|2910|lyfalmen||||100|0|5,0000|Icepharma hf|Pfizer ApS|Morfín||1412||1412|2910|
563528|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|30|spr|einnota sprauta|M09AX01|01.01.2001||R|||0|0|E|0|NYG|0|0|0|100|DKK|210426|266630|lyfalmen||||60|0|171,6667|Gróco ehf|Nycomed Danmark A/S|Natríumhýalúrónat||210426||210426|266630|
563577|S01ED5104|Fotil|augndr|25|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED51|01.10.1995||R|||0|0|*|0|SAO|0|0|0|100|XEU|3652|5975|lyfalmen||||15|0|60,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||3652||3652|5975|
563593|S01ED5105|Fotil forte|augndr|45|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED51|01.10.1995||R|||0|0|*|0|SAO|0|0|0|100|XEU|3786|6158|lyfalmen||||15|0|60,0000|Icepharma hf|Santen Oy|Tímólól í blöndum||3786||3786|6158|
563779|M05BA0708|Risedronate Bluefish|filmhtfl|35|mg|12|stk|1|ţpakki||M05BA07|01.07.2012||R|||0|0|E|0|BLP|0|0|0|100|XEU|2287|3640|lyfalmen|V0207|3640||12|0|84,0000|LYFIS ehf|Bluefish Pharmaceuticals AB|Rísedrónsýru||1945||1945|3640|
563899|QP54AA0105|Noromectin|áhella|0,5|w/v|1000|ml|1|fl|lausn|QP54AA01|01.11.2011||R|||0|0|0|0|NOB|1|0|0|100|XEU|11591|20220|vetorma||||1000|0||Norbrook Laboratories Limited|Norbrook Laboratories Limited|||11591||11591|20220|
564088|J05AB0401|Rebetol|hylki|200|mg|168|stk|1|ţpakki|hart|J05AB04|01.02.2002||R|||0|1|0|1|SCP|0|0|0|100|DKK|83699|106925|lyfsjukr||||168|0|33,6000|Vistor hf|Schering-Plough|Ribavirin||83699||83699|106925|
565306|A02BX1302|Galieve Cool Mint|mixtúra|||300|ml|1|glerfl|dreifa|A02BX13|01.12.2010||L|||0|0|0|0|RBS|0|0|0|100|IKR|||lyflausa||||300|0||Artasan ehf|Reckitt Benckiser (Scandinavia) A/S|Algínsýra||||||
565457|A07EC0301|Dipentum|töflur|500|mg|100|stk|1|glas||A07EC03|01.10.1994||R|||0|0|B|0|UCB|0|0|0|100|DKK|11807|17130|lyfalmen||||100|0|50,0000|Vistor hf|U.C.B|Olsalazín||11807||11807|17130|
566182|S01EC0401|Azopt|augndr|10|mg/ml|5|ml|1|glas||S01EC04|01.01.2001||R|||0|0|*|0|ALC|0|0|0|100|USD|1470|2990|lyfalmen|V0444|2304||5|0|25,0000|K.Pétursson hf|Alcon|Brinzólamíđ||1470||1470|2990|
567016|R06AD0201|Phenergan|mixtúra|1|mg/ml|100|ml|1|glas||R06AD02|01.10.1995||R|||0|0|E|0|SNO|0|0|1|100|NOK|2326|4161|lyfalmen||||100|0|4,0000|Vistor hf|Sanofi-aventis Norge AS|Prómetazín||2326||2326|4161|
567028|L01XE0701|Tyverb|filmhtfl|250|mg|84|stk|1|glas||L01XE07|01.02.2012||R|||0|1|0|1|GGL|0|0|0|100|GBP|217858|275294|lyfsjukr||||84|0||GlaxoSmithKline ehf|Glaxo Group Limited|Labatinibum||217858||217858|275294|
567460|C01CA2407|Jext|stl|150|mcg|1|stk|1|pakki|áfylltur penni|C01CA24|01.10.2011||R|||0|0|B|0|ALK|0|0|1|100|DKK|5934|9096|lyfalmen||||1|0|0,3000|Vistor hf|ALK-Abello A/S|Adrenalín tartrat||||5934|9096|
567503|N05AX0801|Risperdal|töflur|1|mg|60|stk|1|ţpakki||N05AX08|01.01.1995||R|||0|0|*|0|JAS|0|1|0|100|SEK|3391|5618|lyfalmen|V0291|3373||60|0|12,0000|Vistor hf|Janssen-Cilag AB|Risperídón||3391||3391|5618|
567511|N05AX0801|Risperdal|töflur|2|mg|60|stk|1|ţpakki||N05AX08|01.01.1995||R|||0|0|*|0|JAS|0|1|0|100|SEK|6862|10366|lyfalmen|V0292|5566||60|0|24,0000|Vistor hf|Janssen-Cilag AB|Risperídón||6862||6862|10366|
567529|N05AX0801|Risperdal|töflur|3|mg|60|stk|1|ţpakki||N05AX08|01.01.1995||R|||0|0|*|0|JAS|0|1|0|100|SEK|10030|14699|lyfalmen|V0293|8178||60|0|36,0000|Vistor hf|Janssen-Cilag AB|Risperídón||10030||10030|14699|
567537|N05AX0801|Risperdal|töflur|4|mg|60|stk|1|ţpakki||N05AX08|01.01.1995||R|||0|0|*|0|JAS|0|1|0|100|SEK|13172|19076|lyfalmen|V0294|10467||60|0|48,0000|Vistor hf|Janssen-Cilag AB|Risperídón||13172||13172|19076|
567545|R01AC0201|Livostin|nefúđi|0,5|mg/úđask|15|ml|1|glas||R01AC02|01.06.1998||L|||0|0|0|0|MCS|0|0|1|100|IKR|||lyflausa||||15|0|12,5000|Vistor hf|McNeil Sweden AB|Levókabastín||||||
567946|A02BX1302|Galieve Cool Mint|mixtúra|||10|ml|24|skammt|dreifa|A02BX13|01.12.2010||L|||0|0|0|0|RBS|0|0|0|100|IKR|||lyflausa||||240|0||Artasan ehf|Reckitt Benckiser (Scandinavia) A/S|Algínsýra||||||
568709|R01AX0601|Bactroban Nasal|nefsm|20|mg/g|3|g|1|túpa||R01AX06|01.07.1994||R|||0|0|0|0|GSK|0|0|1|100|GBP|1153|2556|lyfalmen||||3|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Mupirocin||1153||1153|2556|
568840|C08CA0201|Feldil|forđatfl|5|mg|100|stk|1|glas||C08CA02|01.04.2003||R|||0|0|B|0|ACA|0|0|0|100|XEU|1434|2941|lyfalmen|V0058|2941||100|0|100,0000|Actavis Group hf|Actavis hf|Felódipín||1434||1434|2941|
568865|C08CA0201|Feldil|forđatfl|10|mg|100|stk|1|glas||C08CA02|01.04.2003||R|||0|0|B|0|ACA|0|0|0|100|XEU|2271|4086|lyfalmen|V0059|4086||100|0|200,0000|Actavis Group hf|Actavis hf|Felódipín||2271||2271|4086|
569467|M03BX0103|Lioresal|stl|2|mg/ml|5|ml|1|lykja|stl.intrathecal.|M03BX01|01.10.1995||R|||0|0|0|1|NOH|0|0|0|100|DKK|17572|23935|lyfsjukr||||5|0|18,1800|Vistor hf|Novartis Healthcare A/S-|Baklófen||17572||17572|23935|
569483|M03BX0103|Lioresal|stl|0,5|mg/ml|20|ml|1|lykja|stl.intrathecal.|M03BX01|01.10.1995||R|||0|0|0|1|NOH|0|0|0|100|DKK|20205|27240|lyfsjukr||||20|0|18,1800|Vistor hf|Novartis Healthcare A/S-|Baklófen||20205||20205|27240|
571524|A02BX1303|Galieve Peppermint|tuggutfl|||24|stk|1|ţpakki|dreifa|A02BX13|01.12.2010||L|||0|0|0|0|RBS|0|0|0|100|IKR|||lyflausa||||24|0||Artasan ehf|Reckitt Benckiser (Scandinavia) A/S|Algínsýra||||||
572422|L04AD0201|Advagraf|forđahlk|5|mg|50|stk|1|ţpakki||L04AD02|01.03.2012||R|||0|1|*|0|APE|0|0|0|100|XEU|85715|110117|lyfalmen||||50|0|50,0000|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||85715||85715|110117|
572612|N03AX1404|Levetiracetam Actavis|filmhtfl|500|mg|100|stk|1|ţpakki||N03AX14|01.12.2011||R|||0|0|0|0|APC|0|0|0|100|XEU|13124|11656|lyfalmen|V0253|10136||100|0|33,3300|Actavis Group PTC ehf|Actavis Group PTC ehf|Levetíracetam||7805||7805|11656|
572768|B02BC1001|Tisseel Duo Quick|vefjalím|||0,5|ml|10|stk|samsett pk|B02BC10|01.03.2001||R|||0|0|0|1|BAX|0|0|0|100|SEK|161440|204490|lyfsjukr||||5|0||Icepharma hf|Baxter|Fíbrínógen manna||161440||161440|204490|
572776|B02BC1001|Tisseel Duo Quick|vefjalím|||1|ml|10|stk|samsett pk|B02BC10|01.03.2001||R|||0|0|0|1|BAX|0|0|0|100|SEK|191559|242289|lyfsjukr||||10|0||Icepharma hf|Baxter|Fíbrínógen manna||191559||191559|242289|
572784|B02BC1001|Tisseel Duo Quick|vefjalím|||2|ml|10|stk|samsett pk|B02BC10|01.03.2001||R|||0|0|0|1|BAX|0|0|0|100|SEK|403390|508137|lyfsjukr||||20|0||Icepharma hf|Baxter|Fíbrínógen manna||403390||403390|508137|
572798|A02BX1303|Galieve Peppermint|tuggutfl|||48|stk|1|ţpakki|dreifa|A02BX13|01.12.2010||L|||0|0|0|0|RBS|0|0|0|100|IKR|||lyflausa||||48|0||Artasan ehf|Reckitt Benckiser (Scandinavia) A/S|Algínsýra||||||
573065|A02BC0506|Esomeprazole Krka (LYFIS)|sţ-hylki|20|mg|98|stk|1|glas||A02BC05|01.08.2011||R|||0|0|E|0|LYF|0|0|0|100|XEU|10612|5659|lyfalmen|V0011|5497||98|0|65,3300|LYFIS ehf|LYFIS ehf|Esómeprazól||3421||3421|5659|
573120|N03AX0903|Lamotrin|dreifit.|100|mg|98|stk|1|ţpakki||N03AX09|01.12.2010||R|||0|0|E|0|ACA|0|0|0|100|IKR|5300|5973|lyfalmen|V0245|5473||98|0|32,6700|Actavis Group hf|Actavis hf|Lamótrigín||3651||3651|5973|
573177|S01ED5110|Duotrav|augndr|||2,5|ml|1|glas|40 mcg/ml+5 mg/ml|S01ED51|01.10.2011||R|||0|0|*|0|ALC|0|0|0|100|USD|3772|6139|lyfalmen|V0464|5388||2|0|25,0000|K.Pétursson hf|Alcon|Tímólól í blöndum||3772||3772|6139|
573287|G03CA0306|Evorel|forđapl|25|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993||R|||0|0|E|0|JAS|0|0|0|100|SEK|3271|5453|lyfalmen|V0129|5453||26|0|45,5000|Vistor hf|Janssen-Cilag AB|Estradíól||3271||3271|5453|
573477|L01XC0301|Herceptin|sts|150|mg/hgl|1|hgl|1|pakki||L01XC03|01.01.2002||R|||0|1|0|1|ROC|0|0|0|100|DKK|98781|125853|lyfsjukr||||1|0||Icepharma hf|Roche|Trastuzumab||98781||98781|125853|
573634|J01DH0201|Meronem|sts/irs|500|mg/hgl|500|mg|10|hgl||J01DH02|01.10.1995||R|||0|0|0|1|AZA|0|0|0|100|SEK|24174|32221|lyfsjukr||||5000|0|2,5000|Vistor hf|AstraZeneca AB|Meropenem||24174||24174|32221|
573642|J01DH0201|Meronem|sts/irs|1|g/hgl|1|g|10|hgl||J01DH02|01.10.1995||R|||0|0|0|1|AZA|0|0|0|100|SEK|40931|53251|lyfsjukr||||10|0|5,0000|Vistor hf|AstraZeneca AB|Meropenem||40931||40931|53251|
573790|M01AB0506|Voltaren Rapid|töflur|50|mg|100|stk|1|ţpakki||M01AB05|01.01.1996||R|||0|0|E|0|NOH|0|0|1|100|IKR|2756|2659|lyfalmen|V0189|2116||100|0|50,0000|Vistor hf|Novartis Healthcare A/S-|Díklófenak||1228||1228|2659|
575324|N06AB0601|Zoloft|töflur|50|mg|28|stk|1|ţpakki||N06AB06|01.10.1995||R|||0|0|B|0|PER|0|1|0|100|DKK|2529|2131|lyfalmen|V0151|2049||28|0|28,0000|Icepharma hf|Pfizer ApS|Sertralín||842||842|2131|
575340|N06AB0601|Zoloft|töflur|50|mg|98|stk|1|ţpakki||N06AB06|01.10.1995||R|||0|0|B|0|PER|0|1|0|100|DKK|7878|7072|lyfalmen|V0322|4247||98|0|98,0000|Icepharma hf|Pfizer ApS|Sertralín||4454||4454|7072|
575357|N06AB0601|Zoloft|töflur|100|mg|28|stk|1|ţpakki||N06AB06|01.03.2001||R|||0|0|B|0|PER|0|1|0|100|DKK|4664|2131|lyfalmen|V0152|2049||28|0|56,0000|Icepharma hf|Pfizer ApS|Sertralín||842||842|2131|
575365|N06AB0601|Zoloft|töflur|100|mg|98|stk|1|ţpakki||N06AB06|01.03.2001||R|||0|0|B|0|PER|0|1|0|100|DKK|13963|7072|lyfalmen|V0323|6676||98|0|196,0000|Icepharma hf|Pfizer ApS|Sertralín||4454||4454|7072|
575472|P03AX0301|Prioderm|hársápa|10|mg/ml|40|g|1|túpa||P03AX03|01.04.1994||L|||0|0|0|0|NOP|0|0|0|100|IKR|||lyflausa||||40|0||Icepharma hf|Norpharma |Malatíón||||||
575506|C01EB1001|Adenocor|stl|3|mg/ml|2|ml|6|hgl||C01EB10|01.11.2007||R|||0|0|0|1|SAA|0|0|0|100|NOK|7129|10289|lyfsjukr||||12|0|2,4000|Vistor hf|Sanofi - Aventis|Adenósín||7129||7129|10289|
576032|N03AX0903|Lamotrin|dreifit.|25|mg|42|stk|1|ţpakki||N03AX09|01.12.2010||R|||0|0|E|0|ACA|0|0|0|100|IKR|1150|2046|lyfalmen|V0243|1793||42|0|3,5000|Actavis Group hf|Actavis hf|Lamótrigín||780||780|2046|
578259|A04AA0104|Ondansetron Billev|filmhtfl|8|mg|10|stk|1|ţpakki||A04AA01|01.05.2012||R|||0|0|E|0|MYL|0|0|0|100|SEK|3735|5935|lyfalmen|V0384|5799||10|0|5,0000|Actavis Group PTC ehf|Mylan AB|Ondansetrón||3623||3623|5935|
578654|QP52AA5104|Zantel|töflur|550|mg|20|stk|1|ţpakki|50+500 mg|QP52AA51|01.07.2011||R|||0|0|0|0|ICE|0|0|0|100|USD|6044|10543|vetorma||||20|0||Icepharma hf|Icepharma hf|||6044||6044|10543|
579110|R03CC0301|Bricanyl|stl|0,5|mg/ml|1|ml|10|lykjur||R03CC03|01.12.1972||R|||0|0|B|0|AZD|0|0|0|100|SEK|1302|2760|lyfalmen||||10|0|0,3300|Vistor hf|AstraZeneca A/S DK|Terbútalín||1302||1302|2760|
579421|A02BC0506|Esomeprazole Krka (LYFIS)|sţ-hylki|40|mg|28|stk|1|ţpakki||A02BC05|01.08.2011||R|||0|0|0|0|LYF|0|0|0|100|XEU|4880|2211|lyfalmen|V0005|1835||28|0|37,3300|LYFIS ehf|LYFIS ehf|Esómeprazól||901||901|2211|
579854|L04AX0301|Methotrexate Wyeth Lederle|töflur|2,5|mg|30|stk|1|glas||L04AX03|01.01.1994||R|||0|0|*|0|PER|0|0|0|100|DKK|722|1967|lyfalmen||||30|0|30,0000|Icepharma hf|Pfizer ApS|Metótrexat||722||722|1967|
580190|N06AB1005|Escitalopram LYFIS|filmhtfl|5|mg|100|stk|1|ţpakki||N06AB10|01.02.2012||R|||0|0|B|0|LYF|0|1|0|100|XEU|2832|3335|lyfalmen|V0324|3335||100|0|50,0000|LYFIS ehf|LYFIS ehf|Escítalópram||1722||1722|3335|
580227|A10BX0202|Repaglinid Krka (LYFIS)|töflur|0,5|mg|90|stk|1|ţpakki||A10BX02|01.11.2011||R|||0|0|*|0|LYF|0|0|0|100|XEU|2971|2977|lyfalmen|V0462|2977||90|0|11,2500|LYFIS ehf|LYFIS ehf|Repaglíníđ||1461||1461|2977|
581806|A10BX0202|Repaglinid Krka (LYFIS)|töflur|2|mg|90|stk|1|ţpakki||A10BX02|01.11.2011||R|||0|0|*|0|LYF|0|0|0|100|XEU|3428|3378|lyfalmen|V0472|3378||90|0|45,0000|LYFIS ehf|LYFIS ehf|Repaglíníđ||1754||1754|3378|
581890|QN02AF0103|Torphasol vet.|stl|10|mg/ml|20|ml|1|hgl||QN02AF01|01.02.2011||R|||0|0|0|0|ANI|1|0|0|100|XEU|14678|28357|vetalmen||||20|0||Dýraheilsa ehf|aniMedica GmbH|Bútorfanóltartrat||14678||14678|28357|
581969|S01EE0401|Travatan|augndr|40|mcg/ml|2,5|ml|1|glas||S01EE04|01.07.2011||R|||0|0|*|0|ALC|0|0|0|100|USD|2454|4336|lyfalmen||||2|0|25,0000|K.Pétursson hf|Alcon|Cýklópentólat||2454||2454|4336|
582080|H01AC0107|Humatrope 6 mg|sts|6|mg/rörly|1|rörlykj|1|pakki||H01AC01|01.04.1989||R|||0|1|0|1|ELI|0|0|0|100|XEU|28678|37873|lyfsjukr||||1|0|9,0000|Icepharma hf|Eli Lilly Danmark A/S|Sómatrópín||28678||28678|37873|
582114|H01AC0108|Humatrope 12 mg|sts|12|mg/rörly|1|rörlykj|1|pakki||H01AC01|01.04.1989||R|||0|1|0|1|ELI|0|0|0|100|XEU|55345|71340|lyfsjukr||||1|0|18,0000|Icepharma hf|Eli Lilly Danmark A/S|Sómatrópín||55345||55345|71340|
582130|H01AC0109|Humatrope 24 mg|sts|24|mg/rörly|1|rörlykj|1|pakki||H01AC01|01.04.1989||R|||0|1|0|1|ELI|0|0|0|100|XEU|110689|140797|lyfsjukr||||1|0|36,0000|Icepharma hf|Eli Lilly Danmark A/S|Sómatrópín||110689||110689|140797|
582213|R01AA0503|Nezeril|nefúđi|0,1|mg/ml|7,5|ml|1|glas|sk-úđari|R01AA05|01.10.1994||L|||0|0|0|0|GSC|0|0|1|100|IKR|||lyflausa||||8|0|1,8750|GlaxoSmithKline ehf|GlaxoSmithKline CH AB c/o GSK CH A/S|Oxýmetazólín||||||
582221|V08AB0201|Omnipaque|stl|140|mg J/ml|200|ml|10|plastf||V08AB02|01.04.2011||R|||0|0|0|1|GEH|0|0|0|100|NOK|68283|87578|lyfsjukr||||2000|0||Icepharma hf|GE Healthcare AS|Jóhexól||68283||68283|87578|
582247|QP54AA0301|Dectomax vet.|stl|10|mg/ml|50|ml|1|hgl||QP54AA03|01.02.1999||R|||0|0|0|0|PAL|1|0|0|100|DKK|5077|8857|vetorma||||50|0||Icepharma hf|Pfizer Oy Animal Health|||5077||5077|8857|
582262|QP54AA0301|Dectomax vet.|stl|10|mg/ml|200|ml|1|hgl||QP54AA03|01.02.1999||R|||0|0|0|0|PAL|1|0|0|100|DKK|19132|33375|vetorma||||200|0||Icepharma hf|Pfizer Oy Animal Health|||19132||19132|33375|
582451|A02BC0507|Esomeprazole Portfarma|sţ-tfl|20|mg|56|stk|1|ţpakki||A02BC05|01.11.2011||R|||0|0|0|0|POF|0|0|0|100|XEU|4649|3748|lyfalmen|V0011|3141||56|0|37,3300|Portfarma ehf|Portfarma|Esómeprazól||2024||2024|3748|
582452|V08AB0201|Omnipaque|stl|300|mg J/ml|100|ml|10|plastf||V08AB02|01.06.2004||R|||0|0|0|1|GEH|0|0|0|100|NOK|45915|59506|lyfsjukr||||1000|0||Icepharma hf|GE Healthcare AS|Jóhexól||45915||45915|59506|
582635|V08AB0201|Omnipaque|stl|300|mg J/ml|500|ml|6|plastf||V08AB02|01.06.2004||R|||0|0|0|1|GEH|0|0|0|100|NOK|104458|132977|lyfsjukr||||3000|0||Icepharma hf|GE Healthcare AS|Jóhexól||104458||104458|132977|
582783|C07AB0205|Seloken|töflur|100|mg|28|stk|1|ţpakki||C07AB02|01.12.2001||R|||0|0|B|0|AZD|0|0|0|100|SEK|824|2106|lyfalmen||||28|0|18,6667|Vistor hf|AstraZeneca A/S DK|Metóprólól||824||824|2106|
582882|V08AB0901|Visipaque|stl|270|mg J/ml|100|ml|10|plastf|lausn|V08AB09|01.06.2004||R|||0|0|0|1|GEH|0|0|0|100|NOK|50615|65404|lyfsjukr||||1000|0||Icepharma hf|GE Healthcare AS|Jódixanól||50615||50615|65404|
582990|H01AC0104|Saizen|sts|8|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.05.2011||R|||0|1|0|1|EMA|0|0|0|100|SEK|53870|69489|lyfsjukr||||2|0|18,0000|Icepharma hf|E. Merck AB|Sómatrópín||53870||53870|69489|
583401|V08AB0901|Visipaque|stl|270|mg J/ml|200|ml|10|plastf|lausn|V08AB09|01.06.2004||R|||0|0|0|1|GEH|0|0|0|100|NOK|100654|128203|lyfsjukr||||2000|0||Icepharma hf|GE Healthcare AS|Jódixanól||100654||100654|128203|
583443|C07AA0705|Sotalol Mylan|töflur|80|mg|100|stk|1|ţpakki||C07AA07|01.01.1994||R|||0|0|B|0|MYL|0|0|0|100|SEK|1110|2497|lyfalmen||||100|0|50,0000|Actavis Group PTC ehf|Mylan AB|Sótalól||1110||1110|2497|
583450|V08AB0901|Visipaque|stl|270|mg J/ml|500|ml|6|plastf|lausn|V08AB09|01.06.2004||R|||0|0|0|1|GEH|0|0|0|100|NOK|120139|152657|lyfsjukr||||3000|0||Icepharma hf|GE Healthcare AS|Jódixanól||120139||120139|152657|
583518|V08AB0901|Visipaque|stl|320|mg J/ml|100|ml|10|plastf|lausn|V08AB09|01.06.2004||R|||0|0|0|1|GEH|0|0|0|100|NOK|54858|70729|lyfsjukr||||1000|0||Icepharma hf|GE Healthcare AS|Jódixanól||54858||54858|70729|
583609|V08AB0901|Visipaque|stl|320|mg J/ml|200|ml|10|plastf|lausn|V08AB09|01.06.2004||R|||0|0|0|1|GEH|0|0|0|100|NOK|113005|143704|lyfsjukr||||2000|0||Icepharma hf|GE Healthcare AS|Jódixanól||113005||113005|143704|
583708|V08AB0901|Visipaque|stl|320|mg J/ml|500|ml|6|plastf|lausn|V08AB09|01.06.2004||R|||0|0|0|1|GEH|0|0|0|100|NOK|123528|156910|lyfsjukr||||3000|0||Icepharma hf|GE Healthcare AS|Jódixanól||123528||123528|156910|
583849|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|250|ml|20|plpok|Excel umbúđir|B05BB01|01.11.2002||R|||0|0|0|1|FRP|0|0|0|100|DKK|3887|5610|lyfsjukr||||5000|0||Icepharma hf|Fresenius Kabi|Elektrólýtar||3887||3887|5610|
584029|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|1000|ml|9|plpok|Excel umbúđir|B05BA03|01.11.2002||R|||0|0|0|1|FRP|0|0|0|100|DKK|2354|3397|lyfsjukr||||9000|0||Icepharma hf|Fresenius Kabi|Kolvetni||2354||2354|3397|
584292|N06AG0201|Aurorix|töflur|300|mg|30|stk|1|ţpakki||N06AG02|01.07.1995||R|||0|0|B|0|MAS|0|1|0|100|SEK|1868|3534|lyfalmen||||30|0|30,0000|Vistor hf|Meda AS|Móklóbemíđ||1868||1868|3534|
585646|B01AB0101|Heparin Leo|stl|25000|ae/ml|2|ml|10|hgl||B01AB01|01.11.1981||R|||0|0|0|1|LEP|0|0|0|100|DKK|10163|14637|lyfsjukr||||20|0|50,0000|Vistor hf|LEO Pharma A/S|Heparín||10163||10163|14637|
585679|B01AB0101|Heparin Leo|stl|5000|ae/ml|5|ml|5|hgl||B01AB01|01.12.1972||R|||0|0|0|1|LEP|0|0|0|100|DKK|4673|6744|lyfsjukr||||25|0|12,5000|Vistor hf|LEO Pharma A/S|Heparín||4673||4673|6744|
585869|J07BC0201|Havrix|bóluefni|1440|ein/ml|1|ml|1|dćla|einnota dćla|J07BC02|01.07.1994||R|||0|0|0|0|GSK|0|0|0|100|GBP|4672|7370|lyfalmen||||1|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lifrarbólga-A, dauđ veira (inactiv­ated whole virus)||4672||4672|7370|
585975|C07AB0312|Atenolol LYFIS|filmhtfl|25|mg|100|stk|1|ţpakki||C07AB03|01.05.2012||R|||0|0|B|0|LYF|0|0|0|100|XEU|477|1631|lyfalmen|V0541|1631||100|0|33,3300|LYFIS ehf|LYFIS ehf|Atenólól||477||477|1631|
586107|L04AD0102|Sandimmun Neoral|mixtúra|100|mg/ml|50|ml|1|glas||L04AD01|01.07.1994||R|||0|0|*|0|NOH|0|0|0|100|DKK|33212|44226|lyfalmen||||50|0|20,0000|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||33212||33212|44226|
586206|D07AB0201|Locoid|smyrsli|1|mg/g|100|g|1|túpa||D07AB02|01.03.1977||R|||0|0|B|0|ASP|0|0|1|100|XEU|1767|3396|lyfalmen||||100|0||Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||1767||1767|3396|
586223|J01GB0304|Gentamicin B. Braun|irl|3|mg/ml|80|ml|10|fl||J01GB03|01.08.2011||R|||0|0|0|1|BRA|0|0|0|100|XEU|14415|19973|lyfsjukr||||800|0|10,0000|Actavis Group hf|Braun|Gentamícín||14415||14415|19973|
586241|J01GB0101|Tobi Podhaler|innönddu|28|mg|224|stk|1|ţpakki|hart hylki+innönd.tćki|J01GB01|01.04.2012||R|||0|1|0|1|NOE|0|0|0|100|DKK|386178|486536|lyfsjukr||||224|0|20,9100|Vistor hf|Novartis Europharm Ltd|Tobramýcín||386178||386178|486536|
587641|C09DA0602|Candpress Comp|töflur|28,5|mg|100|stk|1|ţpakki|16 + 12,5 mg|C09DA06|01.01.2012||R|||0|0|0|0|AGP|0|0|0|100|XEU|10289|15054|lyfalmen|V0095|5305||100|0|100,0000|Actavis Group hf|Actavis Group PTC ehf|Candesartan og ţvagrćsilyf||10289||10289|15054|
588395|N03AX2101|Trobalt|filmhtfl|50|mg|84|stk|1|ţpakki||N03AX21|01.12.2011||R|||0|0|E|0|GGL|0|0|0|100|GBP|4863|7631|lyfalmen||||84|0||GlaxoSmithKline ehf|Glaxo Group Limited|Retigabín||4863||4863|7631|
588574|J01FF0101|Dalacin|hylki|300|mg|20|stk|1|ţpakki||J01FF01|01.10.1995||R|||0|0|0|0|PER|0|0|1|100|DKK|2230|4029|lyfalmen|V0461|4028||20|0|5,0000|Icepharma hf|Pfizer ApS|Klindamýcín||2230||2230|4029|
588608|B01AC0501|Ticlid|töflur|250|mg|100|stk|1|ţpakki||B01AC05|01.04.1995||R|||0|0|E|0|SNO|0|0|0|100|NOK|9907|14531|lyfalmen||||100|0|50,0000|Vistor hf|Sanofi-aventis Norge AS|Tíklópídín||9907||9907|14531|
588772|H05BA0103|Miacalcic Nasal|nefúđi|200|ae/sk|2|ml|1|úđagl|14 skammt|H05BA01|01.03.2002||R|||0|0|E|0|NOH|0|0|0|100|DKK|8946|13217|lyfalmen||||2|0|14,0000|Vistor hf|Novartis Healthcare A/S-|Samtengt laxakalsítónín||8946||8946|13217|
589358|QP54AA0501|Stronghold vet.|bl.lausn|120|mg|1|ml|3|túpa||QP54AA05|01.04.2004||R|||0|0|0|0|PFA|1|0|0|100|XEU|6190|10798|vetorma||||3|0||Icepharma hf|Pfizer Animal Health|||6190||6190|10798|
589366|QP54AA0501|Stronghold vet.|bl.lausn|15|mg|0,25|ml|3|túpa||QP54AA05|01.04.2004||R|||0|0|0|0|PFA|1|0|0|100|XEU|2399|4185|vetorma||||1|0||Icepharma hf|Pfizer Animal Health|||2399||2399|4185|
589374|QP54AA0501|Stronghold vet.|bl.lausn|240|mg|2|ml|3|túpa||QP54AA05|01.04.2004||R|||0|0|0|0|PFA|1|0|0|100|XEU|5972|10418|vetorma||||6|0||Icepharma hf|Pfizer Animal Health|||5972||5972|10418|
589382|QP54AA0501|Stronghold vet.|bl.lausn|30|mg|0,25|ml|3|túpa||QP54AA05|01.04.2004||R|||0|0|0|0|PFA|1|0|0|100|XEU|3225|5626|vetorma||||1|0||Icepharma hf|Pfizer Animal Health|||3225||3225|5626|
589390|QP54AA0501|Stronghold vet.|bl.lausn|60|mg|0,5|ml|3|túpa||QP54AA05|01.04.2004||R|||0|0|0|0|PFA|1|0|0|100|XEU|3350|5844|vetorma||||2|0||Icepharma hf|Pfizer Animal Health|||3350||3350|5844|
589408|QP54AA0501|Stronghold vet.|bl.lausn|45|mg|0,75|ml|3|túpa||QP54AA05|01.04.2004||R|||0|0|0|0|PFA|1|0|0|100|DKK|3237|5647|vetorma||||2|0||Icepharma hf|Pfizer Animal Health|||3237||3237|5647|
590497|D01AC0101|Canesten|krem|10|mg/g|20|g|1|túpa||D01AC01|01.12.1982||L|||0|0|0|0|BAE|0|0|1|100|IKR|||lyflausa||||20|0||Icepharma hf|Bayer AB|Klótrímazól||||||
590562|C01DA1403|Ismo|forđatfl|60|mg|98|stk|1|glas||C01DA14|01.10.1999||R|||0|0|B|0|ACA|0|0|0|100|XEU|2064|3802|lyfalmen|V0041|3630||98|0|147,0000|Actavis Group hf|Actavis hf|Ísósorbíđ mónónítrat||2064||2064|3802|
590752|N05AF0102|Fluanxol Depot|stl|100|mg/ml|1|ml|10|lykjur||N05AF01|01.03.1979||R|||0|0|*|0|LBK|0|1|0|100|DKK|23368|31872|lyfalmen||||10|0|250,0000|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||23368||23368|31872|
590919|B01AD1101|Metalyse|sts/irs|10000|ein|1|stk|1|hgl|+ leysir áfyllt sprauta|B01AD11|01.07.2001||R|||0|0|0|1|BOI|0|0|0|100|DKK|183510|232188|lyfsjukr||||1|0|0,7500|Vistor hf|Boehringer Ingelheim|Tenekteplasi||183510||183510|232188|
592378|D08AC0201|Hibiscrub|lyf.sápa|40|mg/ml|500|ml|1|glas||D08AC02|01.10.1976||L|||0|0|0|0|REM|0|0|0|100|IKR|||lyflausa||||500|0||Vistor hf|Regent Medical Overseas Limited|Klórhexidín||||||
592977|L01XE1201|Caprelsa|filmhtfl|300|mg|30|stk|1|ţpakki||L01XE12|01.07.2012||R|||0|1|0|1|AZA|0|0|0|100|SEK|801563|1007844|lyfsjukr||||30|0||Vistor hf|AstraZeneca AB|Vandetaníb||801563||801563|1007844|
593384|N03AE0101|Rivotril|töflur|0,5|mg|50|stk|1|glas||N03AE01|01.01.1978||R|||0|0|E|0|ROC|0|0|0|100|DKK|527|1700|lyfalmen|V0238|752||50|0|3,1250|Icepharma hf|Roche|Klónazepam||527||527|1700|
593392|N03AE0101|Rivotril|töflur|0,5|mg|150|stk|1|glas||N03AE01|01.01.1978||R|||0|0|E|0|ROC|0|0|0|100|DKK|934|2257|lyfalmen|V0238|2257||150|0|9,3750|Icepharma hf|Roche|Klónazepam||934||934|2257|
593434|N03AE0101|Rivotril|töflur|2|mg|100|stk|1|glas||N03AE01|01.01.1978||R|||0|0|E|0|ROC|0|0|0|100|DKK|1377|2863|lyfalmen||||100|0|25,0000|Icepharma hf|Roche|Klónazepam||1377||1377|2863|
593654|N07BA0146|Nicotinell Tropical Fruit|tyggigúm|4|mg|204|stk|1|ţpakki||N07BA01|01.11.2011||L|||0|0|0|0|NOS|0|0|1|100|IKR|||lyflausa||||204|0|27,2000|Artasan ehf|Novartis Healthcare A/S|Nikótín||||||
594325|H02AB0802|Lederspan|stl|20|mg/ml|1|ml|12|hgl|dreifa|H02AB08|01.12.2003||R|||0|0|B|0|MAB|0|0|1|100|SEK|20975|28869|lyfalmen||||12|0|32,0000|Vistor hf|Meda AB|Tríamcínólón||20975||20975|28869|
594408|C10AA0504|Atorvastatin Portfarma|filmhtfl|40|mg|100|stk|1|ţpakki||C10AA05|01.06.2006||R|||0|0|0|0|POF|0|0|0|100|IKR|7867|6047|lyfalmen|V0114|6047||100|0|200,0000|Portfarma ehf|Portfarma|Atorvastatín||3705||3705|6047|
594713|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|10|g|1|spr||QP52AF02|01.07.1995||L|||0|0|0|0|PAL|0|0|0|100|DKK|345|602|vetorma||||10|0||Icepharma hf|Pfizer Oy Animal Health|||||345|602|
594721|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|10|g|10|spr||QP52AF02|01.07.1995||L|||0|0|0|0|PAL|0|0|0|100|DKK|2865|4998|vetorma||||100|0||Icepharma hf|Pfizer Oy Animal Health|||||2865|4998|
595066|H05BA0102|Miacalcic|stl|100|ae/ml|1|ml|5|lykjur||H05BA01|01.03.1979||R|||0|0|0|1|NOH|0|0|0|100|DKK|6082|8778|lyfsjukr||||5|0|5,0000|Vistor hf|Novartis Healthcare A/S-|Samtengt laxakalsítónín||6082||6082|8778|
595991|J07BB0201|Fluarix|bóluefni|||0,5|ml|1|spr|einnotaspr|J07BB02|01.10.1994||R|||0|0|0|0|GSK|0|0|0|100|GBP|652|1871|lyfalmen||||0|0||GlaxoSmithKline ehf|GlaxoSmithKline ehf|Inflúensa, hreinsađir  mótefnavakar||652||652|1871|
596023|D08AC0201|Hibiscrub|lyf.sápa|40|mg/ml|250|ml|1|glas||D08AC02|01.06.1982||L|||0|0|0|0|REM|0|0|0|100|IKR|||lyflausa||||250|0||Vistor hf|Regent Medical Overseas Limited|Klórhexidín||||||
596085|B03XA0201|Aranesp|stl|50|mcg/spr|0,5|ml|4|áf.spr|nálavörn|B03XA02|01.11.2010||R|||0|1|0|1|AMG|0|0|0|100|DKK|66156|84908|lyfsjukr||||2|0|44,4400|Vistor hf|Amgen|Darbepóetín alfa||||66156|84908|
596881|N05CM1801|Dexdor|irţ|100|mcg/ml|2|ml|5|lykjur|lausn|N05CM18|01.03.2012||R|||0|1|0|1|ORC|0|0|0|100|DKK|19769|26693|lyfsjukr||||10|0||Vistor hf|Orion Corporation|Dexmedetómid||19769||19769|26693|
597401|J01FF0101|Dalacin|hylki|150|mg|24|stk|1|ţpakki||J01FF01|01.06.1979||R|||0|0|0|0|PER|0|0|1|100|DKK|2383|4239|lyfalmen||||24|0|3,0000|Icepharma hf|Pfizer ApS|Klindamýcín||2383||2383|4239|
597433|L01XC1101|Yervoy|stţ|5|mg/ml|10|ml|1|hgl|lausn|L01XC11|01.05.2012||R|||0|1|0|1|BMS|0|0|0|100|DKK|696671|876205|lyfsjukr||||10|0||Vistor hf|Bristol-Myers Squibb Pharma EEIG|Ipilimumab||696671||696671|876205|
597567|D01AC0301|Pevaryl|krem|10|mg/g|30|g|1|túpa||D01AC03|01.05.1978||L|||0|0|0|0|MCS|0|0|1|100|IKR|||lyflausa||||30|0||Vistor hf|McNeil Sweden AB|Ekónazól||||||
598094|R06AD0101|Vallergan|mixtúra|5|mg/ml|150|ml|1|glas||R06AD01|01.03.2004||R|||0|0|0|0|SNO|0|0|1|100|NOK|468|1619|lyfalmen||||150|0|25,0000|Vistor hf|Sanofi-aventis Norge AS|Alímemazín||468||468|1619|
692098|N06BA0104|Amfetamin Glostrup|töflur|5|mg|100|stk|1|glas||N06BA01|01.07.2011||R|||1|0|0|0|PCO|0|0|0|100|DKK|4196|6719|lyfalmen||||100|1|33,3300|Distica|Distica - óskráđ lyf|Amfetamín||||4196|6719|
916827|A03FA0301|Motilium|töflur|10|mg|100|stk|1|glas||A03FA03|01.05.1998||R|||0|0|0|0|PCO|0|0|1|100|SEK|2789|4794|lyfalmen||||100|1|33,3333|Distica|Distica - óskráđ lyf|Dómíperídón||2789||2789|4794|
923351|S01XA2006|Lacri - Lube|augnsm|||3,5|g|1|túpa||S01XA20|01.01.1998||R|||0|0|E|0|PCO|0|0|0|100|IKR|480|1636|lyfalmen||||4|1||Distica|Distica - óskráđ lyf|Gervitár og ađrar óvirkar samsetningar||480||480|1636|
938483|M04AC0101|Colchicine|töflur|0,5|mg|100|stk|1|glas||M04AC01|01.01.1998||R|||0|0|E|0|LDR|0|0|0|100|GBP|6501|9872|lyfalmen||||100|1|50,0000|Parlogis hf|Parlogis - óskráđ lyf|Kolkisín||6501||6501|9872|
938780|C09AA0104|Captopril|hylki|1|mg|100|stk|1|glas||C09AA01|01.01.2000||R|||0|0|0|0|LDR|0|0|0|100|GBP|18678|25986|lyfalmen||||100|1|2,0000|Parlogis hf|Parlogis - óskráđ lyf|Kaptópríl||18678||18678|25986|
940313|G03BA0302|Testosteron|vefjatfl|100|mg|1|stk|1|pakki||G03BA03|01.04.1998||R|||0|0|E|0|PCO|0|0|0|100|GBP|3048|5148|lyfalmen||||1|1|33,3300|Distica|Distica - óskráđ lyf|Testósterón||3048||3048|5148|
944505|H02AB1005|Cortisonacetat|töflur|5|mg|100|stk|1|glas||H02AB10|01.12.2002||R|||0|0|E|0|PCO|0|0|1|100|DKK|5514|8522|lyfalmen||||100|1|13,3300|Distica|Distica - óskráđ lyf|Kortisón||5514||5514|8522|
944852|A06AX0102|Glycerol infant|eţ-stíll|||12|stk|1|pakki||A06AX01|01.10.1998||R|||0|0|0|0|LDR|0|0|0|100|IKR|342|1447|lyfalmen||||12|1||Parlogis hf|Parlogis - óskráđ lyf|Glýceról||342||342|1447|
944985|A06AX0103|Glycerol adult|eţ-stíll|||12|stk|1|pakki||A06AX01|01.10.1998||R|||0|0|0|0|LDR|0|0|0|100|IKR|664|1887|lyfalmen||||12|1||Parlogis hf|Parlogis - óskráđ lyf|Glýceról||664||664|1887|
945850|R06AD0202|Atosil|stl|25|mg/ml|2|ml|5|lykjur||R06AD02|01.03.2001||R|||0|0|0|0|PCO|0|0|1|100|IKR|2293|4116|lyfalmen||||10|1|10,0000|Distica|Distica - óskráđ lyf|Prómetazín||2293||2293|4116|
947715|H02AB1004|Cortisone Acetat|töflur|25|mg|100|stk|1|glas||H02AB10|01.01.1998||R|||0|0|E|0|LDR|0|0|1|100|IKR|5033|7864|lyfalmen||||100|1|66,6667|Parlogis hf|Parlogis - óskráđ lyf|Kortisón||5033||5033|7864|
948242|H02AB0203|Dexamethason|töflur|0,5|mg|100|stk|1|pakki||H02AB02|01.04.2005||R|||0|0|E|0|LDR|0|0|1|100|IKR|1990|3701|lyfalmen||||100|1|33,3300|Parlogis hf|Parlogis - óskráđ lyf|Dexametasón||1990||1990|3701|
951592|H02AB0907|Hydrocortison|töflur|1|mg|100|stk|1|glas||H02AB09|01.08.2009||R|||0|0|E|0|PCO|0|0|1|100|DKK|5514|8522|lyfalmen||||100|1|3,3300|Distica|Distica - óskráđ lyf|Hýdrókortisón||5514||5514|8522|
954421|C03CA0109|Furosemid|mixtúra|10|mg/ml|60|ml|1|glas||C03CA01|01.08.2009||R|||0|0|E|0|LDR|0|0|0|100|IKR|1870|3537|lyfalmen||||60|1||Parlogis hf|Parlogis - óskráđ lyf|Fúrósemíđ||||1870|3537|
954504|C07AA0510|Syprol|mixtúra|2|mg/ml|150|ml|1|fl||C07AA05|01.08.2009||R|||0|0|0|0|LDR|0|0|0|100|IKR|5690|8763|lyfalmen||||150|1||Parlogis hf|Parlogis - óskráđ lyf|Própranólól||||5690|8763|
961393|A04AD0501|Vogalene|hylki|15|mg|20|stk|1|glas||A04AD05|01.01.1998||R|||0|0|E|0|LDR|0|0|1|100|IKR|1960|3660|lyfalmen||||20|1|20,0000|Parlogis hf|Parlogis - óskráđ lyf|Metópímazín||1960||1960|3660|
961591|H02AB0906|Hydrocortisone|töflur|10|mg|20|stk|1|glas||H02AB09|01.08.2009||R|||0|0|E|0|LDR|0|0|1|100|IKR|1850|3510|lyfalmen||||20|1|6,6700|Parlogis hf|Parlogis - óskráđ lyf|Hýdrókortisón||1850||1850|3510|
961658|H02AB0905|Hydrocortisone|töflur|20|mg|25|stk|1|glas||H02AB09|01.01.2009||R|||0|0|E|0|LDR|0|0|1|100|IKR|4320|6888|lyfalmen||||25|1|16,7000|Parlogis hf|Parlogis - óskráđ lyf|Hýdrókortisón||4320||4320|6888|
962466|H02AB0203|Dexamethason|töflur|4|mg|100|stk|1|glas||H02AB02|01.08.2009||R|||0|0|E|0|LDR|0|0|1|100|IKR|3451|5700|lyfalmen||||100|1|266,6600|Parlogis hf|Parlogis - óskráđ lyf|Dexametasón||||3451|5700|
962945|R06AB0201|Polaramin|töflur|2|mg|30|stk|1|ţpakki||R06AB02|01.11.2009||R|||0|0|E|0|LDR|0|0|0|100|IKR|2360|4207|lyfalmen||||30|1|10,0000|Parlogis hf|Parlogis - óskráđ lyf|Dexklórfeníramín||2360||2360|4207|
965767|A03AA0703|Dicykloverin Syrup|mixtúra|2|mg/ml|120|ml|1|glas||A03AA07|01.08.2011||R|||0|1|E|0|LDR|0|0|0|100|IKR|8480|12579|lyfalmen||||120|1|3,0000|Parlogis hf|Parlogis - óskráđ lyf|Dícýklóverín||8480||8480|12579|